Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.5113491408454857,-2.101024339213863,0.0,0.04263641956754134,0.036,50/87,24.46%,RPL37A;RPL19;RPL8;RPL37;RPS15;RPS29;RPL35A;RPS7;RPS20;RPL32;RPS27;RPL27;RPL26;RPS24;RPLP0;RPS19;RPL31;RPL41;RPL13A;RPL30;SEC61B;RPL29;RPS16;RPL3;RPLP1;RPS17;RPL23;RPL17;RPS3;RPL9;RPL38;RPL36;RPS26;RPS8;RPL18A;RPS12;RPS21;RPS18;RPS6;RPS15A;RPLP2;RPL14;RPS2;RPL10A;RPL34;RPL5;RPL39;RPL22;RPS9;RPS14
prerank,heart trabecula morphogenesis (GO:0061384),-0.7090461110094992,-2.0659440116081145,0.0,0.04488044165004352,0.07,8/18,2.94%,ENG;TEK;ADGRG6;TGFBR3;RBPJ;FKBP1A;RBP4;TGFBR1
prerank,cellular response to zinc ion (GO:0071294),-0.769742424484999,-2.0572692217169934,0.0,0.033660331237532634,0.079,11/15,16.03%,MT1E;MT1M;MT1G;MT1B;MT1F;MT1A;MT1X;MT1H;GLRA2;MT2A;P2RX4
prerank,protein targeting to ER (GO:0045047),-0.4830776529853935,-2.0499891107918153,0.0,0.029452789832841057,0.093,52/99,22.14%,RPL37A;RPL19;RPL8;RPL37;RPS15;RPS29;RPL35A;RPS7;RPS20;RPL32;RPS27;RPL27;RPL26;RPS24;RPLP0;RPS19;RPL31;RPL41;SGTA;RPL13A;RPL30;RPL29;RPS16;RPL3;RPLP1;RPS17;RPL23;RPL17;SEC62;RPS3;RPL9;RPL38;RPL36;RPS26;RPS8;ZFAND2A;RPL18A;RPS12;RPS21;SPCS1;RPS18;RPS6;RPS15A;SGTB;RPLP2;RPL14;RPS2;RPL10A;RPL34;RPL5;GET3;RPL39
prerank,cotranslational protein targeting to membrane (GO:0006613),-0.48374648605361176,-2.0311605801318335,0.0,0.03186511357153089,0.124,42/91,16.42%,RPL37A;RPL19;RPL8;RPL37;RPS15;RPS29;RPL35A;RPS7;RPS20;RPL32;RPS27;SSR1;RPL27;RPL26;RPS24;RPLP0;RPS19;RPL31;RPL41;RPL13A;RPL30;RPL29;RPS16;RPL3;RPLP1;RPS17;RPL23;RPL17;SEC62;RPS3;RPL9;RPL38;RPL36;RPS26;RPS8;RPL18A;RPS12;RPS21;RPS18;RPS6;RPS15A;RPLP2
prerank,negative regulation of smooth muscle cell migration (GO:0014912),-0.7624422750445954,-2.01001229521407,0.0,0.0357173514798263,0.157,6/14,2.66%,PRKG1;LRP1;SLIT2;TPM1;IGFBP3;IGFBP5
prerank,somite development (GO:0061053),0.9061454435844964,2.0024385699044656,0.0,0.39387830952863045,0.271,2/11,0.06%,PTCH1;MEOX2
prerank,blood vessel diameter maintenance (GO:0097746),-0.5996339961365997,-1.9975353507724527,0.0,0.04055268477664646,0.209,17/34,19.39%,ROCK2;ECE1;NOS3;GCLM;NPR1;ACE;BDKRB2;AGTR1;KLF2;EDNRA;EDN1;ACE2;NOS1;PER2;EDN3;GCLC;AGT
prerank,basement membrane organization (GO:0071711),0.8472256222102849,1.9927559656885698,0.0,0.24216919987765076,0.325,5/14,1.51%,NTNG2;NTNG1;PXDN;NID1;LAMB2
prerank,dopamine metabolic process (GO:0042417),-0.7082845139905691,-1.9823485301798072,0.0,0.04572194993098183,0.26,7/18,7.54%,SNCAIP;MOXD1;MAOA;COMT;ATP7A;GCH1;MAOB
prerank,smoothened signaling pathway (GO:0007224),0.7419428884043969,1.9808340264440627,0.0,0.20667617836510274,0.387,6/32,5.49%,PTCH1;PTCH2;GLI1;GLI2;STIL;HIPK1
prerank,dorsal/ventral pattern formation (GO:0009953),0.8082196654943395,1.975112198840042,0.0,0.17126168123643204,0.412,5/20,4.28%,PTCH1;FBXL15;GLI2;BMPR1B;NBL1
prerank,regulation of smoothened signaling pathway (GO:0008589),0.6823225432620551,1.9681892045662877,0.0,0.15849361641798002,0.452,10/50,7.26%,PTCH1;RORA;GPC3;PTCH2;GLI1;GLIS2;INTU;KIF7;IFT81;PDCL
prerank,regulation of cell morphogenesis (GO:0022604),0.7455160923085484,1.9676185725429731,0.0014814814814814814,0.13364850135919637,0.456,5/30,2.67%,NTNG2;NTNG1;EFNA5;FMNL2;CAPZB
prerank,negative regulation of cell activation (GO:0050866),-0.7413497376750102,-1.9588488728968585,0.0,0.05772123467769485,0.347,6/14,6.72%,PDGFRA;NOS3;THBD;LDLR;CD200;APOE
prerank,regulation of smooth muscle cell migration (GO:0014910),-0.6836964547630604,-1.9582153418219774,0.0,0.05262231783467602,0.351,7/20,4.83%,IGF1;PDGFRB;LRP1;SLIT2;IGFBP3;IGFBP5;ACE
prerank,regulation of SMAD protein signal transduction (GO:0060390),-0.6601816802634102,-1.9567275842457332,0.0,0.04855247778504708,0.355,9/21,9.62%,RBPMS;BMP6;DAB2;BMP4;TGFBR1;CCN3;JAK2;TGFB3;SLC2A10
prerank,angiogenesis involved in wound healing (GO:0060055),-0.7829350349735282,-1.9551205886498064,0.0,0.04544144717066906,0.36,7/11,9.06%,ADIPOR2;NDNF;PRCP;KDR;CD34;GATA2;MCAM
prerank,cellular response to copper ion (GO:0071280),-0.706198992371506,-1.9474900421382089,0.0,0.047901240607257985,0.399,8/16,3.81%,MT1E;MT1M;MT1G;MT1B;MT1F;MT1A;MT1X;MT1H
prerank,embryonic skeletal system morphogenesis (GO:0048704),-0.6026473954627345,-1.9458108103343186,0.0,0.045601734462276354,0.409,15/31,17.25%,OSR1;PDGFRA;HOXA3;TGFBR1;FGFR2;HOXB4;DSCAML1;HOXB9;TBX1;HOXC4;HOXA9;FUZ;MEGF8;HOXD4;HOXD3
prerank,positive regulation of embryonic development (GO:0040019),-0.6631417546503054,-1.943248511002711,0.0026041666666666665,0.044581238705709895,0.423,5/19,6.43%,PLCB1;OSR1;WNT4;CFL1;ZBED3
prerank,cell-substrate junction assembly (GO:0007044),0.7117646472477976,1.9427429792064768,0.0028368794326241137,0.18280476566639786,0.605,8/33,5.38%,ITGB4;ITGA6;DLC1;SORBS1;LAMC1;PEAK1;SRC;FN1
prerank,hemidesmosome assembly (GO:0031581),0.880056416639288,1.9287951729084745,0.0,0.20695101370867336,0.684,3/11,1.50%,ITGB4;ITGA6;LAMC1
prerank,cellular response to sterol (GO:0036315),0.8696652965486283,1.9214534980856472,0.0,0.2059432841155811,0.721,4/13,4.11%,PTCH1;RORA;GPLD1;GRAMD1B
prerank,regulation of glucose import (GO:0046324),-0.5949340505598902,-1.9153360521234482,0.0,0.0630429953802955,0.556,10/30,2.90%,PRKAG2;IGF1;OSBPL8;INSR;PID1;ENPP1;GRB10;PIK3R1;CREBL2;APPL2
prerank,response to zinc ion (GO:0010043),-0.6290970307031042,-1.913126341540511,0.005747126436781609,0.060654596877044095,0.566,13/25,17.30%,MT1E;MT1M;MT1G;MT1B;MT1F;MT1A;MT1X;MT1H;GLRA2;MT2A;P2RX4;SLC30A4;D2HGDH
prerank,regulation of neuroinflammatory response (GO:0150077),-0.6439314902262163,-1.9117975383321875,0.0028169014084507044,0.05809523835811188,0.567,7/19,7.25%,IGF1;NUPR1;IL18;TNFRSF1B;IL33;CD200;DAGLA
prerank,negative regulation of smoothened signaling pathway (GO:0045879),0.757129612243909,1.893126131069881,0.0015503875968992248,0.29163956172036154,0.858,6/23,5.68%,PTCH1;GPC3;PTCH2;GPR161;GLIS2;KIF7
prerank,regulation of Golgi organization (GO:1903358),-0.6690701808790329,-1.8920412051098208,0.0,0.07074574881151598,0.662,7/17,7.76%,PDE4DIP;MYO5A;STX18;USP6NL;PDCD10;RBSN;MAP2K2
prerank,erythrocyte differentiation (GO:0030218),-0.5279020737662113,-1.884326260554177,0.0,0.07539914197207312,0.705,22/44,29.59%,TGFBR3;LYN;MFHAS1;KIT;CEBPG;UBA5;RPS19;CASP3;JAK2;SLC25A38;TAL1;ID2;CDK5RAP3;ABCB10;ALAS1;NCKAP1L;INHBA;RPS14;JAK3;ALAS2;KMT2E;UFL1
prerank,smooth muscle contraction (GO:0006939),-0.7104701383718642,-1.8826240744432365,0.0,0.0735718668477499,0.712,8/14,12.63%,ROCK2;MYLK;SLC8A1;BDKRB2;MYH11;PIK3C2A;ACTA2;EDNRA
prerank,cellular zinc ion homeostasis (GO:0006882),-0.6045297878371692,-1.8824316542718982,0.002898550724637681,0.07027869158381815,0.712,11/26,3.81%,SLC30A10;SLC39A10;SLC39A8;MT1E;MT1M;MT1G;MT1B;MT1F;MT1A;MT1X;MT1H
prerank,positive regulation of cholesterol transport (GO:0032376),0.7160750228808187,1.8719093431476854,0.004431314623338257,0.36672314986778315,0.916,2/27,0.25%,PTCH1;CAV1
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),-0.7118129698185697,-1.8618681988644856,0.0,0.08844373990383575,0.8,7/13,8.28%,RBPMS;BMP6;DAB2;BMP4;TGFBR1;JAK2;TGFB3
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),0.7455334360667791,1.8569924344266122,0.006482982171799027,0.41453022248836524,0.953,3/19,4.75%,THBS4;RIPOR2;RAC2
prerank,extracellular matrix assembly (GO:0085029),0.7470860251520675,1.856139664578059,0.0015503875968992248,0.38822455388946353,0.954,5/23,1.51%,NTNG2;NTNG1;TNXB;PXDN;LAMB2
prerank,positive regulation of cholesterol efflux (GO:0010875),0.7510364100814834,1.8542607529474264,0.004724409448818898,0.3704556075949388,0.96,2/21,0.25%,PTCH1;CAV1
prerank,regulation of cholesterol efflux (GO:0010874),0.7108635916111266,1.8537107894848492,0.004451038575667656,0.34896236195080416,0.961,2/30,0.25%,PTCH1;CAV1
prerank,zinc ion homeostasis (GO:0055069),-0.5848247276931323,-1.8465636227981317,0.0060790273556231,0.10247700843426603,0.858,11/28,3.81%,SLC30A10;SLC39A10;SLC39A8;MT1E;MT1M;MT1G;MT1B;MT1F;MT1A;MT1X;MT1H
prerank,embryonic axis specification (GO:0000578),0.8009611869017098,1.8445144797565725,0.0,0.37102771382033073,0.975,3/15,3.55%,PTCH1;COBL;STIL
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.7814348587118617,1.8432068946280875,0.010221465076660987,0.35502259675357134,0.976,5/16,7.92%,RORA;FOXK1;PDK4;BCKDK;FOXK2
prerank,regulation of cell projection organization (GO:0031344),0.82504804138323,1.841000799224993,0.0,0.34446029727517125,0.977,2/13,0.09%,NTNG2;NTNG1
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.7394990910199644,1.836236656240899,0.001594896331738437,0.3478051605041911,0.98,6/20,4.80%,SMOC2;SULF1;SPRY1;CREB3L1;SPRY4;APLN
prerank,embryonic appendage morphogenesis (GO:0035113),0.8389969633530423,1.8332383772230876,0.0,0.34417237453428773,0.983,1/12,0.01%,PTCH1
prerank,regulation of neuron projection arborization (GO:0150011),0.7871231302607761,1.833049775545538,0.003355704697986577,0.328770377525208,0.983,3/15,4.77%,NTNG2;NTNG1;WNT5A
prerank,regulation of histone modification (GO:0031056),-0.7144339038927247,-1.829882992801921,0.0,0.11718283314826361,0.902,8/13,16.92%,SETD5;IGF2;PARG;UBE2N;CDK9;MTHFR;MYOCD;AKAP8L
prerank,transition metal ion transport (GO:0000041),-0.5328810436811158,-1.8225053754031746,0.0,0.12242866630882061,0.917,11/35,6.49%,SLC30A10;TRPC3;FTH1;TFRC;SLC39A8;ATP7A;TRPC1;SLC31A1;SLC31A2;SLC11A2;ATP2C1
prerank,metanephros development (GO:0001656),0.7262868812811683,1.82233129576814,0.001519756838905775,0.36256849610263775,0.993,3/26,3.16%,PTCH1;FOXD1;NF1
prerank,regulation of glucose metabolic process (GO:0010906),0.6686827505266845,1.8151275364601818,0.004629629629629629,0.37859678160537485,0.995,9/34,9.47%,RORA;OGT;GPLD1;FOXK1;PDK4;BCKDK;SELENOS;FOXK2;SIRT7
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),0.7528309273937133,1.8148707017929577,0.009950248756218905,0.364196092423004,0.995,3/17,4.75%,THBS4;RIPOR2;RAC2
prerank,cellular response to amyloid-beta (GO:1904646),-0.5280017160439274,-1.8138470374837803,0.0,0.12936371745980135,0.928,8/35,9.29%,IGF1R;IGF1;LRP1;GJA1;EPHA4;VCAM1;LGMN;GRIN1
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.8022008718491794,1.8138002829872535,0.006482982171799027,0.3540004864203729,0.995,3/16,1.42%,CLDN1;CLDN11;CLDN19
prerank,cellular transition metal ion homeostasis (GO:0046916),-0.4421815790690102,-1.8099479303034107,0.005649717514124294,0.13071428630575174,0.936,23/91,8.27%,BMP6;SLC30A10;ABCG2;SLC39A10;FTH1;TFRC;SLC39A8;SCARA5;ATP7A;MT1E;MT1M;MT1G;MT1B;MT1F;MT1A;MT1X;MT1H;SLC31A1;FTL;SLC31A2;SLC11A2;NEDD8;SLC39A14
prerank,manganese ion transport (GO:0006828),-0.7088704439589206,-1.8091440149846283,0.00267379679144385,0.12767711848719274,0.937,8/14,13.92%,SLC30A10;TRPC3;SLC39A8;TRPC1;SLC11A2;ATP2C1;SLC39A14;TRPC7
prerank,cytoplasmic translation (GO:0002181),-0.43926737237708835,-1.808497157292498,0.0,0.12409442116237032,0.938,36/91,12.66%,RPL37A;RPL19;RPL8;RPL37;RPS15;RPS29;RPL35A;RPS7;RPS20;RPL32;RPS27;RPL27;RPL26;RPS24;RPLP0;RPS19;RPL31;RPL41;RPL13A;RPL30;RPL29;RPS16;RPL3;RPLP1;RPS17;RPL23;RPL17;RPS3;RPL9;RPL38;RPL36;RPS26;RPS8;RPL18A;RPS12;RPS21
prerank,positive regulation of neutrophil migration (GO:1902624),0.7379323333967989,1.8055777364632837,0.009836065573770493,0.37666334844783367,0.997,3/18,4.75%,THBS4;RIPOR2;RAC2
prerank,synaptic membrane adhesion (GO:0099560),0.794048248340354,1.8036426805385497,0.0016666666666666668,0.37168208368597505,0.998,3/14,2.26%,NTNG1;PTPRF;GPC6
prerank,inositol phosphate-mediated signaling (GO:0048016),0.7524293739721021,1.8010547060608013,0.0032626427406199023,0.3688402488408911,0.998,4/19,1.45%,HRH1;NFATC2;PLCE1;NFATC1
prerank,actin filament-based transport (GO:0099515),-0.6162427074990593,-1.7957253216880091,0.0,0.13703012265085868,0.957,5/21,2.67%,MYO1D;SYNE2;MYO1B;MYO5A;MYO6
prerank,skin development (GO:0043588),0.609504740577929,1.793177584555705,0.0025031289111389237,0.3900766462540182,0.999,12/65,6.61%,ITGB4;CLDN1;ITGA6;WNT10A;JAG1;COL5A3;WNT16;ALOXE3;LSR;WNT5A;COL3A1;TMEM79
prerank,regulation of wound healing (GO:0061041),0.645846084175362,1.7918363550565213,0.005333333333333333,0.38275925677160216,1.0,11/42,10.61%,CLDN1;CAV1;PRKCE;CLDN19;AJAP1;CASK;TNFAIP3;EPHB2;KANK1;OCLN;ADRA2A
prerank,response to cholesterol (GO:0070723),0.7654008634342626,1.7903831204825564,0.009316770186335404,0.37612673268307406,1.0,3/17,4.11%,PTCH1;GPLD1;GRAMD1B
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.6323646050834131,1.7903097529949432,0.005312084993359893,0.36466723872626794,1.0,14/46,10.19%,NTNG2;NTNG1;PARVA;PXN;LAMC1;LAMB2;PEAK1;FN1;FER;LAMA5;ITGB7;SRCIN1;NTN4;FERMT2
prerank,limb morphogenesis (GO:0035108),0.7384902930013718,1.7894222812011984,0.0015151515151515152,0.35750010405237453,1.0,3/20,4.13%,PTCH1;PCSK5;BMPR1B
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.739835342872794,1.7794184574065324,0.00782472613458529,0.3902199970562283,1.0,4/18,5.41%,CAV1;NEDD4L;CAMK2D;ATP1A2
prerank,digestive tract development (GO:0048565),0.6788485757841193,1.7780516390672014,0.0014184397163120568,0.3850476816731697,1.0,10/32,7.70%,STRA6;PKDCC;GLI1;RARB;COBL;PCSK5;GLI2;CHD8;CCDC39;CLMP
prerank,copper ion transport (GO:0006825),-0.7226353258197169,-1.7775600060397536,0.002403846153846154,0.16293704089668143,0.976,5/11,6.35%,STEAP3;ATP7A;SLC31A1;SLC31A2;SLC11A2
prerank,muscle tissue development (GO:0060537),0.7740812732826904,1.7758049973226364,0.006644518272425249,0.3841412859278429,1.0,4/13,4.42%,PTCH1;STRA6;NF1;CSRP3
prerank,embryonic digestive tract development (GO:0048566),0.7322162229877301,1.7704274393953605,0.01088646967340591,0.39797855573541374,1.0,5/18,2.75%,STRA6;PKDCC;RARB;PCSK5;GLI2
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.5878610915506312,1.7702807197657273,0.0012626262626262627,0.38807577084632755,1.0,18/70,10.82%,NTNG2;NTNG1;PARVA;PXN;LAMC1;LAMB2;SPI1;OPHN1;PEAK1;FN1;FER;POF1B;LAMA5;ITGB7;SRCIN1;NTN4;FERMT2;RELN
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.711894192462044,1.7658000361278625,0.006359300476947536,0.39622196037050733,1.0,6/21,9.36%,CNKSR3;CAV1;PDE4D;NCK2;RASSF2;NLRP2B
prerank,response to interleukin-6 (GO:0070741),-0.7213097267914366,-1.761675224066218,0.0,0.18669583719726435,0.982,3/10,1.02%,ST3GAL6;PTGIS;PID1
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),-0.5754539278449996,-1.7612979594626657,0.009036144578313253,0.18166678770844819,0.982,7/25,10.41%,ANK2;ACTN2;DMD;SLC6A9;ATP1B1;ANK3;ATP1B2
prerank,regulation of melanin biosynthetic process (GO:0048021),-0.725361460134458,-1.7543884163647596,0.009259259259259259,0.18907488917996904,0.988,4/10,10.07%,RAPGEF2;ZEB2;ATP7A;CTNS
prerank,external encapsulating structure organization (GO:0045229),0.5174156568704865,1.7475059312172339,0.0,0.4706751569606481,1.0,38/205,7.49%,ITGB4;TGFBI;DCN;VIT;ITGA6;ADAMTS14;SMOC2;F11R;LAMA2;ECM2;PXDN;MMP28;LAMA4;NID1;ADAMTS12;LAMC1;LAMB2;ADAMTSL5;COL6A3;ADAMTS1;MFAP5;ADAM19;COL5A3;NF1;MMP15;ITGAX;SH3PXD2A;ITGA7;ADAMTS19;IBSP;FN1;COL3A1;NCAN;LAMA5;COL4A1;DAG1;ADAMTS2;ITGB7
prerank,beta-catenin destruction complex disassembly (GO:1904886),0.7054433259252286,1.7473750605550156,0.012364760432766615,0.4596089645205714,1.0,7/21,11.39%,CAV1;FZD2;AXIN1;GSK3B;CSNK1A1;DVL3;APC
prerank,neural tube development (GO:0021915),0.7780648944017828,1.745305172376191,0.008264462809917356,0.45878432168779704,1.0,3/15,4.94%,PTCH1;STIL;DACT1
prerank,pharyngeal system development (GO:0060037),0.748867034186242,1.7450054071696097,0.015126050420168067,0.44975845247388513,1.0,3/15,4.50%,PTCH1;FOLR1;BMP5
prerank,camera-type eye development (GO:0043010),0.67736042467082,1.7449410599439596,0.0106544901065449,0.4397936583558045,1.0,5/25,6.20%,ALDH1A3;STRA6;EFEMP1;NF1;SHROOM2
prerank,integrin-mediated signaling pathway (GO:0007229),0.5745374741757796,1.7433108099022137,0.005037783375314861,0.43718188975750916,1.0,20/73,10.75%,ITGB4;TEC;ITGBL1;CEACAM1;ADAMTS1;DOCK1;CDH17;TXK;PLPP3;SRC;FN1;COL3A1;ADAM10;LAMA5;ITGB7;CUL3;PLEK;FERMT2;LAT;ZYX
prerank,toll-like receptor 4 signaling pathway (GO:0034142),0.7263091168915883,1.7419647672500742,0.014218009478672985,0.4337208990872526,1.0,4/19,2.55%,LBP;PRKCE;PIK3AP1;TNIP3
prerank,regulation of water loss via skin (GO:0033561),0.7603079362458638,1.7414935718949507,0.015280135823429542,0.418083450858814,1.0,5/15,9.45%,CLDN1;ALOXE3;LSR;TMEM79;SFN
prerank,establishment of skin barrier (GO:0061436),0.7603079362458638,1.7414935718949507,0.015280135823429542,0.418083450858814,1.0,5/15,9.45%,CLDN1;ALOXE3;LSR;TMEM79;SFN
prerank,melanocyte differentiation (GO:0030318),-0.7196608152862977,-1.7355082920544433,0.0047169811320754715,0.22315552931549415,0.995,4/11,4.22%,ENPP1;LRMDA;KIT;MITF
prerank,extracellular structure organization (GO:0043062),0.5131140120200751,1.732137028956893,0.0,0.45049278776573076,1.0,38/204,7.49%,ITGB4;TGFBI;DCN;VIT;ITGA6;ADAMTS14;SMOC2;F11R;LAMA2;ECM2;PXDN;MMP28;LAMA4;NID1;ADAMTS12;LAMC1;LAMB2;ADAMTSL5;COL6A3;ADAMTS1;MFAP5;ADAM19;COL5A3;NF1;MMP15;ITGAX;SH3PXD2A;ITGA7;ADAMTS19;IBSP;FN1;COL3A1;NCAN;LAMA5;COL4A1;DAG1;ADAMTS2;ITGB7
prerank,regulation of neutrophil chemotaxis (GO:0090022),0.6713027816398222,1.731870237732094,0.0208,0.4426136831382495,1.0,5/23,8.22%,THBS4;RIPOR2;MPP1;RAC2;DPP4
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),-0.7010448511496183,-1.7300777173807826,0.0,0.22989096496552694,0.997,4/11,15.93%,RAPGEF2;LYN;ANXA1;LGALS9
prerank,actin cytoskeleton reorganization (GO:0031532),0.5818465085315808,1.724097340871868,0.005161290322580645,0.469520386609511,1.0,10/63,4.06%,GAB1;FGF7;CXADR;SIPA1L1;PARVA;CLDN19;PDLIM4;MINK1;TRPV4;THSD7A
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.7731936238415728,1.7210099712586402,0.022146507666098807,0.47364700287354355,1.0,3/12,4.86%,DCN;ADAMTS12;ATP2B4
prerank,muscle tissue morphogenesis (GO:0060415),-0.6206010037574781,-1.7194502193327337,0.019337016574585635,0.24967698328471577,0.998,6/16,10.45%,MYLK;TGFBR3;BMP4;TBX1;PROX1;BMP2
prerank,ventricular septum morphogenesis (GO:0060412),-0.5481951250869377,-1.7176969009630614,0.005988023952095809,0.24738904983892576,0.999,9/27,13.01%,ROBO1;TGFBR3;SLIT2;BMP4;TGFBR1;BMPR2;CITED2;PROX1;TGFB2
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.674963989181912,1.7168807438758649,0.013574660633484163,0.48424950422638385,1.0,6/27,9.14%,NTNG2;NTNG1;BRSK1;ULK4;FRMD7;GSK3B
prerank,embryonic organ development (GO:0048568),0.5921567741502491,1.716234828761875,0.0013175230566534915,0.4784577958960446,1.0,12/61,6.70%,ALDH1A3;STRA6;PKDCC;RARB;COBL;PBX1;PCSK5;GLI2;KMT2A;STIL;TEAD3;TBX2
prerank,mesoderm formation (GO:0001707),0.7408604493607728,1.7155533535770082,0.016420361247947456,0.4728424299556621,1.0,1/17,0.03%,ITGB4
prerank,regulation of small molecule metabolic process (GO:0062012),0.6479095750372149,1.7143187164712523,0.019877675840978593,0.46991795754468824,1.0,6/28,10.46%,RORA;FOXK1;PDK4;BCKDK;FOXK2;NCOR2
prerank,negative regulation of locomotion (GO:0040013),-0.6941352659564892,-1.7140033351984676,0.007317073170731708,0.2500962610948675,1.0,6/12,13.70%,FBLN1;FRMD5;DUSP3;CCDC125;CRK;SPOCK3
prerank,limb development (GO:0060173),0.6528544675426058,1.7107565782294958,0.0072254335260115606,0.47787460310350544,1.0,8/28,10.68%,PTCH1;LRP4;PCSK5;BMPR1B;INTU;ZNRF3;KREMEN1;LNPK
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),-0.46109100364318223,-1.7107304906258392,0.007782101167315175,0.25143993773207307,1.0,8/49,7.53%,IGF1;IL31RA;GHR;IL6R;LYN;KIT;IL18;JAK2
prerank,regulation of tissue remodeling (GO:0034103),0.7148746461926663,1.710474647631329,0.018581081081081082,0.4708701140516539,1.0,3/18,1.56%,THBS4;CEACAM1;LEPR
prerank,regulation of multicellular organism growth (GO:0040014),0.7317865202503508,1.7102009161400222,0.030405405405405407,0.46410306530664475,1.0,1/15,0.01%,PTCH1
prerank,regulation of store-operated calcium entry (GO:2001256),0.8129057996439382,1.7093266478642408,0.014652014652014652,0.4600743651372101,1.0,3/10,1.83%,HOMER2;EFHB;SLC8B1
prerank,cellular response to superoxide (GO:0071451),-0.7008422843593083,-1.708939522334873,0.009280742459396751,0.24962074212976582,1.0,4/10,6.08%,NOS3;ATP7A;SOD3;PRDX2
prerank,response to amyloid-beta (GO:1904645),-0.47065838919517455,-1.7063363187583962,0.0,0.2501823689189635,1.0,9/44,9.54%,IGF1R;IGF1;LRP1;GJA1;EPHA4;VCAM1;LGMN;GRIN1;MMP2
prerank,chordate embryonic development (GO:0043009),0.5920780651281006,1.7052757718138243,0.01437908496732026,0.47089914454744575,1.0,10/55,6.29%,PTCH1;FGFR1;SULF1;KIAA1217;PCSK5;STIL;BMP5;WNT5A;DACT1;ADAM10
prerank,macrophage differentiation (GO:0030225),-0.6520244164280905,-1.703105786797734,0.011547344110854504,0.25232498302680717,1.0,6/13,19.52%,IL31RA;BMP4;CDC42;CSF1;CASP8;PARP1
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.7711236606338167,1.702762377139034,0.01839464882943144,0.4739123880121066,1.0,4/12,5.94%,DCN;CSPG4;UST;NCAN
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.6805144343040257,1.6994207205635465,0.0171606864274571,0.4808982838902,1.0,3/22,1.92%,NGF;NTRK3;RAP1A
prerank,positive regulation of vasoconstriction (GO:0045907),0.7675766174701256,1.6928819168696283,0.015517241379310345,0.5022419592793302,1.0,3/13,3.91%,CAV1;SMTNL1;SMTNL2
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),-0.5226410905503903,-1.6895503948925343,0.003076923076923077,0.28032822526191065,1.0,7/31,3.88%,ENG;TGFBR3;RBPJ;TPM1;FKBP1A;TGFBR1;FGFR2
prerank,regulation of neural precursor cell proliferation (GO:2000177),-0.5553673245359464,-1.6889261335538117,0.010752688172043012,0.27599032460339257,1.0,11/22,16.34%,KDM2B;APPL2;NES;GATA2;PROX1;SLC16A2;TOX;LRRK2;KDM1A;ID2;TAFA1
prerank,dermatan sulfate metabolic process (GO:0030205),0.7574772191020225,1.6881491505738837,0.025423728813559324,0.5161733930466108,1.0,4/13,5.94%,DCN;CSPG4;UST;NCAN
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.5910278724617206,1.6866279407828053,0.01084010840108401,0.5152484526815552,1.0,10/45,6.23%,GAB1;FAM83A;PLCE1;EFEMP1;EGFR;REPS2;SOX9;SRC;KIF16B;NCK2
prerank,response to copper ion (GO:0046688),-0.5629564276471382,-1.684434857047591,0.010256410256410256,0.2821022228609384,1.0,8/20,3.81%,MT1E;MT1M;MT1G;MT1B;MT1F;MT1A;MT1X;MT1H
prerank,response to alcohol (GO:0097305),-0.5387561183248183,-1.6838790175752307,0.006493506493506494,0.27760423178954,1.0,8/27,13.07%,TGFBR3;SLIT2;TGFBR1;GRIN3A;GRIN2B;GRIN1;PMVK;ABCA2
prerank,cellular response to alcohol (GO:0097306),0.6075989781363642,1.6832022598544993,0.016483516483516484,0.5230427169667131,1.0,6/42,7.51%,PTCH1;PTGFR;GPLD1;GRAMD1B;ADCY5;PTGER4
prerank,regulation of neuron projection development (GO:0010975),0.5037402350867851,1.6823028453810085,0.0,0.5191616544641902,1.0,29/163,10.96%,ROR2;NTNG2;NTNG1;ROR1;ITGA6;SIPA1L1;NTRK3;LPAR1;RAP1A;PPFIA2;RAB29;RTN4R;TRPV4;LZTS3;WNT5A;BRSK1;ULK4;ABL2;SEMA3A;EFNB2;SRCIN1;KANK1;CDH2;FRMD7;GSK3B;HDAC2;RTN4RL1;RELN;S100A9
prerank,negative regulation of protein localization to membrane (GO:1905476),-0.5515473479661742,-1.6811532953338504,0.009433962264150943,0.2789227855812143,1.0,4/24,1.68%,PICALM;NUMB;PID1;DAB2
prerank,regulation of axon guidance (GO:1902667),-0.6887908802935263,-1.6809119776594188,0.007228915662650603,0.27381557450691546,1.0,8/10,29.95%,ZSWIM6;YTHDF1;ZSWIM4;NRP1;TUBB2B;ZSWIM8;MYCBP2;ZSWIM5
prerank,actin filament organization (GO:0007015),-0.3826458753865344,-1.680663517094425,0.0,0.2689306464363392,1.0,39/151,11.30%,MYO1D;HIP1;RHOBTB1;EPS8;NEDD9;SVIL;MYO1B;ARHGEF2;RUFY3;MYO5A;TPM1;ELMO1;DSTN;CDC42;MYO6;SHROOM3;RHOBTB3;TRIOBP;TMOD3;PLS3;HIP1R;ERMN;ZBED3;RHOC;MARCKS;ARHGAP17;CAPG;NEBL;FLNA;ABI1;EVL;RHOB;PROX1;RHOH;BAIAP2L1;TPM3;LMOD1;AVIL;TPM2
prerank,smooth muscle tissue development (GO:0048745),0.7883868609130465,1.679827855533477,0.02292768959435626,0.5226446426728457,1.0,3/10,3.16%,PTCH1;STRA6;NF1
prerank,atrial septum development (GO:0003283),-0.6499817947217585,-1.6794438993481768,0.010025062656641603,0.26669339365122013,1.0,6/13,13.01%,NOTCH2;ANK2;NPHP3;BMPR2;DAND5;TGFB2
prerank,cardiac muscle tissue morphogenesis (GO:0055008),-0.5171139119403338,-1.6792843438249887,0.01238390092879257,0.2620001631419521,1.0,7/29,10.45%,ENG;TGFBR3;TPM1;FKBP1A;FGFR2;PROX1;BMP2
prerank,nerve growth factor signaling pathway (GO:0038180),0.7927849772227291,1.6790986766239504,0.02456140350877193,0.5187859251853687,1.0,2/10,1.92%,NGF;RAP1A
prerank,vasoconstriction (GO:0042310),-0.6861140369462069,-1.6777074902233853,0.009615384615384616,0.26103379094884105,1.0,7/11,24.36%,SLC8A1;PIK3C2A;ACTA2;EDNRA;EDN1;EDN3;HTR2B
prerank,positive regulation of wound healing (GO:0090303),0.626569719038583,1.6759933287687212,0.018309859154929577,0.5248835252897031,1.0,10/36,10.61%,CLDN1;SMOC2;ST3GAL4;PRKCE;PLPP3;RREB1;KANK1;OCLN;FERMT2;ADRA2A
prerank,glycosaminoglycan catabolic process (GO:0006027),0.5793097619967421,1.6738719547713257,0.004,0.5276315100663299,1.0,19/55,17.83%,DCN;GPC3;CSPG4;PRELP;GPC6;NCAN;SDC1;HEXA;HSPG2;GPC2;SDC3;CEMIP2;HEXB;HGSNAT;VCAN;CEMIP;CHP1;SDC4;GPC5
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.6832921427649361,1.671996421714073,0.023076923076923078,0.5286777847336999,1.0,2/21,1.25%,NGF;USP50
prerank,catecholamine metabolic process (GO:0006584),-0.6350628666571225,-1.669988172183283,0.026634382566585957,0.27505590671251673,1.0,3/14,3.39%,SNCAIP;COMT;ATP7A
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.6933649004391627,-1.6683938629470851,0.004405286343612335,0.2743717714087928,1.0,5/11,2.33%,IGF1R;PLCB1;IGF1;GHR;PIK3R1
prerank,peptide biosynthetic process (GO:0043043),-0.36634938890497126,-1.6635186253728917,0.0,0.2817625621836504,1.0,69/153,23.09%,DMD;RPL37A;RRBP1;RPL19;RPL8;RPL37;RPS15;RPS29;RPL35A;FARSB;RPS7;RPS20;RPL32;RPS27;EEF1A1;RPL27;RPL26;RPS24;RPLP0;HARS1;RPS19;HBS1L;RPL31;RPL41;RPL13A;RPL30;RPL29;RPS16;MRPS6;RPL3;RPLP1;RPS17;RPL23;RPL17;RPS3;RPL9;RPL38;RPL36;DHPS;FURIN;RPS26;RPS8;RPL18A;RPS12;RPS21;MRPL32;MRPL18;RPS18;RPS6;CARNS1;RPS15A;EIF4G1;RPLP2;MRPL28;MRPL9;GSPT2;MRPS11;MRPS16;MRPS18B;RPL14;RPS2;MRPL42;RPL10A;RPL34;RPL5;MRPS12;RPL39;RPL22;MRPL55
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.5292045802320482,1.6625845342537977,0.0024067388688327317,0.5645606081488866,1.0,21/93,16.09%,NGF;CNKSR3;CAV1;NTRK3;EGFR;RAPGEF3;AXIN1;PDE4D;ATP2B4;NCK2;IRGM;RASSF2;NLRP2B;DOCK7;HDAC6;PTEN;CAPRIN2;TXN;MTCP1;TNKS1BP1;TBK1
prerank,negative regulation of T cell activation (GO:0050868),0.628622997562725,1.66209613375389,0.011594202898550725,0.5592443800235534,1.0,6/35,4.25%,RIPOR2;CEACAM1;GLMN;ARG1;IL4I1;PTPN22
prerank,negative regulation of developmental growth (GO:0048640),0.6220970285262366,1.6593725415404363,0.023529411764705882,0.5641729009846786,1.0,3/30,4.35%,PTCH1;RTN4R;CDKL3
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),-0.5522364127676379,-1.6580478438265658,0.006535947712418301,0.29180025079709326,1.0,7/27,7.63%,FLT1;TEK;PDGFRB;PDGFRA;KIT;EPHA8;TNFAIP8L3
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.5051515696108457,1.6569466308991467,0.0,0.5676762263845805,1.0,18/159,4.59%,NTNG1;TENM2;CLDN1;CXADR;CDH13;CLDN11;CEACAM1;CDH11;CLDN19;PTPRF;MPZL2;GPC6;CDH5;CDH17;HMCN1;CDH9;DSCAM;TRO
prerank,GPI anchor metabolic process (GO:0006505),0.6559457206545755,1.6552605229864557,0.02245508982035928,0.568238683759606,1.0,5/26,9.38%,PIGU;GPLD1;PGAP3;PIGB;PIGA
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.5259513299011125,1.6552572534732817,0.001182033096926714,0.5610696445374977,1.0,16/100,5.38%,ROR2;GAB1;DCN;ROR1;NTRK3;FGFR1;HCST;PTPN13;CEACAM1;PIK3AP1;EGFR;WNT16;SOX9;SRC;PIP4K2B;FN1
prerank,acylglycerol homeostasis (GO:0055090),0.6713069346981425,1.654001255232427,0.027649769585253458,0.5599456027715778,1.0,1/20,0.03%,RORA
prerank,iron ion homeostasis (GO:0055072),-0.4369464904905708,-1.653941188240473,0.004273504273504274,0.2973139087952459,1.0,22/58,23.13%,PICALM;BMP6;ABCG2;FTH1;TFRC;SCARA5;NEO1;B2M;FTL;SLC11A2;NEDD8;BDH2;FXN;SLC40A1;HFE;SMAD4;CYBRD1;CUL1;SKP1;BOLA2;CCDC115;ISCU
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.3859276872309266,-1.650189217568609,0.0,0.301278664759938,1.0,57/110,22.31%,RPL37A;RPL19;RPL8;RPL37;RPS15;RPS29;RPL35A;RPS7;RPS20;RPL32;RPS27;RPL27;RPL26;RPS24;RPLP0;RPS19;RPL31;RPL41;RPL13A;RPL30;RPL29;RPS16;RPL3;PABPC1;RPLP1;RPS17;RPL23;RPL17;PNRC2;RPS3;RPL9;RPL38;RPL36;RPS26;RPS8;RPL18A;RPS12;RPS21;MAGOH;RPS18;RPS6;RPS15A;EIF4G1;NCBP1;RPLP2;MAGOHB;RNPS1;GSPT2;CTIF;RPL14;RPS2;RPL10A;RPL34;RPL5;PPP2R1A;RPL39;EIF3E
prerank,maintenance of blood-brain barrier (GO:0035633),0.6202832167041893,1.647997738573442,0.02373887240356083,0.5818366014257916,1.0,8/30,4.70%,CLDN1;F11R;LAMA2;LAMC1;SLC12A2;CDH5;TJP2;LSR
prerank,regulation of tube diameter (GO:0035296),-0.6536309139935349,-1.6473006784495114,0.01288659793814433,0.2993416876344233,1.0,6/13,5.68%,ROCK2;NOS3;GCLM;NPR1;ACE;AGTR1
prerank,vascular process in circulatory system (GO:0003018),-0.6536309139935349,-1.6473006784495114,0.01288659793814433,0.2993416876344233,1.0,6/13,5.68%,ROCK2;NOS3;GCLM;NPR1;ACE;AGTR1
prerank,cellular response to arsenic-containing substance (GO:0071243),-0.625744307402887,-1.6464300897416237,0.013368983957219251,0.2965849185707042,1.0,11/15,29.00%,MKNK2;CPEB2;VCP;ZC3H12A;HSF1;DHX36;GSTO1;HNRNPA1;GSTO2;ATF3;DDX3X
prerank,regulation of developmental growth (GO:0048638),-0.5117515314901674,-1.6450978247849641,0.006172839506172839,0.29545706372194663,1.0,7/29,6.72%,PLCB1;IGF1;INSR;GHR;LATS2;MBD5;APOE
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.5414124529071042,1.643054758337265,0.009925558312655087,0.598482210250922,1.0,12/72,5.38%,ROR2;GAB1;DCN;ROR1;NTRK3;FGFR1;HCST;PIK3AP1;WNT16;SOX9;SRC;FN1
prerank,negative regulation of signal transduction (GO:0009968),0.4810494663817431,1.6430533587638771,0.0,0.5912942870576947,1.0,38/249,9.36%,PTCH1;DCN;APOD;GPC3;UBASH3B;PTCH2;VGLL4;NTN1;RGS14;SULF1;ADAMTS12;NFATC1;NRARP;LEPROT;EGFR;SOCS5;SPRY1;CREB3L1;GLIS2;BMP5;SPRY4;IRAK3;APLN;PIP4K2B;DACT1;PTPRC;TNFAIP3;KANK2;KIF7;EGFL7;HIC1;SIAH1;KANK1;PTPRJ;PALM;SLC27A4;PLEK;NLRP2B
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),-0.5539187477527332,-1.6417386347050704,0.013736263736263736,0.30009479926384863,1.0,7/20,3.60%,ENG;TGFBR3;RBPJ;BMP4;TBX3;TGFBR1;ACVRL1
prerank,long-term synaptic potentiation (GO:0060291),0.6786379839511919,1.6396686655488368,0.03162650602409638,0.5998702039770881,1.0,4/21,2.80%,PLK2;TSHZ3;RGS14;SLC24A1
prerank,negative regulation of lipid metabolic process (GO:0045833),0.6659748862019033,1.6384896065327281,0.020967741935483872,0.5983225477590555,1.0,4/22,10.61%,APOD;CEACAM1;NCOR1;ADRA2A
prerank,SNARE complex assembly (GO:0035493),0.7630113311249462,1.6365271736247442,0.030303030303030304,0.6003170885936391,1.0,1/10,0.06%,STXBP6
prerank,positive regulation of protein export from nucleus (GO:0046827),0.7186940827639599,1.635895042577089,0.03005008347245409,0.5964928818311133,1.0,10/15,22.04%,GTSE1;RAPGEF3;BAG3;RBM22;GSK3B;TPR;EMD;YWHAE;TCF7L2;XPO4
prerank,respiratory tube development (GO:0030323),0.6212202998563247,1.6357755829836211,0.02384500745156483,0.5901642841906934,1.0,5/28,2.75%,STRA6;FGF7;PCSK5;FGF1;GLI2
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),-0.6298097488595363,-1.634257591287887,0.009779951100244499,0.31480909790738854,1.0,6/13,13.07%,PLCB1;IGF1;IL33;SLC2A10;GOLGA2;ABCA2
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.7557712460192236,1.633774033732763,0.019572953736654804,0.5859384825747016,1.0,7/12,18.02%,HOMER2;ATP2B4;RCAN1;GSK3B;HOMER3;CHP1;DYRK2
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.7557712460192236,1.633774033732763,0.019572953736654804,0.5859384825747016,1.0,7/12,18.02%,HOMER2;ATP2B4;RCAN1;GSK3B;HOMER3;CHP1;DYRK2
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.7194864611163072,1.6325198828471763,0.025044722719141325,0.5853500962023227,1.0,5/14,4.80%,SULF1;SPRY1;CREB3L1;SPRY4;APLN
prerank,vesicle transport along actin filament (GO:0030050),-0.5759707257490333,-1.6324966356631458,0.013192612137203167,0.31520137042429813,1.0,4/19,2.67%,MYO1D;MYO1B;MYO5A;MYO6
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),0.7362419919829966,1.631105740397025,0.03672787979966611,0.5850100739896709,1.0,2/11,0.83%,CAV1;NEDD4L
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.6351904089953441,1.6306085047465424,0.030303030303030304,0.5808777971208618,1.0,5/26,3.75%,RORA;SULF1;CXCL17;IL1A;EIF2AK3
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.7540320715513917,1.6304396632595377,0.02821869488536155,0.57529970945353,1.0,3/11,1.91%,CAV1;LEPROT;BCL3
prerank,regulation of signal transduction (GO:0009966),0.48483814623385774,1.6303722748974452,0.0,0.5695414891245016,1.0,22/190,6.23%,PTCH1;RORA;MDFIC;IGFBP6;UBASH3B;RGS6;GLI1;PXN;RGS14;SULF1;PLCE1;DTX1;AXIN1;SOCS5;CDC42SE2;OGT;CD55;SRC;NUP62;INTU;IFT81;NCK2
prerank,regulation of coagulation (GO:0050818),0.7474186164751904,1.6291332485727796,0.047217537942664416,0.5690662099589284,1.0,4/11,11.64%,CAV1;EPHB2;PROC;HS3ST5
prerank,cell-matrix adhesion (GO:0007160),0.5169420576993273,1.6290040403831672,0.005773672055427252,0.5637629806931519,1.0,12/95,5.68%,ITGB4;ITGBL1;DLC1;SORBS1;ECM2;ADAMTS12;PPFIA2;ITGA7;PEAK1;SRC;FN1;COL3A1
prerank,positive regulation of behavior (GO:0048520),0.7584296628220121,1.6277559867649376,0.02702702702702703,0.5637698203933256,1.0,4/10,11.72%,STRA6;NPAS2;SGIP1;CFAP20
prerank,negative regulation of complement activation (GO:0045916),0.7543971482272073,1.627059413149353,0.046632124352331605,0.5610257889552479,1.0,3/10,8.44%,SERPING1;CD55;SUSD4
prerank,sodium-independent organic anion transport (GO:0043252),-0.673349392493107,-1.626961404245616,0.0182648401826484,0.3254657027746722,1.0,4/10,10.87%,SLCO3A1;SLCO1C1;SLCO2A1;SLC16A2
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.6365001968299732,1.624987658084048,0.027820710973724884,0.5649138405394958,1.0,5/25,4.46%,ITGA6;GLMN;EGFR;SRC;DSCAM
prerank,negative regulation of protein localization to cell periphery (GO:1904376),-0.5549445572574506,-1.6244725632594401,0.028328611898016998,0.32744835271990086,1.0,4/20,1.68%,PICALM;NUMB;PID1;DAB2
prerank,tube closure (GO:0060606),0.610432641908038,1.621155107462819,0.018731988472622477,0.5760206714815286,1.0,7/31,5.34%,DLC1;PRICKLE1;COBL;FOLR1;STIL;LMO4;MTHFD1
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.6424821577489612,1.6208237383631061,0.032208588957055216,0.5717221817665435,1.0,5/24,3.75%,RORA;SULF1;CXCL17;IL1A;EIF2AK3
prerank,action potential (GO:0001508),0.5740922472773137,1.620553174478863,0.01646090534979424,0.5675986425903474,1.0,5/44,4.85%,GNA14;SCN10A;SLC4A3;GNAQ;CACNA1H
prerank,positive regulation of neuron differentiation (GO:0045666),0.5877583570621803,1.619889701745826,0.024566473988439308,0.5651943538000544,1.0,7/40,5.11%,NGF;FGFR1;DLX1;ZC4H2;MMD2;NBL1;HEYL
prerank,cardiac conduction system development (GO:0003161),-0.5260214612665668,-1.6158502203518466,0.008620689655172414,0.3469899288714793,1.0,8/24,17.21%,NOTCH2;GJB6;BMP4;GJA1;SMAD5;CACNA1G;GATA6;SMAD4
prerank,pigment granule transport (GO:0051904),-0.5749988609181702,-1.614796225064515,0.028985507246376812,0.340109596879236,1.0,9/18,21.38%,MYO5A;RAB11A;BBS2;MKKS;BLOC1S6;RAB11B;MLPH;BBS5;RAB27A
prerank,melanosome transport (GO:0032402),-0.5749988609181702,-1.614796225064515,0.028985507246376812,0.340109596879236,1.0,9/18,21.38%,MYO5A;RAB11A;BBS2;MKKS;BLOC1S6;RAB11B;MLPH;BBS5;RAB27A
prerank,negative regulation of anoikis (GO:2000811),0.7033126291784035,1.614725012834421,0.04873949579831933,0.5824893924942998,1.0,4/14,7.18%,CAV1;SRC;PDK4;MCL1
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.6879753094688558,1.6145361832899512,0.03305785123966942,0.5777587110949328,1.0,7/16,16.32%,CAV1;LEPROT;BCL3;INPP5F;NF2;PIBF1;SOCS1
prerank,monoacylglycerol metabolic process (GO:0046462),0.7213506255709828,1.6131265463919489,0.039735099337748346,0.5787349833942897,1.0,4/13,8.25%,MOGAT2;MOGAT3;AWAT2;ABHD12
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.5599590544493972,1.611566391008764,0.014824797843665768,0.5802253974010496,1.0,18/51,17.10%,NGF;EPB41L3;MINK1;KIF20B;GAS7;NBL1;CNTNAP1;TRIO;GPM6A;PLXNB1;SLC9A6;SNX2;SGK1;CTTN;DICER1;CNTNAP2;SNX1;ALS2
prerank,cell cycle checkpoint signaling (GO:0000075),0.7298932749788971,1.6104966283122246,0.03231292517006803,0.5796742058542819,1.0,5/12,14.80%,PLK2;WEE1;CHFR;ZWILCH;ZW10
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.5301302201439605,1.60866520055213,0.007614213197969543,0.5827394467660754,1.0,6/73,2.22%,NGF;CAV1;NTRK3;EGFR;RAPGEF3;AXIN1
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.6099663036163973,-1.6070321355129338,0.034653465346534656,0.35738357165986706,1.0,6/13,15.10%,NOS3;CALM1;GCH1;AKT1;QDPR;MTHFD1L
prerank,response to sterol (GO:0036314),0.7570908563112331,1.6056216047416496,0.040268456375838924,0.5903760299187164,1.0,1/11,0.03%,RORA
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.7207592702797668,1.602652161155378,0.048859934853420196,0.5979772054371882,1.0,3/12,9.21%,APOD;PTPRJ;CBLB
prerank,regulation of steroid metabolic process (GO:0019218),0.644134940957651,1.6019411202947766,0.03333333333333333,0.5957540768864366,1.0,1/23,0.03%,RORA
prerank,aortic valve development (GO:0003176),-0.48665502186142084,-1.6014498235052004,0.016891891891891893,0.36877773709876965,1.0,10/34,5.47%,ROBO1;ROCK2;ELN;SMAD6;SLIT2;NOS3;BMP4;TIE1;BMPR2;TNFRSF1B
prerank,cardiac atrium morphogenesis (GO:0003209),-0.583697822185212,-1.5978690287633721,0.030534351145038167,0.37458712615847983,1.0,6/16,13.01%,NOTCH2;ENG;BMPR2;PROX1;BMP2;TGFB2
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.5399104401734895,-1.5974383834767139,0.03125,0.3707951225271358,1.0,11/22,20.98%,ANK2;AKAP6;CALM1;ATP1B1;VMP1;SLC9A1;JPH2;CALM3;P2RY6;STAC3;GSTO1
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),0.6969790727724111,1.5966801616435708,0.0457516339869281,0.6139284303267334,1.0,2/13,0.31%,APOD;MDFIC
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.7544427909021929,1.5966408438010524,0.04189435336976321,0.6087374115144791,1.0,1/10,0.15%,DCN
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),-0.4904878902317553,-1.596284898400527,0.022508038585209004,0.3692727767192866,1.0,11/34,12.11%,FLT1;TEK;PDGFRB;PDGFRA;PIK3R1;KIT;PIK3R3;EPHA8;TNFAIP8L3;RUBCN;AMBRA1
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.6821655576964349,1.5961564742562142,0.04313099041533546,0.6054473693305027,1.0,4/15,5.94%,DCN;CSPG4;UST;NCAN
prerank,negative regulation of lymphocyte migration (GO:2000402),0.7538606500491168,1.5957072196496533,0.05641025641025641,0.6023182663623623,1.0,2/10,1.08%,APOD;RIPOR2
prerank,skeletal muscle organ development (GO:0060538),0.6272630935674242,1.5948526246344836,0.041979010494752625,0.6008632617422,1.0,3/26,4.42%,STRA6;CAV1;CSRP3
prerank,response to ethanol (GO:0045471),-0.6115109776149988,-1.5943584781361495,0.02857142857142857,0.369889639932442,1.0,5/14,11.47%,ADCY7;GRIN3A;GRIN2B;GRIN1;GLRA2
prerank,amino acid import (GO:0043090),-0.5481660040887463,-1.5943315144442787,0.02824858757062147,0.36530691129138265,1.0,11/21,16.85%,SLC6A6;SLC47A1;SLC7A5;SLC22A4;SLC7A1;SLC25A38;SLC16A2;SLC6A1;SLC1A1;SLC1A3;SLC22A2
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.5873870864710283,1.5941475457075502,0.024147727272727272,0.5988863396379193,1.0,5/35,5.03%,PIGU;CAV1;LEPROT;BCL3;PTPRC
prerank,eye morphogenesis (GO:0048592),0.6726951491413504,1.5937011587648402,0.040983606557377046,0.5955446322023603,1.0,5/19,6.20%,ALDH1A3;EFEMP1;MFAP5;NF1;SHROOM2
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),0.6855575048933472,1.5933064706772366,0.05392156862745098,0.5922270094316361,1.0,1/15,0.04%,NGF
prerank,retinal metabolic process (GO:0042574),0.7216820541102398,1.5917062745495132,0.02337228714524207,0.5941695543850202,1.0,3/12,5.95%,ALDH1A3;RDH10;BCO1
prerank,release of sequestered calcium ion into cytosol (GO:0051209),0.6146957623808387,1.5912242905461145,0.039097744360902256,0.5914839639414654,1.0,7/26,7.16%,ITPR2;ITPR3;SLC8B1;ERO1A;IBTK;PTPRC;CHERP
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.5191296343563021,1.590593988959257,0.017766497461928935,0.589442021052772,1.0,4/76,1.25%,GNA14;HRH1;LPAR1;PLCE1
prerank,aortic valve morphogenesis (GO:0003180),-0.4943392918276671,-1.5902695623872833,0.018404907975460124,0.3731808723201118,1.0,8/30,2.82%,ROBO1;ROCK2;ELN;SMAD6;SLIT2;NOS3;BMP4;TIE1
prerank,mesoderm development (GO:0007498),-0.5523286408783366,-1.5892761412250913,0.024657534246575342,0.3712471347724742,1.0,7/18,13.51%,TBX3;TIE1;TBX1;BMX;JAK2;MEST;MESD
prerank,regulation of cell-cell adhesion (GO:0022407),0.5704085261310529,1.5891146807520322,0.03404255319148936,0.5911793046538524,1.0,7/39,4.43%,MAGI1;EFNA5;CEACAM1;JAG1;MINK1;FLOT2;SRC
prerank,aorta morphogenesis (GO:0035909),-0.5713040549072457,-1.5878728415612369,0.0345679012345679,0.37101621199418594,1.0,8/17,10.04%,ENG;PDGFRB;MYLK;LRP1;RBPJ;ACVRL1;TBX1;PROX1
prerank,negative regulation of potassium ion transport (GO:0043267),0.7023243505918685,1.5873183700396931,0.04690117252931323,0.5942874942090481,1.0,2/13,0.83%,CAV1;NEDD4L
prerank,glycolipid biosynthetic process (GO:0009247),0.5896604510907064,1.5858681742422323,0.025956284153005466,0.5961224974714292,1.0,9/38,12.96%,PIGU;ST3GAL4;A4GALT;PGAP3;PIGB;PIGA;ST8SIA5;ST8SIA3;SCCPDH
prerank,ganglioside biosynthetic process (GO:0001574),-0.5971387923698259,-1.5838858372239195,0.032432432432432434,0.37757699268896544,1.0,4/15,2.13%,ST3GAL5;ST3GAL1;ST8SIA4;ST6GALNAC3
prerank,embryonic eye morphogenesis (GO:0048048),0.7298114480290525,1.5820596657253692,0.0497335701598579,0.6076683062956191,1.0,4/11,6.70%,ALDH1A3;EFEMP1;MFAP5;TBX2
prerank,negative regulation of hemostasis (GO:1900047),-0.621837990515209,-1.5817184515126053,0.02810304449648712,0.3788390137138494,1.0,6/12,14.09%,TFPI;THBD;CD34;SERPINE2;APOE;EDN1
prerank,extracellular matrix organization (GO:0030198),0.4602234090811184,1.5816129256431768,0.0,0.6046961926061462,1.0,43/276,7.49%,ITGB4;TGFBI;DCN;VIT;ITGA6;ADAMTS14;SMOC2;F11R;LAMA2;ECM2;PXDN;MMP28;LAMA4;NID1;ADAMTS12;LAMC1;LAMB2;ADAMTSL5;KLK2;COL6A3;ADAMTS1;MFAP5;ADAM19;COL5A3;NF1;MMP15;ITGAX;SH3PXD2A;ITGA7;CREB3L1;ADAMTS19;IBSP;SERPINH1;SH3PXD2B;FN1;COL3A1;NCAN;ADAM10;LAMA5;COL4A1;DAG1;ADAMTS2;ITGB7
prerank,neuron projection morphogenesis (GO:0048812),0.48133712555388825,1.5772125414234377,0.005793742757821553,0.6187890578974908,1.0,27/137,12.97%,NGF;NTNG2;NTNG1;LRP4;EPB41L3;PARD6B;MINK1;KIF20B;GAS7;S100A6;NBL1;DIP2A;CNTNAP1;TRIO;BRSK1;EPHB2;RAB3A;S100B;ISL1;GPM6A;POU4F1;DOCK7;PLXNB1;SLC9A6;SGK1;PTEN;CTTN
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),0.5162823260091102,1.576991974248575,0.019455252918287938,0.6149933837627168,1.0,13/75,10.83%,NTNG2;NTNG1;LRP4;PARD6B;MINK1;OPHN1;S100A6;BRSK1;RAB3A;S100B;ISL1;POU4F1;DOCK7
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.5842034602761854,1.5765022068551167,0.029329608938547486,0.6122474825111013,1.0,5/38,5.24%,RORA;PPM1N;TNIP3;PPM1A;TNFAIP3
prerank,cardiac myofibril assembly (GO:0055003),-0.5762776936385993,-1.5761281074152376,0.028169014084507043,0.3908558462522907,1.0,6/15,10.04%,PDGFRB;PDGFRA;OBSL1;MEF2A;NEBL;PROX1
prerank,positive regulation of activated T cell proliferation (GO:0042104),-0.5658145616612926,-1.57575644627257,0.023809523809523808,0.38749825507207625,1.0,4/18,3.90%,IGF1;IGFBP2;IGF2;IL18
prerank,epithelium development (GO:0060429),0.4991924988459826,1.5751788870691432,0.015133876600698487,0.6133758075950855,1.0,12/107,7.15%,PTCH1;MEOX2;CDHR2;RIPK4;STIL;SOX9;DACT1;MTHFD1;KANK2;ANXA4;TBX2;DAG1
prerank,regulation of epithelial cell differentiation (GO:0030856),0.6781767910636776,1.5747021505157688,0.041666666666666664,0.6110697232989168,1.0,5/17,7.43%,CAV1;CEACAM1;AJAP1;SOX9;MAFG
prerank,intestinal absorption (GO:0050892),0.7080638194728597,1.574584953397228,0.05555555555555555,0.6070807366870925,1.0,5/13,15.09%,F11R;TJP2;SLC2A2;ADRA2A;SLC46A1
prerank,negative regulation of glucose transmembrane transport (GO:0010829),-0.6635497385849481,-1.5745635552258919,0.03349282296650718,0.3867069088725732,1.0,4/10,2.90%,PID1;ENPP1;GRB10;APPL2
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.6036431773512532,-1.574226144602598,0.03981264637002342,0.38329427184193415,1.0,4/14,10.41%,ANK2;ACTN2;ATP1B1;ATP1B2
prerank,Rap protein signal transduction (GO:0032486),0.736834378840387,1.5730694591202847,0.05299145299145299,0.6087764527938289,1.0,3/10,1.92%,PLK2;RAPGEF3;RAP1A
prerank,regulation of amyloid-beta formation (GO:1902003),-0.47214235028511004,-1.5729153161617984,0.020134228187919462,0.38278226118546943,1.0,12/34,15.74%,IGF1;PICALM;ROCK2;EPHA4;APOE;CASP3;RTN1;GSK3A;SP1;ABCA2;ABCG1;GGA3
prerank,positive regulation of leukocyte proliferation (GO:0070665),-0.6229721656054539,-1.572492387293075,0.04390243902439024,0.3797259367274098,1.0,5/12,15.93%,LYN;BST2;IL34;PTK2;CSF1
prerank,spinal cord development (GO:0021510),0.7246854689943922,1.5722853742094678,0.04159733777038269,0.6077030726799953,1.0,6/12,13.63%,VIT;GLI2;NF1;RELN;PKD1;SOX4
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),-0.4594328695948599,-1.5722616616784526,0.007246376811594203,0.37620660319399113,1.0,21/40,30.38%,HIP1;INSR;ANGPT1;DAB2;B2M;HNRNPK;ANXA2;LDLRAP1;HFE;AHI1;EGF;PICK1;CLU;CCL19;GREM1;NTF3;ARRB2;C3;VTN;CBL;ATAD1
prerank,cell junction maintenance (GO:0034331),0.6832630480419752,1.5721217378182102,0.04975124378109453,0.6040027325770416,1.0,1/14,0.19%,CLDN1
prerank,glucan catabolic process (GO:0009251),-0.5866564493852203,-1.5713594645628162,0.029490616621983913,0.3747272962334884,1.0,10/15,34.73%,PGM2L1;CALM1;AGL;PHKG1;PYGB;PYGL;PHKA2;PHKB;PYGM;STBD1
prerank,response to axon injury (GO:0048678),0.6564378214660243,1.569596699354318,0.0473186119873817,0.6099412588470103,1.0,4/18,10.64%,APOD;FOLR1;SARM1;RTN4RL1
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.7073256750026405,1.5695916988881673,0.04865771812080537,0.6056114582154325,1.0,3/12,3.04%,CAV1;CAMK2D;PDE4D
prerank,icosanoid secretion (GO:0032309),-0.6312971294409444,-1.5688769664129918,0.03365384615384615,0.3775748123332693,1.0,4/12,7.85%,ABCC4;ACE;BDKRB2;ANXA1
prerank,regulation of anoikis (GO:2000209),0.640839050316913,1.5663114626394652,0.05128205128205128,0.6151700476843456,1.0,5/19,7.18%,CAV1;MYBBP1A;SRC;PDK4;MCL1
prerank,ERBB signaling pathway (GO:0038127),0.5237423489971414,1.5644693404275078,0.018276762402088774,0.618966796947108,1.0,11/64,6.23%,GAB1;FAM83A;PLCE1;EFEMP1;EGFR;REPS2;PRKCA;SOX9;SRC;KIF16B;NCK2
prerank,digestive tract morphogenesis (GO:0048546),0.6836598704754586,1.563871882382378,0.05227655986509275,0.617036920806052,1.0,2/14,0.56%,STRA6;GLI1
prerank,transepithelial transport (GO:0070633),0.686885111938038,1.5599426902277427,0.03885135135135135,0.6291700821183595,1.0,5/15,9.43%,CXADR;SLC12A2;GPLD1;ABCC1;BEST1
prerank,chondroitin sulfate catabolic process (GO:0030207),0.6978127105730884,1.5585061409879346,0.048414023372287146,0.6309331350522303,1.0,3/13,5.94%,DCN;CSPG4;NCAN
prerank,catecholamine biosynthetic process (GO:0042423),-0.6328713922303575,-1.5573228837958106,0.05,0.4074451797138924,1.0,3/11,13.01%,MOXD1;GCH1;TGFB2
prerank,retinoid metabolic process (GO:0001523),0.5092700118910064,1.5562669252439798,0.01668806161745828,0.6362604933515923,1.0,17/71,12.39%,ALDH1A3;STRA6;GPC3;RDH10;GPC6;RDH5;AWAT2;CYP2S1;BCO1;OPN1MW;SDC1;SCPEP1;AKR1B10;RDH13;HSPG2;GPC2;SDC3
prerank,activation of phospholipase C activity (GO:0007202),0.5983722639988218,1.5558336842553813,0.053929121725731895,0.6339642094258626,1.0,5/29,4.55%,LPAR1;EGFR;ITK;TXK;GNAQ
prerank,heterotypic cell-cell adhesion (GO:0034113),0.606590756563216,1.5556342213265035,0.05311077389984825,0.6306102263929382,1.0,6/25,9.00%,CXADR;PARVA;ITGAX;ITGA7;ITGB7;CD200R1
prerank,negative regulation of cellular component movement (GO:0051271),-0.5934160065195556,-1.5552280189500147,0.03640776699029126,0.40980567483505526,1.0,6/15,6.94%,FBLN1;TGFBR3;FRMD5;SP100;CCDC125;CRK
prerank,negative regulation of cell migration (GO:0030336),-0.35683647138669145,-1.5542643582922344,0.0,0.40856395801056544,1.0,37/137,12.09%,ROBO1;PHLDB2;PTPRG;MCC;ENG;AFDN;CLDN5;LIMCH1;LRP1;SLIT2;RECK;DACH1;TPM1;CLIC4;IGFBP3;IGFBP5;GJA1;EPHA4;PTPRK;ACVRL1;PODN;MITF;CYP1B1;SRGAP1;DUSP10;DUSP3;TMEFF2;BST2;CITED2;EVL;RHOB;SINHCAF;ATP1B2;TRIB1;ARID2;FUZ;NEXMIF
prerank,response to organic cyclic compound (GO:0014070),-0.4171063135310162,-1.5541938778699276,0.02631578947368421,0.4045485995537685,1.0,22/52,28.06%,PAQR7;IGFBP5;IL18;CYP1B1;ALPL;ARL6IP5;ANXA1;HLCS;ESR1;FGFR4;LRRK2;ABCA2;SLC1A1;DHFR;TRPM2;TLR3;ABCB4;KYNU;GGT5;STRN3;STAT3;CDKN2D
prerank,positive regulation of neuroinflammatory response (GO:0150078),-0.6184140310733481,-1.55356519096887,0.042328042328042326,0.40224095828851497,1.0,4/12,11.96%,NUPR1;IL18;IL33;TTBK1
prerank,amino acid import across plasma membrane (GO:0089718),-0.5211284902911706,-1.5531407867918128,0.02849002849002849,0.3992432621227482,1.0,11/24,16.85%,SLC6A6;SLC47A1;SLC6A9;SLC7A5;SLC22A4;SLC7A1;SLC16A2;SLC1A1;SLC1A3;SLC3A2;SLC22A2
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.5742965282023734,1.5523139350205948,0.03299856527977044,0.640992964562689,1.0,13/37,16.82%,DYNLL1;DYNC2I1;CEP131;IFT81;KIF3C;CLUAP1;IFT74;DYNLL2;TTC21B;TRIP11;PCM1;DYNC2LI1;DYNC2H1
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.6851716281026672,1.5500438531782397,0.05025996533795494,0.6466577241557846,1.0,3/13,10.07%,PIGU;PTPRC;PTPRT
prerank,neurotrophin signaling pathway (GO:0038179),0.6202767315239056,1.5498217953674736,0.06441717791411043,0.6434610432907517,1.0,2/21,1.92%,NGF;RAP1A
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.6373531732315649,-1.5491276096011561,0.04292929292929293,0.4075929509552827,1.0,6/11,13.76%,NOS3;CALM1;GCH1;AKT1;QDPR;DHFR
prerank,positive regulation of mitochondrial fission (GO:0090141),0.6462959499838002,1.5486060906982662,0.04326123128119801,0.6443545626480397,1.0,10/18,21.16%,DCN;DDHD1;FIS1;MIEF1;BNIP3;RALBP1;PINK1;RALA;MUL1;PRKN
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.5747413014021154,1.5482498839099332,0.0446927374301676,0.6418182817743635,1.0,5/37,7.53%,TENM2;CXADR;HMCN1;AMIGO2;CRTAM
prerank,electron transport chain (GO:0022900),0.6861844034978233,1.5476824826701503,0.053156146179401995,0.639963530628215,1.0,2/15,0.66%,PPARGC1A;POR
prerank,positive regulation of nuclear division (GO:0051785),-0.5030531105345952,-1.5474954293628185,0.03724928366762178,0.4080120942878213,1.0,5/25,3.54%,IGF1;INSR;TGFA;PDGFRB;IGF2
prerank,positive regulation of lipid transport (GO:0032370),-0.6155828732444787,-1.547357857414926,0.02877697841726619,0.404539980912255,1.0,3/12,6.72%,LRP1;DBI;APOE
prerank,muscle cell development (GO:0055001),-0.4736009756494864,-1.5464022102555355,0.022435897435897436,0.40354270896258787,1.0,10/30,9.33%,MYOF;IGF1;ENG;ANK2;DMD;SLC8A1;DYSF;MYH11;RAMP2;NEBL
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),0.672222456213593,1.5459307458559577,0.05175292153589316,0.6433791538157816,1.0,1/14,0.11%,GAB1
prerank,tight junction assembly (GO:0120192),0.5441507440731412,1.5441750318894907,0.03748326639892905,0.6465274944852927,1.0,13/49,11.39%,CLDN1;F11R;CLDN11;CLDN19;PARD6B;CDH5;LSR;POF1B;OCLN;PDCD6IP;CLDN10;STRN;APC
prerank,lymphocyte mediated immunity (GO:0002449),0.7163620453189624,1.542687954459191,0.058319039451114926,0.6484653654757467,1.0,3/12,7.73%,JAG1;CD55;MSH2
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),-0.4837872038682468,-1.5424481675786272,0.02654867256637168,0.4115407036496538,1.0,9/28,17.09%,STMN2;STMN4;CAMSAP1;GBA2;STMN1;MAP1B;MAPT;SKA2;ARL2
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.5923484935512798,1.5419495837976456,0.05547226386806597,0.647814239233366,1.0,4/28,7.30%,NGF;SPI1;TRADD;BAG3
prerank,regulation of chondrocyte differentiation (GO:0032330),0.6194477165316042,1.5418219751127495,0.05701078582434515,0.644279235384062,1.0,7/24,4.14%,PKDCC;MBOAT2;ADAMTS12;EFEMP1;PTHLH;BMPR1B;SOX9
prerank,regulation of monooxygenase activity (GO:0032768),0.616088307951445,1.5404006212242694,0.043219076005961254,0.6465540719690664,1.0,6/23,7.57%,CAV1;POR;EGFR;IL1A;DDAH2;NOS1AP
prerank,bicellular tight junction assembly (GO:0070830),0.5450187125210223,1.539698987320171,0.03978779840848806,0.6455114047153215,1.0,12/46,11.39%,CLDN1;F11R;CLDN11;CLDN19;PARD6B;CDH5;POF1B;OCLN;PDCD6IP;CLDN10;STRN;APC
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),-0.6156665330798257,-1.5390882136042618,0.04128440366972477,0.41751633717869047,1.0,3/12,5.60%,IGF1R;INSR;UVRAG
prerank,triglyceride homeostasis (GO:0070328),0.5923492125592723,1.5387947999736817,0.06092124814264487,0.6453308365668887,1.0,1/26,0.03%,RORA
prerank,protein localization to microtubule organizing center (GO:1905508),0.6773181813067682,1.5383352270973527,0.043973941368078175,0.6434239840438856,1.0,11/15,24.85%,STIL;CEP131;NEDD1;SNX10;C2CD3;HOOK3;PCM1;PIBF1;DCTN2;CEP83;CSNK1D
prerank,positive regulation of neuron projection development (GO:0010976),0.493624074263532,1.534555465386083,0.02877697841726619,0.6556460464847349,1.0,8/85,4.77%,ROR2;ROR1;ITGA6;NTRK3;COBL;RAP1A;BMP5;WNT5A
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.6871213711928859,1.5336712465053206,0.04643449419568822,0.6556586173506239,1.0,4/15,6.81%,RIPOR2;RAPGEF3;CD53;EHD2
prerank,positive regulation of DNA replication (GO:0045740),0.6739917827734517,1.5335840319835548,0.04730831973898858,0.6520664837172543,1.0,6/16,14.53%,GLI1;EGFR;GLI2;STN1;FAF1;BRPF3
prerank,protein localization to centrosome (GO:0071539),0.6565647324688952,1.5324346549952912,0.04038772213247173,0.6529636365581999,1.0,10/17,19.40%,STIL;CEP131;NEDD1;SNX10;GOLGB1;C2CD3;HOOK3;PCM1;PIBF1;DCTN2
prerank,negative regulation of intracellular protein transport (GO:0090317),0.6196814713739764,1.5316942095791377,0.04813664596273292,0.6521618347548196,1.0,2/22,0.31%,APOD;MDFIC
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),-0.6073319923500708,-1.531163570161312,0.04336734693877551,0.4378065912942099,1.0,5/12,10.98%,CYP26B1;TRIM16;SNW1;KLF2;CTBP2
prerank,regulation of neuron migration (GO:2001222),0.5960780388303019,1.5303933110623174,0.04084720121028744,0.6537224653985487,1.0,6/26,7.07%,NTNG2;NTNG1;KIF20B;COL3A1;ULK4;SEMA3A
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),-0.6380171018346422,-1.5300802825685769,0.04568527918781726,0.43690271059557545,1.0,4/10,7.76%,LYN;FAS;NBR1;MAP2K2
prerank,response to cadmium ion (GO:0046686),-0.48776652281465477,-1.526392101123138,0.04945054945054945,0.4439215906727684,1.0,9/26,8.34%,MT1E;MT1M;MT1G;MT1B;MT1F;MT1A;MT1X;MT1H;AKT1
prerank,cellular glucan metabolic process (GO:0006073),-0.6385549255269413,-1.5249194183052188,0.06483790523690773,0.4444501901660387,1.0,4/11,12.53%,PRKAG2;GBE1;UGP2;PPP1R3C
prerank,regulation of keratinocyte migration (GO:0051547),0.7017983868508476,1.5246397302920458,0.06324786324786325,0.6746759633762366,1.0,4/12,12.65%,FGF7;ARF6;MAPRE2;PTEN
prerank,regulation of cardiac muscle cell action potential (GO:0098901),0.6045882041469997,1.5241396707037842,0.0514820592823713,0.6727638581623918,1.0,5/25,8.42%,CAV1;CXADR;CAMK2D;NOS1AP;TBX18
prerank,peripheral nervous system development (GO:0007422),0.612297711613066,1.5240963045287474,0.04962406015037594,0.6690496644163023,1.0,3/23,6.17%,NGF;NF1;ARTN
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.5745087920634073,1.5234577389691253,0.041428571428571426,0.6679220546860548,1.0,6/32,4.43%,APOD;DLC1;JAG1;AJAP1;CASK;SRC
prerank,cell-cell junction organization (GO:0045216),0.49820737899795065,1.5218263340996632,0.022304832713754646,0.6706469775850529,1.0,11/79,3.64%,CLDN1;CXADR;CDH13;TLN2;CDH11;PARD6B;CDH5;CDH17;CDH9;TRPV4;TJP2
prerank,negative regulation of T cell mediated immunity (GO:0002710),0.717069019423781,1.5216532610680984,0.07035175879396985,0.667471621701689,1.0,3/11,5.03%,CEACAM1;IL4I1;PTPRC
prerank,primary neural tube formation (GO:0014020),0.5788761876241385,1.5193267090702136,0.04405286343612335,0.6737766912142448,1.0,6/30,5.34%,DLC1;PRICKLE1;COBL;STIL;LMO4;MTHFD1
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.6937060570002527,1.5187918751278389,0.07512520868113523,0.6685301354380494,1.0,3/12,7.66%,EFNA5;SPRY4;KANK1
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.6937060570002527,1.5187918751278389,0.07512520868113523,0.6685301354380494,1.0,3/12,7.66%,EFNA5;SPRY4;KANK1
prerank,regulation of membrane repolarization (GO:0060306),0.6782493577407201,1.5183230594546733,0.06802721088435375,0.6668220489468492,1.0,2/13,0.83%,CAV1;NEDD4L
prerank,regulation of peptide hormone secretion (GO:0090276),0.5050622342705102,1.5155206925190317,0.03620474406991261,0.674885669672003,1.0,17/67,13.11%,ITPR2;ITPR3;KCNA5;SLC8B1;RAPGEF3;RAP1A;STX1A;PRKCA;TFR2;RAPGEF4;SLC2A2;DPP4;RASL10B;KCNS3;ADRA2A;ENSA;GCK
prerank,regulation of urine volume (GO:0035809),-0.6313471363845615,-1.5152757760865634,0.0556792873051225,0.4709896348160817,1.0,5/10,27.73%,NPR3;NPR1;ADM;ADCY6;HAS2
prerank,cellular response to cadmium ion (GO:0071276),-0.4968201991367754,-1.5152617963169666,0.04736842105263158,0.46679702599076794,1.0,9/24,8.34%,MT1E;MT1M;MT1G;MT1B;MT1F;MT1A;MT1X;MT1H;AKT1
prerank,regulation of trans-synaptic signaling (GO:0099177),0.572488266253862,1.5151699325586903,0.047895500725689405,0.6727188305133641,1.0,2/33,1.38%,NGF;CEL
prerank,phosphate ion homeostasis (GO:0055062),-0.6473039412166364,-1.5144561288485314,0.046189376443418015,0.46531400753598684,1.0,2/10,11.84%,ENPP1;FGFR4
prerank,regulation of mitochondrial fusion (GO:0010635),-0.6121224255136786,-1.5124875605128263,0.05128205128205128,0.46751122005545326,1.0,3/11,2.97%,PID1;OMA1;TFRC
prerank,regulation of apoptotic signaling pathway (GO:2001233),-0.4464492777267773,-1.5123611426116979,0.022727272727272728,0.4637645637171163,1.0,15/36,21.05%,SGMS1;TGFBR1;MADD;FAS;MAZ;NR4A2;BCL2L12;RPS3;BDNF;CSNK2A1;DEPTOR;TPD52L1;STYXL1;QARS1;TMBIM6
prerank,negative regulation of epithelial cell differentiation (GO:0030857),0.6573965897945807,1.5097326552510502,0.06879194630872483,0.6919275319461429,1.0,3/14,3.52%,CAV1;SPRED1;SPRY1
prerank,calcineurin-mediated signaling (GO:0097720),0.7150097838017109,1.5096583924702351,0.0763765541740675,0.6847240921511016,1.0,2/10,1.45%,NFATC2;NFATC1
prerank,calcineurin-NFAT signaling cascade (GO:0033173),0.7150097838017109,1.5096583924702351,0.0763765541740675,0.6847240921511016,1.0,2/10,1.45%,NFATC2;NFATC1
prerank,positive regulation of cellular metabolic process (GO:0031325),-0.36711320487410065,-1.5087404162518934,0.0,0.4710982880592067,1.0,35/98,25.32%,INSR;PDGFRB;ECE1;PID1;ANGPT1;PPARD;SLCO1C1;IL10RB;NR1H3;XDH;ANXA2;AGTR1;KLF4;APOE;NR1H2;AKT1;ZC3H12A;ACLY;THBS1;GHITM;CSF1;AHI1;EIF4G1;ACE2;EGF;IFNAR1;ROMO1;AGT;PICK1;INHBA;GRB2;RIPK1;GREM1;NTF3;ARRB2
prerank,neural tube closure (GO:0001843),0.5657406766115438,1.5077048864292377,0.043859649122807015,0.6894933273538296,1.0,7/34,5.34%,DLC1;PRICKLE1;COBL;FOLR1;STIL;LMO4;MTHFD1
prerank,positive regulation of lipid kinase activity (GO:0090218),-0.482709522553611,-1.5076535220582254,0.022364217252396165,0.4705191991522342,1.0,7/29,7.63%,FLT1;TEK;PDGFRB;PDGFRA;KIT;EPHA8;TNFAIP8L3
prerank,regulation of metal ion transport (GO:0010959),-0.5572323051487699,-1.5071731773658863,0.04657534246575343,0.4679936822572166,1.0,5/16,15.12%,ANK2;SLC30A10;ORAI1;EPB41;SRI
prerank,negative regulation of cartilage development (GO:0061037),0.6713647076529843,1.5063040354302175,0.07236842105263158,0.6918707472091311,1.0,6/13,12.16%,ADAMTS12;EFEMP1;PTHLH;SOX9;WNT9A;CHADL
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),-0.622942868895124,-1.5038486269187783,0.05034324942791762,0.47456312760847924,1.0,6/10,27.84%,LYN;KIT;CD24;CD40;BTLA;FGR
prerank,secondary palate development (GO:0062009),-0.5687124217814434,-1.5038462616792432,0.0725,0.47057520216639115,1.0,7/14,17.46%,LEF1;TGFBR3;CHD7;TGFB3;TGFB2;SMAD4;WNT11
prerank,positive regulation of ruffle assembly (GO:1900029),-0.5847992712642573,-1.5035593918493335,0.046620046620046623,0.46759810144139086,1.0,10/13,37.91%,EPS8;EPS8L2;PFN1;HRAS;P2RY12;DEF8;PLEKHM1;NLGN1;FAM98A;CARMIL2
prerank,cholesterol homeostasis (GO:0042632),0.5085735159622218,1.5034819395147714,0.03722084367245657,0.6999420027259219,1.0,6/64,8.05%,RORA;CAV1;CYP7B1;GRAMD1B;SOAT1;ABCA1
prerank,type I interferon signaling pathway (GO:0060337),-0.42765773839574056,-1.5032662065516726,0.01910828025477707,0.46080625591709634,1.0,19/41,26.04%,SP100;IFNAR2;ADAR;SAMHD1;IRF2;IFIT2;IFIT3;BST2;IRF1;IFIT1;GBP2;ISG15;IFNAR1;RSAD2;PSMB8;XAF1;IRF5;IRF8;MYD88
prerank,cellular response to type I interferon (GO:0071357),-0.42765773839574056,-1.5032662065516726,0.01910828025477707,0.46080625591709634,1.0,19/41,26.04%,SP100;IFNAR2;ADAR;SAMHD1;IRF2;IFIT2;IFIT3;BST2;IRF1;IFIT1;GBP2;ISG15;IFNAR1;RSAD2;PSMB8;XAF1;IRF5;IRF8;MYD88
prerank,muscle cell migration (GO:0014812),0.7096396479244116,1.5009842440565753,0.07880910683012259,0.706980089021078,1.0,1/10,0.08%,THBS4
prerank,nucleoside phosphate catabolic process (GO:1901292),-0.5842635432976218,-1.5007359414834514,0.053864168618266976,0.4650142833321683,1.0,3/13,4.43%,ENPP1;ENTPD1;ENPP3
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.5620341073782358,1.4970585417838325,0.058394160583941604,0.7197869095080871,1.0,5/35,3.29%,CDH13;CDH11;CDH5;CDH17;CDH9
prerank,lipid modification (GO:0030258),0.5478899341077663,1.4970189213983325,0.04922644163150492,0.7161919753088583,1.0,5/37,4.08%,DGKA;MBOAT2;PLPP2;DGKZ;PLPP3
prerank,epidermis development (GO:0008544),0.5232870471280008,1.4965605280385599,0.04743083003952569,0.7143761990075496,1.0,6/56,3.90%,FGF7;GLI1;WNT10A;EMP1;FLOT2;PTHLH
prerank,carboxylic acid transport (GO:0046942),-0.4030797593145251,-1.4959484962624925,0.01646090534979424,0.47654704434298223,1.0,21/55,22.76%,SLC16A12;SLC13A3;SLC6A6;SLC6A9;SLC7A5;SLC17A5;SLC7A1;SLC7A6;SLC16A6;SLC16A4;SLC15A4;SLC16A2;SLC16A7;SLC1A1;LLGL2;SLC3A2;SLC38A5;SLC25A29;SLC1A4;SLC6A17;SLC38A1
prerank,vesicle organization (GO:0016050),0.5289162489799256,1.4958919738055627,0.052702702702702706,0.7135707073891642,1.0,10/46,6.77%,CAV1;USP50;HOOK2;PI4K2B;CAV2;PHETA2;DNM1;ZFYVE16;USP8;SNX10
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.655581045544495,1.4956315446442727,0.07849829351535836,0.7109378010722414,1.0,3/14,7.87%,MEOX2;CARD10;STARD13
prerank,fructose 6-phosphate metabolic process (GO:0006002),0.6974076182328479,1.4955871847266005,0.08602150537634409,0.7074723175454134,1.0,2/10,3.19%,HK2;PFKP
prerank,cellular polysaccharide catabolic process (GO:0044247),-0.5408318883102229,-1.4943064497882106,0.06382978723404255,0.47800363183795347,1.0,10/16,34.73%,PGM2L1;CALM1;AGL;PHKG1;PYGB;PYGL;PHKA2;PHKB;PYGM;STBD1
prerank,regulation of cell-matrix adhesion (GO:0001952),0.499578669427356,1.492609697173886,0.03773584905660377,0.7169397054743621,1.0,9/64,4.22%,EFNA5;CDH13;UTRN;JAG1;MINK1;AJAP1;CASK;NF1;PEAK1
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.6520894822813149,1.4918459435993723,0.07248764415156507,0.7164116074201543,1.0,6/14,12.16%,ADAMTS12;EFEMP1;PTHLH;SOX9;WNT9A;CHADL
prerank,protein maturation (GO:0051604),0.47303935754960585,1.4913803513144364,0.03361344537815126,0.7146308862217413,1.0,16/95,11.94%,PTCH1;PCSK5;ADAM19;OGT;APH1B;CPE;NCSTN;ADAM10;NAA35;PCSK7;LMF1;XPNPEP3;MME;TASP1;MMP16;TSPAN14
prerank,neutral amino acid transport (GO:0015804),-0.4709590844084437,-1.491204664294854,0.019553072625698324,0.48359566362875256,1.0,14/28,25.56%,SLC6A6;SLC6A9;SLC7A5;CTNS;SLC43A2;SLC1A1;LLGL2;SLC3A2;SLC38A5;SLC1A4;SLC6A17;SLC38A1;SLC7A10;SLC1A5
prerank,negative regulation of protein localization to nucleus (GO:1900181),0.636878378420807,1.4908946492879573,0.07119741100323625,0.7131536953202399,1.0,2/18,0.31%,APOD;MDFIC
prerank,sulfur compound catabolic process (GO:0044273),0.5484244030200206,1.4905550997912311,0.06128133704735376,0.7109763446107852,1.0,10/38,16.60%,DCN;CSPG4;PRELP;NCAN;ACAT1;HEXA;HEXB;GGT1;TXN2;VCAN
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.5920420975061743,1.490053544223752,0.06472491909385113,0.7095651785675821,1.0,8/23,12.18%,CAV1;SOCS5;PTPRC;TSG101;SRCIN1;CBLB;SOCS4;MVP
prerank,positive regulation of cell projection organization (GO:0031346),0.46543683426096216,1.4893481033351037,0.025611175785797437,0.7090728424007287,1.0,10/115,4.77%,ROR2;NGF;ROR1;ITGA6;NTRK3;TIAM2;RAP1A;CDKL3;PLXNA3;WNT5A
prerank,regulation of endothelial cell proliferation (GO:0001936),0.47608178655413974,1.488589770867506,0.028151774785801713,0.7087673086298568,1.0,13/88,6.81%,THBS4;CAV1;CDH13;NR2F2;SULF1;NRARP;NRP2;NF1;CAV2;PRKCA;WNT5A;NRAS;EGFL7
prerank,regulation of transforming growth factor beta production (GO:0071634),-0.5168669638255683,-1.4885572300534402,0.05434782608695652,0.488419357515946,1.0,7/18,17.21%,SMAD3;HIF1A;CD34;CD200;TGFB2;LGALS9;SMAD4
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.6786460364823328,1.4884798306539262,0.07512520868113523,0.6989145141842376,1.0,6/12,18.14%,CUL3;ANAPC5;ANAPC7;ANAPC11;ANAPC4;CDC23
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.6786460364823328,1.4884798306539262,0.07512520868113523,0.6989145141842376,1.0,6/12,18.14%,CUL3;ANAPC5;ANAPC7;ANAPC11;ANAPC4;CDC23
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.6786460364823328,1.4884798306539262,0.07512520868113523,0.6989145141842376,1.0,6/12,18.14%,CUL3;ANAPC5;ANAPC7;ANAPC11;ANAPC4;CDC23
prerank,axon development (GO:0061564),0.4869340351139862,1.4875412604762226,0.028314028314028315,0.6993823804256223,1.0,13/78,10.83%,NTNG2;NTNG1;FOLR1;PARD6B;S100A6;BRSK1;EPHB2;RAB3A;S100B;ISL1;POU4F1;RTN4RL1;DOCK7
prerank,presynapse assembly (GO:0099054),0.6442297919574683,1.4856134133691898,0.07667731629392971,0.7043159259284928,1.0,3/16,4.77%,LRP4;CEL;WNT5A
prerank,lipid translocation (GO:0034204),0.5916784302990249,1.484711490327377,0.07923930269413629,0.7047306738657445,1.0,10/21,9.87%,ATP8B3;ATP8B1;ABCC1;RFT1;ATP9B;ABCA1;ATP11C;ATP9A;ATP8B2;ATP10B
prerank,regulation of T cell migration (GO:2000404),0.6419829637278849,1.4835210394573108,0.07606973058637084,0.7063813116160135,1.0,2/18,1.08%,APOD;RIPOR2
prerank,negative regulation of fat cell differentiation (GO:0045599),0.5538585354922767,1.4833878544160377,0.05873925501432665,0.7035919408637257,1.0,4/34,4.97%,RORA;TRIB2;WNT5A;TRIO
prerank,modulation of chemical synaptic transmission (GO:0050804),0.4670373918337369,1.4830643410939905,0.02558139534883721,0.701601600265153,1.0,18/107,13.23%,NGF;CLSTN2;CEL;SLC12A2;OPHN1;DGKZ;CLSTN3;NPTX2;ATP1A2;RIMS2;CPLX1;CDH2;GRID1;RELN;PTEN;DLGAP2;HCRT;GRM1
prerank,regulation of Ras protein signal transduction (GO:0046578),0.48048569385124823,1.482908923760649,0.022304832713754646,0.6989366513391218,1.0,20/85,7.87%,NGF;DLC1;ARHGEF28;PLCE1;OGT;AKAP13;LZTR1;SPRY1;OPHN1;MMD2;MFN2;SPRY4;NUP62;KANK2;LRRC59;EPHB2;RDX;KANK1;ARF6;STARD13
prerank,GPI anchor biosynthetic process (GO:0006506),0.5704287887048697,1.4825073711520607,0.07342143906020558,0.697185931106819,1.0,4/30,9.38%,PIGU;PGAP3;PIGB;PIGA
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.6090535748294964,1.481641324802947,0.08794788273615635,0.6976443845124388,1.0,2/19,0.38%,DCN;SMOC2
prerank,ear morphogenesis (GO:0042471),-0.5092764949459212,-1.481156709199121,0.07977207977207977,0.5082008759966646,1.0,5/20,6.20%,OSR1;CHD7;MYO6;FGFR2;TBX1
prerank,positive regulation of positive chemotaxis (GO:0050927),0.6406236687344253,1.4798905463403664,0.08852459016393442,0.7016661368710931,1.0,2/15,0.51%,NTRK3;CDH13
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.4557420426074137,1.4791407134567145,0.036556603773584904,0.7012750976137072,1.0,16/113,7.43%,THBS4;CLDN1;FGF7;CDH13;LAMC1;NRARP;EGFR;FGF1;NRP2;PRKCA;SOX9;BMP5;WNT5A;NRAS;EGFL7;RREB1
prerank,apical junction assembly (GO:0043297),0.5112706905457499,1.4775826488621382,0.046875,0.7046351210196774,1.0,15/53,14.58%,CLDN1;F11R;CLDN11;CLDN19;PARD6B;CDH5;POF1B;OCLN;PDCD6IP;CLDN10;STRN;APC;PATJ;FBF1;CTNNA1
prerank,negative regulation of proteolysis (GO:0045861),-0.4485054931609833,-1.4765827014941053,0.032679738562091505,0.5194824143392439,1.0,9/34,12.09%,TIMP3;PTPN3;DNAJC1;EPHA4;GAS1;SERPINE2;AKT1;CAMK2N1;LRRK2
prerank,diacylglycerol metabolic process (GO:0046339),0.5931841455163006,1.475364102911492,0.07535321821036106,0.710644233275351,1.0,4/23,3.64%,DGKA;PLCE1;MOGAT2;DGKZ
prerank,epithelial structure maintenance (GO:0010669),0.6846098307910331,1.474666333464475,0.09044368600682594,0.7103853603787982,1.0,1/11,0.29%,CXADR
prerank,sterol homeostasis (GO:0055092),0.49957268662690135,1.474308835819857,0.038605230386052306,0.7086126064053467,1.0,6/65,8.05%,RORA;CAV1;CYP7B1;GRAMD1B;SOAT1;ABCA1
prerank,positive regulation of fat cell differentiation (GO:0045600),-0.4096536529332968,-1.4742304140232223,0.043478260869565216,0.5227190515563914,1.0,18/47,18.85%,SOX13;TMEM64;CREBL2;PPARD;NAPEPLD;AKT1;CREB1;CMKLR1;ASXL2;ZC3H12A;BMP2;NOCT;ID2;CEBPB;ZFP36;LRP5;PIM1;RARRES2
prerank,negative regulation of cell motility (GO:2000146),-0.34586409157414666,-1.4740515080428498,0.007194244604316547,0.5194568522201315,1.0,31/108,11.62%,ROBO1;ENG;AFDN;CLDN5;LIMCH1;FBLN1;SLIT2;FRMD5;RECK;DACH1;TPM1;CLIC4;IGFBP5;EPHA4;PTPRK;ACVRL1;PODN;MITF;CYP1B1;SRGAP1;DUSP10;DUSP3;CCDC125;CRK;TMEFF2;BST2;CITED2;RHOB;SINHCAF;ARID2;FUZ
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),-0.4325649434981483,-1.4737425941720077,0.04398826979472141,0.51647358240498,1.0,10/35,9.13%,IRAG1;KSR1;RAPGEF2;PDE7B;ADGRG6;ADCY1;AKAP6;APOE;ADCY2;PDE2A
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.6909247698464074,1.4732696435470178,0.0821917808219178,0.7098405326695257,1.0,2/10,8.07%,APOD;PTPRJ
prerank,protein kinase B signaling (GO:0043491),-0.4806821681820663,-1.4716772315037154,0.05232558139534884,0.5192127183822515,1.0,4/23,8.34%,IGF1;PIK3R3;KDR;AKT1
prerank,regulation of cholesterol esterification (GO:0010872),-0.6117993013539653,-1.4708976343315499,0.0687960687960688,0.5178918277046346,1.0,5/10,19.39%,AGTR1;APOE;ABCA2;ABCG1;AGT
prerank,negative regulation of cell differentiation (GO:0045596),0.44111093302466353,1.4695530801357088,0.015300546448087432,0.7222036144842172,1.0,32/181,13.03%,PTCH1;RORA;CAV1;TRIB2;ADAMTS12;EFEMP1;EGFR;DTX1;JAG1;SPRED1;SPRY1;PTHLH;SOX9;BMP5;WNT5A;TRIO;LEO1;ANKRD2;PAF1;LDLRAD4;ABCA1;NELFB;RORB;SDHAF2;FERMT2;WNT9A;MEN1;CHADL;SEMA4D;PTEN;HOPX;SPRED2
prerank,regulation of Rho protein signal transduction (GO:0035023),0.48206808522046485,1.4695050404640624,0.045743329097839895,0.719121377766537,1.0,16/72,8.05%,DLC1;ARHGEF28;F11R;LPAR1;RIPOR2;SCAI;AKAP13;RTN4R;OPHN1;KANK2;COL3A1;ABL2;KANK1;CUL3;STARD13;ABCA1
prerank,mesonephric tubule development (GO:0072164),-0.5610490351996184,-1.4694945511331863,0.06516290726817042,0.5186184368449472,1.0,4/15,3.88%,OSR1;SLIT2;BMP4;FGFR2
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),-0.6132312327391414,-1.467478926350725,0.060810810810810814,0.5217103839381989,1.0,10/10,38.72%,ACER2;CYP1B1;NEXMIF;WNK1;PDE3B;JAM3;HRG;SNAI2;SERPINE1;MUC1
prerank,respiratory system development (GO:0060541),0.5349876137801365,1.4671702105204656,0.08296943231441048,0.7256830936022404,1.0,4/32,2.75%,STRA6;FGF7;FGF1;GLI2
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.4712246815257185,1.4670421606985697,0.02403846153846154,0.7229687673995477,1.0,24/95,12.39%,DCN;GPC3;CSPG4;ST3GAL4;PRELP;UST;XYLT2;GPC6;GLCE;B4GAT1;CHST7;NCAN;NDST1;SDC1;SLC35D2;GCNT2;CHST2;HEXA;CHST12;HS3ST6;HS3ST5;HSPG2;GPC2;SDC3
prerank,embryonic limb morphogenesis (GO:0030326),0.5476693359082339,1.4668601712872456,0.06821480406386067,0.7204660864167629,1.0,2/34,1.16%,PTCH1;AFF3
prerank,positive regulation of keratinocyte migration (GO:0051549),0.7025704034419168,1.466038529857514,0.08499095840867993,0.7206670458999803,1.0,3/10,12.50%,FGF7;ARF6;MAPRE2
prerank,regulation of RNA splicing (GO:0043484),0.4861324646659625,1.4653839477690556,0.045743329097839895,0.7202959075820256,1.0,21/69,15.16%,AHNAK;AHNAK2;CLK1;QKI;SLC38A2;CELF1;SON;ZNF326;CLK4;RBM22;SRPK1;DYRK1A;PTBP3;RPS13;KHDRBS2;SRPK2;PTBP2;ERN1;TRA2B;RBM38;SF1
prerank,response to histamine (GO:0034776),0.6951789151824563,1.4645777781008815,0.09009009009009009,0.720487625469851,1.0,3/10,12.09%,HRH1;GABRG2;GABRB3
prerank,positive regulation of filopodium assembly (GO:0051491),0.572637274619241,1.464407456464016,0.09063444108761329,0.7180638384935878,1.0,3/24,2.03%,TENM2;RIPOR2;ARAP1
prerank,metanephric mesenchyme development (GO:0072075),-0.6188782064241256,-1.463280376562218,0.06451612903225806,0.5321362584327696,1.0,2/10,3.07%,OSR1;WNT4
prerank,protein localization to cell-cell junction (GO:0150105),0.6290293392103109,1.462041158369597,0.09259259259259259,0.7244353717363458,1.0,5/15,7.65%,F11R;CDH5;TJP2;LSR;CGNL1
prerank,cellular response to estradiol stimulus (GO:0071392),0.6220978811550779,1.4618932878263118,0.08818897637795275,0.7219139231761292,1.0,9/18,18.66%,EGFR;SSTR1;NRIP1;POU4F1;NCOA3;LCOR;CCDC62;GPER1;RUVBL2
prerank,positive regulation of transforming growth factor beta production (GO:0071636),-0.5946289412866602,-1.461570052386346,0.07178217821782178,0.5337195129846841,1.0,5/11,15.93%,CD34;CD200;THBS1;GATA6;LGALS9
prerank,ERBB2 signaling pathway (GO:0038128),0.5504646063100609,1.460541199744155,0.060382916053019146,0.7241983761208177,1.0,4/31,4.43%,GAB1;EGFR;PRKCA;SRC
prerank,aminoglycan biosynthetic process (GO:0006023),0.5112102482326453,1.4604078720015758,0.059379217273954114,0.7216229802666351,1.0,19/49,17.83%,GPC3;XYLT2;GPC6;B3GALT1;B4GAT1;NDST1;SDC1;SLC35D2;GCNT2;HEXA;HS3ST6;HS3ST5;HSPG2;GPC2;SDC3;EXT1;EXT2;SDC4;GPC5
prerank,sulfation (GO:0051923),0.6740053983123767,1.4597343320460636,0.08163265306122448,0.7210142342246837,1.0,3/11,11.64%,UST;SULT1A1;HS3ST5
prerank,regulation of centriole replication (GO:0046599),0.6160203294481028,1.4594521029249758,0.08667736757624397,0.7191449404531333,1.0,3/17,5.07%,PLK2;STIL;NUP62
prerank,regulation of protein export from nucleus (GO:0046825),0.5853362465267088,1.4591491159375283,0.09193548387096774,0.7173629878396443,1.0,9/23,13.07%,GTSE1;RAPGEF3;PTPN14;BAG3;RBM22;GSK3B;SIRT7;TPR;EMD
prerank,endocrine system development (GO:0035270),0.5896740347456749,1.4589984153788724,0.0770440251572327,0.7150298422114223,1.0,3/21,3.16%,STRA6;GLI2;NF1
prerank,regulation of activated T cell proliferation (GO:0046006),-0.451902404441819,-1.4587184387431948,0.04477611940298507,0.5398971834106404,1.0,9/30,18.79%,IGF1;IGFBP2;IGF2;IL18;RPS3;LGALS9;RC3H1;ICOSLG;CD24
prerank,regulation of nuclear division (GO:0051783),0.5960524933358136,1.4586982621739153,0.0953125,0.713299732554006,1.0,5/20,7.40%,FBXO43;KIF20B;CAV2;CDK13;FBXO5
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.4455443376755825,1.458659551922172,0.02367531003382187,0.7104650680068162,1.0,20/142,9.55%,CAV1;LPAR1;ACKR3;PLCE1;ITPR3;PTGFR;SLC8B1;CD55;FKBP1B;TRPV4;CAV2;WNT5A;ATP2B4;FIS1;ATP1A2;ADCY5;ABL2;PTGER4;HCRTR2;HMGB1
prerank,diterpenoid metabolic process (GO:0016101),0.4934286742284267,1.458185329103771,0.05442176870748299,0.7092648179118416,1.0,13/55,12.39%,STRA6;GPC3;RDH10;GPC6;RDH5;AWAT2;BCO1;OPN1MW;SDC1;AKR1B10;HSPG2;GPC2;SDC3
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.6727950891987089,1.4574529199062245,0.10193321616871705,0.7092231497140391,1.0,2/10,3.14%,RAPGEF3;KMT2A
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),0.6846906524016654,1.4568664649196577,0.10806174957118353,0.708464441204253,1.0,3/10,13.02%,CAV1;KCNAB1;KCNRG
prerank,positive regulation of sodium ion transport (GO:0010765),0.659703047476133,1.4566470420630468,0.078125,0.7063989209354509,1.0,1/12,0.19%,CNKSR3
prerank,protein processing (GO:0016485),0.4632342601918902,1.4562656454686533,0.034924330616996506,0.7051271726954496,1.0,10/102,6.29%,PTCH1;KLK2;PCSK5;ADAM19;OGT;APH1B;CD5L;CPE;NCSTN;ADAM10
prerank,inner ear receptor cell stereocilium organization (GO:0060122),-0.6053188952413431,-1.455382726031468,0.07126948775055679,0.5478138765262632,1.0,4/10,21.18%,ADGRV1;PDZD7;TSKU;PLS1
prerank,regulation of neurotransmitter transport (GO:0051588),-0.5236563204071396,-1.4552102433358538,0.07341772151898734,0.5444777409611573,1.0,7/16,20.49%,SNCAIP;MCTP2;SYN1;CAMK2A;CPLX2;FLOT1;RIMS1
prerank,negative regulation of synaptic transmission (GO:0050805),0.5928803423360353,1.4550195471699812,0.0794392523364486,0.7072212448611329,1.0,2/23,2.80%,PLK2;SLC24A1
prerank,gland development (GO:0048732),0.4912368990769135,1.454264595510565,0.061224489795918366,0.7073908860648919,1.0,10/59,5.76%,STRA6;CAV1;COBL;WNT10A;GLI2;NF1;SOX9;LSR;IGSF3;GFER
prerank,negative regulation of response to external stimulus (GO:0032102),0.4568411804087404,1.4540790742002685,0.027809965237543453,0.7053478112226562,1.0,22/105,11.38%,RORA;CLDN19;CDH5;CXCL17;AJAP1;CASK;RTN4R;PCBP2;FNDC4;IRAK3;TNFAIP3;TRIM21;SELENOS;PTGER4;MAPK7;ISL1;ACOD1;TRAFD1;INPP5F;SHARPIN;RTN4RL1;PROC
prerank,acylglycerol biosynthetic process (GO:0046463),0.5767939983881083,1.4536212648067979,0.08809891808346214,0.7043126352261826,1.0,6/23,3.77%,PLCE1;MOGAT2;MOGAT3;GPAT3;AWAT2;AGMO
prerank,regulation of ion transmembrane transport (GO:0034765),0.542472129196078,1.4535442248387778,0.07418397626112759,0.7017780724672361,1.0,11/33,16.59%,NEDD4L;KCNJ4;SCN10A;KCNJ16;ANO6;KCNJ13;CASQ2;NEDD4;CHRM3;WWP2;YWHAE
prerank,monocyte differentiation (GO:0030224),-0.6222672672206978,-1.452255144510612,0.07972665148063782,0.5501567800647148,1.0,6/10,19.78%,IL31RA;BMP4;MT1G;PIR;PDE1B;MYH9
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.6224657587705824,1.4522090461056234,0.10702875399361023,0.7013947538177109,1.0,3/16,4.43%,APOD;DLC1;SRC
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.6224657587705824,1.4522090461056234,0.10702875399361023,0.7013947538177109,1.0,3/16,4.43%,APOD;DLC1;SRC
prerank,regulation of cell communication by electrical coupling (GO:0010649),0.6423409652526094,1.451537218986384,0.08429752066115702,0.7011886069879874,1.0,3/13,3.04%,CAV1;CAMK2D;PDE4D
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.4642066105718463,1.4514676430616178,0.05555555555555555,0.69870625792697,1.0,9/86,5.48%,THBS4;EFNA5;FGF7;TEC;CSPG4;EGFR;SRC;PTPRC;BANK1
prerank,negative regulation of sequestering of calcium ion (GO:0051283),0.560653911304644,1.4514622989691568,0.08520179372197309,0.6959847097116981,1.0,6/24,7.16%,ITPR2;ITPR3;ERO1A;IBTK;PTPRC;CHERP
prerank,sprouting angiogenesis (GO:0002040),-0.3987664493855825,-1.4513716115004591,0.03488372093023256,0.5493538675048596,1.0,23/51,16.82%,ROBO1;ENG;TEK;CCBE1;RSPO3;ANGPT1;RNF213;SLIT2;RECK;BMP4;PIK3R3;ACVRL1;KDR;AKT1;VEGFC;RAMP2;FLT4;VEGFD;THBS1;ESM1;BMPER;NAXE;NRP1
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.601534314841923,1.4508949375236542,0.08268330733229329,0.6956217509557063,1.0,8/21,9.81%,ARHGAP12;LZTR1;SPRY1;MFN2;SPRY4;EPHB2;CGNL1;MAPKAP1
prerank,superoxide anion generation (GO:0042554),-0.5651036462657983,-1.4507084599985325,0.09024390243902439,0.5477595569441075,1.0,4/13,11.07%,NOX4;CYBA;NOX1;NCF2
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),-0.4737012552682272,-1.4497967580340203,0.05128205128205128,0.5471467497642978,1.0,9/22,15.38%,PICALM;ROCK2;LYN;EPHA4;CASP3;GSK3A;SP1;ABCA2;ABCG1
prerank,cardiac cell development (GO:0055006),0.6820984304119283,1.449661953898178,0.10344827586206896,0.6978318390272943,1.0,2/11,2.27%,CXADR;JAG1
prerank,regulation of DNA replication (GO:0006275),0.5089866706534842,1.4495379047951866,0.07171853856562922,0.6955945584637605,1.0,20/49,19.81%,GLI1;EGFR;GLI2;CDAN1;SMC3;STN1;ORC5;FBXO5;ORC3;OBI1;FAF1;CDC6;NUCKS1;BRPF3;USP37;GMNN;DSCC1;PPP2CA;DHX9;ATR
prerank,negative regulation of lipid storage (GO:0010888),-0.50058579758151,-1.4486432758567436,0.06951871657754011,0.5472339878452566,1.0,5/19,8.10%,OSBPL8;PPARD;NR1H3;ABHD5;NR1H2
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.6696210503803444,1.4478640495069017,0.09124087591240876,0.6994867224565734,1.0,2/10,4.25%,LBP;PTPN22
prerank,clathrin coat assembly (GO:0048268),-0.5407226477054987,-1.447285048980324,0.06860158311345646,0.5479535554518068,1.0,6/15,10.40%,PICALM;HIP1;HIP1R;EPS15;PIK3C2A;NSG1
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.5560396860125798,1.4463022416180484,0.07964601769911504,0.7030118959094144,1.0,5/27,5.94%,DCN;CSPG4;XYLT2;CHST7;NCAN
prerank,sympathetic nervous system development (GO:0048485),0.6342960307166273,1.4449071190393856,0.10135135135135136,0.7056291393128359,1.0,5/15,14.48%,NRP2;NF1;SEMA3A;SOX4;FZD3
prerank,regulation of long-term synaptic potentiation (GO:1900271),-0.4611747475025557,-1.4448922537023465,0.049342105263157895,0.5524994639479511,1.0,11/28,14.85%,SHANK3;EPHA4;ADCY1;SQSTM1;APOE;LGMN;EIF2AK4;NSG1;YTHDF1;CALB1;ZDHHC2
prerank,amyloid precursor protein catabolic process (GO:0042987),0.6388533495963311,1.4446473822241457,0.09983361064891846,0.7038925770762845,1.0,5/14,8.30%,ADAM19;APH1B;NCSTN;ADAM10;DYRK1A
prerank,regulation of sodium ion transmembrane transport (GO:1902305),0.5581264882158736,1.4437259535588596,0.10087719298245613,0.7046306465703711,1.0,5/27,4.86%,UTRN;SLMAP;NEDD4L;CAMK2D;ATP2B4
prerank,aminoglycan catabolic process (GO:0006026),0.5594799553923792,1.4427778034639196,0.08042488619119878,0.7054844804948884,1.0,9/28,17.83%,GPC3;GPC6;SDC1;HSPG2;GPC2;SDC3;HGSNAT;SDC4;GPC5
prerank,"wound healing, spreading of cells (GO:0044319)",-0.4774003379152604,-1.4426288157402647,0.06060606060606061,0.5565174764605396,1.0,10/24,9.92%,ARHGAP24;COL5A1;DDR1;ACVRL1;PDCD10;ARHGAP35;TMEFF2;RHOC;FLNA;CCN1
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.5860065234633185,1.4422755678519443,0.0764525993883792,0.7047068601211709,1.0,5/23,9.24%,UBASH3B;CAMK2D;ATP1A2;NOS1AP;CASQ2
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.633840375825533,1.4422519698987788,0.09491525423728814,0.702163859813181,1.0,7/13,16.93%,CDH13;CD9;ABCA1;CD81;LPL;PPARG;SYK
prerank,regulation of filopodium assembly (GO:0051489),0.5292810756098402,1.4408819400339221,0.08285714285714285,0.7048983950270727,1.0,8/38,9.44%,TENM2;RIPOR2;ARAP1;CAPZB;FXR2;ARF6;PALM;GPM6A
prerank,skeletal system morphogenesis (GO:0048705),-0.41174857046236707,-1.4403768302291298,0.048327137546468404,0.5601004317189348,1.0,20/42,18.91%,PDGFRA;CYP26B1;HOXA3;TGFBR1;FGFR2;HOXB4;DSCAML1;HOXB9;LRP6;HOXC4;SPEF2;HOXA9;FUZ;MEGF8;HOXD4;HOXD3;ANKRD11;WWOX;LRP5;RFLNB
prerank,amide biosynthetic process (GO:0043604),0.5095239434777896,1.4401297894204992,0.0687757909215956,0.7052462436938712,1.0,7/47,5.80%,SGMS2;CERS6;ARG1;ASS1;PCSK5;ALOXE3;CLN8
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.5260885086167285,1.4397058962745404,0.09379509379509379,0.7043549660133168,1.0,9/33,8.77%,GLI1;EGFR;CCND3;ADAMTS1;UBE2E2;FAM83D;PAF1;RDX;DDRGK1
prerank,negative regulation of cellular senescence (GO:2000773),-0.5510720689999741,-1.4397022643307325,0.06682577565632458,0.5586946237127685,1.0,5/13,8.15%,SLC30A10;AKT3;ZKSCAN3;RBL1;CDK6
prerank,regulation of embryonic development (GO:0045995),-0.43192631902740575,-1.4394501964407276,0.07260726072607261,0.5558236012113448,1.0,8/34,9.44%,PLCB1;PHLDB2;INSR;NPHP3;CFL1;ZBED3;SOX17;WDPCP
prerank,positive regulation of synaptic transmission (GO:0050806),0.4797774115048009,1.438200586220802,0.05816831683168317,0.707508188707258,1.0,8/72,6.79%,CLSTN2;PLK2;TSHZ3;RGS14;SLC24A1;CLSTN3;EPHB2;RIMS2
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),-0.5154036926129757,-1.437988683024941,0.06162464985994398,0.5574048185258427,1.0,7/16,13.76%,NPR3;HIF1A;APOE;GCH1;AKT1;S100A1;DHFR
prerank,regulation of interleukin-13 production (GO:0032656),-0.5457729023263646,-1.4371438700295283,0.07783018867924528,0.5564154754567895,1.0,5/13,15.93%,LEF1;IL18;TNFRSF21;PRKCZ;LGALS9
prerank,regulation of calcium ion import (GO:0090279),-0.4800549564173775,-1.4370775517310903,0.06631299734748011,0.5530790555276733,1.0,9/21,32.54%,PDGFRB;CXCL12;EGF;PLPP4;PLN;TRIM27;STC1;PSEN2;CCL2
prerank,miRNA metabolic process (GO:0010586),0.5916489373549513,1.43582026882394,0.09865470852017937,0.7141360974409745,1.0,8/20,17.58%,DDX17;DIS3L2;LIN28B;DGCR8;DICER1;RAN;PRKRA;XPO5
prerank,positive regulation of growth (GO:0045927),-0.3752179707158539,-1.4345288281582025,0.02586206896551724,0.5582148777793554,1.0,23/64,17.28%,PLCB1;INSR;ADNP2;CDC42;TGFBR1;CXCL16;RFTN1;AKAP6;AKT1;SLC25A33;MFSD2A;TGFB2;CSNK2A1;SPHK1;LGI1;CDKN2AIP;FXN;ZPR1;HDGFL2;PABIR1;EIF4G1;NCBP1;DERL2
prerank,regulation of protein autophosphorylation (GO:0031952),-0.4256767641009866,-1.4324962111835047,0.03741496598639456,0.5611484519683785,1.0,5/36,1.19%,PDGFD;ENG;EPHA7;ERRFI1;ENPP1
prerank,B cell receptor signaling pathway (GO:0050853),0.5410507465425483,1.4321319000699586,0.09090909090909091,0.725610343070119,1.0,4/32,5.03%,TEC;NFATC2;ITK;PTPRC
prerank,protein neddylation (GO:0045116),-0.5517192988274867,-1.4317274023918347,0.08651399491094147,0.560132056333937,1.0,7/13,24.53%,RBX1;UBA3;NEDD8;NAE1;DCUN1D4;UBE2F;DCUN1D3
prerank,regulation of fatty acid biosynthetic process (GO:0042304),-0.4587769912900751,-1.4307545832095283,0.05232558139534884,0.5599117362771544,1.0,11/26,14.61%,PRKAG2;LPGAT1;ADIPOR2;NR1H3;ERLIN1;WDTC1;NR1H2;PRKAB2;SLC45A3;ERLIN2;MID1IP1
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.5346639861455317,1.4303644785001202,0.07602339181286549,0.729845317400397,1.0,1/31,0.01%,PTCH1
prerank,negative regulation of transport (GO:0051051),-0.39124224672291685,-1.4297609324349774,0.031746031746031744,0.5599466227053632,1.0,19/51,23.37%,EPHA3;CTTNBP2NL;DYSF;NR1H3;SIRPA;PIP4P2;ARL6IP5;BST2;NR1H2;SCAMP5;RUBCN;CRYAB;PXK;EGF;YRDC;RACK1;PRKD1;RAB7A;ERBB3
prerank,regulation of establishment of protein localization (GO:0070201),-0.5543873115093376,-1.4295813724267183,0.07389162561576355,0.5569286482085758,1.0,7/13,18.29%,DNAJA1;CORO2B;CEP135;CTSD;CEP120;SCFD1;GAPVD1
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.5567797286558286,1.429544613971799,0.09748427672955975,0.7302492578661723,1.0,5/24,7.30%,PPARGC1A;LEPR;SDHAF4;LYRM7;COX15
prerank,cyclooxygenase pathway (GO:0019371),-0.609558217544707,-1.429540492887564,0.09684684684684684,0.5536639668988392,1.0,5/10,17.55%,PTGIS;PTGDS;PTGS1;TBXAS1;HPGDS
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.6137663910412106,1.4291739815764402,0.12111292962356793,0.7291186067826767,1.0,2/15,0.71%,SMOC2;FGFR1
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),-0.400601499833908,-1.4276149695082945,0.032490974729241874,0.5565381269705013,1.0,19/47,26.38%,PDGFRB;PID1;XDH;AGTR1;PLCG2;CYBA;GRIN1;ZC3H12A;THBS1;MAPT;ACE2;ADGRB1;ROMO1;AGT;RAB27A;GRB2;RIPK1;ITGB2;ITGAM
prerank,long-chain fatty acid transport (GO:0015909),-0.4400499384520035,-1.4273136037830236,0.034782608695652174,0.554102416109554,1.0,12/30,14.61%,PRKAG2;ACSL1;ACSL3;RPS6KB1;APOE;ABCD4;CPT2;PRKAB2;ABCD2;MFSD2A;CPT1A;MID1IP1
prerank,regulation of axonogenesis (GO:0050770),0.5011156440199998,1.426787482236391,0.07537012113055182,0.7356334986809555,1.0,10/51,9.14%,NGF;SIPA1L1;LRP4;TIAM2;RTN4R;PLXNA3;BRSK1;GDI1;CDH2;GSK3B
prerank,postsynaptic membrane organization (GO:0001941),0.6075153180195015,1.4265528771985045,0.11483253588516747,0.7339983155880941,1.0,3/17,1.86%,LRP4;CEL;MUSK
prerank,aspartate family amino acid metabolic process (GO:0009066),0.5878690784444375,1.426212975406056,0.1156773211567732,0.7327070714938854,1.0,8/18,14.42%,ASS1;NAALAD2;SLC25A12;NIT2;MTHFD1;SLC25A13;GOT1;SMS
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.4767555697363612,1.4257667801363627,0.06030150753768844,0.7318776542723044,1.0,6/67,2.15%,VIT;CDH13;UTRN;DOCK5;ECM2;DOCK1
prerank,negative regulation of neuron differentiation (GO:0045665),0.5753177923648274,1.4257202123736403,0.11292719167904904,0.7294657253513022,1.0,4/22,9.14%,DLX1;DTX1;SOX9;GSK3B
prerank,regulation of mitochondrial depolarization (GO:0051900),0.6676995406337378,1.4254222237590164,0.12248322147651007,0.7280467893354302,1.0,2/10,4.43%,DCN;SRC
prerank,embryonic digit morphogenesis (GO:0042733),-0.4994974701447108,-1.4251494986006836,0.08270676691729323,0.5576666877694574,1.0,7/18,9.44%,ECE1;OSR1;MAP3K20;GLI3;TBX3;HDAC1;WDPCP
prerank,regulation of establishment of planar polarity (GO:0090175),0.46304613280233653,1.4250147079915438,0.05378973105134474,0.7270388922728032,1.0,28/88,18.81%,ROR2;PRICKLE1;PRICKLE2;FZD2;SPEF1;SAPCD2;PSME3;WNT5A;DACT1;PSMB5;DVL3;VANGL1;FZD7;PSMA6;FZD3;PSMB2;PSMA2;PSMD13;AP2A2;PSMA7;CELSR1;PSME4;CELSR2;RHOA;PSMD12;PSMD14;PSMB6;PSMC4
prerank,triglyceride metabolic process (GO:0006641),0.5037853625734139,1.4249551528563416,0.07029177718832891,0.7247262337513538,1.0,5/48,3.77%,CAV1;MOGAT2;MOGAT3;GPAT3;AGMO
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.5324181611666462,1.4240354872600118,0.08460471567267684,0.7259369153782946,1.0,12/35,9.81%,DLC1;RIPOR2;SCAI;LZTR1;SPRY1;MFN2;SPRY4;EPHB2;ABL2;KANK1;CUL3;MAPKAP1
prerank,regulation of mitochondrial fission (GO:0090140),0.5594766018951767,1.4231913751270373,0.09162717219589257,0.7265307436618845,1.0,11/24,21.16%,DCN;DDHD1;FIS1;MIEF1;STAT2;BNIP3;RALBP1;PINK1;RALA;MUL1;PRKN
prerank,regulation of insulin secretion (GO:0050796),0.4549778540746207,1.4229635301869918,0.04441776710684274,0.7249162453359141,1.0,17/101,10.61%,EFNA5;INHBB;ITPR2;ITPR3;KCNA5;SLC8B1;RAPGEF3;RAP1A;STX1A;PRKCA;RAPGEF4;ADCY5;SLC2A2;DPP4;ISL1;KCNS3;ADRA2A
prerank,epithelial cell-cell adhesion (GO:0090136),0.6612222526424474,1.4217429116703744,0.12244897959183673,0.7269968038084668,1.0,1/11,0.08%,THBS4
prerank,acylglycerol metabolic process (GO:0006639),0.5239459412953644,1.4216659189001315,0.0847457627118644,0.724730985447728,1.0,7/37,13.12%,CAV1;DGKA;AWAT2;DGKZ;ABHD12;LMF1;GK
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.6150587284924204,1.4202980112699242,0.13125,0.7276063975858932,1.0,7/15,16.51%,MGAT3;CHST7;EXTL2;CHST2;NAGK;GNPDA2;OGA
prerank,regulation of platelet aggregation (GO:0090330),0.6043477463970108,1.420181319753916,0.10526315789473684,0.7255393127476237,1.0,4/17,4.15%,F11R;CEACAM1;PRKCA;CD9
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.37452486638791077,-1.4201710353508252,0.028455284552845527,0.571259079357941,1.0,7/57,3.90%,IGF1;IL31RA;GHR;IL6R;LYN;KIT;IL18
prerank,myelin assembly (GO:0032288),0.6685369106514862,1.4194448134837134,0.12302284710017575,0.7258891189187021,1.0,5/10,14.26%,EPB41L3;CD9;CNTNAP1;NCMAP;DICER1
prerank,protein localization to cell surface (GO:0034394),0.5652967187499606,1.4193559555535629,0.09226190476190477,0.7237259002260107,1.0,3/26,2.90%,PIGU;FGF7;RIC3
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.577069233390017,-1.4185948575772978,0.08048780487804878,0.5732267067574944,1.0,4/11,1.90%,RSPO3;NKD1;DAB2;WNT5B
prerank,regulation of hydrolase activity (GO:0051336),0.4696244174486028,1.4185463673482774,0.05926860025220681,0.7244847257438534,1.0,16/71,9.32%,CAV1;EFNA5;SIPA1L1;ARHGAP12;ARHGAP9;CFAP73;TDG;NF1;VAV2;PLXNA3;ARHGEF5;RAB3GAP2;RDX;PAFAH1B1;RAPGEF6;OCRL
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),-0.5873436988771408,-1.4179509585452725,0.10823529411764705,0.5719852001006438,1.0,5/10,24.18%,KDR;IL33;JAK2;NOD2;NAMPT
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.6094232045360714,1.4173173692486971,0.102803738317757,0.7267415702461378,1.0,5/15,8.77%,GLI1;FAM83D;PAF1;CUL3;DDRGK1
prerank,positive regulation of tissue remodeling (GO:0034105),-0.5958360464473269,-1.4169592637389254,0.1,0.5718936751086905,1.0,2/10,3.90%,ROCK2;IL18
prerank,superoxide metabolic process (GO:0006801),-0.4439685733932146,-1.4167225903254996,0.06369426751592357,0.5692358016163681,1.0,9/29,11.07%,NOS3;ATP7A;SOD3;PRDX2;NOX4;NRROS;CYBA;NOX1;NCF2
prerank,negative regulation of leukocyte activation (GO:0002695),-0.5193056265682396,-1.4166214915812438,0.08951406649616368,0.5662678180236922,1.0,11/15,35.08%,IL31RA;NR1H3;CD200;ZC3H12A;GRN;FCGR2B;LRFN5;CD300LF;MILR1;CD300A;CD84
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),-0.5966835774143892,-1.4154607411134084,0.08139534883720931,0.5669417418321631,1.0,8/10,31.80%,PARD3;PLPP1;GAP43;PRKD3;PICK1;HTR2B;F2R;CHRM1
prerank,negative regulation of MAPK cascade (GO:0043409),0.4639359100611983,1.4153828022951322,0.04691358024691358,0.7316886118627427,1.0,15/87,8.57%,CNKSR3;CAV1;RGS14;STK38;SPRED1;NF1;SPRY1;SPRY4;IRAK3;PTPRC;EPHB2;DAG1;PTPRJ;PIK3R2;TNIP1
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),-0.5012371636887188,-1.4148537317678342,0.0670391061452514,0.565513021629414,1.0,8/18,13.48%,AKT3;HDAC7;HDAC9;KDR;ANXA1;PIK3C2A;GATA2;SRPX2
prerank,fatty acid elongation (GO:0030497),0.643180581868109,1.4138326912365144,0.11686143572621036,0.7352747409788227,1.0,7/13,13.02%,ELOVL5;ELOVL1;HACD4;ELOVL2;HACD2;ABCD1;ELOVL6
prerank,regulation of dopamine secretion (GO:0014059),-0.447276049584447,-1.4133261897647598,0.06645569620253164,0.5672217197276477,1.0,18/25,43.24%,SYT9;SYT7;DTNBP1;SYT13;SYT6;KCNA2;CHRNA4;SYT15;SYT1;SYT5;SYT17;CHRNB2;SNCA;SYT4;SYT3;DRD3;FGF20;SYT8
prerank,regulation of neuron differentiation (GO:0045664),0.4605625568147623,1.4131455087094704,0.06132665832290363,0.735438756829504,1.0,7/76,5.11%,NGF;FGFR1;DTX1;ZC4H2;MMD2;NBL1;HEYL
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.5613523061442461,1.4121849384195024,0.10429447852760736,0.736645150292443,1.0,7/23,16.34%,PLK2;WEE1;CHFR;CHMP4C;ZWILCH;ZW10;INTS3
prerank,positive regulation of phospholipase C activity (GO:0010863),0.5139349293780404,1.4120031036308374,0.09024745269286755,0.7348999916435999,1.0,8/40,6.50%,NTRK3;FGFR1;LPAR1;EGFR;ITK;TXK;GNAQ;ABL2
prerank,heart development (GO:0007507),0.4296189648322192,1.40798642747758,0.03421633554083885,0.7478505271708076,1.0,22/150,5.68%,STRA6;CXADR;DLC1;GPC3;NTRK3;PLCE1;SGCD;PCSK5;PDLIM4;GLI2;NF1;AKAP13;SMYD4;SGCG;SOX9;CSRP3;BMP5;APLN;SH3PXD2B;MTHFD1;FN1;COL3A1
prerank,toxin transport (GO:1901998),0.6669115733449804,1.4075621412321861,0.13485113835376533,0.7470689878046294,1.0,5/10,12.38%,RAB29;SLC29A4;SLC22A3;ADAM10;RAB40B
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.5266517619391555,-1.4073041353690348,0.07368421052631578,0.5841381825503092,1.0,5/15,19.39%,PRKCH;IL18;AGTR1;CSF1;AGT
prerank,positive regulation of BMP signaling pathway (GO:0030513),0.5447695450257819,1.4070284437726257,0.09883720930232558,0.7466327231829671,1.0,6/25,4.13%,SULF1;ZNF423;FOXD1;FBXL15;CDH5;BMPR1B
prerank,cellular response to exogenous dsRNA (GO:0071360),0.6275269924686077,1.4065266075194487,0.1166077738515901,0.7461589098001117,1.0,1/12,0.25%,CAV1
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.6267952818294479,1.4056451971015587,0.12413793103448276,0.7472721330906166,1.0,1/12,0.25%,CAV1
prerank,negative regulation of secretion by cell (GO:1903531),0.5146571638383775,1.4056122571784424,0.0896551724137931,0.744933281945516,1.0,1/38,0.06%,STXBP6
prerank,glycogen catabolic process (GO:0005980),-0.5264998220208652,-1.4054816569892454,0.10610079575596817,0.5870094015190848,1.0,10/15,34.73%,PGM2L1;CALM1;AGL;PHKG1;PYGB;PYGL;PHKA2;PHKB;PYGM;STBD1
prerank,morphogenesis of an epithelium (GO:0002009),0.551193404480671,1.4043138856269757,0.1058282208588957,0.747373530031098,1.0,7/25,8.42%,RIPK4;WNT10A;ARHGAP12;SOX9;LAMA5;DAG1;TBX18
prerank,mitotic chromosome condensation (GO:0007076),-0.46141623524203745,-1.404199498733468,0.0950920245398773,0.5880669055696167,1.0,13/26,30.39%,PHF8;SMC4;NCAPD3;MCPH1;CSNK2A1;CSNK2B;AKAP8L;NCAPG2;NCAPD2;NUSAP1;NCAPH;TTN;NCAPG
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.4608801751756,1.4039588255436335,0.0605296343001261,0.7463632702245762,1.0,10/75,6.81%,THBS4;CDH13;FGFR1;NRARP;NRP2;PRKCA;WNT5A;APLN;NRAS;EGFL7
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),-0.4406428897275785,-1.4031160904776863,0.06287425149700598,0.5884317568080355,1.0,9/28,12.45%,PID1;ENPP1;GRB10;APPL2;RPS6KB1;PIP4K2A;PRKCZ;GSK3A;PIP4K2C
prerank,regulation of dendritic cell apoptotic process (GO:2000668),-0.5629260227486353,-1.4027673030941497,0.1,0.586341658216253,1.0,3/10,7.35%,RAPGEF2;LYN;CXCL12
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.6502334180905356,1.402543927127458,0.13277310924369748,0.7496304811918396,1.0,3/11,7.57%,CAMK2D;SESTD1;NOS1AP
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.5282592243813409,1.4018460619874444,0.09461426491994178,0.7497904606389069,1.0,10/30,16.32%,CAV1;PTPRC;SRCIN1;INPP5F;NF2;MVP;SEMA4D;PTPN6;PIBF1;SOCS1
prerank,negative regulation of defense response (GO:0031348),0.4596899515619802,1.4016281358531029,0.07329192546583851,0.7481955278509395,1.0,16/77,11.38%,RORA;CDH5;CXCL17;PCBP2;FNDC4;IRAK3;TNFAIP3;TRIM21;SELENOS;PTGER4;MAPK7;ISL1;ACOD1;TRAFD1;SHARPIN;PROC
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),-0.51878402566288,-1.4014421752283914,0.09319899244332494,0.5873914802789654,1.0,10/15,35.18%,JMY;ARPC3;IQGAP2;ACTR2;ARPC1A;ARPC5;TRIM27;ARPC5L;WASHC1;ARPC1B
prerank,platelet degranulation (GO:0002576),-0.3220336507017387,-1.4011894578245334,0.015267175572519083,0.5850016794138476,1.0,30/118,15.09%,IGF1;TIMP3;VWF;ACTN2;ABCC4;PECAM1;PCDH7;CLEC3B;LYN;SPARC;CDC37L1;IGF2;NHLRC2;CALM1;PROS1;TGFB3;VEGFC;CYRIB;QSOX1;SYTL4;PHACTR2;FLNA;MANF;VEGFD;THBS1;TGFB2;TMSB4X;F5;LGALS3BP;TLN1
prerank,dendritic spine organization (GO:0097061),-0.4426507943946697,-1.4010957090255787,0.0647887323943662,0.5820709696802414,1.0,6/26,9.22%,IGF1R;INSR;SHANK3;CDC42;ITGA3;LGMN
prerank,phospholipid translocation (GO:0045332),0.5387855265139087,1.400729199496394,0.09402985074626866,0.7494589388433971,1.0,11/28,9.87%,ATP8B3;ATP8B1;ANO6;ABCC1;ATP9B;ABCA1;ATP11C;PLSCR1;ATP9A;ATP8B2;ATP10B
prerank,sodium ion homeostasis (GO:0055078),0.5712022400148105,1.4006932388313629,0.10746268656716418,0.7472168957962898,1.0,5/21,9.89%,NEDD4L;SLC12A2;SLC12A3;ATP1A2;ATP1B3
prerank,regulation of cellular localization (GO:0060341),0.4904067882293723,1.4005963522131906,0.09746328437917223,0.7452420625416509,1.0,10/46,11.30%,EFNA5;CAMK2D;PARD6B;GOSR1;BRSK1;ADCY5;FER;TRIM46;WWC1;DVL3
prerank,organic hydroxy compound transport (GO:0015850),0.5131889272675776,1.3982158130516087,0.09490084985835694,0.7518024543476755,1.0,3/36,1.93%,STRA6;CEACAM1;ATP8B1
prerank,canonical Wnt signaling pathway (GO:0060070),0.4708559508253679,1.3977593547368914,0.08138101109741061,0.7511597690627803,1.0,25/68,19.58%,CAV1;WNT10A;FZD2;AXIN1;WNT2B;WNT16;PLPP3;WNT5A;GSK3B;CSNK1A1;RARG;DVL3;APC;WNT9A;PTEN;BCL9;FZD7;FZD9;FZD3;PPP1CA;WNT6;CDH3;RAB5A;TCF7L1;SCYL2
prerank,regulation of B cell apoptotic process (GO:0002902),-0.545962816713835,-1.3971727799213534,0.11538461538461539,0.5918945459032651,1.0,4/12,13.50%,FOXP1;LYN;FNIP1;NOC2L
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),-0.3995378821292672,-1.3966718550835115,0.04868913857677903,0.5905009956610413,1.0,16/43,14.09%,IGF1;PDGFRB;IL6R;MEF2D;FOXP1;BMP4;IGFBP5;GJA1;IL18;NOX1;AKT1;LDLRAP1;MMP2;THBS1;ID2;EDN1
prerank,purine-containing compound salvage (GO:0043101),-0.5365565868351249,-1.3966470451082946,0.11166253101736973,0.5874182670290492,1.0,2/12,3.37%,ADK;HPRT1
prerank,positive regulation of cell aging (GO:0090343),-0.5648707085748227,-1.395898525999748,0.1186046511627907,0.5867333544477799,1.0,5/11,19.72%,B2M;YPEL3;LMNA;EEF1E1;CGAS
prerank,positive regulation of amyloid-beta formation (GO:1902004),-0.49371106050492697,-1.395280429238819,0.09428571428571429,0.5856357630016709,1.0,8/18,15.38%,PICALM;ROCK2;EPHA4;CASP3;GSK3A;SP1;ABCA2;ABCG1
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.5126980079652618,-1.3948429605265815,0.09647058823529411,0.5838933522382987,1.0,9/16,33.06%,AGTR1;PDCD10;GATA2;THBS1;APLNR;DLL4;PPP1R16B;HMOX1;JCAD
prerank,cellular iron ion homeostasis (GO:0006879),-0.3773172724995775,-1.394831450034254,0.05172413793103448,0.5808158425549348,1.0,19/55,23.13%,BMP6;ABCG2;FTH1;TFRC;SCARA5;FTL;SLC11A2;NEDD8;SLC39A14;FXN;SLC40A1;HFE;SMAD4;CYBRD1;CUL1;SKP1;BOLA2;CCDC115;ISCU
prerank,regulation of chemotaxis (GO:0050920),-0.43863056335954265,-1.3948184695946633,0.05194805194805195,0.57784159156558,1.0,19/30,34.14%,PDGFRB;PDGFRA;DUSP3;CYRIB;ZSWIM6;YTHDF1;THBS1;ZSWIM4;P2RX4;RARRES2;ZSWIM8;CCL19;P2RY12;MYCBP2;PPM1F;ZSWIM5;CXCR4;AIF1;TREM2
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.5127046040756824,-1.3947929008109847,0.09181141439205956,0.5749219821790719,1.0,7/15,25.40%,IGF1;AKT1;FXN;GHITM;OPA1;CLU;PSMD10
prerank,histone H3-K4 trimethylation (GO:0080182),0.6400462411554073,1.39472504331132,0.12695652173913044,0.7607998938578574,1.0,3/11,3.76%,OGT;KMT2A;BEND3
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.663241624547231,1.3934755247031054,0.12762237762237763,0.7633759125628091,1.0,4/10,5.41%,NEDD4L;PRKCE;CAMK2D;ATP1A2
prerank,presynaptic endocytosis (GO:0140238),0.5557309822932622,1.3931997215047427,0.10574018126888217,0.7621902649405248,1.0,11/24,22.17%,CEL;STX1A;OPHN1;STON1;STON2;SNCG;PACSIN1;AMPH;VAMP2;NLGN3;NLGN2
prerank,regulation of cellular respiration (GO:0043457),-0.5008629956956812,-1.3924509620056242,0.08290155440414508,0.579588828496265,1.0,6/17,17.68%,CBFA2T3;IL10RB;PRDM16;VCP;NOA1;IFNAR1
prerank,regulation of cellular senescence (GO:2000772),-0.43288524083377267,-1.3918476277261,0.06790123456790123,0.5786030720341815,1.0,11/28,19.72%,SLC30A10;AKT3;B2M;ZKSCAN3;RBL1;CDK6;YPEL3;VASH1;EEF1E1;NUAK1;CGAS
prerank,RNA splicing (GO:0008380),0.44194653562991976,1.3917264269567287,0.05804111245465538,0.7655905885889701,1.0,22/95,15.71%,DHX8;PPARGC1A;HNRNPC;SF3B2;SF3B1;RBM8A;RNPC3;SRSF4;ZRSR2;SNRPF;PRPF3;SRPK1;SRPK2;DBR1;TCERG1;SNRPA1;SFPQ;PPIG;TRA2B;DHX16;PDCD7;SYNCRIP
prerank,regulation of cardiac muscle cell contraction (GO:0086004),0.5315458510168088,1.3898025402072907,0.13157894736842105,0.7705450556661511,1.0,3/27,3.04%,CAV1;CAMK2D;PDE4D
prerank,regulation of amyloid-beta clearance (GO:1900221),-0.5161985674480651,-1.3892245662585252,0.07526881720430108,0.5839720455987815,1.0,6/16,22.34%,LRP1;APOE;HDAC1;MYOCD;CLU;SRF
prerank,phosphatidylcholine biosynthetic process (GO:0006656),-0.4326165672837,-1.389193608717619,0.07120743034055728,0.5810578717986724,1.0,11/32,13.14%,CHKA;GPAT4;CHPT1;LPIN2;PCYT1A;SLC44A5;ABHD3;CEPT1;LPIN3;MFSD2A;CSNK2A1
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.5011125880239491,1.389170676362399,0.09735744089012517,0.7706984809372199,1.0,9/41,7.16%,ITPR2;ITPR3;SLC24A1;TRPV4;ERO1A;ATP2B4;IBTK;PTPRC;CHERP
prerank,chondroitin sulfate biosynthetic process (GO:0030206),0.5613681524666752,1.3889297172427957,0.11773940345368916,0.7692121835058112,1.0,4/21,5.94%,DCN;CSPG4;CHST7;NCAN
prerank,endothelial tube morphogenesis (GO:0061154),-0.5713514698029755,-1.388375668319613,0.1180722891566265,0.5804976001942171,1.0,5/10,16.50%,RBPJ;BMP4;ACVRL1;RHOB;CSNK2B
prerank,retinoic acid metabolic process (GO:0042573),0.6127623417474123,1.3877993596005396,0.10679611650485436,0.771063745080319,1.0,3/14,8.22%,ALDH1A3;CYP2S1;SCPEP1
prerank,organophosphate ester transport (GO:0015748),-0.4489932898259859,-1.3875315338664884,0.07017543859649122,0.580432828552993,1.0,10/24,13.94%,OSBPL8;PLTP;PITPNB;LDLR;TNFAIP8L3;OSBPL5;SCP2;EPG5;PRELID2;PRELID3A
prerank,regulation of muscle contraction (GO:0006937),0.5580857561362665,1.3874000655104763,0.09523809523809523,0.7700944493058922,1.0,4/26,5.41%,CAV1;MYBPH;PLCE1;ATP1A2
prerank,negative regulation of centrosome duplication (GO:0010826),-0.562953456578766,-1.3859345842411097,0.10319410319410319,0.5823520640214674,1.0,8/11,32.56%,NPM1;TRIM37;KAT2B;KAT2A;CCNF;BRCA1;CDK5RAP2;MDM1
prerank,negative regulation of interleukin-10 production (GO:0032693),0.6009044975942771,1.3858014187262924,0.13924050632911392,0.7741296182859354,1.0,1/16,0.38%,TRIB2
prerank,protein localization to cell periphery (GO:1990778),0.42885620597060936,1.3846496307907235,0.03699551569506727,0.7763363795223179,1.0,17/133,8.91%,PTCH1;CAV1;F11R;SLMAP;EPB41L3;RAP1A;RAB8B;RAB29;KCNIP4;FLOT2;RABEP1;EHD2;RDX;RAB3A;EFR3A;ZDHHC23;RAPGEF6
prerank,mesenchyme development (GO:0060485),-0.5147283841640609,-1.384393311005967,0.10741687979539642,0.5844380728237324,1.0,5/15,10.45%,BMP4;TGFBR1;FGFR2;BMPR2;BMP2
prerank,positive regulation of GTPase activity (GO:0043547),0.4189189398471775,1.3843808046704174,0.036996735582154515,0.7750399913122845,1.0,31/188,11.30%,ARHGAP42;ITGA6;SIPA1L1;DOCK9;NTRK3;F11R;RGS6;TIAM2;GRTP1;RAPGEF3;RAP1A;ARAP1;SGSM2;NF1;RTN4R;CAV2;ZC3H15;ARHGEF5;TBC1D16;RAPGEF6;SLC27A4;GSK3B;PKP4;FOXJ1;TBC1D2;FERMT2;TBC1D8;DOCK7;RIC1;PLXNB1;DVL3
prerank,vascular transport (GO:0010232),-0.3449454556685239,-1.384310094443097,0.041025641025641026,0.5817963852199266,1.0,18/81,5.71%,SLC24A3;SLC16A12;SLC13A3;SLC22A8;SLC6A6;SLCO3A1;INSR;ABCC4;LRP1;SLC6A9;ABCG2;SLCO1C1;SLC7A5;TFRC;ABCC9;SLC5A6;SLC7A1;SLC15A2
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),-0.4342064526432856,-1.383535349781674,0.09036144578313253,0.5812575408129019,1.0,8/27,19.39%,PRKCH;IL18;NR1H3;AGTR1;NR1H2;ABCG1;CSF1;AGT
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.5825499254687898,1.382777782690003,0.1310452418096724,0.7791840546125077,1.0,2/19,2.90%,CHRNB3;RIC3
prerank,positive regulation of ERAD pathway (GO:1904294),0.6233640757906144,1.3816362007733711,0.10732538330494037,0.7811691631453643,1.0,6/13,18.57%,CAV1;USP13;NFE2L2;RNF185;UBQLN1;TMEM259
prerank,transport across blood-brain barrier (GO:0150104),-0.3419016921200642,-1.3815934999027257,0.046153846153846156,0.5848232599566561,1.0,18/83,5.71%,SLC24A3;SLC16A12;SLC13A3;SLC22A8;SLC6A6;SLCO3A1;INSR;ABCC4;LRP1;SLC6A9;ABCG2;SLCO1C1;SLC7A5;TFRC;ABCC9;SLC5A6;SLC7A1;SLC15A2
prerank,glycogen metabolic process (GO:0005977),-0.43809762323275925,-1.381542312981407,0.09345794392523364,0.582135807377775,1.0,10/27,17.41%,PRKAG2;PGM2L1;CALM1;GBE1;UGP2;AGL;PPP1R3C;PHKG1;PYGB;PER2
prerank,response to iron ion (GO:0010039),-0.5340114740496337,-1.3811579976304031,0.10739856801909307,0.5804757122237246,1.0,6/12,15.84%,BMP6;B2M;HIF1A;SLC11A2;FXN;HFE
prerank,positive regulation of glucose import (GO:0046326),-0.46816635441188914,-1.3810360974887606,0.07871720116618076,0.5780163026558287,1.0,5/21,2.50%,IGF1;OSBPL8;INSR;PIK3R1;CREBL2
prerank,negative regulation of cell aging (GO:0090344),-0.49552129128251793,-1.380795037589335,0.10335917312661498,0.5759674833940718,1.0,5/16,8.15%,SLC30A10;AKT3;ZKSCAN3;RBL1;CDK6
prerank,carboxylic acid transmembrane transport (GO:1905039),-0.4028870965681111,-1.380452924560709,0.05818181818181818,0.5743395648838902,1.0,10/40,13.14%,SLC7A11;SLC13A3;SLC7A5;SLC5A6;SLC38A11;SLC7A6;SLC25A30;SLC25A11;SLC16A7;SLC38A7
prerank,regulation of centrosome duplication (GO:0010824),0.5281256372183853,1.3799276314287927,0.12463343108504399,0.7855979123586699,1.0,8/29,13.12%,PLK2;STIL;CEP131;CHMP5;PDCD6IP;CHMP4B;CHMP4C;GEN1
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.5946570897801046,1.3787615951780479,0.13174603174603175,0.7876142787843715,1.0,6/16,13.62%,LEPROT;CHMP5;CHMP4B;CHMP4A;CHMP4C;LEPROTL1
prerank,detection of mechanical stimulus (GO:0050982),0.5806906307231898,1.3764736338820889,0.10593900481540931,0.794395240764094,1.0,5/19,13.24%,PIEZO2;CSRP3;PIEZO1;CDH2;PKD1
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.46064351548041155,1.376357359032501,0.10065359477124183,0.7924482741372102,1.0,8/61,5.73%,NGF;F11R;LPAR1;AKAP13;RTN4R;MMD2;COL3A1;LRRC59
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.5032617321521039,1.376088454195947,0.12572254335260116,0.7911195315931326,1.0,18/35,26.63%,NR3C2;RBFOX2;PGR;SRC;UBR5;DDX17;TMF1;NEDD4;YAP1;GPER1;RNF14;DAXX;ARID1A;DDX54;NR3C1;TRIP4;PMEPA1;TADA3
prerank,regulation of ERBB signaling pathway (GO:1901184),0.5924624946513214,1.3757399011234543,0.13550600343053174,0.7901840773242266,1.0,4/15,5.87%,CDH13;CEACAM1;EGFR;FER
prerank,circulatory system development (GO:0072359),0.4292424790874905,1.3755653530680556,0.06534422403733955,0.7885194273577835,1.0,34/118,16.76%,STRA6;CXADR;NTRK3;PLCE1;PCSK5;PDLIM4;CDH5;GLI2;NF1;AKAP13;SMYD4;SOX9;SH3PXD2B;MTHFD1;FN1;COL3A1;ISL1;POU4F1;TAB2;HSPG2;POPDC3;NXN;PTEN;KDM6B;PKD1;SOX4;ERBB4;FOXF1;POU6F1;TNNI3;FOXC2;PDLIM2;FGF12;FBXW7
prerank,positive regulation of glucose transmembrane transport (GO:0010828),-0.4427616179416097,-1.375554792598037,0.08227848101265822,0.5874483000688748,1.0,6/26,3.57%,IGF1;OSBPL8;INSR;PIK3R1;CREBL2;C2CD5
prerank,collagen fibril organization (GO:0030199),0.44486058425623176,1.3753996927733276,0.07692307692307693,0.786814326450733,1.0,11/88,7.41%,ITGB4;ITGA6;ADAMTS14;PXDN;COL6A3;COL5A3;NF1;SERPINH1;COL3A1;COL4A1;ADAMTS2
prerank,negative regulation of coagulation (GO:0050819),-0.5243214665637811,-1.373720541565753,0.09112709832134293,0.5906233910302437,1.0,5/14,6.72%,TFPI;THBD;CD34;SERPINE2;APOE
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.5854166746574481,1.3735960101178575,0.125,0.7916150006177181,1.0,4/15,3.51%,TEC;EGFR;ITK;TXK
prerank,cellular modified amino acid catabolic process (GO:0042219),0.6112689602800297,1.373585754073645,0.132013201320132,0.7893271067348073,1.0,3/15,8.25%,PRODH;HOGA1;ABHD12
prerank,negative regulation of chemokine production (GO:0032682),0.6181818353464094,1.373201717860366,0.12833333333333333,0.788563110670495,1.0,1/14,0.18%,APOD
prerank,dicarboxylic acid metabolic process (GO:0043648),0.4786607642275626,1.3731987768223366,0.09881422924901186,0.7862616621653795,1.0,21/52,17.67%,ASS1;FOLR2;MDH1B;AADAT;NIT2;MTHFD1;ALDH18A1;HOGA1;OGDH;ALDH5A1;MDH1;DLST;ACOT8;L2HGDH;GOT1;SLC46A1;GGT1;PHYH;ALDH1L2;ME2;SLC19A1
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.49602294967140226,-1.3731175462034837,0.09424083769633508,0.5897450320107325,1.0,7/17,24.04%,LYN;PDCD10;ARL6IP5;TAOK2;TGFB2;NOD2;STK25
prerank,lipid oxidation (GO:0034440),0.6135655242702956,1.3728790380920706,0.13220338983050847,0.7851281186285254,1.0,1/12,0.60%,PPARGC1A
prerank,lung development (GO:0030324),0.5084868913009037,1.3726634299092995,0.12334801762114538,0.7836632779968339,1.0,4/33,2.75%,STRA6;FGF7;FGF1;GLI2
prerank,xenobiotic transport (GO:0042908),-0.4930981489784678,-1.370831003541462,0.11299435028248588,0.5942510800089648,1.0,7/17,9.91%,SLC47A1;ABCG2;SLC7A5;GJA1;SLC22A4;SLC15A2;SLC22A18
prerank,negative regulation of growth (GO:0045926),-0.326779033618259,-1.370415769837383,0.0070921985815602835,0.592898155222615,1.0,23/121,7.69%,NOTCH2;SMAD3;ENPP1;SLIT2;SMARCA2;GJA1;ACVRL1;MT1E;MT1M;MT1G;MT1B;MT1F;MT1A;MT1X;MT1H;BMPR2;CCN3;NPR1;DNAJB2;APBB2;SOX17;JADE1;BST2
prerank,neurotransmitter uptake (GO:0001504),0.6174358944157816,1.3702863387453672,0.15198618307426598,0.7904821456371889,1.0,5/12,6.95%,SLC1A7;SLC29A4;SLC22A3;ATP1A2;SLC1A6
prerank,negative regulation of response to wounding (GO:1903035),0.5696978213740568,1.3696234054592091,0.13636363636363635,0.7908402374710867,1.0,6/19,10.64%,CLDN19;AJAP1;CASK;RTN4R;INPP5F;RTN4RL1
prerank,cognition (GO:0050890),0.4902180479201988,1.3689678859282772,0.12219101123595505,0.7911771956867377,1.0,4/42,3.16%,STRA6;ST3GAL4;MGAT3;NF1
prerank,protein lipidation (GO:0006497),0.47151576947714136,1.3675464991715542,0.09431524547803617,0.7942929254085938,1.0,15/59,14.94%,PIGU;GPLD1;PGAP3;ZDHHC1;ATG5;ZDHHC7;PIGB;ZDHHC23;PIGA;ZDHHC13;ATG7;ZDHHC20;GLUL;PIK3C3;ZDHHC8
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),-0.5678445705044028,-1.3675273354295852,0.13053613053613053,0.5997438736647951,1.0,4/11,13.01%,TGFBR3;TGFBR1;BMP2;TGFB2
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.5000776013473978,1.3674584619147652,0.12535211267605634,0.7923733112817722,1.0,5/39,1.41%,UTRN;SLMAP;NEDD4L;PRKCE;CAMK2D
prerank,positive regulation of glucose metabolic process (GO:0010907),0.5996436687087531,1.3669080498202044,0.13131313131313133,0.7922493838058635,1.0,2/14,2.87%,PPARGC1A;GPLD1
prerank,amino acid transport (GO:0006865),-0.37350976723603607,-1.3661666300455584,0.0411522633744856,0.6014398624485738,1.0,17/49,23.69%,SLC7A11;SLC6A6;SLC7A5;SLC7A1;SLC38A11;SLC7A6;SLC43A2;SLC38A7;SLC25A47;SLC3A2;SLC38A5;SLC25A29;SLC1A4;SLC6A17;SLC38A1;SLC38A9;SLC7A10
prerank,regulation of NMDA receptor activity (GO:2000310),-0.414036985715721,-1.36586818533455,0.0708955223880597,0.5995505138845232,1.0,8/32,9.29%,DAPK1;ACTN2;SLC6A9;GRIA2;NEFL;GRIN2B;CAMK2A;GRIN1
prerank,hematopoietic progenitor cell differentiation (GO:0002244),-0.4153122710842474,-1.3658397472866781,0.07142857142857142,0.5968527344944039,1.0,6/30,6.09%,FLT1;BMP4;KIT;HOXB4;ACE;KDR
prerank,glycine transport (GO:0015816),-0.5808776173407201,-1.3651115783144356,0.12735849056603774,0.5964445237441381,1.0,4/10,21.87%,SLC6A9;SLC25A38;SLC38A5;SLC6A17
prerank,translation (GO:0006412),-0.2907637594614237,-1.364668264876378,0.014285714285714285,0.5951702421476757,1.0,80/208,23.33%,RPL37A;RRBP1;RPL19;RPL8;RPL37;RPS15;RPS29;RPL35A;FARSB;RPS7;RPS20;RPL32;RPS27;EEF1A1;RPL27;RPL26;RPS24;RPLP0;HARS1;RPS19;HBS1L;RPL31;QRSL1;RPL41;RPL13A;RPL30;RPL29;RPS16;MRPS6;RPL3;RPLP1;RPS17;EEF1D;RPL23;RPL17;RPS3;RPL9;RPL38;YARS1;RPL36;DHPS;RPS26;RPS8;RPL18A;RPS12;RPS21;MRPL32;ABCE1;MRPL18;APEH;RARS1;EEF1B2;NOA1;RPS18;RPS6;RPS15A;EIF4G1;RPLP2;MRPL28;MRPL9;GSPT2;MRPS11;EEF1E1;MRPS16;MRPS18B;PPA1;QARS1;RPL14;RPS2;MRPL42;GATC;RPL10A;RPL34;RPL5;MRPS12;RPL39;EEF2;RPL22;MRPL55;MRPS34
prerank,negative regulation of angiogenesis (GO:0016525),0.447014515207771,1.3646083304611232,0.08058608058608059,0.7988487491683884,1.0,9/84,5.07%,THBS4;DCN;SULF1;SLC12A2;ADAMTS1;SPRED1;CREB3L1;ATP2B4;AMOT
prerank,cGMP-mediated signaling (GO:0019934),-0.5233154172399714,-1.3639622806765184,0.10886075949367088,0.5947273319201314,1.0,3/13,9.13%,IRAG1;APOE;PDE2A
prerank,muscle cell differentiation (GO:0042692),0.5219035816141926,1.3634668492707127,0.13204747774480713,0.8010024074350623,1.0,2/32,1.37%,RORA;GLMN
prerank,Golgi to endosome transport (GO:0006895),-0.4891691473814116,-1.3633489926541906,0.10344827586206896,0.5939416447364508,1.0,11/16,27.13%,AP2A1;VPS13C;DOP1B;EPS15;WIPI1;SORT1;MON2;SYS1;AP1AR;CORO7;KLHL20
prerank,transition metal ion homeostasis (GO:0055076),-0.4311457241254921,-1.3628208408300218,0.07580174927113703,0.592990450760756,1.0,7/28,8.27%,PICALM;NEO1;COMMD1;B2M;FTL;BDH2;SLC39A14
prerank,regulation of smooth muscle contraction (GO:0006940),0.564713623985089,1.3627461644056478,0.1347068145800317,0.8014091539813856,1.0,2/20,1.25%,CAV1;PLCE1
prerank,negative regulation of mitochondrion organization (GO:0010823),-0.4053019647135403,-1.362208320716936,0.09933774834437085,0.5922045033176293,1.0,9/33,15.47%,IGF1;OMA1;TFRC;AKT1;ACAA2;MAPT;FXN;GHITM;OPA1
prerank,cell junction organization (GO:0034330),0.44475563242989874,1.36211296348601,0.07740324594257178,0.8015012780686256,1.0,7/71,3.64%,CLDN1;CXADR;LRP4;RAB8B;PPFIA2;OPHN1;TJP2
prerank,myofibril assembly (GO:0030239),-0.40455335788692814,-1.3620922629659464,0.08148148148148149,0.5899815815518445,1.0,10/42,11.01%,PGM5;PDGFRB;ACTN2;PDGFRA;TPM1;OBSL1;TMOD3;CFLAR;CSRP2;LMOD1
prerank,female gonad development (GO:0008585),0.5636262920840039,1.3618137444864473,0.1282442748091603,0.8004083613138336,1.0,2/19,0.73%,INHBB;NR2F2
prerank,positive regulation of cell communication (GO:0010647),0.5162767925705205,1.3613441243919586,0.11627906976744186,0.7999745707976765,1.0,3/28,6.79%,CLSTN2;CLSTN3;RIMS2
prerank,regulation of blood coagulation (GO:0030193),0.5339648559563879,1.361044534886206,0.12756598240469208,0.7988550260774047,1.0,3/27,1.37%,CAV1;ST3GAL4;FAP
prerank,regulation of synapse assembly (GO:0051963),0.4846570204514337,1.3609804191298158,0.10821917808219178,0.7968839239126481,1.0,5/46,6.25%,CLSTN2;MUSK;GPC6;CLSTN3;EPHB2
prerank,iron ion transmembrane transport (GO:0034755),-0.5742836687861437,-1.3605826525844986,0.13839285714285715,0.5922314886217906,1.0,5/10,15.04%,SLC39A8;SCARA5;SLC11A2;SLC39A14;SLC40A1
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.5256973593547165,1.3605675116184035,0.13425925925925927,0.7962451488227699,1.0,3/26,4.25%,CAV1;LBP;PTPN22
prerank,negative regulation of nuclear division (GO:0051784),0.6257947663923498,1.3604898117863018,0.15357766143106458,0.7943736654668895,1.0,4/11,9.73%,FBXO43;TOM1L1;FBXO5;TOM1L2
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.5381594376500636,1.3599494795107492,0.1297134238310709,0.7942270282887519,1.0,10/25,17.54%,HK2;PFKP;FOXK1;ALDOB;FOXK2;ADPGK;ENO3;GCK;PGK1;ENO2
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.6121298013561065,1.3596317883401312,0.1443478260869565,0.7932172177632338,1.0,3/13,4.72%,TDG;UPP2;NTHL1
prerank,regulation of stem cell proliferation (GO:0072091),-0.4938010893792587,-1.3592574494780754,0.0855614973262032,0.5940175788170204,1.0,5/17,12.22%,FBLN1;GJA1;ACE;AGO3;KDM1A
prerank,actin nucleation (GO:0045010),-0.4595483502749813,-1.359184817048527,0.0881542699724518,0.5916423796324487,1.0,14/21,40.55%,JMY;ARPC3;IQGAP2;LMOD1;ACTR2;ARPC1A;ARPC5;TRIM27;ARPC5L;WASHC1;ARPC1B;SPIRE2;SCIN;SPIRE1
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.455238014144711,1.3589676889477451,0.10269576379974327,0.793449419970179,1.0,9/69,4.18%,NGF;FGFR1;PLCD3;PLCE1;PLCB3;OGT;NF1;PLCL1;TPTE
prerank,negative regulation of macromolecule metabolic process (GO:0010605),-0.30065251407482424,-1.358915628171771,0.012987012987012988,0.5898416986636886,1.0,50/182,15.93%,IGF1;ROBO1;SLC24A3;PICALM;NOTCH2;ENG;ROCK2;CLDN5;FOXP1;BMP4;SLC7A5;WNT4;ACVRL1;ANKRD13A;LDLR;HIF1A;RBL1;XDH;KLF4;KDR;PDCD10;CD34;MYADM;APOE;HINFP;HDAC1;MAP2K2;CRKL;SUB1;CITED2;GATA2;LGMN;SLC2A10;RBMS3;AGO3;ZC3H12A;BMP2;ESR1;TTBK1;NOCT;TGFB2;SH3GL2;ID2;AGO4;PARP10;MAPT;MOV10;RBL2;TLE5;LGALS9
prerank,positive regulation of keratinocyte differentiation (GO:0045618),0.6393139662897448,1.3584073708573192,0.16552901023890784,0.7933143283425944,1.0,1/10,0.21%,ETV4
prerank,cellular response to gamma radiation (GO:0071480),-0.4887630634602115,-1.3575112799548918,0.11056511056511056,0.5918755875631232,1.0,6/17,14.42%,MAP3K20;WRN;RPL26;CRYAB;KDM1A;HSF1
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.38879827036935044,1.3574777979226451,0.015321756894790603,0.7946322486257716,1.0,42/390,6.76%,ROR2;NGF;GAB1;ROR1;EFNA5;FGF7;SIPA1L1;NTRK3;UBASH3B;ARHGEF28;SORBS1;FGFR1;PXN;SH2D2A;RGS14;SULF1;EGFR;MUSK;EFNB1;CYFIP2;FGF1;DOCK1;NRP2;GPLD1;RBFOX2;SPRED1;GIGYF2;APH1B;CAV2;EIF2AK3;VAV2;DNM1;SRC;ATP6V0D2;KIF16B;PDK4;FER;NCSTN;NCK2;EPHB2;LCP2;SHB
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.4468746306669189,-1.3573900905999003,0.10204081632653061,0.5870995947979443,1.0,7/23,12.84%,ZEB2;DAB2;EP300;CITED2;SLC2A10;SNW1;THBS1
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.4468746306669189,-1.3573900905999003,0.10204081632653061,0.5870995947979443,1.0,7/23,12.84%,ZEB2;DAB2;EP300;CITED2;SLC2A10;SNW1;THBS1
prerank,phosphatidic acid biosynthetic process (GO:0006654),0.4866650767397054,1.356076608782494,0.10833333333333334,0.7976597271083314,1.0,10/46,11.07%,DGKA;DDHD1;GPAT3;ACP6;DGKZ;SLC27A1;AGPAT4;LCLAT1;PLD1;AGPAT5
prerank,sterol metabolic process (GO:0016125),-0.3648032017007888,-1.3559525096829068,0.04201680672268908,0.5889246525091424,1.0,17/60,15.38%,PRKAG2;CYP26B1;PPARD;INSIG2;CYP1B1;ARV1;APOE;SCAP;OSBPL1A;LDLRAP1;OSBPL5;GBA2;NSDHL;PMVK;LIPA;FDXR;ABCG1
prerank,regulation of MAPK cascade (GO:0043408),0.4098056335974922,1.355908076346168,0.046994535519125684,0.7961960593966003,1.0,23/157,8.20%,ROR2;ROR1;CAV1;NTRK3;FGFR1;LPAR1;CEACAM1;EGFR;PELI2;MINK1;SPRED1;NF1;CAV2;FAM83D;PTPRC;STYX;FN1;ULK4;ARHGEF5;DAG1;PTPRJ;PIK3R2;PHLPP1
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.44437059445248317,1.3553042521748002,0.08004926108374384,0.7961396854341365,1.0,25/85,18.81%,ROR2;PRICKLE1;PRICKLE2;FZD2;PSME3;WNT5A;PSMB5;DVL3;VANGL1;FZD7;PSMA6;FZD3;PSMB2;PSMA2;PSMD13;AP2A2;PSMA7;CELSR1;PSME4;CELSR2;RHOA;PSMD12;PSMD14;PSMB6;PSMC4
prerank,2-oxoglutarate metabolic process (GO:0006103),0.6096415586043228,1.3551503355968617,0.15584415584415584,0.7945472712108255,1.0,8/13,22.00%,AADAT;OGDH;DLST;L2HGDH;GOT1;PHYH;GPT2;IDH2
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),0.631613195485712,1.3549961841170093,0.1501766784452297,0.7929481661279142,1.0,3/10,1.41%,NEDD4L;PRKCE;CAMK2D
prerank,small GTPase mediated signal transduction (GO:0007264),0.42627339292933164,1.3525044506670225,0.07142857142857142,0.8003247650389226,1.0,21/103,10.73%,PLK2;NTN1;TIAM2;ARHGAP31;USP50;PLCE1;ARHGAP18;ARHGAP32;RGL1;MRAS;NF1;NUCB1;USP8;NRAS;KRAS;RREB1;RAPGEF6;KSR2;LAT;ADRA2A;PLD1
prerank,regulation of membrane depolarization (GO:0003254),0.5658117242539591,1.3524052199045646,0.15658914728682172,0.7985510761401269,1.0,6/18,13.87%,NEDD4L;CAMK2D;SCN10A;SCN2B;ABCD1;FHL1
prerank,negative regulation of cytokine production (GO:0001818),0.4131402344577688,1.3520788438139981,0.04907306434023991,0.7976658896936503,1.0,26/163,10.23%,APOD;TRIB2;INHBB;HOMER2;CEACAM1;UBE2L6;BCL3;PCBP2;PTPN22;IRAK3;PTPRC;TNFAIP3;FN1;CHID1;ANXA4;SELENOS;N4BP1;PTGER4;RARA;ACOD1;CD200R1;HMGB1;FOXJ1;NPLOC4;AXL;TAX1BP1
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.4814456352346391,-1.3511827032248966,0.13032581453634084,0.601238321712474,1.0,4/17,6.38%,ITGA1;PDGFRB;PPP1R12A;CALM1
prerank,positive regulation of calcium-mediated signaling (GO:0050850),0.6354034476338456,1.351171202915288,0.1438721136767318,0.7990413940528635,1.0,1/11,0.51%,CDH13
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.505727866296641,1.3510622728984523,0.12112259970457903,0.7973332345583632,1.0,9/32,12.92%,BCL3;MYBBP1A;PPP1R13B;FHIT;PHLDA3;HIPK1;MSH2;POU4F1;CDIP1
prerank,positive regulation of response to wounding (GO:1903036),0.5354898404970627,1.350985902432643,0.14392803598200898,0.7955135717941979,1.0,5/24,10.61%,CLDN1;PRKCE;KANK1;OCLN;ADRA2A
prerank,positive regulation of chondrocyte differentiation (GO:0032332),0.6434556197964454,1.3505943598549843,0.16494845360824742,0.7949265635978889,1.0,3/10,4.14%,PKDCC;BMPR1B;SOX9
prerank,amyloid-beta metabolic process (GO:0050435),0.5609764978480879,1.350356164230574,0.14606741573033707,0.7936903130835131,1.0,6/16,11.01%,MGAT3;APH1B;NCSTN;DYRK1A;BACE2;MME
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.5063865833246345,1.3490313368543763,0.11764705882352941,0.7966759919306909,1.0,6/33,9.55%,MEOX2;ATP2B4;CARD10;STARD13;MECP2;HMGB1
prerank,positive regulation of cellular component organization (GO:0051130),-0.31770666857522334,-1.3483864778331038,0.01875,0.6078025304919734,1.0,32/107,11.60%,IGF1R;ASAP1;TRABD2B;INSR;ATP10A;SHANK3;DAB2;LRP1;TGFBR1;TFRC;BCL2L11;FNIP1;TMED9;FNIP2;FRMPD4;APOE;RHOC;SLF2;TGFB3;NOX1;SH3GLB1;SURF4;SLF1;VCP;AR;RPS3;AJUBA;BID;MMP1;NRXN1;MPP7;CLIP3
prerank,phosphatidic acid metabolic process (GO:0046473),0.4766070083153475,1.3482220848955324,0.11796982167352538,0.797689228458524,1.0,10/48,11.07%,DGKA;DDHD1;GPAT3;ACP6;DGKZ;SLC27A1;AGPAT4;LCLAT1;PLD1;AGPAT5
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.541017379908305,1.3481453851651382,0.1329394387001477,0.7958603354734001,1.0,9/23,15.58%,TPTE;MTMR7;MTMR6;MTMR3;OCRL;INPP5F;PTEN;MTMR12;MTMR1
prerank,regulation of execution phase of apoptosis (GO:1900117),0.6284190128241336,1.3481249182058581,0.15959252971137522,0.7938407130521651,1.0,2/11,1.37%,DLC1;FAP
prerank,response to progesterone (GO:0032570),0.5687210530094721,1.3476943193849857,0.13666666666666666,0.7934498424495808,1.0,4/18,8.70%,CAV1;SRC;CATSPERD;ACOD1
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.5028871044986594,1.347488117802792,0.14243759177679882,0.7921285615162685,1.0,5/30,5.68%,F11R;LPAR1;AKAP13;RTN4R;COL3A1
prerank,negative regulation of viral life cycle (GO:1903901),-0.5115418244092931,-1.3464491428489853,0.12318840579710146,0.6113905292642894,1.0,3/15,7.69%,LY6E;MID2;BST2
prerank,regulation of protein kinase activity (GO:0045859),0.42149283450105474,1.346421749126471,0.07294117647058823,0.794092555281362,1.0,19/106,11.19%,TRIB2;UBASH3B;PLCE1;CEACAM1;RAP1A;SPRED1;NF1;PRKAG1;MMD2;GNAQ;PTPRC;LCP2;RASSF2;SFN;CEP85;LAT;RTRAF;RELN;TAB2
prerank,cellular response to chemical stress (GO:0062197),0.43177404494254906,1.3459610184076851,0.07287933094384708,0.7938142143849397,1.0,13/96,7.25%,CAV1;PPARGC1A;LRRC8D;GPX8;MGAT3;ETV5;TRPV4;FOXO3;ERO1A;KEAP1;FANCC;SELENOS;SLC4A11
prerank,negative regulation of ERBB signaling pathway (GO:1901185),-0.393026507928711,-1.345865114937668,0.07777777777777778,0.6105267909228047,1.0,11/39,9.22%,ITGA1;TGFA;ERRFI1;PTPN3;RNF115;CDC42;ZFYVE28;DUSP3;EPS15;SH3KBP1;LGMN
prerank,iron ion transport (GO:0006826),-0.3715730139008141,-1.3446498860062455,0.052830188679245285,0.6118763602076907,1.0,17/47,21.68%,STEAP3;FTH1;TFRC;SCARA5;ATP6V0A4;ARHGAP1;SLC11A2;SLC39A14;ATP6V0C;ATP6V1C1;SLC40A1;HFE;ATP6V1D;TTYH1;RAB11B;ATP6V1F;ATP6V1E1
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.46788152336927974,1.3445730870923123,0.11409395973154363,0.7969891336631891,1.0,9/54,11.21%,CAV1;NEDD4L;KCNJ4;KCNJ16;KCNIP4;GABBR2;NOS1AP;KCNAB1;NEDD4
prerank,cell-cell junction assembly (GO:0007043),0.4543113975086126,1.3442131365146828,0.0917312661498708,0.7963078635898855,1.0,11/63,4.43%,CLDN11;TLN2;CDH11;EPB41L3;PARD6B;CDH5;CDH9;TRPV4;PRKCA;CD9;CNTNAP1
prerank,histone H2A monoubiquitination (GO:0035518),-0.4976929071956227,-1.344037486735344,0.13315926892950392,0.611155153368045,1.0,12/17,29.24%,PCGF5;KDM2B;PCGF2;BMI1;RYBP;TRIM37;SKP1;RNF2;PCGF6;RING1;BCOR;DDB1
prerank,copper ion homeostasis (GO:0055070),-0.47946665229182894,-1.3438350965517034,0.11989100817438691,0.6092001377461737,1.0,4/17,5.18%,ATP7A;COMMD1;SLC31A1;SLC31A2
prerank,response to ATP (GO:0033198),-0.4851972005509073,-1.3437298819106158,0.12598425196850394,0.6069704164619012,1.0,7/18,27.31%,TRPC3;ABCC9;P2RX7;P2RX4;CIB2;P2RY12;P2RY1
prerank,regulation of chromatin organization (GO:1902275),-0.5027293019955837,-1.3427787928411123,0.135,0.6073445766292138,1.0,5/14,7.19%,SETD5;IGF2;PARG;SETD1A;CDK9
prerank,sterol biosynthetic process (GO:0016126),-0.40933780224369687,-1.3423837314800797,0.08722741433021806,0.6060768438220243,1.0,11/33,19.60%,PRKAG2;INSIG2;ARV1;HMGCS1;ACAA2;ACLY;NSDHL;PMVK;MVK;ACAT2;DHCR7
prerank,positive regulation of integrin activation (GO:0033625),0.6287864701654263,1.341976029004741,0.1512455516014235,0.8028503008860507,1.0,5/11,10.19%,CDH17;SRC;PIEZO1;PLEK;FERMT2
prerank,regulation of astrocyte differentiation (GO:0048710),-0.5247268055268499,-1.3407832990274795,0.1466992665036675,0.6086260801490561,1.0,6/12,24.87%,EPHA4;SERPINE2;BMP2;ID2;CLCF1;NOTCH1
prerank,regulation of protein neddylation (GO:2000434),-0.5570498243398208,-1.3404952447411063,0.1407766990291262,0.6070172079756142,1.0,9/10,42.19%,HIF1A;EPAS1;DCUN1D4;RPL5;DCUN1D3;RPL11;DCUN1D5;COPS9;DCUN1D1
prerank,myeloid leukocyte differentiation (GO:0002573),-0.3570859569346421,-1.3401419685145861,0.053811659192825115,0.6056560419802491,1.0,21/65,19.88%,LEF1;IL31RA;FOXP1;BMP4;CDC42;KIT;CBFA2T3;EP300;MT1G;DEK;CAMK4;PIR;TNFRSF11A;CDK4;PDE1B;CSF1;LGALS9;CASP8;PARP1;MYH9;SBNO2
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.5743494890895228,1.3399546272273286,0.15771812080536912,0.8088310295374461,1.0,2/15,2.14%,SMOC2;FGF1
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),-0.5320988880188728,-1.3394049827630845,0.1375921375921376,0.6055287505971483,1.0,4/12,6.72%,PICALM;ROCK2;FKBP1A;APOE
prerank,regulation of acrosome reaction (GO:0060046),-0.5637236585734053,-1.3370752600978035,0.11778846153846154,0.610492592973407,1.0,1/10,0.08%,PLCB1
prerank,modulation by symbiont of entry into host (GO:0052372),0.5733665658738581,1.3347605986483588,0.16169544740973313,0.8264365224877839,1.0,4/16,15.79%,CAV1;TRIM21;HS3ST5;TRIM5
prerank,neuron migration (GO:0001764),-0.3647941414699727,-1.334628988222565,0.08118081180811808,0.6159976893113158,1.0,15/48,12.26%,NAV1;RAPGEF2;MARK1;CEP85L;ADGRL3;NDNF;SPOCK1;ELP3;DCX;NR4A2;CDKL5;DCDC2;TUBB2A;MDGA1;MAP1B
prerank,central nervous system neuron development (GO:0021954),-0.4929768228897467,-1.333904755084877,0.14049586776859505,0.6156899861723258,1.0,5/15,14.26%,RAPGEF2;ATP7A;ARHGAP35;GBA2;MAPT
prerank,cellular glucose homeostasis (GO:0001678),0.4781804719745454,1.3336982403599047,0.1404494382022472,0.8283378599813582,1.0,15/41,15.74%,PPARGC1A;LRRC8D;HK2;ZBTB20;FOXK1;FOXK2;PIK3R2;GCK;NUCKS1;SOX4;ERN1;UNC13B;TRA2B;GPER1;ADCY8
prerank,regulation of catabolic process (GO:0009894),0.5623114896088462,1.3330831056987436,0.16938110749185667,0.8285588504429835,1.0,5/18,12.23%,NEDD4L;FAP;FAM83D;ZDHHC7;FAF1
prerank,focal adhesion assembly (GO:0048041),0.5325175705332394,1.3330013812733268,0.1490015360983103,0.8267910303403982,1.0,4/21,4.43%,DLC1;SORBS1;PEAK1;SRC
prerank,response to interferon-gamma (GO:0034341),-0.3467954842037776,-1.3325339613573008,0.04326923076923077,0.6174575460263215,1.0,23/67,26.01%,DAPK1;SP100;CXCL16;SIRPA;GBP3;GBP4;GCH1;BST2;RPL13A;GBP6;GAPDH;CCL13;GBP7;GBP2;LGALS9;PDE12;DAPK3;CD40;SHFL;CCL19;AQP4;KYNU;IRF8
prerank,post-Golgi vesicle-mediated transport (GO:0006892),-0.3228107731183314,-1.3323539361022658,0.047619047619047616,0.6155846257161618,1.0,31/88,17.91%,EXOC6B;MYO1B;CLINT1;MYO5A;ARFGEF2;AP1S2;FTH1;DNAJC6;NAPA;COMMD1;AP2A1;FTL;HSPA8;VPS35L;EXOC6;VPS13C;DOP1B;EPS15;EXOC4;OSBPL5;SORCS1;AP4E1;TXNDC5;VAMP7;SH3GL2;SORT1;DTNBP1;MON2;SCFD1;SYS1;BLOC1S6
prerank,regulation of myoblast fusion (GO:1901739),0.6187761418704457,1.3320934411104381,0.17796610169491525,0.8283230332499638,1.0,3/11,6.81%,RIPOR2;CD53;EHD2
prerank,negative regulation of cell junction assembly (GO:1901889),0.5230253568811412,1.332009035558372,0.15851851851851853,0.8265838455480125,1.0,3/25,4.43%,APOD;DLC1;SRC
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",0.5631394597635294,1.330899441606244,0.1507293354943274,0.8287082750126747,1.0,7/16,19.61%,CDK13;DDX17;CELF4;HNRNPM;SFPQ;SLU7;DHX9
prerank,cellular response to increased oxygen levels (GO:0036295),0.6124113659454472,1.3306443509013626,0.1703958691910499,0.8276557090213232,1.0,1/11,0.25%,CAV1
prerank,protein modification by small protein conjugation or removal (GO:0070647),-0.5068650551999344,-1.3294005196594578,0.13349514563106796,0.6227071875673319,1.0,6/13,9.34%,ATG10;UBA5;UBA3;UBA2;UBA7;NAE1
prerank,high-density lipoprotein particle remodeling (GO:0034375),-0.4908544070383546,-1.328963427777024,0.12718204488778054,0.6216742604989063,1.0,7/15,35.30%,PLTP;APOE;ABCG1;SCARB1;LCAT;APOC1;LIPC
prerank,linoleic acid metabolic process (GO:0043651),0.5684266204482187,1.328883814051443,0.16352201257861634,0.8323403177344605,1.0,6/17,13.04%,ELOVL5;ALOXE3;ELOVL1;ELOVL2;ABCD1;PNPLA8
prerank,regulation of leukocyte activation (GO:0002694),-0.5199455968588211,-1.328432725819573,0.13613861386138615,0.620804717780602,1.0,7/14,19.48%,LYN;MFHAS1;CD200;GPR137B;MYO18A;PJA2;MIF
prerank,carboxylic acid catabolic process (GO:0046395),0.6113088812107625,1.3283301974285662,0.17647058823529413,0.8323655540063939,1.0,5/12,14.38%,IL4I1;BCKDK;NAGK;ACOT8;GNPDA2
prerank,positive regulation of cell junction assembly (GO:1901890),0.45973875559033284,1.328166643405418,0.11583011583011583,0.8308900631210719,1.0,6/56,8.07%,CLSTN2;CAV1;CLDN19;CLSTN3;EPHB2;PTPRJ
prerank,arachidonate transport (GO:1903963),-0.5617237183897045,-1.3281406021616473,0.16,0.6168948706097451,1.0,3/10,7.85%,ACE;BDKRB2;ANXA1
prerank,arachidonic acid secretion (GO:0050482),-0.5617237183897045,-1.3281406021616473,0.16,0.6168948706097451,1.0,3/10,7.85%,ACE;BDKRB2;ANXA1
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.3999958923108388,-1.3281319042574187,0.10631229235880399,0.6145158050108351,1.0,6/30,5.70%,ENG;SMAD3;TGFBR3;LATS2;FKBP1A;ITGA3
prerank,regulation of protein import into nucleus (GO:0042306),0.4894620019971562,1.3281284117458436,0.1391304347826087,0.8289707587727011,1.0,6/36,8.08%,APOD;MDFIC;UBR5;BAG3;RBM22;PIK3R2
prerank,regulation of gastrulation (GO:0010470),-0.50121984964967,-1.3279837379241086,0.14354066985645933,0.6126485891351124,1.0,2/14,1.08%,PHLDB2;OSR1
prerank,membrane lipid biosynthetic process (GO:0046467),0.45088466719428544,1.3272888319403933,0.10427807486631016,0.8301480662937178,1.0,14/58,13.02%,SGMS2;ST3GAL4;CERS6;ACER3;ELOVL5;PLPP2;PLPP3;ELOVL1;HACD4;ELOVL2;CERT1;HACD2;SCCPDH;ELOVL6
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.5106716766765228,1.3270312750290485,0.1485884101040119,0.829004717994624,1.0,7/29,16.08%,DHX34;DND1;TENT5C;AXIN2;TENT5D;TAF15;E2F1
prerank,regulation of glycogen metabolic process (GO:0070873),-0.5316374148862208,-1.3268342139623497,0.15058823529411763,0.6137095974043111,1.0,9/12,40.53%,AKT1;PPP1R3B;PPP1R3C;RUBCNL;PPP1R3E;KHK;PPP1R3F;PPP1R3D;GCGR
prerank,regulation of B cell receptor signaling pathway (GO:0050855),-0.4389362347082484,-1.326605528772764,0.12885154061624648,0.6119812114456272,1.0,6/21,10.55%,PRKCH;FOXP1;LYN;SLC39A10;ELF2;LPXN
prerank,negative regulation of TOR signaling (GO:0032007),-0.4064860703764055,-1.3263793607073784,0.09375,0.6102790670447936,1.0,16/36,29.65%,UBR1;FNIP1;DEPDC5;RNF152;TMEM127;SPAAR;GSK3A;DEPTOR;TNFAIP8L1;CASTOR2;CASTOR1;FLCN;PRKAA1;TSC1;ATM;SH3BP4
prerank,regulation of endocytosis (GO:0030100),0.44765002167947127,1.3258094024197107,0.12148337595907928,0.8316222058170847,1.0,13/61,9.52%,GPC3;CDH13;NEDD4L;OPHN1;TFR2;SRC;LRSAM1;ZFYVE16;STON1;ABL2;PACSIN2;STON2;CALY
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.5449274243496968,1.3256174770204483,0.16253869969040247,0.830262158881105,1.0,9/21,18.76%,GLI1;KIF7;PDCL;SMO;RAB34;TEDC1;ARMC9;STK36;TUBD1
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.48196220081677743,1.3253403504618122,0.14147018030513175,0.8292337401687357,1.0,7/44,13.15%,NGF;SRC;RPS6KA3;SFN;USP47;DHCR24;AQP1
prerank,ventricular cardiac muscle tissue development (GO:0003229),-0.44220292174698705,-1.3251553416479518,0.13424657534246576,0.612063471341786,1.0,6/23,14.04%,TGFBR3;TPM1;FKBP1A;FGFR2;PROX1;ID2
prerank,positive regulation of cell-cell adhesion (GO:0022409),0.47595385524329176,1.3248053272588471,0.15074024226110364,0.8290554286770234,1.0,5/41,7.99%,MAGI1;ADAM19;PLPP3;PIEZO1;GCNT2
prerank,aorta development (GO:0035904),-0.4990225063215913,-1.3246363986709024,0.15550239234449761,0.6113846728746959,1.0,5/14,9.13%,ROBO1;PDGFRB;LRP1;TBX1;PDE2A
prerank,calcium import into the mitochondrion (GO:0036444),-0.5438698699445191,-1.3239583951440637,0.152317880794702,0.6111248579358777,1.0,5/10,20.38%,SMDT1;SLC25A23;MICU1;MICU2;MAIP1
prerank,positive regulation of immune system process (GO:0002684),-0.48732831258534404,-1.3238320538220727,0.11466666666666667,0.6092052449392886,1.0,5/16,21.82%,ANXA1;TGFB2;LGALS9;RSAD2;NCKAP1L
prerank,negative regulation of macrophage activation (GO:0043031),-0.48320828462014037,-1.3236827334675947,0.15846994535519127,0.6073170556036738,1.0,5/16,10.10%,IL31RA;NR1H3;LDLR;CD200;ZC3H12A
prerank,regulation of RNA metabolic process (GO:0051252),0.4514090775235228,1.3234649290129352,0.12258064516129032,0.8322314443609529,1.0,9/59,7.10%,AHNAK;AHNAK2;CLK1;PCBP2;CELF1;SON;ZNF326;CLK4;IGF2BP2
prerank,phospholipid dephosphorylation (GO:0046839),0.48906660924887185,1.3234636535569468,0.14444444444444443,0.8302012564412757,1.0,12/37,15.58%,PLPP2;PLPP3;TPTE;MTMR7;MTMR6;MTMR3;OCRL;INPP5F;PTEN;PLPPR1;MTMR12;MTMR1
prerank,regulation of muscle cell differentiation (GO:0051147),-0.40055148324984546,-1.3233426051202277,0.11145510835913312,0.6060673400003009,1.0,8/31,7.77%,CDC42;IGF2;FGFR2;HDAC9;MEF2A;MAPK12;CDK9;CDON
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.39645260362429185,1.3229487956950965,0.0536480686695279,0.8300402760692095,1.0,26/190,9.13%,RORA;CAV1;VGLL4;PPM1N;ARHGAP12;TNIP3;PDE4D;SPRED1;NF1;PHLDA3;SPI1;SRC;ATP2B4;PPM1A;TNFAIP3;UACA;BANK1;NDUFS3;DAG1;MCL1;CGNL1;PTPRJ;PIK3R2;PHLPP1;TNIP1;PLEK
prerank,regulation of kinase activity (GO:0043549),0.42739482861696393,1.322923279594283,0.0970873786407767,0.828128469442537,1.0,8/89,1.86%,ROR2;ROR1;NTRK3;FGFR1;PLCE1;LDB2;EGFR;MUSK
prerank,inositol lipid-mediated signaling (GO:0048017),0.46391238478126984,1.3228415047558666,0.13774104683195593,0.826447793874327,1.0,7/50,3.78%,NGF;FGFR1;PLCD3;PLCE1;PLCB3;OGT;PLCL1
prerank,negative regulation of gluconeogenesis (GO:0045721),-0.5366644704457935,-1.322305153493322,0.14588235294117646,0.6069869618741185,1.0,6/11,19.06%,EP300;SIK1;C1QTNF3;PGP;CLK2;CRY1
prerank,regulation of oxidative phosphorylation (GO:0002082),-0.47010963573501363,-1.3220269292120645,0.14986376021798364,0.605731057766161,1.0,6/16,19.78%,NUPR1;ATP7A;VCP;SLC25A33;PDE12;COX7A2
prerank,negative regulation of cellular protein catabolic process (GO:1903363),-0.5538865926334459,-1.3218558135277472,0.14350797266514806,0.6040715578036758,1.0,6/10,21.75%,EPHA4;ANXA2;RGP1;FURIN;CDK5RAP3;NELL1
prerank,androgen metabolic process (GO:0008209),0.568176756012323,1.3215370262496142,0.1610305958132045,0.8294912833638153,1.0,2/18,8.17%,HSD17B3;HSD17B4
prerank,histone deubiquitination (GO:0016578),0.5434290730191302,1.3212494539966517,0.17295597484276728,0.8286166115026414,1.0,5/18,13.31%,BRCC3;TAF10;UIMC1;TRRAP;USP15
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.5401398770093888,1.3197411521946723,0.17091454272863568,0.8323327358075121,1.0,4/20,9.74%,LBP;PRKCE;PTPN22;TICAM1
prerank,regulation of cellular biosynthetic process (GO:0031326),-0.4140052980978575,-1.3196698617574778,0.12048192771084337,0.6087657906147986,1.0,10/28,11.84%,PRKAG2;ADIPOR2;MITF;SIRPA;TNFRSF1B;JAK2;PRKAB2;CTNS;AVIL;FGFR4
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.5183561208999387,1.3193690022146143,0.14454277286135694,0.8317952076536888,1.0,8/25,15.19%,LEO1;CDK13;ELL;NELFB;SUPT4H1;HEXIM1;TCERG1;RECQL5
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),-0.5259190851310351,-1.3193130360774774,0.15609756097560976,0.6075834697549709,1.0,7/12,26.33%,DMD;ATP1B1;ANK3;ATP1B2;NOS1;WNK1;WNK2
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.5759804671013307,1.3188962708308516,0.1777059773828756,0.8315675760245546,1.0,2/14,4.50%,HNRNPC;HNRNPA0
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",-0.4238662109405247,-1.318682002797846,0.10084033613445378,0.607370976889008,1.0,10/21,25.76%,PAXIP1;MITF;MED17;SUB1;MED24;DHX36;MED14;MED30;SRF;BCLAF1
prerank,negative regulation of response to stimulus (GO:0048585),-0.3468478024539625,-1.3178462454615398,0.04,0.6075751437332951,1.0,17/60,8.23%,SLIT2;SLC30A10;LYN;IGFBP3;APPL2;DDAH1;BRAP;AKT3;NR1H3;ZKSCAN3;RBL1;KLF4;CD34;VPS13C;NR1H2;CDK6;AQP11
prerank,striated muscle tissue development (GO:0014706),0.5165275488250416,1.3177788990224149,0.1688888888888889,0.8336877479041614,1.0,6/29,6.70%,CAV1;SGCD;SGCG;CSRP3;BMP5;TBX2
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),-0.43647153768047764,-1.3167856887420832,0.13253012048192772,0.60871555946356,1.0,10/22,25.67%,PAXIP1;MED17;SUB1;MED24;ESR1;DHX36;MED14;MED30;SRF;PSMC5
prerank,regulation of mRNA polyadenylation (GO:1900363),-0.46701035246448125,-1.315878225042366,0.12433862433862433,0.6093907167644408,1.0,8/17,22.67%,CDK9;CCNT1;ZC3H3;HSF1;NCBP1;CPSF7;CPEB1;CPSF6
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.6252965625351379,1.3157320082909956,0.18835616438356165,0.8392566207028151,1.0,2/10,5.03%,CEACAM1;PTPRC
prerank,establishment of melanosome localization (GO:0032401),-0.460920884693381,-1.3155677863521738,0.14326647564469913,0.608097462298923,1.0,9/19,21.38%,MYO5A;RAB11A;BBS2;MKKS;BLOC1S6;RAB11B;MLPH;BBS5;RAB27A
prerank,myotube differentiation (GO:0014902),-0.48538859624031716,-1.3153862247997823,0.12530712530712532,0.6064894989006647,1.0,8/17,20.84%,IGF1;ADAMTS5;KCNH1;ADAMTS15;SORT1;MYEF2;NOS1;ADAM12
prerank,negative regulation of biomineral tissue development (GO:0070168),-0.44460482493339437,-1.3150783240194275,0.11242603550295859,0.6053370647877812,1.0,4/21,8.36%,ROCK2;ENPP1;NOS3;ASPN
prerank,cellular metal ion homeostasis (GO:0006875),0.4177808264082801,1.3147825480674196,0.10082063305978899,0.8408862171886547,1.0,12/102,5.41%,CAV1;STC2;NEDD4L;CTRC;SLC12A2;SLC8B1;CDH5;SLC24A1;TRPV4;CSRP3;ATP2B4;ATP1A2
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.5368847884717366,1.3145745305196648,0.16796267496111975,0.8396700031803164,1.0,8/21,16.57%,SULF1;EXTL3;XYLT2;GLCE;HS3ST5;EXT1;HS6ST3;EXT2
prerank,positive regulation of cytokinesis (GO:0032467),0.4957791001598712,1.3128603486780024,0.16517857142857142,0.844256215794165,1.0,12/32,18.19%,PRKCE;KIF20B;RACGAP1;SPAST;OPN1MW;CSPP1;CUL3;PKP4;CDC6;CIT;CDC14A;RHOA
prerank,genitalia development (GO:0048806),0.5936229117736896,1.3123872662931417,0.18683274021352314,0.8441115087970738,1.0,2/12,4.77%,STRA6;WNT5A
prerank,positive regulation of MAP kinase activity (GO:0043406),-0.3446950874302759,-1.3123018845474954,0.0593607305936073,0.6119866459658307,1.0,23/66,19.53%,FLT1;PDGFD;ROBO1;SASH1;PDGFRB;KIT;PDCD10;TRAF6;PIK3R6;MAP3K10;RPS3;LRRK2;IL34;TNFRSF11A;EDN1;DVL2;EGF;TPD52L1;EDN3;DIRAS2;CD24;CD40;MST1R
prerank,positive regulation of protein catabolic process (GO:0045732),0.4301336644494776,1.3122887791047222,0.12453760789149199,0.8424807066590089,1.0,22/84,18.11%,PLK2;GPC3;VGLL4;NEDD4L;AXIN1;GPLD1;WNT5A;DACT1;TNFAIP3;RDX;GSK3B;ADRA2A;NEDD4;APC;FAF1;ATG7;WWP2;FZR1;ITCH;EZR;STX5;VPS11
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.4709960561785268,-1.3118426898100688,0.15254237288135594,0.6110952992528246,1.0,6/17,10.41%,GJC1;GJD3;GJA1;SLC8A1;ATP1B1;ATP1B2
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),-0.5447254400020395,-1.3117733480283686,0.14942528735632185,0.6091242218999812,1.0,4/10,21.28%,UBE2J1;OS9;DERL2;SVIP
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.5034991185887624,-1.3117661760290527,0.14540816326530612,0.6070039945542809,1.0,4/14,9.90%,DMD;ATP1B1;SLC9A1;ANK3
prerank,glycosaminoglycan metabolic process (GO:0030203),0.45436136744416933,1.3112805924937267,0.15066666666666667,0.8442498322674467,1.0,18/54,17.83%,GPC3;XYLT2;GPC6;NDST1;SDC1;SLC35D2;GCNT2;HEXA;HS3ST6;HS3ST5;HSPG2;GPC2;SDC3;EXT1;HGSNAT;EXT2;SDC4;GPC5
prerank,positive regulation of cell migration (GO:0030335),0.386003254505908,1.311268118531483,0.05919661733615222,0.8423056283755302,1.0,32/253,7.43%,ROR2;GAB1;CLDN1;ITGA6;CAV1;NTRK3;CDH13;DOCK5;PRKCE;EGFR;GTSE1;FGF1;DOCK1;SEMA4B;SH3RF2;CDH5;KIF20B;ITGAX;PRKCA;SOX9;SRC;PTPRC;FN1;FER;TRADD;EPHB2;ADAM10;RDX;RIPOR1;SEMA3A;FBXO5;RREB1
prerank,regulation of transmembrane transport (GO:0034762),0.48609043164687427,1.311208972158622,0.14244186046511628,0.8405713472821565,1.0,7/31,11.21%,NEDD4L;KCNJ4;SCN10A;KCNJ16;KCNJ13;OCLN;NEDD4
prerank,negative regulation of heart contraction (GO:0045822),0.6065210997853697,1.3103379751819095,0.15912897822445563,0.8420155005709951,1.0,3/11,5.41%,PDE4D;FKBP1B;ATP1A2
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.5530310890335987,1.3102810855355835,0.17901234567901234,0.8402526407262935,1.0,6/17,17.12%,CEACAM1;DGKZ;PTPN22;PTPRJ;SH2D1A;EZR
prerank,cellular macromolecule biosynthetic process (GO:0034645),-0.2738465232118854,-1.3102410168845777,0.0,0.6095295246321589,1.0,125/306,26.31%,RPL37A;RRBP1;CREBL2;WRN;RPL19;RPL8;RPL37;RPS15;RPS29;RPL35A;TOP3A;FARSB;RPS7;RPS20;RPL32;RPS27;EEF1A1;RPL27;RPL26;BLM;RPS24;RPLP0;MEF2A;ATRIP;APOE;RBMS1;HARS1;PTMA;RPS19;MCM6;HBS1L;RPL31;RPL41;RPL13A;RPL30;RPL29;ORC2;RPS16;MRPS6;RPL3;NR4A2;RPLP1;RPS17;EEF1D;RPL23;RPL17;RPS3;RRAGC;RPL9;RPL38;RPL36;DHPS;RPS26;RPS8;POLA1;POLR3A;RPL18A;RPS12;RPS21;MMS19;MRPL32;CLSPN;CDC7;MRPL18;TOPBP1;RAD1;GCNT1;EEF1B2;TIPIN;RPS18;BARD1;RPS6;RPS15A;EIF4G1;RPLP2;PWP1;MRPL28;MRPL9;RNPS1;HOXD3;POLR2F;GSPT2;RAD17;RFC2;POLR2A;MRPS11;POLR2J;RAD9B;MRPS16;MRPS18B;GAL3ST2;POLR2D;TIMELESS;RPL14;POLR2K;RPS2;TOP1MT;MRPL42;RPL10A;THAP1;RPL34;FUT9;RPL5;ALAS1;INHBA;THRB;MRPS12;RPL39;POLD2;EEF2;RPL22;MRPL55;RMI2;CDC45;RPS9;RPS14;BRCA1;PCLAF;CDK2;MRPL36;POLA2;RPS25;RFC4;RPS6KB2;POLR2I
prerank,megakaryocyte differentiation (GO:0030219),-0.5430396202443333,-1.3097513040480402,0.16176470588235295,0.608781856970084,1.0,3/11,13.54%,KIT;UBA5;TAL1
prerank,regulation of supramolecular fiber organization (GO:1902903),-0.44382147564536356,-1.3093574530099128,0.12569832402234637,0.6078662133413745,1.0,8/22,17.09%,AEBP1;HSPA8;APOE;CAMSAP1;GBA2;MAP1B;MAPT;ARL2
prerank,fibrinolysis (GO:0042730),0.5829638076504623,1.3091180324807827,0.1751227495908347,0.8427448710935462,1.0,1/13,0.72%,SERPINB2
prerank,negative regulation of MAP kinase activity (GO:0043407),0.46715840189794483,1.3083142617158936,0.14705882352941177,0.843797886767534,1.0,9/44,10.30%,RGS14;STK38;NF1;SPRY1;PTPN22;SPRY4;IRAK3;PTPRJ;MAPK8IP1
prerank,glucose catabolic process to pyruvate (GO:0061718),0.5198506025791354,1.3071193356817723,0.17443609022556392,0.8444856806437905,1.0,9/24,17.54%,HK2;PFKP;FOXK1;ALDOB;FOXK2;ENO3;GCK;PGK1;ENO2
prerank,canonical glycolysis (GO:0061621),0.5198506025791354,1.3071193356817723,0.17443609022556392,0.8444856806437905,1.0,9/24,17.54%,HK2;PFKP;FOXK1;ALDOB;FOXK2;ENO3;GCK;PGK1;ENO2
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.5400234954671681,1.3068389206372897,0.17996870109546165,0.843651505837105,1.0,7/22,16.39%,NFATC2;IL4I1;CBFB;RUNX1;MDK;SOCS1;LAG3
prerank,regulation of lymphocyte proliferation (GO:0050670),0.5475373741077767,1.306698474892659,0.1853035143769968,0.8422427936135697,1.0,2/16,4.25%,TNFSF8;PTPN22
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.5504187363243376,1.306683286381486,0.162754303599374,0.840378041955746,1.0,6/18,7.77%,DLC1;RIPOR2;SCAI;ABL2;KANK1;CUL3
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),-0.3554009115955326,-1.306509773882727,0.08695652173913043,0.6147247415620863,1.0,17/48,13.48%,ETS1;ANGPT1;NOS3;AKT3;HIF1A;HDAC7;HDAC9;KDR;ANXA1;AKT1;PIK3C2A;GATA2;SP1;THBS1;TMSB4X;MAP2K3;SRPX2
prerank,positive regulation of calcium ion import (GO:0090280),-0.5199293434020261,-1.3060671887628545,0.16037735849056603,0.61393942131732,1.0,2/12,7.35%,PDGFRB;CXCL12
prerank,BMP signaling pathway (GO:0030509),-0.3459734239065644,-1.3056484383370375,0.07758620689655173,0.6130309909202211,1.0,15/62,13.42%,ENG;SMAD3;BMP6;SMAD6;TGFBR3;BMP4;SMAD9;ACVRL1;BMPR2;SMAD5;TGFB3;SLC33A1;BMP2;TGFB2;MEGF8
prerank,regulation of inclusion body assembly (GO:0090083),-0.5299154206542046,-1.305458448769908,0.15330188679245282,0.6115348413933049,1.0,7/11,31.70%,SNCAIP;DNAJB2;DNAJA4;HSPA1A;HSPA1B;DNAJB1;HSPA2
prerank,nitric oxide mediated signal transduction (GO:0007263),-0.47305267280704744,-1.305206789878464,0.15151515151515152,0.6102811503544193,1.0,4/16,6.72%,NOS3;NDNF;DDAH1;APOE
prerank,positive regulation of mitochondrion organization (GO:0010822),0.4453984682574437,1.3050507431233553,0.12836970474967907,0.8446693674707516,1.0,18/57,21.16%,DCN;PPARGC1A;DDHD1;CIDEB;FIS1;MIEF1;GSK3B;HTT;HTRA2;GPER1;BAD;BNIP3;RALBP1;PINK1;BAX;RALA;MUL1;PRKN
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.48273620539770573,1.3045839538856445,0.14306569343065692,0.8445179161591561,1.0,11/39,15.42%,EFNA5;JAG1;AJAP1;CASK;SPRY4;KANK1;GCNT2;NF2;FZD7;PTPRO;PLG
prerank,negative regulation of neuroinflammatory response (GO:0150079),-0.5026133447175375,-1.3039765982909164,0.15949367088607594,0.6116926585921653,1.0,4/14,6.69%,IGF1;LDLR;TNFRSF1B;CD200
prerank,atrial cardiac muscle cell action potential (GO:0086014),-0.48372059988140303,-1.3037940587757546,0.15690866510538642,0.6101242437088065,1.0,5/13,10.17%,ANK2;GJC1;GJA1;CACNB2;KCNN2
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),0.5887778980798766,1.3037336541608242,0.17567567567567569,0.8458460605389524,1.0,6/13,13.02%,ELOVL5;ELOVL1;HACD4;ELOVL2;HACD2;ELOVL6
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),-0.2923582035061612,-1.3035634549268114,0.02912621359223301,0.608815445028342,1.0,72/168,22.99%,CNOT6L;RPL37A;RPL19;RPL8;RPL37;RPS15;RPS29;RPL35A;RPS7;RPS20;RPL32;RPS27;RPL27;RPL26;RPS24;RPLP0;TENT2;RPS19;RPL31;RPL41;RPL13A;RPL30;RPL29;RPS16;RPL3;PABPC1;RPLP1;RPS17;ZC3H12A;RPL23;RPL17;PNRC2;RPS3;RPL9;RPL38;RPL36;NBAS;RPS26;RPS8;RPL18A;RPS12;RPS21;CNOT11;MAGOH;TUT7;MTPAP;RPS18;RPS6;RPS15A;EIF4G1;NCBP1;RPLP2;MAGOHB;ZFP36;RC3H1;RNPS1;GSPT2;CNOT9;PDE12;CTIF;POLR2D;RPL14;RPS2;RPL10A;RPL34;RPL5;NBDY;PPP2R1A;RPL39;EIF3E;DCP2;RPL22
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.4028522805247567,1.3035196979385304,0.08607021517553794,0.8447824543450402,1.0,36/119,20.36%,PIGU;PTPN13;SOCS5;PI4K2B;SLC27A1;PIP4K2B;PIK3R4;PGAP3;SOCS6;PLEKHA4;EFR3A;MTMR7;PIK3R2;PIGB;MTMR6;MTMR3;OCRL;INPP5F;PIGA;SOCS4;SOCS7;PTEN;PIK3C3;PLEKHA1;MTMR12;MTMR1;PI4K2A;SOCS1;PITPNM2;SOCS2;RAB5A;PITPNM3;FIG4;ITPKA;VAC14;PIK3C2B
prerank,regulation of cell motility (GO:2000145),0.40407741637668637,1.3026228314037411,0.11098130841121495,0.8462407254819164,1.0,20/121,9.33%,FGF7;NTN1;CEACAM1;ARHGAP18;LDB2;EGFR;KIF2A;FGF1;AMOTL1;PARD6B;MGAT3;MINK1;LMO4;PLXNA3;CAVIN1;AMOT;ABL2;SRCIN1;FGF18;INPP5F
prerank,positive regulation of macroautophagy (GO:0016239),0.4515259095317537,1.3021122125835616,0.146374829001368,0.8462448490574664,1.0,9/48,11.05%,DCN;PIP4K2B;LRSAM1;RAB3GAP2;SCOC;BAG3;SESN1;IRGM;PAFAH1B2
prerank,autonomic nervous system development (GO:0048483),0.5735825992759519,1.3020362802877445,0.15798045602605862,0.844583457152063,1.0,5/17,13.63%,NF1;FN1;SEMA3A;KIF26A;SOX4
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),-0.4662993959457701,-1.3020051189387436,0.1227154046997389,0.611522732030444,1.0,5/17,8.34%,ROBO1;SLIT2;PIK3R3;KDR;AKT1
prerank,regulation of protein acetylation (GO:1901983),0.5860066124453838,1.3018556976008444,0.1865546218487395,0.8433264154746585,1.0,3/12,13.66%,RAPGEF3;GSK3B;FAM161A
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.48625258104559255,1.3016386740737613,0.17196531791907516,0.8422401893178472,1.0,12/33,16.76%,GLI1;FAM83D;PSME3;ATP2B4;PAF1;DDRGK1;INO80;PTEN;PKD1;PTPN6;E2F1;FBXW7
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),-0.4852824024485557,-1.3015612872684683,0.1529126213592233,0.610868451984194,1.0,4/15,6.20%,PDGFRA;TGFBR1;FGFR2;TBX1
prerank,regulation of cell migration (GO:0030334),0.37209498408544694,1.301014331860602,0.027466937945066123,0.8427729855908587,1.0,51/382,8.36%,ROR2;NTNG2;NTNG1;CLDN1;ITGA6;CAV1;FGF7;DLC1;NTRK3;CDH13;SULF1;CEACAM1;CLDN19;LDB2;EGFR;KIF2A;GTSE1;FGF1;JAG1;AMOTL1;PARD6B;MGAT3;SEMA4B;SCAI;SH3RF2;CDH5;MINK1;NF1;ITGAX;ARPIN;FOXO3;PRKCA;LMO4;SRC;PLXNA3;AMOT;FER;ULK4;TRADD;EPHB2;ADAM10;RDX;RIPOR1;SEMA3A;DAG1;LDLRAD4;SRCIN1;KANK1;GCNT2;PTPRJ;FGF18
prerank,cellular sodium ion homeostasis (GO:0006883),0.5716391304863769,1.3009575016826198,0.19484702093397746,0.841102607202212,1.0,4/15,9.89%,NEDD4L;SLC12A2;ATP1A2;ATP1B3
prerank,mature B cell differentiation involved in immune response (GO:0002313),-0.5202958608969032,-1.3007951556582575,0.15151515151515152,0.6110866350748998,1.0,4/12,14.69%,NOTCH2;DOCK11;LFNG;MFNG
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),-0.5179759555401541,-1.3007643297896343,0.16519823788546256,0.607060685244951,1.0,4/12,9.50%,IGF1;CAMTA1;AKAP6;SLC9A1
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),-0.5179759555401541,-1.3007643297896343,0.16519823788546256,0.607060685244951,1.0,4/12,9.50%,IGF1;CAMTA1;AKAP6;SLC9A1
prerank,endosome organization (GO:0007032),0.4707331995290081,1.3005118775910847,0.1648793565683646,0.840827884789203,1.0,14/41,18.11%,USP50;HOOK2;PI4K2B;PHETA2;DNM1;USP8;SNX10;HOOK3;LAPTM4B;PI4K2A;ANXA8L1;ANXA8;ALS2;VPS11
prerank,muscle organ development (GO:0007517),0.45342544185772,1.3005088644076779,0.14913448735019974,0.8389615128360414,1.0,10/54,5.86%,UTRN;LAMA2;SGCD;COL6A3;MRAS;ITGA7;SGCG;CHD2;CACNA1H;ANKRD2
prerank,peptidyl-lysine trimethylation (GO:0018023),0.5119661804050348,1.2998149057426722,0.16930379746835442,0.8396560018412433,1.0,12/26,22.59%,OGT;KMT2A;BEND3;KMT5C;SUV39H1;ATPSCKMT;KMT2D;SETD2;SUV39H2;ETFBKMT;VCPKMT;EEF2KMT
prerank,neuromuscular junction development (GO:0007528),0.5074482756662261,1.2997914931406944,0.16941529235382308,0.8378987038999688,1.0,4/24,2.67%,LRP4;PDZRN3;MUSK;ZC4H2
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),-0.42638091791314625,-1.2994919932830913,0.1424581005586592,0.6086778559702055,1.0,4/22,4.38%,GHR;KIT;IL10RB;CYP1B1
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),-0.32882194290027617,-1.2982065186860754,0.052132701421800945,0.6103104258149209,1.0,21/69,17.28%,UBXN4;USP19;TRIM25;ERLIN1;DNAJB2;UBE4A;STT3B;SGTA;SEC61B;SYVN1;VCP;UBE2J1;FBXO17;ERLIN2;UBE4B;OS9;ANKZF1;RNF103-CHMP3;SGTB;FBXO44;DERL2
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),-0.37074798728555586,-1.2979311181942297,0.0888030888030888,0.6091327118334935,1.0,15/45,17.21%,ENG;RBPMS;BMP6;DAB2;BMP4;TGFBR1;ACVRL1;BMPR2;TGFB3;BMP2;TGFB2;HFE;CSNK2B;TWSG1;SMAD4
prerank,low-density lipoprotein particle remodeling (GO:0034374),-0.5192606990399511,-1.2976260892335436,0.15113350125944586,0.6080408179177254,1.0,6/11,36.70%,AGTR1;ABCG1;AGT;LIPC;PLA2G7;PLA2G5
prerank,C4-dicarboxylate transport (GO:0015740),0.5610276322391555,1.2971780219503664,0.18561872909698995,0.8457930878031195,1.0,5/14,12.83%,LRRC8D;SLC25A12;SLC1A6;SLC25A13;SLC25A22
prerank,positive regulation of endothelial cell migration (GO:0010595),-0.3227884017794577,-1.2968609332462435,0.05202312138728324,0.608404006856613,1.0,37/84,20.50%,SASH1;TEK;ETS1;ANXA3;ROCK2;ANGPT1;NOS3;FOXP1;SPARC;BMP4;AKT3;BMPR2;HIF1A;KDR;AKT1;GATA2;LGMN;AAMP;RHOB;PROX1;ZC3H12A;SP1;FLT4;THBS1;TMSB4X;MAP2K3;EDN1;P2RX4;NRP1;RIN2;EGF;HSPB1;CD40;AGT;BCAR1;MET;GFUS
prerank,lipoprotein catabolic process (GO:0042159),-0.5288934620115083,-1.2967366492578123,0.17523364485981308,0.6068123595497783,1.0,6/11,14.68%,LYPLA1;APOE;NOTUM;CTSD;ABHD17B;LYPLAL1
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),0.5051191223937017,1.2965321654417101,0.15328467153284672,0.8462162027523117,1.0,4/27,3.39%,AHNAK;CAMK2D;PDE4D;FKBP1B
prerank,myeloid cell differentiation (GO:0030099),-0.367843189068915,-1.2956794095131245,0.12916666666666668,0.6077694693349991,1.0,20/47,29.59%,LYN;SNRK;MFHAS1;KIT;UBA5;RPS19;CASP3;JAK2;SLC25A38;TAL1;TET2;INHBA;RPS14;JAK3;RASGRP4;ALAS2;CEBPA;KMT2E;KAT6A;UFL1
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.4173036574269701,1.2949847711020515,0.12702366127023662,0.8501969952131708,1.0,5/90,2.56%,EBF2;CAV1;PPARGC1A;LEPR;OGT
prerank,alanine transport (GO:0032328),-0.5326224514219424,-1.2949616454043738,0.15468409586056645,0.6080126498701157,1.0,4/10,23.69%,SLC6A6;SLC1A4;SLC6A17;SLC7A10
prerank,negative regulation of B cell proliferation (GO:0030889),-0.5357958878152919,-1.2947425038778198,0.2023529411764706,0.6066753902394645,1.0,6/11,32.67%,LYN;TNFRSF21;RC3H1;FCGR2B;ATM;CD300A
prerank,negative chemotaxis (GO:0050919),-0.38322635860602094,-1.2947255795509867,0.1366906474820144,0.6047493796623721,1.0,7/33,4.84%,ROBO1;EPHA7;SEMA6D;SLIT2;SEMA7A;SEMA3C;SEMA6A
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),0.4952493832112451,1.2946548115059895,0.15532544378698224,0.8496662787925197,1.0,10/34,14.93%,UBASH3B;PTPN13;PTPRF;PTPN22;PTPRJ;PTPRT;PTPN18;DUSP8;PTPN6;PTPRO
prerank,positive regulation of chemotaxis (GO:0050921),0.4637587175571736,1.2943882251911552,0.13532763532763534,0.8488423904203508,1.0,4/43,4.46%,SMOC2;NTRK3;CDH13;DSCAM
prerank,positive regulation of catabolic process (GO:0009896),0.4378026818753114,1.2940819411972895,0.13151041666666666,0.8481231412483224,1.0,7/65,5.24%,PLK2;GPC3;NEDD4L;AXIN1;WNT5A;DACT1;TNFAIP3
prerank,ion homeostasis (GO:0050801),0.4976527789661257,1.2939022382184138,0.17715959004392387,0.8469564606734873,1.0,5/30,7.25%,NEDD4L;CAMK2D;SLC4A3;SLC4A4;SLC4A11
prerank,cellular response to mechanical stimulus (GO:0071260),0.4616712429888666,1.2938001771080307,0.1514726507713885,0.8455300363402807,1.0,11/46,15.49%,F11R;PIEZO2;MAP3K1;SOX9;TLR7;PTGER4;PIEZO1;TMEM150C;AQP1;KCNK4;BAD
prerank,outflow tract septum morphogenesis (GO:0003148),-0.4197322237763517,-1.2937812700903617,0.12535612535612536,0.6054792786619301,1.0,8/24,6.20%,ROBO1;ENG;SMAD6;BMP4;SEMA3C;FGFR2;BMPR2;TBX1
prerank,regulation of glucose transmembrane transport (GO:0010827),-0.4478140425871465,-1.2934191435792664,0.14395886889460155,0.6045685041497313,1.0,2/18,3.57%,PRKAG2;C2CD5
prerank,regulation of angiogenesis (GO:0045765),0.38800472554636467,1.292791189058441,0.08131868131868132,0.8475430364792631,1.0,21/192,5.49%,THBS4;GAB1;DCN;SMOC2;SULF1;CEACAM1;HK2;RAPGEF3;ADAMTS1;FGF1;CDH5;SPRED1;NF1;ITGAX;IL1A;PRKCA;WNT5A;ATP2B4;AMOT;TNFAIP3;HIPK1
prerank,regulation of sodium ion transport (GO:0002028),0.4818326749237459,1.2926766421917426,0.17221418234442837,0.8461256161765853,1.0,3/34,4.86%,CNKSR3;SLMAP;ATP2B4
prerank,negative regulation of platelet activation (GO:0010544),-0.4763616148859994,-1.2923249483406094,0.1717948717948718,0.605893177780676,1.0,6/16,6.72%,PRKG1;PDGFRA;NOS3;THBD;SERPINE2;APOE
prerank,establishment of epithelial cell polarity (GO:0090162),-0.44591279178513155,-1.2922807575773179,0.16886543535620052,0.6040914638474327,1.0,4/19,2.99%,PARD3;MSN;CDC42;CYTH3
prerank,positive regulation of phosphorylation (GO:0042327),0.37729403708339376,1.291635124081006,0.06645569620253164,0.8480266331760861,1.0,26/240,6.63%,ROR2;ROR1;ITGA6;EFNA5;FGF7;NTRK3;FGFR1;GLMN;CLDN19;LEPR;EGFR;CCND3;MUSK;ZBTB20;PELI2;FGF1;AXIN1;FXR2;SOX9;LMO4;DSCAM;LIMK2;NBN;SLC4A4;EPHB2;KRAS
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.5827171998821088,1.2914929368349637,0.19365609348914858,0.8466692412627922,1.0,5/14,12.85%,EHHADH;DECR2;HSD17B4;ACOT8;ABCD1
prerank,regulation of cell-substrate adhesion (GO:0010810),0.4636240095752282,1.2911491517040439,0.1601123595505618,0.8461137749649841,1.0,5/42,4.75%,VIT;ECM2;MINK1;NF1;RAC2
prerank,heart morphogenesis (GO:0003007),-0.3540397370397047,-1.290890429007503,0.09689922480620156,0.6063232956526885,1.0,11/50,7.14%,ENG;INSR;TGFBR3;NOS3;CHD7;FKBP1A;TBX3;TGFBR1;ACVRL1;TBX1;SOX17
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.5177475240170853,1.2907431847742725,0.18333333333333332,0.8457451034194119,1.0,1/22,0.16%,AHNAK
prerank,RNA processing (GO:0006396),0.38880681945743956,1.2900030710249633,0.08758314855875832,0.846718657927958,1.0,38/176,15.71%,DHX8;PPARGC1A;HNRNPC;NUFIP1;SF3B2;SF3B1;PIWIL2;RBM8A;RNPC3;CELF1;SRSF4;HNRNPA0;TSEN54;ZRSR2;SNRPF;SON;PABPC4;HNRNPR;TUT1;FASTKD2;DDX17;PRPF3;CSTF3;SRPK1;RBM5;LIN28B;CELF2;SUPT4H1;SRPK2;TSEN34;TCERG1;SNRPA1;DICER1;SFPQ;PPIG;DHX16;PDCD7;SYNCRIP
prerank,mononuclear cell differentiation (GO:1903131),-0.428039605409971,-1.289994101200277,0.138801261829653,0.6068972015261418,1.0,8/24,19.78%,IL31RA;LYN;BMP4;MT1G;PIR;PDE1B;TRPM2;MYH9
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),-0.39396523244565995,-1.2893592058155106,0.12292358803986711,0.6068156285669097,1.0,20/33,34.59%,ACER2;LYN;CYP1B1;EPHA8;RET;NEXMIF;TGFB2;PTK2;NCKAP1L;CIB1;FERMT3;PDE3B;PLAU;RAC3;P2RY12;JAM3;ADA;HRG;SNAI2;SERPINE1
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),-0.40720104613457686,-1.2880667412301736,0.11470588235294117,0.6084957031468518,1.0,8/27,12.45%,PID1;ENPP1;GRB10;RPS6KB1;PIP4K2A;PRKCZ;GSK3A;PIP4K2C
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.5435039585203252,1.287922622185443,0.18181818181818182,0.8526093528183118,1.0,3/18,4.25%,ASS1;IL4I1;PTPN22
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),-0.42458074048752814,-1.2877346565124064,0.1513353115727003,0.6075955248400173,1.0,9/23,19.16%,IGF1;INSR;HIF1A;PFKFB3;P2RX7;PFKFB1;EGF;ENTPD5;GAPDHS
prerank,positive regulation of developmental growth (GO:0048639),0.4531874486734826,1.287310488955051,0.1695827725437416,0.8531110543463349,1.0,3/49,0.88%,NGF;NEDD4L;NTN1
prerank,negative regulation of cell population proliferation (GO:0008285),0.37185230423101767,1.287304082262025,0.047276464542651594,0.8513081274518912,1.0,62/351,14.43%,ROR2;NGF;ZBTB7C;APOD;IGFBP6;DLC1;VGLL4;CDH13;GLMN;FAP;CLDN19;ADAMTS1;SSTR1;GPLD1;GNRH1;NF1;IL1A;PTPN14;PTHLH;CELF1;BMPR1B;SOX9;TPTE;MFN2;BMP5;KLF10;MORC3;WNT5A;ACVR1C;NUP62;TNFAIP3;PDS5B;KANK2;NCK2;CTCF;PEX2;CHERP;DIS3L2;PTPRJ;RBM5;DLG3;CNOT7;PBRM1;STRN;AXIN2;MTSS1;RARG;PLXNB1;APC;ZBTB49;NF2;WNT9A;MEN1;PTEN;CDC6;EMD;CTNNBIP1;SOX4;CDKN1C;PTPN6;CLMN;DNAJA3
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),0.5778368565112522,1.2870014329770803,0.20764119601328904,0.8506376090809601,1.0,4/13,7.44%,CYFIP2;CIDEB;NLRC4;PERP
prerank,positive regulation of T cell proliferation (GO:0042102),-0.35214143721979657,-1.285651291662476,0.08812260536398467,0.6120358529828221,1.0,10/55,11.01%,IGF1;IGFBP2;TFRC;IGF2;IL18;SLC7A1;VCAM1;ANXA1;RPS3;CD80
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.5593492225275078,1.2852467192206922,0.19523809523809524,0.8552935910554909,1.0,2/16,5.03%,CEACAM1;PTPRC
prerank,negative regulation of protein ubiquitination (GO:0031397),0.4458163645706346,1.2852198950539924,0.15595075239398085,0.8536033077036744,1.0,15/50,17.49%,CAV1;OGT;SH3RF2;TNFAIP3;N4BP1;FBXO5;SIRT7;SPOPL;NXN;USP4;SOX4;CHP1;BAG2;GNL3L;MINAR1
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.4264543812453695,-1.284511116069994,0.16066481994459833,0.6135149339008966,1.0,8/21,14.07%,RAD51B;NPM1;CDC25B;CDC25A;RAB11A;CDK4;CDC7;RAD51C
prerank,negative regulation of neuron projection development (GO:0010977),0.4368043033288958,1.2843720490464094,0.14018691588785046,0.8549681792243555,1.0,17/56,18.19%,LRP4;LPAR1;RAB29;RTN4R;TRPV4;GDI1;SEMA3A;EFNB2;KANK1;HDAC2;RTN4RL1;PTEN;RTN4;PTPRO;EFNB3;MINAR1;RHOA
prerank,positive regulation of cation channel activity (GO:2001259),-0.37406472687241493,-1.2838692478867997,0.14285714285714285,0.6135752441926613,1.0,13/40,22.74%,ANK2;ACTN2;SHANK3;AKAP6;CALM1;ANK3;TMSB4X;JPH2;CALM3;P2RY6;STAC3;GSTO1;LRRC38
prerank,regulation of cellular component biogenesis (GO:0044087),-0.3711313845950065,-1.283767088190147,0.10801393728222997,0.611964395922739,1.0,9/39,10.51%,SNCAIP;RAPGEF2;ROCK2;MSN;TIE1;HSPA8;APOE;ANKRA2;GFAP
prerank,sulfur compound biosynthetic process (GO:0044272),0.4087426576002076,1.2836221652760789,0.11374407582938388,0.855941627730885,1.0,20/104,11.61%,DCN;CSPG4;ST3GAL4;PRELP;UST;GLCE;SLC35B2;B4GAT1;MGST2;CHST7;NCAN;SLC35D2;CHST2;GSTA4;GSTZ1;GGTA1;GSTK1;CHST12;TPK1;GSTA3
prerank,negative regulation of mononuclear cell migration (GO:0071676),-0.5096148749371494,-1.2834586207806669,0.18518518518518517,0.6108757753534494,1.0,4/12,8.34%,PLCB1;SLIT2;CCN3;AKT1
prerank,prostanoid biosynthetic process (GO:0046457),-0.47379651622534924,-1.2834224965562095,0.16707616707616707,0.6090644146060665,1.0,6/15,19.48%,PTGIS;PTGDS;PTGS1;TBXAS1;EDN1;MIF
prerank,inner dynein arm assembly (GO:0036159),0.6083202324079059,1.2830439489758885,0.20104895104895104,0.8562226079606183,1.0,3/10,15.37%,CFAP73;CCDC39;CCDC40
prerank,primary alcohol metabolic process (GO:0034308),-0.4224728447571151,-1.2829401291714935,0.14545454545454545,0.6085213030237111,1.0,5/25,4.38%,IGF1;GPD2;RBP4;NAPEPLD;CYP1B1
prerank,positive regulation of mitotic nuclear division (GO:0045840),-0.38124263619649124,-1.2826291198466069,0.12341772151898735,0.6075258245666467,1.0,5/34,3.54%,IGF1;INSR;TGFA;PDGFRB;IGF2
prerank,positive regulation of signaling (GO:0023056),0.46434460937241634,1.2825442094704151,0.16096866096866097,0.8563084061821601,1.0,5/37,9.33%,CLSTN2;RAB29;CLSTN3;RIMS2;INPP5F
prerank,negative regulation of protein transport (GO:0051224),0.5018382823060135,1.2825143548451154,0.1732283464566929,0.854619884996773,1.0,1/25,0.22%,PKDCC
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.42377552926119444,1.2824281349369695,0.12622549019607843,0.8531355610980461,1.0,7/75,5.07%,THBS4;DCN;SULF1;ADAMTS1;SPRED1;ATP2B4;AMOT
prerank,negative regulation of myoblast differentiation (GO:0045662),0.5733892247887684,1.2824182032337517,0.18307426597582038,0.8513820256813307,1.0,3/13,5.86%,PRICKLE1;SOX9;ANKRD2
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.41916217918553755,1.2822030347258964,0.14213197969543148,0.8504112249529735,1.0,12/72,14.11%,FGF7;FGFR1;FGF1;RBFOX2;SPRED1;KIF16B;FGF18;HNRNPM;GTF2F2;FLRT2;SPRED2;TIAL1
prerank,response to estradiol (GO:0032355),0.4855271611641416,1.282018094090394,0.18435754189944134,0.8493543455168335,1.0,12/31,20.31%,EGFR;SSTR1;NRIP1;POU4F1;NCOA3;LCOR;CCDC62;GPER1;GGT1;SOCS2;RUVBL2;STAT5B
prerank,membrane depolarization (GO:0051899),0.48513501729793135,1.2818510182652256,0.16946564885496182,0.8481767337820512,1.0,3/32,4.85%,CAV1;SCN10A;CACNA1H
prerank,sensory organ development (GO:0007423),0.448670668650733,1.2817593032736678,0.1738544474393531,0.8467601337401336,1.0,9/51,8.78%,STRA6;WNT10A;PBX1;BMPR1B;SH3PXD2B;HIPK1;SHROOM2;FREM2;ABCB5
prerank,negative regulation of bone remodeling (GO:0046851),0.5878419519465612,1.2817464932676335,0.2061328790459966,0.8450573545847959,1.0,2/11,5.24%,UBASH3B;TNFAIP3
prerank,prostaglandin biosynthetic process (GO:0001516),-0.4539593404000025,-1.2813956781399596,0.17994858611825193,0.6092588789026613,1.0,7/18,19.48%,PTGIS;PTGDS;PTGS1;TBXAS1;EDN1;HPGDS;MIF
prerank,odontogenesis of dentin-containing tooth (GO:0042475),0.5588738375815724,1.2801506216003478,0.19262981574539365,0.8489084949138862,1.0,2/15,2.75%,EDA;GLI2
prerank,regulation of proteolysis (GO:0030162),0.45407596263891026,1.2799694593556508,0.15575916230366493,0.8478093534234878,1.0,10/48,11.59%,CAV1;CYFIP2;OGT;CLN8;LTBP4;PERP;IST1;HDAC2;HDAC6;SPOPL
prerank,intracellular lipid transport (GO:0032365),-0.4333487477729766,-1.2796054202509093,0.1544502617801047,0.6126866530516109,1.0,8/21,14.61%,PRKAG2;ARV1;ABCD4;CPT2;PRKAB2;ABCD2;CPT1A;MID1IP1
prerank,regulation of cholesterol transport (GO:0032374),-0.4369929834582767,-1.2771567867954368,0.1544502617801047,0.6181938760756527,1.0,11/20,32.67%,LRP1;NR1H3;ARV1;NR1H2;ABCA2;NAXE;ABCB4;TSPO;ABCA13;NUS1;APOC1
prerank,regulation of receptor-mediated endocytosis (GO:0048259),-0.3894021120392785,-1.2759251087825096,0.12012987012987013,0.6199162158430859,1.0,7/35,8.38%,PICALM;HIP1;TNK2;B2M;HNRNPK;HIP1R;LDLRAP1
prerank,cellular response to alkaloid (GO:0071312),-0.4571311237913572,-1.2755457223646487,0.1700507614213198,0.619101892328142,1.0,4/17,7.13%,TGM2;SLC8A1;BLM;CASP3
prerank,negative regulation of chemotaxis (GO:0050922),-0.3931227774049515,-1.275143797965884,0.1188118811881188,0.6183806229947764,1.0,7/31,6.13%,ROBO1;SEMA6D;SLIT2;SEMA7A;SEMA3C;SEMA6A;DUSP3
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),-0.5078252151690174,-1.2747407283730976,0.16883116883116883,0.6176839759653692,1.0,6/13,9.74%,NUPR1;USP19;NR1H3;NR1H2;AQP11;MANF
prerank,neuromuscular process (GO:0050905),0.5389264624725546,1.274512141619638,0.2129032258064516,0.8664970659210182,1.0,1/16,0.21%,STRA6
prerank,positive regulation of cell division (GO:0051781),0.46259969506978554,1.2731449451879386,0.17705382436260622,0.8696704242911203,1.0,11/38,13.78%,PRKCE;FGF1;KIF20B;RACGAP1;SPAST;OPN1MW;CSPP1;CUL3;PKP4;CDC6;CIT
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.5222932584988885,1.273082982152049,0.2071097372488408,0.8681058518065262,1.0,5/19,8.07%,PTGFR;FKBP1B;FIS1;PTPRC;PTPRJ
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.6021486580136348,1.2727427875662998,0.2170138888888889,0.8657999411286673,1.0,8/10,28.65%,MGMT;ALKBH1;ASCC2;ASCC1;ALKBH2;ALKBH3;FTO;MPG
prerank,DNA dealkylation (GO:0035510),0.6021486580136348,1.2727427875662998,0.2170138888888889,0.8657999411286673,1.0,8/10,28.65%,MGMT;ALKBH1;ASCC2;ASCC1;ALKBH2;ALKBH3;FTO;MPG
prerank,activation of GTPase activity (GO:0090630),0.4093710166928579,1.2723929844066053,0.1354292623941959,0.8653712692189277,1.0,13/89,10.83%,ARHGAP42;SIPA1L1;NTRK3;TIAM2;GRTP1;SGSM2;ARHGEF5;TBC1D16;SLC27A4;FOXJ1;TBC1D2;TBC1D8;DOCK7
prerank,positive regulation of nervous system development (GO:0051962),0.4506061313627068,1.2720646472714532,0.16897506925207756,0.8648430351097431,1.0,4/42,6.25%,CLSTN2;RGS14;CLSTN3;EPHB2
prerank,regulation of synapse organization (GO:0050807),-0.40496923713734917,-1.2719305631726345,0.1464968152866242,0.6235786949410813,1.0,8/26,14.16%,EPHA4;SETD5;ARHGAP22;PDLIM5;CDKL5;MDGA1;ABHD17B;YWHAZ
prerank,motor neuron axon guidance (GO:0008045),0.5467669217581321,1.2714265867914938,0.20442930153321975,0.8654003853502065,1.0,5/15,7.19%,NTN1;RAC2;NTN5;SEMA3A;NTN3
prerank,regulation of osteoblast proliferation (GO:0033688),-0.44008880262585326,-1.2708185284015066,0.178117048346056,0.6247787469941387,1.0,5/17,10.45%,NPR3;FGFR2;MN1;CCN1;BMP2
prerank,protein K11-linked ubiquitination (GO:0070979),0.4805969514252135,1.2703874024225275,0.20437956204379562,0.8676439958765471,1.0,11/27,21.16%,UBE2E2;ANAPC5;ANAPC7;ANAPC11;ANAPC2;UBE2D3;ANAPC4;FZR1;CDC23;UBE2W;PRKN
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.3988474964088452,1.2702666415715487,0.1362048894062864,0.8663487618787318,1.0,29/109,18.81%,TEC;NFATC2;NFATC1;ITK;MAP3K1;MAPK10;VAV2;PSME3;FER;LCP2;PIK3R2;PSMB5;GAB2;LAT;TAB2;PSMA6;PSMB2;PSMA2;PSMD13;PSMA7;SYK;BTK;PSME4;NFATC3;PSMD12;PDPK1;PSMD14;PSMB6;PSMC4
prerank,negative regulation of histone methylation (GO:0031061),-0.5459213554573565,-1.270132278993294,0.19904076738609114,0.6247993842157215,1.0,7/10,28.54%,JARID2;KDM1A;DNMT3B;BRCA1;AASS;WDR5;BCOR
prerank,negative regulation of T cell differentiation (GO:0045581),-0.5318813971462031,-1.2698455918476768,0.18403547671840353,0.623774691882677,1.0,4/10,10.63%,GLI3;BMP4;ZC3H8;IRF1
prerank,positive regulation of cilium assembly (GO:0045724),-0.43657594780439024,-1.2688433628096427,0.17473118279569894,0.6249235264710585,1.0,6/18,14.14%,ARHGAP35;ENTR1;CEP135;FUZ;CEP120;CROCC
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),-0.43740736166282324,-1.2684800277761072,0.16279069767441862,0.6241368992720326,1.0,4/19,8.19%,IGF1;PICALM;APOE;RTN1
prerank,alpha-amino acid catabolic process (GO:1901606),0.48513400968258225,1.2682339451819742,0.1704225352112676,0.8721685937611477,1.0,7/29,10.65%,PRODH;IL4I1;AADAT;HOGA1;ACAT1;BLMH;GSTZ1
prerank,protein localization to cilium (GO:0061512),0.4818342813137142,1.268097872981184,0.19219653179190752,0.8709754365827634,1.0,15/32,24.85%,ZNF423;RAB29;RABEP1;SNX10;TCTN2;TTC21B;NPHP4;INVS;EHD1;BBS1;TCTN1;TULP2;IFT140;ARL3;CSNK1D
prerank,negative regulation of kinase activity (GO:0033673),0.42710798361296537,1.2678545340385876,0.15374677002583978,0.8701401852796845,1.0,17/62,18.37%,TRIB2;UBASH3B;CEACAM1;SPRED1;NF1;GNAQ;PTPRC;SFN;CEP85;RTRAF;CDKN1C;YWHAG;WARS1;DBNDD1;CHP1;IRS2;PDPK1
prerank,regulation of protein-containing complex assembly (GO:0043254),-0.3082959825780803,-1.267569845480831,0.08695652173913043,0.6251454969335227,1.0,26/110,12.16%,TRABD2B;CDC42;TFRC;BCL2L11;EP300;PREB;NAPA;FNIP1;FNIP2;HSPA8;APOE;RHOC;SLF2;SH3GLB1;SLF1;VCP;ANKRA2;RPS3;GFAP;PRKCZ;AJUBA;BID;MMP1;MPP7;CRYAB;SAR1B
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),-0.3424489029084266,-1.2675210838019233,0.08264462809917356,0.6234652352660125,1.0,17/56,17.21%,ENG;RBPMS;BMP6;SMAD6;DAB2;BMP4;TGFBR1;ACVRL1;BMPR2;TGFB3;BMP2;TGFB2;BMPER;HFE;CSNK2B;TWSG1;SMAD4
prerank,response to gamma radiation (GO:0010332),-0.4216395988822867,-1.2672718915487,0.14327485380116958,0.6224199959479826,1.0,12/24,26.13%,MAP3K20;WRN;RPL26;CRYAB;KDM1A;HSF1;HRAS;TRIM13;FANCD2;DCUN1D3;LIG4;PRKAA1
prerank,response to purine-containing compound (GO:0014074),-0.4625832118586688,-1.2672555705616715,0.15567282321899736,0.6206656691201375,1.0,6/17,18.76%,TRPC3;ABCC9;P2RX7;P2RX4;TRPM2;P2RY6
prerank,ATP synthesis coupled proton transport (GO:0015986),-0.44354076200963705,-1.2670800740895365,0.20051413881748073,0.6193370100937347,1.0,11/17,30.00%,ATP5PD;VPS9D1;DMAC2L;ATP5MC3;ATP5PF;ATP5ME;ATP5PO;ATP5MC2;ATP5MF;ATP5MC1;ATP5F1E
prerank,lipid phosphorylation (GO:0046834),0.5906546738587468,1.2670723307813596,0.2328042328042328,0.8711627068314647,1.0,2/10,3.64%,DGKA;DGKZ
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),-0.49407712299855305,-1.2669621091907868,0.1920374707259953,0.6178823477689639,1.0,3/13,2.56%,NFIB;BMP4;PPARD
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),-0.40424662635041164,-1.2664216449464756,0.153125,0.6177174874004323,1.0,4/25,5.76%,ANK2;TRPC1;CACNB2;AKAP6
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.5715761579752018,1.2664079280954188,0.22203672787979967,0.8720175148106472,1.0,5/13,10.26%,MGAT3;CHST7;EXTL2;CHST2;NAGK
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),0.5857754119441352,1.2663700296152616,0.20917431192660552,0.8704324713570977,1.0,3/10,9.47%,OGT;SELENOS;SIRT7
prerank,macrophage chemotaxis (GO:0048246),0.6182412946966269,1.2659290295504702,0.21291448516579406,0.8703767598638149,1.0,1/10,2.69%,CXCL17
prerank,positive regulation of B cell proliferation (GO:0030890),0.474964073038833,1.2659226457105563,0.18382352941176472,0.8686647788737125,1.0,7/29,12.82%,NFATC2;PTPRC;EPHB2;CD320;GPR183;IL7;CD81
prerank,natural killer cell activation (GO:0030101),0.49512202667499816,1.2656375978849628,0.19405320813771518,0.8679429209838485,1.0,5/23,12.60%,PBX1;PTPRC;IL21R;AXL;ULBP1
prerank,regulation of interleukin-2 production (GO:0032663),0.4457755390481887,1.2655585375986382,0.167574931880109,0.8665181279515055,1.0,6/43,5.24%,HOMER2;GLMN;PDE4D;IL1A;PTPRC;TNFAIP3
prerank,lysine catabolic process (GO:0006554),0.574527810685629,1.2655194067028896,0.226890756302521,0.8632290631013635,1.0,5/12,14.03%,AADAT;OGDH;GCDH;DLST;HYKK
prerank,lysine metabolic process (GO:0006553),0.574527810685629,1.2655194067028896,0.226890756302521,0.8632290631013635,1.0,5/12,14.03%,AADAT;OGDH;GCDH;DLST;HYKK
prerank,regulation of receptor internalization (GO:0002090),-0.379030322469849,-1.2648185247944732,0.1423728813559322,0.6203845500369563,1.0,13/35,25.32%,INSR;ANGPT1;ANKRD13A;AHI1;EGF;FLOT1;PICK1;MKLN1;GREM1;ANKRD13D;NTF3;RIN3;ARRB2
prerank,regulation of cellular protein catabolic process (GO:1903362),0.5238468241731475,1.2645463157560535,0.1970684039087948,0.8651005145545615,1.0,8/18,18.11%,VGLL4;DACT1;RDX;RIC1;FAF1;EZR;WDR91;VPS11
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.4034036301130429,1.2641785472823635,0.16009557945041816,0.864692038931415,1.0,44/94,25.71%,DYNLL1;MKS1;SFI1;CEP89;CEP131;CEP78;NEDD1;TUBG1;CKAP5;CCP110;CEP162;PAFAH1B1;TCTN2;C2CD3;CEP290;SSNA1;NDE1;CETN2;RPGRIP1L;PCM1;FBF1;B9D2;NPHP4;YWHAG;YWHAE;CEP57;OFD1;ALMS1;CEP250;DCTN2;TCTN1;HAUS8;CEP43;HAUS3;CC2D2A;HAUS7;TMEM67;SCLT1;CEP83;NPHP1;CSNK1D;DYNC1I2;RAB3IP;TTBK2
prerank,muscle filament sliding (GO:0030049),-0.3696108048834376,-1.2638955796124722,0.12244897959183673,0.6194661648783161,1.0,8/38,14.21%,ACTN2;DMD;TPM1;MYL6;TPM3;TPM2;DES;VIM
prerank,actin-myosin filament sliding (GO:0033275),-0.3696108048834376,-1.2638955796124722,0.12244897959183673,0.6194661648783161,1.0,8/38,14.21%,ACTN2;DMD;TPM1;MYL6;TPM3;TPM2;DES;VIM
prerank,cardiac ventricle development (GO:0003231),0.5156425599541168,1.263856327267997,0.20222929936305734,0.864192961196566,1.0,2/20,5.11%,STRA6;HEYL
prerank,cardiac ventricle morphogenesis (GO:0003208),-0.36875045962745867,-1.2632278046215781,0.11036789297658862,0.6195912146218722,1.0,7/41,3.88%,ENG;TGFBR3;RBPJ;TPM1;FKBP1A;BMP4;FGFR2
prerank,indolalkylamine catabolic process (GO:0046218),0.591467120615665,1.2624477983438056,0.21452702702702703,0.8677410656972985,1.0,2/10,3.80%,IL4I1;AADAT
prerank,carnitine shuttle (GO:0006853),-0.5090935523574994,-1.2623561820937168,0.18064516129032257,0.620263732332762,1.0,5/11,14.61%,PRKAG2;CPT2;PRKAB2;CPT1A;MID1IP1
prerank,positive regulation of protein acetylation (GO:1901985),0.5815322675862904,1.2621757278238743,0.2134646962233169,0.8670598178764272,1.0,3/12,13.66%,RAPGEF3;DIP2A;FAM161A
prerank,regulation of exocytosis (GO:0017157),0.44189238666485187,1.2621276012639895,0.17583892617449665,0.8655195913990844,1.0,5/46,7.36%,STXBP6;RAB8B;RIMS2;RAB3A;CPLX1
prerank,negative regulation of protein phosphorylation (GO:0001933),0.38486370545573806,1.2619275002023231,0.1271282633371169,0.8645690188915223,1.0,29/150,13.03%,CNKSR3;CAV1;TRIB2;NTRK3;UBASH3B;PTPN13;CEACAM1;PDE4D;SPRED1;NF1;PLPP3;GNAQ;IBTK;PTPRC;NCK2;EPHB2;LDLRAD4;OCLN;RASSF2;NLRP2B;SFN;CEP85;RTRAF;SNX25;MEN1;MVP;SEMA4D;PTEN;SPRED2
prerank,protein-containing complex subunit organization (GO:0043933),0.3998688820807411,1.2616174545092882,0.13216374269005848,0.8640275357321469,1.0,14/109,8.62%,MAGI1;PPARGC1A;WIPF1;LAMC1;REPS2;PARD6B;CD3G;KMT2A;SOX9;FANCC;CARD10;TAPBP;DARS1;OCLN
prerank,negative regulation of cell communication (GO:0010648),0.5033286698178863,1.261263613620454,0.20726172465960666,0.8636193756559217,1.0,2/21,2.28%,UBASH3B;SOCS5
prerank,regulation of protein-containing complex disassembly (GO:0043244),-0.46380816319299645,-1.2610649932691635,0.17422434367541767,0.6222142597078113,1.0,2/16,0.62%,IGF1R;INSR
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.42825318666926293,-1.261061016523803,0.16338028169014085,0.6204561681550157,1.0,4/20,11.50%,IGF1;EP300;TRAF6;H1-0
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.49900693478585856,1.260959281291829,0.19937205651491366,0.8630963692347828,1.0,7/23,16.55%,OTOP1;ARG1;TXK;IRGM;SOCS1;PPARG;JAK1
prerank,regulation of lamellipodium morphogenesis (GO:2000392),0.5811179437464662,1.2593860150699188,0.2103448275862069,0.8672995504341212,1.0,4/11,7.66%,ARPIN;SRC;RREB1;KANK1
prerank,regulation of cytokinesis (GO:0032465),0.41398920058136324,1.2589795781744209,0.16605166051660517,0.8670958444257373,1.0,21/78,14.52%,PLK2;PRKCE;KIF20B;RACGAP1;PIK3R4;SPAST;OPN1MW;CSPP1;CCP110;CUL3;KIF13A;PKP4;ZFYVE26;KLHL21;MAP9;CHMP4C;CETN2;AHCTF1;CDC6;CIT;PIK3C3
prerank,cellular response to growth factor stimulus (GO:0071363),-0.2891543064559045,-1.258936488562787,0.027522935779816515,0.6247757968879252,1.0,47/151,17.38%,FLT1;SOX5;RAPGEF2;SMAD3;BMP6;PDE8A;CLEC3B;BMP4;SMAD9;NDNF;APPL2;TGFBR1;WNT4;ACVRL1;STMN2;MT1G;GAS1;BMPR2;SEMA6A;DSTYK;EEF1A1;KLF4;KDR;DUSP3;TBX1;RPS6KB1;CRKL;ANXA1;AKT1;RAMP2;PDE2A;LGMN;BMP2;SOX6;FLT4;MAPKAPK2;MAP2K3;SPHK1;PLK5;MAPT;ZPR1;NRP1;ZFP36;HSPB1;SMAD4;NOS1;WWOX
prerank,positive regulation of cellular respiration (GO:1901857),-0.5123862653811944,-1.258579986171935,0.1958997722095672,0.6239649198442208,1.0,5/11,23.13%,NUPR1;IL10RB;VCP;IFNAR1;ISCU
prerank,neuropeptide signaling pathway (GO:0007218),0.4372785820521311,1.2574570147660085,0.17857142857142858,0.8710437102868316,1.0,4/58,4.84%,SORCS2;SSTR1;KISS1R;CPE
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),-0.4087199593509948,-1.257306053969785,0.17313432835820897,0.6260505550732831,1.0,5/23,7.53%,GHR;KIT;IL10RB;CYP1B1;JAK2
prerank,ganglion development (GO:0061548),0.5755887876695761,1.2569482525697153,0.2195540308747856,0.8712126952737252,1.0,3/11,14.48%,NRP2;SEMA3A;FZD3
prerank,positive regulation of synapse assembly (GO:0051965),0.49288907923604275,1.256871179419234,0.1996996996996997,0.8698513850542788,1.0,3/27,6.25%,CLSTN2;CLSTN3;EPHB2
prerank,positive regulation of protein phosphorylation (GO:0001934),0.35881705226141847,1.256773559708375,0.057911065149948295,0.8685348325786919,1.0,34/348,6.63%,NGF;THBS4;CAV1;EFNA5;FGF7;TEC;NTRK3;INHBB;CSPG4;CLDN19;LEPR;EGFR;CCND3;MUSK;RAPGEF3;PELI2;RAP1A;FGF1;AXIN1;FXR2;PRKAG1;MMD2;SOX9;SRC;BMP5;ATP2B4;LIMK2;PTPRC;TOM1L1;BANK1;BMP15;NBN;LCP2;KRAS
prerank,maintenance of protein localization in organelle (GO:0072595),0.524547778909067,1.2565649155292458,0.20865533230293662,0.8676038022698387,1.0,3/19,4.69%,HK2;BCL3;MORC3
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),-0.5357919545010961,-1.2562883588003655,0.19626168224299065,0.6273333924320865,1.0,3/10,7.53%,GHR;LYN;JAK2
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.40710939998156437,1.2557379540827056,0.16049382716049382,0.86896755200731,1.0,11/79,4.86%,DLX1;SULF1;ADAMTS12;CASK;SPRY1;BMPR1B;CREB3L1;NBL1;SPRY4;APLN;ATP2B4
prerank,histone H4-K16 acetylation (GO:0043984),0.5142428641644168,1.2554289665940894,0.209375,0.8685094862083351,1.0,4/19,7.63%,OGT;KMT2A;KANSL2;MSL3
prerank,cAMP-mediated signaling (GO:0019933),-0.4156572650718967,-1.2550400673922486,0.14942528735632185,0.6292501921934042,1.0,8/24,9.13%,KSR1;RAPGEF2;PDE7B;ADGRG6;ADCY1;AKAP6;ADCY2;PDE2A
prerank,hexose transmembrane transport (GO:0008645),-0.41666969519499203,-1.254490542785748,0.17732558139534885,0.6291159785821603,1.0,10/21,26.79%,PPARD;SLC2A12;SLC2A10;SLC45A3;SLC2A8;SLC2A9;SLC2A1;SLC45A1;SLC2A3;SLC2A4
prerank,cellular amino acid catabolic process (GO:0009063),0.40635245082600324,1.2543168092267591,0.17675544794188863,0.8709300033891345,1.0,22/87,14.03%,PRODH;ARG1;IL4I1;ACAD8;AADAT;HMGCLL1;BCKDK;HOGA1;OGDH;ACAT1;ALDH5A1;GCDH;ABAT;BLMH;DLST;GLDC;GSTZ1;BCKDHB;BCAT2;GOT1;GLUL;HYKK
prerank,regulation of GTPase activity (GO:0043087),0.38171093750880597,1.2537358787982675,0.11450381679389313,0.8714015646476835,1.0,30/177,11.30%,ITGA6;EFNA5;SIPA1L1;DOCK9;F11R;RGS6;ARHGAP12;RAPGEF3;RAP1A;ARAP1;ARHGAP9;SGSM2;NF1;RTN4R;CAV2;VAV2;PLXNA3;ZC3H15;ARHGEF5;RAB3GAP2;RDX;RAPGEF6;GSK3B;OCRL;PKP4;TBC1D2;FERMT2;RIC1;PLXNB1;DVL3
prerank,protein K63-linked deubiquitination (GO:0070536),0.4727042965591377,1.2534780307916518,0.1994219653179191,0.8706872579846011,1.0,11/31,18.39%,USP50;BRCC3;TNFAIP3;USP8;OTUB2;UIMC1;USP13;OTUD7B;STAMBPL1;STAMBP;PSMD14
prerank,positive regulation of cellular senescence (GO:2000774),-0.5213435602231924,-1.2529860753211777,0.23006833712984054,0.6317828522137672,1.0,4/10,19.72%,B2M;YPEL3;EEF1E1;CGAS
prerank,energy reserve metabolic process (GO:0006112),-0.4333119989679622,-1.2526999957206186,0.18328840970350405,0.6308351244567401,1.0,4/19,7.03%,PRKAG2;PID1;GBE1;UGP2
prerank,regulation of actin filament bundle assembly (GO:0032231),-0.40622832498105427,-1.2523263221453753,0.15669515669515668,0.6301381843112723,1.0,7/26,9.50%,ROCK2;SHANK3;SYNPO2;CDC42;ASAP3;ACTG1;SLC9A1
prerank,positive regulation of coagulation (GO:0050820),0.586805717617586,1.2516462945092153,0.22942206654991243,0.8742456190135648,1.0,1/10,0.81%,ST3GAL4
prerank,positive regulation of hemostasis (GO:1900048),0.586805717617586,1.2516462945092153,0.22942206654991243,0.8742456190135648,1.0,1/10,0.81%,ST3GAL4
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),-0.4793765155997644,-1.2513192542503082,0.20565552699228792,0.6313202788626218,1.0,6/13,14.85%,SHANK3;ADCY1;SQSTM1;LGMN;EIF2AK4;ZDHHC2
prerank,regulation of purine nucleotide metabolic process (GO:1900542),-0.35215231190652985,-1.2512023919539574,0.14625850340136054,0.6299149260075048,1.0,9/41,7.39%,PRKAG2;NUP107;EP300;LACC1;HIF1A;AAAS;SEH1L;NUP133;PGAM1
prerank,regulation of feeding behavior (GO:0060259),0.5691927306948595,1.2511797965900886,0.2222222222222222,0.874360911582549,1.0,4/11,16.46%,LEPR;SGIP1;CFAP20;AGRP
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),-0.4279543633330428,-1.2510228718020484,0.17579250720461095,0.6287423135692051,1.0,9/19,35.30%,ADK;HPRT1;CDA;POLD2;APRT;ADA;POLL;TYMS;GMPR
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.5477621533275812,1.2509880323576719,0.23739837398373984,0.8734276041638637,1.0,7/15,21.33%,ATL2;REEP3;LNPK;RTN4;REEP4;ZFYVE27;RAB18
prerank,gene expression (GO:0010467),-0.25500780493645464,-1.250956232305784,0.0,0.6271949500508,1.0,115/348,21.11%,RBPMS;RPL37A;RRBP1;CREBL2;ADAR;NUP107;RPL19;RPL8;RPL37;RPS15;RPS29;RPL35A;SNRNP40;FARSB;RPS7;RPS20;RPL32;HNRNPK;AAAS;RPS27;EEF1A1;SEH1L;RPL27;RPL26;NUP133;RPS24;RPLP0;NOX4;FYTTD1;MEF2A;RBMS1;HARS1;PTMA;RPS19;HBS1L;THOC2;RPL31;RBMS2;RPL41;TSPAN17;GLE1;RPL13A;RPL30;RPL29;RPS16;MRPS6;RPL3;HNRNPH3;NR4A2;RPLP1;RPS17;RPL23;RPL17;RPS3;RRAGC;RPL9;RPL38;RPL36;DHPS;RPS26;RPS8;POLR3A;ZC3H11A;RPL18A;RPS12;RPS21;MMS19;MRPL32;MAGOH;MRPL18;CDC40;LMF2;NUP88;RPS18;RPS6;NOL9;HHEX;RPS15A;EIF4G1;NCBP1;RPLP2;PWP1;MRPL28;MRPL9;DNAJB11;ANGPT2;MAGOHB;CPSF1;RNPS1;DDX20;HOXD3;POLR2F;TSPAN5;GSPT2;CLP1;POLR2A;MRPS11;POLR2J;MRPS16;U2AF2;MRPS18B;NOVA1;POLR2D;RPL14;POLR2K;HNRNPH1;RPS2;MRPL42;SRRM1;NUP54;THOC7;RPL10A;THAP1;DUSP11;RPL34
prerank,inner mitochondrial membrane organization (GO:0007007),-0.3417100983404877,-1.2509399365404354,0.13405797101449277,0.6255242211014193,1.0,18/47,21.51%,IMMT;ATP5PD;DMAC2L;ATP5MC3;MICOS13;SAMM50;GHITM;ATP5PF;OPA1;ATP5ME;MTX2;TIMM8B;TIMM10B;ATP5PO;ROMO1;MAIP1;TIMM29;ATP5MC2
prerank,positive regulation of metabolic process (GO:0009893),0.39816772429776387,1.2507546416751518,0.15085158150851583,0.8726404506067972,1.0,17/103,13.55%,EBF2;CAV1;PPARGC1A;LEPR;OGT;BEND3;MFN2;ACACA;TSHR;PIGA;KSR2;APC;PRLR;KDM6B;ELOVL6;HCRT;TRPV2
prerank,Fc receptor signaling pathway (GO:0038093),0.3915402093981819,1.250561644649362,0.1633835457705678,0.8716769173132539,1.0,29/110,18.81%,TEC;NFATC2;NFATC1;ITK;MAP3K1;MAPK10;VAV2;PSME3;FER;LCP2;PIK3R2;PSMB5;GAB2;LAT;TAB2;PSMA6;PSMB2;PSMA2;PSMD13;PSMA7;SYK;BTK;PSME4;NFATC3;PSMD12;PDPK1;PSMD14;PSMB6;PSMC4
prerank,endothelial cell migration (GO:0043542),0.4676967521690623,1.250371600817112,0.2033195020746888,0.8707766335824833,1.0,6/37,8.22%,CDH13;PXN;FAP;CDH5;STARD13;DPP4
prerank,cellular response to dsRNA (GO:0071359),0.5383905861337227,1.249467599763549,0.24006908462867013,0.8724333446245365,1.0,1/15,0.25%,CAV1
prerank,regulation of heart contraction (GO:0008016),0.4056896481746594,1.2494241363842162,0.16502463054187191,0.8709650771283154,1.0,16/90,10.93%,CORIN;ITPR2;CAMK2D;ITPR3;SCN10A;PDE4D;FKBP1B;APLN;CACNA1H;ATP2B4;ATP1A2;TBX2;CASQ2;CELF2;ATP1B3;FXYD6
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.4396931517713993,1.24922782131025,0.18716577540106952,0.8700519183469992,1.0,7/50,13.15%,NGF;SRC;RPS6KA3;SFN;USP47;DHCR24;AQP1
prerank,positive regulation of DNA binding (GO:0043388),0.4758594896865427,1.2488888734650754,0.2088235294117647,0.8696785977179442,1.0,1/31,0.04%,NGF
prerank,cellular response to interleukin-4 (GO:0071353),-0.5428746187190586,-1.2482327403923872,0.22696629213483147,0.6315362964338889,1.0,3/10,25.17%,LEF1;XBP1;JAK3
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.3831831756377844,1.2481242982000587,0.12260967379077616,0.870690538262421,1.0,15/152,8.96%,GNA14;LPAR1;ADGRG5;ADGRG2;PTGFR;AKAP12;GPR161;MC5R;PTHLH;GNAQ;ADCY5;PTGER4;ABCA1;GNAL;TSHR
prerank,glutamate receptor signaling pathway (GO:0007215),-0.36468326434232673,-1.2479564977430302,0.13688212927756654,0.6306677713606116,1.0,10/37,9.29%,PLCB1;KCNB1;GRM3;GRIA2;CPEB4;GRIN3A;GRIN2B;DAGLA;GRIK2;GRIN1
prerank,mRNA metabolic process (GO:0016071),0.39995796788413707,1.2475534156871013,0.15121951219512195,0.8712093841547252,1.0,19/90,14.30%,PPARGC1A;SF3B2;PCBP2;CELF1;CNOT10;SRSF4;HNRNPA0;SNRPF;SON;DXO;HNRNPR;PRPF3;CSTF3;DIS3L2;SUPT4H1;TCERG1;ZFP36L2;ERN1;SFPQ
prerank,regulation of intracellular protein transport (GO:0033157),0.46365573993294656,1.2469069292568706,0.18235294117647058,0.8719532348993647,1.0,11/32,16.04%,RAB29;KIF20B;PTPN14;CEP131;RIPOR1;SIRT7;GCC2;TPR;CEP290;PCM1;LCP1
prerank,secretion (GO:0046903),-0.4623332460570758,-1.2468842796450177,0.19210526315789472,0.6320358131014936,1.0,4/14,5.56%,SLC22A6;SLC22A4;NPR1;FBLN5
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.49453498285816927,1.246453937112078,0.19751166407465007,0.8719318769449803,1.0,8/26,20.06%,EFNA5;GPLD1;ADCY5;ADRA2A;ADCY8;STX4;KLF7;TRPM4
prerank,skeletal muscle tissue development (GO:0007519),0.47646089414666587,1.2462339133543865,0.19971056439942114,0.8711219017648187,1.0,3/32,4.42%,CAV1;CAV2;CSRP3
prerank,heterochromatin organization (GO:0070828),-0.48014977993028995,-1.2459497792174639,0.20050125313283207,0.6328597141997183,1.0,3/14,9.19%,MECOM;PRDM16;BAHD1
prerank,negative regulation of multicellular organismal process (GO:0051241),0.3711425299084833,1.2453588146826537,0.12081984897518878,0.8725801802006431,1.0,30/199,11.86%,PTCH1;LRP4;DLX1;IL18R1;LAMA4;ZNF423;EGFR;SPRED1;SPI1;SPRY1;PLCL1;SOX9;PCTP;BMP5;ATP2B4;ACVR1C;ACOT13;N4BP1;HOXC10;LDLRAD4;PTGER4;TBX18;LNPEP;GSK3B;SDHAF2;DOCK7;WWC1;PROC;HS3ST5;RAB11FIP5
prerank,cilium organization (GO:0044782),0.3674792424265389,1.2451548476751824,0.10215053763440861,0.8717100756651341,1.0,60/209,19.73%,DYNLL1;PARVA;UBXN10;RAB8B;ABLIM3;MKS1;PTPDC1;DZIP1;DYNC2I1;CYS1;EXOC3;CNGB1;INTU;CEP89;CEP131;IFT81;CEP78;CNGA4;SNX10;EHD2;CCP110;CLUAP1;CEP162;ARMC2;UNC119B;OCRL;TMEM237;TCTN2;FOXJ1;IFT74;DYNLL2;HDAC6;EXOC5;CFAP20;IQCG;CEP290;FAM161B;PKD1;PDE6D;PCM1;FAM161A;FBF1;DNAH5;B9D2;CFAP298;PIBF1;CFAP70;CFAP410;CFAP61;CDC14A;DYNC2H1;EHD1;OFD1;ARMC9;STK36;CEP250;SNAP29;BBS1;TTC29;TCTN1
prerank,positive regulation of glycolytic process (GO:0045821),-0.41886204208543604,-1.2445490140842126,0.1878453038674033,0.6335712831025867,1.0,8/20,19.16%,IGF1;INSR;HIF1A;PFKFB3;P2RX7;PFKFB1;ENTPD5;GAPDHS
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),-0.41886204208543604,-1.2445490140842126,0.1878453038674033,0.6335712831025867,1.0,8/20,19.16%,IGF1;INSR;HIF1A;PFKFB3;P2RX7;PFKFB1;ENTPD5;GAPDHS
prerank,negative regulation of T cell proliferation (GO:0042130),0.48652184691284706,1.242959281169819,0.2155425219941349,0.8779249246881038,1.0,4/28,7.53%,GLMN;ARG1;IL4I1;CRTAM
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.5111131126915021,1.242915442688485,0.22523961661341854,0.8764794643693515,1.0,6/19,17.56%,HNRNPC;SRC;STN1;EXOSC10;GNL3L;TERF2
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.5207068750673608,1.2426471655197981,0.20993589743589744,0.875827629844151,1.0,3/17,7.73%,JAG1;CD55;MSH2
prerank,regulation of protein localization to membrane (GO:1905475),0.4783080199543974,1.2424836421741263,0.20030581039755352,0.8748282114144433,1.0,10/28,17.83%,GPC3;GPC6;ZDHHC7;VAMP8;SLC5A3;GPC2;MMP14;CRIPT;SPTBN1;GPC5
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.4161552393637946,-1.2418580704260973,0.17647058823529413,0.6396365356880196,1.0,7/23,7.11%,ACSL1;ACSL3;FAR2;ACOT7;ELOVL7;ACSL6;HSD17B12
prerank,ephrin receptor signaling pathway (GO:0048013),0.40332394439009306,1.241700134927149,0.16117216117216118,0.8760032588393034,1.0,13/82,8.16%,EFNA5;SIPA1L1;ARHGEF28;EFNB1;APH1B;VAV2;DNM1;SRC;NCSTN;NCK2;EPHB2;EFNB2;KALRN
prerank,sphingolipid biosynthetic process (GO:0030148),0.41664788666014024,1.2415406475150874,0.17446270543615677,0.8749850198391615,1.0,16/71,11.18%,SGMS2;CERS6;ACER3;ELOVL5;A4GALT;PLPP2;PLPP3;ALOXE3;CLN8;ELOVL1;HACD4;ELOVL2;CERT1;ST8SIA5;ST8SIA3;HACD2
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.557594386588964,1.2414731251787787,0.24040066777963273,0.8736648417558219,1.0,8/13,27.32%,NELFB;SUPT4H1;HEXIM1;TCERG1;RECQL5;EAPP;HNRNPU;NELFA
prerank,dendrite self-avoidance (GO:0070593),-0.44995023707179016,-1.2401624301918661,0.1964735516372796,0.6428793263121307,1.0,6/16,13.57%,BSG;DSCAML1;NEXN;ROBO4;PALLD;CNTN2
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.3662394717066794,1.2397771560153812,0.10756123535676251,0.8783234798490602,1.0,19/214,6.25%,ROR2;CNKSR3;ROR1;NTRK3;ACKR3;RGS14;CEACAM1;EGFR;RAP1A;SPRED1;SPRY1;PRKCA;PTPN22;FAM83D;PTPRC;STYX;FN1;ARHGEF5;EPHB2
prerank,potassium ion export across plasma membrane (GO:0097623),0.5485298690468293,1.2395261923079104,0.2020033388981636,0.8776719728040362,1.0,2/13,8.50%,KCNA5;KCNK5
prerank,response to interleukin-4 (GO:0070670),-0.5347220130595124,-1.2391645299638423,0.22014051522248243,0.6442198435036112,1.0,1/10,0.68%,LEF1
prerank,ether lipid metabolic process (GO:0046485),0.5510940343916442,1.2390486995439902,0.21112929623567922,0.8778266204091867,1.0,4/14,12.34%,AGMO;NCEH1;PAFAH1B1;LIPE
prerank,renal system development (GO:0072001),0.43211760449916026,1.2381181630379,0.18707015130674004,0.8795618783358269,1.0,5/52,2.75%,STRA6;LRP4;SULF1;PCSK5;GLI2
prerank,regulation of mRNA processing (GO:0050684),0.4627092591787489,1.2377037737084335,0.21658986175115208,0.8794517856646309,1.0,18/32,26.21%,QKI;SON;SRPK1;SLTM;KHDRBS2;SRPK2;SF1;CWC22;SRSF3;DHX9;TIA1;SRSF10;YTHDC1;JMJD6;IWS1;SAFB2;PABPN1;RBM39
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.3874233779597438,1.2368956504865314,0.15826494724501758,0.8807748405490691,1.0,23/118,12.40%,EFNA5;SIPA1L1;FMNL2;NEDD4L;CEACAM1;PPFIA2;CAPZB;NF1;LZTS3;TNFAIP3;BRSK1;DAG1;SRCIN1;CDH2;GSK3B;PHLDB1;SARM1;ZMYM6;FERMT2;NEDD4;HTATIP2;STAT2;SEMA4D
prerank,membrane fusion (GO:0061025),-0.37192415138756496,-1.2366532743167953,0.14551083591331268,0.6499786089392205,1.0,4/33,3.74%,MYOF;DNM3;DYSF;NAPA
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.37624964361313507,1.2364238512193542,0.13997760358342665,0.8808742427026982,1.0,13/138,6.55%,ROR2;NGF;ROR1;NTRK3;FGFR1;EGFR;PTPRF;MUSK;SRC;TRIO;FER;EPHB2;LCP2
prerank,glucose metabolic process (GO:0006006),0.4198182293326223,1.2362366156087599,0.1963109354413702,0.8799824618592196,1.0,14/58,17.61%,APOD;PPARGC1A;SLC25A12;ALDOB;PGM1;ADPGK;MDH1;SLC25A13;ENO3;GOT1;HECTD4;PGK1;ENO2;IRS2
prerank,regulation of glycolytic process (GO:0006110),-0.31758057907663634,-1.2361495433784924,0.12807881773399016,0.6497247491127984,1.0,12/68,7.39%,PRKAG2;IGF1;INSR;NUPR1;CBFA2T3;NUP107;EP300;HIF1A;AAAS;SEH1L;NUP133;PGAM1
prerank,mesenchymal cell differentiation (GO:0048762),-0.33846826699053467,-1.2359759554113583,0.10980392156862745,0.648480825878638,1.0,15/51,13.01%,RANBP3L;ENG;LEF1;ROCK2;TGFBR3;RBPJ;TGFBR1;WNT4;FGFR2;HIF1A;LRP6;TRIM28;BMP2;LOXL3;TGFB2
prerank,positive regulation of dendrite development (GO:1900006),0.5715615397845213,1.2356609109817374,0.2336283185840708,0.8805540627529612,1.0,2/10,4.50%,COBL;BMP5
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.3761039000772141,1.235047808171892,0.15017064846416384,0.8812003579088493,1.0,12/140,7.51%,CAV1;LPAR1;ACKR3;PLCE1;ITPR3;PTGFR;CD55;TRPV4;FIS1;ADCY5;ABL2;PTGER4
prerank,negative regulation of endothelial cell proliferation (GO:0001937),0.45747097926997576,1.2346196584354414,0.2168141592920354,0.881101856080951,1.0,5/35,3.67%,CAV1;NR2F2;SULF1;NF1;CAV2
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.3590390900386327,1.2343785451561036,0.11017838405036726,0.8804054206821633,1.0,70/259,19.13%,DYNLL1;CDH13;PARVA;NTN1;UBXN10;RAP1A;RAB8B;EMP1;ABLIM3;MKS1;ANO6;MINK1;SPEF1;PTPDC1;DZIP1;OPHN1;DYNC2I1;CYS1;EXOC3;CNGB1;INTU;CEP89;CEP131;IFT81;ABLIM2;CNGA4;SNX10;EHD2;CLUAP1;CEP162;ARF6;RAPGEF6;UNC119B;OCRL;TMEM237;TCTN2;FOXJ1;IFT74;DYNLL2;MTSS1;HDAC6;EXOC5;CFAP20;CEP290;ARHGEF6;PKD1;PDE6D;PCM1;FAM161A;FBF1;DNAH5;PTPRO;VSTM5;B9D2;S1PR2;CFAP298;PIBF1;CFAP70;CFAP410;CDC14A;DYNC2H1;ARHGEF7;EZR;EHD1;OFD1;ARMC9;STK36;CEP250;SNAP29;BBS1
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.47795549482843347,1.2341855224471543,0.2225475841874085,0.8795621305936047,1.0,7/26,14.10%,FGFR1;EYA1;IL1A;MCL1;MAPK7;PPP2R1B;HTRA2
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.37347831294789285,1.234136374214573,0.12555555555555556,0.8781504672729282,1.0,45/161,18.81%,CAV1;IGFBP6;LRP4;GLI1;PRICKLE1;DKKL1;AXIN1;MLLT3;SOX9;CHD8;PSME3;WNT5A;DACT1;ZNRF3;CUL3;TBX18;PSMB5;AMFR;GSK3B;STK3;CSNK1A1;SDHAF2;KREMEN1;AXIN2;DVL3;APC;BICC1;EMD;PSMA6;PSMB2;PSMA2;PTPRU;PTPRO;TMEM170B;NPHP4;PSMD13;PSMA7;MDK;INVS;PSME4;PSMD12;PSMD14;PSMB6;RUVBL2;PSMC4
prerank,protein autophosphorylation (GO:0046777),-0.27521779704491023,-1.2337377247277623,0.06315789473684211,0.6532206180501617,1.0,39/157,13.30%,FLT1;IGF1R;DAPK1;INSR;TEK;PDGFRB;GRK5;PDGFRA;LYN;DDR1;EPHA4;KIT;FGFR2;STK17B;SIK1;KDR;BMX;EPHA8;CDK12;JAK2;MAP2K2;MKNK2;ULK2;STK10;AKT1;CAMK2A;MAP3K10;CDKL5;EIF2AK4;CAMK4;OXSR1;MKNK1;FGFR4;LRRK2;TAOK2;FLT4;MAPKAPK2;PIM3;MAPKAPK3
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.45639981426579335,1.2320215460671036,0.2239221140472879,0.8842308505164728,1.0,4/33,4.80%,KLF5;SPI1;FOXO3;APLN
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.35944214905242333,1.2318269974346598,0.12357217030114226,0.8834281979904379,1.0,70/248,18.81%,CAV1;IGFBP6;LRP4;GPC3;GLI1;PRICKLE1;PPM1N;DKKL1;NRARP;EGFR;FOLR1;AXIN1;MLLT3;SOX9;CHD8;GNAQ;PSME3;WNT5A;DACT1;PPM1A;USP8;UBR5;FAM53B;PLEKHA4;KANK1;ZNRF3;CUL3;PSMB5;AMFR;CSNK1G3;RNF220;GSK3B;STK3;COL1A1;USP47;CSNK1A1;SDHAF2;KREMEN1;AXIN2;DVL3;APC;BICC1;EMD;SOX4;FZD7;PSMA6;CAPRIN2;FZD9;PSMB2;PSMA2;PTPRU;PTPRO;TMEM170B;NPHP4;PSMD13;PSMA7;MDK;ATP6AP2;PPP1CA;INVS;PSME4;GPC5;FGF10;CSNK1G1;PSMD12;PSMD14;PSMB6;CDH3;RUVBL2;PSMC4
prerank,negative regulation of stem cell differentiation (GO:2000737),0.5694660418473307,1.2318235428546929,0.2542087542087542,0.8818969220164201,1.0,4/12,13.69%,JAG1;N4BP2L2;NELFB;ZFP36L2
prerank,L-glutamate transmembrane transport (GO:0015813),0.5803445165509618,1.2317758601823934,0.23971377459749552,0.8805485956993884,1.0,5/10,12.83%,SLC25A12;PRAF2;SLC1A6;SLC25A13;SLC25A22
prerank,positive regulation of epidermal cell differentiation (GO:0045606),0.5336815525988893,1.231341891911306,0.2288961038961039,0.8804936428122493,1.0,1/15,0.21%,ETV4
prerank,regulation of epidermal cell differentiation (GO:0045604),-0.41773991259260146,-1.2310916006014845,0.2005813953488372,0.6595623799569126,1.0,4/21,6.67%,ERRFI1;ROCK2;BMP4;CTSL
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.5516314262020474,1.230907382957949,0.24333333333333335,0.8803749690453183,1.0,2/13,0.92%,PPARGC1A;GUCA1A
prerank,protein localization to membrane (GO:0072657),0.37216168252230175,1.2308180670961306,0.12309368191721133,0.8791802689110932,1.0,24/187,10.54%,PTCH1;CAV1;F11R;SLMAP;EPB41L3;RAP1A;RAB8B;RAB29;KCNIP4;FLOT2;CPE;SH3PXD2B;RABEP1;EHD2;RDX;RAB3A;ITGB7;EFR3A;ZDHHC23;RAPGEF6;ATP1B3;DLG3;FERMT2;ANK1
prerank,sterol transport (GO:0015918),0.5095587196770465,1.2299342360983683,0.23717948717948717,0.8808394509235918,1.0,1/19,0.25%,CAV1
prerank,retina homeostasis (GO:0001895),-0.40656000163968675,-1.2292796519560685,0.1867816091954023,0.6633235038728609,1.0,8/23,21.77%,B2M;POTEF;ACTB;ACTG1;ATP1B2;POC1B;HSPB1;TULP1
prerank,cellular response to interleukin-12 (GO:0071349),-0.34327025435615177,-1.2287541256995496,0.13523131672597866,0.6631232113877863,1.0,9/48,9.11%,PLCB1;MSN;CDC42;CFL1;SIRPA;ANXA2;RPLP0;JAK2;CNN2
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),-0.37577237683438813,-1.2283397735017034,0.1609907120743034,0.6625284778959263,1.0,6/31,6.14%,PARD3;MSN;CDC42;LIN7A;ERBIN;SYNJ2BP
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.3607093324898091,-1.2276070694357168,0.15841584158415842,0.66296243019173,1.0,9/37,9.54%,IGF1;PRKG1;MEF2D;TPM1;IGFBP5;GJA1;TGFB3;LDLRAP1;MMP2
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),-0.5223305922907105,-1.22727371297584,0.24651162790697675,0.662213830860785,1.0,6/10,36.06%,NOC2L;BRCA1;THAP7;CTBP1;SNCA;KLF15
prerank,endodermal cell fate commitment (GO:0001711),0.5830823239921772,1.2269486072823892,0.23426573426573427,0.8898910299679212,1.0,4/10,19.87%,LEO1;PAF1;RTF1;CDC73
prerank,artery morphogenesis (GO:0048844),0.46044070776890056,1.2263723821466326,0.21076233183856502,0.8903997877856027,1.0,5/30,6.70%,STRA6;FOLR1;JAG1;NF1;TBX2
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.5485243932141055,1.2256916577472194,0.2422680412371134,0.8912382183206915,1.0,5/12,24.29%,SOX9;SMO;PAX2;LHX1;SIX1
prerank,positive regulation of epithelial cell migration (GO:0010634),0.3895927597928342,1.2253022974121262,0.18488372093023256,0.8911736380852243,1.0,12/92,4.77%,FGF7;SMOC2;DOCK5;PRKCE;FGF1;DOCK1;NRP2;GPLD1;PRKCA;SOX9;SRC;WNT5A
prerank,glucose transmembrane transport (GO:1904659),-0.4182951670861743,-1.2240338534109108,0.2231638418079096,0.6702736995158797,1.0,10/18,27.65%,PPARD;SLC2A10;SORT1;SLC2A8;SLC2A9;SLC2A1;SLC45A1;SLC2A3;SLC2A4;RAB4B
prerank,"synaptic transmission, glutamatergic (GO:0035249)",-0.43466796685167786,-1.2235628457519458,0.21052631578947367,0.6698753826669382,1.0,4/18,7.75%,UNC13C;GRIA2;NAPA;GRIK2
prerank,cellular response to chemokine (GO:1990869),0.43857980799244733,1.2220226453667578,0.2134387351778656,0.9012704969546359,1.0,3/46,1.82%,ACKR3;RIPOR2;SLC12A2
prerank,regulation of protein catabolic process (GO:0042176),0.39227956898343425,1.2203561047698188,0.16626794258373206,0.905583601931838,1.0,11/99,6.16%,PLK2;GPC3;NEDD4L;EGFR;AXIN1;FAM83D;IRAK3;WNT5A;DACT1;TNFAIP3;AZIN2
prerank,protein K48-linked deubiquitination (GO:0071108),0.48566757675645206,1.220295954837782,0.23159509202453987,0.9042314073918911,1.0,6/23,11.13%,USP50;TNFAIP3;USP8;OTUB2;MINDY2;OTUD7B
prerank,vitamin transport (GO:0051180),0.4711223013627962,1.2201505461353401,0.24242424242424243,0.903176993439069,1.0,11/29,15.09%,FOLR1;FOLR2;SLC27A1;SLC2A2;SLC52A1;TTPA;CD320;CUBN;GC;AMN;SLC46A1
prerank,cellular response to lipid (GO:0071396),0.3641097665711752,1.2197435660320382,0.14930182599355532,0.9030990229245661,1.0,44/191,16.45%,RORA;LBP;EGFR;SSTR1;TNIP3;GPLD1;IL1A;SOX9;WNT5A;PDK4;TNFAIP3;ATP1A2;NRIP1;ADCY5;SELENOS;ABL2;PAF1;BRINP1;DEFA6;ACOD1;IRGM;CHMP5;HMGB1;TICAM1;RORB;AXL;POU4F1;WNT9A;NCOA3;NFKBIB;AQP1;HTRA2;KCNK4;FZD7;LCOR;CCR5;CCDC62;GPER1;ADCY8;ADCY3;TICAM2;LPL;PLAA;TESC
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.5187619580056245,1.2197107811419239,0.24584717607973422,0.9016712872634517,1.0,2/16,2.14%,FOXD1;FGF1
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.5724144546783476,1.2194471045840205,0.2607879924953096,0.9011121760687331,1.0,4/10,16.32%,HMGB1;CBFB;RUNX1;SOCS1
prerank,regulation of histone acetylation (GO:0035065),0.4550479697788032,1.2191561823415653,0.22533136966126657,0.9006621511677781,1.0,4/33,3.51%,PPARGC1A;RAPGEF3;KMT2A;SPI1
prerank,positive regulation of dendrite extension (GO:1903861),0.5146190744801772,1.2187598646282607,0.25636942675159236,0.9005570295892052,1.0,3/17,9.22%,NEDD4L;RIMS2;CPNE9
prerank,ribonucleoprotein complex biogenesis (GO:0022613),-0.3223812091251857,-1.2186053544918596,0.10317460317460317,0.6827205843530137,1.0,26/57,28.87%,TGS1;RPS15;RPL35A;RPS7;RPL26;NPM1;HEATR3;RPS24;RPS19;RPS16;RPS17;WDR12;RPL38;RIOK1;NOC2L;RPS6;DHX37;RPL14;RPL5;MRPL36;PAK1IP1;RPS25;RPF2;RPL7;RPL11;NOP16
prerank,anterior/posterior pattern specification (GO:0009952),-0.3350249612811142,-1.218174871700082,0.17959183673469387,0.6824307669355395,1.0,17/53,17.83%,WLS;HOXA3;TGFBR1;BMPR2;HOXA5;HOXB4;HOXB9;TBX1;HOXC4;BMP2;HOXA9;HOXA6;HOXB7;HOXD4;HHEX;HOXD3;LRP5
prerank,T cell mediated immunity (GO:0002456),0.5472005400801241,1.2180069462299068,0.24306688417618272,0.901719814720187,1.0,3/13,7.53%,JAG1;CD55;CRTAM
prerank,proteolysis (GO:0006508),0.35885276601143146,1.217210483885583,0.12896405919661733,0.9030649016496514,1.0,51/252,17.14%,PTCH1;CTRC;ADAMTS12;FAP;TINAGL1;NAALAD2;PCSK5;ADAM19;OGT;SENP6;MMP15;APH1B;CPE;CAPN6;CPA2;RNPEP;NCSTN;ADAM10;LVRN;DPP4;PSMB5;FBXO3;LNPEP;UFSP2;PCSK7;BACE2;XPNPEP3;MMP12;MME;LONP1;CELA1;PROC;TASP1;MMP16;CAPN2;MIPEP;ATG4C;HTRA2;PSMA6;MMP14;FAM111A;PLG;NLN;GGT1;TYSND1;ZMPSTE24;MBTPS1;BACE1;BMP1;PM20D2;CTSB
prerank,mammary gland development (GO:0030879),0.48988075533404696,1.2170789198319512,0.23124042879019907,0.9019948991053189,1.0,3/21,4.80%,CAV1;GLI2;APLN
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),0.5020127525119835,1.2160077045908901,0.2384,0.9042503186538446,1.0,6/20,11.21%,NEDD4L;PRKCE;CAMK2D;CASQ2;ADRA2A;NEDD4
prerank,chondroitin sulfate metabolic process (GO:0030204),0.4642095809398828,1.2156523311908973,0.24300441826215022,0.9040608656636422,1.0,4/30,5.94%,DCN;CSPG4;CHST7;NCAN
prerank,hexose metabolic process (GO:0019318),0.4387881592424053,1.2152376197608357,0.21255349500713266,0.903976396260707,1.0,9/39,17.61%,APOD;ALDOB;PGM1;ADPGK;GALK1;GALK2;HECTD4;PMM1;IRS2
prerank,acyl-CoA biosynthetic process (GO:0071616),0.5203374854685473,1.2144297775921868,0.22644628099173553,0.90543586506211,1.0,5/16,7.98%,DIP2A;ACACA;SCD5;ACAT1;GCDH
prerank,regulation of dendrite extension (GO:1903859),0.5092648427095858,1.214253978867125,0.2548076923076923,0.9045583572828044,1.0,3/18,9.22%,NEDD4L;RIMS2;CPNE9
prerank,plasma membrane bounded cell projection organization (GO:0120036),-0.2805554423489057,-1.2141846722397467,0.104,0.6926864625976044,1.0,27/124,15.21%,FRY;PTPRM;RAPGEF2;TPM1;LYN;FRYL;STMN2;RASGRF1;GPRIN3;EPHA8;APOE;TBC1D24;STMN4;CAMSAP1;RAB13;WDPCP;MANF;ATP1B2;LAMB1;RAB11A;STMN1;LGI1;SH3GL2;MICALL1;MAPT;CDK5R1;DTNBP1
prerank,positive regulation of axonogenesis (GO:0050772),0.4366207389671311,1.2136097679608506,0.23676880222841226,0.9052867780203774,1.0,3/43,1.05%,NGF;NTN1;TIAM2
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.45657715073302807,-1.2135593613364941,0.24078624078624078,0.692785860900157,1.0,7/14,17.12%,SEMA7A;KIT;PLCG2;BCL10;CAMK4;LAPTM5;GPRC5B
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.4627066838828024,1.2131575799871746,0.22753623188405797,0.9053531658642557,1.0,3/31,3.11%,GLMN;ARG1;IL4I1
prerank,sodium ion transport (GO:0006814),0.3939215312929244,1.2129827817116694,0.18050541516245489,0.9044253003167426,1.0,15/85,11.99%,NEDD4L;NALCN;SCN10A;SLC12A2;ANO6;SLC24A1;SLC12A3;KCNK1;ATP1A2;SLC6A13;SLC4A4;SLC4A11;ATP1B3;SCN2B;SGK1
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.5053227215467102,1.2128325103412225,0.23140495867768596,0.9019709214096857,1.0,9/17,21.15%,IL7;IL2RG;SOCS1;JAK1;BRWD1;IRS2;SOCS2;STAT5B;CISH
prerank,cellular response to interleukin-7 (GO:0098761),0.5053227215467102,1.2128325103412225,0.23140495867768596,0.9019709214096857,1.0,9/17,21.15%,IL7;IL2RG;SOCS1;JAK1;BRWD1;IRS2;SOCS2;STAT5B;CISH
prerank,regulation of epithelial cell proliferation (GO:0050678),-0.3012302198048308,-1.2125561917181378,0.10674157303370786,0.6940182122020218,1.0,17/85,8.23%,IGF1;MCC;TGFA;OSR1;ANGPT1;BMP6;TGFBR3;NUPR1;BMP4;TIE1;ACVRL1;FGFR2;B2M;DUSP10;TBX1;CDK6;AQP11
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.3709614071987494,1.2123491386981624,0.18140589569160998,0.9021406449148992,1.0,28/140,9.32%,DLC1;TIAM2;ARHGAP31;PLCE1;ARHGAP18;ARHGAP12;ARHGAP32;ARAP1;ARHGAP9;DEPDC1B;AKAP13;OPHN1;RACGAP1;VAV2;SRC;RAC2;TRIO;NUP62;ARHGEF5;ARHGAP26;RHOJ;ARHGEF1;CGNL1;STARD13;PIK3R2;KALRN;OBSCN;OCRL
prerank,rRNA transcription (GO:0009303),0.5168310587044916,1.2122154292010094,0.24546952224052718,0.9011136408683378,1.0,6/17,13.80%,CAVIN1;GTF3C6;POLR1E;SIRT7;SPIN1;GTF3C5
prerank,morphogenesis of an epithelial sheet (GO:0002011),0.5750904499145687,1.211978414225114,0.25925925925925924,0.9004118985010576,1.0,2/10,4.50%,ARHGAP12;BMP5
prerank,regulation of integrin activation (GO:0033623),0.522540159092039,1.211953320080996,0.24082934609250398,0.899035632094714,1.0,5/15,10.19%,SRC;PTGER4;PIEZO1;PLEK;FERMT2
prerank,cardiolipin metabolic process (GO:0032048),0.5487434926083692,1.2114767746054569,0.2546689303904924,0.8992679600643062,1.0,5/13,13.04%,SLC27A1;HADHB;PTPMT1;LCLAT1;PNPLA8
prerank,hemopoiesis (GO:0030097),-0.3051675424568865,-1.2111787914970675,0.10497237569060773,0.6965204724932897,1.0,21/87,13.54%,FLT1;MECOM;NOTCH2;TEK;TGFBR3;BMP4;SNRK;KIT;FGFR2;FLT3LG;MEIS1;KDR;CD34;MKNK2;PGM3;KIRREL3;BMI1;TOX;FLT4;TGFB2;TAL1
prerank,negative regulation of axonogenesis (GO:0050771),0.4624862634584344,1.2108987788245038,0.2305433186490455,0.8998089807520696,1.0,9/27,18.19%,LRP4;RTN4R;CDKL3;GDI1;TRIM46;PTEN;RTN4;EFNB3;RHOA
prerank,cellular response to nitrogen compound (GO:1901699),-0.416217780810148,-1.210822912187822,0.2,0.6958177102012457,1.0,9/20,20.79%,ROCK2;BLM;EPG5;HSF1;DDI2;NSMCE3;PDE12;TIMELESS;RIOK3
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),-0.38511926687815046,-1.2104575451552788,0.21937321937321938,0.6952037222277374,1.0,6/25,7.00%,SLC7A5;KIT;LACC1;B2M;TRAF6;PLCG2
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),-0.4984426287116386,-1.2100763028755257,0.2552204176334107,0.6945361679792845,1.0,6/10,14.61%,LPGAT1;NR1H3;NR1H2;SLC45A3;ABCD2;MID1IP1
prerank,regulation of heart rate by cardiac conduction (GO:0086091),0.4406223114037401,1.2098426162591007,0.21285714285714286,0.9020690701649093,1.0,3/38,1.77%,CAV1;CAMK2D;KCNA5
prerank,axonogenesis (GO:0007409),0.3566658468572367,1.209453879568869,0.15531914893617021,0.9020007298696473,1.0,40/237,12.77%,NTNG2;NTNG1;GAB1;EFNA5;LAMA2;EFNB1;NRP2;PARD6B;SEMA4B;GLI2;OPHN1;PRKCA;S100A6;SRC;DSCAM;WNT5A;BRSK1;ARTN;EPHB2;LAMA5;SEMA3A;EFNB2;DAG1;NTN3;RAB3A;SIAH1;MAPK7;S100B;ISL1;TNR;GAB2;NTN4;POU4F1;RELN;DOCK7;SLC9A6;SEMA4D;KIF5A;PTEN;PTPRA
prerank,glycoprotein biosynthetic process (GO:0009101),-0.3079395850211868,-1.2094194750223175,0.10112359550561797,0.6948074569629501,1.0,20/79,14.83%,IGF1;ST3GAL6;ST3GAL5;ST8SIA4;CSGALNACT1;CHST11;ATP7A;COG7;BMPR2;CSGALNACT2;ST6GALNAC2;ALG5;FAM20B;ALG1;B4GALT7;GOLGA2;B3GALT2;ST8SIA2;CHST9;GCNT1
prerank,regulation of defense response to virus (GO:0050688),0.5290495437298467,1.2091783768864666,0.2624356775300172,0.9015076574194654,1.0,6/14,21.62%,PCBP2;TNFAIP3;ZMPSTE24;ITCH;DHX9;TRAF3
prerank,eye development (GO:0001654),0.41900239416233154,1.209131489342574,0.23641304347826086,0.9002045615576254,1.0,9/54,8.78%,STRA6;EFEMP1;PBX1;BMPR1B;SH3PXD2B;HIPK1;SHROOM2;FREM2;ABCB5
prerank,kidney development (GO:0001822),0.41034341606179414,1.2087018835323713,0.20418848167539266,0.9002332072208182,1.0,7/65,5.57%,STRA6;LRP4;SULF1;PCSK5;GLI2;NF1;KANK2
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.5005781271083007,-1.2085624045458387,0.23433874709976799,0.6957511531347856,1.0,2/10,4.89%,GRB10;HIF1A
prerank,regulation of establishment of cell polarity (GO:2000114),0.5199114049890704,1.2083102489104527,0.2396694214876033,0.9001131379666786,1.0,4/16,7.66%,RIPOR2;CDH5;KIF20B;KANK1
prerank,early endosome to Golgi transport (GO:0034498),-0.4935102372520327,-1.207833445366251,0.24615384615384617,0.6962654982801236,1.0,4/11,8.98%,TRAPPC10;TMED9;RBSN;SURF4
prerank,positive regulation of kinase activity (GO:0033674),0.37988738170838343,1.207739029411546,0.2044917257683215,0.9006145150384456,1.0,14/107,6.55%,ROR2;ROR1;NTRK3;FGFR1;EGFR;MUSK;RAP1A;PRKAG1;MMD2;LMO4;PTPRC;NBN;EPHB2;LCP2
prerank,regulation of sequestering of calcium ion (GO:0051282),0.548829902124031,1.2076869668450536,0.2713310580204778,0.8993365868458012,1.0,3/12,9.24%,UBASH3B;FKBP1B;CASQ2
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.4517423667533549,1.2075608809582516,0.24599708879184862,0.8983204763018436,1.0,4/29,5.73%,NGF;MMD2;SRC;LRRC59
prerank,negative regulation of protein processing (GO:0010955),-0.4860948336680041,-1.20753852069807,0.24129930394431554,0.6953775629257742,1.0,4/12,12.84%,GAS1;SERPINE2;LRRK2;THBS1
prerank,positive regulation of cell motility (GO:2000147),0.3584903635235319,1.2074420417116671,0.157725321888412,0.897255891238445,1.0,23/205,7.07%,ROR2;CLDN1;ITGA6;CAV1;NTRK3;CDH13;NTN1;EGFR;GTSE1;FGF1;SEMA4B;SH3RF2;CDH5;ITGAX;PRKCA;CAVIN1;FER;TRADD;EPHB2;ADAM10;RDX;RIPOR1;SEMA3A
prerank,establishment of endothelial barrier (GO:0061028),0.46178424151648345,1.207290026761915,0.23283582089552238,0.8963148066364052,1.0,7/29,8.91%,F11R;RAPGEF3;RAP1A;PDE4D;TJP2;RDX;RAPGEF6
prerank,potassium ion import across plasma membrane (GO:1990573),0.4390556222344282,1.2064831917909704,0.2352112676056338,0.8976285439301646,1.0,7/41,5.75%,KCNJ4;SLC12A2;KCNJ16;SLC12A4;SLC12A3;ATP1A2;KCNJ13
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),0.5826784270082073,1.2060813418348935,0.26153846153846155,0.8976185443511376,1.0,6/10,19.36%,FKBP1B;SESTD1;ATP1A2;ADRA2A;YWHAE;CBARP
prerank,response to exogenous dsRNA (GO:0043330),0.501581531486439,1.2058082473346832,0.24328859060402686,0.897106424152192,1.0,3/18,9.74%,CAV1;IRAK3;TICAM1
prerank,cellular biogenic amine biosynthetic process (GO:0042401),-0.44795761733114337,-1.2055184901655929,0.22966507177033493,0.699720780927449,1.0,2/15,5.82%,MOXD1;SAT1
prerank,melanosome localization (GO:0032400),-0.4111633815544032,-1.2054047743521887,0.21176470588235294,0.6983179017111901,1.0,9/21,21.38%,MYO5A;RAB11A;BBS2;MKKS;BLOC1S6;RAB11B;MLPH;BBS5;RAB27A
prerank,response to nutrient levels (GO:0031667),-0.43249408679045664,-1.2053738330296309,0.22404371584699453,0.696676979782282,1.0,8/17,32.26%,KCNB1;RPS6KB1;EIF4G1;ATF4;FAM107A;PRKAA1;MEAK7;ULK1
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.39270515303054715,1.2053659119806588,0.20987654320987653,0.8972528320369605,1.0,15/80,15.05%,TENM2;RIPOR2;PLCE1;ARAP1;CDC42EP4;RAC2;CCP110;PALM;OCLN;GPM6A;APC;AKIRIN1;HTT;CDC42EP3;AUTS2
prerank,positive regulation of cell adhesion (GO:0045785),0.40085960167615337,1.204984843679401,0.20921544209215442,0.897172621190931,1.0,5/74,4.71%,MAGI1;VIT;ECM2;PRKCA;IBSP
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.3761943886728175,1.2049302168148746,0.18636363636363637,0.8959110377020383,1.0,44/129,20.98%,CAV1;GPC3;PPM1N;NRARP;EGFR;AXIN1;PSME3;DACT1;PPM1A;USP8;UBR5;FAM53B;PLEKHA4;KANK1;PSMB5;CSNK1G3;RNF220;COL1A1;USP47;AXIN2;SOX4;PSMA6;CAPRIN2;FZD9;PSMB2;PSMA2;PSMD13;PSMA7;ATP6AP2;PSME4;GPC5;FGF10;CSNK1G1;PSMD12;PSMD14;PSMB6;CDH3;PSMC4;PIN1;TRPM4;GSKIP;USP34;RNF146;CCAR2
prerank,regulation of Wnt signaling pathway (GO:0030111),0.3748913614622403,1.2047918504244512,0.1955241460541814,0.8949660730793908,1.0,22/108,14.16%,MDFIC;GPC3;VGLL4;SULF1;NFATC1;FOLR1;AXIN1;DEPDC1B;GNAQ;DACT1;TNFAIP3;FAM53B;HIC1;KANK1;TMEM237;KREMEN1;SPIN1;NXN;EMD;CTNNBIP1;CBFB;FZD7
prerank,intestinal lipid absorption (GO:0098856),0.5645260915790142,1.2043474900379991,0.26785714285714285,0.8950699426541877,1.0,1/11,1.38%,CEL
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),-0.4769803155517815,-1.2040716291696223,0.2511961722488038,0.6988601296715345,1.0,5/12,21.60%,PIK3R1;BCL2L11;BOK;XBP1;ATF6
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.3889609823713053,1.2038828275652051,0.20125,0.8953172976837971,1.0,13/78,12.26%,CAV1;TRIB2;PRICKLE1;SOCS5;SH3RF2;KEAP1;CDC20;DDRGK1;GSK3B;CSNK1A1;RCHY1;ZYG11B;NFE2L2
prerank,negative regulation of amyloid fibril formation (GO:1905907),-0.4743626320767313,-1.2035581167587113,0.23787528868360278,0.6985640742829272,1.0,6/12,21.69%,LDLR;APOE;VBP1;CRYAB;CLU;PFDN4
prerank,secondary alcohol biosynthetic process (GO:1902653),-0.3768733346059468,-1.2034289926556365,0.1901840490797546,0.6971723384199371,1.0,16/30,33.16%,INSIG2;ARV1;HMGCS1;ACAA2;ACLY;NSDHL;PMVK;MVK;ACAT2;DHCR7;TM7SF2;MVD;PLPP6;LBR;SQLE;EBP
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),-0.41220350519337723,-1.2033850047944556,0.19476744186046513,0.6956358184401339,1.0,6/21,9.54%,IGF1;MEF2D;IGFBP5;GJA1;LDLRAP1;MMP2
prerank,negative regulation of viral release from host cell (GO:1902187),-0.46720128520004217,-1.202896982961789,0.22330097087378642,0.695459843735466,1.0,7/13,21.25%,MID2;TRIM28;TRIM35;CHMP3;TRIM8;TRIM13;TRIM11
prerank,protein localization to plasma membrane (GO:0072659),0.3748258064452078,1.2026988965887702,0.18421052631578946,0.897995879805716,1.0,14/129,8.91%,PTCH1;F11R;SLMAP;EPB41L3;RAP1A;RAB8B;KCNIP4;FLOT2;EHD2;RDX;RAB3A;EFR3A;ZDHHC23;RAPGEF6
prerank,positive regulation of JUN kinase activity (GO:0043507),-0.39073207792811143,-1.2025835959166953,0.192090395480226,0.6946592563951111,1.0,7/23,16.72%,SASH1;TRAF6;MAP3K10;RPS3;TNFRSF11A;EDN1;DVL2
prerank,amyloid fibril formation (GO:1990000),0.4140495532128668,1.2018558567217434,0.2324621733149931,0.8995041595312444,1.0,6/51,7.50%,TGFBI;UBE2L6;APH1B;NCSTN;ADAM10;SIAH1
prerank,T cell activation (GO:0042110),0.39929774634077825,1.2012089350785737,0.2093628088426528,0.9002890190102579,1.0,12/69,11.04%,CXADR;LEPR;ITK;CD3G;RAB29;PTPN22;PTPRC;NCK2;CRTAM;DPP4;LAT;CD276
prerank,positive regulation of lipid metabolic process (GO:0045834),0.4822491758240939,1.2011436257942079,0.2491961414790997,0.8990855877213942,1.0,2/22,1.88%,SORBS1;ZBTB20
prerank,camera-type eye morphogenesis (GO:0048593),0.5648932134042957,1.2009842335953071,0.281195079086116,0.8982144175186826,1.0,3/10,6.70%,NF1;SHROOM2;TBX2
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),-0.4262180778357424,-1.2007906052996702,0.23958333333333334,0.6983259890131984,1.0,7/17,36.70%,LPGAT1;PLA2G4F;LPCAT1;CRLS1;PLA2G4B;LPCAT4;PLA2G5
prerank,regulation of DNA binding (GO:0051101),0.4245717103489853,1.2004790070894356,0.23589001447178004,0.8985182921971716,1.0,18/44,22.80%,NGF;BCL3;HJURP;HMGB1;SMO;TXN;E2F1;PPARG;SUMO1;NME1;RSF1;PRKN;HABP4;MAPK8;FOXC1;JUN;SIRT2;ZBTB7A
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.4160555846558772,1.1993039857819754,0.2369146005509642,0.9011932403248651,1.0,15/54,17.49%,CAV1;OGT;SH3RF2;TNFAIP3;TRIM21;N4BP1;SIRT7;SPOPL;NXN;USP4;SOX4;CHP1;BAG2;GNL3L;MINAR1
prerank,microglial cell activation (GO:0001774),-0.3993049598937345,-1.1988898635504006,0.21505376344086022,0.7023188528380045,1.0,12/21,36.05%,JAK2;MAPT;C1QA;CLU;GRN;ITGB2;ITGAM;AGER;AIF1;TREM2;IFNGR1;SNCA
prerank,cellular response to interferon-gamma (GO:0071346),-0.2915899020966404,-1.1984765398648796,0.12222222222222222,0.701766163074925,1.0,23/88,19.23%,DAPK1;SP100;IRF2;TRIM25;SIRPA;B2M;VCAM1;GBP3;GBP4;JAK2;RPL13A;CAMK2A;IRF1;GBP6;GAPDH;CCL13;GBP7;MT2A;GBP2;LGALS9;PDE12;TRIM8;DAPK3
prerank,positive regulation of cell differentiation (GO:0045597),-0.25561643517154553,-1.1980367314023892,0.0392156862745098,0.7013845872684646,1.0,47/237,10.45%,TCF4;PLCB1;IGF1;RANBP3L;SOX5;SLC6A6;RAPGEF2;LEF1;SMAD3;PRKCH;BMP6;DAB2;ARHGEF2;CCN2;IL6R;TMEM64;CREBL2;BMP4;PPARD;IGFBP3;CDC42;GJA1;TGFBR1;WNT4;ACVRL1;IL18;BMPR2;HOXA5;HOXB4;BRINP3;AGTR1;KDR;CD34;MEF2A;MAPK12;GLIPR2;CDON;TGFB3;AKT1;CREB1;CMKLR1;CCN1;ASXL2;ZC3H12A;LRRC8A;AR;BMP2
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),-0.40090355619197465,-1.197990343421779,0.21774193548387097,0.6998205098354007,1.0,3/21,2.49%,OSBPL8;OSBPL10;PLA1A
prerank,regulation of vasoconstriction (GO:0019229),0.46972044246825534,1.1973043345114414,0.24060150375939848,0.9066496860344365,1.0,3/27,3.91%,CAV1;SMTNL1;SMTNL2
prerank,ERAD pathway (GO:0036503),-0.28973708558651945,-1.197173807549574,0.14210526315789473,0.7005431395412304,1.0,26/83,22.17%,UBXN4;USP19;TRIM25;ERLIN1;DNAJB2;UBE4A;STT3B;SGTA;SEC61B;SYVN1;VCP;UBE2J1;FBXO17;UBXN6;ERLIN2;UBE4B;OS9;ANKZF1;RNF103-CHMP3;SGTB;FBXO44;DERL2;RCN3;TRIM13;RNF121;GET4
prerank,regulation of monocyte differentiation (GO:0045655),-0.46446332852973504,-1.1970476203850282,0.25,0.6992043757761797,1.0,6/14,26.06%,FOXP1;CDK6;IL34;CSF1;FES;HOXA7
prerank,mRNA stabilization (GO:0048255),0.43383652305057957,1.1967660022388933,0.25594405594405595,0.9070674048574658,1.0,11/40,19.61%,HNRNPC;DND1;HNRNPA0;TENT5C;AXIN2;TENT5D;TAF15;SYNCRIP;E2F1;YBX3;DHX9
prerank,neuron differentiation (GO:0030182),0.3616566206979086,1.196594183864958,0.18571428571428572,0.9062215275790336,1.0,13/165,5.55%,TENM2;WNT10A;PBX1;BHLHE22;FZD2;NEUROD6;RUNX2;WNT2B;GLI2;OPHN1;WNT16;WNT5A;BRSK1
prerank,response to reactive oxygen species (GO:0000302),0.4142699118940062,1.196409733549508,0.2232620320855615,0.9054784122565401,1.0,5/54,5.87%,APOD;PXN;EGFR;MPV17;FER
prerank,vasodilation (GO:0042311),-0.4540315080097296,-1.196406892059587,0.23308270676691728,0.6994649119246801,1.0,4/13,17.33%,NOS3;KCNMA1;KLF2;NOS1
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.4012717604806852,1.1959653115985043,0.21614583333333334,0.9056064063897454,1.0,6/63,6.03%,ITGA6;CAV1;FGFR1;SRC;PSME3;TRADD
prerank,positive regulation of leukocyte activation (GO:0002696),0.49584657313555225,1.1958680806719588,0.2483108108108108,0.9045216440100873,1.0,3/18,10.39%,LBP;WNT5A;KARS1
prerank,regulation of focal adhesion assembly (GO:0051893),0.41842427731400256,1.1955628518935548,0.24415584415584415,0.9041905726713336,1.0,5/54,4.43%,APOD;EFNA5;DLC1;PEAK1;SRC
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.3375532865665405,-1.1953739862681345,0.18705035971223022,0.7007388430523571,1.0,10/43,8.04%,ITGA1;TGFA;ERRFI1;PTPN3;RNF115;CDC42;ZFYVE28;DUSP3;EPS15;SH3KBP1
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.37189672652336075,1.195215087958181,0.18372093023255814,0.9039556366774584,1.0,5/121,0.77%,THBS4;EFNA5;FGF7;TEC;CSPG4
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.42771338578202545,1.1948584534094515,0.2154255319148936,0.9037827877556172,1.0,7/46,8.57%,CNKSR3;RGS14;SPRED1;SPRY1;PTPRC;EPHB2;TNIP1
prerank,positive regulation of cellular protein catabolic process (GO:1903364),0.49653459400701583,1.1942839971177697,0.26456692913385826,0.9043427199271515,1.0,7/18,18.11%,VGLL4;DACT1;RDX;FAF1;CD81;EZR;VPS11
prerank,negative regulation of viral entry into host cell (GO:0046597),-0.4798563310862126,-1.1942133657410006,0.22573363431151242,0.7026252722427397,1.0,2/12,3.99%,LY6E;MID2
prerank,positive regulation of catalytic activity (GO:0043085),0.44226839243027205,1.1934062851784386,0.23823109843081314,0.9059903105304322,1.0,6/37,7.73%,CAV1;MSH6;NCSTN;AZIN2;ABL2;MSH2
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.4406600975336134,1.1930122405890757,0.26440177252584934,0.9059779872950782,1.0,9/33,16.54%,APOD;MFN2;APLN;TNFAIP3;TAFA5;EFEMP2;PTEN;GPER1;PPARG
prerank,bone development (GO:0060348),-0.343984458205446,-1.1927731437760352,0.17747440273037543,0.7051331817839663,1.0,9/39,8.10%,RANBP3L;GNAS;CYP26B1;TGM2;GJA1;FGFR2;PLS3;NOTUM;LRP6
prerank,C-terminal protein amino acid modification (GO:0018410),0.5669140398777679,1.192189013637427,0.29173989455184535,0.9075003758186927,1.0,7/11,19.19%,GPLD1;AGBL4;ATG5;ATG7;LCMT1;AGBL1;ICMT
prerank,positive regulation of ERBB signaling pathway (GO:1901186),-0.3791264258214756,-1.1920908521903142,0.1871345029239766,0.7056969729784247,1.0,13/25,23.84%,HIP1;RBPJ;AFAP1L2;HIP1R;AKT1;BCAR3;SHKBP1;CNOT9;AGT;NEU3;PLAUR;PDE6H;DOK1
prerank,regulation of cilium assembly (GO:1902017),-0.3133203521434145,-1.1915231025960138,0.1497584541062802,0.7057024042439484,1.0,18/62,14.14%,TBC1D1;RABGAP1;TBC1D30;USP6NL;TBC1D2B;ARHGAP35;TBC1D24;ENTR1;SGSM3;CDKL5;DCDC2;EVI5L;FUZ;CEP97;TBC1D22B;CEP120;TCHP;CROCC
prerank,ceramide metabolic process (GO:0006672),0.42050570075091415,1.1915129809132434,0.24651810584958217,0.908449805144144,1.0,8/49,6.32%,SGMS2;CERS6;ACER3;PLPP2;PLPP3;ALOXE3;CLN8;CERK
prerank,sensory perception of mechanical stimulus (GO:0050954),0.3901676973517034,1.1909252606815834,0.22303921568627452,0.9090561659270684,1.0,5/85,3.02%,ROR1;HOMER2;PIEZO2;RIPOR2;EYA1
prerank,monocyte chemotaxis (GO:0002548),-0.3695358188990463,-1.190741363302188,0.1986970684039088,0.7063417593305784,1.0,6/32,13.22%,FLT1;IL6R;RPS19;ANXA1;CCL13;TNFRSF11A
prerank,receptor internalization (GO:0031623),0.41813948429470205,1.1904983227218546,0.2547683923705722,0.9090854635520729,1.0,5/44,4.39%,CAV1;ACKR3;CEACAM1;CD9;DNM1
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.44962500574869824,1.1901403092560197,0.25416036308623297,0.9089112055066784,1.0,7/29,13.03%,SPRED1;SPRY1;BMP5;LDLRAD4;SDHAF2;PTEN;SPRED2
prerank,regulation of peptidase activity (GO:0052547),0.5003386350802024,1.190133203455988,0.27301092043681746,0.9075516901232386,1.0,1/19,0.25%,CAV1
prerank,peptide catabolic process (GO:0043171),-0.4024251128411014,-1.189465861861461,0.19420289855072465,0.7084917549960348,1.0,5/23,8.64%,ECE1;CPQ;CTSH;ACE;TPP1
prerank,negative regulation of signaling (GO:0023057),0.4636661748078974,1.1893909295870388,0.2663690476190476,0.9086764976167772,1.0,2/25,2.28%,UBASH3B;SOCS5
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),-0.43851523931667113,-1.1893623750560283,0.23450134770889489,0.707165278923859,1.0,9/14,37.08%,FLNA;SLC2A10;LOXL3;LIMS2;LIMS1;PRKD1;TIMP1;BST1;PHACTR4
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),0.5406914761489438,1.1891374801044228,0.2906574394463668,0.908216375575599,1.0,3/12,14.84%,SORBS1;C1QTNF12;SNX5
prerank,cellular copper ion homeostasis (GO:0006878),-0.4445043125563116,-1.1883375539208632,0.23291139240506328,0.7086526918707399,1.0,3/14,5.18%,ATP7A;SLC31A1;SLC31A2
prerank,negative regulation of lymphocyte activation (GO:0051250),0.48263475825100727,1.1877198960522337,0.2649310872894334,0.9116946301691261,1.0,5/21,9.63%,IL4I1;PTPN22;TNFAIP3;BANK1;FOXJ1
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),-0.42143107350456643,-1.1873266016382678,0.20821114369501467,0.7099150421892422,1.0,7/18,12.29%,FRS2;CCN3;HDAC1;BMP2;GSK3A;SOX6;BDNF
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),-0.4215322100323551,-1.1870100780102586,0.23115577889447236,0.7091817591410468,1.0,4/19,6.14%,PARD3;CLIC4;ERBIN;SYNJ2BP
prerank,odontogenesis (GO:0042476),0.4347456265276503,1.1870037421564075,0.24680851063829787,0.9127564590967657,1.0,4/35,3.19%,EDA;WNT10A;GLI2;TUFT1
prerank,maturation of 5.8S rRNA (GO:0000460),0.4986357591996887,1.1869985853387357,0.26910828025477707,0.9113856950102233,1.0,5/17,11.22%,RRP15;C1D;PES1;EXOSC10;RPF1
prerank,positive regulation of multicellular organismal process (GO:0051240),0.34225039967093496,1.1865531987904825,0.14404145077720207,0.9116095604567794,1.0,44/308,13.17%,EBF2;ETV4;CAV1;INHBB;PPARGC1A;LBP;SMTNL1;GLMN;FOXD1;LEPR;ITK;OGT;ITGAX;TXK;IL1A;SMTNL2;BMPR1B;SOX9;MFN2;KMT5C;WNT5A;SLC27A1;FBXO5;RREB1;PTGER4;CRTAM;GCNT2;ABCA1;TSHR;COL1A1;FOXJ1;KSR2;FERMT2;HILPDA;ADRA2A;AXIN2;APC;PRLR;VAMP8;NCOA3;KDM6B;ELOVL6;HCRT;SMO
prerank,triglyceride biosynthetic process (GO:0019432),0.5014105426638404,1.1861841175577412,0.27580645161290324,0.9115376584291383,1.0,4/18,3.77%,MOGAT2;MOGAT3;GPAT3;AGMO
prerank,lung epithelium development (GO:0060428),0.5600228752395473,1.1855796816252184,0.2927689594356261,0.9122858536000099,1.0,1/10,0.21%,STRA6
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.35337287504048764,1.1855577552941592,0.16866158868335146,0.9109894471631553,1.0,42/186,16.20%,CAV1;IGFBP6;LRP4;VGLL4;GLI1;PRICKLE1;DKKL1;NFATC1;AXIN1;MLLT3;SOX9;CHD8;PSME3;WNT5A;DACT1;HIC1;ZNRF3;CUL3;PSMB5;AMFR;GSK3B;STK3;CSNK1A1;SDHAF2;KREMEN1;AXIN2;DVL3;APC;NXN;BICC1;EMD;CTNNBIP1;PSMA6;PSMB2;PSMA2;PTPRU;PTPRO;TMEM170B;NPHP4;PSMD13;PSMA7;MDK
prerank,peptidyl-tyrosine modification (GO:0018212),0.40924484228436464,1.1852549455679486,0.24101198402130491,0.9106477528637217,1.0,9/56,6.50%,PKDCC;TEC;FGFR1;EFEMP1;EGFR;SRC;FER;EPHB2;ABL2
prerank,regulation of protein localization to centrosome (GO:1904779),0.5729745634606934,1.1847695327796386,0.2987249544626594,0.9108611259293276,1.0,6/10,27.15%,NUP62;GSK3B;APC;CEP250;NSFL1C;MARK4
prerank,regulation of T cell proliferation (GO:0042129),0.4066349373461637,1.184707741165863,0.2214941022280472,0.90969437581551,1.0,8/61,11.17%,TNFSF8;GLMN;ARG1;IL4I1;PTPRC;NCK2;CD276;IL6ST
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.5578270528867845,1.1845471939606906,0.3013698630136986,0.9089252765824258,1.0,2/10,2.87%,PRKCE;GPLD1
prerank,steroid metabolic process (GO:0008202),0.3941400379452776,1.1844844940727326,0.22388059701492538,0.907788898210952,1.0,13/72,14.97%,HSD17B3;CYP7B1;SULT1A1;RDH5;DHRS4;HSD17B4;CUBN;GC;PRLR;MSMO1;DHCR24;STARD3;LSS
prerank,negative regulation of cell adhesion (GO:0007162),0.38936903092572483,1.1843499851038932,0.23737373737373738,0.9069122657455035,1.0,19/72,16.20%,TGFBI;CDH13;RIPOR2;JAG1;DSCAM;PLXNA3;PTPRC;EPHB2;ADAM10;GCNT2;PLXNB1;NF2;SEMA4D;FZD7;SIPA1;PTPRO;PLG;CDH1;MDK
prerank,homeostasis of number of cells (GO:0048872),-0.4676542842320634,-1.1835014707358482,0.27790973871733965,0.7180792201696387,1.0,3/12,4.24%,NOS3;NAPEPLD;CCN3
prerank,Ras protein signal transduction (GO:0007265),0.36228465898631756,1.1834581463921243,0.18863636363636363,0.9086358835922758,1.0,24/137,10.73%,PLK2;CDH13;NTN1;USP50;PLCE1;RAPGEF3;RAP1A;CDC42EP4;MRAS;NF1;RAC2;GDI1;USP8;NRAS;KRAS;RIPOR1;ARHGEF1;RREB1;RAPGEF6;CTNNAL1;KSR2;LAT;ADRA2A;PLD1
prerank,epithelial cell migration (GO:0010631),0.443529743386928,1.1833287271033823,0.2597968069666183,0.9077423457254334,1.0,7/37,8.22%,CDH13;PXN;FAP;KANK2;KANK1;STARD13;DPP4
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.5234922670912789,1.1831824107099818,0.2603648424543947,0.9069005449374041,1.0,4/13,11.55%,KPNA7;KPNA2;CBLB;RANBP2
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.36871063818833244,1.1829977060535923,0.20935672514619882,0.9062264620232918,1.0,42/125,22.72%,PLK2;DYNLL1;KIF2A;STIL;TUBG1;CKAP5;DSN1;PAFAH1B1;EML1;CDC20;NUP160;MECP2;NUP37;DYNLL2;MAP4;RANBP2;BUB3;WDR62;NDE1;AHCTF1;PTPA;TUBG2;ZWILCH;ZW10;CENPU;RAN;B9D2;TBCE;CENPH;SETD2;CENPK;MAD1L1;DCTN2;CENPL;DYNC1LI2;GPSM2;NEK6;NUP43;DYNC1I1;MIS12;DCTN6;SEC13
prerank,cellular response to acid chemical (GO:0071229),-0.3758554726054641,-1.181583974677962,0.21666666666666667,0.72204541698111,1.0,15/27,30.99%,CPEB4;LAMTOR3;KLF2;RRAGC;GLRA2;SPAAR;RRAGD;CPEB1;LAMTOR2;XBP1;SLC38A9;NSMF;LAMTOR4;SH3BP4;GLRA1
prerank,positive regulation of protein-containing complex assembly (GO:0031334),-0.2797841034149248,-1.181525001526822,0.12162162162162163,0.7205159209285088,1.0,36/113,21.22%,ASAP1;TRABD2B;TFRC;BCL2L11;FNIP1;RASIP1;RBX1;FNIP2;RHOC;SLF2;MED25;SH3GLB1;CAPG;SLF1;VCP;RPS3;ESR1;AJUBA;BID;MMP1;MPP7;TTBK1;DHX33;ERCC2;TAL1;XPA;ISG15;SKAP1;EIF4G1;GTF2H4;RACK1;PARP1;ERCC4;ERCC5;CLU;MTLN
prerank,negative regulation of innate immune response (GO:0045824),0.4364751816926501,1.18080059375413,0.2586466165413534,0.9124412241323016,1.0,10/34,13.31%,SERPING1;IRAK3;TNFAIP3;TRIM21;SUSD4;ACOD1;TRAFD1;CNOT7;STAT2;USP15
prerank,regulation of nervous system process (GO:0031644),-0.4068242302164,-1.180640926036995,0.22774869109947643,0.7215543921878957,1.0,3/18,2.19%,ROCK2;NOS3;SLC8A3
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.4101814680298383,1.1800783765243255,0.23157894736842105,0.9136161995303507,1.0,22/52,22.66%,LEPROT;PPP1R13B;ABLIM3;RAC2;SFN;HTRA2;UBE2J2;UBE2D3;BAD;NMT1;YWHAG;E2F1;YWHAE;FBXW7;CSNK2A2;VPS11;PINK1;UBL5;TFDP1;MAPK8;SAE1;YWHAB
prerank,female gamete generation (GO:0007292),0.44032108613075854,1.1800125019931018,0.25970149253731345,0.9124932998083686,1.0,7/29,17.69%,DIAPH2;PIWIL2;BMP15;MEI4;KMT2D;MDK;USP9X
prerank,diol metabolic process (GO:0034311),-0.40992090883522264,-1.1796029814250395,0.24225352112676057,0.7231192729644598,1.0,7/19,13.27%,NOS3;DEGS2;PLPP1;CALM1;GCH1;AKT1;SPHK1
prerank,heterocycle biosynthetic process (GO:0018130),-0.4575523541153008,-1.1792857384098252,0.2649350649350649,0.7223605324172586,1.0,9/14,40.15%,GCH1;NFS1;PYCR2;MOCS3;PYCR3;PYCR1;ALOX5;GPHN;NOXRED1
prerank,response to retinoic acid (GO:0032526),-0.3081272426885647,-1.179129423564664,0.16666666666666666,0.7210894131869405,1.0,13/59,11.05%,EPHA3;CTSH;ACER2;WNT5B;LYN;ADNP2;RBP4;BRINP3;TBX1;CREB1;TRIM16;SNW1;RET
prerank,Notch signaling pathway (GO:0007219),0.40157747266382626,1.1789314582349186,0.23834196891191708,0.914769867973199,1.0,15/59,12.71%,ZNF423;NRARP;PBX1;DTX1;JAG1;MAML2;APH1B;HEYL;NCSTN;ADAM10;DTX4;POFUT1;WWC1;GMDS;CREBBP
prerank,negative regulation of protein kinase activity (GO:0006469),0.3782110184798122,1.178307904814015,0.21894218942189422,0.9156304511242404,1.0,13/88,10.56%,CAV1;TRIB2;UBASH3B;CEACAM1;SPRED1;NF1;GNAQ;PTPRC;SRCIN1;SFN;PTPRT;CEP85;RTRAF
prerank,response to metal ion (GO:0010038),0.3947966691228049,1.1778584357971862,0.24031007751937986,0.915791841263825,1.0,6/67,4.25%,CAV1;NEDD4L;ITPR3;SLC25A12;IL1A;TFR2
prerank,toll-like receptor signaling pathway (GO:0002224),0.3807846547403807,1.1776756736233938,0.2196029776674938,0.9150506501282204,1.0,20/84,17.14%,LBP;PIK3AP1;SCARA3;TNIP3;MAP3K1;IRAK3;PIK3R4;TLR7;TNIP1;RPS6KA3;HMGB1;TICAM1;S100A9;TAB2;UBE2D1;UBE2D3;PIK3C3;TICAM2;BTK;CTSB
prerank,pulmonary valve morphogenesis (GO:0003184),0.49348538988208107,1.1776741448720094,0.2838709677419355,0.9137111144860637,1.0,4/17,5.11%,STRA6;NFATC1;JAG1;HEYL
prerank,regulation of myoblast differentiation (GO:0045661),-0.35402074865840916,-1.177652495173973,0.21864951768488747,0.7238566736357533,1.0,5/32,2.81%,PLCB1;RANBP3L;BMP4;IGFBP3;TBX3
prerank,regulation of protein polymerization (GO:0032271),-0.35401244189832237,-1.1774674311428759,0.21724137931034482,0.7227214598319507,1.0,11/35,18.80%,ARHGAP28;ESAM;FCHSD2;CAMSAP1;HAX1;GBA2;TTBK1;MAPT;DBN1;ARL2;PFN1
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.5081159497339437,1.1774666128368805,0.2812006319115324,0.9131064056183025,1.0,2/16,5.54%,APOD;CHID1
prerank,negative regulation of interleukin-2 production (GO:0032703),0.49789383284535327,1.17715898521203,0.28594249201277955,0.9128138859953497,1.0,3/18,5.24%,HOMER2;PTPRC;TNFAIP3
prerank,endocardial cushion development (GO:0003197),-0.397135750450854,-1.176907615111753,0.26136363636363635,0.7226852623345905,1.0,5/21,3.91%,ENG;NOS3;BMP4;ACVRL1;BMPR2
prerank,regulation of cell cycle process (GO:0010564),0.37194364899327687,1.1768861135284698,0.20774647887323944,0.9124271658598173,1.0,20/104,12.54%,PLK2;FBXO43;KIF20B;CAV2;RACGAP1;SOX9;PIK3R4;CDK13;RPRD1B;FBXO5;CCP110;KIF13A;E4F1;CEP85;ZFYVE26;APC;KLHL21;MAP9;CETN2;AHCTF1
prerank,regulation of complement activation (GO:0030449),0.4195201682448298,1.1765975621584885,0.2556818181818182,0.9120346967859466,1.0,6/40,13.88%,C2;SERPING1;CD55;SUSD4;CD81;CFH
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.44925601057755876,1.1751908055238471,0.2673716012084592,0.9155155626915945,1.0,5/30,8.77%,OGT;FHIT;STYX;N4BP1;DDRGK1
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.383307538791909,1.1751260230366276,0.244228432563791,0.9144188505600535,1.0,36/84,24.38%,FXR2;RBFOX2;QKI;RBM8A;CELF1;SRSF4;RBM15B;SON;DDX17;SRPK1;RBM5;CELF2;CELF4;KHDRBS2;SRPK2;SFSWAP;RBMXL1;NSRP1;FXR1;TRA2B;SF1;CWC22;SRSF3;PRDX6;MBNL2;SAP18;SRSF12;TIA1;SRSF10;YTHDC1;ZBTB7A;JMJD6;RBMX;PUF60;REST;FMR1
prerank,cellular response to insulin stimulus (GO:0032869),0.36602184745744215,1.1744883701335802,0.2305045871559633,0.9153071541638449,1.0,19/124,9.14%,GAB1;INHBB;SORBS1;OTOP1;CEACAM1;RAB8B;GPLD1;CAV2;ATP6V0D2;SLC27A1;PDK4;FER;SELENOS;ZDHHC7;SYAP1;PIK3R2;ATP6V0A1;SLC27A4;GSK3B
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),0.5504503125646069,1.1744621538865376,0.29856115107913667,0.9140757980258181,1.0,3/10,7.01%,CEACAM1;CD9;RDX
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),-0.4050085838546189,-1.1739003192231057,0.264,0.7298004527379485,1.0,7/18,14.07%,RAD51B;CDC25B;CDC25A;RAB11A;CDK4;CDC7;RAD51C
prerank,positive regulation of myoblast differentiation (GO:0045663),-0.4298738384592074,-1.1733313027766044,0.23316062176165803,0.7298018816813951,1.0,3/16,2.57%,PLCB1;RANBP3L;IGFBP3
prerank,negative regulation of extracellular matrix organization (GO:1903054),0.5549454109648906,1.173096123212114,0.29180887372013653,0.9174952889200961,1.0,3/10,12.16%,FAP;DPP4;CHADL
prerank,inhibitory synapse assembly (GO:1904862),0.5445778437375258,1.17259982075195,0.29701230228471004,0.9178966373081673,1.0,4/11,12.09%,WNT5A;GABRG2;PLXNB1;GABRB3
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.5365510778658583,1.172250139962457,0.2912621359223301,0.9178365729826801,1.0,6/12,19.04%,STX1A;STX2;STX19;STX4;SNAP23;SNAP29
prerank,myeloid cell development (GO:0061515),-0.4115134880232612,-1.1722224480487018,0.24603174603174602,0.7315690085947768,1.0,7/18,21.82%,FOXP1;KIT;ANXA2;NRROS;ABCB10;ALAS1;NCKAP1L
prerank,purine nucleotide metabolic process (GO:0006163),0.46078750069938407,1.172156558662363,0.27662721893491127,0.9168547853403456,1.0,8/24,11.92%,FHIT;MTHFD1;PPAT;NT5E;PRPSAP2;NT5C2;PRPS1;PRPS1L1
prerank,synaptic vesicle recycling (GO:0036465),0.44674260647128494,1.1717897393199839,0.27988338192419826,0.9167896064868843,1.0,13/31,22.17%,CEL;STX1A;OPHN1;STON1;RAB3A;STON2;SNCG;RAB5A;PACSIN1;AMPH;VAMP2;NLGN3;NLGN2
prerank,negative regulation of supramolecular fiber organization (GO:1902904),-0.2967715641206502,-1.1715549859457024,0.16908212560386474,0.731926894900472,1.0,20/72,11.81%,SHANK3;PLEKHH2;ARHGEF2;SLIT2;KANK3;STMN2;LDLR;HIP1R;HSPA8;TWF1;MYADM;APOE;EML2;CYRIB;CAMSAP1;VBP1;CLIP3;APC2;STMN1;CRYAB
prerank,nuclear transport (GO:0051169),0.4949692115625774,1.1714319866018124,0.28434504792332266,0.9166039475121655,1.0,2/16,5.26%,RGS14;RBM15B
prerank,positive regulation of interleukin-2 production (GO:0032743),0.451684959639212,1.1714110771394985,0.26947040498442365,0.9153519735144661,1.0,4/25,5.03%,GLMN;PDE4D;IL1A;PTPRC
prerank,cilium assembly (GO:0060271),0.3382981046903922,1.1710568412028461,0.15942028985507245,0.9152567850854376,1.0,79/296,19.40%,DYNLL1;PARVA;UBXN10;RAB8B;ABLIM3;MKS1;PTPDC1;DZIP1;GORAB;DYNC2I1;CYS1;EXOC3;SFI1;CNGB1;INTU;CEP89;CEP131;IFT81;CEP78;CNGA4;KIF3C;NEDD1;SNX10;EHD2;TUBG1;CKAP5;BBOF1;CCP110;CCDC39;CLUAP1;CEP162;PAFAH1B1;UNC119B;OCRL;TMEM237;TCTN2;FOXJ1;IFT74;DYNLL2;C2CD3;HDAC6;EXOC5;CFAP20;CEP290;SSNA1;NDE1;CETN2;RPGRIP1L;TTC21B;TRIP11;PKD1;PDE6D;PCM1;FAM161A;FBF1;DNAH5;CCDC40;B9D2;NPHP4;DYNC2LI1;YWHAG;CFAP298;PIBF1;CFAP70;CFAP410;CDC14A;YWHAE;DYNC2H1;CEP57;EHD1;OFD1;ALMS1;ARMC9;STK36;CEP250;SNAP29;BBS1;TMEM80;DCTN2
prerank,regulation of sequestering of triglyceride (GO:0010889),-0.44020251602252425,-1.1709840526937663,0.25,0.7320628156684693,1.0,4/15,13.69%,OSBPL8;OSBPL11;ABHD5;PLIN3
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.35604027883025186,1.1705408546481981,0.22146118721461186,0.9157059151339,1.0,22/138,13.13%,RORA;PPARGC1A;NR3C2;RARB;MAML2;PGR;TAF10;TAF4B;TEAD3;CDK7;NCOR1;RARA;MED7;RORB;NRBF2;NCOR2;RARG;MED23;GTF2F2;CREBBP;TAF15;GTF2H1
prerank,dopaminergic neuron differentiation (GO:0071542),-0.40737369483714386,-1.1705020509620563,0.2699724517906336,0.7318317016560221,1.0,11/19,48.57%,LRP6;NR4A2;MANF;LMX1B;LMX1A;WNT2;SHH;FOXA1;EN1;FOXA2;CDNF
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),-0.3857074966239894,-1.1703841442863678,0.23976608187134502,0.7305602992570314,1.0,7/24,10.15%,TEK;ANGPT1;NDNF;KDR;GATA2;RAMP2;SCG2
prerank,actin crosslink formation (GO:0051764),-0.4674377178366513,-1.1703824796366096,0.28863636363636364,0.7289348502793391,1.0,3/12,10.86%,EPS8;FLNA;BAIAP2L1
prerank,regulation of phosphate metabolic process (GO:0019220),-0.42447719317653704,-1.1697437051219721,0.2446236559139785,0.7292745456196137,1.0,7/16,18.79%,IGBP1;PGAM1;SRPX2;IKBKB;BARD1;RAD17;CD24
prerank,positive regulation by host of viral transcription (GO:0043923),-0.43108902236007307,-1.1689589253448618,0.26616915422885573,0.7300284696254399,1.0,5/15,12.34%,LEF1;EP300;CCNT1;SNW1;SP1
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.4413426102738002,-1.168891304187637,0.2802056555269923,0.7285874904437631,1.0,3/14,4.06%,TFRC;PAXIP1;SHLD2
prerank,positive regulation of signal transduction (GO:0009967),-0.25008175626027995,-1.1685595010274548,0.07017543859649122,0.7280031506474864,1.0,61/238,14.80%,IGF1;ROBO1;SASH1;VWF;TEK;PTGIS;CCBE1;RSPO3;SHANK3;BMP6;WLS;GRB10;RBPJ;NOS3;PIK3R1;TGFBR1;EP300;IGF2;MBD5;FGFR2;MN1;CCN3;F3;FAS;HIF1A;DSTYK;RSPO2;CUX2;PDCD10;JAK2;JAG2;SLC39A14;CITED2;TRIM16;ATP6V0C;GRIN1;TXNDC15;FLNA;DCDC2;SNW1;ASXL2;TM2D3;MACF1;KLF2;BMP2;RPS3;PRKCZ;CTBP2;CD80;NRXN1;TTC23;LRRK2;BDNF;LOXL3;TGFB2;CSNK2A1;CDKN2AIP;ILK;ESM1;MAML3;RWDD3
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.5367080857652835,1.1683037846815254,0.295668549905838,0.9219760230185524,1.0,4/11,13.50%,PRODH;MAP3K5;STK24;DIABLO
prerank,"phagocytosis, engulfment (GO:0006911)",0.42624667543183614,1.168227733906906,0.2669616519174041,0.9208985259627573,1.0,6/36,8.31%,ARHGAP12;XKR7;DOCK1;XKR4;RAC2;XKR8
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.35941176086274157,1.1681062199104306,0.2166105499438833,0.9200190138171733,1.0,21/136,13.26%,PTCH1;SPI1;GLIS2;HDAC4;IRAK3;KEAP1;HEYL;TNFAIP3;BHLHE40;ANXA4;TRIM21;ZNF431;ACOD1;NLRP2B;FOXJ1;HDAC2;TAX1BP1;MTURN;MEN1;PKD1;CTNNBIP1
prerank,vesicle transport along microtubule (GO:0047496),0.4628799278333236,1.1680541196504826,0.29096477794793263,0.9188722056749787,1.0,9/23,25.15%,PAFAH1B1;KIF13A;NDE1;KIF5A;KIF5B;HTT;FBXW11;DYNC1I1;KIFAP3
prerank,positive regulation of dephosphorylation (GO:0035306),0.44682976757046045,1.1679514599115612,0.2685459940652819,0.9179109528823886,1.0,3/27,4.43%,DLC1;CDH5;SRC
prerank,regulation of gluconeogenesis (GO:0006111),0.44117955560146116,1.1678895256997956,0.26686656671664166,0.9168386597972279,1.0,6/27,13.11%,PPARGC1A;OGT;SELENOS;SIRT7;C1QTNF12;GCK
prerank,axonal fasciculation (GO:0007413),-0.4618386153031717,-1.1676557359485755,0.26252983293556087,0.7292449810792131,1.0,6/12,17.68%,EPHA3;EPHA4;ARHGAP35;MEGF8;CDK5R1;EPHB3
prerank,cellular calcium ion homeostasis (GO:0006874),0.3572618343059883,1.167052131189981,0.2129105322763307,0.9183276328610951,1.0,12/133,4.86%,CAV1;STC2;CTRC;CAMK2D;SLC8B1;CDH5;SLC24A1;FKBP1B;TRPV4;CAV2;CSRP3;ATP2B4
prerank,organic substance transport (GO:0071702),-0.2801315454015612,-1.1670239933948823,0.11450381679389313,0.7295281037660198,1.0,28/121,16.85%,SLC47A1;PLTP;CHKA;TXNIP;ABCG2;TOM1;CALCRL;SLC22A6;SLC22A4;ABCA4;SPNS2;TCN2;ARL6IP5;TAP2;SLCO2A1;ABCA9;RAMP2;SCAMP5;SLC22A18;ABCD2;SLC35F3;MFSD2A;ABCA2;ARRDC4;ABCG1;ARRDC2;CHMP3;SLC22A2
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.42351139650198394,1.1668872195901163,0.27624309392265195,0.9175994684069015,1.0,11/41,13.04%,EPHX1;ELOVL5;ALOXE3;DECR2;ELOVL1;SCD5;ELOVL2;HSD17B4;ACOT8;ABCD1;PNPLA8
prerank,regulation of stress-activated MAPK cascade (GO:0032872),-0.32830349690934557,-1.166643528830127,0.16487455197132617,0.7290421543376798,1.0,9/47,7.76%,IGF1R;TGFBR3;FOXO1;FAS;PDCD10;ARL6IP5;IGBP1;NBR1;MAP2K2
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.400528009045979,1.1665934045778035,0.2446524064171123,0.917265208274105,1.0,8/59,11.30%,ALDH1A3;CYP7B1;OSBPL6;HOGA1;ACACA;HSD17B4;ACOT8;GAMT
prerank,cardiac muscle cell differentiation (GO:0055007),0.48200677188801117,1.1665376718495055,0.28253968253968254,0.9161466485401982,1.0,2/21,3.27%,CXADR;AKAP13
prerank,regulation of phosphorylation (GO:0042325),0.35961742670440877,1.1660732073728304,0.2448512585812357,0.9164227537971272,1.0,23/120,14.16%,ITGA6;DYNLL1;GLMN;LDB2;EGFR;OGT;CDH5;PRKAG1;DSCAM;NUP62;FN1;FER;NUP160;NUP37;TPR;NUP50;RANBP2;STAT2;NUP153;NUP210;GCK;CDKN1C;FZD7
prerank,cytoskeleton organization (GO:0007010),-0.2759567624838891,-1.1659284894847204,0.15172413793103448,0.7295147735697382,1.0,31/114,12.60%,RHOBTB1;NEDD9;MARK1;TPM1;FGD5;MAST4;OBSL1;PLD2;DST;RHOBTB3;CFL1;SEMA6A;SYNE3;ARAP3;WASF3;PRPF40A;APOE;RHOC;SH3KBP1;CNN2;CAMSAP1;DIAPH1;WDPCP;RHOB;RHOH;AJUBA;PAK5;PALLD;CECR2;DES;CCL13
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),-0.32780634872001146,-1.1651845367390596,0.17993079584775087,0.7300025770629496,1.0,11/41,17.12%,TGFA;NEDD9;EPHA4;ACE;DOCK3;NOX4;LRP8;BDNF;IL34;EGF;GPRC5B
prerank,nitric oxide metabolic process (GO:0046209),-0.43936970510752554,-1.16481997369071,0.27945205479452057,0.7294548098449507,1.0,4/14,8.34%,NOS3;CYP1B1;GCH1;AKT1
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),0.4342165103623775,1.164619239242044,0.2927864214992928,0.9201487302744202,1.0,5/36,8.77%,OGT;FHIT;OPHN1;N4BP1;DDRGK1
prerank,gastrulation (GO:0007369),0.5127012395849057,1.1645723913648842,0.31282952548330406,0.9190281840032256,1.0,1/15,0.45%,GPC3
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.3763469459323108,-1.1645639001135448,0.23564954682779457,0.7286270957225582,1.0,8/25,16.03%,INSR;SMAD3;DDAH1;KLF4;AKT1;KLF2;EDN1;P2RX4
prerank,DNA unwinding involved in DNA replication (GO:0006268),-0.4305277307397205,-1.1644883419358045,0.2658536585365854,0.7272787376381943,1.0,10/16,35.51%,WRN;BLM;MCM6;SSBP1;MCMDC2;TWNK;RAD51;MCM7;MCM2;RECQL
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),0.48092845664238104,1.1642525311534293,0.2886762360446571,0.9188279324916748,1.0,2/19,0.56%,VGLL4;GLI1
prerank,tryptophan catabolic process (GO:0006569),0.5399604815238929,1.1640254647429975,0.2901639344262295,0.9182767001521949,1.0,2/11,3.80%,IL4I1;AADAT
prerank,glutamine family amino acid catabolic process (GO:0009065),0.5182939140727089,1.1639431646061822,0.3111111111111111,0.917255865577629,1.0,2/13,1.49%,PRODH;ARG1
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.47100911924539846,1.163819500967608,0.29080118694362017,0.9163986692787909,1.0,4/22,8.07%,CEACAM1;DGKZ;PTPN22;PTPRJ
prerank,cellular response to ionizing radiation (GO:0071479),-0.3220606713160564,-1.1635999412143132,0.2,0.7284222792164033,1.0,17/47,24.64%,MAP3K20;WRN;RPL26;BLM;RHOB;EEF1D;NET1;CRYAB;KDM1A;RAD1;HSF1;RAD9B;KDM4D;HRAS;GRB2;RAD51;LIG4
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),-0.46484117174102424,-1.1634364011470786,0.2860520094562648,0.7273119484833301,1.0,6/12,23.84%,PLCG2;CYBA;GRIN1;ADGRB1;RAB27A;ZNF205
prerank,regulation of lipid metabolic process (GO:0019216),0.36967257104930534,1.163302387716637,0.24535315985130113,0.9168586024583313,1.0,7/88,7.12%,RORA;CAV1;CHD9;SC5D;SIN3B;NCOR1;ACACA
prerank,nitric oxide biosynthetic process (GO:0006809),-0.4454994576523001,-1.163111763974478,0.28272251308900526,0.7267418847579389,1.0,4/13,8.34%,NOS3;CYP1B1;GCH1;AKT1
prerank,rRNA metabolic process (GO:0016072),-0.2602737445462511,-1.1628806246165262,0.12149532710280374,0.7258634286389776,1.0,61/160,24.46%,RPL37A;RPL19;RPL8;RPL37;RPS15;RPL35A;RPS7;RPL32;RPS27;RPL27;RPL26;RPS24;RPLP0;RPS19;RPL31;RPL41;RPL13A;RPL30;RPL29;RPS16;RPL3;DIS3L;RPLP1;RPS17;WDR12;RPL23;RPL17;RPL9;RPL38;RPL36;RRP7A;ESF1;RPL18A;MAPT;EXOSC3;IMP4;HEATR1;LAS1L;TEX10;POP5;RPS6;NOL9;RPLP2;DIS3;HELQ;DHX37;EXOSC1;FBL;RPL14;TBL3;RPS2;RPL10A;RPL34;RPL5;RPL39;UTP4;PWP2;RPL22;RPS9;WDR3;RPS14
prerank,positive regulation of macrophage activation (GO:0043032),0.49327115425167295,1.162814447045655,0.2942097026604069,0.917289654171908,1.0,3/17,10.39%,LBP;WNT5A;KARS1
prerank,response to chemokine (GO:1990868),0.51281900691731,1.1621121245565396,0.2976588628762542,0.9183494501023455,1.0,2/13,1.82%,RIPOR2;SLC12A2
prerank,positive regulation of cyclase activity (GO:0031281),0.5194175542395918,1.161987711034874,0.3144758735440932,0.9175138494880166,1.0,2/14,3.16%,GUCA1A;NF1
prerank,regulation of endothelial cell migration (GO:0010594),0.37159366287508133,1.1619862921167152,0.24468085106382978,0.9162408334367923,1.0,10/85,4.77%,DCN;SMOC2;NR2F2;CEACAM1;FGF1;NRP2;GPLD1;NF1;PRKCA;WNT5A
prerank,regulation of platelet activation (GO:0010543),0.46806833652063484,1.1616237444937103,0.29797191887675506,0.9161136007006966,1.0,3/21,4.02%,TEC;TXK;PRKCA
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.5260182824117485,1.1614081984917084,0.31965811965811963,0.9155782195984362,1.0,7/12,27.32%,NELFB;HEXIM1;TCERG1;RECQL5;EAPP;HNRNPU;NELFA
prerank,substrate-dependent cell migration (GO:0006929),0.5166676695755714,1.1607206707530378,0.2942122186495177,0.9166252336468296,1.0,3/14,5.03%,NTN1;OPHN1;PTPRC
prerank,metallo-sulfur cluster assembly (GO:0031163),-0.3868606883541597,-1.1606998215941722,0.26453488372093026,0.7309235512506034,1.0,9/22,23.13%,CIAPIN1;NFS1;NFU1;MMS19;CIAO3;FXN;ISCA2;GLRX5;ISCU
prerank,lamellipodium organization (GO:0097581),0.4430635587450842,1.1606638036333123,0.27245508982035926,0.9155583075904096,1.0,10/29,16.91%,CDH13;ABLIM3;SPEF1;ABLIM2;SNX2;ARHGEF6;CTTN;PTPRO;SNX1;ARHGEF7
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.35561260973915193,1.1605457157258263,0.22605790645879734,0.9146710858741285,1.0,49/152,20.98%,CAV1;GPC3;PPM1N;SULF1;NRARP;EGFR;AXIN1;DEPDC1B;PSME3;DACT1;PPM1A;TNFAIP3;USP8;UBR5;FAM53B;PLEKHA4;KANK1;PSMB5;CSNK1G3;RNF220;COL1A1;USP47;AXIN2;SPIN1;SOX4;PSMA6;CAPRIN2;FZD9;PSMB2;PSMA2;PSMD13;PSMA7;ATP6AP2;PSME4;GPC5;FGF10;CSNK1G1;PSMD12;PSMD14;PSMB6;CDH3;PSMC4;PIN1;CDC73;TRPM4;GSKIP;USP34;RNF146;CCAR2
prerank,actomyosin structure organization (GO:0031032),0.3848647815975769,1.160450567297535,0.24689826302729528,0.9137162204149822,1.0,12/75,8.93%,F11R;SORBS1;EPB41L4A;EPB41L2;EPB41L3;TMOD2;CSRP3;SRC;KRT19;CUL3;TMOD1;OBSCN
prerank,regulation of mononuclear cell migration (GO:0071675),-0.38926500030658295,-1.1604379538896155,0.25301204819277107,0.7301511032213893,1.0,10/23,18.85%,MSN;SLIT2;LYN;STK10;CMKLR1;IL34;THBS1;PTK2;CSF1;RARRES2
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.44879688815579544,1.1589107334014468,0.2955223880597015,0.9175739513708887,1.0,6/26,9.18%,PCBP2;IRAK3;TNFAIP3;TRIM21;ACOD1;TRAFD1
prerank,T-helper cell differentiation (GO:0042093),-0.4459109607321995,-1.1588719078232748,0.2722772277227723,0.7331702728928695,1.0,3/14,3.39%,LEF1;FOXP1;ATP7A
prerank,thymus development (GO:0048538),-0.4472417717032149,-1.1586608618906138,0.2860635696821516,0.732177213639755,1.0,4/13,17.68%,TGFBR1;TBX1;ZBTB1;EPHB3
prerank,mismatch repair (GO:0006298),0.4490592702815571,1.1585212590990015,0.29411764705882354,0.9176312040111007,1.0,8/27,21.89%,MSH6;TDG;MSH2;ERCC1;SETD2;MLH3;MLH1;RPA3
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),-0.35526245428805514,-1.1585191675632531,0.23648648648648649,0.7309433428069801,1.0,5/33,8.43%,IGF1R;IGF1;PIK3R1;AKT1;PIK3C2A
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.3428614681653869,1.1580272481663008,0.21160042964554243,0.918016615522064,1.0,25/208,11.19%,RORA;ROR1;PLK2;LPAR1;PPM1N;PELI2;TNIP3;AKAP13;REL;SLC35B2;WNT5A;NUP62;PPM1A;TNFAIP3;TRADD;TRIM21;S100B;TNIP1;TFG;TICAM1;TMED4;CANT1;SHARPIN;OTUD7B;TAB2
prerank,negative regulation of stress fiber assembly (GO:0051497),0.45310509381986624,1.157645150839272,0.2938530734632684,0.9180666508575306,1.0,3/24,2.03%,DLC1;F11R;ARAP1
prerank,ovarian follicle development (GO:0001541),0.5194646833030593,1.1573543433410087,0.30084033613445377,0.9177891316201805,1.0,1/13,0.54%,INHBB
prerank,positive regulation of glial cell differentiation (GO:0045687),-0.4125141699954215,-1.157213803348038,0.2546419098143236,0.7332749722689135,1.0,8/17,24.87%,TNFRSF1B;SERPINE2;BMP2;IL34;ID2;PTN;CLCF1;NOTCH1
prerank,actin filament depolymerization (GO:0030042),-0.47097679955071414,-1.1567141497275613,0.27293577981651373,0.7331134019019715,1.0,3/11,6.05%,DSTN;CFL1;TWF1
prerank,positive regulation of autophagy (GO:0010508),0.37447775376661413,1.1563178310677913,0.2660996354799514,0.9200367364810214,1.0,13/81,11.05%,DCN;PLK2;TPCN1;FOXO3;TRIM21;SCOC;SESN1;IRGM;GSK3B;HMGB1;TICAM1;TFEB;PAFAH1B2
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.40090639822068747,1.1559791803033348,0.26490066225165565,0.9199334042013051,1.0,3/53,2.45%,HRH1;MC5R;SSTR1
prerank,protein-DNA complex disassembly (GO:0032986),-0.4131845872171944,-1.1559159902699618,0.26865671641791045,0.7339623290056319,1.0,4/16,11.00%,SMARCE1;SMARCD1;RPL23;ARID2
prerank,protein N-linked glycosylation (GO:0006487),-0.2979356576233477,-1.1553207585730514,0.1910569105691057,0.7341787534148174,1.0,18/66,17.31%,MGAT4C;ST3GAL1;MGAT4A;SLC39A8;DPM1;ALG5;STT3B;GAL3ST1;PGM3;B4GALT1;UBE2J1;ALG1;B4GALT7;RPN2;FUT8;OST4;ENTPD5;ASGR1
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),-0.3166115840373034,-1.1552232086954368,0.2116788321167883,0.7328942841463595,1.0,9/48,7.39%,PRKAG2;NUP107;EP300;HIF1A;AAAS;SEH1L;NUP133;PRDM16;PGAM1
prerank,lipoprotein biosynthetic process (GO:0042158),-0.46405235006757245,-1.154551132250539,0.29508196721311475,0.7332282851666702,1.0,6/11,24.97%,ATG10;APOE;WIPI1;WIPI2;WDR45B;WDR45
prerank,response to cytokine (GO:0034097),-0.263779225359699,-1.1542914006587663,0.11711711711711711,0.7324246631873162,1.0,24/141,8.38%,TIMP3;ALDH1A2;IL1R1;LEF1;SMAD3;PID1;OSMR;IL6R;SP100;IFNAR2;YTHDC2;ADAR;CXCL16;LIFR;AKAP6;TRAF6;CASP3;IGBP1;CDK9;GCH1;JAK2;BST2;ANXA1;LDLRAP1
prerank,fatty acid transmembrane transport (GO:1902001),-0.39783256374510745,-1.154127457912976,0.2457002457002457,0.7313575043580617,1.0,8/19,17.73%,PRKAG2;ABCD4;CPT2;PRKAB2;ABCD2;CPT1A;MID1IP1;SLC2A1
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.4151771171182116,-1.154071138482855,0.2979274611398964,0.7299530403117422,1.0,10/16,30.00%,ATP5PD;DMAC2L;ATP5MC3;ATP5PF;ATP5ME;ATP5PO;ATP5MC2;ATP5MF;ATP5MC1;ATP5F1E
prerank,negative regulation of amyloid-beta formation (GO:1902430),-0.41529351932741976,-1.153597195868099,0.26666666666666666,0.7298905284656815,1.0,3/17,8.19%,IGF1;APOE;RTN1
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.43171705348326256,1.1533230101351268,0.28901734104046245,0.9273853834392667,1.0,4/32,7.87%,MEOX2;CARD10;RHOJ;STARD13
prerank,regulation of interleukin-4 production (GO:0032673),-0.3943110048094567,-1.1531616717364146,0.26666666666666666,0.7296076316527054,1.0,5/21,15.93%,LEF1;SLC7A5;PRKCZ;CEBPB;LGALS9
prerank,neuromuscular synaptic transmission (GO:0007274),-0.4066893363428202,-1.15259619147414,0.27348066298342544,0.7296257436224142,1.0,3/18,7.57%,KIF1B;TBC1D24;FCHSD2
prerank,regulation of microtubule polymerization (GO:0031113),-0.33334561876911034,-1.1515089738139086,0.2629757785467128,0.7312122580603314,1.0,14/40,20.02%,CLIP1;STMN2;EML2;CAMSAP1;RPS3;GBA2;CLIP3;STMN1;MAPT;CDK5R1;TUBB4A;ARL2;MET;FES
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.3866011151606965,1.1513411649498697,0.26631853785900783,0.9325953258805091,1.0,11/67,6.50%,PKDCC;TEC;FGFR1;EFEMP1;EGFR;ITK;TXK;SRC;FER;EPHB2;ABL2
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.38799685166069,-1.150986124682891,0.27298850574712646,0.7312129627190327,1.0,5/22,11.29%,TIMP3;PTPN3;TNFRSF1B;APOE;FURIN
prerank,synaptic vesicle membrane organization (GO:0048499),0.48953109961691765,1.150940120939343,0.291350531107739,0.9326609933771326,1.0,7/17,19.04%,STX1A;SYNGR2;STX2;STX19;STX4;SNAP23;SNAP29
prerank,endothelial cell differentiation (GO:0045446),-0.46830212991779213,-1.1507353362839838,0.30279898218829515,0.7304291878544581,1.0,7/12,16.29%,TIE1;ACVRL1;BMPR2;KDR;PROX1;SCUBE1;SOX18
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",-0.46439589552659033,-1.150457147658062,0.28132387706855794,0.7297044105358861,1.0,7/11,40.48%,SP100;MAD2L2;RPS27L;KAT5;TFAP4;MUC1;FOXM1
prerank,positive regulation of transferase activity (GO:0051347),0.35227215438276593,1.1500325433946728,0.25669642857142855,0.9343809285777641,1.0,13/142,6.25%,ROR2;ROR1;NTRK3;FGFR1;EGFR;MUSK;AXIN1;UBE2I;LMO4;NEK7;RFC3;NBN;EPHB2
prerank,response to amino acid (GO:0043200),-0.35415782552580244,-1.1500265728681458,0.2837370242214533,0.7295019060021846,1.0,17/31,31.14%,CPEB4;LAMTOR3;GRIN1;RRAGC;GLRA2;SPAAR;RRAGD;CPEB1;LAMTOR2;TMBIM6;XBP1;SLC38A9;NSMF;LAMTOR4;SH3BP4;GLRA1;MEAK7
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.4952617278253293,1.1498280645159065,0.30448717948717946,0.9337430248295716,1.0,4/18,9.23%,POR;SIRT3;ABL2;PDP2
prerank,positive regulation of stem cell proliferation (GO:2000648),0.48365108947296104,1.1497009370583549,0.29497568881685576,0.9328900819262865,1.0,5/17,15.31%,PTPRC;LTBP3;N4BP2L2;FERMT2;PDCD2
prerank,regulation of isotype switching (GO:0045191),-0.4392935608882834,-1.1495630506103203,0.2679900744416873,0.7294112809304367,1.0,4/14,8.50%,TFRC;PAXIP1;SHLD2;SLC15A4
prerank,negative regulation of catalytic activity (GO:0043086),-0.38702713715284626,-1.1494882474816004,0.2737752161383285,0.7281320664839955,1.0,11/24,33.13%,PPP1R12A;NES;CAMK2A;IFIT1;NOS1;PLN;OXA1L;NOTCH1;NOSIP;TIMP1;APBA3
prerank,positive chemotaxis (GO:0050918),0.4870121682700871,1.1492224234473252,0.31017770597738287,0.933176562243861,1.0,1/17,0.26%,FGF7
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.4748421084749122,1.1491897582999728,0.30670926517571884,0.9320176750018525,1.0,6/20,13.75%,NR2F2;HEXIM1;APC;MEN1;PTEN;CDKN1C
prerank,protein peptidyl-prolyl isomerization (GO:0000413),0.47072885894717914,1.1490474418526677,0.319672131147541,0.9312543217084982,1.0,6/20,14.63%,FKBP5;FKBP1B;PPIE;PPIL6;PPIC;PPIG
prerank,spliceosomal complex assembly (GO:0000245),0.4079930000571356,1.1490164694890077,0.2662162162162162,0.9300871905853965,1.0,10/46,11.37%,SF3B1;CELF1;ZRSR2;SMN1;SRPK1;RBM5;CELF2;CELF4;SRPK2;LUC7L2
prerank,regulation of keratinocyte proliferation (GO:0010837),0.4635739085646537,1.1485719915772747,0.2902208201892745,0.9303062392856476,1.0,2/22,3.00%,FGF7;CASK
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.361929621007367,1.1482923318802492,0.24970828471411902,0.9299960042182086,1.0,29/124,18.81%,ROR2;PRICKLE1;PRICKLE2;NFATC1;PLCB3;FZD2;PSME3;WNT5A;PSMB5;AGO1;DVL3;VANGL1;FZD7;PSMA6;FZD9;FZD3;PSMB2;PSMA2;PSMD13;AP2A2;PSMA7;CELSR1;PSME4;CELSR2;RHOA;PSMD12;PSMD14;PSMB6;PSMC4
prerank,positive regulation of ATPase activity (GO:0032781),0.41837850167279467,1.1479173962967986,0.2984441301272984,0.9300112244725023,1.0,13/41,19.68%,DYNLL1;MSH6;ALDOB;MSH2;PLSCR1;DNAJC9;ATP1B3;DYNLL2;AHSA1;FGF10;DNAJC24;DHX9;PFN2
prerank,epithelial to mesenchymal transition (GO:0001837),-0.31826846410938814,-1.147684855887791,0.21292775665399238,0.7319981601729223,1.0,9/47,4.89%,ENG;LEF1;ROCK2;TGFBR3;RBPJ;TBX3;TGFBR1;WNT4;HIF1A
prerank,regulation of immune effector process (GO:0002697),0.40903127878148704,1.1476167805262965,0.2680115273775216,0.9297741167993341,1.0,6/41,13.88%,C2;SERPING1;CD55;SUSD4;CD81;CFH
prerank,ceramide catabolic process (GO:0046514),0.5003789291236967,1.1474438046093862,0.2966101694915254,0.9291231855269659,1.0,6/14,18.65%,ACER3;NAGA;NEU1;HEXA;HEXB;ASAH1
prerank,regulation of lysosomal lumen pH (GO:0035751),-0.4655800160009729,-1.1474421402497281,0.2922705314009662,0.731231609685189,1.0,8/12,34.95%,TMEM9;LRRK2;CLN5;GRN;CCDC115;CLN6;VPS33A;TMEM165
prerank,regulation of nitric-oxide synthase activity (GO:0050999),0.4227302050196648,1.1472409839834612,0.28435374149659864,0.9285067021455384,1.0,6/36,7.57%,CAV1;EGFR;IL1A;ATP2B4;DDAH2;NOS1AP
prerank,positive regulation of intracellular protein transport (GO:0090316),0.3481930358449131,1.1471042673338314,0.23964165733482642,0.9277109425393414,1.0,55/144,23.20%,LEPROT;GTSE1;RAPGEF3;PPP1R13B;ABLIM3;RAB29;KIF20B;RAC2;FIS1;CEP131;UBR5;RIPOR1;BAG3;RBM22;PIK3R2;MIEF1;GSK3B;SFN;TPR;CEP290;CD81;EMD;PCM1;HTRA2;TMEM30A;UBE2J2;UBE2D3;BAD;RAN;NMT1;YWHAG;CDH1;ERBB2;E2F1;YWHAE;FBXW7;CSNK2A2;CEMIP;CHP1;TM9SF4;VPS11;PINK1;HDAC3;UBL5;AKT2;TFDP1;MAPK8;TCF7L2;VAMP2;XPO4;TENM1;SAE1;YWHAB;OAZ2;PRNP
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.4831225943709517,1.1469582589082463,0.3177570093457944,0.9269687455377783,1.0,3/17,3.89%,F11R;CDH5;ADD1
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),-0.3689599143423451,-1.1469542981575382,0.24615384615384617,0.7311519557031169,1.0,8/26,16.03%,INSR;SMAD3;DDAH1;KLF4;AKT1;KLF2;EDN1;P2RX4
prerank,cobalamin metabolic process (GO:0009235),0.4840108972619882,1.146928141793885,0.3366013071895425,0.9258450895686695,1.0,6/17,12.86%,CTRC;ABCC1;MMAB;CD320;CUBN;AMN
prerank,phospholipid catabolic process (GO:0009395),-0.37434147592222256,-1.1468532357872663,0.26287262872628725,0.7299872528933125,1.0,3/24,8.25%,GPCPD1;ENPP2;PNPLA6
prerank,positive regulation of cartilage development (GO:0061036),0.4895039631264063,1.1468473606765424,0.308562197092084,0.9248971091528663,1.0,3/17,4.14%,PKDCC;BMPR1B;SOX9
prerank,positive regulation of organelle assembly (GO:1902117),-0.3264236246798227,-1.146658673514471,0.21071428571428572,0.7290649503969697,1.0,13/44,14.14%,ASAP1;CNOT6L;G3BP2;STX18;ARHGAP35;ENTR1;SH3GLB1;CAPG;PIP4K2A;FUZ;PIP4K2C;CEP120;CROCC
prerank,endoderm development (GO:0007492),0.5158502702143467,1.1460997701110853,0.3075601374570447,0.9261361624731932,1.0,2/13,5.17%,LAMC1;KIF16B
prerank,regulation of cellular component organization (GO:0051128),0.3502996498657283,1.146024505613781,0.2421875,0.9251765789703107,1.0,21/135,8.76%,PTCH2;CDH13;PLCE1;CEACAM1;CAMK2D;RAP1A;MLLT3;OPHN1;IRAK3;WNT5A;ZFYVE16;HJURP;STON1;ANGPTL7;ABL2;PACSIN2;LTBP4;STK38L;STON2;EBAG9;IRGM
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.34877843680534626,1.145660823129059,0.2491544532130778,0.9250745773392323,1.0,9/151,5.03%,ROR2;ROR1;NTRK3;ACKR3;EGFR;RAP1A;PRKCA;PTPN22;PTPRC
prerank,acidic amino acid transport (GO:0015800),0.49251615492057826,1.145601195714085,0.3011647254575707,0.9240728748478403,1.0,7/17,12.83%,LRRC8D;SLC25A12;PRAF2;SLC6A13;SLC1A6;SLC25A13;SLC25A22
prerank,regulation of actin polymerization or depolymerization (GO:0008064),-0.35773114022399366,-1.1454915637308467,0.27181208053691275,0.7310084374570552,1.0,8/28,14.82%,ARHGAP28;ESAM;ARHGAP35;CXCL12;FCHSD2;HAX1;GBA2;DBN1
prerank,endomembrane system organization (GO:0010256),0.3403322385819113,1.145362952411044,0.22727272727272727,0.9236071181785896,1.0,50/178,18.27%,ATP8B3;USP50;HOOK2;ATP8B1;RAB29;PI4K2B;A4GALT;LMAN2;CAV2;EIF2AK3;PHETA2;DNM1;RAB30;USP8;SNX10;ATL2;GOLGB1;ATP8B2;SYNGR2;LYSMD3;SUN1;CSNK1A1;NPLOC4;TMED4;REEP3;LNPK;HOOK3;TRIP11;HTT;OTOF;LAPTM4B;ZW10;SEC23IP;FBXW8;TMED2;NUP93;TICAM2;PI4K2A;ATP8B4;TBC1D20;ANXA8L1;ANXA8;DYNC2H1;OSBPL2;ARHGEF7;ALS2;SPTBN1;LEMD2;VPS11;COG3
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),-0.4751201544099083,-1.1452973408386662,0.2882882882882883,0.7300832534157763,1.0,6/10,29.38%,BMP6;NEXMIF;NOTCH4;MAD2L2;NOTCH1;PPM1F
prerank,response to peptide hormone (GO:0043434),0.4054314969628828,1.1452340455224885,0.2772413793103448,0.9227949709737799,1.0,5/43,4.79%,CAV1;OGT;EIF2B3;SRC;SLC27A1
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.32218722969759056,1.1451114649748397,0.036,0.9220333154874759,1.0,275/1668,15.62%,PTCH1;EBF2;RORA;MEOX2;TENM2;ZBTB7C;DCN;KLF5;ETV4;ITGA6;CAV1;CDH13;NFATC2;ETV1;GLI1;PPARGC1A;PAX9;FOXD2;NR2F2;TSHZ3;NEDD4L;NR3C2;DLX1;POU4F3;RARB;FOXP2;FOXD1;CAMK2D;NFATC1;ZBTB32;KLF12;LDB2;ZSCAN25;PBX1;BHLHE22;EGFR;ZBTB20;NPAS3;NEUROD6;RUNX2;FGF1;JAG1;ETV5;TNIP3;OGT;NUFIP1;GLI2;NFIA;HIVEP2;ZSCAN18;HOXB6;TEF;IL4I1;KMT2A;ZKSCAN7;IRF2BP1;CRTC1;MAML2;CHD3;LMO7;TXK;SPI1;KLF3;LMO1;ZNF418;PHF21A;FOXK1;BEND3;FOXO3;FOXP4;NPAS2;UBE2I;BMPR1B;SOX9;ZBTB8A;PGR;REL;TFR2;CHD8;CREB3L1;SLC30A9;GLIS2;ZNF585B;ZNF585A;KAT6B;CSRP3;CHD2;BMP5;KLF10;HDAC4;SATB1;ZBTB3;WNT5A;CHD1;ATP2B4;POU5F2;DACT1;HEYL;PPM1A;N4BP2L2;BHLHE40;ZFP3;SP3;ZNF697;ATAD2;NRIP1;ZFP1;ZFP90;KANK2;CDK13;RPRD1B;MED18;TARBP1;ANXA4;ARID3A;ANKRD2;TEAD3;ONECUT1;RCOR3;ZFP14;NCK2;MED12L;SIN3B;CDK7;CTCF;TBX2;NRF1;NFE2L1;DDX17;PEX2;PAF1;NCOR1;HIC1;ZFP62;NCOA5;ZNF431;PIAS2;PAX3;HOXC10;ONECUT3;RREB1;MAFG;RARA;DBX2;SUV39H1;PKNOX2;MAPK7;RPAP2;USF2;LHX6;FOXK2;PIK3R2;E4F1;KCTD1;ISL1;MYPOP;TBX18;MED7;ZNF462;TNIP1;AATF;ZBTB6;DDRGK1;AGO1;MED13;PLSCR1;SLTM;TCF20;RPS6KA3;TET1;MECP2;SIRT7;HMGB1;SMARCD2;FOXJ1;BAZ2B;RORB;POU4F1;HDAC2;SUPT4H1;RPRD1A;DBP;LEFTY1;TLX3;TMF1;NCOR2;CTDSP1;RTRAF;TPR;TFEB;FHOD1;PAXBP1;FBXL19;MMP12;HEXIM1;RARG;WWC1;ZHX1;OTUD7B;SIX5;DVL3;EN2;HTATIP2;MZF1;EGR1;INO80;PHF20L1;MED23;ZBTB49;JMJD1C;ZNF148;MEN1;ERF;NFE2L2;STAT2;AKIRIN1;NCOA3;SEMA4D;PTEN;CREBBP;CD81;HOPX;KDM6B;PEG3;TTC21B;GTF2H1;PKD1;CRLF3;NUCKS1;ARID4A;NFATC4;TCERG1;NCOA2;CBFB;SOX4;GMEB1;BCL9;CAMTA2;DPF3;ZNF260;TIAL1;ZFP57;EPC2;DICER1;SFPQ;UBE2D1;UBE2D3;YAP1;ZNF182;KAT8;RAI1;DNAJA3;CAPRIN2;PPIL4;MED12;RIPPLY2;LCOR;FOXJ2;BRD8;FOXF1;POU6F1;AUTS2;TADA2A;ZMYM5;NR5A1;COPS5;BATF;WWP2;RUNX1;CCDC62;GPER1;KMT2D;MED8;TOX4;RELB
prerank,mitochondrion distribution (GO:0048311),-0.45357966238637476,-1.1450004747026816,0.2938388625592417,0.7295002353931795,1.0,3/12,14.26%,MEF2A;LRRK2;MAPT
prerank,negative regulation of protein metabolic process (GO:0051248),0.40506537840097095,1.1443033851367714,0.28493894165535955,0.9233155020762532,1.0,5/48,6.16%,INHBB;EGFR;FLOT2;IRAK3;AZIN2
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.47015606878068306,1.144204810231256,0.30269413629160064,0.9224154262688631,1.0,8/19,16.57%,EXTL3;XYLT2;GLCE;NDST1;HS3ST5;EXT1;HS6ST3;EXT2
prerank,T cell proliferation (GO:0042098),-0.4410466305605105,-1.1440057888294035,0.2927461139896373,0.7310253270541531,1.0,2/13,1.74%,MSN;CTPS1
prerank,regulation of cell adhesion (GO:0030155),0.35620313179493385,1.1436532733601725,0.2571756601607348,0.9231009589453307,1.0,14/129,6.50%,TGFBI;EFNA5;CDH13;RIPOR2;MINK1;PRKCA;SRC;DSCAM;PLXNA3;IBSP;RAC2;EPHB2;ADAM10;ABL2
prerank,anterior/posterior axis specification (GO:0009948),-0.4284872160676119,-1.1435183500202937,0.3134715025906736,0.7309856691370142,1.0,2/15,2.81%,WLS;TBX3
prerank,positive regulation of innate immune response (GO:0045089),0.43448155460706595,1.1434613459441862,0.2972972972972973,0.9225278957691744,1.0,6/30,11.87%,LBP;SPI1;WNT5A;POLR3G;PLSCR1;POLR3D
prerank,hydrogen peroxide catabolic process (GO:0042744),0.5432223121145078,1.14344633718859,0.3333333333333333,0.9213921869885245,1.0,1/11,0.87%,PXDN
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.39407390288618477,1.1434381414781642,0.2727272727272727,0.9202225390947748,1.0,14/48,18.91%,BCL3;MSH6;PHLDA3;CIDEB;HIPK1;HIC1;MCL1;MSH2;SFN;CDIP1;HTRA2;E2F1;DYRK2;BAX
prerank,positive regulation of lipid biosynthetic process (GO:0046889),0.44074994534394585,1.1433926839520727,0.30597014925373134,0.9191566816697643,1.0,5/29,4.79%,SORBS1;ZBTB20;ELOVL5;GPLD1;SLC27A1
prerank,regulation of neutrophil migration (GO:1902622),0.5298776692641686,1.143223612307377,0.2982142857142857,0.9185279379134524,1.0,2/10,4.75%,MPP1;RAC2
prerank,activin receptor signaling pathway (GO:0032924),0.49828491995329793,1.1431361748240303,0.31100478468899523,0.9176018444712107,1.0,2/15,4.92%,INHBB;ACVR1C
prerank,positive regulation of calcium ion transport (GO:0051928),-0.34304356690703197,-1.1430660179667258,0.2619047619047619,0.7309100497292801,1.0,9/36,9.29%,PDGFRB;ANK2;MYLK;TRPC3;CACNB2;ORAI1;CXCL12;CAMK2A;GRIN1
prerank,respiratory electron transport chain (GO:0022904),0.5046669391372001,1.142720863166892,0.3014827018121911,0.9178468440499022,1.0,4/14,12.83%,PPARGC1A;SLC25A12;SLC25A13;SLC25A22
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),-0.36150017575598287,-1.142674071902008,0.24233983286908078,0.7306139366604473,1.0,5/25,20.64%,IGF1;TRAF6;H1-0;PER2;MAD2L2
prerank,regulation of carbohydrate catabolic process (GO:0043470),-0.32299739929774507,-1.1422815792277994,0.2332155477031802,0.7303077678219381,1.0,8/41,7.39%,PRKAG2;NUP107;EP300;HIF1A;AAAS;SEH1L;NUP133;PGAM1
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.3621526009717744,1.1422267377564406,0.2653061224489796,0.9183710848837655,1.0,13/87,14.11%,FGF7;FGFR1;FGF1;RBFOX2;SPRED1;KIF16B;FGF18;HNRNPM;GTF2F2;FLRT2;SPRED2;ZFP36L2;TIAL1
prerank,response to fatty acid (GO:0070542),0.4773918822655972,1.1417962223544793,0.2962328767123288,0.9185558651817793,1.0,7/17,17.61%,FOXO3;SOX9;PDK4;GLDC;KCNK4;LPL;SCD
prerank,glutamate metabolic process (GO:0006536),0.46372990667071856,1.1414298824013869,0.2969004893964111,0.9185719443927336,1.0,7/19,15.53%,PRODH;AADAT;ALDH18A1;ALDH5A1;GOT1;GLUL;GGT1
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.4855853631019825,1.1414036286812808,0.3101160862354892,0.9174582048733524,1.0,2/17,1.74%,EGFR;CCND3
prerank,PERK-mediated unfolded protein response (GO:0036499),0.5438179857416872,1.1410223641034292,0.3344887348353553,0.917512134768284,1.0,5/10,24.09%,EIF2AK3;NFE2L2;QRICH1;DDIT3;HSPA5
prerank,regulated exocytosis (GO:0045055),-0.24736396857089704,-1.1407288487691016,0.16129032258064516,0.7333127562304734,1.0,54/173,23.76%,IGF1;TIMP3;VWF;ACTN2;ABCC4;PECAM1;PCDH7;CLEC3B;LYN;SPARC;CDC37L1;IGF2;NHLRC2;SYT9;SYT7;CALM1;PROS1;TGFB3;ARHGAP17;VEGFC;CYRIB;QSOX1;SYTL4;PHACTR2;FLNA;MANF;VEGFD;THBS1;TGFB2;TMSB4X;VAMP7;F5;LGALS3BP;TLN1;DNAJC5;CPLX2;RAB11FIP1;EGF;RAB11B;FAM3C;RARRES2;MYH9;SYT13;TUBA4A;RIMS1;SNAP25;SYT6;CLU;VTI1B;A2M;RIMS3;RAB10;TAGLN2;PCYOX1L
prerank,signal transduction by p53 class mediator (GO:0072331),0.43112599181688877,1.1402834367855623,0.29656160458452724,0.9186903624645748,1.0,6/30,9.95%,BCL3;MYBBP1A;PPP1R13B;FHIT;NBN;POU4F1
prerank,negative regulation of blood coagulation (GO:0030195),-0.32457711972971404,-1.1400009055429345,0.23104693140794225,0.7341109965407193,1.0,8/38,6.72%,PDGFRA;TFPI;NOS3;THBD;F3;CD34;SERPINE2;APOE
prerank,cellular response to lipopolysaccharide (GO:0071222),0.3681197717534402,1.1399813822458265,0.27014218009478674,0.9184648521738233,1.0,16/101,9.91%,LBP;PRKCE;TNIP3;IL1A;PTPN22;WNT5A;TNFAIP3;SELENOS;PAF1;DEFA6;ACOD1;IRGM;CHMP5;HMGB1;TICAM1;AXL
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.39980167242828274,1.1399253956280966,0.2946666666666667,0.9174647708707369,1.0,23/52,25.25%,FXR2;RBFOX2;RBM8A;CELF1;RBM15B;DDX17;RBM5;CELF2;CELF4;KHDRBS2;NSRP1;FXR1;TRA2B;MBNL2;SAP18;SRSF12;YTHDC1;ZBTB7A;RBMX;PUF60;REST;FMR1;THRAP3
prerank,positive regulation of developmental process (GO:0051094),0.34180926126621924,1.1398534112034022,0.2408839779005525,0.9165059649540627,1.0,24/164,9.58%,DCN;FGFR1;DLX1;COBL;FOXD1;RAPGEF3;DDHD1;BMPR1B;SOX9;SRC;BMP5;KMT5C;WNT5A;FIS1;TMEM79;LLPH;DAG1;FBXO5;RREB1;ISL1;MIEF1;CDC20;RPS6KA3;PHLDB1
prerank,response to insulin (GO:0032868),0.3685243862681039,1.1397597476611898,0.2783882783882784,0.9156063966839784,1.0,12/80,8.08%,INHBB;SORBS1;OTOP1;CEACAM1;RAB8B;OGT;GPLD1;SLC27A1;FER;SELENOS;SYAP1;PIK3R2
prerank,embryonic organ morphogenesis (GO:0048562),0.4092641246462856,1.1395765672168436,0.29902642559109877,0.915021620887173,1.0,4/42,3.83%,ALDH1A3;EFEMP1;MFAP5;DYNC2I1
prerank,alcohol catabolic process (GO:0046164),0.5236255094806925,1.1392773947548316,0.3253012048192771,0.9148167036965613,1.0,1/10,1.38%,CEL
prerank,negative regulation of organelle assembly (GO:1902116),-0.33254381952484635,-1.139256972347185,0.23853211009174313,0.7347697166236009,1.0,18/35,26.08%,NUPR1;TBC1D30;EVI5L;LRRK2;CEP97;TCHP;TRIM37;FEZ2;SCFD1;SMAD4;KAT2B;KAT2A;TESK1;STYXL1;SEC22B;NBDY;BRCA1;CDK5RAP2
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),-0.41421860916728725,-1.139140233534771,0.2807486631016043,0.7336636133212854,1.0,5/17,8.98%,ANK2;SLC8A1;KCNJ2;CACNB2;CACNA1G
prerank,cation transport (GO:0006812),0.3448901099814418,1.1389581310108137,0.24092409240924093,0.9146676681078416,1.0,26/167,12.33%,PIEZO2;NEDD4L;KCNJ4;TRPM3;KCNA5;SLC12A2;SLC8B1;KCNJ16;ANO6;SLC29A4;KCNS2;SLC12A3;KCNK1;SLC22A3;CNGB1;ATP1A2;KCNJ13;SLC4A4;SLC4A11;PIEZO1;KCNK5;KCNS3;KCNAB1;PANX2;SGK1;ANO10
prerank,interleukin-12-mediated signaling pathway (GO:0035722),-0.3240885715431819,-1.1386157413979874,0.25357142857142856,0.7337128511200243,1.0,8/46,9.11%,PLCB1;MSN;CDC42;CFL1;ANXA2;RPLP0;JAK2;CNN2
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),-0.45913370998116765,-1.1384382429243973,0.3144208037825059,0.7327865219431066,1.0,11/12,54.12%,ZBTB1;CCR2;SLC11A1;PRKCQ;IL12RB1;CARD9;IL23A;IL12B;IL23R;CLEC6A;IL1B
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),-0.3498525662964736,-1.1383742195506175,0.24299065420560748,0.7315378944169593,1.0,8/33,10.15%,TEK;ANGPT1;NUPR1;NDNF;KDR;GATA2;RAMP2;SCG2
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.5177418109480683,1.1378111413581986,0.32300163132137033,0.9172449306094058,1.0,6/12,12.85%,ELOVL5;ELOVL1;ELOVL2;HSD17B4;ACOT8;ABCD1
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.3553374496399792,1.137810699417928,0.27602905569007263,0.9160776661023957,1.0,14/100,11.15%,TRIB2;PRICKLE1;GLMN;SOCS5;OGT;SH3RF2;FHIT;KEAP1;N4BP1;DDRGK1;GSK3B;CSNK1A1;RCHY1;ZYG11B
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.4105371534555035,1.1371608507955182,0.3062937062937063,0.9168974611282326,1.0,12/40,14.64%,FXR2;NPAS2;WDR76;UBE2V2;MCL1;FBXO5;SIRT7;ARMT1;RFWD3;ETAA1;FXR1;NEK4
prerank,positive regulation of blood coagulation (GO:0030194),0.4811325256495076,1.1370151226037906,0.30658105939004815,0.9162197173286503,1.0,2/17,2.63%,ST3GAL4;ANO6
prerank,endothelial cell proliferation (GO:0001935),-0.42297785014746947,-1.136749649273307,0.3047091412742382,0.7350300970354464,1.0,5/17,6.25%,TEK;BMP4;ACVRL1;BMPR2;CD34
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.4596252724360431,1.1366303610080277,0.30793650793650795,0.9162755250046949,1.0,1/23,1.15%,MBOAT2
prerank,negative regulation of programmed necrotic cell death (GO:0062099),-0.46524799052846866,-1.1364076908381435,0.33254716981132076,0.7346654421401266,1.0,2/11,2.47%,ARHGEF2;NUPR1
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),-0.2741969623114461,-1.1363589830754703,0.1797752808988764,0.7333565565436163,1.0,22/95,12.84%,ENG;ZEB2;SMAD3;SMAD6;DAB2;TGFBR3;LATS2;FKBP1A;SKIL;TGFBR1;EP300;ITGA3;PRDM16;LEMD3;ASPN;VASN;CITED2;SLC2A10;SNW1;HTRA3;DAND5;THBS1
prerank,iron-sulfur cluster assembly (GO:0016226),-0.3731742952734358,-1.1362360449293534,0.27728613569321536,0.7323124063864404,1.0,10/24,23.13%,CIAPIN1;NFS1;NFU1;MMS19;CIAO3;FXN;ISCA2;GLRX5;BOLA2;ISCU
prerank,response to lipid (GO:0033993),-0.2659267828167708,-1.1361045343185492,0.16326530612244897,0.7313140615327833,1.0,24/105,13.49%,CTSH;ACER2;SMAD6;NOS3;FOXP1;PAQR7;PPARD;RBP4;FOXO1;ERBIN;ALPL;GCH1;JAK2;ANXA1;TRIM16;TRIB1;ESR1;FGFR4;NOCT;MAPKAPK2;ABCA2;TNFRSF11A;MAPKAPK3;GATA6
prerank,cellular response to amino acid stimulus (GO:0071230),-0.3429447382424216,-1.1361042095990666,0.26101694915254237,0.7298857137563521,1.0,14/33,23.92%,UBR1;CPEB4;LAMTOR3;RRAGC;GLRA2;SPAAR;RRAGD;CASTOR2;CPEB1;CASTOR1;LAMTOR2;XBP1;SLC38A9;NSMF
prerank,epiboly involved in wound healing (GO:0090505),-0.4205053195246579,-1.1356718957516128,0.2924281984334204,0.7296789933375983,1.0,7/16,9.92%,DDR1;PDCD10;ARHGAP35;TMEFF2;RHOC;FLNA;CCN1
prerank,negative regulation of vascular permeability (GO:0043116),-0.45598270191295476,-1.1355564655828,0.3131067961165049,0.7286151972410736,1.0,6/12,9.13%,ANGPT1;CLDN5;SLIT2;DDAH1;RAMP2;PDE2A
prerank,response to tumor necrosis factor (GO:0034612),-0.2734837764030225,-1.1352650508029014,0.18354430379746836,0.7280348380790505,1.0,34/91,25.74%,PID1;ARHGEF2;YTHDC2;CXCL16;GSDME;ERBIN;TNFRSF21;ZFAND6;GBP3;CASP3;IGBP1;GCH1;JAK2;AKT1;ZC3H12A;RPS3;BAG4;CCL13;TNFRSF11A;SPHK1;IKBKB;GBP2;ZFP36;CASP8;CACTIN;CD40;CCL19;RIPK1;NPNT;BRCA1;CIB1;SMPD4;GGT5;PYCARD
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),-0.3808552587440128,-1.1351656196248303,0.27696793002915454,0.726904420610528,1.0,11/20,24.87%,RBPJ;SMAD9;EP300;SMAD5;HIF1A;BMP2;SMAD4;ATF4;XBP1;SMAD1;NOTCH1
prerank,actin filament bundle assembly (GO:0051017),-0.3527706046895503,-1.1351537592632228,0.2523364485981308,0.7255287992062087,1.0,5/33,5.58%,EPS8;NEDD9;MYO1B;PAWR;PLS3
prerank,brain development (GO:0007420),0.34733339209967823,1.1347019051569145,0.255125284738041,0.9213507803485269,1.0,11/136,8.35%,PTCH1;APOD;PBX1;NF1;CHD8;SHROOM2;AMIGO2;COL4A1;PAFAH1B1;CDH2;EML1
prerank,engulfment of apoptotic cell (GO:0043652),0.49383105814098444,1.1344506963126266,0.33678756476683935,0.921015878027516,1.0,4/15,8.31%,XKR7;XKR4;RAC2;XKR8
prerank,cellular response to oxidative stress (GO:0034599),0.35736587010384024,1.134386858016849,0.2663605051664753,0.9200587895768312,1.0,16/118,7.25%,PPARGC1A;PXN;EGFR;GPX8;MGAT3;ETV5;FOXO3;ERO1A;WNT16;MPV17;KEAP1;FANCC;ANKRD2;FER;SELENOS;SLC4A11
prerank,protein localization to endoplasmic reticulum (GO:0070972),-0.4099188366003971,-1.1341277551409552,0.2849740932642487,0.7269656827290518,1.0,8/16,30.20%,ANK2;SEC16A;SEC16B;LRRK2;TAPT1;BCAP31;PPP1R15A;RYR2
prerank,cellular component maintenance (GO:0043954),0.5119288584427042,1.1339426082801483,0.33049403747870526,0.9203343333635848,1.0,1/12,0.19%,CLDN1
prerank,positive regulation of hydrolase activity (GO:0051345),0.3529319942219939,1.1331953220659579,0.2823397075365579,0.9215502865536126,1.0,23/137,12.50%,ITGA6;DOCK9;F11R;RGS6;RAPGEF3;RAP1A;ARAP1;SGSM2;NF1;RTN4R;CAV2;ZC3H15;RAPGEF6;GSK3B;PKP4;TBC1D2;FERMT2;FNTA;RIC1;PLXNB1;DVL3;SEMA4D;MAPRE2
prerank,lipid transport (GO:0006869),-0.2673470016268279,-1.13318832563028,0.1986754966887417,0.7282738024823439,1.0,23/97,13.94%,OSBPL8;SLCO3A1;ACSL1;PLTP;CHKA;ABCC4;PITPNB;PPARD;SLCO1C1;LDLR;ABCA4;SPNS2;APOE;TNFAIP8L3;SLCO2A1;ABCA9;OSBPL5;SCP2;ABCD2;MFSD2A;ABCA2;PRELID2;PRELID3A
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.35964411832428306,1.1330749348403182,0.28487690504103164,0.9207563547259847,1.0,15/102,8.96%,CAV1;INHBB;SORBS1;OTOP1;CEACAM1;RAB8B;GPLD1;SRC;ADCY5;FER;SELENOS;SYAP1;PIK3R2;PRKAR2A;TSHR
prerank,mitotic recombination (GO:0006312),0.48833581979481433,1.1326776197839623,0.31896551724137934,0.920839152215681,1.0,4/15,13.12%,SMC5;ERCC1;TEP1;GEN1
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),-0.4661154238330889,-1.1323904236773232,0.32407407407407407,0.729371908219433,1.0,6/10,23.35%,PDE8A;GPR37;LRRK2;GPR37L1;RIPK1;STK26
prerank,defense response to protozoan (GO:0042832),-0.4496424770535792,-1.1316948356125112,0.2864450127877238,0.7299403269977135,1.0,8/12,33.57%,GBP4;GBP6;GBP7;GBP2;CD40;MYD88;SLC11A1;BATF2
prerank,thyroid hormone generation (GO:0006590),-0.480182769192401,-1.1310925622446792,0.30238095238095236,0.7303539572290869,1.0,6/10,41.09%,CPQ;DIO2;FOXE1;TG;CTSK;TPO
prerank,phosphatidylcholine metabolic process (GO:0046470),-0.29685478328089726,-1.1310876515868167,0.23076923076923078,0.728966068293974,1.0,15/70,13.14%,CHKA;ENPP2;GPAT4;CHPT1;NR1H3;LPIN2;DBI;PCYT1A;SLC44A5;NR1H2;ABHD3;CEPT1;LPIN3;MFSD2A;CSNK2A1
prerank,cardiac muscle cell development (GO:0055013),-0.3895079294918411,-1.1310617999676513,0.28125,0.7276669851002332,1.0,7/20,8.32%,SORBS2;PDGFRB;PDGFRA;SLC8A1;OBSL1;MYH11;PDLIM5
prerank,metal ion export (GO:0070839),0.42905665614731625,1.130627244694029,0.3127690100430416,0.9262842862789851,1.0,6/31,9.89%,KCNA5;ATP2B4;ATP1A2;SLC4A4;KCNK5;ATP1B3
prerank,cytosolic calcium ion transport (GO:0060401),-0.34965149153276437,-1.1305390485777809,0.2648809523809524,0.727834670894308,1.0,10/28,15.46%,SLC8A1;SLC35G1;JPH1;SMDT1;SLC25A23;MICU1;MICU2;ATP2B3;JPH2;JPH4
prerank,cellular respiration (GO:0045333),0.4049286427735662,1.1304188334072038,0.29444444444444445,0.9258137177577052,1.0,5/41,7.30%,PPARGC1A;SDHAF4;LYRM7;SIRT3;COX15
prerank,regulation of cation channel activity (GO:2001257),0.3650399620113714,1.1303093913202378,0.28150765606595995,0.924974732633918,1.0,8/89,4.32%,AHNAK;SLMAP;CAMK2D;MINK1;GRIA3;PDE4D;FKBP1B;KCNS2
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.3715969734907574,-1.1301183969208692,0.27635327635327633,0.7277478800999856,1.0,12/24,25.94%,B2M;ACE;TAP2;SEC23A;SAR1B;HFE;ERAP1;TAPBPL;SEC31A;MFSD6;PDIA3;TAP1
prerank,supramolecular fiber organization (GO:0097435),0.32527170433907693,1.1298547914285006,0.23076923076923078,0.9253608231086501,1.0,35/333,7.80%,ITGB4;TGFBI;ITGA6;ADAMTS14;TNXB;PXDN;UBE2L6;ARHGAP12;HOOK2;KIF2A;COL6A3;BFSP1;NCKAP5L;COL5A3;NF1;TRPV4;FIGNL2;APH1B;TMOD2;RAC2;SERPINH1;LTBP3;LTBP2;COL3A1;NCSTN;SHROOM2;ADAM10;POF1B;SPAST;COL4A1;CKAP5;ADAMTS2;SIAH1;CGNL1;TMOD1
prerank,mRNA catabolic process (GO:0006402),0.3959142694078777,1.1297771046773497,0.28473177441540576,0.924459718949285,1.0,8/44,13.81%,DHX34;CNOT10;DXO;DIS3L2;AGO1;EXOSC10;ZFP36L2;ERN1
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.43452122567627766,1.1297461778114508,0.30139103554868624,0.9233926402151199,1.0,5/26,7.01%,EGFR;CCND3;ADAMTS1;UBE2E2;RDX
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.5089208040296924,1.1296321257854727,0.3200663349917081,0.9225925814235199,1.0,2/12,4.87%,B3GALT1;B4GAT1
prerank,heart process (GO:0003015),0.5091018178584188,1.1296265858511623,0.33503401360544216,0.9214600777062943,1.0,2/14,3.92%,SGCD;SGCG
prerank,positive regulation of dendrite morphogenesis (GO:0050775),-0.394048901765257,-1.1291296099958064,0.31339031339031337,0.7292667248022322,1.0,8/19,17.70%,CUX1;OBSL1;CUX2;LRP8;CDKL5;PTPRD;DBN1;DHX36
prerank,nucleotide metabolic process (GO:0009117),0.44843230535491374,1.129027325475755,0.31790123456790126,0.9222290404443044,1.0,9/23,20.25%,AK5;RNASEH2B;FHIT;NMNAT3;REXO2;CTPS2;DCK;AK7;NUDT5
prerank,negative regulation of peptidase activity (GO:0010466),-0.30878954026113636,-1.1283204242032443,0.23297491039426524,0.7302506860978955,1.0,10/47,10.91%,TIMP3;SPOCK2;LRP1;SERPIND1;SERPINI1;SPOCK1;SERPINE2;AKT1;SERPINB9;GAPDH
prerank,negative regulation of endothelial cell migration (GO:0010596),0.41455641343391925,1.1280291216081542,0.2846820809248555,0.9244393806461317,1.0,5/36,9.55%,DCN;NR2F2;ATP2B4;MECP2;HMGB1
prerank,positive regulation of protein secretion (GO:0050714),-0.296480120075817,-1.1280037879547162,0.18666666666666668,0.7297441036080988,1.0,13/69,13.15%,IGF1;MYRIP;BMP6;WLS;RBP4;C1QTNF3;TGFB3;NNAT;MYH10;SYTL4;LRRC8A;TGFB2;MYO18A
prerank,regulation of cation transmembrane transport (GO:1904062),0.4386811874038573,1.1279522380600266,0.31791044776119404,0.9235449585895111,1.0,8/29,21.47%,SLMAP;KCNIP4;ATP2B4;KCNAB1;FGF12;KCNIP1;CD63;SNTA1
prerank,carbohydrate homeostasis (GO:0033500),-0.2890419657386346,-1.1276886308890268,0.2081447963800905,0.7292267307385514,1.0,7/67,3.74%,IGF1R;INSR;KCNB1;ADIPOR2;RBP4;APPL2;MBD5
prerank,ion transport (GO:0006811),0.35981393545825296,1.1275579143877568,0.281068524970964,0.9235798663639889,1.0,20/111,12.83%,VDAC2;PIEZO2;TRPM3;SLC12A2;SLC8B1;SLC26A9;ANO6;SLC24A1;SLC12A4;SLC1A7;SLC12A3;CNGB1;SLC1A6;PIEZO1;SLC9A7;SLC9A6;PANX2;ANO10;SLC25A26;SLC25A22
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.3964913091595031,1.1272876890129961,0.2959459459459459,0.9232986465247068,1.0,6/47,7.66%,EFNA5;DOCK5;DOCK1;SPRY4;RREB1;KANK1
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),-0.3050684710716628,-1.1270419444655528,0.22134387351778656,0.7296896325541985,1.0,21/54,19.37%,ETS1;ANGPT1;NOS3;AKT3;ACVRL1;PRCP;HIF1A;KDR;APOE;AKT1;GATA2;SP1;THBS1;TMSB4X;MAP2K3;P2RX4;CSNK2B;ANGPT2;HSPB1;VASH1;CD40
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.5120215949509982,1.126529564180904,0.3220910623946037,0.9244798984541157,1.0,5/12,21.47%,PPARGC1A;ABCD1;IRS2;AKT2;TWIST1
prerank,positive regulation of protein modification process (GO:0031401),0.33119569677909627,1.1264715881123049,0.26695371367061355,0.9235386570095092,1.0,23/203,8.76%,EFNA5;FGF7;DLC1;NTRK3;CLDN19;LEPR;EGFR;CCND3;MUSK;RAPGEF3;PELI2;FGF1;AXIN1;CDH5;FXR2;SOX9;LIMK2;RAB3GAP2;KRAS;NOS1AP;DYRK1A;FGF18;IRGM
prerank,mitotic spindle organization (GO:0007052),0.3415457718354729,1.1255546550454412,0.2839506172839506,0.9253371490591921,1.0,49/153,22.72%,PLK2;DYNLL1;KIF2A;STIL;SMC3;SPAST;TUBG1;CKAP5;DSN1;PAFAH1B1;EML1;CDC20;NUP160;MECP2;NUP37;DYNLL2;MAP4;RANBP2;BUB3;WDR62;MAP9;NDE1;AHCTF1;PTPA;TUBG2;ZWILCH;ZW10;CENPU;ARHGEF10;RAN;B9D2;PIBF1;TBCE;CENPH;CENPK;MAD1L1;RHOA;OFD1;DCTN2;CENPL;DYNC1LI2;GPSM2;NEK6;NUP43;DYNC1I1;PRC1;MIS12;DCTN6;SEC13
prerank,regulation of postsynapse organization (GO:0099175),0.4362016507260841,1.124942956097089,0.32628398791540786,0.9262817554289763,1.0,5/28,7.60%,SIPA1L1;PPFIA2;LZTS3;WNT5A;SRCIN1
prerank,receptor clustering (GO:0043113),0.44453574100233073,1.1247080012747708,0.3317972350230415,0.9258702892561232,1.0,4/27,9.94%,LRP4;MUSK;ITGB7;DLG3
prerank,positive regulation of viral transcription (GO:0050434),0.4423737037491881,1.124602829377904,0.3141524105754277,0.9250593018185124,1.0,4/25,12.03%,MDFIC;NELFB;SUPT4H1;GTF2F2
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),-0.38053079813552226,-1.124336686433141,0.30422535211267604,0.7361088414899642,1.0,6/23,16.57%,IGF1;AKAP6;PROX1;EDN1;MYOCD;ATP11A
prerank,synapse organization (GO:0050808),0.3449435108315933,1.1242545718689487,0.286697247706422,0.9249995138703557,1.0,9/125,2.71%,NTNG1;LRP4;PDZRN3;PTPRF;MUSK;GPC6;PPFIA2;ZC4H2;RAB29
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.4627007452683434,1.1239338357219404,0.3232169954476479,0.9249237056763717,1.0,9/21,17.80%,FBXO5;TEX14;CDC20;TPR;APC;BUB3;KLHL22;ZW10;MAD1L1
prerank,positive regulation of interleukin-17 production (GO:0032740),-0.37946618225647843,-1.1238790541040766,0.3107344632768362,0.7361192363432043,1.0,11/22,37.91%,SLC7A5;IL18;RFTN1;SPHK1;NOD2;NR1H4;MYD88;PRKCQ;TGFB1;LY9;SLAMF6
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.3732494029713847,1.1235000442027567,0.2989949748743719,0.9251468025025578,1.0,2/69,0.60%,NGF;PPARGC1A
prerank,regulation of protein secretion (GO:0050708),0.35237803593882294,1.1231013807260837,0.2799539170506912,0.9252633747401703,1.0,17/119,10.61%,ITPR2;ITPR3;KCNA5;SLC12A2;SLC8B1;RAPGEF3;RAP1A;STX1A;IL1A;PRKCA;FRMD4A;RAPGEF4;SLC2A2;ARF6;DPP4;KCNS3;ADRA2A
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),0.4914664919293475,1.1230188407327995,0.33444816053511706,0.9243798426804105,1.0,4/15,7.67%,GPC3;SPEF1;DACT1;ZNRF3
prerank,mRNA processing (GO:0006397),0.3264308997643861,1.1227845067892064,0.23949579831932774,0.9240500514929103,1.0,70/287,19.87%,DHX8;PPARGC1A;HNRNPC;CSTF1;SF3B2;SF3B1;PCBP2;RBM8A;RBM10;RNPC3;CELF1;SRSF4;HNRNPA0;ZRSR2;SNRPF;RBM15B;SON;RPRD1B;HNRNPR;SF3B5;PPIE;CDK7;PRPF3;CHERP;CSTF3;DDX46;RBM22;RBM5;DNAJC8;ELAVL2;SNU13;SUPT4H1;RPRD1A;HNRNPM;DBR1;UPF3B;GTF2F2;SRRM2;GTF2H1;TCERG1;THOC3;ERN1;SNRPA1;DDX42;SFPQ;TRA2B;DHX16;SF1;SUGP1;PDCD7;SYNCRIP;CTNNBL1;SRRT;THOC5;PSPC1;CMTR1;PRMT9;SLU7;CWC22;SYMPK;GTF2H3;PLRG1;SRSF3;MTREX;LSM3;DHX38;HNRNPD;DHX9;SRSF12;UBL5
prerank,response to hexose (GO:0009746),0.4338063561305521,1.1223702099977826,0.327217125382263,0.9242341024217231,1.0,8/25,21.67%,GPLD1;EIF2B3;SELENOS;EIF2B4;LPL;IRS2;TCF7L2;VAMP2
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),-0.47138445874453677,-1.122216096638913,0.34192037470725994,0.7397078409596357,1.0,5/11,30.15%,TIMM8B;TIMM10B;ROMO1;TIMM29;TIMM10
prerank,calcium ion homeostasis (GO:0055074),0.3585106536321588,1.1213881387797926,0.296028880866426,0.9263469980645613,1.0,9/95,4.86%,CAV1;STC2;CTRC;SLC8B1;CDH5;SLC24A1;TRPV4;CSRP3;ATP2B4
prerank,B cell activation involved in immune response (GO:0002312),0.506818434981703,1.1209497170510423,0.3226890756302521,0.9266297111969606,1.0,4/13,15.34%,MSH6;MSH2;GPR183;BATF
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.4195894340254623,1.1207655387957935,0.32791728212703103,0.9261101032814948,1.0,8/33,17.12%,CEACAM1;RAB29;DGKZ;PTPN22;PTPRJ;CD81;SH2D1A;EZR
prerank,MAPK cascade (GO:0000165),-0.23710408576321546,-1.120333644678017,0.15789473684210525,0.7435850294652396,1.0,44/295,9.29%,IGF1;KSR1;RAPGEF2;TEK;TGFA;PDGFRB;PTPN3;ACTN2;SHANK3;MAP3K20;ANGPT1;PDGFRA;IL31RA;CTSH;NRK;RASGRP3;PIK3R1;KL;PSMA1;KIT;BRAP;FGFR2;IL18;NEFL;FRS2;RBX1;LAMTOR3;RASGRF1;FLT3LG;GRIN2B;KDR;LYPLA1;CALM1;MEF2A;PSMD11;RASGRF2;MAPK12;JAK2;MAP2K2;RGL2;PSMD7;CAMK2A;PSMD4;GRIN1
prerank,regulation of histone deacetylation (GO:0031063),0.5003350639371753,1.12017595076977,0.3322314049586777,0.9268961164235876,1.0,3/13,15.83%,CAMK2D;PRMT6;SAP30BP
prerank,anion transport (GO:0006820),0.4157290863559639,1.120126619365032,0.319364161849711,0.9259416623034132,1.0,4/33,4.98%,VDAC2;LRRC8D;SLC26A9;SLC22A3
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.33696244364009786,1.1200519816779082,0.2645739910313901,0.9250293957884008,1.0,27/166,13.69%,RORA;PPARGC1A;NR3C2;RARB;MAML2;PGR;TAF10;CAVIN1;TAF4B;TEAD3;POLR1E;CDK7;NCOR1;RARA;MED7;RORB;NRBF2;NCOR2;TFB2M;RARG;MED23;GTF2F2;NAT14;CREBBP;TAF15;GTF2H1;BRF2
prerank,response to organophosphorus (GO:0046683),-0.41434612291235734,-1.1196025560478275,0.30526315789473685,0.7442554619728601,1.0,5/16,16.03%,TRPC3;ABCC9;TRIM16;P2RX7;P2RX4
prerank,organelle disassembly (GO:1903008),-0.3380705572251615,-1.119599173202402,0.2764505119453925,0.7428799584220843,1.0,9/33,13.98%,UBA5;KLC1;ULK2;UFM1;VCP;EIF2D;GOLGA2;MTIF2;PLK5
prerank,cellular response to thyroid hormone stimulus (GO:0097067),-0.4435988218124219,-1.1193870569719075,0.3356643356643357,0.7421060276685192,1.0,3/12,6.67%,CTSH;LMO2;CTSL
prerank,granulocyte differentiation (GO:0030851),-0.38948835467269494,-1.1192511127212519,0.3268765133171913,0.7411351299419431,1.0,6/18,13.54%,LEF1;CBFA2T3;EP300;DEK;CDK4;TAL1
prerank,aspartate family amino acid catabolic process (GO:0009068),0.4711393811857764,1.11889771113941,0.3515625,0.9276153749500592,1.0,6/19,14.03%,AADAT;OGDH;GCDH;DLST;GOT1;HYKK
prerank,mitotic DNA replication (GO:1902969),-0.4705482319278381,-1.1188794752323468,0.35147392290249435,0.7408555793451952,1.0,7/10,33.47%,MCM6;POLA1;MCMDC2;CDC45;GINS1;MCM3;MCM2
prerank,pulmonary valve development (GO:0003177),0.46378183634660475,1.1186820151265635,0.32211538461538464,0.9272125148380717,1.0,4/18,5.11%,STRA6;NFATC1;JAG1;HEYL
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),-0.36380419056012614,-1.1185518404408774,0.3092485549132948,0.7404318851778483,1.0,3/24,4.89%,GRB10;TMEM204;HIF1A
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.3591173960692941,-1.1184112858286341,0.28735632183908044,0.7394715203787842,1.0,13/27,34.48%,ETS1;SIRPA;TRAF6;CYRIB;SKAP1;NR4A3;ITGB2;PYCARD;HAS2;CCR2;HSPD1;CCL2;PRKCQ
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.4628938198117998,1.1184061018930944,0.34520123839009287,0.9269707016872222,1.0,5/21,9.65%,ADAM19;NCSTN;ADAM10;DAG1;BACE2
prerank,inorganic anion transport (GO:0015698),-0.3023561200056492,-1.118359615162016,0.25882352941176473,0.7382729335498341,1.0,10/53,9.18%,SLC26A7;SLC4A10;ENPP1;ANO1;CLIC4;ANO4;ENPP3;CLIC5;SLC25A30;SLC25A11
prerank,regulation of glycogen biosynthetic process (GO:0005979),-0.3734722651190119,-1.1181433671394936,0.2953216374269006,0.7375490079176912,1.0,8/24,12.53%,IGF1;INSR;ENPP1;IGF2;AKT1;PPP1R3B;GSK3A;PPP1R3C
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.36996715730115365,1.1178628854849355,0.3119383825417201,0.927615066817961,1.0,11/67,8.08%,PXN;SH2D2A;SULF1;CYFIP2;DOCK1;NRP2;VAV2;SRC;NCK2;SHB;PIK3R2
prerank,positive regulation of cation transmembrane transport (GO:1904064),-0.32314702851288307,-1.1178397131714237,0.2635135135135135,0.7370397886864898,1.0,10/41,10.17%,ANK2;ACTN2;KCNJ6;KCNJ2;KCNMA1;AKAP6;KCNJ10;FLNA;ANK3;KCNN2
prerank,negative regulation of interleukin-6 production (GO:0032715),0.431267740803085,1.117813815374203,0.31462333825701627,0.9266575711514821,1.0,7/27,14.13%,PTPN22;IRAK3;TNFAIP3;SELENOS;CD200R1;FOXJ1;PTPN6
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.41629693965049724,1.1175918486435004,0.31213872832369943,0.9262476145338377,1.0,11/29,19.19%,AXIN1;KANK2;ISL1;DDRGK1;UFSP2;CBFB;YAP1;RUNX1;KMT2D;VPS11;CNOT1
prerank,acute inflammatory response (GO:0002526),0.44993320281327337,1.1175095067711587,0.3124042879019908,0.9253946110563251,1.0,4/23,13.26%,LBP;ANO6;PLSCR1;CTNNBIP1
prerank,protein-containing complex disassembly (GO:0032984),0.38683850340033593,1.1171236465865317,0.32114882506527415,0.9255118986726519,1.0,16/54,19.08%,CAV1;FZD2;AXIN1;TSG101;GSK3B;CSNK1A1;DVL3;APC;VAMP8;LIX1;PYM1;UBQLN1;PPP1CA;LAMP2;SNAP29;MAP1LC3B
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),-0.4002219757272794,-1.1168635260526691,0.3088235294117647,0.7385319159417348,1.0,5/16,5.76%,IGF1;TGFBR3;RBPJ;FGFR2;AKAP6
prerank,modulation by host of symbiont process (GO:0051851),-0.34098321010284716,-1.116758451290316,0.2829581993569132,0.7374914986680368,1.0,7/31,12.34%,LEF1;EP300;NAPEPLD;HDAC1;CCNT1;SNW1;SP1
prerank,aggrephagy (GO:0035973),0.4319130029128105,1.1166218873337124,0.3338368580060423,0.9259974818716366,1.0,5/27,11.44%,DYNLL1;WDR81;ATG5;DYNLL2;HDAC6
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),-0.3354734061471877,-1.1166147508564113,0.2764505119453925,0.7365244923614007,1.0,12/35,20.00%,ITGA1;PDGFRB;FKBP1A;PPP4R4;PPP1R12A;CALM1;PPP1R11;CALM3;CSNK2B;STYXL1;NUAK1;CRY2
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.36226512319894644,1.1159585694297323,0.2938271604938272,0.9269851363116247,1.0,25/82,21.72%,DYNLL1;GTSE1;SFI1;CEP131;CEP78;NEDD1;TUBG1;CKAP5;CCP110;PAFAH1B1;CEP290;SSNA1;NDE1;CETN2;PCM1;YWHAG;YWHAE;CEP57;OFD1;ALMS1;CEP250;DCTN2;HAUS8;CEP43;HAUS3
prerank,tetrapyrrole metabolic process (GO:0033013),0.47130684345566337,1.1158528185586,0.34223706176961605,0.9262185339618155,1.0,6/18,12.86%,CTRC;ABCC1;MMAB;CD320;CUBN;AMN
prerank,response to calcium ion (GO:0051592),0.35895197869431733,1.1145782132366886,0.2922705314009662,0.9291454345945527,1.0,8/102,4.77%,CAV1;GUCA1A;CAMK2D;ITPR3;SLC25A12;GPLD1;ADD1;WNT5A
prerank,negative regulation of cyclase activity (GO:0031280),-0.4201971491210497,-1.1143845885995276,0.31695331695331697,0.7414939743341183,1.0,2/14,2.21%,ADGRV1;GRM3
prerank,modulation of excitatory postsynaptic potential (GO:0098815),-0.3598044610177597,-1.1143498183120262,0.27941176470588236,0.7402702446962678,1.0,7/26,12.09%,SHANK3;SLC8A3;CUX2;GRIN1;PRKCZ;NRXN1;LRRK2
prerank,negative regulation of adenylate cyclase activity (GO:0007194),-0.42619296112952093,-1.1143407775147236,0.31971153846153844,0.7389532136596797,1.0,2/13,2.21%,ADGRV1;GRM3
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),-0.445995898315511,-1.1142182090839592,0.32061068702290074,0.7379621098089446,1.0,7/13,22.90%,PDE8A;GPR37;LRRK2;GPR37L1;RACK1;MET;NR4A3
prerank,cellular response to fluid shear stress (GO:0071498),0.5148491721281159,1.1140228424410803,0.34668989547038326,0.9298240561450183,1.0,4/12,12.26%,ASS1;MAPK7;MTSS1;NFE2L2
prerank,microtubule polymerization (GO:0046785),0.42478721607826886,1.1139594118174339,0.32575757575757575,0.9289189982620497,1.0,17/28,29.98%,TRPV4;TUBG1;CKAP5;TUBGCP5;NDE1;TUBG2;SLAIN2;TUBGCP6;PIN1;MAP7D3;FGF13;CSNK1D;CLASP2;CCDC57;NDEL1;HDGFL3;CLASP1
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.31313294102560146,1.1135774822361997,0.167,0.9289628592162411,1.0,140/834,15.49%,RORA;MEOX2;DCN;KLF5;ETV4;ITGA6;CDH13;ETV1;GLI1;PPARGC1A;FOXD2;NR2F2;DLX1;POU4F3;RARB;NFATC1;LDB2;PBX1;EGFR;RUNX2;FGF1;JAG1;ETV5;TNIP3;OGT;NUFIP1;GLI2;NFIA;IL4I1;KMT2A;CRTC1;MAML2;LMO7;TXK;SPI1;LMO1;FOXO3;NPAS2;BMPR1B;SOX9;PGR;REL;TFR2;CHD8;SLC30A9;GLIS2;KAT6B;CSRP3;BMP5;KLF10;HDAC4;WNT5A;APLN;LEO1;HEYL;SP3;ATAD2;NRIP1;CDK13;RPRD1B;ONECUT1;NCK2;CDK7;NRF1;DDX17;PAX3;HOXC10;RREB1;RARA;MAPK7;USF2;FOXK2;PIK3R2;E4F1;ISL1;ELL;ZNF462;TNIP1;AATF;DDRGK1;AGO1;MED13;PLSCR1;TCF20;RPS6KA3;TET1;SIRT7;HMGB1;SMARCD2;FOXJ1;RORB;POU4F1;HDAC2;SUPT4H1;DBP;TMF1;RTRAF;TFEB;FHOD1;PAXBP1;MMP12;RARG;WWC1;DVL3;HTATIP2;MZF1;EGR1;INO80;ZBTB49;MEN1;NFE2L2;AKIRIN1;NCOA3;CREBBP;CD81;KDM6B;PEG3;PKD1;CRLF3;TCERG1;NCOA2;SOX4;BCL9;CAMTA2;DPF3;SFPQ;YAP1;KAT8;CAPRIN2;MED12;FOXJ2;BRD8;FOXF1;AUTS2;NR5A1;COPS5;RUNX1;CCDC62;GPER1;KMT2D
prerank,regulation of DNA repair (GO:0006282),0.3906927957521782,1.1134351003459841,0.30727023319615915,0.9283113539507778,1.0,11/44,11.08%,EGFR;BRCC3;EYA1;NPAS2;UBR5;UBE2V2;UIMC1;WRAP53;SIRT7;AXIN2;ERCC6
prerank,establishment of endothelial intestinal barrier (GO:0090557),0.5183921844511951,1.113122579915246,0.33273703041144903,0.9282274379768318,1.0,3/11,8.91%,F11R;TJP2;RAPGEF6
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.4516031110737308,1.1130857014482565,0.35,0.9272337670502481,1.0,6/23,17.50%,GUCA1A;CNGB1;FNTA;FNTB;NMT1;CAMKMT
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),-0.3705247709187367,-1.1126069530830551,0.2873900293255132,0.7412475655614216,1.0,12/23,24.63%,NUPR1;CBFA2T3;EP300;SIK1;C1QTNF3;GSK3A;PGP;CLK2;PFKFB1;CRY1;GIT1;TIGAR
prerank,positive regulation of translational initiation (GO:0045948),-0.39453764808019703,-1.1123212237143616,0.31607629427792916,0.7407662715269231,1.0,12/18,42.94%,RPS6KB1;YTHDF1;YTHDF2;POLR2D;KHDRBS1;YTHDF3;RPS6KB2;DDX3X;BOLL;CCL5;DAZL;UHMK1
prerank,purine nucleotide biosynthetic process (GO:0006164),0.5087954495372923,1.1120957342718345,0.37748344370860926,0.9292408514884705,1.0,7/12,20.39%,MTHFD1;PPAT;PRPSAP2;PRPS1;PRPS1L1;GART;ADSL
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.45972385001320754,1.1118551220997084,0.34345047923322686,0.92890248396328,1.0,8/20,17.68%,PSMG2;PFDN6;PSMG1;LONP1;CCT2;HOPX;PSMG3;HSPA4
prerank,regulation of aerobic respiration (GO:1903715),-0.41214860520060814,-1.110800596104869,0.32727272727272727,0.7438367143870297,1.0,4/15,11.97%,CBFA2T3;ATP7A;VCP;SLC25A33
prerank,regulation of vesicle-mediated transport (GO:0060627),0.359217380664782,1.1104705830139903,0.30759951749095293,0.9321140684667453,1.0,37/91,22.82%,CDH13;RAB8B;OPHN1;SRC;PTPRC;ZFYVE16;STON1;ABL2;PACSIN2;RIMS2;RAB3A;RINT1;CPLX1;STON2;ATP9A;INPP5F;PLD1;RAB21;MBTPS1;RUFY2;RAB33B;SYK;STX4;SNX12;RAB5A;DENND10;PACSIN3;SNX17;RALA;NSF;PACSIN1;CPLANE2;TSC2;VAMP2;HCK;AP2S1;MAPK1
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.34701744210659763,1.1101046770434126,0.30274135876042907,0.9321460352570615,1.0,21/94,17.46%,PRODH;MYBBP1A;PPP1R13B;MSH6;FHIT;ERO1A;CIDEB;HIC1;MCL1;CUL3;MAP3K5;STK24;SFN;POU4F1;DIABLO;ERN1;HTRA2;BAD;E2F1;QRICH1;BNIP3
prerank,carbohydrate biosynthetic process (GO:0016051),0.4578205355684255,1.1099946693767317,0.33176100628930816,0.931395269678214,1.0,2/21,2.68%,ST3GAL4;B3GALT1
prerank,cellular response to organic substance (GO:0071310),-0.2568800231200998,-1.109954338799409,0.23308270676691728,0.7450738535493487,1.0,20/116,9.00%,LEF1;SMAD3;PID1;GHR;CLEC3B;SLIT2;IGFBP5;TGFBR1;ACVRL1;IL18;BMPR2;CYP1B1;AKAP6;KLF4;RPS6KB1;TRAF6;ARL6IP5;CDK9;LDLRAP1;RAMP2
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.4371130676536973,1.1096687355495272,0.32965299684542587,0.931341638397906,1.0,10/26,18.02%,HOMER2;EFHB;ATP2B4;CHERP;RCAN1;GSK3B;HOMER3;STIMATE;CHP1;DYRK2
prerank,positive regulation of cellular catabolic process (GO:0031331),0.3470904190211183,1.1095649833509178,0.30821147356580425,0.9305725657398248,1.0,20/132,10.78%,DCN;PLK2;VGLL4;ZBTB20;TPCN1;GPLD1;FOXO3;DACT1;DXO;SLC4A4;TRIM21;RDX;IRGM;LIN28B;GSK3B;HMGB1;TICAM1;CNOT7;ADRA2A;TFEB
prerank,Wnt signaling pathway (GO:0016055),0.35953219649142365,1.109436913732691,0.3070489844683393,0.9298759958626743,1.0,23/92,14.48%,WNT10A;FZD2;AXIN1;WNT2B;WNT16;PLPP3;WNT5A;CPE;CSNK1G3;GSK3B;CSNK1A1;FERMT2;STRN;RARG;DVL3;APC;WNT9A;NXN;PTEN;BCL9;FZD7;FZD9;FZD3
prerank,negative regulation of metabolic process (GO:0009892),0.38527578527793627,1.108731444506999,0.31341301460823373,0.93091337508623,1.0,11/54,10.83%,IL18R1;LAMA4;ZNF423;PLCL1;PCTP;FIS1;ACOT13;HOXC10;ZDHHC7;LNPEP;DOCK7
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.4017826499048853,1.1087060567330114,0.35733333333333334,0.929927082498301,1.0,6/42,11.79%,CDH13;UTRN;PTPRJ;GSK3B;FERMT2;EFEMP2
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),-0.3551920858200367,-1.1085652148917684,0.2972972972972973,0.7477770497705343,1.0,14/27,20.10%,SLC47A1;SLC6A9;SLC7A5;SLC7A1;ARL6IP5;SLC25A38;SLC1A1;SLC1A3;SLC3A2;SLC22A2;SLC38A5;SLC25A18;SLC25A29;SLC1A4
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.38083029136349195,1.1083918233423857,0.35047361299052776,0.9298435561922829,1.0,12/53,14.38%,EGFR;FXR2;BRCC3;EYA1;SPRED1;NPAS2;HIC1;UIMC1;WRAP53;ERCC6;SPRED2;FXR1
prerank,acute-phase response (GO:0006953),0.4981348067470242,1.1080049879116496,0.34966216216216217,0.9299570397219483,1.0,2/12,8.99%,LBP;PLSCR1
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.40153415319001473,1.1077031700371547,0.3141592920353982,0.9298758696870273,1.0,16/39,22.19%,SOCS5;PI4K2B;PIP4K2B;SOCS6;EFR3A;PIK3R2;SOCS4;SOCS7;PIK3C3;PI4K2A;SOCS1;SOCS2;ITPKA;PIK3C2B;CISH;TMEM150A
prerank,muscle contraction (GO:0006936),-0.26181606953579756,-1.1072263277451866,0.2047244094488189,0.7502554044615115,1.0,28/126,15.09%,MYOF;ITGA1;ROCK2;ACTN2;MYLK;DMD;TPM1;GJC1;SLC8A1;DYSF;SNTB1;TMOD3;BDKRB2;CALM1;MYL9;MYL6;MYH11;TPM3;LMOD1;ACTA2;TPM2;CRYAB;DES;EDNRA;VIM;SLC6A8;ITGB5;TLN1
prerank,diol biosynthetic process (GO:0034312),-0.409344227960555,-1.1066838897618176,0.3391959798994975,0.7504628053906427,1.0,6/15,13.76%,ACER2;GCH1;QDPR;ABCA2;SPHK1;DHFR
prerank,cholesterol transport (GO:0030301),0.3918470495483905,1.106645374045953,0.3543091655266758,0.9321884654350093,1.0,4/45,8.05%,CAV1;CEL;SOAT1;ABCA1
prerank,regulation of viral release from host cell (GO:1902186),-0.3722418249104792,-1.106482604737657,0.31767955801104975,0.7496616592561888,1.0,10/21,21.25%,MID2;TRIM25;VPS4A;TRIM28;TRIM35;CHMP3;CHMP2B;TRIM8;TRIM13;TRIM11
prerank,positive regulation of osteoblast differentiation (GO:0045669),-0.3099852618731759,-1.1058467406138346,0.26838235294117646,0.7501153815782273,1.0,6/43,3.91%,IGF1;BMP6;IL6R;BMP4;WNT4;BMPR2
prerank,actin polymerization or depolymerization (GO:0008154),-0.3046798302910136,-1.1058342247747641,0.3,0.7488106036138866,1.0,12/50,11.17%,SVIL;DSTN;ARHGAP6;CFL1;WASF3;TWF1;JAK2;CAPG;DIAPH1;ABI1;EVL;AVIL
prerank,negative regulation of gene expression (GO:0010629),-0.2261510907704902,-1.105651455324099,0.16666666666666666,0.7480385831661716,1.0,88/302,21.76%,IGF1;ROBO1;SLC24A3;DAPK1;PICALM;NOTCH2;ENG;ROCK2;CLDN5;LGR4;FOXP1;BMP4;SLC7A5;IGFBP5;WNT4;RPS6KA5;ACVRL1;HIF1A;RBL1;XDH;KLF4;HDAC9;KDR;PDCD10;CD34;MYADM;APOE;HINFP;HDAC1;MAP2K2;CRKL;PPP1R11;RPL13A;CITED2;GATA2;PAIP2;JARID2;LGMN;SLC2A10;RBMS3;AGO3;ZC3H12A;BMP2;RPS3;ESR1;GAPDH;BMI1;RPS26;TTBK1;NOCT;NUDT12;TGFB2;NCL;DHFR;SH3GL2;ID2;AGO4;PARP10;MAPT;MOV10;RBL2;TLE5;LGALS9;SUZ12;ASB1;TWSG1;DNMT3B;TNRC6C;ZFP36;KAT2B;CNOT9;DHX36;YTHDF2;EED;METTL16;DAPK3;ANXA7;RACK1;MIF;ZC3H10;TASOR;RIDA;TMBIM6;HRAS;CILP;DNMT3A;APLNR;LSM5
prerank,negative regulation of cell division (GO:0051782),-0.44516106679233597,-1.105571655772626,0.2987951807228916,0.7469669144252388,1.0,3/11,9.94%,TXNIP;BLM;VPS4A
prerank,regulation of cell communication (GO:0010646),0.40809844153627833,1.1053675009582526,0.32971506105834464,0.9351541921888371,1.0,6/35,9.24%,CXADR;CAMK2D;CDC42SE2;NUP62;TBX18;CASQ2
prerank,cellular response to organic cyclic compound (GO:0071407),0.340581088080904,1.105287058171085,0.30371203599550056,0.9343175934920885,1.0,10/141,5.56%,RORA;HRH1;EGFR;FOLR1;RAPGEF3;RAP1A;SSTR1;ATP1A2;NRIP1;ADCY5
prerank,positive regulation of vasculature development (GO:1904018),0.3564991364095014,1.104846463279861,0.315203955500618,0.9345815484693006,1.0,11/94,5.49%,GAB1;SMOC2;HK2;RAPGEF3;FGF1;CDH5;ITGAX;IL1A;PRKCA;WNT5A;HIPK1
prerank,RNA metabolic process (GO:0016070),0.34092052049683425,1.1045655509833507,0.30484988452655887,0.9344015883732743,1.0,18/127,10.28%,DHX8;HNRNPC;RNASEH2B;NUFIP1;RBFOX2;PCBP2;HNRNPA0;WDR74;PABPC4;HNRNPR;FASTKD2;DDX17;SIDT2;RBM5;AGO1;CELF2;HNRNPM;ATXN2
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.38826523247850026,1.1035958301094435,0.30980392156862746,0.9363498375313308,1.0,15/49,18.91%,CAV1;EIF2AK3;SRC;FIS1;NDUFS3;MCL1;PTPMT1;SIAH1;S100A9;P4HB;BAD;UBQLN1;DAPK2;PINK1;BAX
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),-0.39331093928893324,-1.1033019174686052,0.3246753246753247,0.7523232971107294,1.0,5/17,10.45%,NOTCH2;RBPJ;BMP4;GALNT11;BMP2
prerank,autophagosome maturation (GO:0097352),-0.335585127014673,-1.1032232732425553,0.28434504792332266,0.7512200920958741,1.0,14/32,22.19%,UVRAG;GABARAPL1;CALM1;VMP1;GABARAP;VCP;TECPR1;STX17;EPG5;VAMP7;CHMP3;MAP1LC3A;WIPI2;VTI1B
prerank,regulation of cardiac conduction (GO:1903779),0.38088190621337775,1.102734653557171,0.3425559947299078,0.9379613286046395,1.0,9/54,10.93%,CORIN;ITPR2;ITPR3;FKBP1B;ATP2B4;ATP1A2;CASQ2;ATP1B3;FXYD6
prerank,positive regulation of lyase activity (GO:0051349),0.4896195667759824,1.1027289188610228,0.3566775244299674,0.9368978181407975,1.0,2/14,3.16%,GUCA1A;NF1
prerank,positive regulation of smooth muscle cell migration (GO:0014911),-0.40197197961600706,-1.1026231060176084,0.3005181347150259,0.7515970046238812,1.0,4/17,2.66%,IGF1;DOCK4;PDGFRB;IGFBP5
prerank,regulation of humoral immune response (GO:0002920),0.39165497230364527,1.1020827292556827,0.31721194879089615,0.9378832857611766,1.0,6/44,13.88%,C2;SERPING1;CD55;SUSD4;CD81;CFH
prerank,histone H2A ubiquitination (GO:0033522),-0.394464746960014,-1.1018763530171054,0.32225063938618925,0.7523972948786719,1.0,9/17,29.24%,KDM2B;RYBP;TRIM37;RNF8;SKP1;RNF2;RING1;BCOR;DDB1
prerank,semaphorin-plexin signaling pathway (GO:0071526),-0.3163289716715417,-1.1018644248226437,0.288135593220339,0.7511163896712687,1.0,8/35,9.55%,PLXNA2;PLXNA4;SEMA6D;SEMA7A;SEMA3C;SEMA6A;ARHGDIA;FLNA
prerank,positive regulation of DNA recombination (GO:0045911),-0.34639440490843687,-1.101739523135079,0.3128834355828221,0.7501529608953983,1.0,10/27,20.64%,TFRC;PAXIP1;SHLD2;ARID2;ACTR2;MMS19;ERCC2;PARP1;TIMELESS;MAD2L2
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.42622568983050924,1.10153363099224,0.3704268292682927,0.9385158369677892,1.0,8/26,23.49%,ST3GAL4;TNIP1;SCCPDH;GK;GBGT1;TKT;GOLPH3;RRM2B
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),-0.44642418027474023,-1.10142400810765,0.3416289592760181,0.7497509646821673,1.0,6/11,17.21%,FOXO1;LMNA;GSK3A;MLIP;P2RX4;SMAD4
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.3132800440922493,-1.1011618307310087,0.28431372549019607,0.7492424883730582,1.0,22/38,35.24%,ARHGEF2;NOS3;SP100;MADD;FAS;CFLAR;FEM1B;THBS1;TNFSF10;CASP8;ICAM1;RIPK1;BRCA1;RNF34;DDX3X;TRAF2;SFRP1;RFFL;HMOX1;FAIM2;SERPINE1;PMAIP1
prerank,negative regulation of apoptotic process (GO:0043066),-0.22023144167046346,-1.100690609201651,0.0,0.7493721805474128,1.0,85/444,13.49%,IGF1R;IGF1;NOTCH2;TEK;LEF1;OSR1;PRKCH;ANGPT1;GRK5;IL31RA;RNF213;CTSH;TPT1;SMAD6;DAB2;SLC30A10;PIK3R1;DNAJC3;NUPR1;BMP4;NDNF;TBX3;KDM2B;TFRC;FOXO1;CPEB4;FNIP1;SQSTM1;CFL1;CAT;FAS;HNRNPK;ZFAND6;DSTYK;NPM1;KLF4;AREL1;NAA15;PRDX2;KDR;PDCD10;TBX1;DNAJA1;MAZ;RPS6KB1;APOE;IFIT3;TRAF6;HDAC1;PTMA;RNF144B;CASP3;IGBP1;ATF5;ANXA1;UNC5B;TGFB3;AKT1;UFM1;CITED2;SERPINB9;ARHGDIA;LGMN;CFLAR;NR4A2;CIAPIN1;MERTK;FLNA;UBE2O;ZC3H12A;HAX1;FOXQ1;BID;CRYAB;BABAM2;BDNF;BAG4;FLT4;TXNDC5;THBS1;CSNK2A1;MYO18A;SPHK1;PIM3;GATA6
prerank,macrophage activation involved in immune response (GO:0002281),0.4780333816089345,1.1003448302770815,0.33557046979865773,0.9411269396095072,1.0,1/13,0.69%,LBP
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.4462757125702943,-1.1002763238611335,0.3568075117370892,0.7492101670954695,1.0,6/11,35.35%,UQCRC2;CYC1;UQCRQ;UQCRFS1;UQCR10;UQCR11
prerank,organelle fusion (GO:0048284),0.4447730658730643,1.100275266112556,0.35441176470588237,0.9402477232621637,1.0,13/22,28.77%,MFN2;FIS1;MIEF1;STX4;MIGA1;VPS11;BAX;CHCHD3;THG1L;MFF;SPG7;AFG3L2;EEA1
prerank,phosphorylation (GO:0016310),0.3142650932909368,1.1001851151637545,0.2729124236252546,0.9394754653712242,1.0,52/384,9.88%,TEC;PLK2;FAM20C;TRIB2;CDK15;FGFR1;HCST;DGKA;PRKCE;CAMK2D;MINK1;STK38;MAP3K1;TXK;MAPK10;DGKZ;EIF2AK3;PRKAG1;PRKCA;BMPR1B;PEAK1;CDKL3;IRAK3;MORC3;LIMK2;ACVR1C;PIK3R4;PDK4;HIPK1;BRSK1;CDK13;NEK7;FER;BCKDK;COQ8A;EPHB2;ADAM10;CERK;CDK7;GMFB;BMP2K;STK38L;RARA;SRPK1;MAP3K5;DYRK1A;NRBP2;GSK3B;STK24;STK3;CSNK1A1;TYK2
prerank,epidermal cell differentiation (GO:0009913),0.4028371823448816,1.1001409764135475,0.33649932157394846,0.9385201942693508,1.0,4/41,4.77%,GLI1;JAG1;WNT16;WNT5A
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.4111324210798808,-1.1001381401966572,0.33419689119170987,0.7483774618673756,1.0,8/16,25.13%,SHLD2;POLQ;UBQLN4;CGAS;MAD2L2;RMI2;SMCHD1;PARPBP
prerank,oligosaccharide biosynthetic process (GO:0009312),0.4582427074595586,1.1001280114068455,0.34379905808477235,0.9374807618085789,1.0,2/20,2.68%,ST3GAL4;B3GALT1
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.33518934372674974,1.0998427165584523,0.3192436040044494,0.9372512332691008,1.0,12/149,7.19%,ROR1;EDA;CAV1;IL18R1;RIPK4;FLOT2;IRAK3;WNT5A;FER;TRADD;TRIM21;NLRC4
prerank,negative regulation of programmed cell death (GO:0043069),-0.2285210100780546,-1.0994305075977115,0.08695652173913043,0.7492209248595784,1.0,66/355,13.49%,IGF1R;IGF1;MECOM;NOTCH2;TEK;LEF1;OSR1;ANGPT1;GRK5;IL31RA;CTSH;TPT1;SMAD6;DAB2;PIK3R1;DNAJC3;NUPR1;BMP4;TBX3;TFRC;FOXO1;SQSTM1;CFL1;CAT;FAS;HNRNPK;ZFAND6;DSTYK;GPX4;NPM1;AREL1;NAA15;PRDX2;KDR;PDCD10;DNAJA1;RPS6KB1;IFIT3;TRAF6;HDAC1;PTMA;RNF144B;CASP3;ATF5;ANXA1;AKT1;UFM1;CITED2;SERPINB9;ARHGDIA;CFLAR;CIAPIN1;FLNA;UBE2O;HAX1;BID;CRYAB;BABAM2;BAG4;FLT4;TXNDC5;THBS1;MYO18A;SPHK1;PIM3;GATA6
prerank,pyrimidine-containing compound metabolic process (GO:0072527),0.5118201700514885,1.099395298828928,0.35413153456998314,0.9374896064991223,1.0,6/11,16.96%,THTPA;TPK1;CTPS2;SLC25A19;NT5C3A;DCK
prerank,positive regulation of cell death (GO:0010942),0.37647954289083135,1.0993050860147442,0.3472584856396867,0.9367055428311282,1.0,15/59,12.23%,PRODH;CELF1;CIDEB;WNT5A;SLC6A13;EFNB2;MAP3K5;GSK3B;SARM1;AXIN2;RARG;HTATIP2;APC;EGR1;FAF1
prerank,T cell homeostasis (GO:0043029),-0.4637150976039273,-1.09893803924423,0.3401360544217687,0.7493283651680099,1.0,5/10,25.17%,FAS;AKT1;ZC3H8;NCKAP1L;JAK3
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.38808475676334064,1.0988182282635162,0.330567081604426,0.9371363212157067,1.0,13/45,17.39%,PLK2;WEE1;TOM1L1;CHFR;BRINP1;TOM1L2;ZFP36L2;CDKN1C;ZWILCH;FZD3;ZW10;RGCC;SCRIB
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.4237643137523987,1.0987712143555775,0.3567251461988304,0.9362084871811199,1.0,11/30,19.87%,LEPROT;ABLIM3;RAC2;HTRA2;UBE2J2;UBE2D3;FBXW7;CSNK2A2;VPS11;PINK1;UBL5
prerank,cellular response to peptide (GO:1901653),-0.29454746974704515,-1.098483139162929,0.27927927927927926,0.7492859616515396,1.0,11/56,10.29%,IGF1R;IGF1;ARHGEF2;LRP1;GJA1;EPHA4;VCAM1;NOD1;LGMN;GRIN1;RPL23
prerank,oogenesis (GO:0048477),0.46485042106887775,1.0983669875059006,0.35343383584589616,0.936433025882453,1.0,4/15,16.20%,PIWIL2;MEI4;KMT2D;MDK
prerank,mitochondrial genome maintenance (GO:0000002),-0.4301914597047479,-1.0982743543629119,0.3349875930521092,0.7486042164484029,1.0,6/11,19.52%,AKT3;TOP3A;MEF2A;SLC25A33;OPA1;PARP1
prerank,response to thyroid hormone (GO:0097066),-0.4257837321041459,-1.0981209587548046,0.33886255924170616,0.7477661929435828,1.0,3/13,6.67%,CTSH;LMO2;CTSL
prerank,interleukin-15-mediated signaling pathway (GO:0035723),-0.42300229423551367,-1.097859119538745,0.3684210526315789,0.7459387734676283,1.0,2/13,7.58%,PLCB1;IL15RA
prerank,cellular response to interleukin-15 (GO:0071350),-0.42300229423551367,-1.097859119538745,0.3684210526315789,0.7459387734676283,1.0,2/13,7.58%,PLCB1;IL15RA
prerank,cyclic purine nucleotide metabolic process (GO:0052652),-0.3709094727211264,-1.0975182846909552,0.3323943661971831,0.7456408092439069,1.0,5/21,8.09%,ADCY1;ADCY7;NPR1;ADCY4;ADCY2
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.4626624652588598,1.097307874697913,0.34811165845648606,0.9387161777712297,1.0,6/17,16.08%,MAPK7;NFE2L2;HTRA2;P4HB;SFPQ;UBQLN1
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.39274803002287345,1.0967867299180878,0.3267882187938289,0.9392924581040889,1.0,7/38,12.18%,CAV1;PTPRC;NCK2;SRCIN1;DLG3;RELN;MVP
prerank,glycerolipid metabolic process (GO:0046486),0.508261711733504,1.0967371666249477,0.366723259762309,0.938399506461852,1.0,2/11,3.64%,DGKA;DGKZ
prerank,in utero embryonic development (GO:0001701),-0.35657311926101515,-1.0957771954685958,0.2956521739130435,0.7490096138475049,1.0,7/25,10.45%,CHD7;TGFBR1;IGF2;FGFR2;HINFP;TGFB3;BMP2
prerank,ceramide transport (GO:0035627),-0.4382885597381614,-1.0955642843953541,0.33753148614609574,0.7483238254867192,1.0,8/12,34.46%,PLTP;ABCA2;PLEKHA3;ABCB4;PLEKHA8;ABCA13;PSAP;CPTP
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.3271552375042053,1.094961446872665,0.3213507625272331,0.9429670447241157,1.0,56/184,18.86%,DYNLL1;PSME3;SFI1;CEP131;CEP78;NEDD1;TUBG1;CKAP5;FBXO5;CCP110;PAFAH1B1;CUL3;PSMB5;CDC20;ANAPC5;ANAPC7;ANAPC11;INO80;BUB3;CEP290;SSNA1;NDE1;CETN2;CDC6;PKD1;PCM1;ANAPC2;ZFP36L2;PTPN6;UBE2D1;PSMA6;PSMB2;PSMA2;ZW10;ANAPC4;PSMD13;YWHAG;FZR1;PSMA7;E2F1;NEK11;CDC14A;YWHAE;RGCC;CEP57;PSME4;ANAPC16;KLHL18;CDC23;PSMD12;PSMD14;OFD1;ALMS1;PSMB6;PSMC4;CEP250
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),-0.3292790191101511,-1.0947173520043845,0.3354632587859425,0.7494612522743145,1.0,14/33,23.84%,HIP1;TGFA;AFAP1L2;HIP1R;AKT1;BCAR3;SHKBP1;EGF;CNOT9;AGT;NEU3;PLAUR;PDE6H;DOK1
prerank,positive regulation of DNA metabolic process (GO:0051054),0.3644539201280282,1.0947016443591655,0.3360544217687075,0.9427083238542334,1.0,11/61,11.08%,SMOC2;EGFR;BRCC3;EYA1;NPAS2;NBN;UIMC1;WRAP53;MECP2;HMGB1;ERCC6
prerank,retinoic acid receptor signaling pathway (GO:0048384),0.5136577079767094,1.0943095620197074,0.37725631768953066,0.9428739531528683,1.0,4/10,16.54%,RARB;RARA;RARG;PPARG
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.42820002247235206,1.0940684193283725,0.36128048780487804,0.9426042224800956,1.0,4/24,9.67%,HNRNPC;SRC;STN1;EXOSC10
prerank,cellular defense response (GO:0006968),0.4014141972046447,1.0937337121656872,0.34289617486338797,0.9425550036798109,1.0,3/40,4.01%,LBP;ITK;CD5L
prerank,cellular response to metal ion (GO:0071248),-0.25558572626396175,-1.093511008542423,0.22522522522522523,0.75148744278029,1.0,24/123,9.90%,ADGRV1;BMP6;CLIC4;ADCY1;ADCY7;MT1E;MT1M;MT1G;MT1B;MT1F;MT1A;MT1X;MT1H;B2M;SYT9;SYT7;KCNH1;RASGRP2;MEF2A;PLCG2;AKT1;SLC41A1;LGMN;ANK3
prerank,regulation of protein localization to plasma membrane (GO:1903076),-0.2772360422526895,-1.0930797161643286,0.2549019607843137,0.7513924757782413,1.0,17/78,11.60%,PICALM;NUMB;EPHA3;PID1;PRKCH;DAB2;LRP1;PIK3R1;SQSTM1;STX8;ITGA3;ACTB;AKT1;LDLRAP1;VPS4A;AR;CLIP3
prerank,endocardial cushion morphogenesis (GO:0003203),-0.3774799466706015,-1.0929356829206582,0.32989690721649484,0.7505701432689705,1.0,6/18,13.01%,ENG;NOS3;BMP4;ACVRL1;BMP2;TGFB2
prerank,positive regulation of cellular component biogenesis (GO:0044089),-0.2659087926430843,-1.092824882790345,0.29533678756476683,0.7496193800871104,1.0,19/88,11.52%,TRABD2B;SMAD3;SYNPO2;TFRC;BCL2L11;FNIP1;STX18;FNIP2;RHOC;SLF2;SH3GLB1;SLF1;VCP;VPS4A;RPS3;AJUBA;BID;MMP1;MPP7
prerank,Golgi inheritance (GO:0048313),-0.4395881361127373,-1.0924395116761625,0.3533487297921478,0.7494141462512617,1.0,8/11,37.44%,PDCD10;GOLGA2;PLK5;YWHAZ;STK25;PLK3;VRK1;CDK1
prerank,lipoprotein transport (GO:0042953),-0.4761611026962548,-1.0921629580990746,0.36065573770491804,0.7489575323464693,1.0,3/10,7.48%,LRP1;ZDHHC17;VMP1
prerank,insulin receptor signaling pathway (GO:0008286),0.3621429501984848,1.0918684175315252,0.35141800246609123,0.9473828966556552,1.0,10/69,9.14%,GAB1;SORBS1;GPLD1;CAV2;ATP6V0D2;PDK4;FER;PIK3R2;ATP6V0A1;GSK3B
prerank,regulation of BMP signaling pathway (GO:0030510),0.3559907476979413,1.0915378197650627,0.32731648616125153,0.9473549119145247,1.0,8/73,4.28%,DLX1;SULF1;ZNF423;FOXD1;FBXL15;CDH5;BMPR1B;NBL1
prerank,response to interferon-alpha (GO:0035455),-0.3988422102231661,-1.0913419040333445,0.32225063938618925,0.7498231392420192,1.0,5/16,18.38%,IFNAR2;ADAR;BST2;IFNAR1;PDE12
prerank,regulation of MAP kinase activity (GO:0043405),0.34830088578561014,1.0913147059960753,0.3313032886723508,0.9470008932932501,1.0,13/92,8.36%,TRIB2;FGFR1;RGS14;EGFR;FGF1;STK38;NF1;SPRY1;SPRY4;IRAK3;TSG101;PTPRJ;FGF18
prerank,gluconeogenesis (GO:0006094),0.395614436865606,1.091284011794148,0.33666191155492153,0.9460268772277677,1.0,13/39,20.79%,PPARGC1A;SLC25A12;ALDOB;PGM1;MDH1;SLC25A13;ENO3;GOT1;PGK1;ENO2;SLC37A4;SLC25A10;ENO1
prerank,negative regulation of cellular process (GO:0048523),0.31081798354932494,1.0909487547705656,0.2620967741935484,0.9459973376613365,1.0,85/521,15.06%,ROR2;NGF;ZBTB7C;TGFBI;IGFBP6;DLC1;VGLL4;CDH13;RIPOR2;GLMN;CLDN19;ADAMTS1;DCBLD2;PPP1R13B;SSTR1;SPEF1;GPLD1;CASK;GNRH1;PIWIL2;IL1A;PTPN14;EIF2AK3;WNT16;PTHLH;CELF1;NPAS2;CD9;TPTE;DSCAM;BMP5;KLF10;PLXNA3;NUP62;PDS5B;KANK2;NCK2;EPHB2;ADAM10;ATG5;CTCF;NDUFS3;CHERP;FBXO5;DIS3L2;BRINP1;PTPRJ;RBM5;PLSCR1;NLRP2B;SIRT7;DLG3;CNOT7;PBRM1;CHMP4B;FERMT2;STRN;AXIN2;RARG;PLXNB1;APC;VAMP8;ZBTB49;NF2;WNT9A;MEN1;SEMA4D;TEX15;PTEN;CDC6;HOPX;CRLF3;SOX4;FHL1;HTRA2;PTPN6;CLMN;NAIF1;DNAJA3;RTN4;CAPRIN2;SIPA1;ERBB4;PTPRU;NDRG3
prerank,high-density lipoprotein particle assembly (GO:0034380),0.5111170561859569,1.0906281477962463,0.36507936507936506,0.945940429081874,1.0,4/10,16.72%,ABCA1;PRKACB;ZDHHC8;BMP1
prerank,positive regulation of rRNA processing (GO:2000234),0.5153111615789092,1.0903085780613442,0.3792517006802721,0.9458910259446988,1.0,3/10,9.47%,BUD23;UTP15;SIRT7
prerank,protein heterooligomerization (GO:0051291),-0.40322609208093896,-1.0898885786895631,0.3394255874673629,0.7528146303626512,1.0,7/17,27.24%,FARSB;GRIN2B;GRIN1;TMEM120A;CPSF7;CPSF6;HSD17B8
prerank,interleukin-1-mediated signaling pathway (GO:0070498),-0.2589873031226125,-1.0897260959301411,0.23255813953488372,0.7519831142435338,1.0,14/94,8.89%,PLCB1;IL1R1;IL1RAP;PSMA1;RPS6KA5;SQSTM1;RBX1;IRAK4;UBE2N;PSMD11;TRAF6;NOD1;PSMD7;PSMD4
prerank,regulation of amyloid fibril formation (GO:1905906),-0.4020168104494589,-1.089248794223239,0.36674816625916873,0.7520900251709599,1.0,6/15,21.69%,LDLR;APOE;VBP1;CRYAB;CLU;PFDN4
prerank,protein sumoylation (GO:0016925),0.3768718505050873,1.089204737260407,0.3535075653370014,0.9483369661413171,1.0,12/49,12.63%,STX1A;EYA1;UBE2I;NUP62;PIAS2;NUP160;NUP37;TPR;NUP50;RANBP2;NUP153;NUP210
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.34207474401455445,1.089182030296711,0.3313679245283019,0.9473574292879111,1.0,11/107,4.86%,CAV1;STC2;CTRC;SLC8B1;SLC39A13;CDH5;SLC24A1;TRPV4;SLC30A9;CSRP3;ATP2B4
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.4147574929043968,1.0889702091187314,0.3573407202216066,0.9469662517969906,1.0,5/37,9.74%,APOD;IL17RA;CHID1;PLD3;TICAM1
prerank,regulation of plasminogen activation (GO:0010755),-0.42927518964609757,-1.0884859232384376,0.3497536945812808,0.7529276705593438,1.0,3/12,12.84%,CLEC3B;SERPINE2;THBS1
prerank,DNA packaging (GO:0006323),0.45923700474848106,1.0875917058239426,0.37061769616026713,0.9501583363480162,1.0,3/16,4.97%,HAT1;CDAN1;BANF2
prerank,retinol metabolic process (GO:0042572),0.48095636421702637,1.0875012457041093,0.3777038269550749,0.9493928180034853,1.0,1/14,0.62%,RDH10
prerank,mitochondrion localization (GO:0051646),-0.37785230232632516,-1.087310018068276,0.33858267716535434,0.7550271222203473,1.0,4/19,12.09%,MARK1;ZBED3;MEF2A;LRRK2
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),0.48532179294237704,1.0868367884904726,0.36482084690553745,0.9504067928618135,1.0,2/13,4.87%,B3GALT1;B4GAT1
prerank,actin filament bundle organization (GO:0061572),-0.33855615695955854,-1.086218010492028,0.2974683544303797,0.7568367198403645,1.0,5/33,5.58%,EPS8;NEDD9;MYO1B;PAWR;PLS3
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),0.4769446317831473,1.0861293037172792,0.3758169934640523,0.9515513373220424,1.0,2/15,3.05%,HSPH1;CD55
prerank,negative regulation of bone mineralization (GO:0030502),-0.4178294561406248,-1.0859688514234211,0.3434343434343434,0.7563439028705541,1.0,5/13,28.54%,ENPP1;RFLNB;GREM1;RFLNA;BCOR
prerank,amyloid precursor protein metabolic process (GO:0042982),0.46144799846120665,1.085871276258169,0.37756714060031593,0.9512872177719534,1.0,4/18,6.29%,ADAM19;APH1B;NCSTN;ADAM10
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),-0.40456139937762625,-1.0852861610883773,0.3659147869674185,0.757027010324848,1.0,3/15,5.88%,DAB2;TNK2;HIP1R
prerank,ureteric bud morphogenesis (GO:0060675),-0.39457268475947455,-1.0847778583188934,0.3492063492063492,0.7571132942956407,1.0,5/16,24.26%,BMP4;BMP2;SALL1;WNT11;NPNT
prerank,neuron maturation (GO:0042551),-0.3784548683929725,-1.0845754137761632,0.3398328690807799,0.7563805775598129,1.0,10/18,31.73%,EPHA8;LGI4;CLN5;C1QA;PICK1;SCARF1;ACTL6B;C3;RND1;MTCH1
prerank,monocarboxylic acid transport (GO:0015718),-0.29272904234122316,-1.0845733010904721,0.2777777777777778,0.7551357223720732,1.0,11/51,11.80%,SLC16A12;SLCO3A1;ABCC4;ABCG2;SLCO1C1;SLC5A6;SLC16A6;SLC16A4;SLCO2A1;SLC16A2;SLC16A7
prerank,fat cell differentiation (GO:0045444),-0.29705811210530336,-1.0844572975559192,0.3333333333333333,0.7542065491104585,1.0,16/57,12.87%,OSBPL8;PID1;SMAD6;WNT5B;FOXO1;EP300;KLF4;OSBPL11;PRDM16;ATF5;C1QTNF3;NR4A2;CTBP2;CLIP3;BBS2;TMEM120A
prerank,nuclear pore complex assembly (GO:0051292),0.5198593778962187,1.084350419899134,0.3833922261484099,0.954992164691106,1.0,5/10,15.65%,TPR;AHCTF1;NUP153;RTN4;NUP93
prerank,carboxylic acid metabolic process (GO:0019752),-0.32892286779492974,-1.0842259866842296,0.31629392971246006,0.7536377825773665,1.0,4/33,2.58%,PTGIS;ST3GAL1;DDO;CSGALNACT1
prerank,regulation of histone H3-K9 methylation (GO:0051570),-0.45969709967491923,-1.084079194895425,0.3695150115473441,0.7528564695076698,1.0,4/10,24.75%,JARID2;KDM1A;DNMT3B;BRCA1
prerank,regulation of ERAD pathway (GO:1904292),-0.44042348197210957,-1.0839641580390238,0.36790123456790125,0.7519079485602501,1.0,3/11,8.23%,USP19;RNFT1;AQP11
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.5028361132321736,1.083752087171107,0.3690909090909091,0.9558130461287891,1.0,5/10,19.43%,INPP5F;NF2;PIBF1;SOCS1;PPP2CA
prerank,blood vessel morphogenesis (GO:0048514),0.3746148788036842,1.083731251599773,0.3416557161629435,0.9548193715544939,1.0,8/54,7.94%,STRA6;CAV1;GLMN;NF1;COL4A1;EGFL7;EFNB2;CDH2
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),-0.3994179229145688,-1.0834382912085325,0.34430379746835443,0.7521693032678618,1.0,6/16,9.50%,IGF1;ROCK2;TRPC3;AKAP6;MEF2A;SLC9A1
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.3635382574739839,1.0829542542801331,0.34744707347447074,0.9561773816902375,1.0,19/67,18.82%,CAV1;ATP8B1;CAPZB;FXR2;FER;ATG5;RDX;ARF6;TBC1D16;TBC1D2;PLD1;TBC1D8;EVI5;FXR1;DYNC2LI1;TBC1D20;ATG3;TBC1D5;RAB5A
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.4435076429858094,1.0829427720177365,0.3629283489096573,0.9551543292056791,1.0,5/19,12.92%,BCL3;PHLDA3;HIPK1;MSH2;CDIP1
prerank,chondrocyte differentiation (GO:0002062),0.4150205450511206,1.0828288520681753,0.35912408759124087,0.9544417469954686,1.0,7/32,4.14%,SULF1;RUNX2;WNT2B;GPLD1;EIF2AK3;BMPR1B;SOX9
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.5014367249076528,1.0827951860039289,0.35547576301615796,0.9534923087510657,1.0,6/11,24.31%,LANCL1;P4HB;UBQLN1;PINK1;PRKN;REST
prerank,sphingosine metabolic process (GO:0006670),0.4582099747707414,1.0824258265316993,0.36597110754414125,0.95353798862331,1.0,3/17,4.08%,ACER3;PLPP2;PLPP3
prerank,leukotriene metabolic process (GO:0006691),0.4477286798775757,1.0823608336160806,0.38064516129032255,0.9526795465440178,1.0,5/19,15.53%,MGST2;ABCC1;ABCC10;LTA4H;GGT1
prerank,regulation of protein localization to cell periphery (GO:1904375),-0.3892549385455863,-1.0822948615045518,0.3387096774193548,0.7542599666256862,1.0,7/18,14.85%,STX8;ACTB;LDLRAP1;VPS4A;AR;ABCA2;ZDHHC2
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.41679247976317907,1.0820930483812374,0.34575260804769004,0.9524553149464728,1.0,3/27,2.03%,DLC1;F11R;ARAP1
prerank,regulation of organelle organization (GO:0033043),-0.274621425222058,-1.0820332560632098,0.2613065326633166,0.7537122942243806,1.0,17/80,9.28%,ZEB2;PDE4DIP;MSN;MYO5A;CLIC4;EP300;PREB;TMED9;SQSTM1;STX18;USP6NL;PDCD10;RBSN;NEXN;SURF4;PDE2A;DIAPH1
prerank,regulation of leukocyte chemotaxis (GO:0002688),-0.38798616037723666,-1.082013190277556,0.35658914728682173,0.7525430721348023,1.0,3/18,2.16%,SLIT2;IL6R;LYN
prerank,toll-like receptor 9 signaling pathway (GO:0034162),0.4940780776625039,1.081927234407207,0.3773913043478261,0.9519467193881321,1.0,3/13,5.56%,PIK3AP1;PIK3R4;TLR7
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),0.41881317607240626,1.0815695443816469,0.3770739064856712,0.9519629617239193,1.0,9/26,16.59%,NEDD4L;KCNS2;CASQ2;ATP1B3;KCNAB1;NEDD4;FHL1;WWP2;YWHAE
prerank,non-motile cilium assembly (GO:1905515),0.4118772925554276,1.0815555560670258,0.3746397694524496,0.9509709669597475,1.0,11/30,20.09%,GORAB;CEP89;C2CD3;CEP290;RPGRIP1L;PCM1;PIBF1;CEP250;BBS1;TMEM80;IFT57
prerank,estrogen metabolic process (GO:0008210),0.4661335482601888,1.0811269348040355,0.3587662337662338,0.9512618742530601,1.0,3/15,11.46%,SULT1A1;HSD17B4;HSD17B2
prerank,regulation of JUN kinase activity (GO:0043506),-0.32157801544783315,-1.0808298506390297,0.3292307692307692,0.7546375370087598,1.0,9/33,16.72%,SASH1;DUSP10;DNAJA1;TRAF6;MAP3K10;RPS3;TNFRSF11A;EDN1;DVL2
prerank,protein-containing complex assembly (GO:0065003),0.3178201356147554,1.0806657407658813,0.3357438016528926,0.95156345047122,1.0,49/259,16.19%,CLDN1;MAGI1;PPARGC1A;WIPF1;LAMC1;FOLR1;REPS2;AXIN1;PARD6B;CD3G;ANO6;KMT2A;SOX9;LEO1;SH3PXD2B;FANCC;FN1;CARD10;TRADD;TAPBP;CNIH1;ADAM10;TRAPPC9;CUL3;DARS1;OCLN;GSK3B;TFG;CSNK1A1;GRIA1;FERMT2;TRRAP;AXIN2;APC;PYGO1;MEN1;CREBBP;GSDMD;BCL9;YAP1;ZW10;MDN1;SEC23IP;TMED2;KMT2D;BAD;ADCY8;HGSNAT;TBC1D20
prerank,endothelial cell development (GO:0001885),-0.3549072494624978,-1.0805320691156797,0.3072289156626506,0.7542563897549026,1.0,8/25,9.71%,RAPGEF2;COL22A1;MSN;PECAM1;MYADM;COL15A1;PDE2A;ROBO4
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.3526635882088635,1.0804917360607462,0.3551980198019802,0.9510780993592746,1.0,17/80,16.93%,NGF;SRC;ACVR1C;FIS1;UACA;MAP3K5;RPS6KA3;SFN;HMGB1;USP47;DHCR24;AQP1;HTRA2;GPER1;BAD;YWHAE;SYK
prerank,protein exit from endoplasmic reticulum (GO:0032527),-0.371696297778307,-1.080244525652736,0.3463687150837989,0.7538910772698875,1.0,10/23,18.03%,PREB;TMED9;SEC61B;SURF4;SYVN1;VCP;SEC16A;OS9;DERL2;TECPR2
prerank,chromosome condensation (GO:0030261),-0.3188016994452746,-1.0799519973986194,0.29411764705882354,0.7534978077204404,1.0,17/36,30.39%,PHF8;SMC4;NCAPD3;MCPH1;H1-0;CSNK2A1;CSNK2B;AKAP8L;NCAPG2;NCAPD2;NUSAP1;TOP2A;BANF1;AIFM1;NCAPH;TTN;NCAPG
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.30969382830861925,1.07989688591991,0.3010204081632653,0.9519605901915356,1.0,99/366,22.37%,RORA;BNC2;NFATC2;PPARGC1A;ZNF423;EFEMP1;MYBBP1A;NFIA;CHD3;SPI1;FOXO3;KAT6B;SMC3;TOM1L1;BHLHE40;SP3;ONECUT1;ORC5;TGFBRAP1;PPIE;HIC1;LIN54;ZNF431;FBXO5;RREB1;MSL3;FOXK2;ZNF628;ELAVL2;POFUT1;ACTR8;MLF2;EIF4E;RORB;SUPT4H1;TRRAP;ATXN2;ORC3;TFEB;SAP30L;OBI1;USP13;WWC1;MZF1;EIF2B4;MED23;JMJD1C;SPIN1;CREBBP;NUCKS1;NCOA2;SOX4;BAZ2A;FZD7;SFPQ;REXO4;KMT2D;TAF5;E2F1;DMTF1;BACH1;SRRT;PSPC1;MAGED1;HP1BP3;USP37;ESRRA;GMNN;MTF2;DSCC1;CREM;CELSR2;RABL3;ASCC2;FOXO4;SPTY2D1;TCF7L1;TCF3;FADS1;ASCC1;PPP2CA;HNRNPD;HCFC2;ZNF22;DDIT3;RNF14;HMG20A;GZF1;CCAR2;ARNT2;ZSCAN21;DAXX;FOXC1;ATXN1L;SRSF10;PCGF1;NR1D2;ERC1;DDX25
prerank,early endosome to late endosome transport (GO:0045022),0.4530735167841801,1.0798586456650368,0.36281859070464767,0.9510292977600875,1.0,8/20,18.82%,HOOK2;WDR81;KIF16B;HOOK3;PIK3C3;WDR91;LMTK2;RAB5A
prerank,regulation of biosynthetic process (GO:0009889),-0.44485594124662603,-1.079703747121711,0.35467980295566504,0.7529566964104039,1.0,11/11,55.55%,SLC25A33;MID1IP1;SNCA;ALOX5;SPHK2;THRSP;GSTP1;CCN6;PIKFYVE;UCP1;PCK1
prerank,calcium ion import across plasma membrane (GO:0098703),0.47577478275202356,1.079479768038172,0.38385502471169686,0.9511876031848848,1.0,3/14,4.86%,SLC24A1;TRPV4;ATP2B4
prerank,cell projection assembly (GO:0030031),0.43302381078794877,1.0791434248930005,0.36436597110754415,0.9511656915710721,1.0,3/22,6.72%,PARVA;RAC2;RHOJ
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.4371002689472206,1.0790884380590304,0.3678516228748068,0.9503005623302122,1.0,6/22,13.75%,NR2F2;HEXIM1;APC;MEN1;PTEN;CDKN1C
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.3289303582698716,1.0789060690459935,0.337116912599319,0.9498258483940806,1.0,23/151,11.61%,SGMS2;ST3GAL4;CERS6;ARG1;ASS1;PCSK5;ACER3;ELOVL5;PLPP2;PLPP3;PCTP;SLC27A1;MGST2;ELOVL1;HACD4;ELOVL2;TNIP1;CERT1;GSTA4;GSTZ1;HACD2;GSTK1;GSTA3
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),0.4868347923211016,1.0787519248103719,0.39622641509433965,0.9492818709314861,1.0,3/13,14.84%,SORBS1;C1QTNF12;SNX5
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.39960431554339787,-1.0785981985997326,0.36989795918367346,0.754826573570206,1.0,3/16,1.23%,PDGFD;PDGFRB;PDGFRA
prerank,cellular response to interleukin-6 (GO:0071354),-0.3474881101637468,-1.0785314340739782,0.33933933933933935,0.753801094746044,1.0,4/26,1.81%,ST3GAL6;PTGIS;PID1;IL6R
prerank,activation of protein kinase B activity (GO:0032148),0.40715525005050895,1.0784487187077105,0.36503067484662577,0.949233619345455,1.0,6/29,10.61%,NTRK3;PRR5;FGF1;WNT5A;MAPKAP1;ADRA2A
prerank,negative regulation of inclusion body assembly (GO:0090084),-0.4512260956307011,-1.0774658661593248,0.3511627906976744,0.755578522435533,1.0,7/10,32.72%,DNAJB2;DNAJA4;HSPA1A;HSPA1B;DNAJB1;HSPA2;SORL1
prerank,B cell differentiation (GO:0030183),-0.3069560251514654,-1.077290653466304,0.30451127819548873,0.7548695153182319,1.0,10/46,9.77%,KLF6;KIT;CEBPG;FNIP1;HDAC9;VCAM1;PLCG2;NHEJ1;SYVN1;DCAF1
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.38401545862279274,1.0771010279554833,0.35207496653279785,0.9522990018014593,1.0,16/42,20.56%,HNRNPC;CHD3;CHD8;SMARCAD1;ACTR8;SMARCD2;HDAC2;PBRM1;ERCC6;INO80;INO80B;ACTR6;SPTY2D1;RBBP4;ZNHIT1;ARID1B
prerank,rRNA processing (GO:0006364),-0.23652637221011055,-1.0770095972113691,0.22340425531914893,0.7544387810362138,1.0,58/172,22.99%,RPL37A;RPL19;RPL8;RPL37;RPS15;RPL35A;RPS7;RPL32;RPS27;RPL27;RPL26;RPS24;RPLP0;RPS19;RPL31;RPL41;RPL13A;RPL30;RPL29;RPS16;RPL3;RPLP1;RPS17;WDR12;RPL23;RPL17;RPL9;RPL38;RPL36;RRP7A;ESF1;RPL18A;RIOK1;EXOSC3;IMP4;HEATR1;LAS1L;TEX10;POP5;RPS6;NOL9;RPLP2;DIS3;HELQ;DHX37;EXOSC1;FBL;RPL14;TBL3;RPS2;RIOK3;RPL10A;RPL34;RPL5;RPL39;UTP4;PWP2;RPL22
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.3028542560220526,1.0768039465722528,0.18,0.9521866788963662,1.0,290/1646,16.89%,EBF2;RORA;MEOX2;ZBTB7C;BNC2;KLF5;ETV4;FGF7;MDFIC;CDK15;VGLL4;NFATC2;ETV1;GLI1;PPARGC1A;PRICKLE1;PAX9;FOXD2;NR2F2;TSHZ3;PHC2;NR3C2;DLX1;POU4F3;RGS14;FOXP2;ZNF423;FOXD1;CAMK2D;NFATC1;ZBTB32;EFEMP1;KLF12;ZSCAN25;PBX1;BHLHE22;FZD2;EGFR;ZBTB20;BCL3;ATP8B1;NPAS3;NEUROD6;MYBBP1A;RUNX2;AXIN1;ETV5;OGT;GLI2;NFIA;HIVEP2;ZSCAN18;RBFOX2;HOXB6;TEF;KMT2A;ZKSCAN7;IRF2BP1;SFMBT2;CHD3;CIART;MLLT3;SPI1;KLF3;ZNF418;L3MBTL3;FOXK1;FOXO3;FOXP4;NPAS2;UBE2I;SOX9;ZBTB8A;PGR;REL;CHD8;CREB3L1;GLIS2;ZNF585B;ZNF585A;KAT6B;CHD2;KLF10;LANCL2;HDAC4;SATB1;ZBTB3;WNT5A;CHD1;ATP2B4;POU5F2;NUP62;HEYL;PPM1A;RBM15B;BHLHE40;ZFP3;SP3;ZNF697;ZNF326;ATAD2;ZFP1;ZFP90;RGMB;MED18;TARBP1;ANXA4;ARID3A;ANKRD2;TEAD3;ONECUT1;RCOR3;ZFP14;TGFBRAP1;PPIE;MED12L;CTCF;TBX2;NRF1;NFE2L1;DDX17;NCOR1;HIC1;ZFP62;LIN54;ZNF431;PIAS2;PAX3;HOXC10;ONECUT3;FBXO5;RREB1;MAFG;RARA;DBX2;SUV39H1;PKNOX2;MSL3;USF2;LHX6;FOXK2;ILF2;POLR3G;MAP3K5;E4F1;TSC22D4;KCTD1;ISL1;MYPOP;DYRK1A;ZNF628;TBX18;UIMC1;MED7;ELAVL2;AATF;ZBTB6;MED13;POFUT1;SLTM;TCF20;RPS6KA3;MECP2;ACTR8;MLF2;COL1A1;HMGB1;USP47;SMARCD2;FOXJ1;BAZ2B;RORB;POU4F1;HDAC2;SUPT4H1;CNOT7;DBP;TRRAP;TLX3;KARS1;NCOR2;CTDSP1;ILF3;TFEB;SAP30L;USP13;FBXL19;HEXIM1;ERCC6;WWC1;ZHX1;SIX5;DVL3;EN2;HTATIP2;MZF1;HDAC6;EGR1;PHF20L1;MED23;ZBTB49;JMJD1C;ZNF148;BICRA;TASP1;KDM8;CEP290;MEN1;ERF;NFE2L2;STAT2;NAT14;SPIN1;CREBBP;CDC6;HOPX;PEG3;TTC21B;TAF15;GTF2H1;CRLF3;NUCKS1;ARID4A;NFATC4;MBD1;NCOA2;CBFB;SOX4;SFMBT1;GMEB1;BRF2;BAZ2A;CDKN1C;CAMTA2;DPF3;ZNF260;TIAL1;FZD7;ZFP57;EPC2;SFPQ;YAP1;ZNF182;KAT8;RAI1;MED12;NEK4;LCOR;FOXJ2;ERBB4;SNX5;FOXF1;REXO4;POU6F1;TADA2A;NR5A1;PRMT6;BATF;WWP2;RUNX1;KMT2D;SCML2;MED8;TAF5;TOX4;RELB;FOXC2;CDH1;ERBB2;E2F1;SCML4;PCGF3;GBX1;PCBD2;DMTF1;BRIP1;BACH1;TESC;SRRT;MED29;PPARG;ELOA;PBX4;MTERF3;PSPC1;MAGED1;ARHGEF11;BRWD1;HP1BP3;PGBD1
prerank,adherens junction organization (GO:0034332),0.3800754760128838,1.076737344936481,0.3754993342210386,0.951376753550497,1.0,5/48,3.29%,CDH13;CDH11;CDH5;CDH17;CDH9
prerank,regulation of macrophage cytokine production (GO:0010935),-0.4211633218883991,-1.0766382570678878,0.3894736842105263,0.7543101933231411,1.0,7/13,17.12%,SEMA7A;PLCG2;TGFB3;CUEDC2;TGFB2;LAPTM5;GPRC5B
prerank,positive regulation of DNA repair (GO:0045739),0.3787518672594166,1.076602416036358,0.3406896551724138,0.9507296716187458,1.0,10/46,12.29%,EGFR;FAM168A;BRCC3;EYA1;NPAS2;UIMC1;WRAP53;HMGB1;ERCC6;MGMT
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.379232564873766,1.075854346695468,0.35939643347050754,0.9520019652543779,1.0,17/46,22.04%,GTSE1;RAPGEF3;UBR5;BAG3;RBM22;PIK3R2;GSK3B;TPR;NEDD4;EMD;RAN;CDH1;YWHAE;HDAC3;DHX9;TCF7L2;XPO4
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.4192912496716603,-1.075686752137785,0.36649214659685864,0.7558542457443466,1.0,6/13,24.18%,KDR;IL33;JAK2;EDN1;NOD2;NAMPT
prerank,ribosome biogenesis (GO:0042254),-0.23885225413716557,-1.0752987123808426,0.24050632911392406,0.7557112382447606,1.0,71/187,25.84%,RPL37A;RPL19;RPL8;RPL37;RPS15;RPL35A;RPS7;RPL32;RPS27;RPL27;RPL26;NPM1;HEATR3;RPS24;RPLP0;RPS19;RPL31;RPL41;RPL13A;RPL30;RPL29;RPS16;RPL3;RPLP1;RPS17;WDR12;RPL23;RPL17;EIF2A;RPL9;RPL38;RPL36;RRP7A;ESF1;RPL18A;RIOK1;ABCE1;NOC2L;EXOSC3;IMP4;HEATR1;LAS1L;TEX10;POP5;RPS6;NOL9;RPLP2;DIS3;HELQ;DHX37;EXOSC1;FBL;RPL14;TBL3;RPS2;DHX29;RPL10A;RPL34;RPL5;RPL39;UTP4;PWP2;RPL22;RPS9;WDR3;RPS14;MRPL36;PAK1IP1;RPS25;NOB1;RPF2
prerank,cation transmembrane transport (GO:0098655),0.3851282178564913,1.0752211846612467,0.3616133518776078,0.9529024977433853,1.0,7/44,7.11%,TRPM3;SFXN2;SLC29A4;CACNA1H;SLC25A20;ATP1A2;SLC7A2
prerank,lamellipodium assembly (GO:0030032),0.4188706750214806,1.0751446860501905,0.37325038880248834,0.9521164866818391,1.0,4/26,6.40%,CDH13;ABLIM3;SPEF1;ABLIM2
prerank,branching morphogenesis of an epithelial tube (GO:0048754),-0.3173314513746672,-1.0749572415553241,0.3413793103448276,0.7555220865405847,1.0,13/39,20.01%,ENG;SLIT2;BMP4;TIE1;RASIP1;KDR;LRP6;BMP2;NRP1;SALL1;LRP5;MET;NOTCH4
prerank,regulation of ossification (GO:0030278),0.3870330876574098,1.0746647838564196,0.36554621848739494,0.9525468485543217,1.0,5/36,7.17%,LRP4;SGMS2;SOX9;WNT5A;BMP2K
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.36861531849747375,1.0746384534983624,0.3736979166666667,0.9516117292364473,1.0,13/51,22.82%,HNRNPC;SRC;NEK7;STN1;NAF1;EXOSC10;CCT2;GNL3L;TERF2;ATR;CCT3;SMG6;MAPK1
prerank,negative regulation of transmembrane transport (GO:0034763),-0.4553094634421004,-1.0745343866211283,0.3544600938967136,0.7554945924075747,1.0,3/10,12.84%,CTTNBP2NL;AKT1;THBS1
prerank,myotube cell development (GO:0014904),-0.4567549087883276,-1.0742865914191968,0.391705069124424,0.7549633528520059,1.0,2/10,7.53%,IGF1;SELENON
prerank,regulation of catecholamine secretion (GO:0050433),-0.31964861335064343,-1.0738276659895205,0.33226837060702874,0.7550509977151717,1.0,21/29,43.24%,KCNB1;SYT9;SYT7;DTNBP1;SYT13;SYT6;KCNA2;CHRNA4;SYT15;SYT1;SYT5;SYT17;CHRNB2;SNCA;SYT4;SYT3;DRD3;CHGA;FGF20;HRH3;SYT8
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.4813835459557073,1.0736171169848192,0.3870967741935484,0.953736025393638,1.0,5/13,18.37%,FGFR1;APLN;HMGB1;MDK;PDPK1
prerank,negative regulation of blood pressure (GO:0045776),-0.4120622356654569,-1.073502828250751,0.375609756097561,0.7547697035699799,1.0,5/13,18.25%,NOS3;BMPR2;PRCP;NOS1;GPR37L1
prerank,blood circulation (GO:0008015),0.38284492560873584,1.0729701287864848,0.37632978723404253,0.954691246384688,1.0,4/49,3.92%,MEOX2;SERPING1;SGCD;SGCG
prerank,myeloid cell activation involved in immune response (GO:0002275),0.4439496567028529,1.0729134153555901,0.3703099510603589,0.9538452344330159,1.0,3/18,10.39%,LBP;DOCK2;KARS1
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),-0.39658852082557067,-1.0727318158399117,0.36538461538461536,0.7557517856967034,1.0,4/16,2.66%,IGF1;IGFBP2;IGFBP3;IGFBP5
prerank,regulation of programmed cell death (GO:0043067),-0.24339054301558666,-1.072018428363342,0.2627118644067797,0.7566011605919954,1.0,27/161,11.21%,MECOM;DAPK1;HIP1;ACTN2;OMA1;TPT1;ACER2;STEAP3;TGM2;IGFBP3;WRN;BCL2L11;MADD;GAS1;FAS;PRDX2;LRP8;USP42;JAK2;AKT1;HS1BP3;NAE1;VCP;HAX1;RPS3;BID;USP36
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",-0.4464421864195329,-1.0717675895548686,0.3976190476190476,0.7561219999286043,1.0,7/10,45.53%,SP100;RPS27L;KAT5;TFAP4;MUC1;FOXM1;RPS6KA6
prerank,glial cell differentiation (GO:0010001),-0.334666223887225,-1.0712688040129172,0.3519736842105263,0.7563504744809639,1.0,3/28,2.19%,NFIB;ADGRG6;SLC8A3
prerank,regulation of T cell differentiation (GO:0045580),0.40365038141001686,1.0707629837607815,0.367816091954023,0.9593823222777377,1.0,6/33,16.20%,NFATC2;CRTAM;IL7;CBFB;RUNX1;MDK
prerank,regulation of macrophage activation (GO:0043030),-0.3345777832051446,-1.0704708973888128,0.32903225806451614,0.7573574528444844,1.0,11/30,14.21%,IL31RA;MFHAS1;NR1H3;IL33;CD200;ZC3H12A;GPR137B;THBS1;MYO18A;SPHK1;PJA2
prerank,positive regulation of leukocyte migration (GO:0002687),-0.33721210543629254,-1.0699165901505718,0.33436532507739936,0.7577032298320396,1.0,10/27,32.81%,IL6R;CSF1;EDN3;ICAM1;NCKAP1L;PTN;ADAM8;JAM3;ADAM17;AIF1
prerank,positive regulation of isotype switching (GO:0045830),-0.4026912246263262,-1.0698527247827763,0.37777777777777777,0.756663461713789,1.0,8/15,26.75%,TFRC;PAXIP1;SHLD2;CD40;MAD2L2;CLCF1;TNFSF13;HMCES
prerank,protein heterotetramerization (GO:0051290),-0.43296509246953885,-1.0695881419772868,0.3853904282115869,0.7562442349932117,1.0,6/13,27.24%,FARSB;GRIN2B;GRIN1;CPSF7;CPSF6;HSD17B8
prerank,membrane repolarization during action potential (GO:0086011),-0.4149238675749693,-1.069537576913525,0.37433155080213903,0.7552170280255719,1.0,6/13,29.91%,KCNJ2;ATP1B1;KCNE4;KCNH2;ATP1A1;KCNQ1
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.3044124250976234,1.0695374388456045,0.2752752752752753,0.9621669610140162,1.0,122/807,14.43%,PTCH1;TENM2;CAV1;MDFIC;VGLL4;PRICKLE1;PAX9;NR2F2;TSHZ3;PHC2;NEDD4L;DLX1;RARB;FOXP2;ZNF423;FOXD1;ZBTB32;KLF12;LDB2;BCL3;ATP8B1;MYBBP1A;RUNX2;ETV5;GLI2;RBFOX2;IRF2BP1;SFMBT2;CHD3;CIART;SPI1;L3MBTL3;PHF21A;FOXK1;BEND3;FOXO3;FOXP4;UBE2I;SOX9;CHD8;CREB3L1;GLIS2;KAT6B;KLF10;LANCL2;HDAC4;SATB1;WNT5A;DACT1;HEYL;PPM1A;N4BP2L2;RBM15B;BHLHE40;SP3;NRIP1;ZFP90;KANK2;ANKRD2;RCOR3;SIN3B;CTCF;TBX2;PEX2;PAF1;NCOR1;HIC1;NCOA5;ZNF431;RREB1;RARA;SUV39H1;FOXK2;E4F1;TSC22D4;KCTD1;ISL1;MYPOP;UIMC1;MECP2;SIRT7;HMGB1;USP47;FOXJ1;RORB;POU4F1;HDAC2;SUPT4H1;CNOT7;LEFTY1;NCOR2;ILF3;TPR;HEXIM1;RARG;WWC1;ZHX1;OTUD7B;MZF1;HDAC6;ZNF148;KDM8;MEN1;ERF;SEMA4D;CREBBP;PEG3;ARID4A;TCERG1;MBD1;CBFB;SFMBT1;CDKN1C;DPF3;ZFP57;DICER1;SFPQ;UBE2D1;UBE2D3;YAP1;KAT8;DNAJA3
prerank,body fluid secretion (GO:0007589),-0.39887718447569176,-1.0688960681874051,0.3592964824120603,0.7558690350725746,1.0,3/15,4.35%,GPAT4;SLC22A4;NPR1
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.3906202360807828,1.0687831034490154,0.3871866295264624,0.9634376125633624,1.0,10/39,16.73%,UTRN;NEDD4L;SCN2B;FXYD6;NEDD4;FHL1;CHRM3;WWP2;YWHAE;FGF12
prerank,oligodendrocyte development (GO:0014003),0.4639798403985877,1.0687388941514895,0.3971061093247588,0.9625318913557195,1.0,4/15,13.39%,EIF2B3;CNTNAP1;EIF2B4;NSUN5
prerank,sodium ion transmembrane transport (GO:0035725),0.35025350313996667,1.0687038011444951,0.3553921568627451,0.9615961150886985,1.0,14/84,11.27%,NALCN;SCN10A;SLC12A2;ANO6;SLC24A1;SLC12A3;KCNK1;ATP1A2;SLC6A13;SLC4A4;ATP1B3;SCN2B;SLC9A7;SLC9A6
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),-0.40196657080676684,-1.0681720951298328,0.36318407960199006,0.7567605639754256,1.0,2/14,1.71%,RAPGEF2;PKIG
prerank,vasculature development (GO:0001944),0.4479560235397312,1.0681129733231993,0.3778877887788779,0.9623792104697302,1.0,2/16,2.62%,STRA6;CDH5
prerank,protein autoprocessing (GO:0016540),-0.3784479045228802,-1.0678955247044495,0.3695652173913043,0.7563228258407138,1.0,4/17,14.57%,OMA1;CTSL;SPRTN;FXN
prerank,mitochondrial fusion (GO:0008053),0.45399273603579915,1.0675069531867147,0.3941267387944359,0.963206516717575,1.0,11/18,28.39%,MFN2;FIS1;MIEF1;MIGA1;BAX;STOML2;CHCHD3;THG1L;MFF;SPG7;AFG3L2
prerank,ribosome assembly (GO:0042255),-0.29699281565658026,-1.0673984606427194,0.3233082706766917,0.7565600048727086,1.0,25/47,29.59%,RPS15;RPS27;NPM1;RPLP0;RPS19;RPL3;EIF2A;RRP7A;MRPL20;DHX37;MRPS11;NLE1;DHX29;PPAN;RPL5;C1QBP;RPS27L;PWP2;ERAL1;RPS14;RPF2;RPL11;DDX3X;RPL24;MRPS2
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),-0.42687044615804604,-1.0672095712402836,0.395,0.755883506662965,1.0,8/12,45.65%,INSIG2;OS9;GPAA1;TAPT1;ANKRD13C;KDELR1;KDELR2;RER1
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),-0.383571877090439,-1.0671663890410945,0.34877384196185285,0.7548646748257047,1.0,8/17,30.36%,ANK2;SCN4B;SCN1B;KCNE4;KCNH2;SCN5A;KCNQ1;GJA5
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.34709316932724993,1.0670032314407483,0.366751269035533,0.9637153201521307,1.0,11/74,9.14%,ITGA6;EYA1;IL1A;SRC;BMP5;PSME3;TNFAIP3;TRADD;MCL1;MAPK7;GSK3B
prerank,calcium-mediated signaling (GO:0019722),0.3420108121821118,1.066981995711191,0.35125448028673834,0.9627732915543945,1.0,13/93,10.34%,ACKR3;PLCE1;PTGFR;EGFR;FKBP1B;EIF2AK3;FIS1;PTPRC;RCAN1;PTPRJ;IRGM;KSR2;LAT
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.38353188653726034,1.0669103735119287,0.38482758620689655,0.9619485519857225,1.0,5/43,4.80%,KLF5;SPI1;FOXO3;SOX9;APLN
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.45410487978378605,1.0661937715472725,0.4044750430292599,0.9630568035643992,1.0,3/16,6.98%,CEACAM1;SOX9;NCOR1
prerank,positive regulation of vasculogenesis (GO:2001214),0.5088111827067728,1.0661545965528054,0.41924398625429554,0.9621581184473391,1.0,2/10,1.92%,CEACAM1;RAP1A
prerank,negative regulation of G0 to G1 transition (GO:0070317),-0.31869343165302616,-1.0660296808701268,0.32592592592592595,0.7568433425221773,1.0,16/36,30.35%,PCGF2;PHC3;BMI1;RYBP;CDC7;SUZ12;EED;EHMT2;L3MBTL2;RAD51;BRCA1;RNF2;PCGF6;RING1;MAX;E2F6
prerank,mitochondrial transcription (GO:0006390),0.4999485691930908,1.0659566404051508,0.411663807890223,0.9617171115313693,1.0,4/10,14.04%,FOXO3;TFB2M;MTERF2;TEFM
prerank,negative regulation of interleukin-8 production (GO:0032717),0.4558440971747495,1.0658566054827034,0.3770491803278688,0.9610216618857228,1.0,4/17,11.13%,BCL3;PTPN22;ANXA4;OTUD7B
prerank,cell projection organization (GO:0030030),0.4056114784399716,1.0657377341708143,0.3773006134969325,0.9603454694973781,1.0,5/30,9.13%,PARVA;RAC2;PACSIN2;RHOJ;PLEK
prerank,clathrin-dependent endocytosis (GO:0072583),-0.3380646780003821,-1.0656785337438706,0.3677811550151976,0.7566551120845049,1.0,6/26,15.15%,PICALM;DNAJC6;AP2A1;FCHSD2;LMBRD1;FNBP1L
prerank,glutathione derivative biosynthetic process (GO:1901687),0.4374716386609017,1.0655303271441163,0.38580246913580246,0.9589549052151909,1.0,5/20,11.61%,MGST2;GSTA4;GSTZ1;GSTK1;GSTA3
prerank,glutathione derivative metabolic process (GO:1901685),0.4374716386609017,1.0655303271441163,0.38580246913580246,0.9589549052151909,1.0,5/20,11.61%,MGST2;GSTA4;GSTZ1;GSTK1;GSTA3
prerank,ncRNA processing (GO:0034470),-0.23132318594024592,-1.0653285337652183,0.23376623376623376,0.7563791561804305,1.0,70/200,24.46%,SMAD3;RPL37A;INTS9;ADAR;SSB;RPL19;RPL8;RPL37;RPS15;RPL35A;RPS7;RPL32;RPS27;RPL27;RPL26;RPS24;RPLP0;RPS19;RPL31;RPL41;RPL13A;RPL30;RPL29;RPS16;RPL3;RPLP1;AGO3;RPS17;WDR12;RPL23;RPL17;RPL9;RPL38;RPL36;RRP7A;ESF1;RPL18A;PUS10;AGO4;INTS1;EXOSC3;TUT7;IMP4;HEATR1;LAS1L;TEX10;POP5;RPS6;NOL9;RPLP2;DIS3;HELQ;DHX37;EXOSC1;FBL;RPL14;TBL3;RPS2;RPL10A;RPL34;RPL5;RPL39;UTP4;PWP2;RPL22;SMAD1;MRPL44;RPS9;WDR3;RPS14
prerank,sulfate transport (GO:0008272),-0.41334120060975943,-1.0651677892880849,0.3804878048780488,0.7556355375947368,1.0,4/14,9.18%,SLC26A7;SLC26A2;SLC25A30;SLC25A11
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.39095095908328925,1.0651176404611375,0.3702127659574468,0.9591927624185418,1.0,3/35,1.86%,NTRK3;F11R;RAPGEF3
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.38969658835652027,1.0648659331837762,0.3892709766162311,0.9589378066462702,1.0,12/38,21.44%,PHLDA3;BANK1;DAG1;PTPRJ;PHLPP1;PTEN;PLEKHA1;GPER1;DDIT3;MUL1;TSC2;PPP2R5C
prerank,protein insertion into mitochondrial membrane (GO:0051204),-0.3589898266324928,-1.0644186609818946,0.3324022346368715,0.7564960935989701,1.0,8/23,21.33%,BCL2L11;SAMM50;TIMM8B;COX18;TIMM10B;ROMO1;MAIP1;TIMM29
prerank,positive regulation of programmed cell death (GO:0043068),0.3093702045816948,1.0643084874214632,0.3447204968944099,0.9596551838664766,1.0,61/272,17.46%,NGF;ITGA6;DKKL1;TIAM2;ANO6;TNFAIP8;GPLD1;NF1;TFPT;AKAP13;RNF122;PHLDA3;APH1B;FOXO3;VAV2;ACVR1C;TRIO;NCSTN;TRADD;ARHGEF5;PHLDA1;NLRC4;ARHGEF1;SIAH1;MAP3K5;KALRN;RBM5;OBSCN;SLC27A4;RASSF2;STK3;NLRP2B;HMGB1;RARG;HTATIP2;APC;HDAC6;ARHGEF6;FAF1;PTPA;ATG7;ADAMTSL4;DIABLO;SOX4;HTT;HTRA2;FZD9;AIFM2;UNC13B;PDCD2;GPER1;BAD;CTNNBL1;E2F1;PLEKHG2;ARHGEF11;ARHGEF7;SYK;QRICH1;SCRIB;BNIP3
prerank,positive regulation of neurogenesis (GO:0050769),0.355680347983248,1.0642890367631228,0.3798449612403101,0.9587065773224511,1.0,5/68,4.61%,NGF;RGS14;TIAM2;CDKL3;PLXNA3
prerank,regulation of actin filament-based process (GO:0032970),0.35407302128923684,1.0642788248548012,0.3787878787878788,0.9577452237200818,1.0,4/70,1.32%,EFNA5;DLC1;F11R;ARHGAP18
prerank,anion transmembrane transport (GO:0098656),0.35707116188167504,1.0642011524825836,0.38051948051948054,0.9569780554018795,1.0,11/67,7.11%,LRRC8D;SLC35A1;SLC25A12;SFXN2;PRAF2;SLC27A1;ABCC1;SLC6A13;SLC35C2;SLC1A6;SLC7A2
prerank,negative regulation of response to cytokine stimulus (GO:0060761),0.5049283882989564,1.0641032681977802,0.395910780669145,0.9562996587870215,1.0,3/10,7.62%,IRAK3;PTPRC;MAPK7
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),-0.3409717613578786,-1.063857728094913,0.3343558282208589,0.7569731080484797,1.0,7/26,13.27%,ACER2;NOS3;CYP1B1;GCH1;AKT1;ABCA2;SPHK1
prerank,peptidyl-proline modification (GO:0018208),0.4158067836935515,1.063492003981763,0.38664596273291924,0.957065954163709,1.0,6/25,14.63%,FKBP5;FKBP1B;PPIE;PPIL6;PPIC;PPIG
prerank,regulation of oligodendrocyte differentiation (GO:0048713),-0.3734101406921858,-1.0633999736150386,0.38292011019283745,0.7570993214699634,1.0,6/18,12.50%,TNFRSF21;OPALIN;TNFRSF1B;SLC45A3;DAAM2;IL34
prerank,protein modification process (GO:0036211),0.3494985533690596,1.0628467545151623,0.37333333333333335,0.9580144263238753,1.0,17/76,15.38%,SLC35A1;UBE2L6;DUSP12;STK38;MMP15;ERO1A;UBE2I;CDKL3;CPE;ABL2;CSNK1G3;MANBA;FBXO11;LCMT1;UBE2D3;CHRM3;WWP2
prerank,positive regulation of cellular protein localization (GO:1903829),0.3491868438417737,1.062659298617165,0.385,0.957564582036731,1.0,18/69,19.01%,GTSE1;RIC3;EIF2AK3;LIMK2;NUP62;CARD10;DDRGK1;GSK3B;FERMT2;APC;SLC5A3;YAP1;RTN4;STX4;GNL3L;TM9SF4;CEP250;LAMTOR5
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.47217896180071506,1.0625758754246066,0.36902800658978585,0.9568191298160356,1.0,6/13,22.73%,VDAC2;BAD;BNIP3;BAX;BLOC1S2;RHOT2
prerank,vesicle cytoskeletal trafficking (GO:0099518),-0.3100931459667311,-1.062384601943149,0.34965034965034963,0.7587217357951019,1.0,4/39,2.67%,MYO1D;MYO1B;MYO5A;MYO6
prerank,nucleic acid metabolic process (GO:0090304),0.35290906010262063,1.0623246748180208,0.37084398976982097,0.9565682907942488,1.0,12/69,12.03%,HNRNPC;RBFOX2;PCBP2;HNRNPA0;WDR74;DXO;KPNA2;HNRNPR;NT5E;HNRNPM;ATXN2;GTF2F2
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.30203319600807277,1.062186201971389,0.3373493975903614,0.9559908932623896,1.0,61/509,11.23%,ROR2;GAB1;DCN;ROR1;CAV1;FGF7;PLK2;NTRK3;CDH13;FGFR1;LPAR1;NR3C2;HCST;PIK3AP1;EGFR;PELI2;FGF1;AKAP13;CAV2;WNT16;SOX9;REL;SLC35B2;SRC;RAC2;WNT5A;WDR24;FIS1;PTPRC;NUP62;MIOS;PPM1A;FN1;TLR7;TRADD;TRIM21;SIAH1;NOS1AP;GCNT2;PTPRJ;PIK3R2;S100B;FGF18;GAB2;TFG;HMGB1;TICAM1;TMED4;AXL;FERMT2;CANT1;STRN;SHARPIN;ADRA2A;RELN;S100A9;HEXIM1;WWC1;TAB2;NEDD4;PLXNB1
prerank,regulation of cellular protein metabolic process (GO:0032268),-0.2942420586963154,-1.0621431240631143,0.3384615384615385,0.758247856101991,1.0,21/47,29.91%,NR1H3;AGTR1;KLF4;APOE;NR1H2;AKT1;EIF2A;TCOF1;EDN1;CSF1;EIF4G1;AGT;RBM4B;INHBA;GEMIN5;TSC1;MTPN;NANOS3;GRM5;RBM3;VPS35
prerank,regulation of osteoblast differentiation (GO:0045667),0.3433589596009521,1.0621308917004182,0.3682266009852217,0.9551842196183703,1.0,4/82,4.14%,PTCH1;RUNX2;BMPR1B;SOX9
prerank,regulation of JNK cascade (GO:0046328),-0.25766943042610785,-1.0619190422970295,0.3103448275862069,0.7577017646296621,1.0,13/101,6.81%,IGF1R;PLCB1;MECOM;TNFRSF19;TGFBR3;CCN2;MFHAS1;SIRPA;DUSP10;SH3RF3;DUSP3;ANKRD6;TRAF6
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.3612171644311432,1.0617048110508707,0.3811944091486658,0.9555080174754575,1.0,8/66,4.14%,CAV1;NR2F2;SULF1;CEACAM1;CASK;NF1;CAV2;SOX9
prerank,long-chain fatty acid metabolic process (GO:0001676),0.35863277358394824,1.0616686458319744,0.39185750636132316,0.9546268382775344,1.0,14/64,13.04%,AIG1;EPHX1;ELOVL5;ALOXE3;ELOVL1;ELOVL2;HSD17B4;SLC27A4;ACOT8;ACOT2;LTA4H;ABCD1;ELOVL6;PNPLA8
prerank,protein transmembrane import into intracellular organelle (GO:0044743),-0.3270835177178655,-1.061590939334073,0.37752161383285304,0.7574173162384535,1.0,16/31,33.11%,TIMM44;PAM16;TIMM17B;PEX26;PEX6;PEX1;ROMO1;PEX10;GRPEL1;DNLZ;AIFM1;TIMM50;HSPD1;TIMM21;PEX5;TIMM23
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.2983844308916839,1.0615442616792867,0.2822822822822823,0.9540092201517903,1.0,174/1082,15.49%,RORA;MEOX2;DCN;KLF5;ETV4;ITGA6;FGF7;MDFIC;CDH13;NFATC2;ETV1;GLI1;PPARGC1A;FOXD2;NR2F2;DLX1;POU4F3;RARB;ZNF423;NFATC1;LDB2;PBX1;FZD2;EGFR;BCL3;NPAS3;RUNX2;FGF1;AXIN1;JAG1;ETV5;TNIP3;OGT;NUFIP1;GLI2;NFIA;IL4I1;KMT2A;CRTC1;MAML2;LMO7;MLLT3;TXK;SPI1;LMO1;FOXK1;EIF2AK3;FOXO3;NPAS2;BMPR1B;SOX9;PGR;REL;TFR2;CHD8;SLC30A9;GLIS2;KAT6B;CSRP3;BMP5;KLF10;HDAC4;WNT5A;NUP62;HEYL;PPM1A;SP3;ATAD2;NRIP1;ZFP90;RGMB;RPRD1B;ONECUT1;NCK2;CDK7;CTCF;NRF1;DDX17;UTP15;PAX3;HOXC10;RREB1;RARA;MAPK7;USF2;FOXK2;ILF2;PIK3R2;MAP3K5;E4F1;ISL1;DYRK1A;ELL;ZNF462;TNIP1;AATF;DDRGK1;AGO1;MED13;PLSCR1;TCF20;RPS6KA3;TET1;SIRT7;COL1A1;HMGB1;SMARCD2;FOXJ1;RORB;POU4F1;HDAC2;SUPT4H1;DBP;KARS1;TMF1;RTRAF;ILF3;TFEB;FHOD1;PAXBP1;MMP12;ERCC6;RARG;DVL3;HTATIP2;MZF1;EGR1;INO80;ZBTB49;BICRA;TASP1;KDM8;CEP290;MEN1;NFE2L2;AKIRIN1;NCOA3;NAT14;SPIN1;CREBBP;CD81;KDM6B;PEG3;TAF15;GTF2H1;PKD1;CRLF3;TCERG1;NCOA2;SOX4;BCL9;CDKN1C;CAMTA2;DPF3;FZD7;SFPQ;YAP1;KAT8;RAI1;CAPRIN2;MED12;NEK4;FOXJ2;ERBB4;SNX5;BRD8;FOXF1;AUTS2;NR5A1;COPS5;RUNX1;CCDC62;GPER1;KMT2D
prerank,excitatory postsynaptic potential (GO:0060079),-0.36503035436495934,-1.0612945052023492,0.3685636856368564,0.7570517603385727,1.0,5/19,12.09%,GRIN2B;AKT1;GRIN1;GSK3A;LRRK2
prerank,negative regulation of epithelial cell migration (GO:0010633),0.3921802901055117,1.0607748577298368,0.391304347826087,0.9553539635517098,1.0,2/33,0.73%,DCN;NR2F2
prerank,B cell homeostasis (GO:0001782),-0.4528004416608954,-1.0607604959812225,0.4022727272727273,0.7574870468249328,1.0,2/10,2.16%,DOCK11;LYN
prerank,negative regulation of developmental process (GO:0051093),-0.2700914570465824,-1.060754256808999,0.3316831683168317,0.7563580287455246,1.0,22/69,20.01%,NFIB;ROCK2;OMA1;NOS3;BMP4;TFRC;GRIN3A;TBX1;CDK6;WDR77;SINHCAF;BMP2;FUZ;ARHGEF15;DCC;MAPT;SUZ12;RC3H1;WNT11;VASH1;MIF;NOTCH4
prerank,cell junction assembly (GO:0034329),0.33896620799600174,1.0603702962885182,0.37648456057007124,0.9556056337952054,1.0,16/100,10.19%,ITGA6;TLN2;CDH11;PARD6B;CDH5;RAB29;CDH9;TRPV4;OPHN1;DSCAM;FN1;CDH2;GPM6A;PKP4;POU4F1;FERMT2
prerank,central nervous system development (GO:0007417),0.30969084097492666,1.0603334510588152,0.3637316561844864,0.954727969572125,1.0,23/250,9.63%,PTCH1;APOD;VIT;PBX1;NF1;NPAS2;SOX9;CHD8;GLIS2;LSR;NCAN;SHROOM2;AMIGO2;COL4A1;TAGLN3;ALDH5A1;CDH2;S100B;EML1;JRKL;PTS;RPS6KA3;FOXJ1
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),-0.29328052460786624,-1.0602908354752747,0.33941605839416056,0.7565210446137335,1.0,26/50,28.90%,CCNT2;BLM;ACTB;MNAT1;CNPPD1;CDC25A;CCNT1;CAMK2N1;TTBK1;CDK5R1;SERTAD1;CCNE2;CCNJL;CCNH;CDK5RAP3;BCCIP;CDC37;STOX1;CCND2;CCNF;CDKN2C;CDKN1B;CCNK;CCND1;CDKN2D;CCNB2
prerank,keratan sulfate biosynthetic process (GO:0018146),0.41490128797712994,1.059951970107776,0.38439306358381503,0.9549034938500233,1.0,5/26,9.48%,ST3GAL4;PRELP;B4GAT1;SLC35D2;CHST2
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.3092435058705154,1.0598258389081432,0.37777777777777777,0.9543128652332041,1.0,78/264,23.99%,DHX8;HNRNPC;CSTF1;SF3B2;SF3B1;PCBP2;RBM8A;RBM10;RNPC3;SRSF4;HNRNPA0;ZRSR2;SNRPF;RBM15B;CDK13;HNRNPR;SF3B5;PPIE;DDX17;PRPF3;SMN1;CHERP;CSTF3;DDX46;RBM22;SRPK1;RBM5;DNAJC8;ELAVL2;SNU13;CELF4;HNRNPM;SRPK2;DBR1;UPF3B;GTF2F2;SRRM2;SNRPA1;DDX42;SFPQ;TRA2B;DHX16;SF1;SUGP1;PDCD7;SYNCRIP;CTNNBL1;SRRT;PSPC1;SLU7;CWC22;SYMPK;STRAP;PLRG1;SRSF3;MTREX;LSM3;DHX38;HNRNPD;DHX9;SRSF12;UBL5;NUDT21;SRSF11;SRSF10;ELAVL1;CWC25;YTHDC1;RBM6;DCPS;PCF11;LSM2;HNRNPA3;CPSF2;CWF19L2;RBMX;PUF60;WDR33
prerank,negative regulation of endopeptidase activity (GO:0010951),-0.2920073583805429,-1.0597636796008048,0.3545816733067729,0.7569449737476249,1.0,10/47,10.91%,TIMP3;SPOCK2;RECK;SERPIND1;SERPINI1;SPOCK1;SERPINE2;AKT1;SERPINB9;GAPDH
prerank,atrial septum morphogenesis (GO:0060413),-0.4466280687268419,-1.059334608406886,0.41216216216216217,0.7570083074147295,1.0,3/10,13.01%,NOTCH2;BMPR2;TGFB2
prerank,skeletal system development (GO:0001501),0.3246228676259714,1.0588505206232428,0.3546576879910213,0.9562092470275049,1.0,28/148,13.98%,PKDCC;FGFR1;SULF1;PRELP;CDH11;KIAA1217;PCSK5;GLI2;AKAP13;EIF2AK3;PTHLH;BMPR1B;SOX9;BMP5;WNT5A;SH3PXD2B;NCAN;PTGER4;DDRGK1;RPS6KA3;COL1A1;ANKH;MMP16;TRIP11;PKD1;TNFRSF11B;SOX4;EXT1
prerank,DNA replication checkpoint signaling (GO:0000076),-0.38844646214944234,-1.0586896706910425,0.3825136612021858,0.7576079168476596,1.0,8/16,23.95%,NAE1;CLSPN;TOPBP1;TIPIN;RAD17;RAD9B;TIMELESS;CDC45
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),-0.3554380425472149,-1.0581701068539782,0.3917808219178082,0.7578559366655221,1.0,11/22,19.52%,IGF1;ROCK2;MEF2A;SLC9A1;MLIP;EDN1;P2RX4;SMAD4;LMCD1;AGT;PARP1
prerank,histone H3-K4 methylation (GO:0051568),0.41265526013946446,1.0579160391206073,0.3806646525679758,0.9579159911949942,1.0,6/26,15.67%,OGT;KMT2A;BEND3;MEN1;KMT2D;DYDC2
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.42564581639029725,1.057871443501359,0.4116743471582181,0.9570683315120211,1.0,4/23,5.21%,SLC12A2;SLC12A4;SLC12A3;PDK4
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),-0.26293026078672316,-1.0578284165468468,0.3114754098360656,0.7576510316733229,1.0,21/87,13.01%,PARD3;ENG;SMAD3;CLDN5;SMAD6;TGFBR3;FKBP1A;SMAD9;APPL2;TGFBR1;PTPRK;ACVRL1;SMAD5;NRROS;TGFB3;LPXN;ZFYVE9;PRKCZ;FURIN;FMOD;TGFB2
prerank,regulation of erythrocyte differentiation (GO:0045646),-0.3136156737931442,-1.057818091684368,0.34296028880866425,0.7565420574331246,1.0,15/35,28.82%,ETS1;LYN;HOXA5;HIF1A;CDK6;TAL1;ZFP36;ABCB10;NCKAP1L;INHBA;HSPA1A;FAM210B;ACVR1B;STAT3;HSPA1B
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.37237461588422055,1.0576864122142833,0.3895582329317269,0.9566459994119682,1.0,7/52,7.82%,SORBS1;EPB41L2;PRKCE;EGFR;ATP2B4;EPHB2;ARF6
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.4883647115969654,1.0568198276141454,0.4192982456140351,0.9582453708694993,1.0,3/12,6.67%,PFAS;ATIC;PPAT
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.3090537691782131,1.0564619168147087,0.3738019169329074,0.9582981605982158,1.0,70/241,23.99%,DHX8;HNRNPC;CSTF1;SF3B2;SF3B1;PCBP2;RBM8A;RBM10;RNPC3;SRSF4;HNRNPA0;ZRSR2;SNRPF;RBM15B;HNRNPR;SF3B5;PPIE;PRPF3;CHERP;CSTF3;DDX46;RBM22;RBM5;DNAJC8;ELAVL2;SNU13;HNRNPM;DBR1;UPF3B;GTF2F2;SRRM2;SNRPA1;DDX42;SFPQ;TRA2B;DHX16;SF1;SUGP1;PDCD7;SYNCRIP;CTNNBL1;SRRT;PSPC1;SLU7;CWC22;SYMPK;PLRG1;SRSF3;MTREX;LSM3;DHX38;HNRNPD;DHX9;SRSF12;UBL5;NUDT21;SRSF11;SRSF10;ELAVL1;CWC25;YTHDC1;RBM6;PCF11;LSM2;HNRNPA3;CPSF2;CWF19L2;RBMX;PUF60;WDR33
prerank,pseudouridine synthesis (GO:0001522),0.4681701097526415,1.0560718274273326,0.3961605584642234,0.9585241712439284,1.0,3/13,6.65%,RPUSD2;PUS7;PUS3
prerank,regulation of cell cycle phase transition (GO:1901987),0.3396725094172744,1.0560299767668495,0.39489671931956255,0.957684023529272,1.0,28/91,18.81%,GTSE1;PSME3;ATP2B4;FBXO5;PSMB5;CDC20;ANAPC5;ANAPC7;ANAPC11;BUB3;ANAPC2;UBE2D1;PSMA6;PSMB2;PSMA2;ANAPC4;PSMD13;FZR1;PSMA7;NEK11;FBXW7;PSME4;ANAPC16;CDC23;PSMD12;PSMD14;PSMB6;PSMC4
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),-0.30067631667925043,-1.0559034964941947,0.3157894736842105,0.7604644309452201,1.0,11/44,10.41%,ANK2;ACTN2;KCNJ6;KCNJ2;KCNMA1;AKAP6;ATP1B1;KCNJ10;FLNA;KCNN2;ATP1B2
prerank,fat-soluble vitamin metabolic process (GO:0006775),-0.35507717224936225,-1.055844469669875,0.3670520231213873,0.7595141327501227,1.0,2/22,1.27%,ALDH1A2;RBP1
prerank,ribosomal small subunit biogenesis (GO:0042274),-0.30359084125799163,-1.055347244892714,0.3624161073825503,0.7597591267025883,1.0,21/39,25.79%,RPS15;RPS7;RPS27;NPM1;RPS24;RPS19;RPS16;RPS17;RRP7A;RIOK1;RPS6;MRPS11;RIOK3;RPS27L;UTP4;PWP2;ERAL1;WDR3;RPS14;RPS25;NOB1
prerank,secondary alcohol metabolic process (GO:1902652),-0.3029367054989669,-1.055273942810527,0.3767123287671233,0.7588545839950491,1.0,21/42,35.20%,PPARD;APOE;SCAP;OSBPL1A;LDLRAP1;OSBPL5;GBA2;NSDHL;ABCG1;TSKU;PIP4P1;CLN6;LCAT;CH25H;IDH3G;SOAT2;RXRA;SQLE;EBP;IDH3A;SULT2B1
prerank,positive regulation of triglyceride metabolic process (GO:0090208),-0.3858605082775726,-1.0549635779026962,0.40100250626566414,0.7585480219374362,1.0,6/16,12.92%,NR1H3;LDLR;CTDNEP1;ABHD5;NR1H2;MFSD2A
prerank,epithelial tube morphogenesis (GO:0060562),-0.31537192525640917,-1.0548995939400572,0.3503184713375796,0.7576396252640847,1.0,9/32,16.50%,SLIT2;BMP4;ACVRL1;RASIP1;SOX17;PODXL;RHOB;MEGF8;CSNK2B
prerank,regulation of ruffle assembly (GO:1900027),0.41798477718060023,1.0546491383901602,0.39191290824261277,0.9607667022446491,1.0,3/23,7.66%,CAV1;RDX;KANK1
prerank,membrane assembly (GO:0071709),0.3968401829978848,1.0542168645696164,0.39106145251396646,0.9610401241715798,1.0,13/34,22.17%,LRP4;CEL;FLOT2;SPAST;CHMP4B;STX2;PTEN;STX4;SPTBN1;S100A10;NLGN3;CHMP2A;NLGN2
prerank,histone H3-K36 demethylation (GO:0070544),-0.4396540287748613,-1.0538298263126766,0.41705069124423966,0.7594764365494324,1.0,3/10,13.49%,PHF8;KDM2B;KDM7A
prerank,metal ion homeostasis (GO:0055065),0.3827914602261398,1.0535777509845445,0.4002770083102493,0.9619586728705405,1.0,4/40,4.40%,CAV1;SLC12A2;SLC12A4;SLC12A3
prerank,positive regulation of actin nucleation (GO:0051127),-0.423108429118718,-1.0535456188647108,0.38530066815144765,0.7591253693516188,1.0,2/11,7.57%,WASF3;FCHSD2
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.4217436104400782,1.0528314231651568,0.409375,0.9631364238716149,1.0,1/22,0.41%,DYNLL1
prerank,regulation of cell junction assembly (GO:1901888),0.4117093309984195,1.051637627878426,0.3979289940828402,0.9657518851875121,1.0,3/27,1.92%,F11R;CLDN19;RAP1A
prerank,miRNA mediated inhibition of translation (GO:0035278),-0.4296727688322757,-1.051158603105777,0.41745283018867924,0.7635384722492462,1.0,5/11,20.01%,AGO3;AGO4;TNRC6C;ZFP36;NOTCH4
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.4296727688322757,-1.051158603105777,0.41745283018867924,0.7635384722492462,1.0,5/11,20.01%,AGO3;AGO4;TNRC6C;ZFP36;NOTCH4
prerank,regulation of actomyosin structure organization (GO:0110020),-0.41275007446781675,-1.0508337337512217,0.38613861386138615,0.7632906870064916,1.0,5/13,9.50%,ROCK2;CDC42;ASAP3;ACTG1;SLC9A1
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.35991416976119756,1.0508179288917665,0.382699868938401,0.9671478322943603,1.0,11/56,10.32%,EGFR;CCND3;ADAMTS1;UBE2E2;RDX;FBXO5;CUL3;ANAPC5;ANAPC7;MECP2;ANAPC11
prerank,cristae formation (GO:0042407),-0.3367193444521071,-1.0508051371011942,0.37658227848101267,0.7622393592924057,1.0,13/27,30.00%,IMMT;ATP5PD;DMAC2L;ATP5MC3;MICOS13;SAMM50;ATP5PF;ATP5ME;ATP5PO;ATP5MC2;ATP5MF;ATP5MC1;ATP5F1E
prerank,neurotransmitter transport (GO:0006836),0.34792415394828907,1.0507815519348886,0.39420654911838793,0.9662802226494442,1.0,12/73,7.36%,PPFIA2;STX1A;CASK;SLC38A2;SLC1A7;SLC29A4;SLC22A3;ATP1A2;BRSK1;SLC1A6;RAB3A;CPLX1
prerank,L-serine metabolic process (GO:0006563),-0.45166065132003846,-1.0506573971505644,0.41904761904761906,0.7615513615671577,1.0,6/10,33.84%,SERINC3;PSPH;CBS;PHGDH;SHMT2;SHMT1
prerank,negative regulation of hormone secretion (GO:0046888),-0.4317834754751849,-1.0503631356520575,0.38875878220140514,0.7612547911965947,1.0,3/10,16.77%,GJA1;RAB11FIP3;RAB11FIP1
prerank,regulation of protein phosphorylation (GO:0001932),0.30571314804611005,1.0498960164380677,0.39937106918238996,0.9680476555044321,1.0,24/256,6.63%,EFNA5;FGF7;NTRK3;PTPN13;PLCE1;CLDN19;LEPR;EGFR;CCND3;MUSK;PELI2;FGF1;AXIN1;CDH5;FXR2;EIF2AK3;PLPP3;SOX9;LIMK2;IBTK;FN1;FER;EPHB2;KRAS
prerank,receptor signaling pathway via STAT (GO:0097696),-0.335640445554375,-1.049609569958587,0.35964912280701755,0.762176663263955,1.0,4/25,7.53%,IL31RA;GHR;IFNAR2;JAK2
prerank,positive regulation of binding (GO:0051099),0.3397996448300473,1.0494724898668384,0.3968636911942099,0.9683762896954429,1.0,28/84,22.39%,NGF;CAV1;ADD1;DACT1;TRIM21;RARA;AMFR;GSK3B;STK3;HMGB1;MEN1;PKD1;CAPRIN2;TXN;RAN;PPARG;GMNN;DHX9;PIN1;NME1;DDX11;PRKN;FOXC1;TCF7L2;NMD3;AKTIP;DERL1;SIRT2
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",-0.399707658405954,-1.0494126757824276,0.41784037558685444,0.7616151721623111,1.0,7/13,37.83%,UBE2J1;OS9;DERL2;SVIP;BCAP31;EDEM1;UBAC2
prerank,regulation of sprouting angiogenesis (GO:1903670),0.3862345515065969,1.0488526061734778,0.3948497854077253,0.9692014528814739,1.0,10/33,18.37%,CEACAM1;FGF1;CREB3L1;RHOJ;FGF18;CEMIP2;GLUL;JAK1;ITGA5;PDPK1
prerank,negative regulation of protein autophosphorylation (GO:0031953),0.47829977572012594,1.0482772882320268,0.41228070175438597,0.9699530572678382,1.0,1/10,0.25%,CAV1
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),-0.3052820124203991,-1.0480929694864702,0.3392857142857143,0.7641305883101919,1.0,17/40,29.83%,IGF1;BCL2L11;AKT1;BID;MLLT11;FXN;GHITM;TNFSF10;OPA1;PLAUR;BBC3;CLU;PSMD10;PYCARD;BIK;BMF;TRIAP1
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.40068362136200114,1.0479359744958168,0.41150442477876104,0.9699593381937107,1.0,10/30,13.02%,ELOVL5;ELOVL1;HACD4;PEX2;ELOVL2;SLC27A4;HACD2;ACOT2;ABCD1;ELOVL6
prerank,rRNA pseudouridine synthesis (GO:0031118),0.4892069318755737,1.0478790485353333,0.41134751773049644,0.9691573876235516,1.0,3/10,18.71%,RPUSD2;NAF1;RPUSD4
prerank,ERK1 and ERK2 cascade (GO:0070371),-0.3540185242632016,-1.0478142604501781,0.3941176470588235,0.7637876915604261,1.0,4/21,7.76%,IGF1;CTSH;KDR;MAP2K2
prerank,tryptophan metabolic process (GO:0006568),0.4855278551961652,1.0478013653611193,0.41,0.9684145799464241,1.0,2/11,3.80%,IL4I1;AADAT
prerank,regulation of lymphocyte differentiation (GO:0045619),0.4390663353954197,1.0477260272359261,0.4155844155844156,0.9676751424698641,1.0,4/18,19.35%,IL4I1;CRTAM;ZFP36L2;XRCC6
prerank,cortical actin cytoskeleton organization (GO:0030866),0.4239479434167842,1.0474324697889115,0.3867924528301887,0.9676639055599299,1.0,4/20,10.85%,FMNL2;ARF6;PLEK;FHOD1
prerank,regulation of phospholipase C activity (GO:1900274),0.44669523206503303,1.0473139277359973,0.41638795986622074,0.9670733974206531,1.0,2/15,0.71%,NTRK3;FGFR1
prerank,negative regulation of TORC1 signaling (GO:1904262),-0.4133680329346489,-1.0471283681331482,0.3888888888888889,0.764571082954951,1.0,5/13,20.26%,DEPDC5;RNF152;SPAAR;CASTOR2;CASTOR1
prerank,negative regulation of cytoskeleton organization (GO:0051494),-0.31955814331831395,-1.0469661556924197,0.4069400630914827,0.7638458169853634,1.0,8/29,8.96%,SHANK3;PLEKHH2;SLIT2;KANK3;HIP1R;TWF1;MYADM;CYRIB
prerank,positive regulation of interferon-gamma production (GO:0032729),0.36223302949840536,1.0465928662613326,0.4054421768707483,0.9681976676767754,1.0,8/48,11.04%,IL18R1;PDE4D;TXK;PTPN22;TLR7;CRTAM;ISL1;CD276
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.4122394687282305,1.0462102309559704,0.4148264984227129,0.9683652047443011,1.0,4/26,9.76%,SMOC2;PRKCA;CUL3;EIF4E
prerank,nucleoside catabolic process (GO:0009164),0.4854554912594376,1.0461593763155008,0.41889483065953653,0.9675591748469402,1.0,5/11,15.21%,DPYS;UPP2;NT5E;DERA;NT5C3A
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.31435873548595317,1.0460883331808106,0.3988950276243094,0.9667959609878319,1.0,35/163,18.81%,TEC;NFATC2;ITK;CD3G;PDE4D;TXK;EIF2B3;PTPN22;PSME3;PTPRC;LCP2;PTPRJ;PIK3R2;PSMB5;LAT;CD276;TAB2;EIF2B4;PSMA6;PSMB2;PSMA2;PLEKHA1;PSMD13;NFKBIZ;PSMA7;PAK3;SYK;BTK;PSME4;PSMD12;PDPK1;PSMD14;PSMB6;MS4A1;PSMC4
prerank,calcium ion import into cytosol (GO:1902656),0.45182714408076785,1.0460833147888848,0.4176182707993475,0.9658499216910197,1.0,3/15,4.86%,SLC24A1;TRPV4;ATP2B4
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.42240957784280553,1.0453316209510426,0.40752351097178685,0.9670922896216501,1.0,4/22,8.70%,LBP;PTPN22;TNFAIP3;ACOD1
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.36575823166779775,1.04514318380146,0.3945945945945946,0.9666932222100431,1.0,5/47,4.86%,CAV1;DKKL1;CEACAM1;SLC27A1;ATP2B4
prerank,ribosomal subunit export from nucleus (GO:0000054),-0.4013844595695912,-1.0450946184775274,0.39598997493734334,0.7678034246346472,1.0,5/13,15.11%,RPS15;NPM1;NOP9;ABCE1;NUP88
prerank,regulation of intracellular signal transduction (GO:1902531),0.29863379176292576,1.044989295170446,0.37296747967479676,0.9662081794740955,1.0,59/420,10.01%,DLC1;NTRK3;TIAM2;ARHGAP31;PRR5;PTPN13;CEACAM1;ARHGAP18;ARHGAP12;ARHGAP32;AKAP12;EGFR;BCL3;ARAP1;ARHGAP9;FGF1;PPP1R13B;MINK1;DEPDC1B;SPRED1;GPAT3;AKAP13;CHD3;OPHN1;RACGAP1;PRKAG1;TPTE;VAV2;PTPN22;FAM83D;RAC2;WNT5A;PIP4K2B;TAF10;TRIO;HIPK1;TAF4B;ULK4;RFC3;ARHGEF5;NBN;ARHGAP26;RHOJ;CCNG1;ARHGEF1;PTPMT1;STARD13;PIK3R2;KALRN;PRKAR2A;PHLPP1;OBSCN;RASSF2;STK3;OCRL;DIPK2A;MAPKAP1;POU4F1;HDAC2
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.3446756329065386,1.044971551456625,0.39828431372549017,0.9653065422749904,1.0,9/76,6.03%,NR3C2;EGFR;BCL3;SPI1;PTPN22;PPM1A;UACA;TLR7;TRADD
prerank,negative regulation of neuron death (GO:1901215),0.33533333269701054,1.0449328638983106,0.39663461538461536,0.9644690719524023,1.0,10/93,10.17%,NGF;PPARGC1A;MSH2;ISL1;NRBP2;CD200R1;GSK3B;POU4F1;CHMP4B;CHMP4A
prerank,proteoglycan biosynthetic process (GO:0030166),-0.32651014558887376,-1.0448453665279365,0.3653250773993808,0.7674245664457096,1.0,10/31,11.28%,IGF1;CSGALNACT1;NDST3;CHST11;BMPR2;CSGALNACT2;PXYLP1;FAM20B;HS3ST3B1;B4GALT7
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.36765146577794255,-1.0442450547390807,0.4076923076923077,0.7679962019482482,1.0,5/18,7.11%,ACSL1;ACSL3;ELOVL7;ACSL6;HSD17B12
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.43485684266346625,1.0441729883863982,0.4251207729468599,0.9657206238901239,1.0,2/20,1.74%,EGFR;CCND3
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.3191967387124307,1.044089648944902,0.3972602739726027,0.9649726788699523,1.0,41/128,21.84%,DYNLL1;FBXL15;WEE1;SFI1;BRSK1;CEP131;PHLDA1;CEP78;CDK7;NEDD1;TUBG1;CKAP5;CCP110;PAFAH1B1;MASTL;FBXL17;KDM8;CEP290;SSNA1;NDE1;ENSA;CETN2;LCMT1;PCM1;YWHAG;FBXL12;BACH1;YWHAE;PPP1R12B;FBXL3;CEP57;OFD1;ALMS1;CEP250;DCTN2;TAF2;HAUS8;CEP43;HAUS3;FBXW11;BORA
prerank,glucose homeostasis (GO:0042593),0.33972912792514004,1.0436750640463905,0.4076827757125155,0.9651610733027992,1.0,20/83,18.30%,PPARGC1A;LRRC8D;LEPR;HK2;SLC8B1;FOXK1;PDK4;FOXK2;PIK3R2;BACE2;ADRA2A;GCK;NUCKS1;SOX4;BAD;ADCY8;HECTD4;PPARG;KLF7;WFS1
prerank,positive regulation of apoptotic process (GO:0043065),0.30351630880860214,1.0433904366451319,0.38366080661840746,0.9650458196340712,1.0,63/293,17.46%,NGF;ITGA6;DLC1;DKKL1;TIAM2;FAP;MYBBP1A;ANO6;TNFAIP8;GPLD1;NF1;TFPT;AKAP13;RNF122;PHLDA3;APH1B;FOXO3;VAV2;ACVR1C;TRIO;NCSTN;TRADD;ARHGEF5;PHLDA1;NLRC4;ARHGEF1;SIAH1;MAP3K5;KALRN;RBM5;OBSCN;SLC27A4;RASSF2;STK3;NLRP2B;HMGB1;SRPK2;RARG;APC;ARHGEF6;FAF1;PTPA;ATG7;ADAMTSL4;DIABLO;SOX4;HTT;HTRA2;FZD9;AIFM2;UNC13B;PDCD2;GPER1;BAD;CTNNBL1;E2F1;PLEKHG2;BACE1;ARHGEF11;ARHGEF7;QRICH1;SCRIB;BNIP3
prerank,Rac protein signal transduction (GO:0016601),0.4399601805236732,1.043307182236418,0.41080196399345337,0.9643572634912986,1.0,2/18,4.75%,CDH13;RAC2
prerank,response to laminar fluid shear stress (GO:0034616),0.4884783523534164,1.0430254219783046,0.4098939929328622,0.9641967442889974,1.0,4/10,12.26%,ASS1;MAPK7;ABCA1;NFE2L2
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.3915134924577577,1.0428389370249642,0.39173789173789175,0.9637739188434682,1.0,1/32,0.25%,CAV1
prerank,positive regulation of RNA metabolic process (GO:0051254),0.3749513853565465,1.0427861122396398,0.4029451137884873,0.9629888626690425,1.0,9/45,9.47%,EGFR;SLC38A2;BUD23;DXO;UTP15;RBM22;DYRK1A;LIN28B;SIRT7
prerank,plasma membrane repair (GO:0001778),-0.4012481005801224,-1.042644649153233,0.38967136150234744,0.7713354338743312,1.0,4/13,9.16%,MYOF;DYSF;SYT7;SYTL4
prerank,long-chain fatty acid import into cell (GO:0044539),-0.4344338867117168,-1.0424070230903022,0.4,0.7708313278376848,1.0,3/10,6.54%,ACSL1;ACSL3;RPS6KB1
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.4528894663608737,1.0423202152097581,0.4077669902912621,0.9634771163125838,1.0,2/15,9.36%,USP50;NLRP2B
prerank,inorganic cation import across plasma membrane (GO:0098659),0.346676657425321,1.0418185367562178,0.41551939924906134,0.9639782445958617,1.0,10/75,5.75%,KCNJ4;SLC12A2;KCNJ16;SLC24A1;TRPV4;SLC12A4;SLC12A3;ATP2B4;ATP1A2;KCNJ13
prerank,isotype switching (GO:0045190),0.49956656695505763,1.041705898293771,0.4253075571177504,0.9633481946926525,1.0,3/10,15.34%,MSH6;MSH2;BATF
prerank,positive regulation of B cell activation (GO:0050871),0.35746014948992416,1.0415607499060242,0.3997395833333333,0.9628169173637583,1.0,13/50,17.61%,NFATC2;KMT5C;PTPRC;EPHB2;CD320;GPR183;IL7;CD81;PPP2R3C;MMP14;SYK;BTK;IRS2
prerank,zymogen activation (GO:0031638),0.38340284260527435,1.0407568226972113,0.41440217391304346,0.9642117115204513,1.0,12/39,20.05%,KLK2;CYFIP2;CD5L;CIDEB;NLRC4;PERP;MMP14;BAD;GGT1;PGK1;PLAT;TBC1D10A
prerank,lipoprotein localization (GO:0044872),-0.4355608851732192,-1.0403402604840661,0.39436619718309857,0.7753598930049046,1.0,3/11,7.48%,LRP1;ZDHHC17;VMP1
prerank,ncRNA transcription (GO:0098781),0.4678884116857998,1.0401933967732568,0.43529411764705883,0.9648800766690964,1.0,4/13,12.53%,CAVIN1;RPAP2;SIRT7;SPIN1
prerank,positive regulation of viral process (GO:0048524),0.3462749059656033,1.0399732695496176,0.38852672750977835,0.9645617242036145,1.0,10/60,12.03%,MDFIC;KPNA2;PPIE;SRPK1;NELFB;AXL;SUPT4H1;CNOT7;SRPK2;GTF2F2
prerank,positive regulation of cellular component movement (GO:0051272),-0.3313641030433708,-1.0398136711397716,0.3993993993993994,0.775741919472776,1.0,5/24,7.04%,ETS1;SPOCK2;LYN;TGFBR1;RPS19
prerank,nucleotide-sugar metabolic process (GO:0009225),-0.42269835689179286,-1.0392810701679884,0.454337899543379,0.7760436252000753,1.0,6/12,20.50%,CSGALNACT1;PARG;UGP2;FUT8;SLC35A3;GFUS
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.3583529812073704,1.0390778872763726,0.4168900804289544,0.9662789031500226,1.0,13/54,19.19%,PLK2;GTSE1;CNOT10;ARID3A;SFN;CNOT7;SOX4;TNKS1BP1;E2F1;RGCC;CNOT8;BAX;CNOT1
prerank,negative regulation of inflammatory response (GO:0050728),0.3126464184681889,1.0382987999857929,0.42764578833693306,0.9675531911255597,1.0,19/182,9.00%,RORA;PLK2;MC5R;CD3G;CDH5;CXCL17;PTHLH;FNDC4;SRC;TNFAIP3;ADCY5;SELENOS;PTGER4;MAPK7;PRKAR2A;ISL1;ACOD1;TSHR;CD200R1
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.4374332260122625,-1.0381030767945552,0.45121951219512196,0.7782494598730171,1.0,1/10,1.01%,SHANK3
prerank,vasculogenesis (GO:0001570),0.39018005772309394,1.0380129519967234,0.44395924308588064,0.9674573082052618,1.0,4/32,6.81%,CAV1;GLMN;SPRED1;EGFL7
prerank,positive regulation of protein processing (GO:0010954),-0.3598227857630889,-1.0378597604432003,0.41292134831460675,0.7778470510259516,1.0,2/19,1.71%,CCBE1;CLEC3B
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.46042956839448174,1.0376430435739845,0.43500866551126516,0.967551714933847,1.0,6/13,26.49%,WNT5A;AXL;IL7;DHX9;IFIH1;TRIM44
prerank,lymphocyte chemotaxis (GO:0048247),0.3847295919304802,1.0373486737767874,0.3807471264367816,0.9674487146697311,1.0,2/34,1.91%,SLC12A2;CYP7B1
prerank,cellular response to UV (GO:0034644),-0.26567489959263546,-1.0372730723154695,0.3564356435643564,0.7784325870655162,1.0,20/76,19.97%,USP28;PTPRK;EP300;RPL26;NPM1;CDC25A;MMP2;EIF2AK4;MFAP4;MMP1;KDM1A;NOC2L;POLK;XPA;ZBTB1;NSMCE3;DHX36;ATF4;PARP1;ERCC4
prerank,negative regulation of hippo signaling (GO:0035331),0.4682346164735266,1.0371554069261237,0.4307178631051753,0.9671032711986376,1.0,3/12,13.78%,VGLL4;WWC1;CIT
prerank,regulation of T cell activation (GO:0050863),0.3683989986568666,1.0368944239202296,0.415041782729805,0.9669197974357622,1.0,5/42,10.34%,TNFSF8;IL4I1;PTPN22;CRTAM;LAT
prerank,response to estrogen (GO:0043627),0.39398225465446696,1.0368637672260557,0.43509272467902993,0.9660720660349741,1.0,3/31,7.54%,CAV1;KRT19;RARA
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.34397119142845545,1.0361351036878201,0.4060529634300126,0.9672515364657874,1.0,12/73,11.44%,GLMN;MYBBP1A;TDG;SF3B1;SPI1;HDAC4;POLR1E;CTCF;MECP2;PPHLN1;ERCC6;HDAC6
prerank,regulation of dephosphorylation (GO:0035303),0.444517403637162,1.0358319138728853,0.43322475570032576,0.967156591669985,1.0,7/15,26.97%,SRC;MTMR3;SMG7;MTMR1;SMG6;PPP1R16A;SMG5
prerank,synaptic vesicle endocytosis (GO:0048488),0.3892801875394378,1.0352957266449696,0.40486409155937053,0.9678007760372896,1.0,6/33,8.15%,CEL;STX1A;OPHN1;DNM1;STON1;STON2
prerank,microtubule polymerization or depolymerization (GO:0031109),0.41166326462330705,1.0351243946551563,0.4354066985645933,0.9673572270924145,1.0,4/24,7.39%,KIF2A;NCKAP5L;TRPV4;CKAP5
prerank,negative regulation of ossification (GO:0030279),0.41313949519137927,1.0351236711768321,0.40929535232383807,0.9664279819631011,1.0,2/23,4.14%,LRP4;SOX9
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.435431830077266,1.0348659788468504,0.42260061919504643,0.9662201404000206,1.0,4/17,13.59%,COX5A;COX15;COX7C;COX5B
prerank,negative regulation of receptor binding (GO:1900121),0.4946955805142077,1.034065965219386,0.44181818181818183,0.9675852955028498,1.0,1/10,1.75%,PTPRF
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.4479640494149518,1.033998935691725,0.4066115702479339,0.9668581657455595,1.0,4/14,16.93%,CD55;PTPN22;CD81;SYK
prerank,positive regulation of phosphatase activity (GO:0010922),-0.35000930180596435,-1.0335136086791044,0.40437158469945356,0.7876806853404162,1.0,5/21,14.98%,ITGA1;PDGFRB;CALM1;BMP2;CALM3
prerank,protein import into nucleus (GO:0006606),0.34353344630559496,1.0334578371501721,0.4157014157014157,0.9675070569645686,1.0,16/66,16.93%,PRICKLE1;KPNA7;IPO8;NUP62;KPNA2;FAM53B;CBLB;TPR;MMP12;NUP50;RANBP2;CSE1L;NUP153;RAN;NUP93;SYK
prerank,bone morphogenesis (GO:0060349),-0.39541125724672227,-1.0333368888259733,0.425,0.787051418870384,1.0,4/14,8.10%,CYP26B1;FGFR2;BMPR2;LRP6
prerank,L-amino acid transport (GO:0015807),0.39401155127505816,1.0331897512054198,0.41478129713423834,0.9673630001539418,1.0,7/28,12.83%,SLC25A12;SLC38A2;PRAF2;SLC1A6;SLC7A2;SLC25A13;SLC25A22
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.4063384961183941,-1.0330039174539818,0.4387755102040816,0.7868326828981503,1.0,8/12,33.28%,UNC13C;SYT7;UNC13A;RIMS1;RIMS3;SYT1;SYT5;DOC2B
prerank,negative regulation of lyase activity (GO:0051350),-0.3728611019937558,-1.0329514430099571,0.4253164556962025,0.785839887194075,1.0,2/16,2.21%,ADGRV1;GRM3
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.332363364731976,1.032798804445841,0.420863309352518,0.9675336166065078,1.0,14/95,9.91%,LBP;TNIP3;IL1A;WNT5A;TNFAIP3;SELENOS;PAF1;DEFA6;ACOD1;IRGM;CHMP5;HMGB1;TICAM1;AXL
prerank,negative regulation of defense response to virus (GO:0050687),0.4843543061459783,1.0322336241148482,0.444636678200692,0.9682142031402542,1.0,4/10,22.15%,PCBP2;ITCH;MUL1;TSPAN6
prerank,positive regulation of angiogenesis (GO:0045766),0.3264911999224694,1.0321964881480392,0.4266984505363528,0.9673946341891254,1.0,11/108,5.49%,GAB1;SMOC2;HK2;RAPGEF3;FGF1;CDH5;ITGAX;IL1A;PRKCA;WNT5A;HIPK1
prerank,establishment of protein localization to organelle (GO:0072594),0.3416520684727834,1.0318944405498935,0.43376623376623374,0.9673518408884596,1.0,28/72,26.11%,PRICKLE1;HK2;IPO8;LRSAM1;NUP62;FAM53B;LAMP1;TPR;MMP12;NUP50;CSE1L;NUP153;RAN;NUP93;SYK;PINK1;LAMP2;RALA;RPAIN;TSC2;SEC13;CD68;IPO13;SPRN;PTTG1IP;NUP188;RANBP17;TNPO1
prerank,negative regulation of protein depolymerization (GO:1901880),-0.3318190050056718,-1.0313268330180279,0.4175257731958763,0.789198911482382,1.0,6/24,14.61%,PLEKHH2;ARHGEF2;STMN2;CAMSAP1;APC2;MID1IP1
prerank,regulation of cell differentiation (GO:0045595),0.31293932488293597,1.0309176587086393,0.42058165548098436,0.9691730736167078,1.0,15/148,9.58%,NGF;FGFR1;DLX1;MBOAT2;RUNX2;NF1;FLOT2;PTHLH;BMPR1B;DDX17;DAG1;LTBP4;ISL1;RPS6KA3;PHLDB1
prerank,protein dephosphorylation (GO:0006470),0.3169068077030497,1.0309144936118029,0.4147465437788018,0.9682607921181875,1.0,31/135,14.93%,UBASH3B;PTPN13;PTPRF;DUSP12;EYA1;PTPN14;TPTE;PTPN22;PTPRC;PPM1A;RPRD1B;PPM1M;RPAP2;MTMR7;PTPRJ;MTMR6;MTMR3;PDP2;SDHAF2;PTPRT;RPRD1A;CTDSP1;PPP2R1B;PTPN18;PTEN;PTPRA;DUSP8;PTPN6;CTDSP2;PTPRU;PTPRO
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.33300439855835595,1.0307825493348937,0.413151364764268,0.9677354026194808,1.0,11/76,11.15%,TRIB2;PRICKLE1;AXIN1;SOCS5;SH3RF2;KEAP1;DDRGK1;GSK3B;CSNK1A1;RCHY1;ZYG11B
prerank,regulation of mRNA metabolic process (GO:1903311),0.4756641146752485,1.030431418872658,0.4506517690875233,0.967855313648502,1.0,6/11,25.18%,SRPK1;SLTM;SRPK2;DHX9;IWS1;SAFB2
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.4048010362638548,-1.029637550234377,0.4254278728606357,0.7928659900361688,1.0,6/13,27.74%,NFU1;MMS19;ISCA2;GLRX5;BOLA2;CIAO2B
prerank,spindle assembly checkpoint signaling (GO:0071173),0.4241414734317835,1.0295014218427907,0.4170403587443946,0.967683644519064,1.0,8/20,17.80%,TEX14;CDC20;TPR;APC;BUB3;KLHL22;ZW10;MAD1L1
prerank,mitotic spindle checkpoint signaling (GO:0071174),0.4241414734317835,1.0295014218427907,0.4170403587443946,0.967683644519064,1.0,8/20,17.80%,TEX14;CDC20;TPR;APC;BUB3;KLHL22;ZW10;MAD1L1
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),0.4241414734317835,1.0295014218427907,0.4170403587443946,0.967683644519064,1.0,8/20,17.80%,TEX14;CDC20;TPR;APC;BUB3;KLHL22;ZW10;MAD1L1
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),-0.3286549572034806,-1.0294191317148946,0.40189873417721517,0.7923517659591862,1.0,6/26,12.33%,SLC30A10;PLCG2;CYBA;GRIN1;SLC25A33;ABCD2
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),-0.398374896778685,-1.0291052116042667,0.41797752808988764,0.7921270630830838,1.0,5/13,13.84%,ERLIN1;APOE;SCAP;BMP2;ERLIN2
prerank,protein homotetramerization (GO:0051289),0.35893648486729646,1.0283037207268546,0.44823066841415465,0.9701459558167128,1.0,4/49,7.12%,ALDH1A3;ALDH9A1;ACOT13;ACACA
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.3678724011073845,1.0278349429338525,0.4074585635359116,0.9705328843801722,1.0,14/42,20.14%,RARS2;TARS2;CARS2;VARS1;DARS1;KARS1;AIMP1;WARS1;TARS1;SARS2;DARS2;WARS2;HARS2;TARS3
prerank,glutamine family amino acid metabolic process (GO:0009064),0.3942777255747655,1.0277258426809754,0.4156804733727811,0.9699714508255209,1.0,11/33,16.74%,PRODH;AADAT;NIT2;DDAH2;ALDH18A1;ALDH5A1;CAD;GOT1;GLUL;GGT1;KYAT1
prerank,tyrosine metabolic process (GO:0006570),0.4862379940711088,1.027535771801637,0.44329896907216493,0.9696253148041551,1.0,2/11,10.65%,IL4I1;GSTZ1
prerank,mammary gland epithelium development (GO:0061180),-0.39187620171974286,-1.0275135814236616,0.4338235294117647,0.7954788109839882,1.0,4/14,14.04%,WNT4;JAK2;AKT1;ID2
prerank,neuron development (GO:0048666),-0.2342090681537333,-1.0274333993352243,0.3805309734513274,0.7945536265147006,1.0,38/141,16.20%,FRY;PTPRM;RAPGEF2;LYN;FRYL;PBX3;ATP7A;STMN2;RASGRF1;GPRIN3;EPHA8;APOE;TBC1D24;THOC2;STMN4;DCX;VSX1;CAMSAP1;RAB13;MANF;RP1;LGI4;MYT1L;LAMB1;GBA2;RAB11A;STMN1;HS6ST1;TGFB2;LGI1;SH3GL2;MICALL1;MAPT;CLN5;CDK5R1;DTNBP1;UNK;ATP8A2
prerank,fatty acid oxidation (GO:0019395),0.35361989205694255,1.0274190384282658,0.4266666666666667,0.9690355989573867,1.0,8/57,8.81%,PPARGC1A;EHHADH;HADHB;PEX2;ACAT1;ADH5;HSD17B4;ACADS
prerank,regulation of fat cell differentiation (GO:0045598),0.34239772050102907,1.0273927971305008,0.41656210790464243,0.9681870203026903,1.0,4/74,4.97%,RORA;TRIB2;WNT5A;TRIO
prerank,mitotic nuclear membrane organization (GO:0101024),0.3583098371713276,1.027206677903566,0.42935528120713307,0.9668772331793395,1.0,21/51,22.72%,UBE2I;SPAST;NUP160;NUP37;IST1;CHMP4B;CHMP4A;REEP3;CHMP4C;AHCTF1;EMD;RAN;NUP93;LEMD2;PPP2CA;REEP4;SUMO1;CHMP2A;NUP43;SIRT2;SEC13
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.3583098371713276,1.027206677903566,0.42935528120713307,0.9668772331793395,1.0,21/51,22.72%,UBE2I;SPAST;NUP160;NUP37;IST1;CHMP4B;CHMP4A;REEP3;CHMP4C;AHCTF1;EMD;RAN;NUP93;LEMD2;PPP2CA;REEP4;SUMO1;CHMP2A;NUP43;SIRT2;SEC13
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.4387410520449296,1.0271065923479155,0.43559322033898307,0.9662772712956703,1.0,2/15,2.74%,PPARGC1A;ELOVL5
prerank,glial cell development (GO:0021782),0.3922923555655158,1.0267255685480745,0.41262848751835535,0.966441285437518,1.0,7/25,16.20%,NF1;EIF2B3;S100A9;EIF2B4;NSUN5;SOX4;MDK
prerank,intracellular protein transmembrane transport (GO:0065002),-0.2903319020736265,-1.0266095851784256,0.42071197411003236,0.7956167615420602,1.0,19/42,33.11%,C2CD5;SEC61B;TIMM44;SEC62;PAM16;TIMM17B;PEX26;PEX6;PEX1;ROMO1;PEX10;GRPEL1;DNLZ;AIFM1;TIMM50;HSPD1;TIMM21;PEX5;TIMM23
prerank,regulation of interleukin-12 production (GO:0032655),-0.2856738175674088,-1.026117282198778,0.4235294117647059,0.795866644209511,1.0,13/47,25.17%,PLCB1;FOXP1;PLCG2;CMKLR1;THBS1;LGALS9;LAPTM5;CD40;TLR3;C1QBP;CCL19;IRF5;JAK3
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.3496317345812095,1.025999555304761,0.43483870967741933,0.9675861421825227,1.0,9/59,7.94%,CDH13;CEACAM1;MPZL2;CDH17;HMCN1;DSCAM;TRO;AMIGO2;CDH2
prerank,blood vessel endothelial cell migration (GO:0043534),-0.3491816295552812,-1.0258914906462533,0.4255952380952381,0.7953809847649667,1.0,5/22,8.34%,ROBO1;SLIT2;PIK3R3;KDR;AKT1
prerank,leukotriene biosynthetic process (GO:0019370),0.45240919042423305,1.0256850680220722,0.42857142857142855,0.9676198083658275,1.0,4/14,15.53%,MGST2;GGTA1;LTA4H;GGT1
prerank,signal transduction in response to DNA damage (GO:0042770),-0.2846489814964196,-1.0256671096674248,0.4034334763948498,0.7948525053622422,1.0,10/49,14.33%,MAP3K20;ACER2;USP28;MYO6;PAXIP1;ATRIP;HINFP;BID;CLSPN;RAD1
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.3659890787146863,1.0256592176289514,0.4371584699453552,0.9667878069420446,1.0,9/46,10.83%,IL18R1;LAMA4;ZNF423;PLCL1;PCTP;ACOT13;HOXC10;LNPEP;DOCK7
prerank,positive regulation of Notch signaling pathway (GO:0045747),-0.29543323380990694,-1.0255832573176915,0.42071197411003236,0.7940024595204012,1.0,13/39,17.49%,ROBO1;RBPJ;NOS3;EP300;CCN3;PDCD10;JAG2;SNW1;TM2D3;TGFB2;MAML3;KAT2B;TSPAN5
prerank,regulation of stress fiber assembly (GO:0051492),0.3390372004305273,1.02536926375185,0.41967621419676215,0.9667023882733737,1.0,6/74,2.03%,DLC1;F11R;LPAR1;PXN;RAPGEF3;ARAP1
prerank,regulation of exosomal secretion (GO:1903541),0.41780983108187125,1.0251327921203617,0.44568690095846647,0.9664446834109196,1.0,9/19,25.64%,TSG101;SDC1;PDCD6IP;ATP9A;SDC4;PRKN;CHMP2A;SNF8;STAM
prerank,peptidyl-lysine acetylation (GO:0018394),-0.4282875781576108,-1.024743315766034,0.4177777777777778,0.7950982534087547,1.0,3/10,17.75%,EP300;KAT2B;KAT2A
prerank,keratan sulfate catabolic process (GO:0042340),0.4800065606107749,1.0244032624668904,0.4496753246753247,0.9675578270403514,1.0,3/11,14.37%,PRELP;HEXA;HEXB
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.32907066689165176,-1.024107502082061,0.42524916943521596,0.7957006873074066,1.0,18/29,30.87%,RPS19;RPS16;RPS8;NOP9;RPS21;HEATR1;TSR1;DHX37;MRPS11;KRI1;TBL3;UTP4;PWP2;RPS14;WDR46;RRP36;UTP6;ABT1
prerank,regulation of protein kinase B signaling (GO:0051896),0.3036427143168937,1.0239474911554014,0.4311827956989247,0.967925073069608,1.0,22/193,10.46%,GAB1;FGF7;NTRK3;FGFR1;PIK3AP1;EGFR;FGF1;PHLDA3;TPTE;SRC;RAC2;BANK1;DAG1;GCNT2;PTPRJ;PIK3R2;PHLPP1;FGF18;GAB2;AXL;FERMT2;STRN
prerank,regulation of transposition (GO:0010528),0.45922277187990707,1.0237424519706495,0.4342560553633218,0.9675809676059911,1.0,3/13,12.50%,PIWIL2;SIRT7;TEX15
prerank,microtubule anchoring (GO:0034453),0.45045243733504203,1.023663973348834,0.4101694915254237,0.9669149314742115,1.0,3/12,13.52%,DAG1;GCC2;PCM1
prerank,heme biosynthetic process (GO:0006783),-0.3374227958461764,-1.0233803315400058,0.41786743515850144,0.7965148535610416,1.0,11/22,24.21%,ABCG2;SLC25A38;FECH;CPOX;FXN;ABCB10;ALAS1;TSPO;HMBS;UROD;ALAD
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.4354661218589946,1.023333397013341,0.43402225755166934,0.966925326264269,1.0,4/18,7.66%,RIPOR2;CDH5;KIF20B;KANK1
prerank,regulation of neuron apoptotic process (GO:0043523),0.325860871893936,1.0230646114407371,0.4184971098265896,0.9667895895270558,1.0,11/96,12.09%,NGF;PPARGC1A;NF1;FOXO3;EGLN3;MSH2;ISL1;NRBP2;POU4F1;SRPK2;LANCL1
prerank,lymphocyte proliferation (GO:0046651),-0.34554485118277384,-1.0228295696159835,0.4220430107526882,0.796911476157639,1.0,2/22,1.74%,MSN;CTPS1
prerank,response to hydrogen peroxide (GO:0042542),-0.2854888364189021,-1.0225583523844912,0.4076923076923077,0.7966028013849807,1.0,14/45,17.79%,CYP1B1;SIRPA;CAT;PDCD10;ANXA1;RHOB;OSER1;RPS3;NET1;GLRX2;FXN;APTX;ANKZF1;TRPM2
prerank,regulation of phospholipase activity (GO:0010517),0.48777069163126174,1.0215036658099808,0.4517241379310345,0.9701767754965045,1.0,1/10,0.71%,FGFR1
prerank,positive regulation of receptor internalization (GO:0002092),-0.34974812520523757,-1.021428554743851,0.423728813559322,0.7985483846499681,1.0,8/22,25.32%,INSR;ANGPT1;AHI1;EGF;PICK1;GREM1;NTF3;ARRB2
prerank,positive regulation of neuron migration (GO:2001224),-0.41009038538804765,-1.0209153705400382,0.4413145539906103,0.7988671798226191,1.0,3/11,4.84%,RAPGEF2;ARHGEF2;SEMA6A
prerank,regulation of fatty acid metabolic process (GO:0019217),0.4265262428268403,1.0205968125984175,0.41408934707903783,0.9718564912440302,1.0,3/17,6.98%,CAV1;PDK4;NCOR1
prerank,regulation of neurotransmitter secretion (GO:0046928),-0.3142963868863994,-1.0205226671785894,0.40939597315436244,0.7988921199034638,1.0,8/32,16.73%,SNCAIP;MCTP2;SYN1;CAMK2A;LRRK2;PREPL;DTNBP1;CPLX2
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.3446649164793081,1.0205167915184485,0.4354005167958656,0.9711843448357521,1.0,15/66,14.13%,EGFR;CCND3;ADAMTS1;UBE2E2;WEE1;PSME3;DACT1;KANK2;RDX;APC;INO80;PTEN;PKD1;FHL1;PTPN6
prerank,positive regulation of gene expression (GO:0010628),0.292045175397026,1.0204243365265808,0.4213197969543147,0.9705517961772464,1.0,61/442,11.74%,NGF;FGF7;NTRK3;PPARGC1A;GLMN;FOXD1;CLDN19;EGFR;MUSK;BCL3;MYBBP1A;FGF1;ADAM19;ITK;SLC26A9;CDH5;FXR2;SF3B1;ITGAX;SLC38A2;PIWIL2;TXK;IL1A;EIF2AK3;PRKAG1;WNT16;CELF1;SOX9;PTPN22;TFR2;WNT5A;FN1;POLR1E;EPHB2;UBR5;KRAS;CTCF;RIMS2;RDX;PTGER4;CRTAM;NOS1AP;RBM22;DYRK1A;FGF18;OCLN;DDRGK1;AGO1;PLSCR1;GSK3B;TICAM1;POU4F1;HILPDA;METTL5;ADRA2A;PLD1;SRPK2;ERCC6;EGR1;UPF3B;MED23
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.43662580879327073,1.0202541225259751,0.4428341384863124,0.9701355242018547,1.0,3/17,9.55%,ANO6;CXCL17;HMGB1
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),0.42393514505936397,1.020125213163969,0.4281298299845441,0.9696338834138171,1.0,4/20,9.89%,NEDD4L;SLC12A2;ATP1A2;ATP1B3
prerank,positive regulation of immune effector process (GO:0002699),0.3975135950487638,1.0200274835535683,0.4235294117647059,0.9690297246012399,1.0,4/27,12.82%,LBP;PTPRC;PTPRJ;CD81
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.3708002735258243,1.0199472896616224,0.42877094972067037,0.9683580701220357,1.0,6/41,7.54%,LBP;PTPN22;IRAK3;TNFAIP3;SELENOS;RARA
prerank,organic anion transport (GO:0015711),0.3360369957029008,1.0198341982361483,0.43702770780856426,0.9677813612325767,1.0,11/76,7.78%,LRRC8D;SLC35A1;SLC4A3;SLC26A9;SLC35B2;SLC22A3;SLC4A4;SLC35C2;SLC2A2;SLC4A11;SLC52A1
prerank,regulation of protein transport (GO:0051223),-0.32377849777770595,-1.0197777712654128,0.43026706231454004,0.7998195794347439,1.0,7/27,18.29%,DNAJC1;HSPA8;DNAJA1;RHBDF2;LLGL2;SCFD1;GAPVD1
prerank,smooth muscle cell differentiation (GO:0051145),-0.40860803732868856,-1.0195925685934553,0.4262295081967213,0.7992121943597413,1.0,5/12,21.50%,BMP4;TMEM204;GATA6;MYOCD;APLNR
prerank,glycosphingolipid biosynthetic process (GO:0006688),-0.3693896784854429,-1.0191260177123622,0.42670157068062825,0.7993188035282853,1.0,3/16,2.13%,ST3GAL5;ST8SIA4;ST6GALNAC3
prerank,nucleic acid-templated transcription (GO:0097659),-0.2896174144436295,-1.019038479954782,0.40304182509505704,0.7984689292288889,1.0,17/42,22.10%,CREBL2;MEF2A;PTMA;NR4A2;RRAGC;POLR3A;MMS19;PWP1;RNPS1;HOXD3;POLR2F;POLR2A;POLR2J;POLR2D;POLR2K;THAP1;THRB
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.49182192560056937,1.0185161883925549,0.45161290322580644,0.9706593415447606,1.0,3/10,16.32%,CD55;CD81;SOCS1
prerank,regulation of inflammatory response (GO:0050727),0.30589038700572774,1.018512587710684,0.43797195253505933,0.9697784504255879,1.0,21/190,9.00%,RORA;ADAMTS12;PIK3AP1;CDH5;CXCL17;FNDC4;CELF1;WNT5A;MGST2;TNFAIP3;ABCC1;IL17RA;TLR7;TRADD;SELENOS;PTGER4;MAPK7;ISL1;TNIP1;ACOD1;CD200R1
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),-0.39170280238825694,-1.0183136367939059,0.42892156862745096,0.7993160229829663,1.0,2/13,6.81%,ETS1;TRAF6
prerank,cellular protein modification process (GO:0006464),0.2873482738810654,1.0181211276420274,0.418,0.9699600134091162,1.0,216/982,18.94%,PIGU;TEC;PLK2;FAM20C;TRIB2;CDK15;GPC3;STC2;FGFR1;ST3GAL4;SLC35A1;HCST;PRKCE;PTPN13;UBE2L6;CEL;CAMK2D;LAMC1;LAMB2;PTPRF;FBXL15;UST;UBE2E2;SOCS5;CD3G;DUSP12;MINK1;B3GALT1;ASB6;STK38;MAP3K1;MMP15;LMO7;TXK;MAPK10;PTPN14;EIF2AK3;ERO1A;PRKAG1;SCG3;PRKCA;UBE2I;BMPR1B;TPTE;PEAK1;PTPN22;CDKL3;SPSB4;NUCB1;PSME3;IRAK3;MORC3;CPE;LIMK2;ACVR1C;PTPRC;KEAP1;PIK3R4;PPM1A;PDK4;EGLN3;FN1;HIPK1;BMP15;BRSK1;CDK13;SUMF1;COL3A1;NEK7;FER;BCKDK;COQ8A;ADAM10;SIRT3;SOCS6;PPM1M;PTP4A2;ABL2;ATG5;CDK7;GMFB;GOLM1;BMP2K;RAB3A;STK38L;FBXO31;RARA;CUL3;RCN1;CDH2;MTMR7;GCNT2;SRPK1;PTPRJ;MAP3K5;DYRK1A;NRBP2;MTMR6;PSMB5;CSNK1G3;MTMR3;DCAF13;GSK3B;PDP2;STK24;STK3;SIRT7;CSNK1A1;TYK2;SDHAF2;PTPRT;CTDSP1;ILF3;PRKCSH;SRPK2;FBXL19;MANBA;ST8SIA5;ST8SIA3;PROC;PPP2R1B;PTPN18;HS3ST5;FBXL5;KLHL21;HUNK;SGK1;MEN1;FBXO11;LIPE;OARD1;DAD1;PARP6;PTEN;PTPRA;MAP3K21;PARP8;SIK3;ATG7;DUSP8;LCMT1;PRKACB;KLHL22;ERN1;FBXO21;STT3A;PTPN6;FNTB;P4HB;CTDSP2;UBE2D3;PSMA6;PIK3C3;PSMB2;FEM1C;PSMA2;NEK4;CHM;PTPRU;PTPRO;CHRM3;CHGB;COPS5;WWP2;FBXW8;PSMD13;CDKL2;MAN2A2;SERP2;FBXL12;ERBB2;PSMA7;TBK1;NEK11;DDB2;FBXO41;TBCK;MBTPS1;FSTL1;OGA;JAK1;VCAN;FBXW7;PAK3;SYK;CALU;BTK;FBXL3;CUL4B;PPP1CA;MAP3K9;FBN1;PP2D1;LMTK2;PTAR1;PSME4;DAPK2;BTBD6;RNF7;DYRK2;ILKAP;PSMD12;VGF;ATG3;COG3;WFS1;PDPK1;PSMD14;SOCS2;PINK1;PSMB6;STK36;PSMC4;RAB5A;PTPN12;AAK1
prerank,cellular component assembly (GO:0022607),0.29895862714329413,1.0180381656541442,0.4417879417879418,0.9693104696762773,1.0,23/253,6.72%,MAGI1;PPARGC1A;PARVA;WIPF1;LAMC1;REPS2;PARD6B;CD3G;SPEF1;KMT2A;OPHN1;ADD1;SOX9;CDAN1;RAC2;WNT5A;FANCC;TEX11;CARD10;TAPBP;SHROOM2;SPAG17;RHOJ
prerank,cellular response to osmotic stress (GO:0071470),0.40646533566141013,1.0179092759791066,0.43820224719101125,0.9687916711115824,1.0,3/21,7.25%,LRRC8D;TRPV4;SLC4A11
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.3685005100332678,1.0177353530434567,0.43273231622746183,0.9684023956196912,1.0,6/43,7.54%,LBP;PTPN22;IRAK3;TNFAIP3;SELENOS;RARA
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.29176545871195153,1.0177006743860506,0.44064386317907445,0.9676146728031536,1.0,87/572,14.70%,PTCH1;TENM2;CAV1;NR2F2;NEDD4L;DLX1;RARB;FOXP2;ZBTB32;KLF12;LDB2;ETV5;GLI2;IRF2BP1;CHD3;SPI1;PHF21A;BEND3;FOXO3;FOXP4;UBE2I;SOX9;CHD8;GLIS2;KLF10;HDAC4;SATB1;DACT1;PPM1A;N4BP2L2;BHLHE40;NRIP1;ZFP90;KANK2;ANKRD2;SIN3B;CTCF;TBX2;PEX2;PAF1;NCOR1;HIC1;NCOA5;ZNF431;BAG3;RREB1;RARA;SUV39H1;E4F1;KCTD1;ISL1;MYPOP;MECP2;SIRT7;HMGB1;FOXJ1;POU4F1;HDAC2;SUPT4H1;LEFTY1;NCOR2;TPR;HEXIM1;RARG;WWC1;ZHX1;OTUD7B;NEDD4;MZF1;ZNF148;MEN1;ERF;SEMA4D;CREBBP;PEG3;NFATC4;TCERG1;CBFB;ZFP57;DICER1;SFPQ;UBE2D1;UBE2D3;YAP1;DNAJA3;RIPPLY2;LCOR
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.30858224973133747,1.0175437498940285,0.44299674267100975,0.967162585248925,1.0,63/173,25.19%,DYNLL1;FOLR1;CAPZB;RAB29;CD55;TRAPPC3L;LMAN2;GOSR1;CNIH1;SPAST;ACTR10;ATL2;CUL3;COG6;GOLGB1;NRBP2;TFG;TMED4;GRIA1;ANK1;DYNLL2;PROC;COPE;COPG1;TRIP11;GOLT1A;COPA;TEX261;ZW10;TMED2;TICAM2;TBC1D20;ERGIC1;ARCN1;TRAPPC3;SPTBN1;STX5;COG3;BET1;DCTN2;CNIH4;NSF;DYNC1LI2;SEC24B;USO1;SPTB;SPTBN5;COG5;TRAPPC8;DYNC1I1;PGAP1;DCTN6;SEC13;F8;VAPA;VAPB;WHAMM;ARF4;SAR1A;PEF1;LMAN1;SPTAN1;DYNC1I2
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.3334283183171929,1.0173181098005684,0.43883984867591425,0.9669161322293649,1.0,14/75,13.75%,NR2F2;RGS14;STK38;NF1;SPRY1;SPRY4;IRAK3;PTPRJ;PRKAR2A;HEXIM1;APC;MEN1;PTEN;CDKN1C
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.4152937091061686,1.017064322728585,0.43548387096774194,0.9658387550511975,1.0,4/21,7.62%,EYA1;IL1A;MCL1;MAPK7
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),0.4152937091061686,1.017064322728585,0.43548387096774194,0.9658387550511975,1.0,4/21,7.62%,EYA1;IL1A;MCL1;MAPK7
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.3065830564882226,1.0168932643699082,0.447939262472885,0.9654319831669951,1.0,15/166,6.10%,SMOC2;GLI1;PPARGC1A;SORBS1;ASS1;EGFR;BCL3;ELOVL5;GLI2;FXR2;GPLD1;PIWIL2;SLC27A1;DDAH2;STN1
prerank,cell cycle G2/M phase transition (GO:0044839),0.31052312049315617,1.0166072884354043,0.43977272727272726,0.9653320465915266,1.0,40/129,21.84%,DYNLL1;FBXL15;WEE1;SFI1;BRSK1;CEP131;PHLDA1;CEP78;CDK7;NEDD1;TUBG1;CKAP5;CCP110;PAFAH1B1;MASTL;FBXL17;KDM8;CEP290;SSNA1;NDE1;ENSA;CETN2;LCMT1;PCM1;YWHAG;FBXL12;YWHAE;PPP1R12B;FBXL3;CEP57;OFD1;ALMS1;CEP250;DCTN2;TAF2;HAUS8;CEP43;HAUS3;FBXW11;BORA
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.33964773406730114,1.0164679217113906,0.45157232704402517,0.9648827868248652,1.0,23/73,18.86%,KMT2A;SPI1;LMO1;PSME3;PUS7;PSMB5;CBFB;YAP1;PSMA6;PSMB2;PSMA2;PDCD2;RUNX1;PSMD13;KITLG;PSMA7;ITCH;PSME4;PSMD12;PSMD14;PSMB6;PSMC4;TCF3
prerank,negative regulation of immune response (GO:0050777),0.3109650322020284,1.0162926178076435,0.4424581005586592,0.9645028112798709,1.0,18/154,9.18%,PLK2;MC5R;CD3G;PCBP2;SPI1;PTHLH;SRC;IRAK3;TNFAIP3;ADCY5;COL3A1;FER;TRIM21;PTGER4;PRKAR2A;ACOD1;TSHR;TRAFD1
prerank,ubiquinone metabolic process (GO:0006743),0.4364336419169984,1.016282758626802,0.4459234608985025,0.9636506688924811,1.0,5/15,15.72%,COQ7;COQ8A;COQ9;AIFM2;COQ6
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.3427884230496292,1.016241009447277,0.445019404915912,0.9628829387150711,1.0,15/63,19.19%,PLK2;GTSE1;CNOT10;ARID3A;FBXO31;SFN;CNOT7;RFWD3;SOX4;TNKS1BP1;E2F1;RGCC;CNOT8;BAX;CNOT1
prerank,cardiac muscle cell membrane repolarization (GO:0099622),-0.41156964551630704,-1.0157131182606949,0.4387254901960784,0.8055436542978833,1.0,5/11,29.91%,KCNJ2;ATP1B1;KCNH2;ATP1A1;KCNQ1
prerank,bile acid and bile salt transport (GO:0015721),0.403862466302476,1.0156450644303234,0.44042232277526394,0.9636495318906313,1.0,2/24,1.93%,CEACAM1;ATP8B1
prerank,melanosome organization (GO:0032438),0.3961948751017616,1.015445135851413,0.4337899543378995,0.9633377099092721,1.0,4/26,7.88%,RAB29;HPS1;SHROOM2;KIF13A
prerank,myelin maintenance (GO:0043217),0.4852897231285631,1.0154436112319534,0.4442508710801394,0.9624718112164421,1.0,5/10,21.61%,EPB41L3;PTEN;ABCD1;PRX;MYRF
prerank,nuclear membrane reassembly (GO:0031468),0.3515866169850877,1.014616546450376,0.42527173913043476,0.9639380976672965,1.0,21/54,22.72%,UBE2I;SPAST;NUP160;NUP37;IST1;CHMP4B;CHMP4A;REEP3;CHMP4C;AHCTF1;EMD;RAN;NUP93;LEMD2;PPP2CA;REEP4;SUMO1;CHMP2A;NUP43;SIRT2;SEC13
prerank,negative regulation of endocytosis (GO:0045806),0.40983092589956854,1.0141662311997435,0.467175572519084,0.9643369807641127,1.0,3/24,7.82%,CAV1;LRSAM1;ARF6
prerank,negative regulation of BMP signaling pathway (GO:0030514),-0.27318812151643856,-1.01382172891955,0.4025974025974026,0.8097740429325321,1.0,21/51,24.87%,SMAD6;SKIL;SMAD9;BMPR2;CRIM1;SMAD5;GREM2;LEMD3;BMP2;HTRA3;DAND5;CHRDL1;BMPER;SMAD4;VWC2L;SMURF2;FSTL3;BAMBI;SMAD1;GREM1;NOTCH1
prerank,endodermal cell differentiation (GO:0035987),0.3876577425054772,1.0138136571644438,0.4279475982532751,0.9643995217998176,1.0,11/31,21.80%,MMP15;ITGA7;LEO1;FN1;PAF1;MMP14;ITGA5;RTF1;SETD2;CDC73;COL8A1
prerank,receptor metabolic process (GO:0043112),0.348077172728281,1.0136621678429063,0.4485006518904824,0.9639763723373197,1.0,7/53,5.18%,CAV1;ACKR3;PHETA2;CD9;DNM1;KIF16B;PIK3R4
prerank,negative regulation of type I interferon production (GO:0032480),0.370914835007531,1.0136347556984326,0.45027624309392267,0.9631791031330034,1.0,10/40,17.07%,UBE2L6;PCBP2;REL;TNFAIP3;ACOD1;NPLOC4;TAX1BP1;RELB;TBK1;ITCH
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.3180135392284644,1.0135131242657123,0.4454649827784156,0.962629009642987,1.0,21/128,10.75%,F11R;INHBB;PXN;RUNX2;CDH5;BMPR1B;SRC;BMP5;ACVR1C;LTBP2;ZFYVE16;BMP15;RGMB;COL3A1;TGFBRAP1;GCNT2;CGN;FERMT2;LEFTY1;FNTA;ZYX
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.31153281141596534,1.0129663711961645,0.4614499424626007,0.9632431661335181,1.0,9/122,3.36%,SMOC2;GLI1;SORBS1;EGFR;BCL3;HSPH1;GLI2;FXR2;PIWIL2
prerank,negative regulation of cell projection organization (GO:0031345),0.3541566130558483,1.0123547326007314,0.45429362880886426,0.9640676860339693,1.0,10/48,12.65%,LPAR1;RAB29;RTN4R;TRPV4;SEMA3A;EFNB2;KANK1;HDAC2;RTN4RL1;PTEN
prerank,chemical homeostasis (GO:0048878),0.34648161258200244,1.0118551885578706,0.461734693877551,0.9646253638552718,1.0,14/61,18.22%,NEDD4L;ZBTB20;SLC4A3;CLN8;SLC4A4;SLC4A11;USF2;TLCD3A;THADA;PNPLA8;PPARG;FBXW7;IRS2;VGF
prerank,defense response to tumor cell (GO:0002357),0.487665763397497,1.0113364689259696,0.45714285714285713,0.9652208822717874,1.0,2/10,3.51%,DLEC1;SPI1
prerank,regulation of protein localization to nucleus (GO:1900180),0.3632607933427295,1.0110843261982707,0.43370165745856354,0.9650957501688748,1.0,11/43,14.58%,GTSE1;EIF2AK3;LIMK2;CARD10;GSK3B;FERMT2;TPR;OTUD7B;GLUL;YAP1;CTNNA1
prerank,connective tissue development (GO:0061448),0.375552275722817,1.0110274854366046,0.4371508379888268,0.96439096954263,1.0,7/35,13.24%,SULF1;SLC39A13;SOX9;SH3PXD2B;DDRGK1;TRIP11;PKD1
prerank,positive regulation of exosomal secretion (GO:1903543),0.439219189593724,1.0106054960990971,0.46563573883161513,0.9646920554408179,1.0,9/15,29.81%,TSG101;SDC1;PDCD6IP;SDC4;CHMP2A;SNF8;STAM;SDCBP;VPS4B
prerank,pyrimidine-containing compound catabolic process (GO:0072529),0.43984730985738574,1.0104590620889669,0.4838709677419355,0.9642303562735499,1.0,6/16,15.25%,DPYS;UPP2;NT5E;DPYSL2;NT5C3A;DPYSL5
prerank,nucleotide catabolic process (GO:0009166),-0.37873748167578114,-1.0101649006242661,0.45652173913043476,0.8186380586290783,1.0,6/16,18.99%,SAMHD1;XDH;NUDT3;VCP;NT5C;NT5C1A
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),-0.286870859133127,-1.0096186628692712,0.4548736462093863,0.8190973031994173,1.0,16/42,25.13%,SHLD2;ARID2;ACTR2;KDM1A;MMS19;POLQ;UBQLN4;PPP4R2;PARP1;TIMELESS;CGAS;MAD2L2;RMI2;SMCHD1;RAD51;PARPBP
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),-0.2542381356834572,-1.0095657402195,0.4174757281553398,0.8181427852546186,1.0,13/74,13.01%,PHLDB2;LEF1;SMAD3;EPHA3;DAB2;TGFBR1;MCRIP1;GLIPR2;TGFB3;VASN;BMP2;USF3;TGFB2
prerank,regulation of gene expression (GO:0010468),0.28505109384586275,1.009519402394603,0.45545545545545546,0.9658734579916288,1.0,113/903,11.79%,RORA;NGF;BNC2;AHNAK;FGF7;NTRK3;NFATC2;STC2;PPARGC1A;AFF3;ZNF423;GLMN;FOXD1;CLDN19;EFEMP1;MUSK;AHNAK2;MYBBP1A;FGF1;ADAM19;SLC26A9;CDH5;TDG;NFIA;COQ7;CLK1;ITGAX;SLC38A2;SFMBT2;CHD3;PCBP2;TXK;SPI1;IL1A;FLOT2;EIF2AK3;PRKAG1;WNT16;PTHLH;CELF1;SOX9;PGR;REL;PTPN22;CREB3L1;DIP2A;KAT6B;HDAC4;WNT5A;APLN;ATP2B4;PTPRC;ATXN7L3B;BHLHE40;FN1;SON;SP3;ZNF326;ONECUT1;TAPBP;EPHB2;TRIM21;TGFBRAP1;ADAM10;C1D;UBR5;PPIE;KRAS;CTCF;RIMS2;RDX;HIC1;CLK4;LIN54;IGF2BP2;ZNF431;RREB1;NOS1AP;MSL3;FOXK2;GCNT2;FGF18;ZNF628;ELAVL2;ZNF462;OCLN;DDRGK1;AGO1;PLSCR1;POFUT1;GSK3B;MECP2;ACTR8;MLF2;TICAM1;RORB;POU4F1;SUPT4H1;CNOT7;PTBP3;TRRAP;TFEB;SAP30L;USP13;SRPK2;CD276;WWC1;MZF1;HDAC6;EGR1;MED23;JMJD1C;ZNF148
prerank,cellular response to oxygen-containing compound (GO:1901701),0.2952454149257688,1.0092708546253,0.46743697478991597,0.9656659982678204,1.0,52/291,16.45%,RORA;LBP;PXN;EGFR;FOLR1;RAPGEF3;RAP1A;SSTR1;TNIP3;GPLD1;IL1A;MPV17;SOX9;WNT5A;ATP2B4;PDK4;TNFAIP3;NRIP1;FER;SELENOS;ABL2;PAF1;BRINP1;DEFA6;ACOD1;IRGM;TSHR;CHMP5;HMGB1;TICAM1;RORB;AXL;POU4F1;EGR1;WNT9A;NCOA3;NFKBIB;CAPN2;AQP1;HTRA2;KCNK4;FZD7;RRAGB;LCOR;CCR5;CCDC62;GPER1;TICAM2;LPL;PLAA;CPEB3;TESC
prerank,keratan sulfate metabolic process (GO:0042339),0.38705085027488295,1.009123637846926,0.44630404463040446,0.9652273205209007,1.0,6/31,11.02%,ST3GAL4;PRELP;B4GAT1;SLC35D2;CHST2;HEXA
prerank,regulation of keratinocyte differentiation (GO:0045616),0.39998746190866347,1.0090094292923482,0.45068285280728376,0.9647039128003403,1.0,1/24,0.21%,ETV4
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.33038586497636824,-1.0089203970476863,0.42857142857142855,0.818837825289508,1.0,11/24,26.60%,UBE2N;TRAF6;NOD1;AAMP;CASP8;IRAK2;MAP2K6;IKBKG;NOD2;RNF34;UBB
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.2901729537846624,1.0086564715397006,0.46296296296296297,0.9647836652571441,1.0,82/327,22.14%,RORA;BNC2;NFATC2;PPARGC1A;ZNF423;EFEMP1;MYBBP1A;NFIA;CHD3;SPI1;KAT6B;BHLHE40;SP3;ONECUT1;TGFBRAP1;PPIE;HIC1;LIN54;ZNF431;RREB1;MSL3;FOXK2;ZNF628;ELAVL2;POFUT1;ACTR8;MLF2;RORB;SUPT4H1;TRRAP;TFEB;SAP30L;USP13;WWC1;MZF1;MED23;JMJD1C;SPIN1;CREBBP;NCOA2;SOX4;BAZ2A;FZD7;SFPQ;REXO4;KMT2D;TAF5;E2F1;DMTF1;BACH1;SRRT;PSPC1;MAGED1;HP1BP3;ESRRA;MTF2;CREM;CELSR2;ASCC2;FOXO4;SPTY2D1;TCF7L1;TCF3;FADS1;ASCC1;PPP2CA;HNRNPD;HCFC2;ZNF22;DDIT3;RNF14;HMG20A;GZF1;CCAR2;ARNT2;ZSCAN21;DAXX;FOXC1;ATXN1L;SRSF10;PCGF1;NR1D2
prerank,icosanoid biosynthetic process (GO:0046456),0.4725835155775737,1.0086270009696732,0.47469458987783597,0.9640046684073662,1.0,4/10,22.60%,MGST2;LTA4H;FADS1;PLA2G4A
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.4243997135296845,1.008427098831994,0.45297805642633227,0.963717012694345,1.0,1/18,0.54%,INHBB
prerank,regulation of B cell differentiation (GO:0045577),0.4330810026681319,1.0083980947169964,0.44193548387096776,0.962942848755987,1.0,6/17,17.06%,IL4I1;ZFP36L2;PPP2R3C;MMP14;SYK;BTK
prerank,response to ketone (GO:1901654),0.39889070370656476,1.0082751046241862,0.4494556765163297,0.9624296248783083,1.0,1/24,0.25%,CAV1
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.41190291792940814,1.0080278761923382,0.4578125,0.9613875704968879,1.0,10/22,22.71%,ZDHHC1;ZDHHC7;ZDHHC23;ZDHHC20;ZDHHC8;ZDHHC19;GOLGA7B;ZDHHC3;ZDHHC12;GOLGA7
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.41190291792940814,1.0080278761923382,0.4578125,0.9613875704968879,1.0,10/22,22.71%,ZDHHC1;ZDHHC7;ZDHHC23;ZDHHC20;ZDHHC8;ZDHHC19;GOLGA7B;ZDHHC3;ZDHHC12;GOLGA7
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.29730832612499714,1.008012687269515,0.4708377518557794,0.9605790764750001,1.0,18/234,6.25%,ROR1;EDA;CAV1;PPARGC1A;IL18R1;RIPK4;FZD2;LPAR5;CRTC1;FLOT2;PLPP3;HDAC4;IRAK3;WNT5A;FER;TRADD;ARHGEF5;TRIM21
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.32853257593297963,-1.0073565146183059,0.43478260869565216,0.822007974289687,1.0,5/23,5.70%,ENG;SMAD3;TGFBR3;LATS2;ITGA3
prerank,protein prenylation (GO:0018342),0.4672411733318304,1.0073243158221907,0.4570446735395189,0.9616158425561272,1.0,4/10,17.71%,FNTA;FNTB;CHM;PTAR1
prerank,mitotic cell cycle phase transition (GO:0044772),0.2990459708349531,1.0071356230904867,0.4574235807860262,0.9612888598592461,1.0,58/203,21.95%,PLK2;DYNLL1;CCND3;FBXL15;WEE1;SFI1;BRSK1;CEP131;PHLDA1;SPAST;CEP78;CDK7;NEDD1;CCNG1;TUBG1;CKAP5;CCP110;PAFAH1B1;CUL3;CCNJ;ANAPC7;MASTL;EIF4E;CHMP4B;FBXL17;KDM8;CEP290;SSNA1;NDE1;ENSA;CETN2;CRLF3;LCMT1;PCM1;YWHAG;POLE;FBXL12;E2F1;YWHAE;PPP1R12B;USP37;FBXL3;CUL4B;CEP57;CDC23;OFD1;ALMS1;CEP250;DCTN2;ACVR1;TAF2;HAUS8;CEP43;HAUS3;CHMP2A;FBXW11;BORA;CUL5
prerank,regulation of G0 to G1 transition (GO:0070316),-0.29234088029456884,-1.0070190011294642,0.42379182156133827,0.8218937523126796,1.0,20/38,37.02%,PCGF2;PHC3;BMI1;RYBP;CDC7;SUZ12;EED;EHMT2;L3MBTL2;RAD51;BRCA1;RNF2;PCGF6;RING1;MAX;E2F6;CDKN2B;DAB2IP;PHC1;EHMT1
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.34072695817643667,1.0069549871292032,0.45314505776636715,0.9609350562895705,1.0,10/57,9.55%,USP50;CYFIP2;CIDEB;ACVR1C;FIS1;UACA;NLRC4;PERP;MAP3K5;HMGB1
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.2891137711689539,1.0067344942997754,0.4902962206332993,0.9607162518478853,1.0,57/417,12.14%,MDFIC;VGLL4;PRICKLE1;PAX9;NR2F2;TSHZ3;PHC2;FOXP2;ZNF423;FOXD1;BCL3;ATP8B1;MYBBP1A;RUNX2;RBFOX2;SFMBT2;CIART;SPI1;L3MBTL3;FOXK1;UBE2I;SOX9;CHD8;CREB3L1;GLIS2;KAT6B;KLF10;LANCL2;HDAC4;WNT5A;HEYL;RBM15B;BHLHE40;SP3;RCOR3;CTCF;TBX2;NCOR1;RARA;SUV39H1;FOXK2;TSC22D4;KCTD1;UIMC1;MECP2;USP47;RORB;HDAC2;CNOT7;NCOR2;ILF3;HEXIM1;ZHX1;HDAC6;ZNF148;KDM8;MEN1
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.4722903949645544,1.0065548186831177,0.4506065857885615,0.9603801493048424,1.0,2/11,1.56%,NEDD4L;LEPROT
prerank,protein phosphorylation (GO:0006468),0.2848211338063702,1.0061678650653543,0.483248730964467,0.9605555289615478,1.0,60/478,9.88%,PKDCC;TEC;PLK2;FAM20C;TRIB2;CDK15;FGFR1;HCST;PRKCE;CAMK2D;EFEMP1;EGFR;MUSK;MINK1;STK38;MAP3K1;TXK;MAPK10;EIF2AK3;PRKAG1;PRKCA;BMPR1B;PEAK1;CDKL3;SRC;IRAK3;MORC3;LIMK2;ACVR1C;PIK3R4;PDK4;HIPK1;BRSK1;TLR7;CDK13;NEK7;FER;BCKDK;COQ8A;EPHB2;ADAM10;ABL2;CDK7;GMFB;BMP2K;STK38L;RARA;SRPK1;MAP3K5;DYRK1A;NRBP2;CAD;CSNK1G3;GSK3B;RPS6KA3;STK24;STK3;CSNK1A1;MASTL;TYK2
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),-0.40899708161437476,-1.005351344246667,0.43448275862068964,0.8253797543766807,1.0,7/11,42.76%,GRK3;ADM;ARRB2;DRD3;ADRB3;SAG;ARR3
prerank,protein polymerization (GO:0051258),0.3398631399424704,1.0052876447393415,0.47619047619047616,0.9621643083792712,1.0,9/55,10.17%,COBL;GAS7;TRPV4;CKAP5;WASHC3;CASQ2;DIAPH3;CHMP4B;CHMP4A
prerank,pyrimidine nucleoside metabolic process (GO:0006213),0.4425885244975323,1.0052547979741229,0.4750830564784053,0.961420319867877,1.0,4/14,8.88%,DPYS;UPP2;CAD;NT5E
prerank,interleukin-6-mediated signaling pathway (GO:0070102),0.4152839453246352,1.005117752449435,0.4551282051282051,0.9609295191058377,1.0,8/18,20.87%,SPI1;SRC;FER;IL6ST;YAP1;JAK1;ST18;IL6
prerank,sensory perception of sound (GO:0007605),0.3283531434980546,1.00503008793279,0.4467312348668281,0.9603347870307465,1.0,8/88,10.35%,ROR1;HOMER2;RIPOR2;EYA1;TMC2;PAX3;COL1A1;LRTOMT
prerank,regulation of response to external stimulus (GO:0032101),0.3169462740296404,1.004819150343514,0.4690366972477064,0.9601112525448778,1.0,12/121,7.11%,CAV1;GUCA1A;ADAMTS12;PIK3AP1;CD55;CELF1;PTPN22;WNT5A;CNGB1;EPHB2;N4BP1;EFNB2
prerank,sphingolipid metabolic process (GO:0006665),0.3159293503394349,1.0045937064510841,0.460166468489893,0.9598798720300811,1.0,18/108,11.18%,SGMS2;CERS6;ACER3;ELOVL5;PLPP2;TEX2;PLPP3;ALOXE3;SUMF1;CLN8;ELOVL1;HACD4;CERK;NEU1;ELOVL2;CERT1;HEXA;HACD2
prerank,mRNA splice site selection (GO:0006376),0.38353605582752665,1.0045041124693541,0.44925373134328356,0.9592892608532555,1.0,11/30,23.92%,CELF1;CELF2;CELF4;LUC7L2;SFSWAP;SF1;SLU7;SRSF12;SRSF10;YTHDC1;PUF60
prerank,positive regulation of cytoplasmic transport (GO:1903651),-0.40584935414381296,-1.004452593911109,0.45813953488372094,0.8267068944676077,1.0,2/11,1.68%,MSN;DAB2
prerank,protein import into peroxisome membrane (GO:0045046),0.4126654043929729,1.00437266594332,0.46153846153846156,0.9588509734652214,1.0,7/22,19.97%,RAB8B;FIS1;PEX2;PXMP2;ABCD1;SLC25A17;PEX13
prerank,dicarboxylic acid transport (GO:0006835),0.38905805378310987,1.0039579039080593,0.45870206489675514,0.9591511824463571,1.0,6/28,6.95%,FOLR1;FOLR2;SLC25A12;SLC1A7;PRAF2;SLC1A6
prerank,postreplication repair (GO:0006301),0.3503135894925605,1.0039534291710068,0.4412171507607192,0.9583296387110476,1.0,6/45,7.73%,UBE2L6;USP43;POLI;RFC3;UBE2V2;MSH2
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.326626186868972,1.003828805506572,0.4682926829268293,0.9578031200763538,1.0,26/84,18.81%,PSME3;FBXO5;FBXO31;CUL3;PSMB5;CDC20;ANAPC5;ANAPC7;ANAPC11;BUB3;ANAPC2;UBE2D1;PSMA6;PSMB2;PSMA2;ANAPC4;PSMD13;FZR1;PSMA7;PSME4;ANAPC16;CDC23;PSMD12;PSMD14;PSMB6;PSMC4
prerank,positive regulation of biosynthetic process (GO:0009891),-0.2914283593918433,-1.0035989950014235,0.43252595155709345,0.8279831695823653,1.0,11/40,9.29%,CREBL2;BMP4;WNT4;LARP6;APOE;PLCG2;CYBA;TGFB3;AKT1;CREB1;GRIN1
prerank,intermediate filament organization (GO:0045109),-0.36851017725332375,-1.0035769619844181,0.45219638242894056,0.826931271820298,1.0,5/17,14.21%,NEFL;BFSP2;GFAP;DES;VIM
prerank,protein transport (GO:0015031),-0.21038270346307786,-1.0035090556914283,0.42857142857142855,0.8259840875206806,1.0,96/332,22.91%,TBC1D4;STXBP3;VAMP5;TXNIP;WLS;ARHGEF2;LRP1;STEAP3;TBC1D1;MYO6;TFRC;RABGAP1;TOM1;RAB6B;CALCRL;RAB3C;COG7;TBC1D12;PREB;NAPA;TMED9;ATP6V0A4;AP2A1;TBC1D30;STX8;USP6NL;TBC1D2B;NPM1;ZDHHC17;ARHGAP1;APOE;ARL6IP5;VMP1;RAMP2;ATP6V0C;RAB13;SGSM3;SCAMP5;COPZ1;ANK3;EIF2D;SCG2;MACF1;EVI5L;COPZ2;STX17;RAB5C;ATP6V1C1;TMED3;SAR1B;TBC1D22B;RAB24;BBS2;VPS26B;PREPL;STX12;HERC2;SVBP;ARRDC4;CTSA;ABCG1;ARF5;GGA3;TMED1;HFE;RAB3B;ARRDC2;LAPTM5;CHMP3;STX16;SCFD1;ATP6V1D;SYS1;STX6;RAB11B;CHMP2B;SYNDIG1;SLC10A7;MYH9;RAB32;TBC1D17;ATP6V1F;RCN3;SEC31A;TMED7;MON1A;PICK1;CLU;ARF3;OPTN;ATP6V1E1;RAB7A;ARL4C;ARL5B;PRKCB;ACD
prerank,T cell receptor signaling pathway (GO:0050852),0.3071447173668343,1.0033212777116576,0.46878547105561863,0.9583582857766858,1.0,30/138,18.81%,TEC;ITK;CD3G;PDE4D;TXK;EIF2B3;PTPN22;PSME3;PTPRC;LCP2;PTPRJ;PIK3R2;PSMB5;LAT;CD276;TAB2;EIF2B4;PSMA6;PSMB2;PSMA2;PSMD13;NFKBIZ;PSMA7;PAK3;PSME4;PSMD12;PDPK1;PSMD14;PSMB6;PSMC4
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.3552441103418728,1.0032769424857446,0.45977011494252873,0.9576525490853176,1.0,4/46,5.24%,APOD;CDH13;MFN2;TNFAIP3
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.3973902947891905,1.003224954853023,0.45076923076923076,0.956124612048625,1.0,11/23,24.80%,PPP1R13B;SFN;BAD;NMT1;YWHAG;E2F1;YWHAE;TFDP1;MAPK8;YWHAB;YWHAQ
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.3973902947891905,1.003224954853023,0.45076923076923076,0.956124612048625,1.0,11/23,24.80%,PPP1R13B;SFN;BAD;NMT1;YWHAG;E2F1;YWHAE;TFDP1;MAPK8;YWHAB;YWHAQ
prerank,aromatic amino acid family catabolic process (GO:0009074),0.4287159242733563,1.0031761681289,0.4507042253521127,0.9554250952546759,1.0,4/15,16.74%,IL4I1;AADAT;GSTZ1;KYAT1
prerank,cAMP biosynthetic process (GO:0006171),-0.4161724036129434,-1.0030187241366866,0.4858490566037736,0.8262723123335057,1.0,4/10,8.09%,ADCY1;ADCY7;ADCY4;ADCY2
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),0.448421496421378,1.0029643937223471,0.4834983498349835,0.9551502095398401,1.0,1/12,0.99%,IL18R1
prerank,mitochondrion transport along microtubule (GO:0047497),-0.3870663308575179,-1.0027758739944148,0.45758354755784064,0.8258289347524003,1.0,7/13,26.60%,NEFL;HIF1A;MAPT;OPA1;RHOT1;LRPPRC;UBB
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),-0.35441685943696866,-1.002775312006416,0.4463276836158192,0.8247189983129554,1.0,8/18,24.63%,HIP1R;ACAA2;BID;GSK3A;BOK;CHCHD10;ZNF205;HSPA1A
prerank,positive regulation of monooxygenase activity (GO:0032770),-0.3120176173483994,-1.0022955045667417,0.42628205128205127,0.8248686454963657,1.0,8/26,13.76%,NPR3;ATP7A;HIF1A;APOE;GCH1;AKT1;S100A1;DHFR
prerank,regulation of immune response (GO:0050776),0.3094388035392002,1.002202910968281,0.46464646464646464,0.956378902837,1.0,22/135,16.93%,CXADR;HCST;CD3G;CD300LG;IL4I1;PTPN22;COL3A1;N4BP1;ITGB7;CRTAM;PLSCR1;CD200R1;COL1A1;CD276;LAIR1;ULBP1;CD81;SH2D1A;ZMPSTE24;IL15;LAG3;SYK
prerank,regulation of pseudopodium assembly (GO:0031272),0.4675775399128125,1.0021754300126597,0.4632867132867133,0.9547971060826713,1.0,3/10,14.99%,CDC42EP4;APC;CDC42EP3
prerank,positive regulation of pseudopodium assembly (GO:0031274),0.4675775399128125,1.0021754300126597,0.4632867132867133,0.9547971060826713,1.0,3/10,14.99%,CDC42EP4;APC;CDC42EP3
prerank,regulation of interferon-gamma production (GO:0032649),0.33182092937680013,1.0021522022102574,0.45512010113780027,0.9540456539134722,1.0,11/71,11.04%,IL18R1;PDE4D;TXK;PTPN22;TLR7;CRTAM;RARA;ISL1;HMGB1;AXL;CD276
prerank,nucleotide biosynthetic process (GO:0009165),0.4202779622441367,1.0021155962314434,0.45068285280728376,0.9533223039514748,1.0,6/18,11.92%,MTHFD1;PPAT;NMNAT3;PRPSAP2;PRPS1;PRPS1L1
prerank,stress-activated MAPK cascade (GO:0051403),-0.26637987404510866,-1.0018453441617834,0.4533898305084746,0.8250647032422417,1.0,19/61,23.14%,TNFRSF19;MAP3K20;UBE2N;TRAF6;CRKL;NOD1;MAP3K10;TRIB1;TAOK2;MAP2K3;IKBKB;LGALS9;ZFP36;IRAK2;GPS1;CUL1;SKP1;IKBKG;NOD2
prerank,cellular response to heat (GO:0034605),0.36949034569102424,1.0017609215774974,0.46920821114369504,0.9534645770091812,1.0,12/35,21.91%,FGF1;TRPV4;IL1A;BAG3;TPR;CLPB;HTRA2;YWHAE;SLU7;SUMO1;DAXX;RBBP7
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.39587404336701526,1.001702291574917,0.4755043227665706,0.9528029804290351,1.0,7/25,14.56%,LEPROT;CHMP5;CHMP4B;CHMP4A;CHMP4C;LEPROTL1;LAPTM4B
prerank,regulation of viral transcription (GO:0046782),0.35743588677860494,1.0014427943292994,0.43741209563994377,0.9526910444574699,1.0,6/39,12.03%,MDFIC;TRIM21;NELFB;SUPT4H1;HEXIM1;GTF2F2
prerank,protein monoubiquitination (GO:0006513),0.3694243032643874,1.0012974182351138,0.43515850144092216,0.952287870112703,1.0,15/36,23.27%,LEO1;TRIM21;PAF1;CUL3;UBE3D;OBI1;KLHL22;UBE2D3;UBE2R2;FANCL;UBE2W;CDC73;PRKN;DTX3L;RNF20
prerank,regulation of systemic arterial blood pressure (GO:0003073),0.4344119639435479,1.001217187341663,0.45210084033613446,0.9516783261897543,1.0,2/16,1.78%,PLCB3;KLK2
prerank,positive regulation of glycogen metabolic process (GO:0070875),-0.3940425741844259,-1.0007570809284352,0.4485294117647059,0.8269130889259125,1.0,4/13,8.34%,IGF1;INSR;IGF2;AKT1
prerank,DNA modification (GO:0006304),0.4005616819185652,1.0007169480912617,0.4625199362041467,0.9522181964020735,1.0,3/22,5.30%,TDG;NTHL1;EXOSC5
prerank,negative regulation of DNA binding (GO:0043392),-0.31727353946255,-1.0004317077564335,0.45857988165680474,0.8266856867530901,1.0,6/28,20.64%,LEF1;SP100;JAK2;KDM1A;PER2;MAD2L2
prerank,cellular response to BMP stimulus (GO:0071773),0.3380732415308072,1.000171849936247,0.4588688946015424,0.9528968300081411,1.0,9/66,5.61%,DLX1;ADAMTS12;RUNX2;BMPR1B;SOX9;BMP5;ZFYVE16;BMP15;RGMB
prerank,carbohydrate catabolic process (GO:0016052),0.364311288467319,0.9995546617166224,0.4639321074964639,0.9536654651530148,1.0,11/38,17.54%,HK2;NAGA;NEU1;ALDOB;PGM1;MANBA;ENO3;GCK;DERA;PGK1;ENO2
prerank,regulation of interleukin-6 production (GO:0032675),0.31688828898446153,0.999520041050243,0.4642857142857143,0.952948009406944,1.0,13/96,9.63%,LBP;IL1A;PTPN22;IRAK3;WNT5A;TNFAIP3;IL17RA;TLR7;SELENOS;ISL1;CD200R1;HMGB1;FOXJ1
prerank,regulation of macromolecule metabolic process (GO:0060255),-0.2219424707941597,-0.9993406740693188,0.4578313253012048,0.8285254400427672,1.0,32/170,14.75%,IGF1;PRDM6;ROCK2;FOXP1;ADNP2;SLC8A1;NOVA2;PRDM5;SIRPA;LDLR;HIF1A;HNRNPK;ZNF507;APOE;HINFP;ATP1B1;PCBP1;CDK6;TRIM14;PRDM2;PROX1;ZC3H12A;ANKRA2;BMI1;PCBP4;CDK4;MEGF8;CIAO3;CAVIN4;AHR;SORT1;RFXANK
prerank,transferrin transport (GO:0033572),-0.3084301100698312,-0.9990701153580475,0.4594594594594595,0.8281372738577039,1.0,11/33,21.68%,STEAP3;TFRC;ATP6V0A4;ARHGAP1;ATP6V0C;ATP6V1C1;HFE;ATP6V1D;RAB11B;ATP6V1F;ATP6V1E1
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),-0.29687402340784175,-0.9989260274189209,0.4631578947368421,0.8274351424503243,1.0,6/36,7.14%,MECOM;FOXO1;SIRPA;DUSP10;DUSP3;IGBP1
prerank,regulation of alcohol biosynthetic process (GO:1902930),0.45911664138656955,0.9986387116268648,0.4651567944250871,0.9544965038498037,1.0,8/12,30.40%,CLCN2;RAN;MBTPS1;MBTPS2;SEC14L2;SREBF2;SREBF1;DGKQ
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.41695653890892376,0.9980510492481969,0.44936708860759494,0.9553044523412783,1.0,9/19,23.94%,CHD8;POLR3G;ELL;BRF2;RPTOR;ICE2;TENM1;POLR3C;MTOR
prerank,mitochondrial RNA metabolic process (GO:0000959),0.43547536675512105,0.9980262985775186,0.48403361344537815,0.9545592944952259,1.0,5/14,14.46%,FOXO3;TFB2M;MTERF2;TEFM;FASTKD1
prerank,autophagosome organization (GO:1905037),-0.2734234323589364,-0.9978883320272357,0.4798387096774194,0.8292066058104736,1.0,16/50,24.97%,ATG16L2;BECN1;GABARAPL1;VMP1;ULK2;WIPI1;GABARAP;AMBRA1;STX12;ATG13;MAP1LC3A;WIPI2;ATG12;RAB7A;WDR45B;WDR45
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.47050719396849894,0.9972910735947245,0.4931506849315068,0.9556590231348288,1.0,2/10,6.29%,WNT5A;ADAM10
prerank,cholesterol metabolic process (GO:0008203),-0.25787740541540605,-0.9971810699126996,0.4636363636363636,0.830066760346998,1.0,31/68,32.12%,PPARD;INSIG2;ARV1;APOE;HMGCS1;SCAP;OSBPL1A;LDLRAP1;OSBPL5;ACAA2;GBA2;ACLY;NSDHL;PMVK;ABCG1;MVK;ACAT2;DHCR7;TSKU;PIP4P1;TM7SF2;CLN6;SCARF1;LCAT;CH25H;MVD;SOAT2;RXRA;PLPP6;LBR;SQLE
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.33142503731573913,0.9968205243915282,0.47095959595959597,0.9560545733349162,1.0,6/73,7.19%,NGF;DLC1;EIF2AK3;EGLN3;TRADD;NLRC4
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.3206626006181209,-0.9968033433396896,0.44036697247706424,0.8299370751933229,1.0,10/26,23.14%,ALPK1;UBE2N;TRAF6;NOD1;AAMP;CASP8;IRAK2;MAP2K6;IKBKG;NOD2
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.4417765338018642,0.9967539618514173,0.4854202401372213,0.9554109235130003,1.0,1/12,1.61%,ASS1
prerank,cholesterol biosynthetic process (GO:0006695),-0.31283851697635245,-0.9966539437037011,0.4479495268138801,0.8292586657140187,1.0,16/31,33.16%,INSIG2;ARV1;HMGCS1;ACAA2;ACLY;NSDHL;PMVK;MVK;ACAT2;DHCR7;TM7SF2;MVD;PLPP6;LBR;SQLE;EBP
prerank,response to steroid hormone (GO:0048545),0.3773804440273592,0.9966366119997748,0.4745508982035928,0.9548989752170267,1.0,3/31,7.35%,CAV1;ATP1A2;CATSPERD
prerank,regulation of hormone secretion (GO:0046883),-0.3763110991065557,-0.9966113903031268,0.43283582089552236,0.8282765969458727,1.0,8/15,40.22%,ANXA1;EDN1;EDN3;SCG5;NMB;IL11;LIF;VAMP3
prerank,regulation of macrophage differentiation (GO:0045649),-0.36564193503232184,-0.996329468781955,0.4797979797979798,0.8279905776243571,1.0,7/15,23.22%,IL34;ID2;HSF1;CSF1;CASP8;INHBA;RIPK1
prerank,regulation of B cell activation (GO:0050864),0.3955040473857522,0.9951597783729944,0.46153846153846156,0.9579016795520152,1.0,5/25,13.69%,IL4I1;TNFAIP3;BANK1;FOXJ1;ZFP36L2
prerank,alpha-amino acid metabolic process (GO:1901605),0.35715350187062544,0.9951358737720828,0.46879150066401065,0.9571445138498972,1.0,7/45,6.35%,ASS1;NAALAD2;SLC25A12;AADAT;MTHFD1;DDAH2;ALDH18A1
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),-0.24702066558920058,-0.9947440636807724,0.43373493975903615,0.8311724043927512,1.0,14/74,12.78%,RBPJ;PSMA1;EGLN1;EP300;RBX1;HIF1A;PSMD11;PSMD7;CITED2;PSMD4;EPAS1;CUL2;HIF3A;PSMB4
prerank,atrioventricular valve morphogenesis (GO:0003181),-0.3454815772836978,-0.9944589394976003,0.4573002754820937,0.8308105883651177,1.0,7/19,24.87%,SMAD6;BMPR2;BMP2;TGFB2;SMAD4;OLFM1;NOTCH1
prerank,regulation of cell population proliferation (GO:0042127),0.2824890123623254,0.9942097090206995,0.5130260521042084,0.9586664391231892,1.0,92/691,12.82%,ROR2;NGF;ZBTB7C;FGF7;IGFBP6;DLC1;NTRK3;CDH13;GLI1;FGFR1;GLMN;CLDN19;PTGFR;EGFR;FOLR2;ADAMTS1;FGF1;JAG1;SSTR1;ACER3;KIF20B;GPLD1;RBFOX2;GNRH1;ITGAX;IL1A;PTPN14;PTHLH;CELF1;SAPCD2;SOX9;TPTE;BMP5;KLF10;HDAC4;NUP62;EGLN3;PDS5B;FN1;KANK2;CDK13;RPRD1B;FER;CEP131;NCK2;ADAM10;KRAS;CTCF;TBX2;EFNB2;CHERP;HOXC10;FBXO5;RARA;CUL3;DIS3L2;GCNT2;PTPRJ;DPP4;RBM5;S100B;FGF18;DDRGK1;TSHR;GAB2;TET1;MECP2;DLG3;TRNP1;HDAC2;CNOT7;PBRM1;HILPDA;STRN;ADRA2A;AXIN2;TBC1D8;SRPK2;RARG;IL6ST;APC;PRLR;ZBTB49;NF2;SGK1;WNT9A;MEN1;STAT2;IL7;PTEN;CDC6;CD81
prerank,protein import (GO:0017038),0.3179467053676846,0.9940899154435804,0.47073170731707314,0.9581478774622392,1.0,22/84,19.97%,PRICKLE1;RAB8B;IPO8;FIS1;NUP62;PEX2;FAM53B;PXMP2;TPR;MMP12;NUP50;CSE1L;NUP153;ABCD1;RAN;NUP93;SYK;HSPA4;LAMP2;SLC25A17;RPAIN;PEX13
prerank,positive regulation of cell growth (GO:0030307),0.3170877302526251,0.9937263987325646,0.4743276283618582,0.9582214207502809,1.0,12/96,12.40%,NGF;NEDD4L;NTN1;EGFR;ADAM10;RIMS2;CPNE9;RPS6KA3;USP47;S100A9;INO80;SEMA4D
prerank,positive regulation of reproductive process (GO:2000243),0.38338975884890036,0.9936215490890985,0.46835443037974683,0.9576977354013805,1.0,3/31,6.28%,INHBB;CACNA1H;LHFPL2
prerank,monosaccharide transmembrane transport (GO:0015749),-0.3575446452099018,-0.9935821096248052,0.4606741573033708,0.832151272083074,1.0,5/16,17.43%,SLC2A12;SLC2A10;SLC45A3;SLC2A8;SLC2A9
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.3208601059027362,0.9933457252666741,0.48495788206979545,0.9576600209468784,1.0,9/86,5.52%,INHBB;SULF1;ZNF423;FOXD1;FBXL15;CDH5;BMPR1B;BMP5;BMP15
prerank,positive regulation of potassium ion transport (GO:0043268),-0.29339851921905474,-0.9929699980259548,0.4838709677419355,0.8327349835220954,1.0,9/38,10.17%,ANK2;ACTN2;KCNJ6;KCNJ2;KCNMA1;AKAP6;KCNJ10;FLNA;KCNN2
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.38121706718489184,0.9925489423370715,0.4845814977973568,0.958984874373529,1.0,1/29,0.25%,CAV1
prerank,regulation of dendrite development (GO:0050773),0.36256548692291013,0.9921546407679336,0.47007299270072994,0.9591783310000758,1.0,7/37,12.40%,NEDD4L;COBL;BMP5;GSK3B;SARM1;NEDD4;SEMA4D
prerank,response to nitric oxide (GO:0071731),-0.3812009731747997,-0.9919808463501821,0.45614035087719296,0.834381515154559,1.0,5/13,24.95%,EGLN1;FOXO1;MTR;CCL19;CDK2
prerank,regulation of phospholipid metabolic process (GO:1903725),0.4640970527807641,0.9916537958693602,0.4709090909090909,0.9597258142617479,1.0,3/10,19.89%,MTMR3;MTMR1;DNAJC19
prerank,actin filament polymerization (GO:0030041),0.37162774093862755,0.9913546908210551,0.4755043227665706,0.959692075230332,1.0,4/29,10.12%,COBL;GAS7;WASHC3;DIAPH3
prerank,pore complex assembly (GO:0046931),0.4193820601978556,0.9912286280111999,0.46808510638297873,0.9592142146655889,1.0,9/19,15.65%,ANO6;ADAM10;TPR;AHCTF1;NUP153;GSDMD;RTN4;BAD;NUP93
prerank,positive regulation of myeloid cell differentiation (GO:0045639),-0.29673805668335945,-0.9910962618573947,0.4577922077922078,0.8357225424242857,1.0,14/33,28.82%,ETS1;HOXA5;HIF1A;TAL1;FES;ABCB10;NCKAP1L;INHBA;RAB7B;HSPA1A;FAM210B;ACVR1B;STAT3;HSPA1B
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.29708838277957733,0.9910427548854578,0.49192680301399355,0.9588909045523142,1.0,42/172,19.22%,DGKA;PTPN13;PISD;DDHD1;PI4K2B;GPAT3;ACP6;DGKZ;PCTP;SLC27A1;PIP4K2B;PIK3R4;AGPAT4;PLEKHA4;MTMR7;PIK3R2;MTMR6;MTMR3;PLSCR1;LCLAT1;OCRL;INPP5F;ETNK2;PLD1;AGPAT5;CDS2;PTEN;PIK3C3;GPD1;PLEKHA1;MTMR12;STARD10;MTMR1;PI4K2A;PITPNM2;HDHD5;CSNK2A2;LPIN1;SELENOI;RAB5A;PITPNM3;FIG4
prerank,regulation of epithelial cell migration (GO:0010632),0.3472337759225562,0.9909915642883712,0.4783180026281209,0.9582292292160417,1.0,8/51,7.43%,DOCK5;PRKCE;CEACAM1;DOCK1;SOX9;SRC;RHOJ;RREB1
prerank,mitochondrion organization (GO:0007005),0.3007956336707189,0.9907974180712329,0.49122807017543857,0.9579500126430094,1.0,43/165,22.73%,CXADR;PPARGC1A;HK2;PISD;RAB29;WDR81;CAV2;TOMM34;MPV17;DNM1;MFN2;FIS1;ATPAF1;SIRT3;NRF1;MIEF1;IMMP2L;TFB2M;LONP1;MTX1;NIPSNAP2;TOMM40;POLG2;DNAJA3;AIFM2;BCS1L;ESRRA;BNIP3;MIGA1;TMEM70;PINK1;GABPA;BAX;DNAJC19;STOML2;CHCHD3;MUL1;PRKN;ATP5F1D;YME1L1;THG1L;TFB1M;RHOT2
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.36123621379994747,0.9905352580361618,0.4862914862914863,0.957781936504591,1.0,14/37,24.18%,RNASEH2B;PABPC4;SIDT2;DFFB;NUDT18;MTREX;RNASE3;ENTPD2;HNRNPD;NUDT5;EXOSC7;RNASEH1;NUDT1;DNASE1L1
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.3647026911871543,0.9905227647716124,0.4646892655367232,0.9570091160373181,1.0,14/38,22.49%,LEPROT;ABLIM3;RAC2;SIAH3;HTRA2;UBE2J2;UBE2D3;FBXW7;CSNK2A2;VPS11;PINK1;UBL5;PRKN;SAE1
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.40181183051836367,0.9903599437923871,0.4657320872274143,0.9566448120071499,1.0,1/20,0.22%,PKDCC
prerank,negative regulation of neurogenesis (GO:0050768),0.3742586970488709,0.9903372368932752,0.4677871148459384,0.955906566236362,1.0,10/34,18.19%,LRP4;NF1;RTN4R;GDI1;HOOK3;PTEN;PCM1;RTN4;EFNB3;RHOA
prerank,chromatin disassembly (GO:0031498),-0.37187571253522506,-0.9901334391059556,0.5012106537530266,0.8361941892744376,1.0,3/14,11.00%,SMARCE1;SMARCD1;ARID2
prerank,nucleosome disassembly (GO:0006337),-0.37187571253522506,-0.9901334391059556,0.5012106537530266,0.8361941892744376,1.0,3/14,11.00%,SMARCE1;SMARCD1;ARID2
prerank,organelle organization (GO:0006996),0.28350285437170825,0.9897793381343802,0.5162271805273834,0.956597963431441,1.0,79/388,17.39%,CAV1;CXADR;FMNL2;PPARGC1A;ATP8B3;PLCE1;ATP8B1;CAPZB;RAB29;PI4K2B;WDR81;LMAN2;CAV2;EIF2AK3;CNTNAP1;RAB30;TNFAIP3;ZFYVE16;TMEM135;SIRT3;CEP78;PACSIN2;NRF1;PEX2;ATL2;RANBP10;GOLGB1;MICAL3;ARMC2;CHMP5;PDCD6IP;ATP8B2;LYSMD3;CSNK1A1;NPLOC4;ZMYM6;TMED4;DIAPH3;CHMP4B;CHMP4A;HILPDA;TFB2M;ANK1;LNPK;LONP1;IQCG;MTX1;CHMP4C;DPYSL2;FAM161B;NIPSNAP2;ABCD1;TRIP11;RAB34;FAM161A;HTT;POLG2;DNAJA3;SIPA1;SPRYD3;ZW10;BCS1L;SEC23IP;FBXW8;TMED2;TICAM2;PI4K2A;ATP8B4;CFAP410;TBC1D20;MDK;CFAP61;BRWD1;DYNC2H1;ARHGEF7;SIPA1L3;ESRRA;STX4;GEM
prerank,regulation of dendritic spine morphogenesis (GO:0061001),0.37903172175905725,0.9896912198834061,0.4588235294117647,0.9560286664203086,1.0,7/31,14.47%,SIPA1L1;PPFIA2;LZTS3;SRCIN1;RELN;PTEN;CAPRIN2
prerank,regulation of vasculogenesis (GO:2001212),0.4476040017769269,0.9890740832097986,0.4826446280991736,0.9568179133431407,1.0,2/14,1.92%,CEACAM1;RAP1A
prerank,triglyceride catabolic process (GO:0019433),-0.3491737749031278,-0.9888991110149563,0.47540983606557374,0.838539289729553,1.0,9/19,43.19%,PNPLA3;FABP7;FABP3;FABP5;LIPH;LIPC;PNPLA2;FABP4;FABP12
prerank,potassium ion transmembrane transport (GO:0071805),0.30404541482899955,0.9888207106655964,0.4798206278026906,0.9566886999109572,1.0,18/135,11.27%,KCNJ4;NALCN;KCNA5;SLC12A2;KCNJ16;SLC24A1;SLC12A4;KCNS2;SLC12A3;KCNK1;ATP1A2;KCNJ13;KCNK5;ATP1B3;KCNS3;KCNAB1;SLC9A7;SLC9A6
prerank,positive regulation of cell cycle process (GO:0090068),-0.24187089802063064,-0.9886346428399067,0.4388888888888889,0.8381495908187593,1.0,9/91,3.91%,IGF1;INSR;TGFA;PDGFRB;SVIL;MAP3K20;CDC42;IGF2;USP19
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.38142620244167763,0.9886106085228594,0.4791666666666667,0.9564277808695801,1.0,9/26,18.14%,FBXO5;CUL3;ANAPC5;ANAPC7;ANAPC11;CDC6;LCMT1;ANAPC4;CDC23
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.32971113560395976,0.9882708660226968,0.47503201024327785,0.9565729293683012,1.0,9/70,8.29%,WIPF1;PRKCE;CYFIP2;DOCK1;CD3G;VAV2;SRC;PIK3R2;MYH2
prerank,positive regulation of actin filament polymerization (GO:0030838),0.3521734760985771,0.9881405086013051,0.4747191011235955,0.9561651605753418,1.0,12/44,22.34%,PRKCE;CDC42EP4;FER;NCK2;ARF6;CTTN;CDC42EP3;BAIAP2;PFN2;NCK1;HCK;TENM1
prerank,regulation of cellular component size (GO:0032535),-0.29688344408916956,-0.988074600430005,0.475,0.8385059847272819,1.0,3/30,1.27%,PICALM;EPS8;MSN
prerank,positive regulation of interleukin-12 production (GO:0032735),-0.30415962100413,-0.9876593810498498,0.449685534591195,0.8385494528660872,1.0,8/31,24.38%,PLCB1;PLCG2;LGALS9;LAPTM5;CD40;TLR3;CCL19;IRF5
prerank,sphingoid metabolic process (GO:0046519),0.44368931306799836,0.9875998261861443,0.47674418604651164,0.9567653750156168,1.0,2/12,4.08%,PLPP2;PLPP3
prerank,endocytic recycling (GO:0032456),-0.2751885793992538,-0.9875784852031263,0.46124031007751937,0.8376463394143225,1.0,15/50,22.61%,VPS39;VPS35L;ENTR1;EPS15;RAB13;DENND1A;EHD4;EIPR1;MICALL1;RAB11FIP3;STX6;RAB11B;ANKRD27;RAB7A;ARL4C
prerank,protein secretion (GO:0009306),0.3384208754776842,0.9875730288738812,0.4649006622516556,0.9560450697187767,1.0,7/56,8.05%,TANGO6;PCSK5;RAB8B;LTBP2;RIMS2;RAB3A;ABCA1
prerank,regulation of lymphocyte migration (GO:2000401),-0.40674566687895086,-0.9873227643318843,0.49764150943396224,0.8372320747954227,1.0,3/10,8.34%,MSN;STK10;AKT1
prerank,regulation of axon regeneration (GO:0048679),0.452391021045376,0.9873148842189576,0.48547008547008547,0.9558983733834071,1.0,4/12,10.64%,RTN4R;STK24;INPP5F;RTN4RL1
prerank,mitotic cytokinetic process (GO:1902410),0.40790385837161147,0.9871450086391244,0.45384615384615384,0.9555683060945855,1.0,6/20,12.19%,CHMP5;PDCD6IP;CNTROB;CHMP4B;CHMP4A;CHMP4C
prerank,regulation of exit from mitosis (GO:0007096),0.3539101796992697,0.9869767464545062,0.4787379972565158,0.9552091195145703,1.0,13/38,18.14%,CDC20;ANAPC5;ANAPC7;ANAPC11;BUB3;ANAPC2;UBE2D1;ZW10;ANAPC4;CDC14A;RGCC;ANAPC16;CDC23
prerank,plasma membrane tubulation (GO:0097320),0.43634572489745266,0.9869226584442747,0.4788732394366197,0.9545486507610734,1.0,7/13,24.46%,PACSIN2;EHD2;CHMP4A;CAVIN2;PACSIN3;PACSIN1;WHAMM
prerank,negative regulation of DNA replication (GO:0008156),0.4335790811958773,0.9868896128411377,0.4748322147651007,0.9538471870834693,1.0,4/13,19.81%,CDAN1;CDC6;GMNN;ATR
prerank,cellular response to retinoic acid (GO:0071300),-0.2843793126610767,-0.9868387146412902,0.4664179104477612,0.8375119373206479,1.0,9/42,11.05%,EPHA3;WNT5B;LYN;ADNP2;BRINP3;TBX1;CREB1;SNW1;RET
prerank,regulation of protein dephosphorylation (GO:0035304),0.3663080476851162,0.9865109391375797,0.4745042492917847,0.9540954054902503,1.0,16/37,26.09%,DLC1;CDH5;ENSA;PTPA;HTT;PPP6R3;SYMPK;PIN1;CALM2;PPP6R1;CDCA2;YWHAB;PPP6R2;PRKCD;SPPL3;PPP1R16A
prerank,positive regulation of CREB transcription factor activity (GO:0032793),-0.347462362042517,-0.9860526366266628,0.4688279301745636,0.8386333097897596,1.0,6/18,11.84%,ADCY1;RPS6KA5;CRTC3;CD200;LRP8;CRTC2
prerank,second-messenger-mediated signaling (GO:0019932),0.32119811887216293,0.9858215083422478,0.4876847290640394,0.9551174345549022,1.0,8/82,10.34%,HRH1;ACKR3;PLCE1;EIF2AK3;DDAH2;RCAN1;KSR2;LAT
prerank,negative regulation of protein binding (GO:0032091),0.33098784498537204,0.9857668280277553,0.48863636363636365,0.9544739931277233,1.0,5/71,5.34%,CAV1;EFHB;PTPRF;DACT1;STYX
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.3199750209533939,-0.9857444395887639,0.5028409090909091,0.8383910985124277,1.0,11/24,24.63%,NR1H3;NR1H2;AQP11;SYVN1;LRRK2;OPA1;RACK1;TMBIM6;CLU;XBP1;HSPA1A
prerank,histone H4-K5 acetylation (GO:0043981),0.42331611120618606,0.9853807429769981,0.47419354838709676,0.9539424168502098,1.0,3/15,14.41%,OGT;KANSL2;KAT8
prerank,histone H4-K8 acetylation (GO:0043982),0.42331611120618606,0.9853807429769981,0.47419354838709676,0.9539424168502098,1.0,3/15,14.41%,OGT;KANSL2;KAT8
prerank,cellular response to ATP (GO:0071318),-0.3791096867293927,-0.985327228535889,0.5023584905660378,0.8384489114540755,1.0,5/14,27.31%,P2RX7;P2RX4;CIB2;P2RY12;P2RY1
prerank,pyrimidine nucleoside catabolic process (GO:0046135),0.4652934342737439,0.9850321766340276,0.49012567324955114,0.954028221113815,1.0,3/10,8.88%,DPYS;UPP2;NT5E
prerank,positive regulation of phagocytosis (GO:0050766),0.3505882121345072,0.9847365147294022,0.473972602739726,0.9540108209981479,1.0,6/47,8.07%,C2;ANO6;LMAN2;PTPRC;DOCK2;PTPRJ
prerank,response to glucose (GO:0009749),0.345928467583521,0.9846413838233127,0.47150997150997154,0.9534878479393161,1.0,17/46,21.67%,ZBTB20;GPLD1;EIF2B3;SELENOS;EIF2B4;GCK;SOX4;ERN1;UNC13B;TRA2B;GPER1;ADCY8;LPL;IRS2;PAX2;TCF7L2;VAMP2
prerank,negative regulation of biosynthetic process (GO:0009890),0.42462121882938947,0.9844895572384366,0.4809917355371901,0.9531258769458939,1.0,6/16,20.87%,CEACAM1;ABCD1;ABCB7;GPER1;COA8;IL6
prerank,response to hydroxyurea (GO:0072710),-0.40542718691501606,-0.9843597619374642,0.5035799522673031,0.8400016218686928,1.0,4/11,19.67%,BLM;DDI2;NSMCE3;TIMELESS
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),0.4406112524797955,0.9842359038876348,0.4750430292598967,0.9529693460531419,1.0,2/12,1.96%,DOCK5;ADAMTS1
prerank,cellular response to inorganic substance (GO:0071241),-0.32719618765896324,-0.9842193450318073,0.4715909090909091,0.8392845536291696,1.0,6/21,19.67%,FOXO1;BLM;MTR;DDI2;NSMCE3;TIMELESS
prerank,cortical cytoskeleton organization (GO:0030865),0.35379786505201555,0.9841141642040641,0.4700854700854701,0.9525110747117282,1.0,12/41,18.19%,FMNL2;EPB41L3;TRPV4;RAC2;ARF6;PLEK;FHOD1;RND2;PPP2R3C;LCP1;EZR;RHOA
prerank,regulation of vasculature development (GO:1901342),-0.3106879917131538,-0.9839080529203315,0.4791666666666667,0.8390094537677361,1.0,3/26,2.72%,ETS1;SP100;EGLN1
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),-0.30790089894239914,-0.983878646451274,0.49158249158249157,0.8369350390237185,1.0,9/29,19.58%,GPAT4;ACOT7;DBI;ACSL6;MLYCD;ACLY;ACOT6;ACOT11;OXSM
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),-0.30790089894239914,-0.983878646451274,0.49158249158249157,0.8369350390237185,1.0,9/29,19.58%,GPAT4;ACOT7;DBI;ACSL6;MLYCD;ACLY;ACOT6;ACOT11;OXSM
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),-0.39645935092824797,-0.9831814114078788,0.49539170506912444,0.8377831465944193,1.0,4/11,14.21%,LYN;MFHAS1;CYBA;PJA2
prerank,membrane lipid metabolic process (GO:0006643),0.39307010096293327,0.9830937346631063,0.5029498525073747,0.9544498018027077,1.0,5/22,6.32%,AGMO;TEX2;ALOXE3;MGST2;CERK
prerank,regulation of telomere capping (GO:1904353),0.3881912470454118,0.9830109111435372,0.4631083202511774,0.9538869695652645,1.0,8/23,26.87%,NEK7;NBN;TERF2;HNRNPD;SMG6;MAPK1;TNKS;RAD50
prerank,response to glucagon (GO:0033762),-0.3392317504018592,-0.9829757777543462,0.5083798882681564,0.8373010996141895,1.0,8/19,19.06%,ADCY1;ADCY7;ADCY4;ADCY2;CREB1;PRKAR2B;CYSLTR2;CRY1
prerank,negative regulation of wound healing (GO:0061045),0.3894874021231638,0.982834601565175,0.4877675840978593,0.9535562006527875,1.0,4/28,3.00%,CLDN19;SLC12A2;AJAP1;CASK
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),-0.39478370727935874,-0.9825045066330614,0.49414519906323184,0.8374819874710572,1.0,2/11,1.51%,ITM2A;NECAB1
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.31710183780394935,0.9824663279094603,0.49817739975698666,0.9537556268801112,1.0,8/87,6.50%,EFNA5;DLC1;F11R;ARHGAP18;RAPGEF3;RAC2;ARHGEF5;ABL2
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.42867377118926375,0.9823507957952213,0.48148148148148145,0.9532747383999854,1.0,3/15,13.77%,HOMER2;GRM1;HOMER3
prerank,regulation of lipid biosynthetic process (GO:0046890),0.3661435762560068,0.9819907685585768,0.4844903988183161,0.953451779736778,1.0,4/32,5.21%,SORBS1;CEACAM1;ZBTB20;PDK4
prerank,double-strand break repair via break-induced replication (GO:0000727),-0.3929908446648803,-0.9819468709962209,0.5022421524663677,0.8379454289763407,1.0,10/12,37.53%,MCM6;CDC7;MUS81;MCMDC2;CDC45;MCM3;MCM7;MCM5;MCM2;GINS2
prerank,regulation of protein metabolic process (GO:0051246),-0.27615017858432067,-0.9818073700196988,0.46863468634686345,0.8372067603479442,1.0,11/44,11.96%,ROCK2;FKBP1A;LDLR;ACE;SPOP;KLF4;APOE;NEDD8;KLF2;FURIN;TMEM9
prerank,negative regulation of protein secretion (GO:0050709),-0.2800192700685131,-0.981425611957102,0.48494983277591974,0.837210821024252,1.0,12/38,18.13%,KCNB1;CCN3;NR1H3;MIDN;CD200;APOE;SERGEF;RHBDF2;RAB11FIP3;RAB11FIP1;RSAD2;OPRM1
prerank,"base-excision repair, AP site formation (GO:0006285)",0.4175521073723234,0.9813037957933062,0.48713550600343053,0.9543926573089587,1.0,2/17,4.72%,TDG;NTHL1
prerank,DNA conformation change (GO:0071103),0.4152301947565311,0.9812186660359563,0.4975845410628019,0.9538264828867165,1.0,5/17,15.20%,HAT1;TOP3B;HMGB1;TOP1;NAA10
prerank,positive regulation of immunoglobulin production (GO:0002639),-0.29905341897426196,-0.9809563947464486,0.4968152866242038,0.8373837454524924,1.0,4/31,4.06%,RBP4;TFRC;PAXIP1;SHLD2
prerank,regulation of transferase activity (GO:0051338),0.41213692842235716,0.9807384809697912,0.4900990099009901,0.9542771270588546,1.0,1/17,1.64%,LDB2
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.3274072724998233,0.980675248248129,0.491025641025641,0.9536698321372099,1.0,9/71,8.29%,WIPF1;PRKCE;CYFIP2;DOCK1;CD3G;VAV2;SRC;PIK3R2;MYH2
prerank,positive regulation of establishment of protein localization (GO:1904951),-0.3464587812557144,-0.9805033511609568,0.4497354497354497,0.8375004860852355,1.0,5/18,13.37%,CCT7;CORO2B;CEP135;CCT8;CEP120
prerank,response to acidic pH (GO:0010447),-0.38186845940515846,-0.9800408325793453,0.4841075794621027,0.8377154268204988,1.0,6/13,26.41%,GPR4;LGMN;SLC9A1;RAB11B;PKD2L1;PKD1L3
prerank,sulfur compound transport (GO:0072348),0.3806427295611549,0.9799441347614111,0.49022556390977445,0.9547789404008394,1.0,5/27,5.60%,LRRC8D;RACGAP1;SLC35B2;SLC27A1;SLC6A13
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.3915615470037186,0.9798222749685107,0.47878787878787876,0.9543152505878977,1.0,3/22,3.51%,RELL1;MINK1;SPI1
prerank,cellular response to hydroxyurea (GO:0072711),-0.4094725166165553,-0.9795957766650286,0.5,0.8377972329835807,1.0,4/10,19.67%,BLM;DDI2;NSMCE3;TIMELESS
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),-0.24048369410668563,-0.9795935619209477,0.5149700598802395,0.8367397340129987,1.0,19/93,14.21%,PLCB1;SASH1;TNFRSF19;CCN2;MFHAS1;SH3RF3;XDH;PDCD10;ANKRD6;TRAF6;ARL6IP5;MAP3K10;ZC3H12A;BMP2;TAOK2;FLT4;TGFB2;SPHK1;PJA2
prerank,neuron projection organization (GO:0106027),-0.3498264592126558,-0.9795239749736679,0.5094339622641509,0.8358441871774754,1.0,5/15,21.18%,INSR;LGMN;ABCD2;PICK1;PLS1
prerank,regulation of organelle assembly (GO:1902115),0.32789747403241687,0.9789792550272527,0.5086206896551724,0.9556933371486395,1.0,21/72,18.82%,PLK2;SENP6;STIL;TSG101;ATG5;RDX;TBC1D16;MTMR3;PDCD6IP;TBC1D2;ATXN2;TBC1D8;EVI5;DYNC2LI1;TBC1D20;EZR;VPS11;ATG3;ALMS1;TBC1D5;RAB5A
prerank,regulation of ion transport (GO:0043269),0.3216839125834278,0.978880511319905,0.4987405541561713,0.9551815505355901,1.0,5/76,2.47%,NEDD4L;KCNJ4;SCN10A;KCNA5;KCNJ16
prerank,signal release from synapse (GO:0099643),-0.27777007886681665,-0.9788769869168601,0.5155038759689923,0.836636764645289,1.0,20/43,29.53%,STXBP3;LIN7A;HSPA8;SYN1;NRXN1;GAD1;SYN3;NRXN2;DNAJC5;CPLX2;UNC13A;RIMS1;SYN2;SNAP25;SLC32A1;PIP5K1C;PTPRN2;PPFIA3;GRM4;SYT1
prerank,cellular response to decreased oxygen levels (GO:0036294),0.3305403324476874,0.9788004274248042,0.4825436408977556,0.9546354951883913,1.0,14/65,18.47%,RORA;EGLN3;SUV39H1;HILPDA;AQP1;P4HB;BAD;UBQLN1;PGK1;RGCC;HP1BP3;BNIP3;SUV39H2;PINK1
prerank,regulation of p38MAPK cascade (GO:1900744),0.3664933715224565,0.9786588298094404,0.4785714285714286,0.9541901942442264,1.0,6/35,8.20%,RELL1;MINK1;SPI1;PTPN22;ULK4;PHLPP1
prerank,tricarboxylic acid metabolic process (GO:0072350),0.4527888517223659,0.9786140657956325,0.5,0.953514801094815,1.0,1/12,1.61%,ASS1
prerank,steroid hormone mediated signaling pathway (GO:0043401),0.4319396599841148,0.9781364630945276,0.5090252707581228,0.9539669877870517,1.0,2/13,4.20%,NR3C2;PGR
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),-0.39745882858243536,-0.9781249559555183,0.49403341288782815,0.837594717774205,1.0,4/12,8.34%,IGF1;INSR;IGF2;AKT1
prerank,maturation of LSU-rRNA (GO:0000470),0.3806348418693779,0.9779690768605243,0.49770992366412214,0.953622933607769,1.0,5/26,11.22%,RRP15;PES1;RPL35;SNU13;RPF1
prerank,wound healing (GO:0042060),0.33144777464688435,0.9779283062080296,0.4914361001317523,0.9529549513360434,1.0,8/62,7.23%,CLDN1;AHNAK2;DCBLD2;FGF1;NF1;WNT5A;COL3A1;RAB3A
prerank,positive regulation of erythrocyte differentiation (GO:0045648),-0.31666947755616914,-0.977697123259631,0.509090909090909,0.8377229103547011,1.0,11/25,28.82%,ETS1;HIF1A;TAL1;ABCB10;NCKAP1L;INHBA;HSPA1A;FAM210B;ACVR1B;STAT3;HSPA1B
prerank,artery development (GO:0060840),0.39052341096420384,0.9775293357914668,0.4977168949771689,0.9531779464207998,1.0,2/23,3.16%,STRA6;NF1
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.3224754567921449,0.9771060932198362,0.48930817610062893,0.9534976946967526,1.0,9/73,8.29%,WIPF1;PRKCE;CYFIP2;DOCK1;CD3G;VAV2;SRC;PIK3R2;MYH2
prerank,regulation of spindle assembly (GO:0090169),0.383332662481889,0.9768407914512316,0.48773448773448774,0.9533817909592713,1.0,6/25,12.19%,SENP6;CHMP5;PDCD6IP;CHMP4B;TPR;CHMP4C
prerank,regulation of viral life cycle (GO:1903900),0.4031327896970002,0.976792392488403,0.4806201550387597,0.952747206652661,1.0,6/21,15.79%,TSG101;KPNA2;TRIM21;AXL;HS3ST5;TRIM5
prerank,cellular response to hormone stimulus (GO:0032870),0.3235072128644021,0.9765809993018375,0.4913151364764268,0.9524935862473276,1.0,16/69,18.83%,CAV1;SRC;CACNA1H;ATP1A2;RDX;RARA;ADRA2A;NCOA3;GCK;NCOA2;BRD8;GPER1;CTSB;SFR1;SOCS2;LHCGR
prerank,regulation of fibrinolysis (GO:0051917),0.43679161786276877,0.9765018505962211,0.4897959183673469,0.9519265274865384,1.0,1/13,1.37%,FAP
prerank,protein hydroxylation (GO:0018126),-0.3620240396022958,-0.9764522967005793,0.49627791563275436,0.8399306739887636,1.0,6/15,16.53%,PLOD2;PLOD1;P3H2;JMJD4;P3H3;P3H4
prerank,7-methylguanosine mRNA capping (GO:0006370),-0.3028148042722138,-0.9763084963229004,0.5189873417721519,0.8382255165585045,1.0,14/31,27.42%,MNAT1;ERCC2;RAMAC;NCBP1;POLR2F;CCNH;POLR2A;POLR2J;GTF2H4;POLR2D;POLR2K;POLR2I;CMTR2;GTF2H5
prerank,7-methylguanosine RNA capping (GO:0009452),-0.3028148042722138,-0.9763084963229004,0.5189873417721519,0.8382255165585045,1.0,14/31,27.42%,MNAT1;ERCC2;RAMAC;NCBP1;POLR2F;CCNH;POLR2A;POLR2J;GTF2H4;POLR2D;POLR2K;POLR2I;CMTR2;GTF2H5
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.3074651557979625,-0.9761985273314544,0.486646884272997,0.8374769347348258,1.0,14/29,30.85%,IFNAR2;SAMHD1;UBE2K;USP18;ABCE1;ISG15;CACTIN;YTHDF2;CDC37;YTHDF3;TRIM6;TTLL12;ZBP1;NLRC5
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.3106758750556941,0.97613095838159,0.48296122209165687,0.9520812660506479,1.0,24/101,17.12%,VGLL4;BCL3;CYFIP2;OGT;FXR2;PIWIL2;DACT1;RDX;PERP;IST1;HDAC2;METTL5;PLD1;UPF3B;FAF1;ATG7;NSUN5;SOX4;FXR1;PYM1;BAD;ERBB2;CPEB3;EZR
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.45216574421336003,0.9760366060843263,0.4990791896869245,0.9515599939096531,1.0,2/10,8.58%,NUFIP1;NAF1
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.27930029274246576,0.9758352273161716,0.5591506572295247,0.9513330327119898,1.0,63/497,11.12%,MDFIC;VGLL4;PRICKLE1;PAX9;NR2F2;TSHZ3;PHC2;FOXP2;ZNF423;FOXD1;BCL3;ATP8B1;MYBBP1A;RUNX2;FXR2;RBFOX2;SFMBT2;GIGYF2;CIART;SPI1;L3MBTL3;FOXK1;EIF2AK3;CNOT10;UBE2I;SOX9;CHD8;CREB3L1;GLIS2;KAT6B;KLF10;LANCL2;HDAC4;CDAN1;SAMD4B;WNT5A;HEYL;RBM15B;BHLHE40;SP3;PUS7;RCOR3;SELENOS;CTCF;TBX2;NCOR1;IGF2BP2;RARA;SUV39H1;FOXK2;TSC22D4;KCTD1;UIMC1;GSK3B;MECP2;USP47;RORB;HDAC2;CNOT7;NCOR2;ILF3;HEXIM1;ZHX1
prerank,lipid catabolic process (GO:0016042),0.41451276795545844,0.9756521956385261,0.4804560260586319,0.9510679891138963,1.0,5/18,22.39%,CEL;LIPE;LPL;HSD11B1;SIRT2
prerank,axon guidance (GO:0007411),0.29203289140206806,0.975520138782749,0.5330444203683641,0.9506489567890709,1.0,28/201,9.39%,GAB1;EFNA5;LAMA2;NTN1;EFNB1;NRP2;SEMA4B;GLI2;OPHN1;PRKCA;SRC;DSCAM;PLXNA3;RAC2;WNT5A;NTN5;ARTN;EPHB2;LAMA5;SEMA3A;EFNB2;DAG1;NTN3;SIAH1;MAPK7;TNR;GAB2;NTN4
prerank,microtubule depolymerization (GO:0007019),0.41365204347920065,0.9754875865151698,0.514003294892916,0.9499566365695754,1.0,3/17,7.39%,KIF2A;NCKAP5L;CKAP5
prerank,phasic smooth muscle contraction (GO:0014821),-0.4086858114751504,-0.975374392919732,0.5056433408577878,0.8385828870315156,1.0,3/10,24.36%,EDN1;EDN3;HTR2B
prerank,regulation of interleukin-17 production (GO:0032660),-0.29821930963322074,-0.975298217109318,0.5233644859813084,0.8377176270946906,1.0,8/31,26.04%,SLC7A5;IL18;RFTN1;SPHK1;NCKAP1L;NOD2;NR1H4;MYD88
prerank,DNA integrity checkpoint signaling (GO:0031570),-0.2857897738982247,-0.9752560003739906,0.4570446735395189,0.8367955537112337,1.0,10/36,19.67%,MAP3K20;USP28;ATRIP;HINFP;CLSPN;RAD1;TIPIN;RAD17;RAD9B;TIMELESS
prerank,negative regulation of interleukin-1 beta production (GO:0032691),-0.34435005938174973,-0.9749035467856018,0.4935064935064935,0.8366766208919284,1.0,1/19,0.13%,IGF1
prerank,regulation of blood circulation (GO:1903522),-0.2872261024585829,-0.9746404871258524,0.4900662251655629,0.8363016454322856,1.0,11/34,19.39%,ECE1;TPM1;ACE;BDKRB2;AGTR1;S100A1;DES;SRI;ACE2;PER2;AGT
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),-0.3840838539424589,-0.9744940835491356,0.4964200477326969,0.8356394077237919,1.0,2/13,1.31%,PLXNA2;PLXNA4
prerank,response to muramyl dipeptide (GO:0032495),-0.3870277514849219,-0.9743540614873962,0.49521531100478466,0.8349271202853986,1.0,7/12,24.38%,ARHGEF2;ERBIN;NOD1;VIM;TRIM41;NOD2;IRF5
prerank,negative regulation of GTPase activity (GO:0034260),0.39173434133046897,0.9742662190031255,0.45592705167173253,0.9523765662731806,1.0,2/22,7.01%,F11R;RDX
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.31640176658184427,0.9736381796360926,0.49688667496886674,0.952467114186038,1.0,22/78,23.36%,DYNLL1;KIF2A;CAPZB;RACGAP1;KIF3C;ACTR10;DYNLL2;KIF5A;KIF26A;AP2A2;LAG3;KLC2;DCTN2;DYNC1LI2;SEC24B;AP1M1;ACTR1B;DYNC1I1;DCTN6;AP2S1;SEC13;CLTA
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.31640176658184427,0.9736381796360926,0.49688667496886674,0.952467114186038,1.0,22/78,23.36%,DYNLL1;KIF2A;CAPZB;RACGAP1;KIF3C;ACTR10;DYNLL2;KIF5A;KIF26A;AP2A2;LAG3;KLC2;DCTN2;DYNC1LI2;SEC24B;AP1M1;ACTR1B;DYNC1I1;DCTN6;AP2S1;SEC13;CLTA
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.3899747532459228,0.9735292024776,0.49767441860465117,0.9519788643645126,1.0,5/20,13.11%,DKKL1;BCKDK;NCOR1;C1QTNF12;GCK
prerank,positive regulation of nervous system process (GO:0031646),0.4023863545652435,0.9734996044519375,0.48111658456486045,0.9512964860003823,1.0,7/18,14.77%,ITGAX;RIMS2;NCMAP;HCRT;ATPSCKMT;DICER1;UNC13B
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.2962228924090516,-0.9734902216755907,0.49691358024691357,0.8362136168953973,1.0,16/32,37.39%,TRPC1;AKAP6;CALM1;JPH2;CALM3;P2RY6;GSTO1;APLNR;NPSR1;F2R;CASQ1;CXCL10;CAPN3;SNCA;TRDN;THY1
prerank,fatty acid catabolic process (GO:0009062),0.3295939491963674,0.9734761599166954,0.49622166246851385,0.9505979645732775,1.0,11/67,10.43%,EHHADH;CEL;AIG1;PCCB;HADHB;PEX2;ACAT1;HSD17B4;ACADS;SLC27A4;ACOT8
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),-0.33175897034670654,-0.9732393589546122,0.4634146341463415,0.8358355046179533,1.0,9/20,25.77%,ENTPD1;TXNIP;IL18;P2RX7;P2RX4;ENTPD5;SUGT1;PYCARD;C3
prerank,negative regulation of cellular protein localization (GO:1903828),0.3656698668753874,0.9731900695600239,0.5071225071225072,0.9505936131195637,1.0,4/34,3.51%,NEDD4L;RIPOR2;LEPROT;SPI1
prerank,extracellular transport (GO:0006858),0.44225527575956036,0.9731413827466859,0.5008375209380235,0.9499558385429753,1.0,4/12,15.38%,TSG101;SPAG17;CCDC40;WWP2
prerank,phospholipid transport (GO:0015914),0.3361696037054725,0.9722675805799962,0.5187165775401069,0.9514285854393303,1.0,11/52,9.87%,ATP8B3;ATP8B1;PITPNC1;PCTP;ABCC1;ATP9B;ABCA1;ATP11C;ATP9A;ATP8B2;ATP10B
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.3926917118254864,0.9713032547014322,0.48165869218500795,0.9531080648523529,1.0,5/20,18.91%,CAMK2D;FIS1;THADA;WFS1;BAX
prerank,regulation of cell division (GO:0051302),0.3243044419448414,0.9712952040901297,0.49566294919454773,0.9523750628101812,1.0,13/72,12.54%,PLK2;FGF1;MLLT3;PIK3R4;CSPP1;CCP110;KIF13A;SFN;ZFYVE26;KLHL21;NCOA3;CETN2;AHCTF1
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.4429673936633436,0.9712650645208857,0.49326599326599324,0.9516901861147622,1.0,4/12,16.54%,DND1;NCOR1;NCOR2;PPARG
prerank,modified amino acid transport (GO:0072337),0.42089533851676975,0.9711804934090876,0.5056,0.951123340796905,1.0,3/15,5.60%,FOLR1;FOLR2;SLC6A13
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.37983401673917466,-0.9708060927878601,0.4976851851851852,0.8413440162945595,1.0,5/12,29.83%,RPL26;KDM1A;MIF;TAF9;TRIAP1
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.3268337680084351,0.9703762640976036,0.5103092783505154,0.9524203912806077,1.0,21/70,18.86%,KMT2A;LMO1;PSME3;N4BP2L2;PUS7;PSMB5;CBFB;YAP1;PSMA6;PSMB2;PSMA2;RUNX1;PSMD13;PSMA7;ITCH;PSME4;PSMD12;PSMD14;PSMB6;PSMC4;TCF3
prerank,generation of neurons (GO:0048699),0.2873779563321684,0.9698929008428387,0.5217391304347826,0.9528601169036359,1.0,33/190,15.41%,FGFR1;WNT10A;BHLHE22;FZD2;NEUROD6;RUNX2;WNT2B;OPHN1;RACGAP1;WNT16;WNT5A;HEYL;BHLHE40;BRSK1;ARTN;SEMA3A;PAFAH1B1;LHX6;EML1;NRBP2;GPM6A;LRP12;RELN;DOCK7;ERCC6;EN2;WNT9A;CIT;FZD7;YAP1;FZD3;AUTS2;RUNX1
prerank,positive regulation of inflammatory response (GO:0050729),0.31508575104518716,0.9697078109913753,0.5181598062953995,0.9525508140518856,1.0,18/86,16.28%,LBP;WNT5A;MGST2;ABCC1;IL17RA;TLR7;TRADD;PTGER4;TNIP1;KARS1;S100A9;IL6ST;VAMP8;CD81;NFKBIZ;LPL;MDK;IL15
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),0.3981004760904425,0.9695392246719056,0.49768160741885625,0.952228632822504,1.0,2/20,4.37%,PPARGC1A;DIP2A
prerank,negative regulation of DNA metabolic process (GO:0051053),-0.3249214630988891,-0.9693110346700977,0.5154929577464789,0.8442180696860214,1.0,7/24,11.50%,DACH1;ACVRL1;BMPR2;BLM;SUB1;RPS3;H1-0
prerank,homocysteine metabolic process (GO:0050667),-0.3967314196136358,-0.9692963394508998,0.5097560975609756,0.8432246245608237,1.0,6/11,30.47%,NOX4;MTHFR;MTRR;CBS;CTH;MPST
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.3778966548880885,0.9691379801021008,0.4884437596302003,0.952456011350043,1.0,6/25,17.59%,SF3B1;SRSF4;PRPF3;DBR1;TRA2B;SLU7
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.40282446249394865,-0.9688879573620991,0.4748858447488584,0.8433112653062101,1.0,5/10,21.51%,ATP5PD;VPS9D1;ATP5MC3;ATP5PO;ATP5MC2
prerank,histone deacetylation (GO:0016575),0.34751093454761,0.968532143854272,0.4811715481171548,0.9532049628421301,1.0,18/43,24.65%,HDAC4;SMARCAD1;RCOR3;SIN3B;MSL3;SIRT7;HDAC2;HDAC6;BAZ2A;SFPQ;MORF4L2;MTA3;HDAC3;BRMS1L;SIRT2;REST;SIN3A;SUDS3
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.4140158528057536,0.9684468674149296,0.4831649831649832,0.9526830122661568,1.0,2/15,2.87%,PRKCE;GPLD1
prerank,positive regulation of phospholipid transport (GO:2001140),-0.40014588329889433,-0.968160864911278,0.4845605700712589,0.8442620561852382,1.0,2/10,6.72%,DBI;APOE
prerank,proton transmembrane transport (GO:1902600),0.36222769238439523,0.9681210076508876,0.4929378531073446,0.9527710779638083,1.0,5/36,10.25%,OTOP1;ATP1A2;SLC4A11;COX15;NNT
prerank,regulation of cellular catabolic process (GO:0031329),-0.2575110078618545,-0.9671925039511601,0.5267857142857143,0.8458441411149878,1.0,16/62,14.40%,DAPK1;ITPR1;ACER2;NUPR1;EP300;DEPDC5;DRAM1;USP33;RRAGC;PIP4K2A;GPR137B;LRRK2;PIP4K2C;BOK;MAPT;RRAGD
prerank,cardiac right ventricle morphogenesis (GO:0003215),0.4456916672518245,0.9671591770930961,0.49740932642487046,0.9543737740592414,1.0,3/11,13.63%,JAG1;ISL1;SOX4
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),-0.2907817407939282,-0.9671065275154607,0.4641638225255973,0.8450415102886596,1.0,9/33,20.02%,LEF1;TRAF6;HAX1;IL34;ID2;HSF1;CSF1;CASP8;FES
prerank,adrenergic receptor signaling pathway (GO:0071875),0.39646183429732074,0.9665942092242136,0.5047923322683706,0.9550841362798111,1.0,5/20,12.31%,PDE4D;AKAP13;GPR101;ADRA2A;ADCY9
prerank,neuron projection regeneration (GO:0031102),0.4558610205517677,0.9660897152680086,0.5167548500881834,0.9555740583525912,1.0,2/10,10.64%,FOLR1;RTN4RL1
prerank,phospholipid biosynthetic process (GO:0008654),0.3520213661824189,0.9658648360463414,0.49711815561959655,0.9553821355389416,1.0,9/36,20.76%,SGMS2;AGPAT4;AGPAT5;DHDDS;DPAGT1;HDHD5;FADS1;DOLK;DOLPP1
prerank,regulation of calcium ion transport (GO:0051924),0.3373426409407526,0.9658250463747045,0.509829619921363,0.9547319011794131,1.0,3/54,1.83%,HOMER2;EFHB;SLC8B1
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),0.42555513587401356,0.965718227029865,0.4797979797979798,0.9542477137413714,1.0,2/13,6.70%,GLI1;TBX2
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.43555580126449545,0.9656849313685387,0.5041050903119869,0.9535898114807742,1.0,3/12,10.43%,TET1;RESF1;PPHLN1
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.4222072623317896,0.965659684491073,0.5158069883527454,0.952912339830277,1.0,3/16,6.67%,PFAS;ATIC;PPAT
prerank,negative regulation of sprouting angiogenesis (GO:1903671),-0.39202321689987407,-0.9655663824439179,0.5135135135135135,0.8480043522435667,1.0,4/11,12.84%,SEMA6A;SYNJ2BP;KLF2;THBS1
prerank,motile cilium assembly (GO:0044458),0.4344967552324774,0.965114291691934,0.5220949263502455,0.9535030954784965,1.0,3/12,15.37%,BBOF1;CCDC39;CCDC40
prerank,purine ribonucleotide transport (GO:0015868),0.4106575043119255,0.9647246551779491,0.4991596638655462,0.9537352556390505,1.0,2/16,4.29%,LRRC8D;SLC35B2
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),-0.27754237818314337,-0.9645205104286758,0.5163636363636364,0.8497979300809253,1.0,8/40,13.01%,LEF1;SMAD3;DAB2;TGFBR1;GLIPR2;TGFB3;BMP2;TGFB2
prerank,intracellular cholesterol transport (GO:0032367),-0.35317124210294004,-0.9644823175866811,0.5077319587628866,0.8488791362939704,1.0,5/15,15.38%,LDLR;LRP6;LDLRAP1;VPS4A;ABCG1
prerank,positive regulation of histone methylation (GO:0031062),0.3807449538343787,0.9641194707060606,0.5053272450532724,0.9545189264847973,1.0,6/24,17.53%,OGT;KMT2A;PAF1;TET1;AUTS2;MTF2
prerank,apoptotic mitochondrial changes (GO:0008637),0.3632924273496841,0.963728727043286,0.5080058224163028,0.954705203376615,1.0,12/32,20.98%,HK2;FIS1;SFN;NAIF1;FZD9;AIFM2;ERBB4;BAD;BNIP3;ATG3;BAX;CCAR2
prerank,cardiocyte differentiation (GO:0035051),-0.4049497072674034,-0.9636340871630519,0.5175644028103045,0.8500099896001486,1.0,6/10,15.16%,SIK1;BMP2;TGFB2;GATA6;EEF1AKMT4-ECE2;MYOCD
prerank,regulation of actin filament polymerization (GO:0030833),0.3184384394380138,0.9635360388644775,0.50125,0.9544251733854351,1.0,8/69,7.82%,KANK4;PRKCE;ARHGAP18;CDC42EP4;FER;NCK2;KANK1;ARF6
prerank,mitochondrial calcium ion homeostasis (GO:0051560),-0.33271355057084406,-0.9633452217593875,0.5380577427821522,0.8497345308001201,1.0,8/21,16.37%,SLC8A3;TGM2;RAP1GDS1;SMDT1;SLC25A23;MICU1;MICU2;ANXA6
prerank,regulation of biomineral tissue development (GO:0070167),0.37027845199362136,0.9631906841584326,0.4985294117647059,0.9545951260829809,1.0,5/26,10.54%,SGMS2;SOX9;BMP2K;FBXO5;ANKH
prerank,hexose biosynthetic process (GO:0019319),0.3434171924719528,0.9631193070996857,0.5064194008559201,0.9540398055829616,1.0,13/42,20.79%,PPARGC1A;SLC25A12;ALDOB;PGM1;MDH1;SLC25A13;ENO3;GOT1;PGK1;ENO2;SLC37A4;SLC25A10;ENO1
prerank,protein palmitoylation (GO:0018345),0.3676535001081488,0.9627920902872206,0.4816983894582723,0.9540825950135347,1.0,13/30,23.04%,ZDHHC1;ZDHHC7;ZDHHC23;ZDHHC13;ZDHHC20;GLUL;ZDHHC8;ZDHHC19;GOLGA7B;ZDHHC3;ZDHHC12;GOLGA7;ZDHHC5
prerank,actin filament capping (GO:0051693),0.4024348920476431,0.9625178344306855,0.5488,0.9532921027171147,1.0,4/18,7.46%,ADD3;CAPZB;ADD1;VILL
prerank,barbed-end actin filament capping (GO:0051016),0.4024348920476431,0.9625178344306855,0.5488,0.9532921027171147,1.0,4/18,7.46%,ADD3;CAPZB;ADD1;VILL
prerank,morphogenesis of a polarized epithelium (GO:0001738),-0.377935949156614,-0.9622053028806218,0.4988179669030733,0.8517243423505874,1.0,6/12,16.09%,LAMA3;ACTB;ACTG1;FUZ;VANGL2;AHI1
prerank,positive regulation of dendritic spine development (GO:0060999),-0.3324423594443617,-0.9619322388752527,0.5187319884726225,0.8513789641522524,1.0,4/20,6.89%,SHANK3;CUX2;APOE;LRP8
prerank,stem cell differentiation (GO:0048863),-0.28217086490377397,-0.9614683072001466,0.5127272727272727,0.8515434382267737,1.0,8/39,8.88%,OSR1;KIT;FGFR2;HOXB4;ACE;PSMD11;LRP6;JARID2
prerank,regulation of mitochondrial translation (GO:0070129),0.3850353760757768,0.9613398323468013,0.4925373134328358,0.955474492418214,1.0,9/21,23.47%,RMND1;FASTKD2;ALKBH1;MPV17L2;MTG2;RPUSD4;MALSU1;TSFM;MTG1
prerank,synapse assembly (GO:0007416),-0.24087038982627162,-0.9611982383432555,0.536036036036036,0.8512483207568257,1.0,12/67,14.48%,FARP1;SHANK3;DNM3;SPOCK2;ADGRL3;OBSL1;GABRA2;KIRREL3;NRXN1;BDNF;SHANK2;NRXN2
prerank,regulation of lipase activity (GO:0060191),0.4315752818534363,0.9611190697892034,0.5149606299212598,0.9552850215233214,1.0,4/13,18.19%,PCSK5;LMF1;LPL;RHOA
prerank,telomere maintenance via recombination (GO:0000722),0.4479146695749525,0.9609629936593252,0.5134168157423972,0.9549043265065377,1.0,3/11,12.66%,SMC5;ERCC1;TEP1
prerank,platelet aggregation (GO:0070527),-0.28332199604835895,-0.9608951806329219,0.5242424242424243,0.8509935056653886,1.0,10/33,17.19%,STXBP3;GNAS;PDGFRA;ACTB;MYL9;ACTG1;FLNA;ILK;TLN1;HSPB1
prerank,regulation of cellular protein localization (GO:1903827),0.34489421355233,0.9603064732883367,0.5067385444743935,0.9558019536573958,1.0,9/45,17.83%,GPC3;GPC6;TRIM46;DVL3;RAB11FIP5;GPC2;LCP1;SETD2;GPC5
prerank,regulation of lipid kinase activity (GO:0043550),-0.39432292776266215,-0.9600305930756104,0.5114678899082569,0.852172157444593,1.0,5/11,15.32%,PIK3R1;PIK3R3;RBL1;RBL2;PPP2R5A
prerank,neuromuscular process controlling balance (GO:0050885),-0.39075360536722037,-0.9599689301083745,0.5341463414634147,0.8512972826076776,1.0,3/12,11.37%,PCDH15;TPP1;NRXN1
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.30587714686664363,-0.9598415510555879,0.49709302325581395,0.8506421308207915,1.0,9/26,20.42%,CLIP1;STMN2;RPS3;MAPT;CDK5R1;ARL2;MET;FES;KATNB1
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.3880990224626229,0.9595972605192226,0.5088,0.9567978052162732,1.0,4/20,12.93%,RGS14;GPRASP1;PLEK;RPGRIP1L
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.3937737378039502,0.9595652921984462,0.48773006134969327,0.9561429274613988,1.0,8/21,19.19%,CNOT10;SAMD4B;CNOT7;PAN2;TNKS1BP1;CNOT8;PNLDC1;CNOT1
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.33570540184669295,0.959347735060065,0.5174731182795699,0.9559514935785335,1.0,4/48,3.39%,UBASH3B;CAMK2D;PDE4D;FKBP1B
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.3553597823836267,0.95933987112202,0.5042857142857143,0.9552351659471232,1.0,8/33,15.41%,KLK2;AXIN1;DDRGK1;UFSP2;HDAC6;NCOA2;CBFB;RUNX1
prerank,transcription by RNA polymerase II (GO:0006366),0.27505039209442783,0.9592178547242108,0.593167701863354,0.9548156752685788,1.0,43/305,13.54%,RORA;PPARGC1A;NR3C2;RARB;DTX1;CSTF1;MAML2;MLLT3;PGR;INTS10;TAF10;LEO1;SNRPF;CDK13;RPRD1B;MED18;TAF4B;TEAD3;CDK7;PAF1;NCOR1;CSTF3;RREB1;RARA;RPAP2;ELL;MED7;NELFB;RORB;NRBF2;SUPT4H1;RPRD1A;NCOR2;ERCC6;RARG;MED23;GTF2F2;CREBBP;TAF15;GTF2H1;TRIP11;MBD1;CBFB
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.2772714542360896,0.9591587403244147,0.5897959183673469,0.9542172071995183,1.0,41/348,9.95%,NGF;FGF7;NTRK3;PPARGC1A;FOXD1;CLDN19;MUSK;FGF1;ADAM19;SLC26A9;CDH5;RAB29;ITGAX;SLC38A2;IL1A;EIF2AK3;PRKAG1;WNT16;CELF1;SOX9;PTPN22;WNT5A;FN1;EPHB2;UBR5;KRAS;CTCF;RIMS2;RDX;NOS1AP;MAPK7;FGF18;OCLN;DDRGK1;AGO1;PLSCR1;GSK3B;INPP5F;RESF1;TICAM1;POU4F1
prerank,positive regulation of protein localization to membrane (GO:1905477),0.30896302661292535,0.9588183912358323,0.5353658536585366,0.9543484515658736,1.0,31/98,21.42%,SORBS1;PRKCE;EGFR;PPP1R13B;ATP2B4;FIS1;EPHB2;ARF6;MIEF1;SFN;SLC5A3;CD81;KIF5B;ZDHHC8;GPER1;BAD;NMT1;YWHAG;ERBB2;E2F1;YWHAE;CEMIP;CHP1;STX4;SPTBN1;PDPK1;AKT2;ITGB1;PRKN;TFDP1;MAPK8
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.32656534350922967,-0.9585642377317525,0.5026881720430108,0.8529538802525796,1.0,5/20,12.93%,FAS;CASP3;GSK3A;DCC;BOK
prerank,macromolecule catabolic process (GO:0009057),0.3729756246475887,0.9578686540818138,0.49782923299565845,0.955998154861604,1.0,7/26,11.21%,LRSAM1;KIF16B;PIK3R4;CLN8;SIAH1;SNX25;NEDD4
prerank,cellular response to interleukin-1 (GO:0071347),-0.22011416515904386,-0.9576421661193276,0.5445544554455446,0.8543863085121435,1.0,18/143,8.89%,PLCB1;IL1R1;PTGIS;IL1RAP;PSMA1;RPS6KA5;SQSTM1;SIRPA;RBX1;IRAK4;HIF1A;UBE2N;PSMD11;TRAF6;GBP3;NOD1;PSMD7;PSMD4
prerank,regulation of Rac protein signal transduction (GO:0035020),-0.3496691315528969,-0.9576099756076983,0.5171503957783641,0.8534398113950982,1.0,5/16,12.42%,ARHGAP24;RASGRF1;ARHGAP17;GABARAP;ARHGAP44
prerank,adenine nucleotide transport (GO:0051503),0.40336841204318435,0.9575995880468622,0.5149501661129569,0.9559334481945617,1.0,2/17,4.29%,LRRC8D;SLC35B2
prerank,metal ion transport (GO:0030001),-0.23421120169449403,-0.9574110943546696,0.6084656084656085,0.8529029865550746,1.0,14/86,10.51%,ITPR1;TPT1;SLC8A3;TRPC3;SLC8A1;SLC39A8;CALCRL;TRPC1;GRIN3A;ATP2C1;SLC41A1;CAMK2A;RAMP2;CACNG7
prerank,regulation of triglyceride biosynthetic process (GO:0010866),-0.3559342499500264,-0.957241189136237,0.4894179894179894,0.8523187897297435,1.0,6/15,12.92%,NR1H3;LDLR;SIK1;CTDNEP1;NR1H2;MFSD2A
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.31729173217155093,0.9568742756887243,0.5051813471502591,0.956959878341157,1.0,6/70,9.14%,NGF;HIPK1;TRADD;MCL1;BAG3;GSK3B
prerank,positive regulation of collagen biosynthetic process (GO:0032967),-0.35019655976320135,-0.9566270732179056,0.5102040816326531,0.8528998659624258,1.0,5/16,14.21%,BMP4;WNT4;LARP6;TGFB3;VIM
prerank,regulation of B cell proliferation (GO:0030888),0.33590945217351426,0.956326215899126,0.5047879616963065,0.9575770832327899,1.0,7/44,12.82%,NFATC2;PTPRC;EPHB2;CD320;GPR183;IL7;CD81
prerank,negative regulation of catabolic process (GO:0009895),0.3367022088609081,0.9559350187530153,0.5170532060027285,0.9578198872216187,1.0,7/47,10.61%,EGFR;HDAC4;IRAK3;AZIN2;NCOR1;ZDHHC7;ADRA2A
prerank,DNA damage checkpoint signaling (GO:0000077),-0.29703538706650945,-0.9558979963902727,0.536144578313253,0.8537654424214062,1.0,7/28,17.67%,MAP3K20;USP28;ATRIP;HINFP;CLSPN;RAD1;RAD17
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.27237044314139924,0.9558538126487242,0.5933062880324543,0.9572684312254542,1.0,71/476,14.87%,RORA;FGF7;MDFIC;NFATC2;GLI1;PPARGC1A;NR2F2;ZNF423;NFATC1;FZD2;EGFR;BCL3;NPAS3;RUNX2;AXIN1;GLI2;KMT2A;MLLT3;FOXK1;FOXO3;NPAS2;SOX9;CHD8;GLIS2;KAT6B;HDAC4;WNT5A;NUP62;PPM1A;SP3;ATAD2;ZFP90;RGMB;CTCF;PAX3;RREB1;RARA;FOXK2;ILF2;MAP3K5;DYRK1A;MED13;COL1A1;RORB;HDAC2;KARS1;ILF3;TFEB;DVL3;EGR1;BICRA;TASP1;KDM8;CEP290;NAT14;SPIN1;CREBBP;TAF15;GTF2H1;CRLF3;SOX4;CDKN1C;FZD7;YAP1;KAT8;RAI1;MED12;NEK4;ERBB4;SNX5;FOXF1
prerank,axonal transport (GO:0098930),-0.28183226288581065,-0.9554058887865055,0.512987012987013,0.8539931793072911,1.0,9/36,17.91%,KIF1B;DST;NEFL;HIF1A;MAPT;DTNBP1;OPA1;TMEM108;BLOC1S6
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.31042189569051165,0.9552986208350337,0.5267080745341615,0.9578681490239607,1.0,22/79,23.36%,DYNLL1;KIF2A;CAPZB;RACGAP1;KIF3C;ACTR10;DYNLL2;KIF5A;KIF26A;AP2A2;LAG3;KLC2;DCTN2;DYNC1LI2;SEC24B;AP1M1;ACTR1B;DYNC1I1;DCTN6;AP2S1;SEC13;CLTA
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.39014617445296323,0.9551846913364174,0.5031746031746032,0.9573980605255983,1.0,5/21,9.24%,CAMK2D;PDE4D;FKBP1B;ATP1A2;CASQ2
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),-0.34032937911152145,-0.9551612068730573,0.5197044334975369,0.8535988243768334,1.0,1/17,1.46%,LPGAT1
prerank,positive regulation of collagen metabolic process (GO:0010714),-0.3435441501227841,-0.9547925526943107,0.5128205128205128,0.8535547827165386,1.0,4/17,8.28%,BMP4;WNT4;LARP6;TGFB3
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),0.3950854257049994,0.9545465273736337,0.5235920852359208,0.9582432987658603,1.0,6/17,21.67%,KCNS2;NOS1AP;KCNAB1;KCNRG;SUMO1;VAMP2
prerank,positive regulation of cell-substrate junction organization (GO:0150117),-0.3113980401821729,-0.9544884873325068,0.48484848484848486,0.8533055022930971,1.0,4/24,6.13%,TEK;PIK3R1;KDR;DUSP3
prerank,positive regulation of MAPK cascade (GO:0043410),0.27900306977316314,0.9544391210371376,0.5961945031712473,0.9577549674469836,1.0,14/245,5.03%,ROR2;ROR1;NTRK3;FGFR1;LPAR1;ACKR3;EGFR;PELI2;RAP1A;FGF1;CAV2;PRKCA;PTPN22;PTPRC
prerank,snRNA transcription by RNA polymerase II (GO:0042795),-0.24394492493209655,-0.9540660711887305,0.5486725663716814,0.8533329636084185,1.0,19/69,19.88%,POU2F1;INTS9;CCNT2;CDK9;PHAX;RPRD2;CCNT1;SNAPC1;ZC3H8;SP1;INTS1;NCBP1;POLR2F;POLR2A;POLR2J;SNAPC5;TAF6;POLR2D;POLR2K
prerank,regulation of defense response (GO:0031347),-0.24434419027417031,-0.953901408258595,0.5637254901960784,0.8527096465362952,1.0,34/76,29.80%,IL1R1;FOXP1;SEMA7A;APPL2;SAMHD1;LACC1;AGTR1;AREL1;APOE;LRP8;JAK2;ANXA1;USP18;IRF1;CASP12;TMSB4X;ERAP1;ACE2;CASP8;SBNO2;GRN;BCL6B;CASP4;NOD2;SETD6;SPATA2;MYD88;BIRC3;FGR;FCGR2B;LRRC19;CCR2;UFL1;CASP1
prerank,tetrahydrofolate metabolic process (GO:0046653),-0.39740544544883005,-0.9536206277762505,0.5151515151515151,0.8523673150920212,1.0,4/10,15.10%,MTHFS;MTHFR;DHFR;MTHFD1L
prerank,carnitine metabolic process (GO:0009437),0.4358589235677761,0.9533612354631522,0.49137931034482757,0.9596550475253318,1.0,1/12,1.73%,ALDH9A1
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.35591986427485844,0.9530352498168414,0.49927431059506533,0.959750835984384,1.0,12/29,21.55%,LEO1;TRRAP;AXIN2;PYGO1;MEN1;CREBBP;BCL9;KMT2D;TCF7L1;CDC73;ASH2L;TCF7L2
prerank,negative regulation of interleukin-1 production (GO:0032692),0.376613321911838,0.9527442304088233,0.5294117647058824,0.9597540409277253,1.0,3/23,9.36%,CEACAM1;TNFAIP3;NLRP2B
prerank,regulation of chemokine production (GO:0032642),-0.2752682773659953,-0.9527031838567845,0.5371621621621622,0.8538290307531969,1.0,5/36,6.62%,IL6R;FOXP1;IL18;HIF1A;IL33
prerank,regulation of protein kinase C signaling (GO:0090036),-0.36665708892029253,-0.9524346554150702,0.5026041666666666,0.8535648966098807,1.0,6/14,19.37%,ADGRV1;MYADM;GPD1L;FLT4;WNT11;CD40
prerank,tRNA wobble uridine modification (GO:0002098),-0.35104171848944943,-0.9523667363589234,0.5196078431372549,0.852719063468061,1.0,9/14,36.96%,ELP3;TRMT9B;ELP4;GTPBP3;MOCS3;KTI12;ELP1;CTU2;CTU1
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),-0.3108810222922767,-0.9522081558711415,0.5451895043731778,0.8521174743070139,1.0,11/24,24.21%,ABCG2;SLC25A38;FECH;CPOX;FXN;ABCB10;ALAS1;TSPO;HMBS;UROD;ALAD
prerank,regulation of interleukin-8 production (GO:0032677),0.31442580320284785,0.9521858005246825,0.541025641025641,0.9603902095901271,1.0,6/69,5.84%,LBP;BCL3;PTPN22;PTPRC;TLR7;ANXA4
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),-0.2827485800634019,-0.9507513119358603,0.5407166123778502,0.8550561654423322,1.0,8/37,17.06%,PRKAG2;PARD3;CALM1;UBE2K;SPHK1;CALM3;EIF4G1;EGF
prerank,embryo development ending in birth or egg hatching (GO:0009792),0.41906731895524285,0.9505973516583903,0.5085910652920962,0.9635188743773767,1.0,3/15,9.84%,FGFR1;CELF1;CELF4
prerank,histone H3 deacetylation (GO:0070932),0.4093511147479595,0.9504006378101053,0.5204582651391162,0.9632696986129021,1.0,7/15,22.39%,HDAC4;SMARCAD1;SIRT7;HDAC2;SFPQ;HDAC3;SIRT2
prerank,eosinophil migration (GO:0072677),-0.36556906353226115,-0.9501680151850385,0.5392405063291139,0.8545679059066369,1.0,11/14,51.62%,SCG2;CCL13;CCL2;CCL5;CCL4;CCL8;CCL7;CCL1;CCL3;CCL11;LGALS3
prerank,eosinophil chemotaxis (GO:0048245),-0.36556906353226115,-0.9501680151850385,0.5392405063291139,0.8545679059066369,1.0,11/14,51.62%,SCG2;CCL13;CCL2;CCL5;CCL4;CCL8;CCL7;CCL1;CCL3;CCL11;LGALS3
prerank,positive regulation of brown fat cell differentiation (GO:0090336),-0.3685573600642692,-0.9500353796746088,0.5122549019607843,0.8539020652381331,1.0,2/13,4.10%,SOX13;NAPEPLD
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.3188154488121001,0.949860199318177,0.5297157622739018,0.9638467462029955,1.0,10/63,12.82%,NFATC2;PTPRC;NCK2;EPHB2;CD320;CD276;IL6ST;GPR183;IL7;CD81
prerank,protein kinase A signaling (GO:0010737),0.4310140258922171,0.9497322353187397,0.5441941074523396,0.9634327983836688,1.0,4/12,17.12%,RDX;PRKACB;LCP1;EZR
prerank,positive regulation of endocytosis (GO:0045807),0.3386105291836146,0.9497024659311842,0.53232462173315,0.9627683894728515,1.0,7/45,9.91%,GPC3;NEDD4L;ANO6;TFR2;SGIP1;CALY;AXL
prerank,protein glycosylation (GO:0006486),-0.21971392720961586,-0.9496234046238143,0.5925925925925926,0.8539694837525881,1.0,23/125,11.59%,ST3GAL6;MGAT4C;ST3GAL5;ST3GAL1;ST8SIA4;MGAT4A;EOGT;SLC39A8;COG7;DPM1;ST6GALNAC2;ALG5;PLOD2;STT3B;GAL3ST1;PLOD1;AQP11;PGM3;B4GALT1;ALG1;B4GALT7;GOLGA2;RPN2
prerank,regulation of DNA damage checkpoint (GO:2000001),0.450386477535682,0.9493504975861564,0.5060034305317325,0.9628669454744394,1.0,5/10,20.98%,WDR76;RFWD3;ETAA1;THOC5;CCAR2
prerank,ethanol metabolic process (GO:0006067),-0.3829159975982994,-0.9493202459269919,0.5263157894736842,0.8537565710800299,1.0,1/12,0.05%,ALDH1A1
prerank,hepaticobiliary system development (GO:0061008),0.38911656047244747,0.9492760440770293,0.5047169811320755,0.9623214881515345,1.0,4/20,5.76%,COBL;NF1;LSR;GFER
prerank,regulation of protein processing (GO:0070613),-0.330009791370001,-0.9490902992101075,0.5555555555555556,0.853361997585886,1.0,5/21,16.67%,CCBE1;GAS1;SERPINE2;LRRK2;NKD2
prerank,response to X-ray (GO:0010165),0.42036516294925613,0.9479928447937399,0.5307443365695793,0.9647553249925004,1.0,4/14,13.25%,BRCC3;IKBIP;MSH2;NUCKS1
prerank,mRNA methylation (GO:0080009),-0.360513097040713,-0.9477093806902939,0.5408163265306123,0.8559401644371812,1.0,8/15,36.41%,NSUN2;TRMT61B;METTL16;METTL8;METTL14;TRMT6;TRMT61A;TRMT10C
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.3545629925364609,0.9470661266624819,0.5289855072463768,0.9663953846564587,1.0,1/34,0.11%,GAB1
prerank,regulation of adaptive immune response (GO:0002819),-0.33337586885879716,-0.9469384903650198,0.5233160621761658,0.856881939266444,1.0,6/18,16.13%,ADCY7;EIF2AK4;IRF1;SAMSN1;AHR;SKAP1
prerank,visual perception (GO:0007601),0.31289894884629366,0.9465876226519787,0.5445665445665445,0.9668170862743413,1.0,8/84,9.51%,RDH10;POU4F3;EFEMP1;SLC24A1;CNGB1;CRYBB3;BEST1;COL1A1
prerank,negative regulation of actin filament polymerization (GO:0030837),-0.3132155475804395,-0.9465743207336063,0.5631868131868132,0.8567928862130376,1.0,11/22,20.06%,SLIT2;KANK3;HIP1R;TWF1;MYADM;TMSB10;CYRIB;TMSB4X;PFN1;SSH3;SSH2
prerank,cellular protein localization (GO:0034613),0.278871371456025,0.9465371571191408,0.6051813471502591,0.9662156192738092,1.0,76/285,20.78%,PIGU;FGF7;GRTP1;EPB41L3;EGFR;RAB29;STX1A;RIC3;SGSM2;SIL1;CSRP3;CNTNAP1;MFN2;WNT5A;CPE;ARL11;AMOT;SH3PXD2B;RAB3GAP2;SYNRG;ARF6;KIF13A;OCLN;TBC1D16;ARL4A;FOXJ1;TMED4;TBC1D2;FERMT2;AXIN2;TBC1D8;RIC1;STX2;HDAC6;STX19;RTP3;CTTN;USP4;EVI5;COPA;RRAGB;ARL5A;PTPRU;CNTNAP2;SEC23IP;TMED2;AP3B1;TICAM2;TBCK;SNX1;RAB21;CELSR1;ARCN1;STX4;SLU7;STX5;EHD1;SCFD2;FGF10;FAM91A1;TM9SF4;COG3;TM9SF2;RABL3;TBC1D5;RAB5A;CEP250;SNX17;NSF;TBC1D8B;PIGK;TBC1D10A;USO1;PACSIN1;CPLANE2;CD63
prerank,histone lysine demethylation (GO:0070076),-0.30260132480987645,-0.9462378189779236,0.5176470588235295,0.856646233183392,1.0,5/25,13.49%,KDM5C;PHF8;KDM2B;KDM1A;KDM7A
prerank,negative regulation of DNA biosynthetic process (GO:2000279),0.35832590234165956,0.9461967890843954,0.5284431137724551,0.9663430642825384,1.0,7/30,17.56%,HNRNPC;SRC;STN1;EXOSC10;MEN1;GNL3L;TERF2
prerank,intraciliary retrograde transport (GO:0035721),0.43321514944316253,0.9461095546203796,0.5357766143106457,0.9658201426921678,1.0,5/12,22.06%,DYNC2I1;TTC21B;DYNC2LI1;DYNC2H1;IFT140
prerank,regulation of cellular metabolic process (GO:0031323),0.33816120395727667,0.9456996748406716,0.5207756232686981,0.9660716792743604,1.0,11/45,18.47%,COQ7;MPV17;KIF16B;PDK4;ACACA;TBC1D16;NCOR2;PANK2;ACACB;PM20D2;PINK1
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),-0.39160879087392314,-0.9455895971226416,0.5750577367205543,0.857263678085989,1.0,6/11,24.74%,SLIT2;CCN3;MIF;DUSP1;GREM1;RIN3
prerank,negative regulation of insulin secretion (GO:0046676),0.403069728404079,0.945479153909931,0.5319148936170213,0.9658839036933589,1.0,1/17,0.54%,INHBB
prerank,ganglioside metabolic process (GO:0001573),-0.3356847843169624,-0.9452178281921072,0.5389048991354467,0.8572203677975178,1.0,8/20,23.27%,ST3GAL5;ST8SIA4;ST6GALNAC3;ABCA2;ST8SIA2;NEU3;ST6GALNAC4;CLN6
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.4168307708775409,0.9451240151153164,0.5375816993464052,0.9660274858383459,1.0,2/14,6.29%,WNT5A;ADAM10
prerank,nuclear body organization (GO:0030575),0.4160559928379828,0.9451064795682859,0.5371329879101899,0.9653437840268981,1.0,3/12,10.97%,USP50;WRAP53;SRPK2
prerank,stress-activated protein kinase signaling cascade (GO:0031098),-0.2973658955852458,-0.9450631269307395,0.5171428571428571,0.856615498447063,1.0,12/27,35.88%,MAP3K20;TAOK2;IKBKB;CUL1;SKP1;IKBKG;TNIP2;UBB;MAP3K8;CCDC88C;UBC;RPS27A
prerank,negative regulation of cell development (GO:0010721),-0.3060169880306831,-0.9449298610143895,0.5327102803738317,0.855937499853426,1.0,3/25,4.57%,IGF1;APPL2;B2M
prerank,regulation of cytoskeleton organization (GO:0051493),0.29601950323223947,0.9445777297148751,0.5497685185185185,0.9658393261969435,1.0,8/108,6.07%,EFNA5;DLC1;F11R;ARHGAP18;SPEF1;RAC2;CAPN6;ARHGEF5
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.3094338114477654,-0.9445018196296532,0.5710144927536231,0.855974255655261,1.0,8/25,13.56%,ARHGAP24;SLIT2;TBC1D30;EVL;EVI5L;CEP97;ARHGAP44;TCHP
prerank,protein destabilization (GO:0031648),0.35630957474798647,0.9443177156647041,0.5254730713245997,0.9657814554866502,1.0,16/32,24.69%,TRIM21;PEX2;CUL3;IRGM;KDM8;CREBBP;HTT;FBXL3;CDC73;SENP2;MUL1;PRKN;FBXW11;DERL1;PRNP;MDM2
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.3000682826586174,0.9441831964124499,0.5566037735849056,0.9653815966231046,1.0,15/110,10.61%,LPAR1;ADGRG5;ADGRG2;PTGFR;GPR161;MC5R;PTHLH;GNAQ;ADCY5;PTGER4;ABCA1;GNAL;TSHR;GPR101;ADRA2A
prerank,N-glycan processing (GO:0006491),-0.3357582263861519,-0.9440409157520278,0.5417867435158501,0.8561413923786324,1.0,5/18,14.41%,ST8SIA4;MGAT4A;GANC;ST8SIA2;FUT8
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.3304150525234507,-0.9440159039757114,0.5306666666666666,0.8552147990938082,1.0,5/21,10.48%,PRKCH;FOXP1;SLC39A10;BCL10;RPS3
prerank,negative regulation of macroautophagy (GO:0016242),-0.30720703644805053,-0.9437404264028126,0.5368421052631579,0.8549789216180229,1.0,9/26,17.09%,NUPR1;AKT1;QSOX1;RUBCN;USP36;LRRK2;UBQLN4;FEZ2;SCFD1
prerank,establishment of protein localization to extracellular region (GO:0035592),0.3419005773221299,0.943645163849571,0.5254957507082153,0.9660014496718748,1.0,5/39,8.05%,TANGO6;RAB8B;LTBP2;RAB3A;ABCA1
prerank,response to muscle stretch (GO:0035994),-0.34844626054478356,-0.9436105118393106,0.5157384987893463,0.8543080476835266,1.0,4/15,15.12%,DMD;SLC8A1;SLC9A1;PTK2
prerank,negative regulation of DNA recombination (GO:0045910),-0.2732880626857298,-0.9434921902243443,0.5910652920962199,0.8536140528440365,1.0,18/43,26.31%,SHLD2;BLM;H1-0;POLQ;UBQLN4;ZRANB3;POLR2F;POLR2A;POLR2J;POLR2D;CGAS;POLR2K;MAD2L2;ACD;RMI2;SMCHD1;PARPBP;POLR2I
prerank,histone H3-K9 demethylation (GO:0033169),-0.36855961439871066,-0.9434240273979263,0.5271867612293144,0.852798435970743,1.0,4/11,21.01%,PHF8;KDM1A;KDM7A;KDM4D
prerank,macrophage migration (GO:1905517),0.435080220743553,0.9433948367847828,0.5253378378378378,0.9658647110368621,1.0,1/13,2.69%,CXCL17
prerank,regulation of cell development (GO:0060284),-0.28003312251651424,-0.9433524363910436,0.5190311418685121,0.8519691552420817,1.0,5/36,8.34%,NOTCH2;FOXO1;HDAC9;RPS19;AKT1
prerank,neutrophil chemotaxis (GO:0030593),0.3293000664804878,0.9432438635550169,0.5471698113207547,0.965524095345372,1.0,1/53,0.29%,CXADR
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),-0.39087770226350327,-0.9420493770765159,0.5361050328227571,0.8533721257961528,1.0,5/10,28.89%,KLF4;MYADM;WNK1;MAP2K5;MBP
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),-0.39087770226350327,-0.9420493770765159,0.5361050328227571,0.8533721257961528,1.0,5/10,28.89%,KLF4;MYADM;WNK1;MAP2K5;MBP
prerank,snRNA transcription (GO:0009301),-0.23969919906194773,-0.94177521529412,0.59375,0.8531247749983114,1.0,19/70,19.88%,POU2F1;INTS9;CCNT2;CDK9;PHAX;RPRD2;CCNT1;SNAPC1;ZC3H8;SP1;INTS1;NCBP1;POLR2F;POLR2A;POLR2J;SNAPC5;TAF6;POLR2D;POLR2K
prerank,regulation of cardiac muscle contraction (GO:0055117),-0.279017457572878,-0.9417012207072314,0.5610561056105611,0.8523285943131397,1.0,18/34,32.42%,ANK2;SLC8A1;CALM1;ATP1B1;SLC9A1;ZC3H12A;CALM3;SRI;P2RX4;NOS1;PDE4B;PLN;SCN5A;KCNQ1;RYR2;GJA5;STC1;RGS2
prerank,negative regulation of establishment of protein localization (GO:1904950),-0.39419397469907047,-0.9414979815623802,0.5501066098081023,0.8519065279245144,1.0,5/10,29.38%,DNAJA1;CORO2B;MAPT;NDFIP2;PPM1F
prerank,regulation of fatty acid oxidation (GO:0046320),0.40042700763385963,0.9413830977328262,0.5292153589315526,0.969306869790789,1.0,3/16,5.21%,PPARGC1A;SOX9;PDK4
prerank,response to lipopolysaccharide (GO:0032496),0.29118099000305075,0.9413795943373376,0.5654627539503386,0.9685903699874093,1.0,21/138,11.19%,LBP;TNIP3;IL1A;PTPN22;HNRNPA0;IRAK3;WNT5A;TNFAIP3;FER;SELENOS;PAF1;DEFA6;ACOD1;IRGM;CHMP5;RPS6KA3;HMGB1;TICAM1;AXL;S100A9;TAB2
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),-0.283192970108331,-0.9413190793547531,0.5636363636363636,0.8513593320069149,1.0,6/31,9.65%,STXBP3;KCNB1;SYT9;SYT7;CACNA1G;SCAMP5
prerank,cellular component disassembly (GO:0022411),0.3217023175442287,0.9412478505733757,0.5424836601307189,0.9681930144093381,1.0,13/53,16.72%,LAMC1;KLK2;MMP15;SH3PXD2B;ADAM10;MMP12;MMP16;NOXO1;CAPN2;MMP14;PLG;LCP1;BMP1
prerank,potassium ion homeostasis (GO:0055075),0.3776227955621189,0.9408936013618657,0.5272459499263623,0.9683133538142655,1.0,5/23,9.89%,SLC12A2;SLC12A4;SLC12A3;ATP1A2;ATP1B3
prerank,branched-chain amino acid metabolic process (GO:0009081),0.38548051322401566,0.94076119440255,0.5125,0.9672013584478911,1.0,5/20,11.58%,ACAD8;BCKDK;ACAT1;BCKDHB;BCAT2
prerank,branched-chain amino acid catabolic process (GO:0009083),0.38548051322401566,0.94076119440255,0.5125,0.9672013584478911,1.0,5/20,11.58%,ACAD8;BCKDK;ACAT1;BCKDHB;BCAT2
prerank,positive regulation of lamellipodium organization (GO:1902745),0.3512080865762661,0.9405905443118073,0.5184094256259205,0.9669021250993489,1.0,8/32,16.91%,PLCE1;SRC;RAC2;RREB1;OCLN;AKIRIN1;AUTS2;ARHGEF7
prerank,embryonic skeletal system development (GO:0048706),0.34323863092606866,0.9402086619084075,0.5206611570247934,0.9671182041673633,1.0,5/35,4.77%,SULF1;KIAA1217;PCSK5;DYNC2I1;WNT5A
prerank,protein K48-linked ubiquitination (GO:0070936),0.32813079933781547,0.9401612138122027,0.5394190871369294,0.9665412624831978,1.0,16/54,21.78%,NEDD4L;UBE2E2;TNFAIP3;UBR5;CUL3;AMFR;TTC3;FBXO38;UBE2D1;UBE2D3;UBE2R2;ITCH;KBTBD7;RNF146;PRKN;ZNRF1
prerank,membrane organization (GO:0061024),-0.2002289030178395,-0.9400999592747289,0.7358490566037735,0.8535740766488145,1.0,32/227,9.94%,MYOF;PICALM;HIP1;TGFA;ANK2;DNM3;DAB2;TFRC;DNAJC6;DYSF;NAPA;TRIP10;AP2A1;STX18;LDLR;SYT9;HIP1R;HSPA8;MYADM;ATP2C1;ACTB;CTDNEP1;EPS15;SH3KBP1;LEMD3;LDLRAP1;PIK3C2A;SH3GLB1;ACTG1;ARPC3;ANK3;VPS4A
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.43889348980359355,0.9398734141890113,0.5209380234505863,0.9664897586276984,1.0,2/10,8.81%,GCDH;ACADS
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),-0.33496561698028227,-0.9396643301632014,0.5182072829131653,0.85364114861665,1.0,6/19,12.49%,ENPP1;BPNT2;PAPSS1;SLC26A2;TPST1;SLC35B3
prerank,chromatin remodeling (GO:0006338),0.3009383688418114,0.9396239113702565,0.5782556750298686,0.9663880754685256,1.0,33/100,22.05%,HNRNPC;CHD3;SOX9;CHD8;HDAC4;SATB1;SMARCAD1;GATAD1;ACTR8;SMARCD2;BAZ2B;HDAC2;PBRM1;ERCC6;INO80;TOP1;KDM6B;BAZ2A;TADA2A;INO80B;KDM4B;CHD1L;SUV39H2;RUVBL2;HCFC2;RBBP4;NUDT5;ARID1B;CHRAC1;RSF1;KDM5B;DAXX;ARID1A
prerank,regulation of extracellular matrix organization (GO:1903053),-0.3652070498019001,-0.9394365819953501,0.5413105413105413,0.8532400283856373,1.0,6/15,11.84%,AEBP1;LRP1;DDR1;TIE1;SLC2A10;FGFR4
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.3629521255521325,0.9392531455111957,0.5337423312883436,0.9665494919977166,1.0,10/26,22.42%,EGFR;SOX9;SYAP1;ZFP36L2;ERBB2;PDPK1;PTPN12;STAT5B;FOXC1;IQGAP1
prerank,regulation of osteoclast differentiation (GO:0045670),0.35163763145270005,0.9386723593692309,0.5260196905766527,0.9672598757908758,1.0,1/33,0.48%,UBASH3B
prerank,regulation of T cell chemotaxis (GO:0010819),0.4392993413009131,0.937950157758821,0.570446735395189,0.9683501659315481,1.0,2/11,6.29%,WNT5A;ADAM10
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),-0.3393339488987155,-0.9379363553890816,0.5603217158176944,0.8559420051664649,1.0,5/18,11.37%,SHANK3;CUX2;GRIN1;PRKCZ;NRXN1
prerank,regulation of ATP biosynthetic process (GO:2001169),0.39671468335314,0.9370104722668946,0.5395799676898223,0.9698369189899843,1.0,1/16,0.60%,PPARGC1A
prerank,regulation of lamellipodium assembly (GO:0010591),0.3487237388658288,0.9367048494585523,0.534711964549483,0.9698242406919838,1.0,7/34,15.05%,PLCE1;CAPZB;RAC2;FER;OCLN;AKIRIN1;AUTS2
prerank,nonribosomal peptide biosynthetic process (GO:0019184),-0.3720804938508062,-0.93663046277241,0.5642201834862385,0.8582181853964465,1.0,5/12,17.66%,GCLM;BDH2;GGCT;CNDP2;GCLC
prerank,extracellular matrix disassembly (GO:0022617),0.3211817498671492,0.9365968883953485,0.5498687664041995,0.9693717055626149,1.0,13/53,16.72%,LAMC1;KLK2;MMP15;SH3PXD2B;ADAM10;MMP12;MMP16;NOXO1;CAPN2;MMP14;PLG;LCP1;BMP1
prerank,glycolipid metabolic process (GO:0006664),0.3280088366386412,0.9365833039716779,0.5313351498637602,0.9686879098139962,1.0,17/47,23.96%,ST3GAL4;NAGA;SUMF1;PGAP3;CERK;NEU1;HEXA;SCCPDH;HEXB;GBGT1;ASAH1;ST6GALNAC6;SUMF2;PGAP1;ARSA;ESYT2;SMPD2
prerank,regulation of spindle organization (GO:0090224),0.3871393270045791,0.9364260697592964,0.5546623794212219,0.9683555318546221,1.0,3/18,12.04%,SENP6;NUP62;MAP9
prerank,cAMP metabolic process (GO:0046058),0.42154311438242703,0.936424739255165,0.5311973018549747,0.9676464486546058,1.0,6/13,15.75%,PDE4D;PTHLH;ADCY5;ADCY9;ADCY8;ADCY3
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),-0.24362178970520054,-0.9363489442613062,0.6331877729257642,0.8579333468986806,1.0,21/72,20.58%,UVSSA;EP300;RBX1;MNAT1;ERCC2;POLK;XPA;ISY1;LIG3;POLR2F;COPS6;RFC2;CCNH;POLR2A;POLR2J;GTF2H4;POLR2D;GPS1;POLR2K;ERCC4;ERCC5
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.35396456606981075,0.9361760994407639,0.5315315315315315,0.9675287268275026,1.0,9/27,18.66%,KAT6B;MSL3;TRRAP;PHF20L1;CREBBP;KAT8;BRD8;MORF4L2;RUVBL2
prerank,negative regulation of ATP metabolic process (GO:1903579),-0.3431362082336711,-0.9361526876731071,0.5459459459459459,0.8574372636274766,1.0,9/17,25.99%,PID1;NUPR1;CBFA2T3;PFKFB1;PDE12;PARP1;GIT1;TIGAR;FLCN
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.31019725916012475,-0.9359446965187154,0.5705882352941176,0.8570098834832371,1.0,6/25,15.84%,EPHA4;RPS7;SGTA;RPL23;CSNK2A1;HFE
prerank,placenta development (GO:0001890),0.41712059008599434,0.9358104165087943,0.5355285961871751,0.9676749645351104,1.0,1/12,2.17%,ADAM19
prerank,gliogenesis (GO:0042063),-0.34902600073567436,-0.9356814628154695,0.535175879396985,0.856628048340964,1.0,4/15,13.01%,NFIB;ANXA1;CDK6;TGFB2
prerank,tRNA wobble base modification (GO:0002097),-0.34851268368158894,-0.9353490541770441,0.5339805825242718,0.8564468020918439,1.0,9/14,36.96%,ELP3;TRMT9B;ELP4;GTPBP3;MOCS3;KTI12;ADAT2;CTU2;CTU1
prerank,regulation of axon extension (GO:0030516),0.3435190927795465,0.9353283670975329,0.5383522727272727,0.9681122541604367,1.0,8/37,14.46%,NTN1;RTN4R;CDKL3;SEMA3A;GSK3B;TRIM46;CTTN;RTN4
prerank,regulation of DNA metabolic process (GO:0051052),0.3369779970219446,0.935312605062583,0.5305291723202171,0.9674476019651839,1.0,8/44,9.47%,MPV17;WDR18;TOM1L1;SMARCAD1;KPNA2;NBN;UBE2V2;SIRT7
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.334290063200914,-0.9350192453758533,0.5187165775401069,0.8563663501402965,1.0,4/17,10.54%,SASH1;BMP6;NFKBIL1;TRIB1
prerank,midbody abscission (GO:0061952),0.3972966944090279,0.934779217027744,0.5492730210016155,0.9679997857610452,1.0,5/17,12.19%,CHMP5;PDCD6IP;CHMP4B;CHMP4A;CHMP4C
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.34242876720672316,0.9346988058652207,0.5312046444121916,0.9674770159573831,1.0,11/35,18.99%,AWAT2;HMGCLL1;ACACA;SCD5;ACAT1;GCDH;GGTA1;GGT1;HPGD;SCD;BDH1
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),-0.32722281725183294,-0.9346270328336909,0.5196850393700787,0.8563660425320775,1.0,2/18,6.70%,PLCB1;AGRN
prerank,import into cell (GO:0098657),0.33468613657557494,0.9344578883023091,0.5279770444763271,0.9673302730333394,1.0,8/41,6.95%,LRRC8D;SLC12A4;SLC1A7;SLC27A1;LRSAM1;ATP1A2;SLC6A13;SLC1A6
prerank,regulation of neuron death (GO:1901214),0.3069517674977898,0.9341868701341712,0.5712530712530712,0.9672326861158147,1.0,19/82,17.28%,PPARGC1A;RAB29;WNT5A;EGLN3;EFNB2;MAP3K5;CD200R1;GSK3B;SARM1;CHMP4B;CHMP4A;EGR1;LANCL1;SNCG;DHCR24;HTRA2;TBK1;GPR75;CHP1
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.34719107453155257,0.9339150028190074,0.5502121640735502,0.9672034340973261,1.0,5/38,7.57%,CAV1;ASS1;ATP2B4;DDAH2;NOS1AP
prerank,ncRNA metabolic process (GO:0034660),0.3429002122688854,0.933878565090389,0.5502717391304348,0.9665898519700682,1.0,12/37,25.81%,PIWIL2;DDX17;DGCR8;DICER1;RAN;PRKRA;XPO5;DTD1;TDRD9;MEPCE;TENT4B;AGO2
prerank,glucose import (GO:0046323),0.42239775193541035,0.9338571414973484,0.5448613376835236,0.9659448387564947,1.0,3/13,9.11%,SLC27A1;ZDHHC7;SLC27A4
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.2820056472827034,0.9335759684392269,0.5743243243243243,0.965907655154877,1.0,18/158,11.19%,ROR1;PLK2;LPAR1;PELI2;AKAP13;REL;SLC35B2;NUP62;PPM1A;TRADD;TRIM21;S100B;TFG;TICAM1;TMED4;CANT1;SHARPIN;TAB2
prerank,nuclear membrane organization (GO:0071763),0.38029949839906524,0.933432760526042,0.5312024353120244,0.965561464770654,1.0,5/19,15.46%,NEMP1;SPAST;CHMP4B;EMD;GPER1
prerank,positive regulation of lymphocyte differentiation (GO:0045621),0.3832736085356456,0.9333308060061914,0.5276073619631901,0.9650771456713909,1.0,8/19,19.35%,AXL;IL7;PPP2R3C;MMP14;MDK;SYK;BTK;XRCC6
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.38024963602606937,0.9331615913641937,0.5391566265060241,0.9647690969836779,1.0,8/22,19.87%,LEO1;CDK13;ELL;SUPT4H1;ERCC6;TCERG1;THOC5;CDC73
prerank,leukocyte cell-cell adhesion (GO:0007159),0.3679371282155413,0.9330947029242047,0.5131578947368421,0.9642182135483703,1.0,6/24,17.12%,F11R;TNIP1;NT5E;SEMA4D;SYK;EZR
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),-0.3352631618661402,-0.9325231984296491,0.5782828282828283,0.8607092495482003,1.0,5/18,18.96%,NUP133;THOC2;ZC3H11A;HHEX;DDX19A
prerank,divalent inorganic cation homeostasis (GO:0072507),0.3632748869393427,0.9324787445752549,0.5630498533724341,0.9650397965794482,1.0,1/25,0.25%,CAV1
prerank,aerobic respiration (GO:0009060),-0.30930177347968923,-0.9324067101725517,0.5483870967741935,0.8600341269004628,1.0,8/20,28.64%,SDHB;UQCRC2;MTFR1;ME3;OXA1L;NDUFS8;MTFR2;UQCR10
prerank,positive regulation of telomere maintenance (GO:0032206),0.3480517510463466,0.9323611975830474,0.5300146412884333,0.9646058490993945,1.0,12/31,26.87%,NEK7;NBN;NAF1;ERCC1;MRE11;HNRNPD;SLX4;MAPK1;ATRX;TNKS;PML;RAD50
prerank,microvillus organization (GO:0032528),0.41795515249292187,0.9323279713356497,0.5393442622950819,0.9639831155837475,1.0,3/13,8.91%,RAP1A;MINK1;RAPGEF6
prerank,regulation of cholesterol metabolic process (GO:0090181),-0.3200778693069848,-0.932195341427792,0.5508474576271186,0.8595907474937661,1.0,4/20,13.07%,ARV1;APOE;LDLRAP1;ABCA2
prerank,positive regulation of phospholipase activity (GO:0010518),0.377175975099329,0.9316769905640442,0.5734375,0.9647853155409325,1.0,2/22,0.71%,NTRK3;FGFR1
prerank,negative regulation of phosphorylation (GO:0042326),0.3020336230971862,0.9313104751168032,0.5522755227552275,0.9649492811489832,1.0,9/85,8.62%,DYNLL1;NTRK3;PTPN13;PLPP3;HDAC4;IBTK;EPHB2;NCOR1;OCLN
prerank,primary miRNA processing (GO:0031053),-0.38500803632869407,-0.9312693018631293,0.5520361990950227,0.8608793972372127,1.0,4/10,23.77%,SMAD3;PUS10;SMAD1;MRPL44
prerank,phosphatidylinositol metabolic process (GO:0046488),0.2924496767881483,0.9308135547053129,0.5865384615384616,0.9654118682128221,1.0,17/109,9.33%,PTPN13;PLCB3;PI4K2B;TPTE;SLC27A1;PIP4K2B;PIK3R4;PGAP3;PLEKHA4;MTMR7;PIK3R2;MTMR6;MTMR3;LCLAT1;PLEK;OCRL;INPP5F
prerank,cellular modified amino acid biosynthetic process (GO:0042398),-0.31577544111947076,-0.9306980461373815,0.5595567867036011,0.8613346830159462,1.0,8/20,17.98%,MTHFS;GCLM;PLOD2;PTDSS2;GGCT;CNDP2;GCLC;GATM
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.316906803651846,0.9306521085168652,0.5624195624195624,0.9650896783796747,1.0,16/61,18.81%,CAV1;PSME3;PDK4;PSMB5;NCOR2;PSMA6;PSMB2;PSMA2;PANK2;PSMD13;PSMA7;PSME4;PSMD12;PSMD14;PSMB6;PSMC4
prerank,oxoacid metabolic process (GO:0043436),-0.3039265244526388,-0.9305943706684546,0.5580645161290323,0.860611464430538,1.0,8/27,20.66%,ENPP1;DDO;BPNT2;TPST1;PPA1;AGXT;MIF;SULT4A1
prerank,purine-containing compound catabolic process (GO:0072523),-0.3602242270787984,-0.9305461580476456,0.5454545454545454,0.8597576457080249,1.0,5/13,25.11%,DPYD;XDH;NT5C;NT5C1A;GDA
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.3091383006556395,0.9305395232495077,0.5780856423173804,0.9646425879970447,1.0,20/71,19.56%,ADAMTS12;FAP;TNFAIP3;SOCS6;CHFR;PDCD6IP;CHMP4B;OTUD7B;LONP1;ZYG11B;HDAC6;FBXL17;CHMP4C;CAPN2;PSMA6;CTSB;CUL4B;USP9X;HM13;UBE2W
prerank,quinone biosynthetic process (GO:1901663),0.40609546514594497,0.9303144600106915,0.5376712328767124,0.9644793761585483,1.0,4/14,15.72%,COQ7;COQ8A;COQ9;COQ6
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),-0.37711675007056134,-0.9303061172552383,0.5666666666666667,0.8593900174432773,1.0,5/11,12.92%,NR1H3;LDLR;CTDNEP1;NR1H2;MFSD2A
prerank,membrane raft organization (GO:0031579),-0.3445344548586215,-0.9301497710339507,0.5681233933161953,0.8588297190286716,1.0,5/15,18.45%,RFTN1;ANXA2;MYADM;NAXE;FLOT1
prerank,epithelial cell morphogenesis (GO:0003382),-0.3324458502267823,-0.9299127750820193,0.5461741424802111,0.8584714814232709,1.0,5/17,19.84%,COL22A1;COL15A1;DACT2;COL18A1;MET
prerank,regulation of pH (GO:0006885),-0.3798646627634297,-0.9298811012249746,0.5484633569739953,0.8575912749586624,1.0,3/11,9.50%,ATP6V0A4;LACC1;SLC9A1
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.307829331364059,0.9292690841830793,0.5967336683417085,0.9661880584602934,1.0,16/72,19.19%,PLK2;GTSE1;BCL3;CNOT10;ARID3A;NBN;SFN;CNOT7;SOX4;BATF;TNKS1BP1;E2F1;RGCC;CNOT8;BAX;CNOT1
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),-0.3857679254699492,-0.9291587356409209,0.55,0.8584373738698711,1.0,2/10,2.61%,MSN;CDC42
prerank,negative regulation of viral transcription (GO:0032897),-0.3519295014942272,-0.9290186828777303,0.5343137254901961,0.8578005817324021,1.0,6/13,21.25%,MID2;TRIM14;UBP1;ZFP36;TRIM13;TRIM11
prerank,sodium ion export across plasma membrane (GO:0036376),0.4176924517367616,0.928655607850445,0.5453074433656958,0.9669431442821428,1.0,3/13,9.89%,ATP1A2;SLC4A4;ATP1B3
prerank,negative regulation of myeloid cell differentiation (GO:0045638),-0.3120991064552207,-0.9286325837704736,0.5706521739130435,0.8578636534661296,1.0,5/20,10.81%,HOXA5;MEIS1;CDK6;HOXB8;HOXA9
prerank,brain morphogenesis (GO:0048854),-0.36808971724105,-0.9285717656024698,0.5615763546798029,0.8570491947154667,1.0,4/12,14.63%,SHANK3;SPEF2;BBS2;MKKS
prerank,inorganic anion transmembrane transport (GO:0098661),-0.24097764843412833,-0.9285038130553126,0.588495575221239,0.8562689595254412,1.0,24/63,23.19%,ANO1;SLC12A6;ANO4;SLC5A6;ANO3;GABRA2;SLC26A2;SLC25A30;SLC25A11;LRRC8A;GABRB1;GLRA2;SLC12A5;SLC6A1;SLC1A1;SLC1A3;ANO5;SLC12A7;GABRE;GABRA5;SLC37A1;ANO2;SLC12A9;SLC37A2
prerank,cilium movement (GO:0003341),0.3298396023454322,0.9281157613963834,0.5577689243027888,0.9675177863983202,1.0,13/47,22.75%,CFAP73;SPEF1;SPAG17;CCDC39;DNAH5;CCDC40;CFAP70;CFAP61;ODAD1;TTC29;ZBBX;DNAI4;CFAP100
prerank,glycerolipid catabolic process (GO:0046503),-0.3213790091548794,-0.9278899682257042,0.5529715762273901,0.8568341298669254,1.0,3/19,12.60%,GPCPD1;PNPLA6;ABHD2
prerank,substantia nigra development (GO:0021762),-0.2706715937683334,-0.9276663235787642,0.5652173913043478,0.8564365010115469,1.0,14/37,15.06%,CDC42;CKB;GNB4;CALM1;ACTB;MAOB;COX6B1;SEC16A;TTBK1;CNP;S100A1;RAD1;CALM3;ATP5PF
prerank,calcium ion transport into cytosol (GO:0060402),0.3792322919678688,0.9274921567767526,0.5543130990415336,0.9682864405417605,1.0,3/21,4.86%,ITPR3;TRPV4;ATP2B4
prerank,positive regulation of natural killer cell activation (GO:0032816),0.41056640355704976,0.9265652112815321,0.5588723051409619,0.9697574849837486,1.0,3/13,9.91%,TICAM1;LAMP1;AXL
prerank,Rho protein signal transduction (GO:0007266),0.31870406000772866,0.9265563157387579,0.5658602150537635,0.9690794770705149,1.0,14/53,18.19%,CDH13;NTN1;CDC42EP4;RHOJ;RIPOR1;ARHGEF1;CTNNAL1;ADRA2A;CDC42EP3;RTKN;ARHGEF11;CELSR1;ARHGDIB;RHOA
prerank,positive regulation of protein metabolic process (GO:0051247),0.2906590256483353,0.926466180824127,0.5804195804195804,0.9686043154639471,1.0,11/110,9.14%,PLK2;GPC3;NEDD4L;AXIN1;TFR2;WNT5A;DACT1;TNFAIP3;MAPK7;ISL1;GSK3B
prerank,positive regulation of fibroblast proliferation (GO:0048146),-0.2913532101571688,-0.9260008297171436,0.56973293768546,0.859662991152845,1.0,6/27,13.39%,IGF1;PDGFRA;CDK6;BMI1;SPHK1;CDK4
prerank,regulation of bone mineralization (GO:0030500),0.3157990685303057,0.9259452640852504,0.5692695214105793,0.9691276377835539,1.0,4/55,4.13%,PKDCC;SGMS2;ANO6;BMPR1B
prerank,cartilage development (GO:0051216),0.3271285552019816,0.9259122329978354,0.5505464480874317,0.9685171576906888,1.0,6/49,4.14%,SULF1;RUNX2;WNT2B;GPLD1;TRPV4;SOX9
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.35846486273860956,-0.9258546518615905,0.5405405405405406,0.8590893499641142,1.0,2/12,5.81%,FOXP1;KLF4
prerank,negative regulation of RNA splicing (GO:0033119),0.3823373022140632,0.9254437684348437,0.555895865237366,0.9689512405423465,1.0,9/19,23.81%,SRSF4;PTBP3;RPS13;SFSWAP;PTBP2;SAP18;SRSF12;SRSF10;RBMX
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.41584018225351393,0.9253019441205375,0.5606326889279437,0.9685842589463777,1.0,4/13,11.99%,SOCS5;TSG101;CBLB;SOCS4
prerank,regulation of cytoplasmic translation (GO:2000765),-0.3447656075795671,-0.925284066926422,0.56282722513089,0.8596427069055863,1.0,5/14,20.25%,CPEB4;CPEB2;UNK;DHX36;CPEB1
prerank,myelination (GO:0042552),-0.2603499070158857,-0.925173945692447,0.6284584980237155,0.8589774727130265,1.0,12/46,13.81%,PARD3;ADGRG6;SLC8A3;TNFRSF21;BCAS1;CMTM8;PLLP;GAL3ST1;LGI4;SBF2;ABCD2;DEGS1
prerank,regulation of cell death (GO:0010941),0.2939331704405394,0.924301212692569,0.5685096153846154,0.9702022875412285,1.0,18/94,13.63%,PRODH;ACER3;SPEF1;RAB29;WNT16;CELF1;CIDEB;NPAS2;ATG5;SARM1;CHMP4B;FERMT2;AXIN2;APC;FAF1;SNCG;DHCR24;SOX4
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.2516680669106836,-0.9242502947171928,0.5902255639097744,0.8602534113772108,1.0,18/48,20.70%,NEDD9;CUX1;CDC42;OBSL1;TRIOBP;CUX2;MYADM;CRK;CRKL;FLNA;CDKL5;ILK;PTPRD;NRP1;LIMS2;TESK1;CARMIL1;LIMS1
prerank,myeloid dendritic cell activation (GO:0001773),0.4161514673226572,0.9235645644634716,0.5492730210016155,0.9712082412803231,1.0,3/12,15.34%,DOCK2;HMGB1;BATF
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),-0.32387949574252567,-0.9234458987048514,0.5743073047858942,0.861171895144735,1.0,4/18,7.05%,FLT1;AKT3;IGF2;COL4A3
prerank,rRNA methylation (GO:0031167),0.36986612227537097,0.9233451315072686,0.5402843601895735,0.9709914152551071,1.0,6/22,16.36%,MRM2;BUD23;TFB2M;METTL5;NSUN5;MRM1
prerank,regulation of phagocytosis (GO:0050764),-0.24938116667936572,-0.9232497208339859,0.6111111111111112,0.860718245553267,1.0,9/53,9.51%,TGM2;DYSF;SIRPA;SYT7;PIP4P2;IL15RA;CYBA;GATA2;MERTK
prerank,establishment of spindle localization (GO:0051293),-0.3518570586770252,-0.9231077167125868,0.5620253164556962,0.8601496929522447,1.0,8/14,41.34%,CFL1;ZBED3;LLGL2;NUSAP1;TLE6;DYNC1H1;ESPL1;NLRP5
prerank,RNA export from nucleus (GO:0006405),0.29362993289290423,0.9229590650093877,0.5959715639810427,0.9712281965038322,1.0,36/100,25.05%,RBM8A;SRSF4;NUP62;RBM15B;NUP160;UPF2;NUP37;EIF4E;TPR;NUP50;UPF3B;RANBP2;SMG7;NUP153;NUP210;THOC3;RAN;NUP93;THOC5;MCM3AP;XPO5;SLU7;SYMPK;SRSF3;DHX38;SRSF11;NUP43;SMG6;DDX25;YTHDC1;SEC13;CPSF2;WDR33;SARNP;NUP188;NXF1
prerank,dephosphorylation (GO:0016311),0.28083005530939986,0.9228865824316744,0.6115515288788222,0.9707047478130805,1.0,31/147,15.15%,PTPN13;PTPRF;DUSP12;PLPP2;ACP6;PTPN14;PLPP3;TPTE;PTPN22;PTPRC;THTPA;PPM1A;PPM1M;MTMR7;PTPRJ;MTMR6;MTMR3;PDP2;SDHAF2;PTPRT;CTDSP1;PPP2R1B;PTPN18;PTEN;PTPRA;DUSP8;PTPN6;CTDSP2;PTPRU;PTPRO;PLPPR1
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.4230594461068394,0.9228041190587959,0.5557553956834532,0.9702035691157553,1.0,3/11,17.29%,SPI1;TICAM1;STX4
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),-0.3701882297598459,-0.9227405752477922,0.5472972972972973,0.8601095243587497,1.0,4/11,15.16%,FRS2;BMP2;SOX6;MYOCD
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.3780199869781458,0.9224224496693649,0.5663430420711975,0.9704289798424275,1.0,2/21,4.22%,EFNA5;PEAK1
prerank,cochlea morphogenesis (GO:0090103),0.43018282312610073,0.9223546457645176,0.5516014234875445,0.969892444284527,1.0,4/10,21.24%,SOX9;TBX18;MYO3B;PAX2
prerank,nervous system development (GO:0007399),0.26488006469630176,0.9218093634267042,0.6913705583756345,0.9704546720994154,1.0,65/429,13.27%,NGF;EFNA5;LPAR1;LDB2;JAG1;ZC4H2;RAB29;RBFOX2;NF1;OPHN1;STIL;TMOD2;NPAS2;NBL1;GLIS2;DSCAM;HDAC4;PCDHB15;ACVR1C;DACT1;INTU;FN1;NTN5;CLN8;NCAN;ARTN;EPHB2;ARHGAP26;LSAMP;GMFB;IGF2BP2;CHERP;SCD5;TAGLN3;SIAH1;ALDH5A1;CDH2;KALRN;S100B;DYRK1A;JRKL;PTS;MPZ;RPS6KA3;DOC2A;UNC119B;GPM6A;BTBD2;AXL;POU4F1;RELN;BPNT1;ERCC6;TMEM223;APC;FBXL17;PRPS1;WDR62;DPYSL2;PTEN;NDUFV2;SDK1;SMO;PKD1;CHRM2
prerank,gonad development (GO:0008406),0.3337314126405121,0.9217932807861401,0.5523012552301255,0.9697948078914442,1.0,5/41,7.73%,NR2F2;WNT2B;SOX9;WNT5A;MSH2
prerank,regulation of cell killing (GO:0031341),0.3919883530423556,0.9217155726990139,0.5620805369127517,0.9692705912953711,1.0,5/16,14.16%,CD55;WNT5A;NOXO1;CFH;FZD7
prerank,cellular potassium ion homeostasis (GO:0030007),0.4143140866897281,0.9216976060103892,0.5543130990415336,0.9686185340829073,1.0,3/13,9.89%,SLC12A2;ATP1A2;ATP1B3
prerank,apoptotic cell clearance (GO:0043277),0.3486362071445064,0.9216419619430852,0.5560538116591929,0.968053735294213,1.0,6/30,9.55%,XKR7;XKR4;RAC2;RARA;XKR8;HMGB1
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.30455913481013686,-0.92156225203123,0.5684210526315789,0.8622298072187897,1.0,6/23,17.06%,PRKAG2;CALM1;UBE2K;SPHK1;CALM3;EGF
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),0.39183720714250647,0.9215422216319326,0.5688816855753647,0.9676134600894682,1.0,1/17,0.45%,NTRK3
prerank,post-translational protein modification (GO:0043687),0.26655978726391727,0.9206219764193649,0.6521739130434783,0.9690363409448668,1.0,73/332,18.82%,FAM20C;GPC3;STC2;LAMC1;LAMB2;FBXL15;SOCS5;ASB6;LMO7;SCG3;SPSB4;NUCB1;PSME3;KEAP1;FN1;BMP15;SUMF1;ADAM10;SOCS6;PTP4A2;ATG5;GOLM1;RAB3A;FBXO31;CUL3;RCN1;CDH2;PSMB5;DCAF13;PRKCSH;FBXL19;PROC;FBXL5;KLHL21;MEN1;FBXO11;KLHL22;FBXO21;STT3A;P4HB;PSMA6;PSMB2;FEM1C;PSMA2;CHM;CHGB;COPS5;FBXW8;PSMD13;FBXL12;PSMA7;DDB2;FBXO41;MBTPS1;FSTL1;VCAN;FBXW7;CALU;FBXL3;CUL4B;FBN1;DSCC1;PSME4;BTBD6;RNF7;PSMD12;VGF;WFS1;PSMD14;SOCS2;PSMB6;PSMC4;RAB5A
prerank,monocarboxylic acid catabolic process (GO:0072329),-0.31058656520659145,-0.9200037457418005,0.5759162303664922,0.8649623671620585,1.0,6/21,10.23%,CYP26B1;PPARD;LPIN2;FAH;ACBD5;LPIN3
prerank,mesenchyme morphogenesis (GO:0072132),-0.3237484648667524,-0.9198565228582877,0.5564102564102564,0.86441252821147,1.0,5/17,13.01%,ENG;NOS3;ACVRL1;BMP2;TGFB2
prerank,organelle assembly (GO:0070925),0.263984174428035,0.9198254912261833,0.6904276985743381,0.9701606933247101,1.0,90/384,19.84%,DYNLL1;PARVA;UBXN10;RAB8B;ABLIM3;MKS1;PTPDC1;DZIP1;DYNC2I1;TMOD2;CYS1;EXOC3;NUP62;SH3PXD2B;CNGB1;INTU;CEP89;HPS1;TSG101;NEK7;CEP131;IFT81;ATG5;CNGA4;SNX10;EHD2;NCOR1;CLUAP1;CEP162;TMOD1;IRGM;CHMP5;PDCD6IP;UNC119B;OCRL;TMEM237;TCTN2;FOXJ1;IST1;CHMP4B;CHMP4A;ATXN2;IFT74;DYNLL2;TUBGCP5;HDAC6;INO80;EXOC5;CFAP20;UBAP2L;CEP290;CSDE1;CHMP4C;CDS2;MAPRE2;ATG7;PKD1;DDX6;PDE6D;PCM1;FAM161A;FLII;FBF1;PIK3C3;DNAH5;B9D2;CFAP298;PIBF1;CFAP70;UBQLN1;CFAP410;CDC14A;DYNC2H1;MRPL22;EHD1;ATG3;ATG2B;OFD1;ARMC9;STK36;CEP250;HDAC3;SNAP29;MAP1LC3B;BBS1;G3BP1;LSM3;TCTN1;RB1CC1;TUBGCP6
prerank,dendritic cell differentiation (GO:0097028),-0.298571526809221,-0.9197937016741006,0.5379746835443038,0.863622321504351,1.0,11/22,38.07%,LYN;CAMK4;LGALS9;TRPM2;CCL19;IRF8;BATF2;PRTN3;TREM2;LILRB1;FLT3
prerank,RNA 3'-end processing (GO:0031123),0.30847100876782985,0.9197669702166393,0.5907335907335908,0.9696057451963587,1.0,24/69,25.72%,CSTF1;RBM8A;SRSF4;RPRD1B;TUT1;CSTF3;LIN28B;RPRD1A;UPF3B;THOC3;THOC5;SLU7;SYMPK;SRSF3;DHX38;NUDT21;SRSF11;PCF11;CPSF2;WDR33;SARNP;PABPN1;TENT4B;PNPT1
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.3008898936649277,0.9197172363652222,0.5832290362953693,0.9690149045010559,1.0,8/76,9.13%,NTRK3;PRKCE;CDC42EP4;NUP62;FER;NCK2;ARF6;PLEK
prerank,regulation of DNA biosynthetic process (GO:2000278),0.3493185200149192,0.9197100813814737,0.565015479876161,0.9683442648496008,1.0,2/27,5.20%,SMOC2;TOM1L1
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",0.32559486850132596,0.9194247056548528,0.5515320334261838,0.968321192265454,1.0,7/46,13.23%,TSHZ3;OPHN1;DGKZ;ATP1A2;CDH2;RELN;GRM1
prerank,regulation of cellular response to heat (GO:1900034),0.3028482738106857,0.9192200114892629,0.5915841584158416,0.9680905284750446,1.0,26/77,22.82%,CAMK2D;HSPH1;NUP62;BAG3;NUP160;GSK3B;NUP37;TPR;NUP50;RANBP2;NUP153;NUP210;CREBBP;NUP93;DNAJC7;CHORDC1;YWHAE;CAMK2G;BAG2;RPTOR;ATR;CCAR2;RPA3;NUP43;SEC13;MAPK1
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.3532138796659448,0.9191160986113657,0.5616641901931649,0.9676427381110612,1.0,6/28,16.76%,NRARP;EGFR;EGFL7;MMP14;WWP2;FBXW7
prerank,cellular protein catabolic process (GO:0044257),0.31569227913935405,0.9190082090298892,0.5904887714663144,0.9672022245501763,1.0,17/59,23.36%,ADAMTS12;FAP;PISD;CPA2;LONP1;CAPN2;HTRA2;PSMA6;AP2A2;CTSB;BNIP3;PRKN;TCIRG1;YME1L1;AP2S1;MYLIP;CLTA
prerank,mesonephros development (GO:0001823),-0.3751165612251328,-0.9189724431316094,0.581081081081081,0.8647459135404714,1.0,2/11,2.51%,OSR1;BMP4
prerank,regulation of telomerase activity (GO:0051972),0.32424472308286245,0.9185622123763786,0.5862068965517241,0.9675240017904253,1.0,6/45,12.14%,SRC;NEK7;NAF1;WRAP53;CCT2;MEN1
prerank,inorganic cation transmembrane transport (GO:0098662),0.2708128671617681,0.9181153232900033,0.6684266103484688,0.9678466529959788,1.0,32/268,11.27%,KCNJ4;OTOP1;NALCN;SCN10A;TRPM3;KCNA5;SLC12A2;SLC39A13;KCNJ16;ANO6;SLC24A1;TRPV4;KCNS2;SLC12A3;KCNK1;CACNA1H;ATP2B4;ATP1A2;SLC6A13;SLC30A6;SLC4A4;SLC4A11;COX15;KCNK5;ATP1B3;KCNS3;NNT;KCNAB1;TRPC4AP;SCN2B;SLC9A7;SLC9A6
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),-0.3084760495158037,-0.9180528287611236,0.5558823529411765,0.8659563753933192,1.0,4/20,9.88%,TGFBR1;HIF1A;DNAJB2;EPAS1
prerank,activation of protein kinase A activity (GO:0034199),-0.33465729862084537,-0.9177388172527923,0.5694444444444444,0.8658185201654228,1.0,5/16,12.01%,ADCY1;ADCY7;ADCY4;ADCY2;PRKAR2B
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),0.39793951001011124,0.9177078217477703,0.5533333333333333,0.9681111586989436,1.0,2/15,4.68%,PIEZO2;TMC2
prerank,sequestering of extracellular ligand from receptor (GO:0035581),-0.35478047843667854,-0.9176534130270324,0.5734939759036145,0.8650729546131659,1.0,5/13,14.31%,GREM2;NRROS;BMP2;DAND5;CHRDL1
prerank,fatty acid beta-oxidation (GO:0006635),0.3234008070882463,0.917599129048419,0.556282722513089,0.9676788440496812,1.0,9/51,10.43%,EHHADH;DECR2;HADHB;PEX2;ACAT1;GCDH;HSD17B4;ACADS;ACOT8
prerank,ribosomal large subunit biogenesis (GO:0042273),-0.24904712852882696,-0.9173664478677584,0.6304347826086957,0.8648168407430885,1.0,22/54,29.08%,RPL35A;RPL26;NPM1;HEATR3;RPLP0;RPL3;WDR12;NOC2L;LAS1L;MRPL20;RPL14;NLE1;RPL10A;PPAN;RPL5;PAK1IP1;RPF2;RPL7;NHP2;RPL11;NOP16;RPL24
prerank,regulation of nucleocytoplasmic transport (GO:0046822),0.4134029182638219,0.9172338469310386,0.5724258289703316,0.9678192668855479,1.0,4/12,11.21%,PTPN14;SIRT7;TPR;NEDD4
prerank,hippo signaling (GO:0035329),0.35626939066769675,0.9168155500760229,0.5455950540958269,0.9680752939071384,1.0,9/26,16.59%,AMOTL1;TJP2;AMOT;TEAD3;STK3;WWC1;YAP1;NPHP4;YWHAE
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.41427469282540175,0.9163736980335488,0.5498281786941581,0.968389813551843,1.0,4/13,17.29%,GAB2;LAMP1;SYK;STX4
prerank,protein complex oligomerization (GO:0051259),0.2921359127128577,0.9161544219618694,0.5769230769230769,0.9682155651211527,1.0,25/85,24.40%,CLDN1;LRRC8D;BEND3;SPAST;NLRC4;ATL2;PDCD6IP;GSDMD;VSTM5;ADCY8;HGSNAT;ALS2;GLRA3;EHD1;MS4A1;STOML2;NUDT21;CHMP2A;YME1L1;ELAVL1;MPP2;JMJD6;RBMX;PRMT8;DNM1L
prerank,import into nucleus (GO:0051170),0.30090495973589065,0.9161331227428459,0.5927318295739349,0.9675766877499336,1.0,15/73,16.93%,PRICKLE1;IPO8;NUP62;SNRPF;FAM53B;SMN1;TPR;MMP12;NUP50;HTATIP2;CSE1L;NUP153;RAN;NUP93;SYK
prerank,positive regulation of defense response (GO:0031349),0.2941100910332978,0.9158382647791947,0.5910165484633569,0.9675853765615856,1.0,18/89,16.28%,NPAS2;WNT5A;MGST2;LRSAM1;ABCC1;IL17RA;TLR7;TRADD;PTGER4;POLR3G;TNIP1;PLSCR1;S100A9;POLR3D;NFKBIZ;LPL;MDK;IL15
prerank,calcium-ion regulated exocytosis (GO:0017156),-0.2862793452246145,-0.9156213213777284,0.5565749235474006,0.868077161284293,1.0,16/27,38.63%,SYT9;SYT7;ARHGAP17;VAMP7;SYT13;RIMS1;SYT6;RIMS3;SYT15;SYT1;SYT5;DOC2B;SYT17;SYT4;SYT3;SCIN
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.42712852062224516,0.9155276388268158,0.566607460035524,0.9676085601666039,1.0,3/11,15.41%,HMGB1;CBFB;RUNX1
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.2784070615009655,0.915456898231561,0.629086809470124,0.9670953294017451,1.0,16/150,10.46%,GAB1;FGF7;FGFR1;PIK3AP1;EGFR;FGF1;SRC;RAC2;GCNT2;PTPRJ;PIK3R2;FGF18;GAB2;AXL;FERMT2;STRN
prerank,protein insertion into membrane (GO:0051205),0.3414877000304167,0.914597087228765,0.5764192139737991,0.9684041865552554,1.0,12/32,23.20%,EGFR;STX1A;TRAM1;RTP3;EMD;OTOF;UBE2J2;SEC61G;STX5;VAMP2;VAPA;PRNP
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),0.3909979511977552,0.9145219173463622,0.5527156549520766,0.9679023034226958,1.0,2/17,3.00%,SULF1;CASK
prerank,positive regulation of ossification (GO:0045778),0.33240250634654667,0.9142681515590199,0.5799721835883171,0.9678120997355967,1.0,4/39,4.77%,PKDCC;ANO6;BMPR1B;WNT5A
prerank,Notch signaling involved in heart development (GO:0061314),-0.37906344116351,-0.9139819422472351,0.5576923076923077,0.8708497215192325,1.0,3/11,7.21%,NOTCH2;RBPJ;GALNT11
prerank,regulation of cartilage development (GO:0061035),0.38251628396776705,0.9139646058550466,0.546031746031746,0.9678251877825278,1.0,4/18,4.14%,MBOAT2;PTHLH;BMPR1B;SOX9
prerank,activation of protein kinase activity (GO:0032147),0.28611388188497316,0.9138363642128305,0.5957193816884662,0.9674449242981668,1.0,20/106,15.97%,NTRK3;PRR5;FGF1;AXIN1;MINK1;WNT5A;TOM1L1;CARD10;ADCY5;PRKAR2A;STK3;MAPKAP1;ADRA2A;PRLR;ADCY9;PRKACB;TXN;ADCY8;ADCY3;PIBF1
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.4085997052232923,0.9138012680611441,0.5482758620689655,0.9668493030557423,1.0,2/12,6.17%,WDR18;NBN
prerank,bicarbonate transport (GO:0015701),0.3553337348070876,0.9129975162933357,0.5937961595273265,0.9680630306311946,1.0,4/25,7.25%,SLC4A3;SLC26A9;SLC4A4;SLC4A11
prerank,regulation of endopeptidase activity (GO:0052548),0.31090861817953747,0.9129952256936019,0.5834411384217335,0.9673963824360862,1.0,6/59,5.98%,SERPINB2;SERPING1;APH1B;PSME3;SERPINH1;NCSTN
prerank,sensory perception of light stimulus (GO:0050953),0.301264475040097,0.9125828343100337,0.5924574209245742,0.9676585472499009,1.0,8/87,9.51%,RDH10;POU4F3;EFEMP1;SLC24A1;CNGB1;CRYBB3;BEST1;COL1A1
prerank,myoblast differentiation (GO:0045445),-0.3546640384690707,-0.912487192120953,0.6054590570719603,0.8734193446911679,1.0,4/14,9.88%,IGF1;MAPK12;HINFP;EPAS1
prerank,bile acid biosynthetic process (GO:0006699),0.36566314199336947,0.9124334470880086,0.5606060606060606,0.9673333781764354,1.0,4/24,10.43%,CYP7B1;OSBPL6;HSD17B4;ACOT8
prerank,positive regulation of vacuole organization (GO:0044090),0.4260841450960186,0.9123776332541228,0.5539305301645339,0.9667889447187601,1.0,3/10,6.27%,PIP4K2B;LRSAM1;RAB3GAP2
prerank,regulation of receptor recycling (GO:0001919),0.39344355529913616,0.912233452260761,0.5637795275590551,0.9664465327518795,1.0,4/16,9.33%,RAB29;KIF16B;TBC1D16;INPP5F
prerank,regulation of hippo signaling (GO:0035330),0.3799018061799557,0.9117305649092202,0.5739549839228296,0.9669450185040114,1.0,4/17,13.78%,VGLL4;WWC1;NF2;CIT
prerank,cellular response to glucose starvation (GO:0042149),0.33325290179985806,0.9117163213103707,0.5835654596100278,0.9663060591785286,1.0,8/41,8.93%,MYBBP1A;EIF2AK3;FOXO3;PRKAG1;PIK3R4;BRSK1;SESN1;MTMR3
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),-0.3857557982187957,-0.9113387987961528,0.592255125284738,0.8753337566581106,1.0,4/11,19.59%,STMN1;NRP1;MST1R;BCAR1
prerank,RNA catabolic process (GO:0006401),0.31803419908153646,0.9112359429606113,0.574792243767313,0.966738089531913,1.0,15/46,23.42%,RNASEH2B;CNOT10;PABPC4;DXO;DIS3L2;SIDT2;ZFP36L2;ERN1;MTREX;RNASE3;HNRNPD;EXOSC7;LSM2;RNASEH1;RNH1
prerank,positive regulation of cell development (GO:0010720),-0.2777964555221275,-0.911110495752866,0.6080246913580247,0.8749066074354052,1.0,4/31,4.97%,NUMB;TGM2;BMP4;RFX3
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.28815982080812325,0.9110331904917659,0.6163895486935868,0.9665152610764034,1.0,18/112,10.75%,F11R;PXN;DLX1;WNT10A;CDH5;SOX9;SRC;WNT5A;LTBP2;COL3A1;TGFBRAP1;MAPK7;GCNT2;CGN;FERMT2;LEFTY1;FNTA;ZYX
prerank,modification-dependent protein catabolic process (GO:0019941),0.27001505586466057,0.9108843109499788,0.6497844827586207,0.966151429276937,1.0,46/193,18.47%,NEDD4L;UBE2L6;RNF130;WDR81;UBE3C;UBE2I;SPSB4;KEAP1;CHFR;SIAH1;ZNRF3;CUL3;UBL7;AMFR;CDC20;ANAPC5;ANAPC7;NPLOC4;ANAPC11;TRPC4AP;RCHY1;LONP1;NEDD4;TTC3;BUB3;FBXO11;ANAPC2;FBXO21;RNF185;UBA1;FBXO8;UBE2D1;KLHL15;FEM1C;ANAPC4;PSMD13;UBE2R2;FZR1;UBQLN1;ITCH;WDR91;ANAPC16;RNF7;CDC23;PSMD14;PINK1
prerank,covalent chromatin modification (GO:0016569),-0.34467972002087877,-0.9107231493424363,0.6119402985074627,0.8749723208273792,1.0,4/14,12.62%,SETD5;HDAC1;HLCS;PARP2
prerank,positive regulation of intracellular transport (GO:0032388),0.33418040586783265,0.9105540718454918,0.5884057971014492,0.9662110904732178,1.0,15/38,23.09%,RAB29;KIF20B;CEP131;EHD2;RIPOR1;TPR;NEDD4;CEP290;PCM1;TBC1D20;EHD1;VAMP2;TENM1;PGAP1;OAZ2
prerank,negative regulation of DNA recombination at telomere (GO:0048239),-0.31689860276018755,-0.9104804724032907,0.5415617128463476,0.8737334536564896,1.0,9/19,34.45%,POLR2F;POLR2A;POLR2J;POLR2D;POLR2K;ACD;POLR2I;TINF2;POLR2B
prerank,regulation of DNA recombination at telomere (GO:0072695),-0.31689860276018755,-0.9104804724032907,0.5415617128463476,0.8737334536564896,1.0,9/19,34.45%,POLR2F;POLR2A;POLR2J;POLR2D;POLR2K;ACD;POLR2I;TINF2;POLR2B
prerank,modulation by host of viral genome replication (GO:0044827),-0.35307828652881124,-0.9103256792053609,0.5974683544303797,0.8731709735728029,1.0,7/13,29.43%,YTHDC2;ZC3H12A;EIF2AK4;PPIB;FBXL2;CCNK;IFI27
prerank,peptidyl-proline hydroxylation (GO:0019511),0.4143855028606347,0.9103103618370739,0.5611015490533563,0.9660508660770909,1.0,4/11,14.18%,EGLN3;P4HTM;P4HA1;P4HB
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.3746772941449952,-0.9101680559486814,0.5872641509433962,0.8726157354411309,1.0,5/11,26.99%,HIF1A;ATF4;RACK1;NR4A3;FBXO7
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.285639794784331,0.909921318866827,0.6104513064133017,0.9662450347287913,1.0,10/108,8.15%,NGF;DLC1;EIF2AK3;ACVR1C;FIS1;UACA;EGLN3;TRADD;NLRC4;MAP3K5
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.2928610518628199,0.9097129007739767,0.6081582200247219,0.9660207162847597,1.0,11/85,11.15%,TRIB2;PRICKLE1;SOCS5;SH3RF2;KEAP1;DDRGK1;GSK3B;CSNK1A1;USP13;RCHY1;ZYG11B
prerank,regulation of autophagy (GO:0010506),0.2706384256014018,0.9096372697721441,0.6411075612353567,0.9655254407659067,1.0,31/216,11.44%,DCN;PLK2;LEPR;TPCN1;FOXK1;FOXO3;PRKAG1;PTPN22;WDR41;ATP6V0D2;PIP4K2B;WDR24;KEAP1;TRIM21;ABL2;RMC1;MCL1;FOXK2;PIK3R2;IRGM;ATP6V0A1;MTMR3;GSK3B;HMGB1;TICAM1;EIF4E;TFEB;USP13;TAB2;NEDD4;HDAC6
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),-0.36734206824143306,-0.909533125271951,0.5976470588235294,0.8731812907934392,1.0,4/12,14.09%,AP2A1;TMEFF2;AR;EDN1
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.3307346616134361,-0.9091804120908431,0.5843520782396088,0.8731436952537623,1.0,8/15,30.85%,SAMHD1;USP18;ISG15;CACTIN;YTHDF2;YTHDF3;TTLL12;NLRC5
prerank,base conversion or substitution editing (GO:0016553),-0.3731045166912369,-0.9091196170118315,0.5954022988505747,0.8723533626071789,1.0,1/11,3.10%,ADAR
prerank,cellular response to hexose stimulus (GO:0071331),-0.30887459618298085,-0.9090960948531854,0.5977653631284916,0.871478228965224,1.0,2/23,1.55%,IGF1R;KCNB1
prerank,neuron apoptotic process (GO:0051402),-0.3125667392879913,-0.9090845065897577,0.5851063829787234,0.8705629668535794,1.0,5/19,11.13%,TNFRSF21;FAS;NAE1;GAPDH;BID
prerank,mitotic nuclear division (GO:0140014),0.30076216963993935,0.9090613092618517,0.5801242236024845,0.9661197040202114,1.0,19/71,18.44%,KIF2A;SMC3;NUP62;SPAST;TUBG1;DSN1;CHMP4B;INO80;MAP9;NDE1;TUBG2;KLHL22;ZW10;ARHGEF10;RAN;PIBF1;CENPK;RHOA;OFD1
prerank,microtubule nucleation (GO:0007020),0.37510819748038915,0.9089259457571197,0.56957928802589,0.9657740975954464,1.0,11/19,29.98%,TUBG1;TUBGCP5;NDE1;TUBG2;SLAIN2;TUBGCP6;CSNK1D;CLASP2;CCDC57;NDEL1;CLASP1
prerank,negative regulation of phosphatase activity (GO:0010923),0.35750259256123573,0.9087795670849043,0.5601851851851852,0.9654347948451198,1.0,7/25,12.77%,SH3RF2;FKBP1B;BOD1L1;GSK3B;MASTL;SEMA4D;PTPA
prerank,negative regulation of JNK cascade (GO:0046329),0.3490666016345594,0.9087649293941222,0.5845481049562682,0.964798903014508,1.0,12/31,21.87%,SH3RF2;PTPN22;DACT1;NCOR1;MAPK8IP1;MEN1;ITCH;PINK1;HDAC3;AIDA;PRKN;TAOK3
prerank,establishment of protein localization to plasma membrane (GO:0061951),-0.27261539190867273,-0.908640716483341,0.5863192182410424,0.8706829654703341,1.0,12/36,23.25%,AFDN;VAMP5;GORASP2;ANK3;MACF1;BBS2;PREPL;GGA3;SYS1;OPTN;RAB7A;RAB10
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),0.3853546085639716,0.9082811617903377,0.5665584415584416,0.9652588060819829,1.0,5/17,12.71%,PBX1;MAML2;HEYL;WWC1;CREBBP
prerank,chromatin organization (GO:0006325),0.279784240722522,0.908182996820556,0.6296296296296297,0.9648339518848044,1.0,44/132,22.05%,SPI1;SOX9;HDAC4;CDAN1;SATB1;CHD1;SMARCAD1;SUV39H1;GATAD1;SMARCD2;BAZ2B;HDAC2;SUPT4H1;PBRM1;INO80;TOP1;KDM6B;NUCKS1;BAZ2A;TADA2A;KDM4B;BRWD1;HP1BP3;CHD1L;SETD2;MCM3AP;MTF2;SUV39H2;HMGN2;RUVBL2;TCF7L1;HDAC3;HCFC2;RBBP4;NUDT5;HMG20A;CHRAC1;LOXL2;DDX11;SETDB1;RSF1;KDM5B;DAXX;ARID1A
prerank,regulation of cellular component movement (GO:0051270),-0.2507399638586987,-0.9077792473518306,0.6642599277978339,0.8717918019983373,1.0,13/49,13.46%,ETS1;ROCK2;TGFBR3;SP100;LYN;TGFBR1;RPS19;IGBP1;CDK6;DIAPH1;ZSWIM6;YTHDF1;ZSWIM4
prerank,inner ear morphogenesis (GO:0042472),-0.31373324815375947,-0.9074881533138589,0.625,0.8715358322906892,1.0,4/22,6.20%,CHD7;MYO6;FGFR2;TBX1
prerank,arachidonic acid metabolic process (GO:0019369),-0.2701485427247158,-0.9072102520531513,0.6140939597315436,0.8713186445774341,1.0,7/35,10.46%,PTGIS;CYP1B1;GPX4;DAGLA;PTGDS;PTGS1;TBXAS1
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.28532821577131906,0.9050994204471966,0.6120283018867925,0.9710851676598439,1.0,25/114,22.16%,EDA;TNFSF8;FOXO3;PSME3;TRADD;PSMB5;CDIP1;TNFRSF11B;TXNDC17;PSMA6;PSMB2;PSMA2;TNFRSF14;PSMD13;PSMA7;PSME4;PSMD12;PSMD14;PSMB6;PSMC4;ST18;TRAF5;TRAF3;PSMB3;LTBR
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.29865683044372765,0.9048795731921063,0.6127388535031847,0.9709389471721647,1.0,14/78,13.75%,NR2F2;EGFR;CCND3;CDK7;CCNG1;CCNJ;HEXIM1;APC;MEN1;PTEN;CDC6;GTF2H1;PKD1;CDKN1C
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.3914885386227346,0.9043557639424319,0.5658783783783784,0.9714682043025624,1.0,4/16,9.24%,CAMK2D;FKBP1B;ATP1A2;CASQ2
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),-0.22551288190018437,-0.90414201693999,0.6736842105263158,0.877740882169355,1.0,17/76,15.24%,PTGIS;G3BP2;COMMD1;CYP1B1;ERBIN;KLF4;CD200;NFKBIL1;CMKLR1;LRRC14;ZC3H12A;COMMD7;TMSB4X;PARP10;NLRC3;RWDD3;TRIM37
prerank,telomere maintenance in response to DNA damage (GO:0043247),-0.38410969110680837,-0.904079016084263,0.6032110091743119,0.8769583449844753,1.0,4/10,23.70%,DCLRE1B;DCLRE1C;ACD;TFIP11
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.3152119703923435,0.90406484109059,0.584958217270195,0.9714153776810112,1.0,9/43,16.32%,SORBS1;OGT;PIP4K2B;KANK1;SLC27A4;C1QTNF12;NUCKS1;SNX5;SOCS1
prerank,cell chemotaxis (GO:0060326),0.30756089110709056,0.9039768870904221,0.5831234256926953,0.9709516986809765,1.0,3/60,0.80%,PARVA;LPAR1;ACKR3
prerank,actin filament network formation (GO:0051639),0.41274511342893616,0.9039285324040148,0.5709219858156028,0.9703927503910698,1.0,3/11,16.04%,COBL;FHOD1;LCP1
prerank,positive regulation of cell killing (GO:0031343),0.3965202734274804,0.9037696826649131,0.5620689655172414,0.9700899168188227,1.0,6/13,22.54%,WNT5A;NOXO1;FZD7;SYK;MAPK8;RAC1
prerank,regulation of collagen biosynthetic process (GO:0032965),-0.314331106561675,-0.9036495494838095,0.581267217630854,0.8770803188862604,1.0,4/19,8.28%,BMP4;WNT4;LARP6;TGFB3
prerank,reticulophagy (GO:0061709),-0.3596353384572518,-0.9036209536026957,0.5826771653543307,0.876215663836825,1.0,3/12,8.60%,UBA5;ULK2;UFM1
prerank,positive regulation of peptidase activity (GO:0010952),0.3678215336946074,0.9034392091455941,0.5752773375594294,0.9701384457501968,1.0,4/20,8.77%,APH1B;PSME3;NCSTN;DDRGK1
prerank,peptidyl-amino acid modification (GO:0018193),-0.37966809092493997,-0.9034037105640046,0.6014851485148515,0.8757712176821136,1.0,3/10,31.32%,ATP7A;TTLL4;FKBP7
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.2890684236758124,0.9030562838004087,0.6127864897466827,0.9703603366078829,1.0,34/96,25.05%,RBM8A;SRSF4;NUP62;RBM15B;NUP160;UPF2;NUP37;EIF4E;TPR;NUP50;UPF3B;RANBP2;SMG7;NUP153;NUP210;THOC3;NUP93;THOC5;MCM3AP;SLU7;SYMPK;SRSF3;DHX38;SRSF11;NUP43;SMG6;DDX25;YTHDC1;SEC13;CPSF2;WDR33;SARNP;NUP188;NXF1
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),-0.321086517862158,-0.9028906533119608,0.603448275862069,0.8761137135396961,1.0,4/17,16.25%,PARD3;CALM1;CALM3;EIF4G1
prerank,striated muscle cell differentiation (GO:0051146),0.38736445810569775,0.9026578781827493,0.5677966101694916,0.9705678036106243,1.0,5/16,12.91%,AKAP13;PLD3;SDC1;POPDC3;KDM6B
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.3756452032540633,0.9023569417422599,0.595879556259905,0.9706210397355084,1.0,8/20,25.35%,APH1B;NCSTN;ADAM10;MBTPS1;HM13;MBTPS2;ADAM9;RELA
prerank,glycerophospholipid catabolic process (GO:0046475),-0.28614081330771257,-0.9022906896287234,0.5843023255813954,0.876631021915661,1.0,3/27,8.25%,GPCPD1;ENPP2;PNPLA6
prerank,chromatin assembly (GO:0031497),0.3290947908551904,0.9019885117101437,0.5907172995780591,0.9707863811215439,1.0,6/38,7.09%,SOX9;KAT6B;CDAN1;CTCF;PAF1;LIN54
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.34622997514278525,0.9018681559450246,0.5884146341463414,0.9703768977959362,1.0,11/27,25.27%,SPRED1;HIC1;DYRK1A;SPRED2;YJU2;ATR;KMT5A;TWIST1;MDM2;PTTG1IP;SNAI1
prerank,RNA modification (GO:0009451),0.30903142302178677,0.9014030195585975,0.5906735751295337,0.9707815944088798,1.0,18/54,23.45%,MRM2;RBM15B;PUS7;PUS3;WDR4;CDKAL1;FTSJ1;NSUN5;ALKBH1;ANKRD16;URM1;TYW5;ADARB1;TRMT1;THG1L;TFB1M;JMJD6;MEPCE
prerank,phosphate-containing compound metabolic process (GO:0006796),0.2658907705498828,0.901332826706865,0.6633663366336634,0.9702927065873779,1.0,22/198,7.31%,PLCD3;PLCE1;PLCB3;HK2;DUSP12;PFKP;PLPP2;ACP6;PLPP3;TPTE;PIP4K2B;LIMK2;PTPRC;THTPA;PPM1A;CLN8;BCKDK;COQ8A;EPHB2;CERK;PPIP5K2;ALDOB
prerank,positive regulation of secretion (GO:0051047),-0.35797092306252987,-0.9012295300804258,0.597254004576659,0.8782562159493441,1.0,2/11,4.35%,ACSL3;NPR1
prerank,regulation of protein localization to cell surface (GO:2000008),0.3417591721453588,0.9011894654161368,0.5939643347050755,0.9699745294910994,1.0,3/33,2.90%,NEDD4L;LEPROT;RIC3
prerank,epithelial cell development (GO:0002064),0.36461262418619433,0.9011736228417023,0.5835820895522388,0.9693437510232912,1.0,4/20,10.35%,BFSP1;POF1B;TMEM79;LRTOMT
prerank,protein import into mitochondrial matrix (GO:0030150),-0.32377894631907933,-0.9009622805505267,0.59375,0.8779298482088009,1.0,9/18,33.11%,TIMM44;PAM16;TIMM17B;ROMO1;GRPEL1;DNLZ;TIMM50;TIMM21;TIMM23
prerank,transcription preinitiation complex assembly (GO:0070897),0.4032204376442894,0.9009044933682918,0.555,0.9693062714008718,1.0,6/12,29.42%,POLR1E;BDP1;TAF1;TBP;GTF2A2;TAF7
prerank,regulation of centrosome cycle (GO:0046605),0.35661717810035753,0.9008352959650042,0.5714285714285714,0.9688005671244598,1.0,6/21,13.12%,CEP131;CHMP5;PDCD6IP;CHMP4B;CHMP4C;GEN1
prerank,regulation of microtubule-based movement (GO:0060632),0.4151252043699309,0.9005321922378616,0.5776614310645725,0.9688285353971753,1.0,4/11,15.95%,LAMP1;HDAC6;TTC21B;CFAP298
prerank,fatty acid transport (GO:0015908),-0.3220514195096936,-0.9001620888692408,0.6031331592689295,0.8788526863639817,1.0,3/17,6.72%,ACSL1;PPARD;APOE
prerank,positive regulation of histone acetylation (GO:0035066),0.3601380680121133,0.9000725768052249,0.5897435897435898,0.9692514769487967,1.0,1/23,0.60%,PPARGC1A
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),0.3958143086203372,0.9000300876283888,0.5819112627986348,0.9686780728789903,1.0,1/12,1.29%,CEACAM1
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),-0.25147879859523836,-0.899575256936685,0.6456140350877193,0.8792976128076525,1.0,10/45,15.66%,SP100;IRF2;TRIM25;B2M;VCAM1;JAK2;CAMK2A;IRF1;MT2A;GBP2
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),-0.24335408981045636,-0.8995396047047362,0.6518218623481782,0.8784461586244242,1.0,25/54,31.41%,MADD;UBE2K;CFLAR;RNF31;CLIP3;SPHK1;IKBKB;PELI3;LAPTM5;CASP8;RACK1;TRAIP;IKBKG;CASP4;RIPK1;SPPL2B;HSPA1A;SPATA2;PYCARD;BIRC3;HSPA1B;CASP1;TRAF2;ADAM17;RFFL
prerank,positive regulation of stem cell differentiation (GO:2000738),-0.33528721811608697,-0.8993732601343805,0.6136363636363636,0.8779276750409418,1.0,7/16,22.84%,SOX5;HOXB4;SOX6;TGFB2;DHX36;PTN;SP7
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),0.34671840726621894,0.899301338483498,0.5961251862891207,0.9696642661718666,1.0,8/29,13.02%,ELOVL5;ELOVL1;ACACA;SCD5;GCDH;ELOVL2;HACD2;ELOVL6
prerank,regulation of neuronal synaptic plasticity (GO:0048168),-0.28096739851302116,-0.8991227992045864,0.6135593220338983,0.8776127831324457,1.0,6/29,14.85%,SLC4A10;APOE;GRIK2;CAMK2A;DBN1;ZDHHC2
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.35217628002936335,0.8988743361621522,0.5768667642752562,0.9699389120773761,1.0,9/26,20.81%,FKBP1B;ATP1A2;CASQ2;ADRA2A;THADA;UBQLN1;YWHAE;CBARP;CALM2
prerank,regulation of protein localization (GO:0032880),-0.23866239560352764,-0.8988221710527803,0.6622222222222223,0.8774396848390097,1.0,15/58,19.65%,PICALM;AFDN;FKBP1A;TRIM25;TRIM14;WDPCP;VPS4A;CTSD;KDM1A;MMD;STX6;TESK1;RACK1;PARP1;PLEKHM2
prerank,potassium ion transport (GO:0006813),0.28042018347763636,0.8987898158720453,0.6431054461181923,0.9694494413241823,1.0,18/120,14.25%,KCNJ4;NALCN;KCNA5;KCNJ16;SLC24A1;KCNS2;KCNK1;ATP1A2;KCNJ13;KCNK5;ATP1B3;KCNS3;KCNAB1;SLC9A7;SLC9A6;AQP1;KCNK4;KCNK10
prerank,protein O-linked mannosylation (GO:0035269),-0.3175754258177455,-0.8981957550275118,0.6134663341645885,0.8780329712528854,1.0,3/18,4.35%,TMTC2;TMTC1;DPM1
prerank,cytokine-mediated signaling pathway (GO:0019221),0.25509253654202935,0.8981361316793242,0.7560483870967742,0.9702731092227399,1.0,35/532,7.18%,RORA;EDA;TEC;LBP;SERPINB2;TNFSF8;ACKR3;IL19;IL18R1;CEACAM1;CAMK2D;LEPR;PELI2;IL17C;SOCS5;STX1A;ITGAX;SPI1;IL1A;FOXO3;SRC;PSME3;IRAK3;SLC27A1;FN1;IL17RA;FER;TRADD;TRIM21;SOCS6;ABL2;LAMA5;IL21R;SDC1;MCL1
prerank,cytoplasmic microtubule organization (GO:0031122),0.309792987430402,0.8980726754981041,0.589572192513369,0.9697421929694315,1.0,17/54,21.75%,HOOK2;TRPV4;FIGNL2;LIMK2;SPAST;TUBGCP5;HOOK3;PCM1;SLAIN2;CRIPT;EZR;CHP1;RHOA;KATNAL1;TUBGCP6;CLIP4;CCDC88B
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),-0.2982186512319446,-0.8979634573678498,0.5930851063829787,0.877662622074027,1.0,3/23,2.67%,WNT5B;BMP4;GJA1
prerank,determination of heart left/right asymmetry (GO:0061371),-0.25853630411411277,-0.897844317736296,0.6421052631578947,0.8770269063246291,1.0,14/42,22.34%,ENG;TBX3;NPHP3;SOX17;DAND5;ZIC3;VANGL2;MEGF8;MKKS;AHI1;SOX18;BBS5;APLNR;SRF
prerank,Golgi organization (GO:0007030),0.27775569051685445,0.897833970640487,0.625,0.9696095804151809,1.0,28/112,18.27%,ATP8B3;ATP8B1;RAB29;PI4K2B;LMAN2;RAB30;ATL2;GOLGB1;ATP8B2;LYSMD3;CSNK1A1;NPLOC4;TMED4;GCC2;TRIP11;HTT;ZW10;SEC23IP;FBXW8;TMED2;TICAM2;PI4K2A;ATP8B4;TBC1D20;DYNC2H1;ARHGEF7;STX5;COG3
prerank,ubiquinone biosynthetic process (GO:0006744),0.39010112551362475,0.8977422621560935,0.5928449744463373,0.9691596690238339,1.0,4/15,15.72%,COQ7;COQ8A;COQ9;COQ6
prerank,intracellular protein transport (GO:0006886),-0.18513407199302234,-0.8972858747605211,0.8484848484848485,0.8773927238327753,1.0,74/304,20.99%,RANBP3L;TBC1D4;STXBP3;WLS;ARHGEF2;KIF13B;IPO9;TBC1D1;MYO6;APPL2;RABGAP1;RAB6B;COG7;NUP107;C2CD5;TBC1D12;PREB;NAPA;TMED9;AP2A1;TBC1D30;STX8;USP6NL;TBC1D2B;AKAP6;NPM1;HEATR3;NUP133;RANBP6;RASSF9;AKT1;SURF4;SGSM3;GABARAP;COPZ1;EIF2D;SEC16A;EVI5L;AP4E1;COPZ2;STX17;RAB5C;CLIP3;RANBP3;TMED3;SAR1B;TBC1D22B;RAB24;VPS26B;STX12;HERC2;CTSA;NUP88;ARF5;GGA3;TMED1;LAPTM5;STX16;XPO6;SCFD1;STX6;COX18;TECPR2;SYNDIG1;RAB32;TBC1D17;VPS28;MAIP1;KATNB1;SEC31A;CDC37;TMED7;PICK1;E2F3
prerank,cellular response to estrogen stimulus (GO:0071391),-0.33946687515808815,-0.8971872362972185,0.6071428571428571,0.8767211759420009,1.0,4/14,13.77%,SERPINB9;AR;NCOA4;ARID5A
prerank,regulation of translational initiation (GO:0006446),-0.23345786470192764,-0.8971136536109076,0.6715686274509803,0.8759586949507295,1.0,27/63,29.67%,DNAJC3;NPM1;RPS6KB1;GLE1;PAIP2;EIF2AK4;YTHDF1;MTIF2;CEBPB;EIF4G1;NCBP1;HSPB1;KLHL25;YTHDF2;ATF4;CTIF;DDX1;POLR2D;EIF1B;KHDRBS1;EIF3E;YTHDF3;ATF3;RPS6KB2;DDX3X;EIF2B2;EIF5
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),-0.3412848348041677,-0.8970925516321231,0.6130653266331658,0.87510673227451,1.0,2/13,7.75%,SLC4A10;GRIK2
prerank,protein polyubiquitination (GO:0000209),0.259070619078107,0.8970917356987256,0.7050359712230215,0.9699268570410372,1.0,82/297,22.01%,NEDD4L;UBE2L6;ZNRF2;FBXL15;PELI2;UBE2E2;IRF2BP1;UBE3C;LMO7;PSME3;LRSAM1;TMEM129;TNFAIP3;TRIM21;UBR5;CHFR;UBE2V2;FBXO31;SIAH1;CUL3;PSMB5;AMFR;BLMH;LNPEP;ANAPC5;ANAPC7;UBE3D;ANAPC11;SHARPIN;FBXL19;NEDD4;LONRF1;FBXL5;TTC3;FBXL17;FBXO11;FBXO38;ANAPC2;CBFB;FBXO21;ANKRD39;UBE2J2;UBE2D1;UBE2D3;PSMA6;PSMB2;PSMA2;ANAPC4;WWP2;FBXW8;PSMD13;UBE2R2;TRIM5;FZR1;FBXL12;PSMA7;DDB2;FBXO41;FBXW7;ITCH;FBXL3;PSME4;CDC23;PSMD12;PSMD14;PSMB6;PSMC4;HECTD2;UBE2W;DDA1;KBTBD7;RNF14;MKRN1;TRAF5;RNF146;MUL1;PRKN;TRAF3;FBXW11;ZNRF1;AKTIP;PSMB3
prerank,negative regulation of phagocytosis (GO:0050765),-0.32440890017697466,-0.8967525511622468,0.6047120418848168,0.8749889971027168,1.0,3/17,6.52%,DYSF;SIRPA;PIP4P2
prerank,response to light stimulus (GO:0009416),0.3101042591736142,0.8958464335395382,0.5935397039030955,0.9720276654283767,1.0,8/55,12.14%,MSH6;SLC24A1;MAPK10;BRSK1;OPN1MW;OPN1MW3;ERCC6;MEN1
prerank,positive regulation of signaling receptor activity (GO:2000273),-0.26470910400340036,-0.895701829077266,0.6153846153846154,0.876555105570541,1.0,9/36,17.06%,TGFA;SHANK3;HIF1A;HDAC1;JAK2;EDN1;HFE;NRP1;EGF
prerank,positive regulation of protein autophosphorylation (GO:0031954),-0.3008804698670985,-0.8956861543225714,0.6449864498644986,0.8756865529573389,1.0,5/22,14.98%,PDGFD;ACE;CALM1;TAOK2;CALM3
prerank,central nervous system neuron differentiation (GO:0021953),-0.271710815945459,-0.8955696216479142,0.6381578947368421,0.8750511788958834,1.0,9/33,14.26%,ATP7A;SPOCK1;LRP6;NR4A2;PROX1;GBA2;MDGA1;TOX;MAPT
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.3025855835479917,0.8954729467506735,0.6155844155844156,0.9721923730674408,1.0,12/60,20.88%,SMOC2;NEK7;RFC3;NAF1;WRAP53;CCT2;POLG2;RGCC;DSCC1;ATR;CCT3;HGF
prerank,regulation of stem cell differentiation (GO:2000736),0.29123336498126595,0.8953177974065681,0.6149144254278729,0.9718752856820567,1.0,24/89,18.86%,JAG1;KMT2A;LMO1;PSME3;PUS7;SLC4A11;PSMB5;NELFB;CBFB;ZFP36L2;YAP1;PSMA6;PSMB2;PSMA2;RUNX1;PSMD13;PSMA7;ITCH;PSME4;PSMD12;PSMD14;PSMB6;PSMC4;TCF3
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.2816426974737513,0.8951470127019816,0.6420323325635104,0.9716205165608887,1.0,20/117,16.99%,PLK2;MC5R;CD3G;PTHLH;SRC;ADCY5;PTGER4;PRKAR2A;TSHR;KARS1;ADCY9;CD81;PRKACB;GGT1;ADCY8;ADCY3;PTH2R;GPR27;SYK;RXFP1
prerank,positive regulation of lipid localization (GO:1905954),-0.3623052812695687,-0.8947872116149018,0.6073170731707317,0.8759886326676947,1.0,2/11,10.10%,LRP1;ZC3H12A
prerank,protein localization to Golgi apparatus (GO:0034067),-0.2812125132229642,-0.8946511605289276,0.6292834890965732,0.875419237186097,1.0,4/27,7.21%,VPS13D;OBSL1;COG7;VPS13C
prerank,regulation of brown fat cell differentiation (GO:0090335),-0.3301981647605112,-0.8942817122624415,0.5926829268292683,0.8754212964805931,1.0,2/16,4.10%,SOX13;NAPEPLD
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.36990993657777743,0.8940964237979231,0.6025641025641025,0.9733106322749215,1.0,3/18,9.14%,RAP1A;RIMS2;GSK3B
prerank,neuron projection extension (GO:1990138),0.33935214668234265,0.8940141789554922,0.566066066066066,0.9728407993689008,1.0,11/32,22.42%,NRP2;CDKL3;LLPH;SEMA3A;SLC9A6;AUTS2;USP9X;SPG11;NLGN3;IMPACT;IQGAP1
prerank,plasma membrane invagination (GO:0099024),0.3427696015755113,0.8939705694781597,0.5948795180722891,0.9722770505932031,1.0,2/29,2.15%,ARHGAP12;DOCK1
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.3714014830488759,0.8936246078820116,0.5822368421052632,0.9724138463251283,1.0,3/17,7.23%,STX1A;CACNA1H;RAB3A
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.37403825012217,0.8931122748737622,0.5789473684210527,0.9728922528078087,1.0,4/20,10.76%,PFAS;ATIC;PPAT;NT5C2
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.337537422854389,0.8926447858829923,0.6011904761904762,0.9732574235164345,1.0,7/30,13.54%,KLK2;HEYL;NCOR1;PIAS2;NCOR2;HDAC6;NCOA2
prerank,ventricular cardiac muscle cell action potential (GO:0086005),0.38072167763265263,0.8922511071147932,0.5887096774193549,0.9734586673277194,1.0,1/17,0.83%,NEDD4L
prerank,purine ribonucleotide metabolic process (GO:0009150),-0.2272968967325113,-0.8920239339768518,0.7027027027027027,0.8796971830554492,1.0,17/68,20.66%,ENPP1;GPAT4;HPRT1;ACOT7;BPNT2;DBI;ACSL6;TPST1;MLYCD;ACLY;LRRK2;ACOT6;OPA1;ACOT11;HINT1;OXSM;SULT4A1
prerank,fatty acid biosynthetic process (GO:0006633),0.30323614703394736,0.8918394696120893,0.6098535286284953,0.973718064955527,1.0,14/63,17.61%,ELOVL5;DECR2;ELOVL1;HACD4;ACACA;SCD5;ELOVL2;HACD2;LTA4H;ABCD1;ELOVL6;LPL;HPGD;SCD
prerank,microvillus assembly (GO:0030033),0.3965681556024623,0.8917746867975401,0.5759075907590759,0.9732162517676336,1.0,3/14,8.91%,RAP1A;MINK1;RAPGEF6
prerank,water-soluble vitamin metabolic process (GO:0006767),0.3022007114647551,0.8916580705164034,0.6403940886699507,0.9728023096174786,1.0,16/68,15.09%,CTRC;FOLR2;PCCB;ACP5;THTPA;ABCC1;MTHFD1;SLC52A1;MMAB;CD320;CUBN;TPK1;AMN;SLC25A19;PANK2;SLC46A1
prerank,regulation of acute inflammatory response (GO:0002673),-0.31843077898556077,-0.8914780434842452,0.5849056603773585,0.8800973637704578,1.0,1/18,1.30%,OSMR
prerank,neuron projection development (GO:0031175),0.26774854001131426,0.8914729212641085,0.6677740863787376,0.9725487882916516,1.0,25/168,12.97%,NGF;EPB41L3;MINK1;KIF20B;GAS7;OPHN1;NBL1;DIP2A;CNTNAP1;TRIO;EPHB2;GSK3B;GPM6A;HMGB1;POU4F1;LRP12;DOCK7;ERCC6;NEDD4;PLXNB1;SLC9A6;MAP4;SGK1;PTEN;CTTN
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),-0.27549271886296917,-0.891302684143264,0.6291793313069909,0.8796081244523539,1.0,4/29,7.53%,IL31RA;GHR;IFNAR2;JAK2
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.3526628093039149,0.891288249904189,0.5771065182829889,0.9723018693386418,1.0,5/24,15.05%,PLCE1;RAC2;OCLN;AKIRIN1;AUTS2
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.3965330937656533,0.8912657889700596,0.6024518388791593,0.9717134235249951,1.0,3/13,13.03%,SPRED1;HIC1;SPRED2
prerank,defense response to symbiont (GO:0140546),-0.2165930037434568,-0.8911011666801215,0.7297297297297297,0.8791706824227801,1.0,23/92,20.51%,SERINC3;IFNAR2;ABCC9;SAMHD1;IRF2;IFIT2;AGBL5;IFIT3;BST2;FLNA;NDUFAF4;IRF1;ABCE1;MOV10;IFIT1;ISG15;RSAD2;PDE12;CD40;OPRK1;CGAS;TLR3;BNIP3L
prerank,protein localization to synapse (GO:0035418),-0.35996605626263695,-0.890861826874042,0.6102941176470589,0.878787184269832,1.0,3/12,14.48%,BSN;NRXN1;NRXN2
prerank,renal filtration (GO:0097205),0.4211941468402892,0.8907934124302941,0.5868055555555556,0.9720830684016639,1.0,2/10,10.86%,SULF1;XPNPEP3
prerank,regulation of ATP metabolic process (GO:1903578),0.3060963044706517,0.8907560512146322,0.6256613756613757,0.9715193092579657,1.0,14/54,13.11%,OGT;BEND3;PRKAG1;FIS1;NUP62;NUP160;NUP37;TPR;NUP50;RANBP2;NUP153;NUP210;ABCD1;GCK
prerank,plasma membrane organization (GO:0007009),0.3022926092671583,0.8905115601809971,0.6408268733850129,0.9714230700714054,1.0,21/61,20.57%,EPB41L3;AHNAK2;ANO6;A4GALT;PACSIN2;EHD2;RAB3A;PLSCR1;CHMP4A;STX2;ARL8B;ABCD1;OTOF;OSBPL2;STX4;SPTBN1;CAVIN2;PACSIN3;NSF;FA2H;PACSIN1
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.41947187606320463,0.890215286972219,0.6017391304347826,0.9713950233119389,1.0,2/10,7.48%,EMC9;EMC7
prerank,regulation of mitochondrion organization (GO:0010821),0.30964534521179293,0.8899918599706496,0.6068027210884354,0.9712409586630686,1.0,16/47,21.53%,PPARGC1A;PISD;FIS1;GSK3B;SIRT7;HDAC6;STAT2;HTRA2;PRMT6;FBXW7;CSNK2A2;PINK1;MUL1;PRKN;GOLPH3;IAPP
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.27349723724195063,0.8897274070531145,0.6707589285714286,0.9712005971139241,1.0,37/145,19.40%,DYNLL1;PSME3;SFI1;CEP131;CEP78;NEDD1;TUBG1;CKAP5;FBXO5;CCP110;PAFAH1B1;PSMB5;MECP2;USP47;CEP290;SSNA1;NDE1;CETN2;PCM1;FHL1;PSMA6;PSMB2;PSMA2;PSMD13;YWHAG;PSMA7;YWHAE;CEP57;PSME4;PSMD12;PSMD14;OFD1;ALMS1;PSMB6;PSMC4;CEP250;DCTN2
prerank,positive regulation of muscle hypertrophy (GO:0014742),-0.33208419817166573,-0.8894830652540087,0.6028708133971292,0.8809710450452343,1.0,7/15,19.52%,IGF1;ROCK2;MEF2A;SLC9A1;EDN1;AGT;PARP1
prerank,cellular response to hypoxia (GO:0071456),0.27687615380358455,0.8892966700365088,0.651685393258427,0.9714781257449566,1.0,28/126,18.81%,RORA;PSME3;EGLN3;SUV39H1;PSMB5;HILPDA;CREBBP;AQP1;P4HB;PSMA6;PSMB2;PSMA2;BAD;PSMD13;PSMA7;UBQLN1;BACH1;PGK1;RGCC;HP1BP3;BNIP3;PSME4;SUV39H2;PSMD12;PSMD14;PINK1;PSMB6;PSMC4
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.3419465731993005,0.8892815072840351,0.5883256528417818,0.9708671782925982,1.0,9/27,23.41%,CSTF3;POP7;ERN1;DICER1;TOE1;RNASE1;PCF11;RPP30;RNASEH1
prerank,rRNA modification (GO:0000154),0.3641819371984092,0.8889570993863679,0.5828125,0.9709111657308377,1.0,4/21,10.53%,MRM2;BUD23;TFB2M;METTL5
prerank,prostaglandin metabolic process (GO:0006693),-0.28716415582346466,-0.8886599020245932,0.5885885885885885,0.8819881377455449,1.0,8/26,20.54%,PTGIS;PTGDS;PTGS1;TBXAS1;EDN1;HPGDS;MIF;ACOX1
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),-0.3018486285149772,-0.8882812127516374,0.6318681318681318,0.8819374656706092,1.0,4/20,4.84%,SEMA6D;SEMA7A;SEMA3C;SEMA6A
prerank,amino acid transmembrane transport (GO:0003333),0.3110002335460518,0.8881160011364998,0.6115702479338843,0.9720945538821347,1.0,6/45,6.95%,LRRC8D;SLC25A12;SFXN2;SLC38A2;SLC6A13;SLC1A6
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.29244185583112015,0.8876281651096217,0.6207759699624531,0.9725236655671999,1.0,8/69,9.55%,LBP;IL1A;WNT5A;PTPRC;EPHB2;PTPRJ;ISL1;HMGB1
prerank,aerobic electron transport chain (GO:0019646),0.296687955219142,0.8872697504927246,0.6364764267990074,0.972625483821544,1.0,14/68,14.91%,COX5A;NDUFA6;NDUFB10;NDUFS3;COX15;NDUFS6;SDHD;SDHAF2;COX7C;NDUFA3;NDUFV2;COX5B;NDUFV1;NDUFA7
prerank,cellular response to glucagon stimulus (GO:0071377),-0.3148046777119716,-0.8870602610701585,0.6236559139784946,0.8837898372389723,1.0,6/17,15.98%,ADCY1;ADCY7;ADCY4;ADCY2;PRKAR2B;CYSLTR2
prerank,ribosomal small subunit assembly (GO:0000028),0.3832670958362331,0.8866912285589704,0.6065573770491803,0.9731939690084312,1.0,1/16,0.68%,RPSA
prerank,nucleocytoplasmic transport (GO:0006913),0.3179827988687278,0.886670318227094,0.613941018766756,0.9725880272157763,1.0,4/40,7.06%,RGS14;SNRPF;RBM15B;SMN1
prerank,positive regulation of cellular process (GO:0048522),0.25157986980197167,0.8866385501929448,0.7889447236180904,0.9720250379105088,1.0,90/565,14.75%,CAV1;FGF7;NTRK3;PRODH;GLI1;LBP;FGFR1;DLX1;PTGFR;EGFR;FOLR2;FGF1;SMC5;ACER3;FXR2;KIF20B;ITGAX;FKBP1B;LMAN2;PTHLH;CELF1;PRKCA;CIDEB;SAPCD2;BMPR1B;SOX9;BMP5;HDAC4;IBSP;WNT5A;FN1;DOCK2;CDK13;RPRD1B;FER;CEP131;TRIM21;ADAM10;KRAS;TBX2;EFNB2;ACACA;HOXC10;CSPP1;FBXO5;RARA;CUL3;GCNT2;PTPRJ;DPP4;S100B;ISL1;FGF18;DDRGK1;TSHR;NCMAP;GAB2;RPS6KA3;TET1;MECP2;USP47;HDAC2;CNOT7;HILPDA;ADRA2A;AXIN2;TBC1D8;S100A9;SRPK2;IL6ST;APC;PRLR;INO80;FAF1;NOXO1;IL7;PTEN;CDC6;CD81;SOX4;KLHL22;PTPN6;FZD7;HBEGF;P4HB;DICER1;FXR1;CCKBR;IL2RG;ERBB4
prerank,cellular response to purine-containing compound (GO:0071415),-0.37305195892931153,-0.8865844810885621,0.6013215859030837,0.8839668766700761,1.0,5/10,30.20%,SLC8A1;TRPM2;P2RY6;P2RY1;RYR2
prerank,autophagosome assembly (GO:0000045),-0.2398961410835166,-0.8865102717457259,0.7357723577235772,0.8832301297081877,1.0,17/52,24.97%,ATG16L2;BECN1;GABARAPL1;VMP1;ULK2;WIPI1;GABARAP;STX17;AMBRA1;STX12;ATG13;MAP1LC3A;WIPI2;ATG12;RAB7A;WDR45B;WDR45
prerank,regulation of potassium ion transport (GO:0043266),0.3348859281992636,0.8864519391157021,0.5954738330975955,0.9718066234739027,1.0,7/31,13.87%,KCNA5;KCNIP4;CASQ2;KCNAB1;ADRA2A;KIF5B;FHL1
prerank,ncRNA 3'-end processing (GO:0043628),-0.34042542394358666,-0.8863781543220457,0.6286407766990292,0.8826517388754579,1.0,2/14,5.85%,SSB;TRNT1
prerank,regulation of neurotransmitter receptor activity (GO:0099601),-0.24148761273189362,-0.8861241805665315,0.6792452830188679,0.8823353004372955,1.0,8/57,10.51%,DAPK1;ACTN2;GRIA2;NEFL;GRIN2B;CAMK2A;GRIN1;CACNG7
prerank,regulation of viral entry into host cell (GO:0046596),-0.2776842970172376,-0.8861190760484616,0.6503267973856209,0.8814459326041922,1.0,12/30,33.36%,LY6E;MID2;TRIM25;TRIM14;LGALS9;TRIM11;TRIM6;TRIM27;CIITA;LGALS1;IFITM2;TRIM62
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),0.3974781528615914,0.8857250697602567,0.6,0.9727505743798232,1.0,1/14,0.41%,CORIN
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",0.3831122743390213,0.8856452272756261,0.5915032679738562,0.9722999547987363,1.0,4/17,14.80%,CTCF;BUB3;ZWILCH;ZW10
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",-0.285095120842485,-0.8852930225206727,0.6486486486486487,0.882481658708194,1.0,5/25,12.09%,GRIN2B;AKT1;GRIN1;GSK3A;LRRK2
prerank,positive regulation of cell cycle (GO:0045787),0.2989651128798984,0.8852198455526931,0.625,0.9725844696374115,1.0,8/62,10.97%,SMOC2;EGFR;CCND3;PRKCA;TRIM21;RARA;EIF4E;SRPK2
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.3860388678851256,0.8849234708742141,0.5980707395498392,0.9725732566756945,1.0,1/16,0.81%,ST3GAL4
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.4136451146651706,0.8838134317969365,0.5775862068965517,0.9743490799061238,1.0,5/10,20.66%,LEO1;PAF1;CPEB3;CDC73;NUDT21
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.329683820325864,0.8836777714057803,0.5955882352941176,0.9740016475143546,1.0,4/36,4.77%,NFATC1;PLCB3;FZD2;WNT5A
prerank,regulation of interleukin-1 production (GO:0032652),0.388771084730343,0.8835726233605362,0.583756345177665,0.9736090352874418,1.0,2/15,9.55%,CEACAM1;HMGB1
prerank,regulation of T cell cytokine production (GO:0002724),-0.3235983701185955,-0.8835138154059887,0.6223277909738717,0.8857399174232456,1.0,3/15,6.81%,B2M;TNFRSF1B;TRAF6
prerank,ameboidal-type cell migration (GO:0001667),0.30799871751786184,0.8834451720845932,0.6062992125984252,0.973251448312602,1.0,6/51,7.49%,GPC3;AMOTL1;SEMA4B;AMOT;SEMA3A;ITGB7
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.35860155563493445,0.8832981439957732,0.608346709470305,0.9729318973004728,1.0,3/20,4.79%,CEACAM1;BMP5;SLC27A1
prerank,positive regulation of interleukin-6 production (GO:0032755),0.29387904389317365,0.8832211496269448,0.6371681415929203,0.9724533556397049,1.0,7/68,9.55%,LBP;IL1A;WNT5A;IL17RA;TLR7;ISL1;HMGB1
prerank,regulation of fibroblast proliferation (GO:0048145),-0.2514841492432572,-0.8831425003260186,0.6718146718146718,0.8856266663583118,1.0,11/45,14.60%,IGF1;PDGFRA;FTH1;MED25;CDK6;BMI1;B4GALT7;SPHK1;CDK4;PARP10;NLRC3
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.29625712355359424,0.8830604517660017,0.6411609498680739,0.9721648813458637,1.0,8/65,5.87%,CDH13;CEACAM1;EGFR;ARAP1;SPRY1;NUP62;TSG101;FER
prerank,granulocyte chemotaxis (GO:0071621),0.305796197005643,0.8828281246846409,0.6211180124223602,0.9720089379450372,1.0,1/55,0.29%,CXADR
prerank,ceramide biosynthetic process (GO:0046513),0.32136737639647217,0.8824735257516576,0.6263888888888889,0.9721333057015628,1.0,4/40,5.80%,SGMS2;CERS6;ALOXE3;CLN8
prerank,RNA destabilization (GO:0050779),0.3707242930098775,0.8824688150210915,0.6156405990016639,0.9715067466872112,1.0,4/18,8.97%,GIGYF2;CELF1;DXO;LIN28B
prerank,membrane protein proteolysis (GO:0033619),0.32621676704669744,0.8823173935749643,0.620253164556962,0.9712177994951333,1.0,6/37,9.65%,ADAM19;APH1B;NCSTN;ADAM10;DAG1;BACE2
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.41430413141522193,0.882228530353221,0.627147766323024,0.9707704424847687,1.0,2/11,9.67%,EXOSC5;EXOSC10
prerank,replicative senescence (GO:0090399),0.40157454060931447,0.8813779161406501,0.6017391304347826,0.9720514078830058,1.0,3/12,19.81%,WNT16;MME;ATR
prerank,protein N-linked glycosylation via asparagine (GO:0018279),-0.2797359937693436,-0.8809518779853425,0.5899705014749262,0.8895123740165888,1.0,8/30,17.31%,DPM1;ALG5;STT3B;UBE2J1;RPN2;FUT8;OST4;ASGR1
prerank,regulation of cellular response to stress (GO:0080135),0.27525285078180345,0.8809459360249025,0.6732558139534883,0.97230208510076,1.0,39/115,23.21%,CAMK2D;HSPH1;SLC38A2;NPAS2;NUP62;MCL1;BAG3;AMFR;NUP160;GSK3B;NUP37;TPR;NUP50;RANBP2;NUP153;NUP210;CREBBP;ABCD1;ARMT1;NEK4;AIFM2;NUP93;ADCY8;DNAJC7;CHORDC1;YWHAE;CAMK2G;BAG2;PINK1;RPTOR;ATR;CCAR2;PRKN;RPA3;NEK6;NUP43;SEC13;MAPK1;MBTPS2
prerank,base-excision repair (GO:0006284),0.304508816870971,0.8808143585318586,0.6092896174863388,0.9719485128658657,1.0,11/48,17.68%,TDG;NTHL1;RFC3;USP47;APEX2;ERCC6;ADPRS;POLB;PRMT6;POLE;RFC1
prerank,neurotransmitter secretion (GO:0007269),-0.24820282013882156,-0.8807807021175968,0.6862745098039216,0.8889806021973284,1.0,20/44,29.53%,STXBP3;LIN7A;HSPA8;SYN1;NRXN1;GAD1;SYN3;NRXN2;DNAJC5;CPLX2;UNC13A;RIMS1;SYN2;SNAP25;SLC32A1;PIP5K1C;PTPRN2;PPFIA3;GRM4;SYT1
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),-0.2780715216733942,-0.8805988752125076,0.6369230769230769,0.8884998749422923,1.0,10/28,23.14%,LACC1;UBE2N;TRAF6;NOD1;AAMP;CASP8;IRAK2;MAP2K6;IKBKG;NOD2
prerank,relaxation of cardiac muscle (GO:0055119),0.3902935825178992,0.880589081476193,0.59375,0.971816755730279,1.0,2/13,5.41%,CAMK2D;ATP1A2
prerank,positive regulation of interleukin-13 production (GO:0032736),-0.3719131074565625,-0.8805536448937937,0.6152073732718893,0.887711538436791,1.0,3/10,15.93%,IL18;PRKCZ;LGALS9
prerank,regulation of type I interferon production (GO:0032479),0.28511521729192696,0.8804734573555727,0.6575682382133995,0.971419958726364,1.0,26/84,23.77%,UBE2L6;PCBP2;PTPN22;TNFAIP3;TRIM21;POLR3G;DTX4;ACOD1;NPLOC4;NLRP4;TAX1BP1;POLR3D;CREBBP;TBK1;CRCP;ITCH;G3BP1;MRE11;XRCC6;DHX9;PIN1;TRAF3;DHX58;IFIH1;POLR3K;POLR3C
prerank,regulation of cholesterol biosynthetic process (GO:0045540),-0.3118489237082749,-0.8803343627197923,0.6380208333333334,0.8872670645650963,1.0,6/17,15.38%,ERLIN1;APOE;SCAP;ABCA2;ERLIN2;ABCG1
prerank,regulation of mitotic spindle assembly (GO:1901673),0.36557827389086456,0.8802501127159117,0.6009104704097117,0.971285661477607,1.0,5/19,12.19%,CHMP5;PDCD6IP;CHMP4B;TPR;CHMP4C
prerank,regulation of mesenchymal cell proliferation (GO:0010464),0.40461149574062594,0.8799157646949795,0.6116504854368932,0.9713443908209226,1.0,3/11,13.26%,SOX9;WNT5A;CTNNBIP1
prerank,positive regulation of interleukin-1 production (GO:0032732),0.30514672523226943,0.8798609364821157,0.619550858652576,0.9708340091865182,1.0,8/51,16.05%,USP50;WNT5A;NLRC4;ISL1;HMGB1;EGR1;GSDMD;LPL
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.3932165117234546,0.8797930438693773,0.6023489932885906,0.9703389158999961,1.0,1/13,0.89%,NAPRT
prerank,positive regulation of protein import into nucleus (GO:0042307),-0.277206443081284,-0.8797472452663556,0.6428571428571429,0.8877337771968421,1.0,7/28,14.95%,SMAD3;PIK3R1;FLNA;ZC3H12A;TRIM28;ZIC1;ZPR1
prerank,regulation of lymphocyte activation (GO:0051249),0.3974407746864491,0.8791869967012237,0.6314878892733564,0.9710328355817406,1.0,2/12,10.34%,CRTAM;LAT
prerank,sensory perception of chemical stimulus (GO:0007606),-0.3212986000635134,-0.8791746764355537,0.6349614395886889,0.8880920982215491,1.0,1/15,1.09%,GNAS
prerank,cellular response to calcium ion (GO:0071277),0.2950899704046114,0.8790991446399802,0.6475,0.9705906030990549,1.0,5/67,4.77%,GUCA1A;CAMK2D;GPLD1;ADD1;WNT5A
prerank,regulation of sister chromatid cohesion (GO:0007063),0.40752438197714,0.878891277658171,0.6243739565943238,0.9703837543549654,1.0,2/12,10.63%,CTCF;AXIN2
prerank,development of primary male sexual characteristics (GO:0046546),0.32566474684078583,0.8788642587275758,0.5816618911174785,0.9698172775298588,1.0,8/34,15.85%,WNT2B;SOX9;WNT5A;LHFPL2;MSH2;CSDE1;NR5A1;KITLG
prerank,NAD biosynthetic process (GO:0009435),0.369343507325462,0.8785364154732841,0.6068642745709828,0.9698985599436962,1.0,4/20,12.69%,NAPRT;NADSYN1;NMNAT3;NAXD
prerank,purine ribonucleotide biosynthetic process (GO:0009152),-0.24347414779133272,-0.8784445200816046,0.6666666666666666,0.8888248311532511,1.0,13/48,15.25%,ADCY1;ADCY7;NPR1;ACOT7;PAPSS1;SLC26A2;ADCY4;ADCY2;PANK1;SLC35B3;PPCDC;IMPDH1;NUDT2
prerank,folic acid metabolic process (GO:0046655),0.3631994474886618,0.8783700904639152,0.5824508320726173,0.9696373065360716,1.0,6/18,17.67%,FOLR2;MTHFD1;SLC46A1;ALDH1L2;PM20D2;SLC19A1
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),-0.28237926636693167,-0.8779952927891393,0.6149425287356322,0.8889239708767397,1.0,2/25,4.62%,PICALM;ANKRD13A
prerank,negative regulation of cell growth (GO:0030308),-0.20831624086590173,-0.8779753772259055,0.7925925925925926,0.8880711753255921,1.0,30/121,17.86%,SMAD3;ENPP1;SLIT2;SMARCA2;GJA1;ACVRL1;BMPR2;CCN3;NPR1;DNAJB2;APBB2;SOX17;JADE1;RNF6;BST2;ULK2;GSK3A;DCC;TGFB2;TCHP;CDKN2AIP;SERTAD3;CCDC85B;CGRRF1;BTG1;MAG;SEMA3G;SMAD4;WNT11;RERG
prerank,regulation of myeloid cell differentiation (GO:0045637),-0.2342827166454396,-0.8776861839359164,0.7186147186147186,0.8877946159412523,1.0,16/62,17.35%,LYN;EP300;HOXA5;MEIS1;SETD1A;HDAC1;MYL9;CDK6;AGO3;HOXB8;HOXA9;THBS1;AGO4;MOV10;TNRC6C;KAT2B
prerank,"base-excision repair, gap-filling (GO:0006287)",0.3211744476922569,0.8775637785580589,0.6238938053097345,0.9707913453790832,1.0,7/35,17.68%,TDG;NTHL1;RFC3;ADPRS;POLB;POLE;RFC1
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.4089780085846447,0.8774800407448863,0.5985915492957746,0.9703370293411522,1.0,1/11,2.28%,SOCS5
prerank,C21-steroid hormone metabolic process (GO:0008207),-0.2986433240076057,-0.8774781362388154,0.6311475409836066,0.8873903171989045,1.0,6/20,27.05%,AKR1B1;FDXR;TSPO;STARD3NL;HSD17B10;TSPOAP1
prerank,heart contraction (GO:0060047),0.3205903244235804,0.8774554441675296,0.6074766355140186,0.9697602845141219,1.0,7/41,12.05%,SGCD;SGCG;CSRP3;ATP1A2;CASQ2;SCN2B;TNNI1
prerank,growth hormone receptor signaling pathway (GO:0060396),-0.3306165074256594,-0.8771523001611048,0.6318407960199005,0.8872409113351213,1.0,4/14,7.53%,GHR;LYN;PIK3R1;JAK2
prerank,negative regulation of cell cycle (GO:0045786),-0.2285978009738011,-0.8769206215142867,0.7419354838709677,0.8868447150635825,1.0,13/73,11.91%,SMAD3;PTPN3;LATS2;NUPR1;BMP4;PTPRK;GAS1;BRINP3;CDK6;RHOB;TRIM35;BMP2;CAMK2N1
prerank,mRNA transport (GO:0051028),0.27871863498392374,0.8767959712194272,0.6591448931116389,0.9704917422752328,1.0,35/101,25.05%,RBM8A;SRSF4;NUP62;RBM15B;NUP160;UPF2;NUP37;EIF4E;TPR;NUP50;UPF3B;RANBP2;SMG7;NUP153;NUP210;THOC3;NUP93;THOC5;MCM3AP;SLU7;SYMPK;SRSF3;DHX38;SRSF11;NUP43;SMG6;DDX25;YTHDC1;SEC13;CPSF2;WDR33;SARNP;FMR1;NUP188;NXF1
prerank,positive regulation of cytokine production (GO:0001819),0.2528996253594033,0.8767288883855787,0.7510416666666667,0.970012470533472,1.0,45/292,17.41%,RORA;LBP;IL18R1;SULF1;GLMN;ITK;CXCL17;PDE4D;TXK;IL1A;EIF2AK3;PTPN22;WNT5A;PTPRC;IL17RA;TLR7;PTGER4;CRTAM;RARA;POLR3G;ISL1;HMGB1;TICAM1;HILPDA;ADRA2A;CD276;IL6ST;EGR1;POLR3D;IL7;CREBBP;CLEC9A;BATF;TNFRSF14;RUNX1;PIBF1;LPL;TBK1;MDK;CRCP;IL15;RGCC;SYK;SCRIB;SPTBN1
prerank,positive regulation of protein localization to cell surface (GO:2000010),0.39285514780446384,0.8766784726270319,0.5770491803278689,0.9694854293019559,1.0,3/13,18.01%,RIC3;STX4;TM9SF4
prerank,positive regulation of cellular amide metabolic process (GO:0034250),-0.21951903844469373,-0.8766498769319292,0.7360406091370558,0.8865738544101658,1.0,25/80,22.43%,PICALM;ROCK2;EPHA4;LARP6;EIF3C;PRR16;RPL26;NPM1;RPS6KB1;CASP3;ZCCHC4;YTHDF1;GSK3A;SP1;THBS1;ABCA2;VIM;ABCG1;SMPD3;RACK1;CLU;RPL5;RPS27L;EIF3E;EEF2
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.2999351197103292,0.8762142584084286,0.6271637816245007,0.9698391014235942,1.0,10/57,15.75%,LPAR1;AKAP12;ADCY5;GNAL;ADRA2A;ADCY9;CHRM2;CHRM3;ADCY8;ADCY3
prerank,positive regulation of bone mineralization (GO:0030501),0.3239941700831905,0.8758369713381198,0.6211699164345403,0.9699815123504107,1.0,3/35,4.13%,PKDCC;ANO6;BMPR1B
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.27603930011383965,0.875587638814329,0.6685845799769851,0.9698943550438297,1.0,19/116,16.99%,PLK2;MC5R;CD3G;PTHLH;SRC;ADCY5;SELENOS;PTGER4;PRKAR2A;TSHR;ADCY9;PRKACB;GGT1;ADCY8;ADCY3;PTH2R;GPR27;SYK;RXFP1
prerank,calcium ion import (GO:0070509),-0.2780201761120543,-0.8751768611800314,0.6578947368421053,0.888882703174557,1.0,7/28,13.34%,SLC8A1;CACNB2;CACNA1G;SMDT1;SLC25A23;MICU1;MICU2
prerank,relaxation of muscle (GO:0090075),0.3884111870699454,0.8748392910077074,0.5921052631578947,0.9708774931268729,1.0,2/13,5.41%,CAMK2D;ATP1A2
prerank,regulation of calcium-mediated signaling (GO:0050848),0.3477726191891423,0.8747478980056991,0.6376146788990825,0.9704607047074782,1.0,4/25,13.89%,CDH13;PLEK;TMBIM4;HTT
prerank,translesion synthesis (GO:0019985),0.3088714521272153,0.8745652767587547,0.6094839609483961,0.97023483575132,1.0,6/42,10.98%,UBE2L6;USP43;POLI;RFC3;NPLOC4;RCHY1
prerank,mitochondrion morphogenesis (GO:0070584),-0.35425101847275187,-0.8738811300265553,0.6291079812206573,0.8908857249253499,1.0,2/11,12.75%,PID1;SLIRP
prerank,mRNA export from nucleus (GO:0006406),0.27767302575554376,0.8736921343561553,0.6743063932448733,0.9714229954073272,1.0,36/102,25.21%,RBM8A;SRSF4;NUP62;RBM15B;NUP160;UPF2;NUP37;EIF4E;TPR;NUP50;UPF3B;RANBP2;SMG7;NUP153;NUP210;THOC3;NUP93;THOC5;MCM3AP;SLU7;SYMPK;SRSF3;DHX38;SRSF11;NUP43;SMG6;DDX25;YTHDC1;SEC13;CPSF2;IWS1;WDR33;SARNP;NUP188;NXF1;PABPN1
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),0.37484234869802835,0.8736876405672613,0.6188118811881188,0.9708171154757497,1.0,2/16,6.85%,RBFOX2;DDX17
prerank,multivesicular body assembly (GO:0036258),0.3385935036326667,0.8736802680418019,0.6308139534883721,0.9702077994954275,1.0,7/30,12.19%,TSG101;CHMP5;PDCD6IP;IST1;CHMP4B;CHMP4A;CHMP4C
prerank,acetylcholine receptor signaling pathway (GO:0095500),-0.2950168566562688,-0.8735002966768035,0.6744186046511628,0.8908331392053989,1.0,2/20,6.70%,PLCB1;AGRN
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),-0.36225532715775466,-0.8732203444418614,0.6244239631336406,0.8905392694082862,1.0,6/10,40.43%,CALM1;CALM3;GPR35;CRHR1;GNB5;DRD3
prerank,cellular macromolecule catabolic process (GO:0044265),0.3021822708640477,0.8730525110535199,0.6352288488210819,0.9709135425472718,1.0,16/49,26.10%,RNASEH2B;PABPC4;SIDT2;DFFB;MANBA;HTRA2;OGA;MTREX;RNASE3;HNRNPD;PRKN;EXOSC7;RNASEH1;DNASE1L1;PNPT1;UBE2G1
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.28895946296352476,0.8730369867583122,0.6445012787723785,0.9703247605764492,1.0,14/66,15.86%,GTSE1;EIF2AK3;LIMK2;CARD10;UBR5;BAG3;RBM22;PIK3R2;FERMT2;TPR;CCT2;YAP1;RAN;CDH1
prerank,histone H4 deacetylation (GO:0070933),0.4147693438735749,0.8728798235178654,0.6109154929577465,0.970027819037542,1.0,6/10,24.31%,HDAC4;SMARCAD1;HDAC2;HDAC3;SIRT2;REST
prerank,protein O-linked glycosylation (GO:0006493),0.2752161598116903,0.8727335128685763,0.6602870813397129,0.9697324551359939,1.0,12/96,10.16%,ST3GAL4;GALNTL6;OGT;C1GALT1C1;GCNT4;B4GAT1;FKRP;B3GLCT;ST6GAL1;POFUT1;TET1;GALNT18
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),-0.3612208885523349,-0.872612404070746,0.6363636363636364,0.8908443903153576,1.0,3/10,7.83%,CSGALNACT1;CSGALNACT2;PXYLP1
prerank,regulation of cholesterol storage (GO:0010885),-0.31942108113041295,-0.8725766625409029,0.6464379947229552,0.8900235476215972,1.0,4/15,15.38%,PPARD;NR1H3;NR1H2;ABCG1
prerank,snRNA 3'-end processing (GO:0034472),0.3584664408297311,0.8723811337943713,0.5909090909090909,0.9698276912437668,1.0,5/19,21.51%,EXOSC5;TUT1;INTS6L;TOE1;EXOSC7
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.3597964215904493,0.8717985638305209,0.6318327974276527,0.9704074310047283,1.0,1/18,0.79%,TSHZ3
prerank,regulation of adenylate cyclase activity (GO:0045761),-0.2964350798831402,-0.87179300024742,0.6434540389972145,0.8909269062735785,1.0,3/22,5.93%,ADGRV1;GRM3;ORAI1
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.34768652975339737,-0.8717174603484057,0.630272952853598,0.8901988850826079,1.0,3/12,15.38%,NR1H3;NR1H2;ABCG1
prerank,error-prone translesion synthesis (GO:0042276),0.3447040164100221,0.871682707913407,0.6259904912836767,0.9700393522249979,1.0,10/21,27.72%,POLI;RFC3;REV3L;RFC1;RPA3;POLE2;REV1;PRIMPOL;RPA2;RPA1
prerank,regulation of mitotic spindle organization (GO:0060236),0.3187805242888455,0.8714802204885909,0.6342141863699583,0.9698362681273974,1.0,7/35,12.19%,NUP62;CHMP5;PDCD6IP;CHMP4B;TPR;MAP9;CHMP4C
prerank,positive regulation of heterochromatin assembly (GO:0031453),0.40555687596104417,0.8714213474338097,0.6199324324324325,0.9693392742618931,1.0,3/11,10.70%,RESF1;PPHLN1;TPR
prerank,lymphocyte migration (GO:0072676),-0.26990645935090385,-0.871311600969956,0.680379746835443,0.8901762048544656,1.0,23/32,51.17%,MSN;RET;CCL13;CCL19;ADAM8;CCL2;S1PR1;CCL25;MYO1G;ZAP70;CCL15;CCL5;CCL4;GATA3;CCL8;MSMP;CKLF;CCL7;CCR6;CCL1;CCL3;CCL11;TBX21
prerank,positive regulation of acute inflammatory response (GO:0002675),-0.32492580190851084,-0.8711280118316868,0.6373056994818653,0.8896980997090396,1.0,1/14,1.30%,OSMR
prerank,regulation of striated muscle contraction (GO:0006942),0.34293338604716145,0.8708139693379388,0.6274509803921569,0.9699788005186082,1.0,3/27,5.41%,MYBPH;SCN10A;ATP1A2
prerank,homotypic cell-cell adhesion (GO:0034109),0.31777097874599725,0.8704375627815868,0.6333808844507846,0.9701457727755324,1.0,4/39,5.38%,UBASH3B;TJP2;PLPP3;FN1
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.2884534538412722,0.8703410610309746,0.6567901234567901,0.9697324775479356,1.0,4/75,1.25%,RGS6;GUCA1A;RGS14;PLCE1
prerank,peptide cross-linking (GO:0018149),0.34106584538363066,0.8699364165957706,0.6062407132243685,0.9699292137344692,1.0,3/25,5.68%,CD3G;FN1;COL3A1
prerank,cilium-dependent cell motility (GO:0060285),-0.28452762214341176,-0.8698225767968591,0.6452513966480447,0.8915781623795465,1.0,10/22,36.39%,RFX3;EFHC2;DNAH3;CFAP44;DRC1;CFAP54;CCDC65;DNAAF2;TEKT2;DNAH17
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),-0.37229090747439,-0.869614963299528,0.6383928571428571,0.8911384215021141,1.0,5/10,21.20%,CACNB2;CALM1;CALM3;SRI;PDE4B
prerank,regulation of protein ubiquitination (GO:0031396),0.2719159266916773,0.869282919741843,0.6741440377804014,0.9706525743307421,1.0,25/108,18.98%,CAV1;PRICKLE1;AXIN1;OGT;SH3RF2;TNFAIP3;N4BP1;CUL3;SIRT7;RCHY1;SPOPL;NXN;USP4;SOX4;UBE2D1;UBQLN1;FBXW7;CHP1;BAG2;PHF23;GNL3L;MINAR1;WFS1;PINK1;HDAC3
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.3662219681846936,0.8692137766534807,0.6137071651090342,0.9701956655957142,1.0,1/16,0.80%,ACKR3
prerank,positive regulation of ATP metabolic process (GO:1903580),0.3255211845121579,0.8691537365180501,0.634180790960452,0.9697024281657184,1.0,4/32,6.24%,PPARGC1A;ZBTB20;BEND3;SLC4A4
prerank,positive regulation of T cell cytokine production (GO:0002726),0.35615472350886457,0.8690020676273558,0.6463223787167449,0.9694090988784289,1.0,2/20,3.05%,IL18R1;CD55
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.29046470815971753,0.8687286936871351,0.6637717121588089,0.9693319455373499,1.0,14/69,14.91%,COX5A;NDUFA6;NDUFB10;NDUFS3;COX15;NDUFS6;SDHD;SDHAF2;COX7C;NDUFA3;NDUFV2;COX5B;NDUFV1;NDUFA7
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.34121205664598114,0.8686524725221737,0.6390625,0.9688853396776216,1.0,8/26,16.76%,SOCS5;TSG101;NCK2;CBLB;ADRA2A;SOCS4;HBEGF;FBXW7
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.2924000773635825,0.8686050346775287,0.6658031088082902,0.9683745771182133,1.0,16/64,18.12%,MLLT3;LEO1;CDK13;POLR1E;CDK7;PAF1;ELL;NELFB;SUPT4H1;GTF2F2;GTF2H1;ELOA;TCEA1;RTF1;SETD2;GTF2H3
prerank,regulation of TORC1 signaling (GO:1903432),-0.266977932039181,-0.8683641965373136,0.6909620991253644,0.8929756916528413,1.0,10/33,22.51%,SEH1L;DEPDC5;RNF152;RRAGC;GPR137B;SPAAR;RRAGD;CASTOR2;CASTOR1;PIP4P1
prerank,glycerol metabolic process (GO:0006071),-0.36744342768455346,-0.8681830676881324,0.6325,0.8925000312479549,1.0,3/10,13.31%,TPI1;COQ3;PGP
prerank,COPII-coated vesicle budding (GO:0090114),-0.21968015271210276,-0.8673952425240966,0.7864583333333334,0.8933164498745867,1.0,20/68,21.17%,TGFA;TRAPPC10;PREB;NAPA;GOSR2;SCAP;ANKRD28;SEC16A;GOLGA2;SEC16B;SEC23A;SAR1B;F5;TRAPPC2;SCFD1;CTSC;SEC31A;TRAPPC6B;SEC22B;TRAPPC6A
prerank,positive regulation of interleukin-4 production (GO:0032753),-0.3201419480983988,-0.8673732168754705,0.6538461538461539,0.8924968358454064,1.0,4/17,15.93%,SLC7A5;PRKCZ;CEBPB;LGALS9
prerank,RNA transport (GO:0050658),0.29034649897748094,0.8672299731884696,0.6477272727272727,0.9706165693662325,1.0,17/71,19.45%,RBM8A;SRSF4;NUP62;CKAP5;SIDT2;EIF4E;ATXN2;RTRAF;TPR;UPF3B;NUP153;THOC3;THOC5;XPO5;SLU7;SRSF3;DHX38
prerank,embryonic hemopoiesis (GO:0035162),-0.34032249873424825,-0.8668694782717621,0.6442307692307693,0.8926265302847542,1.0,5/12,18.81%,KIT;FLT3LG;KDR;TAL1;ATF4
prerank,regulation of cell size (GO:0008361),0.34038386680260574,0.8668363696286931,0.5969924812030075,0.970770717190685,1.0,12/23,23.94%,VAV2;RDX;PLEK;RARG;PTEN;EZR;RHOA;RAP1GAP2;LAMTOR5;RPTOR;RAC1;MTOR
prerank,peptidyl-asparagine modification (GO:0018196),-0.2730592226458926,-0.8667309346023017,0.6516516516516516,0.8920384559846787,1.0,8/31,17.31%,DPM1;ALG5;STT3B;UBE2J1;RPN2;FUT8;OST4;ASGR1
prerank,regulation of histone H3-K4 methylation (GO:0051569),-0.3187851141051306,-0.8665084744036868,0.6031746031746031,0.8916519343422162,1.0,8/16,28.54%,PAXIP1;SNW1;KDM1A;DNMT3B;SMAD4;BRCA1;WDR5;BCOR
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.2910204299939401,0.8663274911929525,0.6469072164948454,0.9711972840738502,1.0,12/59,16.09%,BCL3;REL;TLR7;TRADD;AZI2;IRAK1BP1;TICAM1;SHARPIN;TAB2;RELB;TICAM2;TBK1
prerank,icosanoid metabolic process (GO:0006690),0.31314111356527674,0.8660580631604959,0.623249299719888,0.971152464561066,1.0,15/40,24.91%,EPHX1;CYP2S1;ALOXE3;ABCC1;ABCC10;LTA4H;PNPLA8;GGT1;HPGD;FADS1;FAAH;PON3;PLA2G4A;PTGR1;DAGLB
prerank,oligosaccharide metabolic process (GO:0009311),0.3051904091096027,0.8657974755934655,0.667989417989418,0.9710934959380233,1.0,7/46,11.17%,ST3GAL4;B3GALT1;NAGA;NEU1;MANBA;ST8SIA5;ST8SIA3
prerank,zinc ion transmembrane transport (GO:0071577),-0.2842742033852171,-0.8653881745591653,0.6739130434782609,0.893142789052361,1.0,7/22,20.09%,SLC30A10;SLC39A10;SLC39A8;SLC39A14;SLC30A4;TRPM2;SLC39A11
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.3183869631511393,-0.8647975140497925,0.651219512195122,0.8935251963414296,1.0,5/14,19.67%,ARID2;ACTR2;MMS19;PARP1;TIMELESS
prerank,regulation of gene silencing by miRNA (GO:0060964),0.28681267668397115,0.8647590974320075,0.6551724137931034,0.9725997653401653,1.0,20/62,22.72%,DND1;IPO8;NUP62;NUP160;AGO1;NUP37;TPR;NUP50;RANBP2;NUP153;NUP210;FXR1;PUM2;NUP93;PPARG;DHX9;PUM1;NUP43;ELAVL1;SEC13
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.42255288839524685,0.8647363573197782,0.6278260869565218,0.9720404412490871,1.0,1/10,5.15%,CNGB1
prerank,regulation of Notch signaling pathway (GO:0008593),0.28907314680501184,0.864426681912981,0.6842105263157895,0.9721109982076227,1.0,15/76,15.38%,NRARP;EGFR;DTX1;JAG1;MAML2;SRC;EGFL7;BMP2K;POFUT1;IL6ST;TSPAN14;CREBBP;YAP1;MMP14;WWP2
prerank,cellular response to cAMP (GO:0071320),0.32783191378436505,0.8644058092737921,0.6190476190476191,0.9715420539087732,1.0,2/30,1.92%,RAPGEF3;RAP1A
prerank,chloride transmembrane transport (GO:1902476),0.30310078371603877,0.8641499373322241,0.6314363143631436,0.9714623745860056,1.0,9/48,12.09%,SLC12A2;ANO6;SLC12A4;SLC12A3;CLCN1;GABRR2;GABRG2;GABRG1;GABRB3
prerank,ketone body metabolic process (GO:1902224),-0.3687954865980855,-0.8640957921790194,0.6282973621103117,0.8941725369547686,1.0,4/10,8.86%,HMGCL;BDH2;HMGCS2;ACSS3
prerank,innate immune response (GO:0045087),-0.18498740205564834,-0.8640518130195629,0.8783783783783784,0.8933938882975195,1.0,48/217,23.14%,SP100;SERINC3;LYN;MFHAS1;ADAR;TNK2;CXCL16;MID2;TRIM25;B2M;IRAK4;ALPK1;PLCG2;GCH1;NRROS;BST2;CYBA;TRIM14;BCL10;TRIM28;TRIM35;PGLYRP1;NCF2;MFAP4;AKAP1;POLR3A;CFP;PJA2;IKBKB;TRIM59;PTK2;IFIT1;ISG15;CYBC1;MASP1;RARRES2;TRIM8;CD40;FES;TLR3;TRIM13;TRIM11;IKBKG;COLEC12;RNF187;RPL39;SHFL;NOD2
prerank,regulation of endothelial cell apoptotic process (GO:2000351),-0.25504990997906357,-0.8637859760993133,0.7087719298245614,0.8930868217047344,1.0,8/39,12.84%,TEK;ANGPT1;NDNF;KDR;GATA2;RAMP2;SCG2;THBS1
prerank,positive regulation of ion transport (GO:0043270),0.30667661086202275,0.8637295644110472,0.6500655307994757,0.9717012167689769,1.0,2/48,2.63%,CNKSR3;ANO6
prerank,response to molecule of bacterial origin (GO:0002237),0.28628466225369004,0.863233498870086,0.6758104738154613,0.9721141933654355,1.0,10/69,11.19%,LBP;PTPN22;HNRNPA0;IRAK3;TNFAIP3;FER;ACOD1;RPS6KA3;S100A9;TAB2
prerank,cGMP metabolic process (GO:0046068),-0.3368866758665796,-0.8631788212977703,0.6494117647058824,0.8935312806802261,1.0,2/12,9.13%,NPR1;PDE2A
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.3489385823179325,0.8630913706994506,0.6180327868852459,0.9718046220313965,1.0,4/21,13.37%,HK2;RPE;GCK;DERA
prerank,vesicle coating (GO:0006901),-0.22334900540224578,-0.8625388932247321,0.7843137254901961,0.892248719942909,1.0,19/61,21.17%,TGFA;TRAPPC10;PREB;NAPA;GOSR2;ANKRD28;SEC16A;GOLGA2;SEC16B;SEC23A;SAR1B;F5;TRAPPC2;SCFD1;CTSC;SEC31A;TRAPPC6B;SEC22B;TRAPPC6A
prerank,COPII vesicle coating (GO:0048208),-0.22334900540224578,-0.8625388932247321,0.7843137254901961,0.892248719942909,1.0,19/61,21.17%,TGFA;TRAPPC10;PREB;NAPA;GOSR2;ANKRD28;SEC16A;GOLGA2;SEC16B;SEC23A;SAR1B;F5;TRAPPC2;SCFD1;CTSC;SEC31A;TRAPPC6B;SEC22B;TRAPPC6A
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.22334900540224578,-0.8625388932247321,0.7843137254901961,0.892248719942909,1.0,19/61,21.17%,TGFA;TRAPPC10;PREB;NAPA;GOSR2;ANKRD28;SEC16A;GOLGA2;SEC16B;SEC23A;SAR1B;F5;TRAPPC2;SCFD1;CTSC;SEC31A;TRAPPC6B;SEC22B;TRAPPC6A
prerank,negative regulation of protein polymerization (GO:0032272),0.3256628179543725,0.8624438710380417,0.6455331412103746,0.9725295461703978,1.0,4/27,8.30%,KANK4;CDH5;KANK1;DYRK1A
prerank,positive regulation of macrophage differentiation (GO:0045651),-0.3473346558963085,-0.8624027299890286,0.6359447004608295,0.8916618473653177,1.0,6/11,23.22%,IL34;ID2;HSF1;CSF1;CASP8;RIPK1
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.40303484711435794,0.8621999676604741,0.606418918918919,0.9724230302290648,1.0,1/11,1.72%,EGFR
prerank,hydrogen peroxide metabolic process (GO:0042743),0.36243688500525234,0.8621339407718903,0.6062015503875969,0.9719521921516343,1.0,1/19,0.87%,PXDN
prerank,snRNA processing (GO:0016180),0.3657511862236382,0.8620133115991506,0.6114754098360655,0.9715888596418739,1.0,5/16,18.52%,INTS10;TUT1;INTS6L;INTS3;TOE1
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.3033684556510515,0.8619346359448505,0.6732673267326733,0.9711379151533226,1.0,4/42,5.93%,UBE2L6;USP43;POLI;RFC3
prerank,axonal transport of mitochondrion (GO:0019896),-0.3560956497786749,-0.8609477603641623,0.6547619047619048,0.8938854992736894,1.0,4/11,15.47%,NEFL;HIF1A;MAPT;OPA1
prerank,negative regulation of transferase activity (GO:0051348),0.32321034624634115,0.8609059255491934,0.6359447004608295,0.9725932398272739,1.0,6/28,17.61%,SRC;FBXO5;GSK3B;MEN1;CDKN1C;IRS2
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.33480339887612365,0.8605888018078448,0.6171516079632465,0.9726083937400798,1.0,6/26,10.46%,HEYL;KANK2;NCOR1;PIAS2;ISL1;NCOR2
prerank,filopodium assembly (GO:0046847),-0.31391986492517265,-0.860401148426217,0.6796116504854369,0.8941938275232312,1.0,3/16,5.96%,DNM3;FGD5;ARHGEF4
prerank,defense response to fungus (GO:0050832),-0.32294659358532657,-0.860353558830866,0.6458852867830424,0.893443693176226,1.0,4/17,18.85%,PLCG2;BCL10;GAPDH;RARRES2
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",-0.23851667239215382,-0.8603450724840502,0.7076271186440678,0.8926016007645029,1.0,17/48,22.32%,EP300;ATAD2B;ACTB;DEK;SMARCD1;TAF1D;H1-0;SMARCA5;SERTAD1;KAT2B;POLR2F;KAT2A;TAF1C;POLR2K;POLR1C;ZMIZ2;POLR1F
prerank,glycoprotein catabolic process (GO:0006516),0.3567266719474461,0.8602893532079321,0.6167471819645732,0.9725854386185264,1.0,5/17,19.63%,ADAMTS12;MMP12;MANBA;OGA;EDEM2
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),0.39132566248184175,0.8601964884637511,0.6230366492146597,0.9721724766817434,1.0,4/12,10.46%,HEYL;NCOR1;PIAS2;NCOR2
prerank,calcium ion transport (GO:0006816),0.26979530562219545,0.858950391595593,0.6968272620446534,0.9740911777112173,1.0,8/113,4.86%,CAV1;NALCN;TRPM3;ANO6;SLC24A1;TRPV4;CACNA1H;ATP2B4
prerank,embryonic heart tube development (GO:0035050),-0.32967949460984514,-0.8583560640074751,0.6575,0.8959605401849512,1.0,4/14,16.29%,SOX17;CITED2;MEGF8;SOX18
prerank,protein deacetylation (GO:0006476),0.31095267313804753,0.8577194804460081,0.6389684813753582,0.975909231589881,1.0,16/41,24.65%,HDAC4;RCOR3;SIRT3;SIN3B;MSL3;SIRT7;HDAC2;HDAC6;BAZ2A;MORF4L2;MTA3;HDAC3;BRMS1L;SIRT2;SIN3A;SUDS3
prerank,regulation of receptor binding (GO:1900120),0.4017114595426124,0.8576481715099618,0.6,0.9754306759224036,1.0,1/10,1.75%,PTPRF
prerank,cellular response to reactive oxygen species (GO:0034614),0.2913658060804786,0.8570565037627799,0.6701846965699209,0.9760889561080148,1.0,10/59,13.15%,PXN;EGFR;MPV17;TNFAIP3;FER;MAPK7;MAP3K5;HDAC6;NFE2L2;AQP1
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),-0.34706496686324984,-0.8569563379721225,0.6636363636363637,0.8979427261416484,1.0,5/12,29.55%,SEH1L;RMDN1;CENPC;CENPE;NDC80
prerank,histone H2B ubiquitination (GO:0033523),0.4047524539805767,0.8568922110839188,0.6167247386759582,0.9758315677218786,1.0,5/10,23.27%,LEO1;PAF1;CDC73;DTX3L;RNF20
prerank,regulation of cell aging (GO:0090342),-0.351420019935587,-0.8568842705801394,0.6642335766423357,0.897200533616168,1.0,4/11,19.53%,LMNA;VASH1;MIF;NUAK1
prerank,negative regulation of nervous system development (GO:0051961),-0.3027242436990567,-0.8567916299782571,0.6702412868632708,0.8965160353618504,1.0,2/17,4.57%,APPL2;B2M
prerank,response to organonitrogen compound (GO:0010243),-0.2560992178735328,-0.8567636891881792,0.6977611940298507,0.8957074674695017,1.0,12/38,24.88%,HLCS;SYVN1;VCP;RRAGC;GLRA2;UBXN6;DHFR;TRPM2;RCN3;IRF5;NR1H4;KYNU
prerank,histone H2A acetylation (GO:0043968),0.36885001410031243,0.8567128705949828,0.6295081967213115,0.9756025043028541,1.0,6/16,19.16%,MSL3;TRRAP;BRD8;MORF4L2;RUVBL2;NAA40
prerank,kinetochore organization (GO:0051383),-0.33011901856233244,-0.8567070018969442,0.6666666666666666,0.8949587703490606,1.0,9/13,39.77%,CENPT;CENPC;CENPE;NDC80;CENPF;CENPA;DLGAP5;NUF2;CENPW
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.30266154356461333,0.8564656881549397,0.6845637583892618,0.9754967588707204,1.0,13/53,21.16%,GLMN;OPHN1;PSME3;DDRGK1;TMF1;PKD1;FBXW7;BAG2;RHBDF1;PSMD14;PINK1;TMTC3;PRKN
prerank,histone H4 acetylation (GO:0043967),0.3032948873232588,0.8562085249282557,0.6629986244841816,0.9753911442307105,1.0,13/47,19.70%,OGT;KMT2A;BEND3;HAT1;KANSL2;MSL3;TRRAP;KAT8;BRD8;MORF4L2;RUVBL2;NAA40;NAA60
prerank,sensory perception of taste (GO:0050909),-0.36223815036858853,-0.8561726049786689,0.6488372093023256,0.8951835629809352,1.0,8/10,49.77%,PKD2L1;PKD1L3;CD36;ASIC1;ASIC3;TAS1R1;TAS1R2;GNAT3
prerank,regulation of gene silencing by RNA (GO:0060966),0.2934876417107874,0.8560505992682989,0.6463576158940397,0.9744946851775904,1.0,12/50,15.65%,IPO8;NUP62;NUP160;AGO1;NUP37;TPR;NUP50;RANBP2;NUP153;NUP210;PUM2;NUP93
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.2934876417107874,0.8560505992682989,0.6463576158940397,0.9744946851775904,1.0,12/50,15.65%,IPO8;NUP62;NUP160;AGO1;NUP37;TPR;NUP50;RANBP2;NUP153;NUP210;PUM2;NUP93
prerank,lymphocyte differentiation (GO:0030098),0.28795257724982315,0.8550943136004243,0.6644993498049415,0.9758009969456356,1.0,9/68,9.91%,LEPR;PBX1;TPD52;PTPN22;HDAC4;PTPRC;MSH2;PTPRJ;AXL
prerank,cellular response to leucine starvation (GO:1990253),0.40280193650282303,0.8548811740894187,0.63668430335097,0.9756361623023065,1.0,5/10,23.94%,SESN1;RRAGB;GCN1;IMPACT;MTOR
prerank,signal peptide processing (GO:0006465),0.40472911415312374,0.8547388030475558,0.6295025728987993,0.9753193233472487,1.0,1/11,2.13%,PCSK5
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),-0.3222448919186824,-0.8544021580334691,0.631578947368421,0.8978836772040586,1.0,5/14,10.23%,CHKA;LPIN2;ETNK1;CEPT1;LPIN3
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.3466354607586914,0.8542182890658195,0.6301587301587301,0.9757570572657521,1.0,9/21,22.39%,AATF;HDAC6;ABCD1;ABCB7;PINK1;COA8;PRKN;PAX2;SIRT2
prerank,regulation of bicellular tight junction assembly (GO:2000810),0.3608508774521709,0.8539552420081439,0.6286173633440515,0.9757056989166858,1.0,5/19,15.61%,F11R;OCLN;CBFB;RUNX1;NPHP4
prerank,regulation of mitotic nuclear division (GO:0007088),0.2892155252234833,0.8537883211564723,0.6653491436100132,0.9754317327865677,1.0,8/55,7.40%,FBXO43;KIF20B;IL1A;CAV2;NUP62;TOM1L1;CDK13;FBXO5
prerank,regulation of actin nucleation (GO:0051125),0.38844312385530244,0.8532163158348367,0.6237113402061856,0.9759636305281191,1.0,1/12,3.48%,ARPIN
prerank,negative regulation of axon extension (GO:0030517),0.3259226582336518,0.8529689910001081,0.6268011527377522,0.9758410032861097,1.0,10/30,19.05%,SEMA4B;RTN4R;CDKL3;SEMA3A;TRIM46;SEMA4D;SEMA6C;RTN4;SEMA4C;SEMA4A
prerank,regulation of secretion by cell (GO:1903530),-0.2345931205797962,-0.8529094274860175,0.7626459143968871,0.9001532783852045,1.0,12/54,16.73%,SNCAIP;DNAJC1;RAB3C;MCTP2;ANXA1;SYN1;CAMK2A;RAB13;RHBDF2;LLGL2;RAB3B;CPLX2
prerank,cellular response to interleukin-2 (GO:0071352),0.4003834100720797,0.8523421250688097,0.63016157989228,0.9759241807673172,1.0,6/11,29.64%,IL2RG;JAK1;SYK;STAT5B;STAT5A;SHC1
prerank,interleukin-2-mediated signaling pathway (GO:0038110),0.4003834100720797,0.8523421250688097,0.63016157989228,0.9759241807673172,1.0,6/11,29.64%,IL2RG;JAK1;SYK;STAT5B;STAT5A;SHC1
prerank,tRNA aminoacylation (GO:0043039),0.31058337484404663,0.8519869039096093,0.655367231638418,0.9760688826760456,1.0,13/37,22.36%,RARS2;VARS1;DARS1;KARS1;AIMP1;WARS1;TARS1;SARS2;DARS2;WARS2;HARS2;GATB;MARS2
prerank,Golgi to plasma membrane transport (GO:0006893),0.29964323296241,0.8516686970163694,0.6707650273224044,0.9761238575720033,1.0,1/47,0.06%,STXBP6
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.30814788611079896,0.8510948508585768,0.6520547945205479,0.9766660781849447,1.0,1/37,0.26%,EFNA5
prerank,"phototransduction, visible light (GO:0007603)",0.3821234889104564,0.8509036433437753,0.6487804878048781,0.976448261130148,1.0,2/14,5.15%,GNAQ;CNGB1
prerank,regulation of mitotic cell cycle (GO:0007346),0.2531370911979582,0.8504508786860094,0.7377049180327869,0.9767854753615137,1.0,37/171,18.81%,SMOC2;FBXO43;KIF20B;CAV2;PRKCA;PSME3;CDK13;NEK7;FBXO5;BRINP1;PSMB5;CDC20;ANAPC5;ANAPC7;EIF4E;ANAPC11;BUB3;ANAPC2;CDKN1C;TTC28;UBE2D1;PSMA6;PSMB2;PSMA2;ANAPC4;PSMD13;FZR1;PSMA7;NEK11;SCRIB;PSME4;ANAPC16;CDC23;PSMD12;PSMD14;PSMB6;PSMC4
prerank,positive regulation of protein ubiquitination (GO:0031398),0.27675918011177214,0.8503649913541171,0.6898203592814371,0.9763736299449635,1.0,4/80,4.45%,CAV1;PRICKLE1;AXIN1;SPSB4
prerank,positive regulation of stress fiber assembly (GO:0051496),0.30707968029986904,0.8502169597382907,0.6662087912087912,0.9760866982777061,1.0,15/44,22.54%,LPAR1;PXN;RAPGEF3;ARHGEF5;FERMT2;FHOD1;NF2;ARHGEF10L;ARHGEF10;RGCC;RHOA;PFN2;S100A10;PPM1E;RAC1
prerank,anterograde trans-synaptic signaling (GO:0098916),0.2516052877655333,0.8501861334854426,0.7569296375266524,0.9755508730030621,1.0,29/224,13.39%,HRH1;CHRNB3;CEL;MINK1;GRIA3;SLC12A4;NPTX2;SLC1A6;CPLX1;GABBR2;PAFAH1B1;PRKAR2A;GABRR2;GABRG2;HCRTR2;MPZ;RPS6KA3;DOC2A;MYCBPAP;GRIA1;SCN2B;GABRG1;GABRB3;KIF5A;SNCG;HCRT;GRM1;CHRM2;PRKACB
prerank,membrane lipid catabolic process (GO:0046466),0.3987448845850995,0.8500917003686912,0.6119133574007221,0.9751382345267938,1.0,2/10,4.91%,NAGA;MGST2
prerank,acetyl-CoA metabolic process (GO:0006084),-0.32200621865495943,-0.849971481869655,0.7007481296758105,0.9051746083154617,1.0,7/15,15.85%,HMGCS1;HMGCS2;MLYCD;ACLY;PMVK;MVK;ACSS1
prerank,protein targeting to membrane (GO:0006612),0.27946593231687583,0.849867845627384,0.7036585365853658,0.9749865379832346,1.0,23/83,20.68%,RAB8B;SIL1;FIS1;ZDHHC1;PEX2;ZDHHC7;ZDHHC23;PXMP2;TRAM1;CHMP4B;CHMP4A;RTP3;ABCD1;ZDHHC20;CHM;ZDHHC19;GOLGA7B;ATG3;ICMT;ZDHHC3;SLC25A17;PEX13;ZDHHC12
prerank,positive regulation of proteolysis (GO:0045862),0.29842604327401484,0.849335269587344,0.6801040312093628,0.9754406218057529,1.0,9/55,10.61%,CYFIP2;OGT;GPLD1;NLRC4;PERP;TNIP1;IST1;HDAC2;ADRA2A
prerank,positive regulation of protein dephosphorylation (GO:0035307),0.32250709824769797,0.8491802261704411,0.6474926253687315,0.9751551329577981,1.0,2/32,2.62%,DLC1;CDH5
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),-0.29130789767672605,-0.8489693157765457,0.71671388101983,0.906428011740819,1.0,8/22,21.82%,ROCK2;FKBP1A;PPP4R4;PPP1R11;IKBKB;STYXL1;CRY2;NCKAP1L
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.29807805862488956,0.848723703165998,0.6702702702702703,0.9754283662071924,1.0,6/52,7.82%,SORBS1;PRKCE;EGFR;ATP2B4;EPHB2;ARF6
prerank,positive regulation of heart rate (GO:0010460),-0.3072110233629769,-0.8485383941254526,0.7095115681233933,0.906452856873392,1.0,5/17,17.59%,TPM1;ADRA1B;EDN1;ADM;EDN3
prerank,amino sugar metabolic process (GO:0006040),-0.3673278242890333,-0.8479605300998119,0.6651884700665188,0.9067404582343029,1.0,2/10,2.58%,ST3GAL1;CSGALNACT1
prerank,regulation of microtubule-based process (GO:0032886),0.308518685369756,0.8478212524376267,0.6685714285714286,0.9766693678396181,1.0,5/36,11.44%,EFNA5;GSK3B;PHLDB1;APC;HDAC6
prerank,stress fiber assembly (GO:0043149),0.3742652647831729,0.8476843973856272,0.6427320490367776,0.9757505815154737,1.0,4/15,10.75%,SORBS1;SRC;CUL3;ZYX
prerank,contractile actin filament bundle assembly (GO:0030038),0.3742652647831729,0.8476843973856272,0.6427320490367776,0.9757505815154737,1.0,4/15,10.75%,SORBS1;SRC;CUL3;ZYX
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.2798713050485655,0.8469770775907653,0.6846733668341709,0.9765626322292671,1.0,6/76,8.57%,CAV1;PRICKLE1;AXIN1;HDAC4;CUL3;TNIP1
prerank,response to endoplasmic reticulum stress (GO:0034976),0.2673214310718416,0.8467140237776751,0.7063020214030915,0.9764777464990712,1.0,29/107,23.21%,THBS4;EIF2AK3;ERO1A;CREB3L1;SELENOS;PIK3R2;MAP3K5;DDRGK1;GSK3B;ERN1;RNF185;P4HB;UBQLN1;MBTPS1;QRICH1;WFS1;ERP44;TMEM259;BAX;CREB3L2;TMTC3;SEL1L;DDIT3;NCK1;PRKN;DERL1;JUN;NIBAN1;MBTPS2
prerank,methylguanosine-cap decapping (GO:0110156),-0.35584047039698935,-0.8466295551949156,0.6603325415676959,0.9086489072577649,1.0,3/10,10.33%,EDC3;EDC4;PNRC2
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.2762904490658054,0.8462672916343673,0.6813048933500627,0.9767640486773079,1.0,8/73,9.55%,LBP;IL1A;WNT5A;PTPRC;EPHB2;PTPRJ;ISL1;HMGB1
prerank,negative regulation of cell death (GO:0060548),0.2738297825212633,0.8459132768245627,0.7080820265379976,0.9769157169156476,1.0,14/88,10.19%,PPARGC1A;SPEF1;WNT16;NPAS2;NUP62;KANK2;AMIGO2;ATG5;CD200R1;GSK3B;POU4F1;CHMP4B;CHMP4A;FERMT2
prerank,regulation of cytokine production involved in immune response (GO:0002718),-0.2793544111008623,-0.84585779114307,0.6903409090909091,0.9093396297365461,1.0,3/22,5.47%,SLC7A5;LACC1;TNFRSF1B
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.2970773122460271,0.8454913542733585,0.672972972972973,0.9771477245000741,1.0,11/49,13.38%,SRC;DACT1;PPM1A;LDLRAD4;PTGER4;ISL1;GSK3B;NLRP2B;HMGB1;HDAC6;LCMT1
prerank,cellular response to organonitrogen compound (GO:0071417),0.26989313657232555,0.8447823569802406,0.7146254458977408,0.977937064526299,1.0,16/99,17.12%,HRH1;FOLR1;RAPGEF3;RAP1A;SOX9;TSHR;GABRG2;EGR1;GABRB3;CAPN2;AQP1;RRAGB;CTNNA1;CDH1;CPEB3;EZR
prerank,cardiac muscle contraction (GO:0060048),0.313596402926931,0.8444247686782821,0.6616643929058663,0.9780472492321763,1.0,6/34,12.05%,CAMK2D;CSRP3;ATP1A2;CASQ2;SCN2B;TNNI1
prerank,determination of left/right symmetry (GO:0007368),0.307701055856171,0.8444156861863361,0.6542699724517906,0.9774698203549417,1.0,8/36,15.37%,ENKUR;STIL;CCDC39;FOXJ1;LEFTY1;SMO;DNAH5;CCDC40
prerank,positive regulation of epithelial cell differentiation (GO:0030858),-0.30589871016478554,-0.8441348693001206,0.6838235294117647,0.9119553860002038,1.0,6/17,16.62%,BMP4;RFX3;VEZF1;BTG1;AHI1;NKX6-1
prerank,pyruvate metabolic process (GO:0006090),0.29088070860313453,0.844062613365687,0.6649214659685864,0.977551669053826,1.0,12/52,17.54%,HK2;HOGA1;ALDOB;DLAT;PGM1;SLC16A1;ENO3;GCK;PGK1;ME2;LDHB;ENO2
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),0.3689671417528805,0.8439125560711351,0.6340640809443507,0.9772775681596721,1.0,5/13,22.76%,PRPF3;USP4;SRSF12;SRSF10;LSM2
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),-0.23539937299912977,-0.8437571012612154,0.7659574468085106,0.9118305900942137,1.0,15/51,22.20%,IL6R;CXCL12;CMKLR1;VEGFC;LGMN;VEGFD;IL34;THBS1;PTK2;CSF1;LGALS9;EDN3;RARRES2;PTN;C1QBP
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.3742908792360524,0.843201275403727,0.6308243727598566,0.9780718437294322,1.0,2/13,4.85%,STX1A;CACNA1H
prerank,chloride transport (GO:0006821),0.2775780174199595,0.8429863261339631,0.6821026282853567,0.9779052391115285,1.0,13/74,12.33%,SLC12A2;SLC26A9;ANO6;SLC12A4;SLC12A3;CLCN2;CLCN1;GABRR2;GABRG2;BEST1;GABRG1;GABRB3;ANO10
prerank,regulation of actin filament-based movement (GO:1903115),-0.34173440769965885,-0.8429182258832733,0.6643518518518519,0.9126529620144861,1.0,7/10,32.14%,ANK2;SRI;PDE4B;PLN;SCN5A;STC1;PDPN
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.3189140901168499,0.842851279815525,0.6482861400894188,0.9775637895517826,1.0,1/27,0.74%,LPAR1
prerank,receptor catabolic process (GO:0032801),0.333279727472416,0.8427899624576319,0.6671597633136095,0.9770887063838263,1.0,6/24,11.21%,KIF16B;PIK3R4;GPRASP1;ZNRF3;SNX25;NEDD4
prerank,regulation of granulocyte chemotaxis (GO:0071622),0.3500178373095002,0.8422407468539737,0.6495176848874598,0.9776018999036374,1.0,2/19,2.86%,CXCL17;MPP1
prerank,negative regulation of B cell activation (GO:0050869),-0.2875448869838275,-0.8419413473544627,0.6914600550964187,0.9137201436369338,1.0,12/21,32.67%,LYN;TNFRSF21;SAMSN1;ID2;LAPTM5;RC3H1;INHBA;FCGR2B;ATM;PARP3;SFRP1;CD300A
prerank,nuclear pore organization (GO:0006999),-0.3228495112329444,-0.8416197047008226,0.6928746928746928,0.9135354227763499,1.0,3/14,6.06%,NUP107;SEH1L;NUP133
prerank,regulation of translation (GO:0006417),0.2531352572330711,0.8412939390716178,0.7603938730853391,0.9789347976510222,1.0,35/173,16.30%,BCL3;FXR2;PIWIL2;GIGYF2;EIF2AK3;FOXO3;CNOT10;SAMD4B;PUS7;EIF5B;IGF2BP2;RPS6KA3;EIF4E;EIF1;CNOT7;ATXN2;METTL5;ILF3;PLD1;UPF3B;EIF2B4;CSDE1;ETF1;NSUN5;ALKBH1;DDX6;SOX4;MIF4GD;FXR1;PYM1;MTG2;SYNCRIP;ERBB2;CPEB3;LTN1
prerank,respiratory chain complex IV assembly (GO:0008535),0.34161377704983154,0.8411830295867019,0.6434108527131783,0.9785385549846976,1.0,7/21,19.42%,COA5;COX15;COX19;COX16;BCS1L;COA8;SURF1
prerank,positive regulation of myelination (GO:0031643),-0.3436145599229373,-0.8410020365844381,0.6883408071748879,0.9139301549026366,1.0,2/11,5.47%,PARD3;TNFRSF1B
prerank,regulation of myotube differentiation (GO:0010830),-0.27547063285696355,-0.8405424642226483,0.6975308641975309,0.913966796816494,1.0,11/24,29.84%,CCN3;SIK1;HDAC9;HDAC1;BDNF;ATP11A;XBP1;DMPK;NOTCH1;RBM24;FBXO22
prerank,apoptotic nuclear changes (GO:0030262),0.34305807123589127,0.840203535375626,0.662613981762918,0.9798352891680611,1.0,6/24,15.46%,ACVR1C;DFFB;HMGB1;EXOG;DICER1;GPER1
prerank,multivesicular body organization (GO:0036257),0.3244156606901629,0.8395162236605985,0.6730205278592375,0.9805749425128605,1.0,7/31,12.19%,TSG101;CHMP5;PDCD6IP;IST1;CHMP4B;CHMP4A;CHMP4C
prerank,UV-damage excision repair (GO:0070914),0.382142755638117,0.839127783731046,0.6838487972508591,0.9807568209438382,1.0,4/12,17.22%,INO80;ERCC1;DDB2;CUL4B
prerank,autophagy of mitochondrion (GO:0000422),-0.24466190502998125,-0.8389455116637086,0.75,0.916217641122529,1.0,16/38,26.99%,SQSTM1;BECN1;GABARAPL1;ULK2;WIPI1;GABARAP;AMBRA1;ATG13;USP30;MAP1LC3A;WIPI2;ATG12;WDR45B;WDR45;CISD2;FBXO7
prerank,positive regulation of transport (GO:0051050),0.2722164391235174,0.838919428312255,0.690734055354994,0.9805742334711751,1.0,7/85,5.53%,GPC3;NEDD4L;GPLD1;KMT2A;LMAN2;TFR2;DOCK2
prerank,Golgi localization (GO:0051645),-0.3350049893504813,-0.8388164330996053,0.6488888888888888,0.9156077158915548,1.0,3/11,6.20%,CDC42;UVRAG;PDCD10
prerank,response to UV-A (GO:0070141),0.3663414824584648,0.8386540532713618,0.6911519198664441,0.9805026565119039,1.0,2/14,11.01%,EGFR;MME
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),-0.2860521871142866,-0.8383584079246025,0.7103658536585366,0.9157084194290672,1.0,11/21,28.18%,RPS7;UBE2S;RPL23;GOLGA2;CDC14B;SKP1;MAD2L2;RPL5;MAD2L1;RPL11;GORASP1
prerank,defense response to virus (GO:0051607),-0.20204710596058206,-0.8378379104327316,0.8703703703703703,0.9158640268070612,1.0,24/100,20.51%,SERINC3;IFNAR2;ABCC9;SAMHD1;IRF2;IFIT2;AGBL5;IFIT3;BST2;FLNA;NDUFAF4;IRF1;AKAP1;ABCE1;MOV10;IFIT1;ISG15;RSAD2;PDE12;CD40;OPRK1;CGAS;TLR3;BNIP3L
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),-0.3092557367685017,-0.8377596067964597,0.707808564231738,0.915161954790556,1.0,4/15,15.84%,TGFB3;CUEDC2;TGFB2;HFE
prerank,neuronal action potential (GO:0019228),0.3362331758889802,0.837514254580893,0.6588419405320813,0.9820750931251238,1.0,2/22,4.85%,SCN10A;CACNA1H
prerank,zinc ion transport (GO:0006829),0.3427281182521065,0.8372200919836693,0.6629392971246006,0.982054079929459,1.0,3/21,6.02%,SLC39A13;SLC30A9;SLC30A6
prerank,positive regulation of muscle cell differentiation (GO:0051149),-0.27796953246087025,-0.8370698203353367,0.7413793103448276,0.9155758147076148,1.0,4/24,7.77%,CDC42;MEF2A;MAPK12;CDON
prerank,phosphatidylserine metabolic process (GO:0006658),0.31792712681668467,0.8367816274811098,0.6714697406340058,0.9823242433873027,1.0,4/32,8.99%,MBOAT2;SLC27A1;ABHD12;PLSCR1
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),-0.27127101374029594,-0.8366947935636811,0.684971098265896,0.9154247201841256,1.0,8/26,20.37%,LGR4;APPL2;NFKBIL1;LRRC14;IRF1;CACTIN;FLOT1;TLR3
prerank,activation of adenylate cyclase activity (GO:0007190),-0.25141292974235513,-0.8366896388592208,0.7344827586206897,0.9145688268022084,1.0,7/35,14.34%,LGR4;ADCY1;ADCY7;ADCY4;ADCY2;EDNRA;LGR5
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.3108093914940591,0.8365045358394293,0.6733812949640288,0.9822720912226195,1.0,4/34,6.25%,PTPN22;WNT5A;PTPRC;EPHB2
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.29578536207859296,0.8362879464208492,0.6839237057220708,0.9820892527060311,1.0,12/43,19.33%,BRCC3;BRSK1;NBN;CHFR;RINT1;UIMC1;CDC6;DONSON;FZR1;INTS3;ORC1;MRE11
prerank,positive regulation of organelle organization (GO:0010638),0.31858775158301456,0.8362500712564375,0.6652110625909753,0.9815748871911094,1.0,10/32,22.07%,PPARGC1A;RAB3GAP2;IRGM;GSK3B;LNPK;HTRA2;SHCBP1L;ADRB2;AKT2;RAB3GAP1
prerank,androgen receptor signaling pathway (GO:0030521),0.38584550715564764,0.8361902760780096,0.6649659863945578,0.9811033536215401,1.0,6/11,25.62%,DDX17;TMF1;RNF14;DAXX;ARID1A;PMEPA1
prerank,sphingolipid catabolic process (GO:0030149),-0.3103371456253811,-0.8357563789515063,0.6844547563805105,0.9154787569717734,1.0,4/15,13.27%,ACER2;ENPP2;PDXDC1;SPHK1
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.3806124571354951,0.8357417539156728,0.6626916524701874,0.9813879048506008,1.0,4/12,15.41%,PTPN22;PTPRC;CBFB;RUNX1
prerank,tRNA export from nucleus (GO:0006409),0.3167045387001488,0.8353567081964159,0.6730486008836525,0.9809754879850701,1.0,10/32,15.65%,NUP62;NUP160;NUP37;TPR;NUP50;RANBP2;NUP153;NUP210;RAN;NUP93
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.3167045387001488,0.8353567081964159,0.6730486008836525,0.9809754879850701,1.0,10/32,15.65%,NUP62;NUP160;NUP37;TPR;NUP50;RANBP2;NUP153;NUP210;RAN;NUP93
prerank,mRNA 3'-end processing (GO:0031124),0.2731175754476472,0.8352589773046722,0.7291925465838509,0.9805778765130728,1.0,26/78,25.30%,CSTF1;RBM8A;SRSF4;LEO1;RPRD1B;TUT1;PAF1;CSTF3;RPRD1A;UPF3B;THOC3;THOC5;SLU7;SYMPK;PAPOLG;SRSF3;DHX38;CDC73;NUDT21;SRSF11;PCF11;CPSF2;WDR33;SARNP;PABPN1;TENT4B
prerank,regulation of interleukin-10 production (GO:0032653),0.29971088719007066,0.835227035388805,0.6826666666666666,0.9800544636035982,1.0,1/44,0.38%,TRIB2
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.2936308763722512,0.8351646516268709,0.6820143884892086,0.9795765448812311,1.0,4/46,4.96%,HK2;TOMM34;MFN2;FIS1
prerank,determination of bilateral symmetry (GO:0009855),-0.2737902347222379,-0.8351039119805134,0.7014492753623188,0.9158960326760218,1.0,6/24,14.63%,NPHP3;TBX1;GALNT11;CITED2;ZIC3;MKKS
prerank,"DNA-templated transcription, termination (GO:0006353)",0.2737073846493471,0.8347228859999388,0.7126582278481013,0.9798867742550073,1.0,8/68,7.27%,CSTF1;CAVIN1;SNRPF;MED18;POLR1E;CDK7;SMN1;CSTF3
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.287580625732633,0.8346325374596872,0.6837146702557201,0.9794840329663274,1.0,7/48,12.27%,OTOP1;ARG1;IRAK3;PTPRC;NLRP2B;CNOT7;STAT2
prerank,regulation of dendritic spine development (GO:0060998),0.3479049719903769,0.834575425025878,0.6525157232704403,0.9790117841950341,1.0,3/19,7.82%,PPFIA2;LLPH;ARF6
prerank,termination of RNA polymerase II transcription (GO:0006369),0.31201417480149324,0.8345214941082357,0.6686390532544378,0.9785367389521868,1.0,4/33,7.27%,CSTF1;SNRPF;MED18;CSTF3
prerank,negative regulation of hydrolase activity (GO:0051346),0.2938815809687988,0.8344381925292634,0.7132867132867133,0.9781243314362299,1.0,4/49,7.62%,F11R;SH3RF2;RDX;MAPK7
prerank,DNA double-strand break processing (GO:0000729),0.3526979758877939,0.8341900968102168,0.6506410256410257,0.9780477485815712,1.0,3/18,6.99%,SMARCAD1;NBN;UBE2V2
prerank,calcium ion transmembrane transport (GO:0070588),0.26931753611966425,0.834100553282949,0.7283653846153846,0.9776310927976497,1.0,7/86,4.86%,NALCN;TRPM3;SLC8B1;ANO6;SLC24A1;TRPV4;ATP2B4
prerank,protein autoubiquitination (GO:0051865),0.2796453973948565,0.8340817093329961,0.7009222661396575,0.9770887706526457,1.0,14/61,17.07%,SH3RF2;RNF122;LRSAM1;TRIM21;CUL3;AMFR;RNF220;UBE3D;OBI1;RNF185;UBE2D3;WWP2;DDB2;ITCH
prerank,stabilization of membrane potential (GO:0030322),-0.30658540834469783,-0.8340146604888392,0.6805896805896806,0.9171892939768497,1.0,1/16,0.21%,KCNK2
prerank,ventricular septum development (GO:0003281),0.3037915587138155,0.8338812841325693,0.6948148148148148,0.9768561671271244,1.0,2/37,5.11%,STRA6;HEYL
prerank,myoblast fusion (GO:0007520),0.37521035081394594,0.8334060459091054,0.6371527777777778,0.9771908871447331,1.0,3/12,12.82%,CD9;CACNA1H;CD81
prerank,chemical synaptic transmission (GO:0007268),0.24357545696335997,0.8333527584741546,0.8148914167528438,0.976716656238565,1.0,37/284,13.39%,HRH1;CHRNB3;CEL;PDLIM4;MINK1;STX1A;RIC3;GRIA3;SLC12A4;NPTX2;BRSK1;SLC1A6;RAB3A;CPLX1;GABBR2;PAFAH1B1;PRKAR2A;GABRR2;GRID1;GABRG2;HCRTR2;MPZ;RPS6KA3;DOC2A;MYCBPAP;GRIA1;SCN2B;GABRG1;GABRB3;KIF5A;SNCG;PTEN;DLGAP2;HCRT;GRM1;CHRM2;PRKACB
prerank,carbohydrate derivative transport (GO:1901264),0.34440975680029706,0.8330828280100152,0.6608557844690967,0.9766846159345177,1.0,1/18,0.69%,LBP
prerank,receptor-mediated endocytosis (GO:0006898),0.25624989065364745,0.8330667847261757,0.7471655328798186,0.9761400018501966,1.0,24/132,16.93%,CAV1;ACKR3;FOLR1;HSPH1;COLEC11;CAV2;CD9;TFR2;DNM1;SGIP1;INPP5F;CUBN;M6PR;NEDD4;HSPG2;CD81;AMN;CTTN;CLEC9A;CLTB;AP2A2;SNX1;SCARB2;SYK
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.27057716883604516,0.8328121199172783,0.7022058823529411,0.9760538269886267,1.0,21/80,18.49%,KIF2A;LMAN2;RACGAP1;PLPP3;TAPBP;KIF3C;RINT1;ATP9B;ATP9A;COPE;KIF5A;KIF26A;COPG1;HTT;COPA;ZW10;TMED2;ERGIC1;ARCN1;COG3;KLC2
prerank,peptidyl-lysine modification (GO:0018205),0.2642640528742213,0.8326695509386285,0.7246022031823746,0.9757403805480914,1.0,30/99,22.49%,STX1A;EYA1;SENP6;UBE2I;HDAC4;NUP62;SIRT3;PIAS2;NUP160;SIRT7;NUP37;TPR;NUP50;HDAC6;RANBP2;NUP153;NUP210;ATPSCKMT;NUP93;TRPM4;SUMO1;SENP2;ETFBKMT;SENP3;LOXL2;VCPKMT;NUP43;VIPAS39;SIRT2;SAE1
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.25414876057712565,-0.8325293589688871,0.755223880597015,0.919209911547618,1.0,16/30,34.59%,ARHGEF2;NOS3;FAS;CFLAR;TNFSF10;CASP8;ICAM1;RIPK1;BRCA1;RNF34;DDX3X;TRAF2;RFFL;HMOX1;FAIM2;SERPINE1
prerank,peptidyl-serine phosphorylation (GO:0018105),0.2524728704549662,0.8324420857505355,0.7710706150341685,0.9755800929281198,1.0,19/153,11.99%,PLK2;PRKCE;CAMK2D;STK38;EIF2AK3;PRKCA;MORC3;HIPK1;BRSK1;STK38L;DYRK1A;CSNK1G3;GSK3B;RPS6KA3;CSNK1A1;MASTL;SRPK2;TOP1;SGK1
prerank,negative regulation of transposition (GO:0010529),0.3556043952614284,0.8323684481440956,0.6622950819672131,0.9751529095105642,1.0,3/16,12.50%,PIWIL2;SIRT7;TEX15
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),0.3741382492038023,0.8317409304039046,0.6376306620209059,0.9757451039448464,1.0,3/14,16.85%,ANO6;GPER1;RGCC
prerank,negative regulation of histone modification (GO:0031057),-0.3149243004776657,-0.831520937520964,0.6966019417475728,0.920360023178149,1.0,6/14,29.71%,JARID2;NOC2L;BRCA1;AASS;THAP7;CTBP1
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.2914283020839793,-0.8313005053350715,0.7060439560439561,0.9199556403715691,1.0,9/19,29.38%,AFDN;BMP6;NEXMIF;FLOT1;NOTCH4;MAD2L2;NOTCH1;TJP1;PPM1F
prerank,regulation of protein kinase A signaling (GO:0010738),-0.28046290421817066,-0.8310332997000508,0.6955307262569832,0.9196411451389326,1.0,7/20,19.48%,ADGRV1;AKAP6;PRKAR2B;LRRK2;PJA2;TCIM;MIF
prerank,nuclear envelope organization (GO:0006998),0.33928865217718956,0.8308357019873457,0.6618819776714514,0.9769100742274399,1.0,7/20,20.02%,NEMP1;SUN1;REEP3;EMD;NUP93;LEMD2;REEP4
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),-0.2951348222625043,-0.8308234711790551,0.7127371273712737,0.9191501878376629,1.0,4/18,12.93%,PIK3R1;BCL2L11;RNFT1;BOK
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.3898072562722544,0.8303113281770631,0.669051878354204,0.9773231656101486,1.0,2/10,12.68%,NPTX2;DLGAP2
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.2899365223507514,0.8300934339954255,0.6925098554533509,0.9771607567527981,1.0,4/50,6.03%,NR3C2;EGFR;TLR7;TRADD
prerank,DNA repair (GO:0006281),0.24047651633866213,0.8300612755197948,0.832109129066107,0.9766514074450489,1.0,65/284,20.17%,FAAP24;MSH6;TDG;BRCC3;EYA1;POLI;SLC30A9;KMT5C;FANCC;PDS5B;KPNA2;RFC3;FANCF;NBN;UBE2V2;MSH2;UIMC1;ACTR8;USP47;APEX2;TRRAP;ERCC6;TDP1;INO80;ERCC1;MDC1;MEN1;MGMT;CETN2;GTF2H1;NUCKS1;ALKBH1;RFWD3;ADPRS;EME2;POLB;RAD51AP2;REXO4;PRMT6;RECQL5;FAM111A;POLE;FANCL;TNKS1BP1;DDB2;INTS3;BRIP1;BACH1;KDM4B;CHD1L;USP45;TDP2;CUL4B;SETD2;RHNO1;PSME4;GTF2H3;ASCC2;ERCC6L2;MRE11;ASCC1;ATR;RPAIN;SUMO1;MLH3
prerank,regulation of primary metabolic process (GO:0080090),-0.1932797074618447,-0.8296895743772918,0.9147286821705426,0.9205734265233423,1.0,24/126,15.63%,ROCK2;PPARD;PSMA1;TGS1;LDLR;PLPP1;TBL1XR1;PSMD11;APOE;HMGCS1;C1QTNF2;TNFAIP8L3;PSMD7;PSMD4;PRKAB2;NFYB;FGFR4;SP1;PMVK;PSMB4;ID2;NFYC;CERS2;MVK
prerank,ureteric bud development (GO:0001657),0.3491020867972086,0.8296267411321524,0.6582491582491582,0.9769084419693902,1.0,1/17,0.45%,GPC3
prerank,negative regulation of protein catabolic process (GO:0042177),-0.23659393051770272,-0.8294548483410107,0.7636986301369864,0.9201546671671468,1.0,14/40,25.45%,TIMP3;PTPN3;FLNA;RGP1;CTSA;TIMP4;BANP;CDK5RAP3;ADGRB1;MAD2L2;NELL1;MAD2L1;CST3;AGAP2
prerank,chromosome organization (GO:0051276),0.26338465073749423,0.8291684568000418,0.7350119904076738,0.9772337453987555,1.0,22/99,18.98%,MSH6;CDAN1;SATB1;SUV39H1;MSH2;GATAD1;HDAC2;SUPT4H1;AXIN2;CETN2;NUCKS1;RFWD3;COPS5;DDB2;CENPH;BRWD1;CUL4B;GEM;MTF2;HMGN2;TCF7L1;HDAC3
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),-0.3262981508755034,-0.8283298416885534,0.6823821339950372,0.9214614923061262,1.0,8/12,39.63%,NAE1;CLSPN;TOPBP1;RAD17;STK33;HUS1B;TICRR;HUS1
prerank,steroid biosynthetic process (GO:0006694),0.28515803562100417,0.828055278224762,0.7127659574468085,0.9787922139254294,1.0,8/56,11.77%,HSD17B3;CYP7B1;OSBPL6;SC5D;HSD17B4;ACOT8;PRLR;MSMO1
prerank,positive regulation of actin filament bundle assembly (GO:0032233),0.2900926217216641,0.8280003127642332,0.6986666666666667,0.9783372319186756,1.0,17/51,22.54%,LPAR1;PXN;RAPGEF3;ARHGEF5;PLEK;FERMT2;FHOD1;NF2;ARHGEF10L;ARHGEF10;RGCC;RHOA;PFN2;CX3CL1;S100A10;PPM1E;RAC1
prerank,neuron projection fasciculation (GO:0106030),-0.3501717857797396,-0.8278438028003444,0.6882494004796164,0.9215395019811539,1.0,7/10,31.60%,EPHA4;ARHGAP35;CDK5R1;EPHB3;SEMA5A;AMIGO1;NRCAM
prerank,cellular senescence (GO:0090398),0.31654796362011156,0.8277978468442391,0.655223880597015,0.9781670716204018,1.0,3/27,6.70%,SMC5;SPI1;TBX2
prerank,cellular response to hydrogen peroxide (GO:0070301),-0.2489773466575873,-0.827749282136035,0.7542087542087542,0.9208582365099169,1.0,10/33,17.79%,CYP1B1;SIRPA;ANXA1;RHOB;OSER1;RPS3;NET1;FXN;ANKZF1;TRPM2
prerank,negative regulation of viral process (GO:0048525),-0.21973538682036972,-0.827584665446541,0.8106995884773662,0.9203313797239228,1.0,20/57,25.04%,MID2;BST2;TRIM14;ZC3HAV1;PROX1;TRIM28;TRIM35;PARP10;UBP1;IFIT1;ISG15;CHMP3;ZFP36;RSAD2;TRIM8;TRIM13;TRIM11;SHFL;BANF1;TRIM6
prerank,regulation of gene expression by genetic imprinting (GO:0006349),-0.3565392988592381,-0.8272978371653631,0.7071583514099783,0.9200032574568614,1.0,3/10,13.10%,PCGF5;IGF2;PRMT7
prerank,bile acid metabolic process (GO:0008206),0.3256933481293306,0.8270449657843528,0.6898638426626323,0.9790287775368841,1.0,4/27,10.43%,CYP7B1;OSBPL6;HSD17B4;ACOT8
prerank,stem cell development (GO:0048864),0.35433480711032944,0.8266978227348493,0.6541737649063032,0.9791048744475609,1.0,2/16,7.94%,PTPRC;CDH2
prerank,negative regulation by host of viral process (GO:0044793),-0.3484856525772987,-0.8266822162864347,0.6820175438596491,0.920348534066745,1.0,2/10,10.11%,ZC3H12A;EIF2AK4
prerank,positive regulation of interleukin-1 beta production (GO:0032731),0.29344341379559125,0.8266730964550123,0.7175368139223561,0.9785863012317668,1.0,7/45,16.05%,USP50;WNT5A;NLRC4;ISL1;EGR1;GSDMD;LPL
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.3232879140552807,0.826450748794656,0.6756352765321375,0.9784351178595608,1.0,3/29,9.55%,ANO6;CXCL17;HMGB1
prerank,prostanoid metabolic process (GO:0006692),0.36554168945648413,0.8263824770083397,0.661641541038526,0.9779802877863857,1.0,6/13,26.33%,CYP2S1;PLAA;HPGD;PTGR1;PTGR2;GSTM1
prerank,protein alkylation (GO:0008213),0.3309450628907465,0.8263069435980518,0.688,0.9775655947405407,1.0,9/22,25.75%,ETF1;LCMT1;METTL22;CAMKMT;ETFBKMT;VCPKMT;EEF2KMT;PRMT8;PRMT3
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.34743716746233155,0.8261027096603896,0.6709886547811994,0.9773855843297439,1.0,7/17,25.19%,ALG9;DHDDS;DPAGT1;DOLK;DOLPP1;ALG12;ALG14
prerank,branching involved in blood vessel morphogenesis (GO:0001569),0.37049712902019616,0.8260775927981668,0.662828947368421,0.9768623827479509,1.0,2/13,6.77%,NRARP;COL4A1
prerank,DNA duplex unwinding (GO:0032508),-0.22434490223125464,-0.8260606345896742,0.8115384615384615,0.9206973268719482,1.0,24/50,35.88%,WRN;RBX1;BLM;MCM6;ANXA1;SSBP1;ERCC2;XPA;GTF2H4;DDX1;MCMDC2;PARP1;TWNK;RAD51;UBB;GTF2H5;DDB1;ASCC3;MCM9;MCM7;MCM2;RECQL;UBC;RPS27A
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.3918170555744629,0.8259983721753968,0.6449912126537786,0.9764402802047117,1.0,1/10,4.77%,WNT5A
prerank,neutrophil migration (GO:1990266),0.28624940226110374,0.8258630757127972,0.7101631116687579,0.9761223928669007,1.0,1/58,0.29%,CXADR
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.2582889387725703,0.825846353434629,0.7578579743888242,0.9755860311546258,1.0,7/104,5.19%,CAV1;DLX1;SPRED1;SPRY1;BMPR1B;NBL1;PPM1A
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.2373878224460675,0.825693174652527,0.8439425051334702,0.9753035448976392,1.0,75/341,18.81%,NEDD4L;UBE2L6;RNF130;WDR81;UBE3C;RNF122;PCBP2;UBE2I;SPSB4;PSME3;KEAP1;TOM1L1;TNFAIP3;TSG101;CHFR;SIAH1;ZNRF3;CUL3;UBL7;PSMB5;AMFR;CDC20;ANAPC5;ANAPC7;SIAH3;NPLOC4;UBE3D;ANAPC11;SHARPIN;TRPC4AP;RCHY1;FBXL19;OTUD7B;NEDD4;SPOPL;TTC3;FBXL17;BUB3;FBXO11;FAF1;NFE2L2;ANAPC2;KLHL22;FBXO21;RNF185;UBA1;FBXO8;UBE2D1;UBE2D3;PSMA6;KLHL15;PSMB2;FEM1C;PSMA2;ANAPC4;WWP2;PSMD13;UBE2R2;FZR1;PSMA7;UBQLN1;PLAA;FBXW7;ITCH;WDR91;USP9X;PSME4;ANAPC16;RNF7;CDC23;PSMD12;PSMD14;PINK1;PSMB6;PSMC4
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.388356645121363,0.8254201028563146,0.6348122866894198,0.9746979452363362,1.0,2/10,18.86%,CNGB1;CEP250
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.388356645121363,0.8254201028563146,0.6348122866894198,0.9746979452363362,1.0,2/10,18.86%,CNGB1;CEP250
prerank,cellular protein metabolic process (GO:0044267),0.23678173514547005,0.8251083711870174,0.8634046890927625,0.9747190730072816,1.0,47/396,12.21%,FAM20C;IGFBP6;GPC3;STC2;RPSA;SLC35A1;UBE2L6;LAMC1;LAMB2;PCSK5;DUSP12;STK38;MMP15;APH1B;ERO1A;SCG3;MRPL37;MRPL43;UBE2I;CDKL3;NUCB1;CPE;FN1;PABPC4;BMP15;NCSTN;ADAM10;ABL2;GOLM1;RCN1;CDH2;IGFALS;DARS1;TNIP1;CSNK1G3;RPL35;MRPL41;RPS13;MRPS33;MRPS15;PRKCSH;MANBA;MRPL3;PROC;L2HGDH;MEN1;FBXO11
prerank,steroid hormone biosynthetic process (GO:0120178),0.3187278965183059,0.8248635953870982,0.6857562408223201,0.9746335325752004,1.0,5/29,20.34%,HSD17B3;HSD17B2;STARD3;STAR;HSD17B11
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),-0.3458181431881396,-0.8245548461389413,0.6830985915492958,0.9226947579370383,1.0,1/10,0.66%,TGFA
prerank,organonitrogen compound catabolic process (GO:1901565),0.28588136295169314,0.8245404948330792,0.7067183462532299,0.9746721635483084,1.0,12/57,15.61%,IL4I1;LRSAM1;CLN8;BCKDK;LVRN;SIAH1;LNPEP;NAGK;LTA4H;PNPLA8;GNPDA2;TXN2
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.30884900278998506,0.8243287340281426,0.7179125528913963,0.9745020797169872,1.0,12/31,22.66%,PPP1R13B;GSK3B;SFN;BAD;NMT1;YWHAG;E2F1;YWHAE;BAX;TFDP1;MAPK8;YWHAB
prerank,dicarboxylic acid catabolic process (GO:0043649),-0.31937244388705355,-0.8241336467552773,0.675609756097561,0.9226217981820326,1.0,2/13,2.52%,DDO;MTHFS
prerank,regulation of cilium movement (GO:0003352),0.38915602146607464,0.8240600938399716,0.6649916247906198,0.974457213252154,1.0,3/10,15.95%,CCDC39;CCDC40;CFAP298
prerank,positive regulation of protein maturation (GO:1903319),0.38448417787951833,0.8239267251645018,0.6915422885572139,0.9741390411341989,1.0,4/11,17.28%,TFR2;NLRC4;SOX4;BAG2
prerank,presynapse organization (GO:0099172),0.377940039381465,0.823861222111106,0.6603119584055459,0.9737039960034157,1.0,3/10,22.17%,WNT5A;NLGN3;NLGN2
prerank,keratinocyte differentiation (GO:0030216),0.3164883610241743,0.8233623114039796,0.6997206703910615,0.9740798584470501,1.0,3/29,4.77%,JAG1;WNT16;WNT5A
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.3762662582329528,0.82332961113944,0.6757188498402555,0.9735810784870057,1.0,3/12,10.46%,NCOR1;LIN28B;NCOR2
prerank,double-strand break repair (GO:0006302),0.24960172604760478,0.8233030782076303,0.7657458563535912,0.9730594672027785,1.0,36/158,19.35%,SMC5;BRCC3;EYA1;PAXX;SMARCAD1;KPNA2;NBN;PALB2;UBE2V2;SWI5;UIMC1;ACTR8;HMGB1;ZSWIM7;ZFYVE26;TDP1;INO80;ERCC1;MDC1;GEN1;NUCKS1;RFWD3;EME2;SFPQ;POLB;RAD51AP2;REV3L;RECQL5;TNKS1BP1;BRIP1;KDM4B;TDP2;SFR1;PSMD14;MRE11;XRCC6
prerank,nucleosome organization (GO:0034728),0.28563308384986197,0.8230535404391952,0.6994884910485933,0.9729530234640146,1.0,17/55,22.05%,SOX9;KAT6B;CTCF;PAF1;LIN54;SMARCD2;INO80;SETD2;MCM3AP;NAP1L1;ACTR6;SPTY2D1;NAA60;ZNHIT1;RSF1;DAXX;ARID1A
prerank,positive regulation of biomineral tissue development (GO:0070169),0.29792085383344713,0.8229620579547731,0.7140902872777017,0.9725525419799225,1.0,4/40,7.40%,PKDCC;ANO6;BMPR1B;FBXO5
prerank,organophosphate catabolic process (GO:0046434),-0.3422145109995297,-0.8229029760303436,0.7299107142857143,0.9240667443318678,1.0,1/11,2.70%,ENPP2
prerank,mitochondrial gene expression (GO:0140053),0.29652341218968087,0.8227312652521175,0.7122905027932961,0.9724361883525636,1.0,10/42,14.91%,FOXO3;FASTKD2;MRPS28;RARS2;PTCD3;TFB2M;MRPS15;TEFM;MRPL16;NDUFA7
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),-0.265936945539369,-0.8226787901045965,0.764367816091954,0.9236303805811769,1.0,7/26,18.81%,PDE8A;AKT1;GPR37;LRRK2;HSPB1;GPR37L1;ATF4
prerank,neural crest cell development (GO:0014032),-0.2316416289172834,-0.8218823824032815,0.7638376383763837,0.9241865341724779,1.0,21/44,33.22%,SEMA6D;SEMA7A;SEMA3C;SEMA6A;TBX1;RADIL;TCOF1;ANXA6;SEMA3G;SOX10;HTR2B;SEMA4G;TAPT1;SEMA3F;SEMA3D;SEMA5A;SEMA5B;NRTN;SEMA4F;NRG1;SNAI2
prerank,cellular protein-containing complex assembly (GO:0034622),0.24845873673548696,0.821509344611266,0.7810055865921788,0.9740894151397999,1.0,32/159,16.66%,STXBP6;PXN;AXIN1;SRC;NCK2;CCDC39;SGIP1;PSMG2;CASQ2;CALY;IMMP2L;CHMP4B;CHMP4A;PFDN6;TPR;PSMG1;LONP1;PRLR;VAMP8;CCT2;AHCTF1;NUP153;VAMP1;HOPX;RTN4;CLTB;POMP;CCDC40;NUP93;PSMD13;TBCE;PSMG3
prerank,negative regulation of immune effector process (GO:0002698),0.3699951147450017,0.8207205130742716,0.6790540540540541,0.9750329322424238,1.0,2/13,5.87%,CD55;FER
prerank,protein polyglutamylation (GO:0018095),0.3841602677957633,0.8205371259187366,0.6535714285714286,0.9748041426255897,1.0,3/11,17.21%,TTLL1;CFAP20;TTLL9
prerank,cellular response to cytokine stimulus (GO:0071345),0.2363330641125123,0.8205185921212559,0.8827726809378186,0.9742790489371003,1.0,42/416,11.54%,RORA;TEC;LBP;IL19;IL18R1;RIPOR2;PTPN13;ADAMTS12;LEPR;SLC12A2;SOCS5;STX1A;ITGAX;IL1A;PTPN14;FOXO3;SOX9;IRAK3;WNT5A;FN1;FER;TRADD;SOCS6;ABL2;LAMA5;SDC1;MCL1;PTPRJ;ACOD1;IRGM;GSK3B;GAB2;TYK2;AXL;POU4F1;PTPRT;TPR;MME;IL6ST;PRLR;EGR1;PTPN18
prerank,tRNA transport (GO:0051031),0.30579015297741935,0.820491825603399,0.6975397973950795,0.9737713567771786,1.0,10/35,15.65%,NUP62;NUP160;NUP37;TPR;NUP50;RANBP2;NUP153;NUP210;RAN;NUP93
prerank,response to ionizing radiation (GO:0010212),-0.206823132523259,-0.8202395905752867,0.8940092165898618,0.9263802542501891,1.0,29/70,27.62%,USP28;PAXIP1;BLM;ANXA1;NHEJ1;RHOB;EEF1D;NET1;BABAM2;TOPBP1;RAD1;CLK2;RNF8;EYA3;ABRAXAS1;RAD9B;XRCC4;KDM4D;TRIM13;FANCD2;GRB2;NABP1;RAD51;DCUN1D3;LIG4;BRCA1;PRKAA1;SMPD1;BRAT1
prerank,Golgi to lysosome transport (GO:0090160),-0.33272428066744375,-0.8199416962855381,0.7114093959731543,0.92606167049129,1.0,3/11,16.21%,RBSN;SORT1;LAPTM5
prerank,protein tetramerization (GO:0051262),0.27606873231240836,0.8197608309398866,0.73053152039555,0.9746056612670783,1.0,4/67,7.12%,ALDH1A3;ALDH9A1;ACOT13;ACACA
prerank,positive regulation of endopeptidase activity (GO:0010950),0.3225830936928027,0.8195855460858399,0.6795252225519288,0.974387926210248,1.0,4/26,5.98%,USP50;APH1B;PSME3;NCSTN
prerank,proteoglycan metabolic process (GO:0006029),0.32252571377989664,0.8195309775066337,0.6821589205397302,0.9739270245616704,1.0,5/26,11.25%,SULF1;ADAMTS12;BMPR1B;CANT1;CHST12
prerank,lysosome organization (GO:0007040),0.3105121422818071,0.8195109020550971,0.7012622720897616,0.9734125902353213,1.0,6/36,11.59%,HOOK2;HPS1;ABCA1;ATP10B;TFEB;HOOK3
prerank,regulation of vacuole organization (GO:0044088),0.3420116436769382,0.8191914156800396,0.6766091051805337,0.9734439139987884,1.0,10/20,26.85%,MTMR3;ENO3;LAPTM4B;SCARB2;ENO2;RAB5A;ENO1;NPRL2;TBC1D14;IFT20
prerank,regulation of programmed necrotic cell death (GO:0062098),0.335662839356872,0.8188144606942183,0.6850393700787402,0.9735859009925196,1.0,3/20,9.01%,OGT;FLOT2;PDCD6IP
prerank,peptide metabolic process (GO:0006518),0.2692992029795997,0.8179174713621006,0.7336561743341404,0.9746505892366378,1.0,17/75,16.71%,PCSK5;MGAT3;CPE;LVRN;LNPEP;BACE2;GSTA4;GSTZ1;MME;GSTK1;GSTA3;LTA4H;MIPEP;ABCB9;NLN;GGT1;BACE1
prerank,organophosphate biosynthetic process (GO:0090407),0.297722210969936,0.817591257690848,0.7165697674418605,0.9746924774960667,1.0,10/37,19.83%,AGPAT4;PPIP5K2;AGPAT5;TPK1;GK;PPIP5K1;MOCS2;FADS1;ITPKA;TKT
prerank,positive regulation of telomerase activity (GO:0051973),0.3039116599883738,0.8175161726577703,0.6953455571227081,0.9742717966291113,1.0,4/33,12.13%,NEK7;NAF1;WRAP53;CCT2
prerank,nucleoside phosphate biosynthetic process (GO:1901293),0.3615819827430978,0.817401669118404,0.6853932584269663,0.9739124767834662,1.0,2/14,8.90%,AK5;NMNAT3
prerank,serine family amino acid biosynthetic process (GO:0009070),-0.32320675978062696,-0.8171270340693995,0.7156398104265402,0.9302956546584938,1.0,7/12,28.69%,SERINC3;PSPH;SEPHS1;CBS;SEPHS2;CTH;PHGDH
prerank,cellular response to pH (GO:0071467),0.3404721424546215,0.8170981844555824,0.6768982229402262,0.9739073311562096,1.0,4/17,17.28%,GPLD1;RAB11FIP5;KCNK4;CHP1
prerank,positive regulation of response to biotic stimulus (GO:0002833),-0.23922866022183958,-0.8170347183564398,0.776595744680851,0.9296309662993862,1.0,5/38,8.50%,SASH1;BMP6;POLR3B;CYBA;SLC15A4
prerank,defense response to Gram-negative bacterium (GO:0050829),0.2940202261248297,0.8169664053150999,0.698744769874477,0.9735900670706255,1.0,6/42,15.40%,LBP;DEFA6;IRGM;AQP1;GSDMD;TNFRSF14
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.349973753497138,0.8169434276710532,0.6649659863945578,0.9730650217575555,1.0,5/15,24.29%,SOX9;SMO;PAX2;LHX1;SIX1
prerank,liver development (GO:0001889),0.30228625575261114,0.8167824478841313,0.6976744186046512,0.972799128089874,1.0,6/32,10.72%,COBL;NF1;LSR;GFER;CCDC39;PRKCSH
prerank,regulation of lamellipodium organization (GO:1902743),0.35844208307624076,0.8167491099656731,0.6766169154228856,0.9723111264679354,1.0,2/14,5.87%,CAPZB;FER
prerank,nucleoside triphosphate metabolic process (GO:0009141),-0.31264692236848407,-0.8164279378500956,0.6876513317191283,0.9298527539698145,1.0,3/14,5.94%,ENPP1;ENPP3;CMPK1
prerank,RNA stabilization (GO:0043489),0.30737844320201085,0.8162449553057035,0.696969696969697,0.9726360392146124,1.0,8/33,16.08%,DND1;NAF1;TENT5C;AXIN2;TENT5D;TAF15;ZCCHC17;E2F1
prerank,regulation of tumor necrosis factor production (GO:0032680),0.2549094206043464,0.8161665294688453,0.7795823665893271,0.9722420569580809,1.0,13/112,9.55%,LBP;IL1A;PTPN22;IRAK3;WNT5A;PTPRC;TNFAIP3;EPHB2;SELENOS;RARA;PTPRJ;ISL1;HMGB1
prerank,positive regulation of actin filament depolymerization (GO:0030836),-0.3388705332273705,-0.8159550103800195,0.7181818181818181,0.9298694786039916,1.0,1/10,0.99%,ACTN2
prerank,hyaluronan catabolic process (GO:0030214),0.3407101271447532,0.8159521697912809,0.6746794871794872,0.9720887890169947,1.0,7/18,24.82%,HEXA;CEMIP2;HEXB;CEMIP;CHP1;FGF2;GUSB
prerank,organic acid transport (GO:0015849),0.26014263649353286,0.8158958227304293,0.7526254375729288,0.9716344619695455,1.0,11/94,9.11%,LRRC8D;CEACAM1;FOLR1;FOLR2;ATP8B1;SLC38A2;SLC27A1;SLC6A13;SLC7A2;SLC7A14;SLC27A4
prerank,protein localization to nucleus (GO:0034504),0.2596347043822293,0.8154087844086133,0.7609467455621302,0.9719724129928994,1.0,14/102,12.55%,PRICKLE1;BCL3;IPO8;NOL8;MORC3;NUP62;PAF1;FAM53B;COL1A1;TPR;MMP12;NUP50;CSE1L;NUP153
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.32923413422852277,0.8151627794641554,0.7027027027027027,0.9718511477288437,1.0,3/24,3.39%,CAMK2D;PDE4D;FKBP1B
prerank,regulation of T cell differentiation in thymus (GO:0033081),-0.3094423071123553,-0.8151405438444047,0.7037037037037037,0.9305201293949303,1.0,4/13,11.77%,BMP4;ZC3H8;CAMK4;TOX
prerank,nucleus organization (GO:0006997),-0.22703904164362612,-0.8150514043119207,0.7984496124031008,0.9298402169653732,1.0,9/47,11.21%,PITPNB;SYNE1;SEH1L;NUP133;RPS19;CTDNEP1;LEMD3;VPS4A;USP36
prerank,reverse cholesterol transport (GO:0043691),-0.3189357869639671,-0.8145362471790483,0.7002457002457002,0.9299533139953268,1.0,5/13,25.84%,APOE;ABCG1;CLU;SCARB1;LCAT
prerank,peroxisomal membrane transport (GO:0015919),0.32049257891213195,0.8142581277587937,0.7055306427503737,0.9729452084386399,1.0,5/27,12.85%,RAB8B;FIS1;PEX2;PXMP2;ABCD1
prerank,protein O-linked glycosylation via serine (GO:0018242),-0.33784201287705873,-0.8137082614606377,0.6939252336448598,0.930625672974562,1.0,4/10,25.08%,GALNT3;MGAT5B;GALNT2;GALNT13
prerank,cellular response to catecholamine stimulus (GO:0071870),-0.27148086878394395,-0.8136990760206237,0.7235294117647059,0.9297949891477081,1.0,10/23,30.20%,TGM2;SLC9A1;LRRK2;ATF4;PDE4B;ADCY6;NR4A3;APLP1;KCNQ1;RYR2
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.37593797044110494,0.8134872183258102,0.6879084967320261,0.9737775866167678,1.0,3/12,16.96%,UPP2;CAD;DCK
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.27416371580721355,0.81330452343003,0.7360931435963778,0.9735325728119675,1.0,15/62,18.12%,MLLT3;LEO1;CDK13;CDK7;PAF1;ELL;NELFB;SUPT4H1;GTF2F2;GTF2H1;ELOA;TCEA1;RTF1;SETD2;GTF2H3
prerank,mitochondrion disassembly (GO:0061726),-0.2448849081148724,-0.8130283730688669,0.7748344370860927,0.9301594267910396,1.0,15/34,26.99%,SQSTM1;BECN1;GABARAPL1;ULK2;WIPI1;GABARAP;AMBRA1;USP30;MAP1LC3A;WIPI2;ATG12;WDR45B;WDR45;CISD2;FBXO7
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.2696580613506162,-0.8127616226701898,0.7263157894736842,0.9297639527049212,1.0,12/22,31.09%,RPL37;RPS15;RPS7;RPS20;RPL23;EEF1E1;CDK5RAP3;UBB;PLA2R1;MSX1;ATM;EIF5A
prerank,inositol phosphate metabolic process (GO:0043647),0.28366750404843694,0.8126995207482437,0.7037552155771906,0.9740234019475289,1.0,3/46,1.49%,PLCD3;PLCE1;PLCB3
prerank,histone acetylation (GO:0016573),0.2710936769122783,0.8123275284535214,0.7484355444305382,0.9741629178248694,1.0,19/69,19.70%,SPI1;BEND3;HAT1;KAT6B;TAF10;MSL3;TRRAP;PHF20L1;CREBBP;KAT8;BRPF3;BRD8;TADA2A;MORF4L2;TAF5;BRD1;RUVBL2;NAA40;NAA60
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.2720635225700008,0.8116625451084046,0.7301790281329923,0.9748470552874364,1.0,7/62,7.62%,ACKR3;CREB3L1;SRC;SELENOS;NDUFS3;MCL1;MAPK7
prerank,positive regulation of microtubule polymerization (GO:0031116),-0.255189458856395,-0.8116155220702018,0.7804154302670623,0.9309465477788621,1.0,12/28,28.82%,CLIP1;RPS3;MAPT;CDK5R1;ARL2;MET;FES;GIT1;HSPA1A;CDK5RAP2;DCTN1;HSPA1B
prerank,apical protein localization (GO:0045176),0.38021006466425167,0.8115541045983491,0.6795774647887324,0.9744804047380181,1.0,2/10,6.20%,ATP8B1;SHROOM2
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.2892641751507726,-0.8113565617734885,0.7479224376731302,0.9305653573125272,1.0,8/17,27.24%,PODXL;RET;TGFB2;SKAP1;NCKAP1L;CIB1;RAC3;P2RY12
prerank,neuron cell-cell adhesion (GO:0007158),0.3614094045018394,0.8111076702849565,0.67779632721202,0.9747686572552937,1.0,1/14,1.38%,CEL
prerank,negative regulation of autophagy (GO:0010507),0.28100409401047666,0.8110356190902818,0.7282184655396619,0.9743502639267297,1.0,10/54,13.66%,LEPR;FOXK1;PTPN22;MCL1;FOXK2;NRBP2;EIF4E;TAB2;ATG7;KLHL22
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.3170397275710457,0.8110146295617048,0.6919575113808801,0.9738476967350125,1.0,2/26,7.54%,CEACAM1;RARA
prerank,establishment of protein localization to membrane (GO:0090150),-0.21012188314395264,-0.8106794230523168,0.8511627906976744,0.9309063704775624,1.0,16/66,18.02%,PARD3;AFDN;RFTN1;GORASP2;SYNE3;AQP11;RABGEF1;BID;RAB11A;TAOK2;MICALL1;ZDHHC2;VPS37C;ZDHHC14;COX18;RAB11B
prerank,phosphatidylcholine catabolic process (GO:0034638),-0.34332279790689824,-0.8104742102292463,0.713302752293578,0.9303986384305358,1.0,6/10,36.70%,ENPP2;PLA2G15;PLA2G6;LIPC;PLA2G7;PLA2G5
prerank,positive regulation of protein binding (GO:0032092),0.2788598153718838,0.8104116218699179,0.737597911227154,0.9744103653648911,1.0,18/56,22.08%,CAV1;ADD1;DACT1;TRIM21;AMFR;GSK3B;STK3;MEN1;PKD1;CAPRIN2;RAN;PPP2CA;PIN1;PRKN;TCF7L2;NMD3;AKTIP;DERL1
prerank,mRNA modification (GO:0016556),0.325755455351056,0.8103224574350387,0.6996904024767802,0.9740322333934144,1.0,3/22,6.65%,RPUSD2;PUS7;PUS3
prerank,positive regulation of vascular permeability (GO:0043117),0.36198540430429593,0.810268929011813,0.6860068259385665,0.97358490567038,1.0,3/12,8.62%,TRPV4;TJP2;OCLN
prerank,cellular amide metabolic process (GO:0043603),0.25959442961213997,0.8095289126752754,0.7714958775029447,0.9743480837044576,1.0,21/102,15.51%,FOLR2;PCCB;PLPP2;PLPP3;CPE;ACOT13;PLAAT5;MTHFD1;CLN8;CERK;NIT1;ST6GAL1;ACSF2;ACOT8;MME;ACOT2;MIPEP;ABCB9;PANK2;SLC46A1;NLN
prerank,maturation of SSU-rRNA (GO:0030490),-0.24283605737676517,-0.8092006797238375,0.785234899328859,0.9319008676442206,1.0,18/34,30.52%,RPS19;RPS16;RPS8;RIOK1;HEATR1;TSR1;DHX37;MRPS11;RIOK3;UTP4;PWP2;WDR3;RPS14;NOB1;NAT10;WDR46;RRP36;UTP6
prerank,defense response to bacterium (GO:0042742),-0.19218000440579444,-0.8091685106433002,0.8888888888888888,0.9311014723708247,1.0,24/105,23.14%,ANXA3;IL6R;GBP4;RPS19;NOD1;PPP1R11;RPL30;STAB1;PGLYRP1;GBP6;CFP;GBP7;CEBPB;GBP2;ISG15;MR1;RARRES2;ADGRB1;ROMO1;TLR3;OPTN;COLEC12;RPL39;NOD2
prerank,glycolytic process (GO:0006096),0.31340019233806743,0.8090145428305051,0.7253731343283583,0.9747080030614552,1.0,7/28,17.54%,HK2;ALDOB;PGM1;ENO3;GCK;PGK1;ENO2
prerank,aminoglycan metabolic process (GO:0006022),0.3948359843335177,0.8090006795221789,0.6837455830388692,0.9741883623465328,1.0,1/10,2.24%,XYLT2
prerank,histone mRNA catabolic process (GO:0071044),-0.30567175307109595,-0.8088590008356409,0.7321428571428571,0.9308721449468834,1.0,4/15,15.15%,SSB;TENT2;TUT7;MTPAP
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.3203994871956107,0.8085651070042181,0.7105666156202144,0.974441381911033,1.0,1/24,0.80%,ACKR3
prerank,regulation of fibroblast migration (GO:0010762),0.3272312106886143,0.8085273663975938,0.7014218009478673,0.9739680533821294,1.0,1/20,1.21%,PRKCE
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.29631229913263485,-0.8085223277282971,0.715311004784689,0.9306462756494986,1.0,6/15,28.08%,RPS7;RPL23;MAD2L2;RPL5;MAD2L1;RPL11
prerank,positive regulation of transmembrane transport (GO:0034764),-0.3127982903970482,-0.8081123566268755,0.7326968973747017,0.9305779162437026,1.0,5/13,15.51%,ACSL1;C2CD5;CLIP3;P2RX7;CA2
prerank,acyl-CoA metabolic process (GO:0006637),0.29872899262936436,0.8069402887542999,0.7209631728045326,0.9761849488627852,1.0,10/35,17.53%,ACOT13;ACACA;OGDH;ACSF2;DLST;ACOT8;ACOT2;ACACB;SUCLG2;SUCLA2
prerank,RNA methylation (GO:0001510),0.2736976722081041,0.8068022600507521,0.730718954248366,0.9758959255079176,1.0,19/60,24.42%,MRM2;BUD23;RBM15B;TARBP1;TFB2M;METTL5;THADA;FTSJ1;TRMT5;NSUN5;CMTR1;THUMPD3;METTL2B;METTL2A;ZC3H13;TRMO;TFB1M;MEPCE;THUMPD2
prerank,negative regulation of double-strand break repair (GO:2000780),-0.25023131951545324,-0.8065675880002836,0.7603550295857988,0.9325137053662889,1.0,13/30,25.13%,SHLD2;POLQ;HSF1;UBQLN4;TRIP12;CYREN;CGAS;MAD2L2;RMI2;TFIP11;SMCHD1;NUDT16L1;PARPBP
prerank,positive regulation of focal adhesion assembly (GO:0051894),-0.28338131854392173,-0.8061151362979616,0.7435158501440923,0.9324508674811273,1.0,9/19,32.35%,TEK;KDR;NRP1;LIMS1;TSC1;PPM1F;SFRP1;MYOC;HRG
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.36521774846625343,0.8055186651124224,0.685374149659864,0.9776082096682652,1.0,4/12,20.06%,GPLD1;ADCY8;STX4;TRPM4
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.30822297336569865,0.805361941829741,0.7176128093158661,0.9773758206497665,1.0,11/29,21.74%,TRAPPC3L;GOSR1;COG6;COPE;COPG1;COPA;RAB33B;TRAPPC3;COG3;NSF;COG5
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.2632430829261791,0.8047799243012055,0.7435897435897436,0.9778841028145447,1.0,14/83,18.20%,PLK2;CDK15;CDK7;FBXO5;CUL3;EIF4E;CDC6;CRLF3;POLE;E2F1;BACH1;USP37;CUL4B;ORC1
prerank,regulation of monocyte chemotaxis (GO:0090025),0.32286405866982437,0.8047458801557545,0.7065217391304348,0.9774004007939068,1.0,4/24,9.55%,ANO6;CXCL17;NBL1;HMGB1
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),-0.32940435169252036,-0.8046130111363724,0.7128712871287128,0.9342460313703709,1.0,2/10,6.20%,FGFR2;TBX1
prerank,response to cAMP (GO:0051591),0.298978899004259,0.8045839888213187,0.7198838896952104,0.9771283987433821,1.0,2/37,1.92%,RAPGEF3;RAP1A
prerank,positive regulation of response to stimulus (GO:0048584),-0.23024935794550808,-0.8045527738817916,0.803448275862069,0.9335192457864744,1.0,11/40,19.72%,B2M;SELENON;YPEL3;ECHDC3;CD80;TGFB2;CDKN2AIP;ILK;RSAD2;EEF1E1;CGAS
prerank,inositol phosphate biosynthetic process (GO:0032958),0.3591780845946852,0.8045446987661822,0.680628272251309,0.9766461891083651,1.0,5/11,26.36%,PPIP5K2;PPIP5K1;ITPKA;FGF2;IP6K2
prerank,photoreceptor cell development (GO:0042461),-0.30724757284571247,-0.8039235817773448,0.7300469483568075,0.933774518029254,1.0,5/14,21.77%,DCX;RP1;MFSD2A;AHI1;TULP1
prerank,cellular response to ketone (GO:1901655),0.29748091227402895,0.8036486767985401,0.759493670886076,0.9777269215060351,1.0,8/35,15.75%,PTGFR;SRC;ADCY5;PTGER4;ACOD1;AQP1;ADCY8;ADCY3
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.36065485211065784,0.8036241593859333,0.6723259762308998,0.9772190930560224,1.0,3/14,6.67%,PFAS;ATIC;PPAT
prerank,dendrite morphogenesis (GO:0048813),0.29194619026149526,0.8034131856098294,0.7134670487106017,0.9770357618725912,1.0,4/35,6.25%,LRP4;MINK1;DIP2A;EPHB2
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.247035121053542,-0.8033220650009664,0.7638036809815951,0.9339527162526081,1.0,9/32,15.87%,ARHGEF2;STMN2;EML2;CAMSAP1;CLIP3;APC2;STMN1;MID1IP1;TUBB4A
prerank,amide transport (GO:0042886),0.31738633563117863,0.80315822611412,0.6858006042296072,0.9769716065503009,1.0,7/26,17.67%,FOLR1;FOLR2;SLC27A1;CERT1;ABCB9;SLC46A1;SLC19A1
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),-0.24829998846127943,-0.8029898945530475,0.782312925170068,0.9336703081543298,1.0,7/29,15.76%,SMAD3;ADAR;AGO3;PUS10;AGO4;TUT7;ZC3H7A
prerank,negative regulation of microtubule depolymerization (GO:0007026),-0.2715072676158579,-0.8029221428398933,0.765,0.9329627468235381,1.0,11/21,34.04%,ARHGEF2;STMN2;CAMSAP1;APC2;MID1IP1;KATNB1;CIB1;TPX2;CAMSAP3;NAV3;ATXN7
prerank,protein stabilization (GO:0050821),0.2426337951786022,0.8026503986298801,0.8152295632698768,0.9773573610489071,1.0,47/168,21.29%,PPARGC1A;PARVA;GTSE1;WDR81;FLOT2;PLPP3;GNAQ;MORC3;CDK7;BAG3;IRGM;RASSF2;STK3;LAMP1;ATP1B3;ZSWIM7;HYPK;USP13;DVL3;CCT2;PTEN;SOX4;RTN4;PER3;RAB21;TESC;FBXW7;PRKRA;CHP1;BAG2;USP9X;COG3;WFS1;RABL3;PINK1;COA8;LAMP2;AAK1;PFN2;PIN1;SEL1L;SUMO1;CCT3;MUL1;PRKN;TAF9B;PDCL3
prerank,cell part morphogenesis (GO:0032990),0.35862908946134875,0.8026014408978542,0.6957236842105263,0.976891361507912,1.0,2/13,6.72%,FIS1;PACSIN2
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.30386746417072574,0.8021522988642913,0.7339181286549707,0.9771731991590892,1.0,2/30,1.77%,NEDD4L;KCNA5
prerank,macroautophagy (GO:0016236),0.24883347560224783,0.7996482166338277,0.7913247362250879,0.9810237740377211,1.0,38/118,22.46%,DYNLL1;PRKAG1;SRC;MFN2;PIP4K2B;PIK3R4;TSG101;ATG5;MTMR3;CHMP4B;CHMP4A;DYNLL2;VAMP8;ARL8B;CHMP4C;ATG7;LIX1;TOMM40;PIK3C3;EI24;UBQLN1;PLAA;MTERF3;CSNK2A2;ATG3;PINK1;TBC1D5;LAMP2;SNAP29;MAP1LC3B;RB1CC1;VPS16;PRKN;ATG14;TCIRG1;CHMP2A;VIPAS39;VPS36
prerank,regulation of innate immune response (GO:0045088),0.2695689940489697,0.7994589822050086,0.7343957503320053,0.9807948399167804,1.0,9/57,9.18%,PTPN22;IRAK3;TNFAIP3;TRIM21;N4BP1;POLR3G;ACOD1;PLSCR1;TRAFD1
prerank,tRNA metabolic process (GO:0006399),0.3307599547533371,0.7992863927871934,0.6857610474631751,0.9805467482467308,1.0,8/17,23.12%,KARS1;POP7;ADAT1;DARS2;DTD1;RPP21;THG1L;RPP30
prerank,protein mannosylation (GO:0035268),-0.26687612846629427,-0.799264590582495,0.7853260869565217,0.9384365627268251,1.0,3/22,4.35%,TMTC2;TMTC1;DPM1
prerank,endoplasmic reticulum organization (GO:0007029),0.2650389846597404,0.7992419217511693,0.752851711026616,0.9800855141684917,1.0,26/72,26.09%,STX1A;LMAN2;CAV2;EIF2AK3;ATL2;TRAM1;REEP3;LNPK;EMD;OTOF;UBE2J2;RTN4;SEC61G;STX5;REEP4;RAB18;VAMP2;VAPA;PRNP;VCPIP1;VAPB;DNM1L;LMAN1;SERP1;SEC61A1;REEP5
prerank,protein insertion into ER membrane (GO:0045048),0.2902639180076712,0.7989489121452261,0.7489300998573466,0.9800629225191813,1.0,14/37,24.76%,STX1A;EMC9;EMC7;TRAM1;EMD;OTOF;UBE2J2;SEC61G;STX5;VAMP2;VAPA;PRNP;EMC1;SERP1
prerank,detection of visible light (GO:0009584),0.34329077334396074,0.7989329277023354,0.6961414790996785,0.979543806018459,1.0,2/16,5.15%,GNAQ;CNGB1
prerank,apoptotic process (GO:0006915),0.235757595093643,0.7989314346719477,0.8319057815845824,0.979002232494578,1.0,16/203,7.50%,EFNA5;DLC1;PRKCE;FAP;HK2;CYFIP2;OGT;MAGI3;IL1A;CIDEB;EGLN3;TRADD;FASTKD2;MAGEH1;PAX3;SIAH1
prerank,polyamine metabolic process (GO:0006595),0.35203919091681307,0.7986053124816931,0.70578231292517,0.9790331236936192,1.0,4/13,14.42%,SAT2;HDAC6;SMOX;SMS
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.29545709958252153,0.7984043646634489,0.7248603351955307,0.9788192564452389,1.0,7/32,15.86%,BRCC3;BRSK1;NBN;RINT1;UIMC1;DONSON;FZR1
prerank,negative regulation of telomere maintenance (GO:0032205),0.3369538213978521,0.7983471423457124,0.68561872909699,0.9783725357481541,1.0,8/15,27.93%,NBN;ERCC1;TERF2;SLX4;SMG6;TNKS;RAD50;TERF2IP
prerank,negative regulation of ATPase activity (GO:0032780),-0.2924457420329471,-0.7981397921507108,0.7610389610389611,0.9395421122560786,1.0,6/16,27.05%,PAM16;PXK;IFIT1;PLN;OXA1L;TSC1
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.32301748540723474,0.7980428511386622,0.7142857142857143,0.978358281474014,1.0,3/22,7.99%,FLOT2;MAPK7;GCNT2
prerank,protein homooligomerization (GO:0051260),0.24846206765699577,0.7978365883255574,0.7920094007050529,0.9781822088068128,1.0,9/114,7.41%,ALDH1A3;ALDH9A1;BEND3;ACOT13;SPAST;ACACA;NLRC4;ATL2;CLYBL
prerank,positive regulation of cell population proliferation (GO:0008284),0.22826572328664943,0.7975676998698031,0.9089989888776542,0.9781101607099514,1.0,73/423,16.28%,FGF7;NTRK3;CDH13;GLI1;FGFR1;LAMC1;PTGFR;EGFR;FOLR2;FGF1;ACER3;KIF20B;ITGAX;PTHLH;S100A6;SAPCD2;SOX9;BMP5;HDAC4;WNT5A;PTPRC;FN1;CDK13;RPRD1B;FER;CEP131;ADAM10;KRAS;TBX2;EFNB2;HOXC10;FBXO5;RARA;CUL3;GCNT2;DPP4;S100B;FGF18;DDRGK1;TSHR;GAB2;TET1;MECP2;HDAC2;CNOT7;HILPDA;ADRA2A;TBC1D8;SRPK2;IL6ST;PRLR;IL7;PTEN;CD81;AQP1;SOX4;PTPN6;HBEGF;YAP1;CCKBR;FZD9;ERBB4;TMEM119;GPER1;KMT2D;BAD;SAAL1;S1PR2;KITLG;ERBB2;E2F1;MDK;IL15
prerank,adipose tissue development (GO:0060612),-0.3222343219621346,-0.7971492037149702,0.7279411764705882,0.9403817404947176,1.0,5/11,24.18%,ARID5B;LRP5;DGAT2;XBP1;NAMPT
prerank,peptidyl-threonine modification (GO:0018210),0.2684688648365312,0.7971081964586493,0.7821011673151751,0.9783448155178118,1.0,16/66,19.99%,CAMK2D;GALNTL6;PRKCA;HIPK1;DYRK1A;CAD;GSK3B;CIT;TBK1;CSNK2A2;GALNT4;LMTK2;DYRK2;PDPK1;ACVR1;CDC42BPG
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.3609786402292662,0.7968523978560547,0.7008403361344537,0.9782519100012719,1.0,2/11,9.74%,SCARA3;TICAM1
prerank,polyol metabolic process (GO:0019751),0.2795496562539007,0.7968220398325562,0.7318435754189944,0.9777632297086526,1.0,3/46,1.49%,PLCD3;PLCE1;PLCB3
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.25875087484721776,0.7965654346544822,0.7646341463414634,0.9776785572230189,1.0,22/87,19.42%,SDHAF4;LYRM7;NDUFA6;COA5;NDUFB10;NDUFS3;NDUFS6;IMMP2L;COX19;SDHAF2;NDUFA3;NDUFV2;NDUFV1;COX16;NDUFA7;BCS1L;NDUFAF5;DMAC2;NDUFS2;NDUFAF6;COA8;SURF1
prerank,positive regulation of protein targeting to membrane (GO:0090314),-0.2604022611251998,-0.7963150897944785,0.8005865102639296,0.9409090338993394,1.0,10/24,26.38%,KCNB1;C2CD5;ANK3;MTCL1;MIEF2;TCAF2;HRAS;ITGB2;CIB1;ITGAM
prerank,ncRNA catabolic process (GO:0034661),0.30814799413543237,0.7959203260546838,0.7151424287856072,0.9782599829600949,1.0,4/28,9.67%,EXOSC5;DIS3L2;LIN28B;EXOSC10
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.30544469083781073,0.7957518681263358,0.7038690476190477,0.978010800611358,1.0,1/29,1.15%,MBOAT2
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.33977595305738273,0.7955692880227123,0.691358024691358,0.9777967158739477,1.0,3/18,10.46%,EGFR;NCOR1;NCOR2
prerank,negative regulation of histone acetylation (GO:0035067),0.36850824966228674,0.7954739481151912,0.7183098591549296,0.9774509254294904,1.0,1/11,3.51%,SPI1
prerank,establishment of apical/basal cell polarity (GO:0035089),0.34957338802819604,0.7949327441744047,0.7045454545454546,0.9778515625643549,1.0,6/14,18.19%,OPHN1;FOXJ1;PATJ;EZR;SCRIB;RHOA
prerank,proteasome assembly (GO:0043248),0.36599275878637183,0.7949265429745297,0.6954314720812182,0.9773239946029963,1.0,4/11,15.66%,PSMG2;PSMG1;POMP;PSMD13
prerank,positive regulation of protein deacetylation (GO:0090312),0.35330119162800444,0.7945689847055665,0.6956521739130435,0.9773871718932347,1.0,3/14,15.83%,DYRK1A;FNTA;SAP30BP
prerank,cellular response to light stimulus (GO:0071482),-0.20964961980774285,-0.7942385361479773,0.8584905660377359,0.9434780468810162,1.0,16/66,19.97%,USP28;PTPRK;EP300;RPL26;NPM1;CDC25A;EIF2AK4;KDM1A;NOC2L;POLK;ZBTB1;NSMCE3;DHX36;ATF4;PARP1;ERCC4
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.345186197167283,0.7939255428466929,0.7140468227424749,0.9779945080846134,1.0,4/15,13.81%,TSEN54;RTRAF;TSEN34;ERN1
prerank,positive regulation of mRNA catabolic process (GO:0061014),-0.22433006443656023,-0.7934641074907725,0.852233676975945,0.9439826203008216,1.0,19/44,30.97%,ROCK2;ZC3HAV1;PABPC1;ZC3H12A;YTHDF1;MOV10;TNRC6C;ZFP36;RC3H1;DHX36;YTHDF2;METTL16;RIDA;YTHDF3;RBM24;NANOS3;MEX3D;METTL14;NANOS1
prerank,synaptonemal complex organization (GO:0070193),0.3469231387897925,0.7934499907371378,0.7179902755267423,0.9777295391947454,1.0,3/15,18.29%,TEX11;REC8;SYCP2
prerank,synaptonemal complex assembly (GO:0007130),0.3469231387897925,0.7934499907371378,0.7179902755267423,0.9777295391947454,1.0,3/15,18.29%,TEX11;REC8;SYCP2
prerank,embryonic heart tube morphogenesis (GO:0003143),-0.22624013303939494,-0.7932730123853988,0.8613138686131386,0.9434332839405226,1.0,10/43,16.29%,ENG;TBX3;NPHP3;SOX17;ZIC3;VANGL2;MEGF8;MKKS;AHI1;SOX18
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.3598801104763874,0.793031865424465,0.7150735294117647,0.9778782531785206,1.0,5/12,22.48%,RBM15B;LRIF1;PCGF3;CDYL;YTHDC1
prerank,carbohydrate derivative catabolic process (GO:1901136),0.32981031641736336,0.7930258972514206,0.7232,0.9773482704950445,1.0,5/18,16.51%,NAGA;BPGM;MANBA;DERA;OGA
prerank,peptidyl-lysine dimethylation (GO:0018027),0.3284864499996879,0.7928918199410566,0.7054140127388535,0.9770189061352617,1.0,5/18,17.85%,KMT2A;SUV39H1;KMT2D;SETD2;SUV39H2
prerank,regulation of presynapse assembly (GO:1905606),-0.2790741727806233,-0.7928376603857241,0.7568306010928961,0.9424782941158125,1.0,10/18,30.87%,LRRC4B;MDGA1;PTPRD;EIF4G1;IL1RAPL2;SLITRK2;SLITRK3;LRFN4;VPS35;LRFN5
prerank,regulation of presynapse organization (GO:0099174),-0.2790741727806233,-0.7928376603857241,0.7568306010928961,0.9424782941158125,1.0,10/18,30.87%,LRRC4B;MDGA1;PTPRD;EIF4G1;IL1RAPL2;SLITRK2;SLITRK3;LRFN4;VPS35;LRFN5
prerank,negative regulation of protein modification process (GO:0031400),0.25914236050382583,0.792721330878241,0.769041769041769,0.9767766930291063,1.0,12/79,12.77%,NTRK3;PTPN13;PLPP3;ATP2B4;IBTK;EPHB2;OCLN;GSK3B;MEN1;ENSA;PTEN;PTPA
prerank,peptidyl-glutamic acid modification (GO:0018200),0.312102961171231,0.7923285871573957,0.7147147147147147,0.9769090807810028,1.0,5/24,17.21%,TTLL1;AGBL4;CFAP20;NAA10;TTLL9
prerank,DNA catabolic process (GO:0006308),0.36099339989688556,0.792228408375877,0.7195945945945946,0.9765562440938853,1.0,4/11,24.97%,DFFB;REXO4;DNASE1L1;FBH1
prerank,positive regulation of protein import (GO:1904591),0.29830223552913643,0.7921944073632645,0.7359307359307359,0.9760712434623217,1.0,8/30,15.86%,ARHGEF5;UBR5;BAG3;RBM22;PIK3R2;TPR;RAN;CDH1
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),-0.2706220783933141,-0.7921113471147787,0.7717391304347826,0.9428493155272619,1.0,5/20,13.34%,SLC8A3;SMDT1;SLC25A23;MICU1;MICU2
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.3048635346771144,0.7916461489515562,0.7263464337700145,0.9764934981349948,1.0,3/29,9.80%,SPI1;CRTAM;LAMP1
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.317476424224821,0.7911408908026963,0.7094281298299846,0.9768096759931884,1.0,9/22,22.01%,PSMB5;NFE2L2;PSMA6;PSMB2;PSMA2;PSMA7;PSME4;PSMB6;PSMB3
prerank,regulation of lipoprotein lipase activity (GO:0051004),-0.27764654627092644,-0.7908666381781616,0.7547169811320755,0.9441174860553582,1.0,5/17,14.44%,NR1H3;HDAC9;NR1H2;FURIN;SORT1
prerank,long-term memory (GO:0007616),-0.28337641577734524,-0.7907248617704292,0.7583333333333333,0.9434928124766291,1.0,8/19,17.75%,LDLR;RASGRF1;APOE;EIF2AK4;CAMK4;CALB1;PJA2;KAT2A
prerank,positive regulation of mitochondrial translation (GO:0070131),0.34867684990768566,0.7906927848848884,0.7029702970297029,0.9770482712029142,1.0,4/14,18.71%,RMND1;FASTKD2;MPV17L2;RPUSD4
prerank,protein depolymerization (GO:0051261),0.3036325674936393,0.7902915101701867,0.7435114503816794,0.9771888255684789,1.0,4/27,8.72%,KIF2A;NCKAP5L;CKAP5;MICAL3
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.26213830972514,0.7902831278966289,0.7749360613810742,0.9766703417584465,1.0,5/65,7.35%,CAV1;SPRED1;SPRY1;PPM1A;LDLRAD4
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.3455207274873838,0.7901159137548457,0.722488038277512,0.9764392754290812,1.0,6/14,23.81%,SRSF4;SFSWAP;SAP18;SRSF12;SRSF10;RBMX
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.2707061374951931,0.789956902406184,0.7558139534883721,0.9761843129056874,1.0,10/58,11.88%,SMC5;BRCC3;PAXX;NBN;UBE2V2;UIMC1;HMGB1;ERCC6;ERCC1;MDC1
prerank,response to unfolded protein (GO:0006986),0.2813585159172672,0.7896037114514414,0.7702127659574468,0.9762824102982236,1.0,14/48,22.08%,HSPH1;DNAJC4;SERPINH1;BAG3;ERN1;HSPA4;ERP44;BAX;DNAJB4;DDIT3;PRKN;DAXX;HSPA9;DERL1
prerank,phospholipid metabolic process (GO:0006644),0.2613614673022245,0.7893881874779628,0.7581274382314694,0.9761376424414827,1.0,11/71,16.10%,PLPP2;ACP6;PLPP3;PIP4K2B;AGPAT4;CLN8;ABHD12;AGPAT5;PLPPR1;LPL;PLAA
prerank,glucan biosynthetic process (GO:0009250),0.3563382590980857,0.7887674456054504,0.7272727272727273,0.9761249099500134,1.0,2/12,7.83%,GYS1;PGM1
prerank,glycogen biosynthetic process (GO:0005978),0.3563382590980857,0.7887674456054504,0.7272727272727273,0.9761249099500134,1.0,2/12,7.83%,GYS1;PGM1
prerank,folic acid-containing compound metabolic process (GO:0006760),0.32392842056538185,0.7880578460604503,0.7219730941704036,0.9768141289745882,1.0,5/19,17.67%,FOLR2;MTHFD1;SLC46A1;ALDH1L2;SLC19A1
prerank,regulation of actin filament depolymerization (GO:0030834),-0.30842930890144915,-0.7880467211553653,0.766109785202864,0.9471116020522381,1.0,1/12,1.07%,PLEKHH2
prerank,synaptic vesicle cycle (GO:0099504),0.30318222410729634,0.7875930740958206,0.7364568081991215,0.9770760065973764,1.0,4/30,7.36%,STX1A;BRSK1;RAB3A;CPLX1
prerank,regulation of response to biotic stimulus (GO:0002831),-0.24866572338107548,-0.7875144847165375,0.8149253731343283,0.9471293716851046,1.0,8/28,17.98%,FOXP1;APPL2;SAMHD1;LRP8;IRF1;GATA6;ERAP1;CASP8
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.3678957745306635,0.7869084791720701,0.717391304347826,0.9777230132682201,1.0,4/11,16.93%,PRKCA;RDX;JAK1;SYK
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.3073772451114302,0.7857845718565544,0.7436281859070465,0.979075269550175,1.0,4/27,11.19%,MAP3K1;IRAK3;TNIP1;TAB2
prerank,protein mono-ADP-ribosylation (GO:0140289),0.36556557676842844,0.7855063323881207,0.7291311754684838,0.9790241233146781,1.0,3/11,12.98%,PARP11;PARP6;PARP8
prerank,positive regulation of axon extension (GO:0045773),0.3198119954046835,0.7854630537205287,0.7109375,0.9785770039351531,1.0,2/22,4.46%,NTN1;DSCAM
prerank,photoperiodism (GO:0009648),0.3036705693779685,0.7854049799618202,0.7263313609467456,0.9781375194256824,1.0,7/28,17.34%,CRTC1;BHLHE40;FBXL17;FBXL12;PER3;FBXL3;PPP1CA
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.2926248467089118,0.7853649276496615,0.7481698389458272,0.9776786034738307,1.0,6/32,18.20%,CDK15;FBXO5;CDC6;E2F1;BACH1;ORC1
prerank,positive regulation of exocytosis (GO:0045921),0.2911774901667574,0.7851206478783814,0.7374631268436578,0.9775543488588386,1.0,14/35,25.99%,TSG101;SDC1;RAB3A;PDCD6IP;RAB2B;SDC4;RAB27B;RAB5A;CHMP2A;RAB9A;SNF8;STAM;ATP6AP1;CLASP2
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.3267024846441795,0.7847312035587768,0.6982055464926591,0.9777045541635117,1.0,4/20,9.24%,CAMK2D;FKBP1B;ATP1A2;CASQ2
prerank,renal water homeostasis (GO:0003091),0.3166827536143871,0.78462185021681,0.7119645494830132,0.9773612821000249,1.0,9/23,18.98%,ADCY5;PRKAR2A;ADCY9;AQP1;PRKACB;ADCY8;ADCY3;WFS1;RAB11FIP2
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.3323440133413821,0.7840417566981259,0.7056962025316456,0.9778012480259217,1.0,4/18,13.07%,NF1;MORC3;PEX2;EMD
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.36804320578430716,0.7837218389509191,0.7341137123745819,0.9778207540208423,1.0,2/11,6.89%,LEO1;PAF1
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.2923820954274324,0.7828002496241314,0.7643758765778401,0.9788496928015953,1.0,3/37,7.50%,CAV1;FIS1;SIAH1
prerank,regulation of defense response to virus by host (GO:0050691),0.29857068596503383,0.7827132159093576,0.7323741007194244,0.9784724727321604,1.0,3/30,6.13%,PTPN22;TNFAIP3;ZDHHC1
prerank,regulation of regulated secretory pathway (GO:1903305),-0.23180827805587728,-0.7823506189964887,0.8156996587030717,0.9546745131449257,1.0,17/34,34.69%,SYT9;SYT7;SYN1;LRRK2;PREPL;DTNBP1;SYT13;RIMS1;SYT6;RAB27A;RIMS3;RAB15;SYT15;SYT1;SYT5;SYT17;UNC13D
prerank,striated muscle cell development (GO:0055002),0.3487936806242825,0.7822177377978824,0.7174657534246576,0.9787833197267874,1.0,4/14,13.90%,TMOD2;SDC1;TMOD1;FLII
prerank,cellular response to leucine (GO:0071233),-0.33134460606559923,-0.7813556871478178,0.735981308411215,0.9545082727836087,1.0,1/10,0.84%,UBR1
prerank,response to leucine (GO:0043201),-0.33134460606559923,-0.7813556871478178,0.735981308411215,0.9545082727836087,1.0,1/10,0.84%,UBR1
prerank,positive regulation of secretion by cell (GO:1903532),-0.2024368392779467,-0.7812174202218121,0.897196261682243,0.9539005131578302,1.0,14/70,16.03%,IGF1;BMP6;KCNB1;CADPS;TGFB3;MYH10;SYTL4;BMP2;TGFB2;MYO18A;EDN1;DTNBP1;ABCG1;P2RX4
prerank,Golgi ribbon formation (GO:0090161),-0.2957358781004105,-0.7800715014936805,0.7697841726618705,0.9548719626414406,1.0,5/13,21.47%,GOLGA2;MYO18A;STX16;STX6;OPTN
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.3046774194066576,0.7794441668120314,0.7313432835820896,0.9829905035897087,1.0,7/27,17.34%,CRTC1;BHLHE40;FBXL17;FBXL12;PER3;FBXL3;PPP1CA
prerank,cellular response to starvation (GO:0009267),0.2415626987893984,0.7790808169367179,0.8502857142857143,0.9830706236957704,1.0,18/147,9.26%,INHBB;MYBBP1A;EIF2AK3;FOXO3;PRKAG1;KLF10;ATP6V0D2;WDR24;MIOS;PIK3R4;PDK4;BRSK1;ATG5;RIPOR1;SESN1;MAP3K5;MTMR3;STK24
prerank,mucosal immune response (GO:0002385),0.3365667074387082,0.7788458490348354,0.7320819112627986,0.9829177483540085,1.0,3/15,18.97%,DEFA6;OTUD7B;RNASE3
prerank,visual system development (GO:0150063),0.29231347219323867,0.778795539232958,0.7602941176470588,0.9824754524914476,1.0,6/37,8.78%,PBX1;BMPR1B;SH3PXD2B;HIPK1;FREM2;ABCB5
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.24684233204484346,0.7783583746773839,0.8305489260143198,0.982698660927698,1.0,14/101,10.61%,FGFR1;EGFR;CCND3;FGF1;SRC;WNT5A;SLC27A1;ATP2B4;SYAP1;FGF18;IRGM;DIPK2A;FERMT2;ADRA2A
prerank,protein deubiquitination (GO:0016579),0.23031766245606788,0.7779789824705042,0.8833510074231177,0.9827655938049787,1.0,54/242,18.81%,USP50;TNIP3;OGT;BRCC3;TFPT;FOXK1;PSME3;TAF10;KEAP1;TNFAIP3;USP8;OTUB2;CCP110;FOXK2;USP48;UIMC1;TNIP1;PSMB5;CDC20;ACTR8;USP47;MINDY2;TRRAP;USP13;OTUD7B;APC;INO80;PTEN;USP4;USP15;UBE2D1;PSMA6;POLB;PSMB2;PSMA2;USP35;COPS5;PSMD13;STAMBPL1;PSMA7;DDB2;INO80B;STAMBP;USP45;USP37;NFRKB;USP9X;PSME4;RHOA;PSMD12;PSMD14;PSMB6;FOXO4;PSMC4
prerank,meiosis I (GO:0007127),-0.2596810429549378,-0.7779739778288086,0.7834757834757835,0.9575311424955627,1.0,3/23,8.65%,BCL2L11;FOXJ3;MYBL1
prerank,negative regulation of signaling receptor activity (GO:2000272),0.3107284745777489,0.7779710741055526,0.7295208655332303,0.9822491548668515,1.0,5/25,11.99%,SOCS5;TSG101;EPHB2;CBLB;SOCS4
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),-0.3088097181781793,-0.7779130440789255,0.7493606138107417,0.9567949154268652,1.0,3/13,9.52%,ENPP1;BPNT2;TPST1
prerank,synaptic vesicle transport (GO:0048489),0.36200277699867106,0.7776677339628052,0.7084048027444254,0.9822357929621071,1.0,4/11,19.75%,KIF5A;KIF5B;TMEM230;SPG11
prerank,cardiac muscle tissue development (GO:0048738),0.2734358345708411,0.7773491181511697,0.7691309987029832,0.982194120986425,1.0,7/50,8.42%,SGCD;AKAP13;SGCG;CSRP3;BMP5;TBX2;TBX18
prerank,positive regulation of neuron death (GO:1901216),0.28000320156839087,0.7769306942233987,0.7554054054054054,0.9823562190023644,1.0,9/46,11.47%,NF1;FOXO3;WNT5A;EFNB2;MAP3K5;GSK3B;SARM1;SRPK2;EGR1
prerank,regulation of autophagosome maturation (GO:1901096),-0.29935563473267557,-0.7766186872585412,0.7475961538461539,0.9580089471625725,1.0,3/13,14.53%,UVRAG;RUBCN;UBQLN4
prerank,axoneme assembly (GO:0035082),0.2973188638971886,0.7765598616836469,0.7426900584795322,0.9824191140440884,1.0,4/30,9.63%,SPEF1;SPAG17;CCDC39;FOXJ1
prerank,cellular response to amino acid starvation (GO:0034198),-0.2026375596282341,-0.776537019025413,0.8809523809523809,0.9572834536262852,1.0,22/71,22.78%,FAS;LAMTOR3;SEH1L;DEPDC5;SH3GLB1;RNF152;ATP6V0C;EIF2AK4;RRAGC;ATP6V1C1;ATF2;RRAGD;CEBPB;ATP6V1D;ATF4;CASTOR2;ATP6V1F;CASTOR1;LAMTOR2;ATP6V1E1;PRKD1;SLC38A9
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.2656759854647348,0.7761686333406437,0.781491002570694,0.9825637484278138,1.0,21/59,24.01%,RUNX2;SOX9;MED7;AGO1;MED13;MECP2;MED23;PTEN;CBFB;MED12;MED8;MED31;BAX;MED15;IL6;TWIST1;TCF7L2;MED16;JUN;MED27;MED20
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),-0.3096576122920241,-0.7761199546325459,0.7444933920704846,0.9570892093676673,1.0,4/12,25.62%,IL18;CD80;PAEP;IL17D
prerank,maintenance of protein location in nucleus (GO:0051457),0.32213602324619284,0.7760221644508039,0.7409733124018838,0.9822686259132783,1.0,3/20,9.60%,BCL3;MORC3;SUN1
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",0.3675612151201593,0.7757879228049179,0.7317939609236235,0.9821256556040926,1.0,1/10,2.63%,ANO6
prerank,organic cation transport (GO:0015695),0.3183422952655262,0.7756885777206,0.7283763277693475,0.9817685662916134,1.0,6/20,17.80%,SLC29A4;SLC22A3;SEC14L1;SLC25A26;SLC25A19;RALBP1
prerank,mesenchymal to epithelial transition (GO:0060231),-0.32556820352887555,-0.7756590829987278,0.7602739726027398,0.9569681381841109,1.0,2/10,16.97%,BMP4;SALL1
prerank,regulation of phosphatase activity (GO:0010921),0.31004932684599096,0.7756226511886309,0.7476780185758514,0.9813594533147201,1.0,8/24,24.75%,SH3RF2;PTPA;HTT;CHP1;PPP6R3;PPP6R1;PPP6R2;URI1
prerank,regulation of steroid biosynthetic process (GO:0050810),0.35658788940326186,0.7756057323167739,0.7220338983050848,0.9808646568478416,1.0,5/11,19.04%,BMP5;EGR1;NR5A1;ASAH1;STAR
prerank,regulation of cellular amide metabolic process (GO:0034248),-0.22941315750229335,-0.7751392248405071,0.8143322475570033,0.9569770824254556,1.0,14/32,31.20%,PICALM;PGAM1;EIF2A;TCOF1;RBM4B;TIGAR;NR1H4;GEMIN5;TSC1;MTPN;NANOS3;GRM5;RBM3;TMED10
prerank,erythrocyte development (GO:0048821),-0.32332914825928977,-0.7747986907039811,0.7858823529411765,0.9566441022089737,1.0,4/10,28.13%,ABCB10;ALAS1;NCKAP1L;ALAS2
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.3283223349226677,0.7743019702165803,0.7361344537815127,0.9825403801564309,1.0,2/15,8.22%,FAP;DPP4
prerank,Golgi to plasma membrane protein transport (GO:0043001),-0.2420826885144281,-0.7741843889901976,0.8253012048192772,0.9567279187045857,1.0,10/30,23.25%,VAMP5;ANK3;SEC16A;MACF1;BBS2;PREPL;GGA3;SYS1;OPTN;RAB10
prerank,protein localization to lysosome (GO:0061462),0.29861391451314195,0.7741571745177792,0.7533834586466165,0.9822633206701816,1.0,9/28,19.01%,ZFYVE16;M6PR;GCC2;NEDD4;CD81;RTN4;SCARB2;AP3M1;LAMTOR5
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.32893776071296543,0.773624952433517,0.7391304347826086,0.9826392227219504,1.0,4/17,12.31%,AKAP13;GPR101;ADRA2A;ADCY9
prerank,response to amino acid starvation (GO:1990928),-0.20066737634635592,-0.7733631738892287,0.8894230769230769,0.9572029194418656,1.0,22/72,22.78%,FAS;LAMTOR3;SEH1L;DEPDC5;SH3GLB1;RNF152;ATP6V0C;EIF2AK4;RRAGC;ATP6V1C1;ATF2;RRAGD;CEBPB;ATP6V1D;ATF4;CASTOR2;ATP6V1F;CASTOR1;LAMTOR2;ATP6V1E1;PRKD1;SLC38A9
prerank,regulation of hemopoiesis (GO:1903706),0.36726494066196946,0.7730677848491093,0.7298245614035088,0.983045882287053,1.0,3/10,15.41%,CREBBP;CBFB;RUNX1
prerank,negative regulation of cilium assembly (GO:1902018),0.3506605272778439,0.7730310115432957,0.7343485617597293,0.982581642914926,1.0,4/12,14.33%,LIMK2;CCP110;MAP4;YAP1
prerank,male gonad development (GO:0008584),0.28644622118859087,0.7729160577029474,0.7449567723342939,0.9822469174898539,1.0,7/34,15.85%,WNT2B;SOX9;WNT5A;MSH2;CSDE1;NR5A1;KITLG
prerank,establishment of spindle orientation (GO:0051294),0.29847517786894956,0.7724475645314591,0.7643593519882179,0.9824915717872434,1.0,9/28,21.76%,SAPCD2;PAFAH1B1;MAP4;NDE1;HTT;ZW10;ITGB1;GPSM2;FBXW11
prerank,pre-replicative complex assembly (GO:0036388),0.2629351537363782,0.7716673878083139,0.7756160830090791,0.9832479831057456,1.0,18/64,18.81%,PSME3;ORC5;PSMB5;ORC3;CDC6;PSMA6;PSMB2;PSMA2;PSMD13;PSMA7;GMNN;PSME4;ORC6;PSMD12;ORC1;PSMD14;PSMB6;PSMC4
prerank,peptidyl-serine modification (GO:0018209),0.23304030387485228,0.7716028015058313,0.8614864864864865,0.9828136947058783,1.0,19/166,11.99%,PLK2;PRKCE;CAMK2D;STK38;EIF2AK3;PRKCA;MORC3;HIPK1;BRSK1;STK38L;DYRK1A;CSNK1G3;GSK3B;RPS6KA3;CSNK1A1;MASTL;SRPK2;TOP1;SGK1
prerank,protein localization to phagophore assembly site (GO:0034497),-0.3145496504038613,-0.7715468173035905,0.7711442786069652,0.9591273754975532,1.0,6/11,24.97%,WIPI1;STX17;ATG13;WIPI2;WDR45B;WDR45
prerank,DNA recombination (GO:0006310),-0.22478503408743244,-0.7715176887206897,0.875,0.9583364567745526,1.0,4/37,5.83%,RAD51B;TSN;WRN;BLM
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),-0.2681536100899291,-0.771352706257748,0.774869109947644,0.957734734178288,1.0,4/19,17.06%,SLCO1C1;KLF4;KLF2;EGF
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.27628670331294714,0.7713091500861883,0.7690140845070422,0.9827716133209523,1.0,8/39,16.85%,ASS1;JAG1;RDX;MAPK7;NF2;PLG;CDH1;RGCC
prerank,polyol biosynthetic process (GO:0046173),0.32236522757142433,0.771279077984532,0.7313432835820896,0.9822974839250468,1.0,2/16,7.05%,ACER3;PPIP5K2
prerank,mRNA polyadenylation (GO:0006378),0.2989142853914476,0.7711420586118535,0.7522388059701492,0.9814717726848042,1.0,12/26,25.72%,LEO1;TUT1;PAF1;CSTF3;SYMPK;PAPOLG;CDC73;PCF11;CPSF2;WDR33;TENT4B;PNPT1
prerank,RNA polyadenylation (GO:0043631),0.2989142853914476,0.7711420586118535,0.7522388059701492,0.9814717726848042,1.0,12/26,25.72%,LEO1;TUT1;PAF1;CSTF3;SYMPK;PAPOLG;CDC73;PCF11;CPSF2;WDR33;TENT4B;PNPT1
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",-0.19218993347165952,-0.770610447768182,0.9326424870466321,0.9579951153908516,1.0,24/80,22.37%,DENND5A;RAB6B;TRAPPC10;TMED9;RHOBTB3;GOSR2;RBSN;SURF4;UBE2O;RGP1;VPS26B;PREPL;BET1L;CLN5;STX16;STX6;PLEKHJ1;YKT6;HEATR5A;TBC1D17;RNF126;VTI1B;RAB7B;RAB7A
prerank,regulation of chromosome segregation (GO:0051983),0.32989356432298156,0.7705640764611025,0.7381342062193126,0.9818858922612085,1.0,5/16,21.09%,SMC5;CDC6;PUM2;CSNK2A2;PUM1
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),-0.289527358205798,-0.7703571843676388,0.7559241706161137,0.9575539085354922,1.0,4/14,23.01%,ENTPD1;ENTPD5;ENTPD3;NUDT16
prerank,neuron fate commitment (GO:0048663),-0.28751381172210905,-0.7699962133099668,0.7721822541966427,0.9572793314981531,1.0,6/14,27.86%,TGFBR1;MYT1L;ID2;POU3F2;DLL4;DLL1
prerank,response to glucocorticoid (GO:0051384),-0.2512108785300927,-0.7698664508426282,0.7933333333333333,0.956657222933749,1.0,3/26,7.85%,SLIT2;BCL2L11;ANXA1
prerank,cellular response to drug (GO:0035690),-0.24446595207666763,-0.7694940047781367,0.7957559681697612,0.9563634476393007,1.0,2/25,2.97%,ACER2;TFRC
prerank,neutrophil activation (GO:0042119),0.34780949829808333,0.7694809848757231,0.7138103161397671,0.9831524324315633,1.0,4/12,24.07%,IL15;SYK;PREX1;PRKCD
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),-0.31421965872632496,-0.7693732637831499,0.7652173913043478,0.954879037821332,1.0,5/11,20.98%,FKBP1A;CALM1;CALM3;SRI;GSTO1
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),-0.31421965872632496,-0.7693732637831499,0.7652173913043478,0.954879037821332,1.0,5/11,20.98%,FKBP1A;CALM1;CALM3;SRI;GSTO1
prerank,epithelial cell differentiation (GO:0030855),0.24919032043620226,0.7679343376300711,0.8098676293622142,0.9851022529851764,1.0,16/88,17.39%,GLI1;CDHR2;JAG1;ANXA4;ZDHHC7;HDAC2;GSTK1;KDM6B;FZD7;ERBB4;UPK1A;FSTL1;PPARG;PGK1;CTSB;SCRIB
prerank,positive regulation of protein depolymerization (GO:1901881),0.34857782185567343,0.7673866720462915,0.7395104895104895,0.9854658784253221,1.0,3/11,14.40%,TRPV4;PLEK;CFL2
prerank,protein ubiquitination (GO:0016567),0.21934734534997768,0.7671683559498697,0.9493414387031408,0.9852873879196926,1.0,91/471,18.54%,NEDD4L;PDZRN3;UBE2L6;ZNRF2;FBXL15;PELI2;DTX1;UBE2E2;SH3RF2;IRF2BP1;LZTR1;UBE3C;RNF122;LMO7;SPSB4;PSME3;LRSAM1;LEO1;TMEM129;KEAP1;TRIM21;UBR5;SELENOS;CHFR;PEX2;PAF1;UBE2V2;FBXO31;SIAH1;ZNRF3;CUL3;DTX4;PSMB5;AMFR;BLMH;LNPEP;RNF220;ANAPC7;UBE3D;ANAPC11;TRPC4AP;OBI1;RCHY1;KLHL7;FBXL19;NEDD4;LONRF1;FBXL5;KLHL21;FBXL17;FBXO11;NFE2L2;CBFB;RFWD3;KLHL22;FBXO21;RNF185;UBA1;UBE2J2;UBE2D1;UBE2D3;PSMA6;PSMB2;PSMA2;WWP2;FBXW8;PSMD13;UBE2R2;TRIM5;FBXL12;FANCL;PSMA7;DDB2;FBXO41;FBXW7;ITCH;RTF1;FBXL3;CUL4B;USP9X;PSME4;ANAPC16;RNF7;KLHL18;VPS11;CDC23;PSMD12;ATG3;PSMD14;PINK1;PSMB6
prerank,eye photoreceptor cell development (GO:0042462),0.3369533236870643,0.7669711232904901,0.7275922671353251,0.9850806679444541,1.0,3/15,12.93%,RORB;CEP290;RPGRIP1L
prerank,lytic vacuole organization (GO:0080171),0.3009814826624939,0.7667238478965469,0.7649635036496351,0.9849414376264509,1.0,5/32,11.59%,HOOK2;HPS1;ABCA1;TFEB;HOOK3
prerank,mitotic spindle assembly (GO:0090307),0.27895288671047536,0.7665698444798422,0.7752808988764045,0.9846843188903128,1.0,8/42,18.44%,KIF2A;RACGAP1;SMC3;MAP9;ARHGEF10;PIBF1;RHOA;OFD1
prerank,peroxisome organization (GO:0007031),0.3027061654963494,0.7663730918572041,0.7656967840735069,0.9844882006483474,1.0,5/25,12.85%,FIS1;TMEM135;PEX2;ACOT8;ABCD1
prerank,protein localization to organelle (GO:0033365),0.2368974003556084,0.7659950862528317,0.851685393258427,0.9845728877213584,1.0,44/133,24.85%,ZNF423;STX1A;SCG3;CSRP3;PACSIN2;SNX10;PAF1;RIPOR1;ARF6;DDRGK1;OBSCN;COL1A1;TRAM1;LAMP1;GCC2;TTC21B;EMD;OTOF;TMEM30A;UBE2J2;SEC61G;YWHAE;RAB33B;STX5;EHD1;COG3;CEP250;LAMP2;BBS1;DHX9;TIA1;TULP2;VAMP2;IFT140;ZBTB7A;VAPA;PRNP;ARL3;CD68;BMP7;SIX1;MDM2;SERP1;CSNK1D
prerank,negative regulation of reproductive process (GO:2000242),0.3210312906526809,0.765945209928952,0.7431192660550459,0.9841214477210275,1.0,2/17,4.92%,SULF1;ACVR1C
prerank,ether lipid biosynthetic process (GO:0008611),-0.3217738580001594,-0.7658432014587992,0.7674943566591422,0.9594233841496921,1.0,1/10,3.53%,CHPT1
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.324257158768741,0.7657519109421166,0.7442622950819672,0.9839323975327435,1.0,6/17,16.54%,APLN;TAFA5;EFEMP2;PTEN;GPER1;PPARG
prerank,protein targeting to peroxisome (GO:0006625),0.293629497228118,0.76502680669916,0.7588757396449705,0.9845845067979272,1.0,5/29,12.85%,RAB8B;FIS1;PEX2;PXMP2;ABCD1
prerank,nitrogen compound transport (GO:0071705),0.23360629255586565,0.7647831962040825,0.8553530751708428,0.9844847757405569,1.0,21/141,14.11%,LRRC8D;SLC12A2;CD3G;SLC38A2;SLC29A4;SLC22A3;ABCC1;SLC6A13;SEC14L1;SLC7A2;SLC52A1;SLC7A14;CERT1;CD320;CUBN;SLC3A1;CEP290;AMN;AQP1;SLC6A4;TMEM30A
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.2802195433273439,0.7643177482948428,0.7684365781710915,0.9847265385090984,1.0,4/37,8.77%,OGT;FHIT;N4BP1;DDRGK1
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.24842747469451015,0.7642106023668996,0.8189349112426035,0.98436448357886,1.0,22/87,18.81%,WEE1;PSME3;DACT1;KANK2;FBXO5;PSMB5;USP47;APC;PTEN;ZFP36L2;FHL1;PSMA6;PSMB2;PSMA2;PSMD13;PSMA7;RGCC;PSME4;PSMD12;PSMD14;PSMB6;PSMC4
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.2985395208138128,-0.763278493178796,0.7658536585365854,0.9625127069874276,1.0,5/12,21.61%,SGTA;SEC61B;SEC62;SGTB;GET3
prerank,negative regulation of autophagosome assembly (GO:1902902),-0.29585727993326705,-0.7631621566907574,0.7852028639618138,0.9618437226727714,1.0,5/13,20.74%,NUPR1;LRRK2;FEZ2;SCFD1;SEC22B
prerank,regulation of dendrite morphogenesis (GO:0048814),0.28711666033823435,0.761733244484405,0.7771428571428571,0.9878160957353546,1.0,8/32,15.43%,NEDD4L;CDKL3;GSK3B;SARM1;NEDD4;SEMA4D;CAPRIN2;FBXW8
prerank,positive regulation of protein polymerization (GO:0032273),0.25571493737084233,0.761201854520484,0.8077922077922078,0.9881667002155478,1.0,16/65,22.54%,PRKCE;CDC42EP4;FER;NCK2;ARF6;OCLN;CTTN;CDC42EP3;SLAIN2;BAIAP2;PINK1;PFN2;NCK1;HCK;TENM1;RAC1
prerank,positive regulation of histone deacetylation (GO:0031065),-0.303916721275875,-0.7611675095038725,0.8123515439429929,0.963933444223426,1.0,4/12,29.71%,AKAP8L;APLNR;PRKD1;CTBP1
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.29986107954077973,0.7609681641580437,0.7676923076923077,0.9880158326375347,1.0,6/24,18.47%,PSME3;TMF1;PKD1;RHBDF1;PSMD14;PINK1
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.28681075337021833,0.7604275304366519,0.746031746031746,0.9883654690302967,1.0,3/30,8.30%,ACKR3;FBXO5;DYRK1A
prerank,regulation of rRNA processing (GO:2000232),0.32889318385543986,0.7602094572433515,0.7528641571194763,0.9881904180552344,1.0,3/16,9.47%,BUD23;UTP15;SIRT7
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),-0.32573956428530987,-0.7599476536002662,0.7727272727272727,0.9640744456824305,1.0,2/10,3.36%,NUPR1;CBFA2T3
prerank,negative regulation of glycolytic process (GO:0045820),-0.32573956428530987,-0.7599476536002662,0.7727272727272727,0.9640744456824305,1.0,2/10,3.36%,NUPR1;CBFA2T3
prerank,negative regulation of secretion (GO:0051048),-0.3241051720469036,-0.7598129591292637,0.7647058823529411,0.9634383128431616,1.0,8/10,42.62%,NR1H3;EGF;ERBB3;SPX;NRG1;VAMP3;TIFAB;CD74
prerank,positive regulation of mRNA processing (GO:0050685),0.3122884688651413,0.7582770379691708,0.7430340557275542,0.990841439819345,1.0,7/21,19.87%,LEO1;PAF1;CELF4;RBMXL1;TRA2B;PRDX6;CDC73
prerank,response to interferon-beta (GO:0035456),-0.2538844517232371,-0.7581894371399817,0.8044692737430168,0.9650086735356452,1.0,4/22,10.63%,IFNAR2;UBE2K;BST2;IRF1
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),-0.3101180132565222,-0.7578555490070555,0.7869955156950673,0.9646574343292177,1.0,4/11,26.43%,FAS;LGALS9;PLAUR;CAAP1
prerank,glycoprotein metabolic process (GO:0009100),-0.20624560162907163,-0.7576610470665206,0.9288888888888889,0.9641255803484412,1.0,14/53,20.08%,ST8SIA4;MGAT4A;ST6GALNAC3;HIF1A;STT3B;GANC;FBXO17;B4GALT7;ST8SIA2;FUT8;GCNT1;FBXO44;GAL3ST2;ST8SIA1
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),0.34251102574470577,0.7575453066301873,0.7558922558922558,0.9914563650342211,1.0,4/14,13.24%,KEAP1;FAF1;NFKBIB;PKD1
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.30475770803753993,0.7573487406032985,0.7736686390532544,0.9912315706532266,1.0,8/24,20.19%,NF1;FOXO3;MCL1;SRPK2;BACE1;FBXW7;BAX;DDIT3
prerank,cell differentiation in spinal cord (GO:0021515),0.37198393523078516,0.7570323081116038,0.7370304114490162,0.9912222237134101,1.0,3/10,13.63%,ZC4H2;ISL1;SOX4
prerank,histone H3 acetylation (GO:0043966),-0.21364125107787532,-0.7566741501925099,0.9224806201550387,0.9647147242637475,1.0,10/40,17.75%,LEF1;JADE1;TRIM16;PHF14;KAT14;SGF29;DR1;KAT2B;JADE2;KAT2A
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),0.35839953171822914,0.7565467104760139,0.7190812720848057,0.9914659735280585,1.0,1/10,3.04%,PDE4D
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),0.3449249890151278,0.7561369096692216,0.7392055267702936,0.991606412691533,1.0,11/11,65.53%,NFKBIZ;MALT1;NFKBID;NLRP10;CLEC6A;IL23R;IL12B;IL23A;CARD9;IL12RB1;PRKCQ
prerank,sarcomere organization (GO:0045214),-0.24139586112930067,-0.7555305856707032,0.8203592814371258,0.9655270673941319,1.0,2/27,2.04%,ACTN2;TPM1
prerank,monocarboxylic acid metabolic process (GO:0032787),0.23473213652267794,0.7555227711039919,0.8539976825028969,0.992053245747755,1.0,22/117,17.09%,ALDH1A3;PCCB;CYP2S1;HOGA1;CKMT2;DLAT;SCPEP1;ABAT;SLC27A4;ACSF2;GAMT;ACOT2;SLC16A1;MSMO1;PNPLA8;AASDH;PANK2;GGT1;LPL;PPARG;ME2;LDHB
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.29101080550615244,0.7554379651292326,0.7829131652661064,0.99168292521917,1.0,5/31,19.04%,HSD17B3;PRLR;LSS;MOCS2;STAR
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.31577370333633714,0.7549659688085264,0.7632,0.9918885089215612,1.0,6/18,19.42%,COA5;COX19;COX16;BCS1L;COA8;SURF1
prerank,regulation of cytokine production (GO:0001817),0.23426391678284395,0.7545841987200586,0.8803317535545023,0.9920082596835134,1.0,16/126,11.04%,GLMN;ITK;TXK;IL1A;PTPRC;TRIM21;N4BP1;PLD3;IGF2BP2;PTGER4;CRTAM;DTX4;NLRP4;HILPDA;ADRA2A;CD276
prerank,negative regulation of microtubule polymerization (GO:0031115),-0.30546688711872466,-0.754579634282735,0.7913486005089059,0.9660534294152865,1.0,5/12,15.87%,STMN2;EML2;CLIP3;STMN1;TUBB4A
prerank,protein acylation (GO:0043543),0.2759832495046364,0.7544129641394444,0.7812061711079944,0.9917378864692129,1.0,10/38,15.20%,ZDHHC1;ZDHHC7;ZDHHC23;CREBBP;ZDHHC13;NAT9;ZDHHC20;GLUL;ZDHHC8;NAA10
prerank,natural killer cell mediated cytotoxicity (GO:0042267),-0.27543904183958623,-0.7543673032043244,0.7958115183246073,0.9655308472840033,1.0,5/16,21.67%,CEBPG;VAMP7;TUBB4B;PLEKHM2;RAET1E
prerank,regulation of macroautophagy (GO:0016241),0.24012637053543812,0.754185271090104,0.8515439429928741,0.9915808507853922,1.0,24/105,21.42%,DCN;PRKAG1;ATP6V0D2;SCOC;SESN1;NRBP2;ATP6V0A1;PAFAH1B2;NEDD4;HDAC6;ERN1;RRAGB;SNX5;UBQLN1;TBK1;BNIP3;PINK1;ATP6V1G1;LAMTOR5;RPTOR;RB1CC1;CAPN1;TSC2;MAPK8
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.35318326607563455,0.7541776109180133,0.7651245551601423,0.9910741809699342,1.0,8/11,31.18%,NAGK;GNPDA2;GFPT2;GFPT1;AMDHD2;RENBP;GNPNAT1;GNPDA1
prerank,chemokine-mediated signaling pathway (GO:0070098),0.27583443209709974,0.7540496616734091,0.7869742198100407,0.9907536497396241,1.0,1/42,0.80%,ACKR3
prerank,cellular response to DNA damage stimulus (GO:0006974),0.2149839766733117,0.7537638870134092,0.9334016393442623,0.9906788410956285,1.0,74/336,21.16%,NFATC2;BCL3;UBE2E2;SMC5;MSH6;POLI;PAXX;CIDEB;WDR76;KMT5C;FANCC;PDS5B;BRSK1;RFC3;FANCF;NBN;UBR5;HIC1;MCL1;FBXO31;SUV39H1;MSH2;AATF;BOD1L1;SFN;SIRT7;USP47;MASTL;TRRAP;APC;TDP1;INO80;ERCC1;MEN1;MGMT;OARD1;GTF2H1;CHCHD6;ALKBH1;RFWD3;ADPRS;ETAA1;UBA1;HTRA2;YAP1;POLB;NEK4;REXO4;RECQL5;BATF;FAM111A;FANCL;E2F1;DDB2;INTS3;BACH1;CHD1L;USP45;CUL4B;PSME4;DYRK2;GTF2H3;MTREX;BAX;MRE11;ATR;RPAIN;SUMO1;DDIT3;SUSD6;SLX4;ASH2L;DDX11;RAD9A
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.2990047191260261,-0.7537424916587679,0.7950617283950617,0.9655888809210507,1.0,2/13,16.83%,CYRIB;MR1
prerank,protein K63-linked ubiquitination (GO:0070534),-0.21725853420687638,-0.7534678387744976,0.8715277777777778,0.965151020732798,1.0,7/41,9.60%,RNF115;TRAF3IP2;UBE2N;TRAF6;RNF152;UBE2S;UBE2O
prerank,protein modification by small protein removal (GO:0070646),0.22269060617189862,0.7534203570576875,0.9049630411826821,0.9906865180191422,1.0,54/252,18.81%,USP50;TNIP3;OGT;BRCC3;SENP6;TFPT;FOXK1;PSME3;TAF10;KEAP1;TNFAIP3;USP8;OTUB2;CCP110;FOXK2;USP48;UIMC1;TNIP1;PSMB5;CDC20;ACTR8;USP47;TRRAP;USP13;OTUD7B;APC;INO80;PTEN;USP4;USP15;UBE2D1;PSMA6;POLB;PSMB2;PSMA2;USP35;COPS5;PSMD13;STAMBPL1;PSMA7;DDB2;INO80B;STAMBP;USP45;USP37;NFRKB;USP9X;PSME4;RHOA;PSMD12;PSMD14;PSMB6;FOXO4;PSMC4
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),-0.3120815589123218,-0.7531923357919309,0.7938388625592417,0.964691870592733,1.0,5/11,19.67%,BLM;TIPIN;ZRANB3;LIG3;TIMELESS
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),0.3525990666772645,0.753058330933433,0.7469458987783595,0.9907044825549816,1.0,2/11,7.10%,PCBP2;IGF2BP2
prerank,negative regulation of JUN kinase activity (GO:0043508),0.3539145184889039,0.75274656612715,0.7418244406196214,0.990661666949229,1.0,2/10,10.30%,PTPN22;MAPK8IP1
prerank,glutathione biosynthetic process (GO:0006750),-0.3084235794788423,-0.7525044769777011,0.8045977011494253,0.9648165284939665,1.0,4/11,17.66%,GCLM;GGCT;CNDP2;GCLC
prerank,protein deacylation (GO:0035601),0.29918440577094113,0.7524637446842344,0.7688751926040062,0.990589020668951,1.0,12/23,27.56%,HDAC4;SIRT3;SIRT7;HDAC6;ABHD10;HDAC3;ABHD17C;LYPLA2;SIRT2;SIN3A;HDAC5;PPT1
prerank,ribosomal large subunit assembly (GO:0000027),-0.24253864516589213,-0.7522395577233305,0.8255813953488372,0.9644043598735086,1.0,11/24,33.84%,RPLP0;RPL3;MRPL20;NLE1;PPAN;RPL5;RPF2;RPL11;RPL24;NOP53;DDX28
prerank,membrane repolarization (GO:0086009),-0.2787983993471707,-0.7522063004741686,0.7976539589442815,0.9636211197387355,1.0,7/15,29.91%,KCNJ2;ATP1B1;ATP1B2;KCNE4;KCNH2;ATP1A1;KCNQ1
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.2896712965477971,-0.7521627003445518,0.8251231527093597,0.9628592657419506,1.0,3/13,20.64%,TMSB4X;PER2;MAD2L2
prerank,negative regulation of osteoclast differentiation (GO:0045671),-0.26758437808100743,-0.7518226910630779,0.7962962962962963,0.9625213697377402,1.0,11/18,43.15%,GPR137B;TLR3;FSTL3;TCTA;TMEM178A;LILRB3;LILRB1;CARTPT;LRRC17;TLR4;IL4
prerank,regulation of DNA recombination (GO:0000018),0.28052789168986525,0.7517673167729008,0.772189349112426,0.9911596563510306,1.0,4/32,7.73%,MSH6;SMARCAD1;KPNA2;MSH2
prerank,positive regulation of sprouting angiogenesis (GO:1903672),0.32352568478513644,0.75135814742459,0.7702265372168284,0.9912776338608382,1.0,6/15,24.11%,FGF1;JAK1;ITGA5;PDPK1;PKM;FGF2
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),-0.28614796733555325,-0.7508469863474371,0.8119266055045872,0.963075365080665,1.0,6/14,35.08%,IL18;CD80;PAEP;IL17D;RASGRP1;CD84
prerank,regulation of necroptotic process (GO:0060544),0.29585657018274203,0.7506326506390424,0.7725856697819314,0.9918879064924695,1.0,3/23,9.01%,OGT;FLOT2;PDCD6IP
prerank,receptor recycling (GO:0001881),-0.3104053005503943,-0.7501762989854718,0.7747747747747747,0.9631893306437066,1.0,4/10,18.02%,ARFGEF2;NSG1;PLEKHJ1;RAB11B
prerank,gas transport (GO:0015669),0.34153553430342576,0.7497601249762218,0.7204861111111112,0.9927145470556539,1.0,2/10,13.15%,IPCEF1;AQP1
prerank,purine nucleotide catabolic process (GO:0006195),-0.29092116690356046,-0.7490362923447893,0.7946210268948656,0.9639140707252868,1.0,5/13,25.11%,XDH;NT5C;HINT1;NT5C1A;GDA
prerank,pyrimidine nucleobase metabolic process (GO:0006206),0.3372623386024513,0.7488714424954361,0.7504273504273504,0.993512975246059,1.0,4/12,15.25%,DPYS;DPYSL2;CTPS2;DPYSL5
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),-0.2539438620386364,-0.7487637345636822,0.828169014084507,0.9634556674132753,1.0,4/21,12.22%,NES;PROX1;TOX;KDM1A
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),-0.2894385934457964,-0.7484587603679783,0.796875,0.9630588437060598,1.0,7/14,28.38%,PAXIP1;SNW1;DNMT3B;SMAD4;BRCA1;WDR5;KMT2E
prerank,T cell differentiation (GO:0030217),0.2720085823852104,0.7483717001814697,0.7736111111111111,0.993773029852957,1.0,4/40,5.03%,LEPR;SPI1;PTPN22;PTPRC
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),-0.1913294982490859,-0.7482492812793655,0.9537037037037037,0.9624832835865075,1.0,18/72,20.58%,ENPP1;EDC3;RBX1;ZC3H12A;EDC4;PNRC2;ERCC2;POLK;XPA;MUS81;SPO11;RFC2;PDE12;GTF2H4;DDX1;PARP1;ERCC4;ERCC5
prerank,transport along microtubule (GO:0010970),-0.2916622147848966,-0.7479364641347551,0.8108108108108109,0.9620784682654531,1.0,3/13,11.60%,CDC42;BORCS5;CLIP3
prerank,release of cytochrome c from mitochondria (GO:0001836),0.31367476126423854,0.7479138475511701,0.7732919254658385,0.9939605938254795,1.0,9/17,28.18%,FIS1;SFN;FZD9;BAD;BAX;DNM1L;MFF;BCL2L1;BCL2
prerank,endochondral bone morphogenesis (GO:0060350),0.3471435883068579,0.7468326698402701,0.7570422535211268,0.9951014740080519,1.0,2/11,4.13%,TRPV4;BMPR1B
prerank,sister chromatid segregation (GO:0000819),0.2810880738310655,0.7467228509384743,0.786628733997155,0.9947616817533883,1.0,8/31,17.63%,TUBG1;DSN1;INO80;TUBG2;KLHL22;ZW10;RAN;CENPK
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.26843252912581733,0.746624123996236,0.7974504249291785,0.9943944690778032,1.0,12/39,22.17%,TFR2;ISL1;RASL10B;GCK;AIMP1;SOX4;GPER1;BAD;IRS2;GLUD1;TCF7L2;NLGN2
prerank,mitotic cytokinesis (GO:0000281),0.26751181357249043,0.7462882053646307,0.8145695364238411,0.9943719258069548,1.0,12/47,17.41%,RACGAP1;SON;USP8;SPAST;PDCD6IP;CNTROB;CHMP4B;APC;CIT;RTKN;STAMBP;SPTBN1
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.2897644743949006,0.7462748330155906,0.7588757396449705,0.9938811798496717,1.0,7/27,18.51%,PISD;SLC27A1;PLAAT5;ETNK2;PNPLA8;LPIN1;SELENOI
prerank,negative regulation of viral genome replication (GO:0045071),0.2713986937659834,0.7462393420033201,0.7960339943342776,0.9934274258580077,1.0,7/40,10.97%,N4BP1;SRPK1;TNIP1;PLSCR1;RESF1;ILF3;SRPK2
prerank,response to prostaglandin E (GO:0034695),-0.3108541660547938,-0.7461390890565253,0.7831325301204819,0.9637155629220143,1.0,1/10,1.69%,TGFBR3
prerank,CENP-A containing chromatin organization (GO:0061641),-0.23123185311252217,-0.7459509800268712,0.8490566037735849,0.9623202994795018,1.0,14/29,31.71%,NPM1;RUVBL1;SMARCA5;CENPT;CENPP;CENPC;MIS18BP1;CENPO;CENPQ;CENPX;CENPI;MIS18A;CENPN;CENPA
prerank,CENP-A containing nucleosome assembly (GO:0034080),-0.23123185311252217,-0.7459509800268712,0.8490566037735849,0.9623202994795018,1.0,14/29,31.71%,NPM1;RUVBL1;SMARCA5;CENPT;CENPP;CENPC;MIS18BP1;CENPO;CENPQ;CENPX;CENPI;MIS18A;CENPN;CENPA
prerank,mitotic sister chromatid segregation (GO:0000070),0.23913722508717494,0.7457847476467395,0.8599033816425121,0.993596986797688,1.0,28/98,22.38%,NUP62;PDS5B;TUBG1;DSN1;CUL3;DIS3L2;TEX14;CHMP5;PDCD6IP;CHMP4B;CHMP4A;INO80;CHMP4C;TUBG2;KLHL22;ZW10;RAN;REC8;PIBF1;CSNK2A2;CENPK;CDC23;DCTN2;KMT5A;RRS1;CHMP2A;PRC1;MIS12
prerank,pre-miRNA processing (GO:0031054),-0.2750016090191695,-0.7456362278191924,0.8222811671087533,0.9619018616384231,1.0,4/14,14.96%,ADAR;AGO3;AGO4;TUT7
prerank,atrioventricular valve development (GO:0003171),-0.27517391380972644,-0.7453084062926513,0.8010335917312662,0.9615134063040456,1.0,5/14,24.87%,BMPR2;BMP2;TGFB2;APLNR;NOTCH1
prerank,spindle assembly (GO:0051225),0.24837187953379797,0.7452975922263761,0.8479087452471483,0.9938266329159812,1.0,17/67,21.94%,KIF2A;SMC3;NEK7;NCOR1;TUBGCP5;INO80;MAP9;MAPRE2;ARHGEF10;PIBF1;RHOA;OFD1;HDAC3;TUBGCP6;HAUS8;HAUS3;NEK6
prerank,regulation of apoptotic process (GO:0042981),0.2111234670724981,0.7449458566589711,0.9779338014042126,0.9938782695568383,1.0,98/676,14.77%,NGF;ITGA6;PLK2;DKKL1;TIAM2;EGFR;BCL3;PPP1R13B;SH3RF2;ANO6;TNFAIP8;GPLD1;NF1;TFPT;AKAP13;RNF122;PHLDA3;STIL;APH1B;FOXO3;CIDEB;SOX9;VAV2;SRC;WNT5A;ACVR1C;TRIO;NUP62;EGLN3;SON;DDAH2;ANXA4;NCSTN;TRADD;ARHGEF5;ADAM10;PHLDA1;MCL1;NLRC4;ARHGEF1;BAG3;PERP;SIAH1;NAA35;MAP3K5;KALRN;PHLPP1;RBM5;AATF;DDRGK1;OBSCN;SLC27A4;GSK3B;RASSF2;RPS6KA3;STK3;NLRP2B;HMGB1;USP47;AXL;HDAC2;TAX1BP1;HYPK;RARG;IL6ST;HTATIP2;PROC;APC;PRLR;NF2;SGK1;LANCL1;ARHGEF6;FBXO11;FAF1;MGMT;SEMA4D;TMBIM4;IL7;CREBBP;PTPA;DHCR24;AQP1;ATG7;LCMT1;ADAMTSL4;DIABLO;SOX4;HTT;DDX42;HTRA2;PTPN6;DNAJA3;RTN4;FZD9;CHM;AIFM2;UNC13B
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.302479851445595,0.7447209360505586,0.7802547770700637,0.9937138199106338,1.0,3/23,5.31%,SPI1;PPM1A;UACA
prerank,negative regulation of RNA metabolic process (GO:0051253),0.3190119425894282,0.744663570496098,0.7597503900156006,0.9932967412486164,1.0,5/18,12.48%,NCOR1;PTBP3;RPS13;NCOR2;PTBP2
prerank,membrane depolarization during action potential (GO:0086010),0.2876769290354992,0.7445241205692914,0.7672281776416539,0.9929785403819923,1.0,3/26,5.41%,SCN10A;CACNA1H;ATP1A2
prerank,UV protection (GO:0009650),0.34868815807331954,0.7443208348487944,0.7508417508417509,0.992776514584655,1.0,1/10,2.16%,SCARA3
prerank,eye photoreceptor cell differentiation (GO:0001754),-0.29999074215406596,-0.744094277684136,0.8181818181818182,0.9622664886143623,1.0,2/12,3.59%,NKD1;PROM1
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.34687941800963323,0.7439710412641712,0.7536496350364964,0.9928261360440697,1.0,5/10,22.39%,BAG3;NCK1;IMPACT;JUN;SIRT2
prerank,interstrand cross-link repair (GO:0036297),0.258560289378608,0.7439103391712096,0.8169582772543742,0.9924166657080542,1.0,13/53,21.89%,FAAP24;MSH6;FANCC;FANCF;ERCC1;NUCKS1;RFWD3;RAD51AP2;FANCL;ERCC6L2;ATR;SLX4;RPA3
prerank,apoptotic DNA fragmentation (GO:0006309),0.32866044778894316,0.7436034053759846,0.7844408427876823,0.9923875336549336,1.0,4/16,14.26%,DFFB;HMGB1;EXOG;DICER1
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.3460948408353637,0.7435959952522622,0.7469458987783595,0.991892122439294,1.0,2/10,7.79%,CHFR;DIS3L2
prerank,GTP metabolic process (GO:0046039),-0.2796918945018057,-0.7434578716914568,0.8137755102040817,0.9623102125577881,1.0,3/15,15.47%,LRRK2;IMPDH1;OPA1
prerank,regulation of TOR signaling (GO:0032006),-0.19598649211999397,-0.7429664681297325,0.9457013574660633,0.9621560273773268,1.0,12/67,14.40%,UBR1;FNIP1;LAMTOR3;SEH1L;FBXO9;DEPDC5;RRAGC;TMEM127;RICTOR;GSK3A;DEPTOR;RRAGD
prerank,regulation of endocytic recycling (GO:2001135),-0.2996262033525625,-0.7429484699586419,0.8114942528735632,0.961376146750497,1.0,4/11,18.02%,ACTN2;ARHGAP1;EIPR1;RAB11B
prerank,establishment of mitotic spindle orientation (GO:0000132),0.2979236268304844,0.7429317527363459,0.7740458015267175,0.9924028474186312,1.0,8/23,21.76%,SAPCD2;PAFAH1B1;NDE1;HTT;ZW10;ITGB1;GPSM2;FBXW11
prerank,negative regulation of cholesterol transport (GO:0032375),-0.3153852060240769,-0.7426503843208568,0.8111888111888111,0.9609540213172028,1.0,3/10,37.42%,ABCA2;APOC1;SHH
prerank,regulation of histone methylation (GO:0031060),0.33046329459168255,0.7424734604392631,0.755,0.9925854206865914,1.0,2/13,9.28%,PAF1;TET1
prerank,T cell migration (GO:0072678),0.3336847894154747,0.7419711965293855,0.7647058823529411,0.9928576409449558,1.0,2/13,11.84%,SLC12A2;GPR183
prerank,organic hydroxy compound biosynthetic process (GO:1901617),-0.21633907429371474,-0.741625642189031,0.9166666666666666,0.9614600945008106,1.0,6/44,12.75%,PRKAG2;INSIG2;OSBPL1A;OSBPL9;SCP2;PMVK
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.2724709344587072,0.7414841472813813,0.8319444444444445,0.9930615170957192,1.0,8/38,14.91%,NDUFA6;NDUFB10;NDUFS3;NDUFS6;NDUFA3;NDUFV2;NDUFV1;NDUFA7
prerank,negative regulation of immune system process (GO:0002683),0.31258833685495746,0.7414533816010642,0.7529411764705882,0.9926041804337613,1.0,2/16,5.68%,SOX9;COL3A1
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),-0.28887451908762785,-0.7414009850782854,0.8301435406698564,0.9609616137518123,1.0,6/12,29.73%,WAC;PLK5;RPS27L;CDK2;CCND1;PLK3
prerank,negative regulation of cellular component organization (GO:0051129),0.24641844740466878,0.7412244672476568,0.8369152970922883,0.9924472637690318,1.0,11/74,13.38%,FAP;RAPGEF3;SRC;IRAK3;LRSAM1;RDX;ISL1;GSK3B;HDAC6;SACS;LCMT1
prerank,dendritic cell chemotaxis (GO:0002407),0.32809837067301273,0.7408868185264242,0.7629032258064516,0.9924249831506198,1.0,4/14,20.06%,HMGB1;GPR183;CCR5;TRPM4
prerank,protein modification by small protein conjugation (GO:0032446),0.21394387167666334,0.7407930944369416,0.9587628865979382,0.9920520151823532,1.0,86/361,22.08%,NEDD4L;PDZRN3;FBXL15;DTX1;STX1A;EYA1;LZTR1;LMO7;UBE2I;SPSB4;LEO1;TMEM129;NUP62;KEAP1;TRIM21;SELENOS;CHFR;PEX2;PAF1;UBE2V2;PIAS2;ZNRF3;CUL3;DTX4;AMFR;NUP160;DDRGK1;RNF220;ANAPC7;NUP37;ANAPC11;TRPC4AP;TPR;RCHY1;KLHL7;NEDD4;NUP50;RANBP2;FBXL5;KLHL21;FBXL17;FBXO11;NFE2L2;NUP153;NUP210;ATG7;RFWD3;UBA1;UBE2J2;UBE2D1;UBE2D3;WWP2;FBXW8;NUP93;UBE2R2;TRIM5;FBXW7;URM1;ITCH;RTF1;FBXL3;CUL4B;USP9X;ANAPC16;RNF7;KLHL18;VPS11;CDC23;ATG3;PINK1;UBE2W;CDC73;PEX13;TRPM4;SUMO1;RNF14;CUL7;MKRN1;MUL1;RNF157;PRKN;FBXW11;TRAF7;CUL5;NUP43;DERL1
prerank,positive regulation of protein kinase activity (GO:0045860),0.22651655429041645,0.7406515869640903,0.8891402714932126,0.9917492456626729,1.0,21/148,11.47%,RAP1A;AXIN1;MINK1;PRKAG1;MMD2;SRC;SLC27A1;PTPRC;TOM1L1;LCP2;SRCIN1;SYAP1;IRGM;RASSF2;STK3;DLG3;LAT;ADRA2A;RELN;TAB2;EGR1
prerank,DNA metabolic process (GO:0006259),0.21500581375967098,0.7405593244327774,0.9291754756871036,0.9913760412736766,1.0,55/270,18.20%,MSH6;TDG;POLI;KMT5C;NTHL1;SMARCAD1;FANCC;PDS5B;KPNA2;RFC3;STN1;ORC5;NBN;UBE2V2;TOP3B;MSH2;DFFB;NT5E;SIRT7;HMGB1;TRRAP;ORC3;AXIN2;SRPK2;LONP1;TDP1;INO80;TOP1;ERCC1;MEN1;MGMT;CDC6;GEN1;GTF2H1;ALKBH1;ADPRS;POLB;REXO4;RECQL5;RAN;POLE;FANCL;DDB2;INTS3;BACH1;CHD1L;USP45;GMNN;TERF2;RFC1;PSME4;ORC6;GTF2H3;NOC3L;ORC1
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.30185094598421724,0.7402493049535979,0.8103448275862069,0.9913351126923794,1.0,3/21,6.41%,EIF2AK3;CREB3L1;SELENOS
prerank,O-glycan processing (GO:0016266),0.25281267486654607,0.7401370244641599,0.8313253012048193,0.9909990382930998,1.0,5/54,9.04%,ST3GAL4;C1GALT1C1;GCNT4;ST6GAL1;POFUT1
prerank,proteasomal protein catabolic process (GO:0010498),0.21874101552774988,0.7397623119320305,0.9144385026737968,0.9910693429867904,1.0,50/201,22.39%,NEDD4L;RNF122;PCBP2;SPSB4;PSME3;SOCS6;SIAH1;CUL3;PSMB5;SIAH3;UBE3D;SHARPIN;FBXL19;NEDD4;SPOPL;FBXL17;FAF1;NFE2L2;KLHL22;RNF185;UBE2D3;PSMA6;PSMB2;FEM1C;PSMA2;WWP2;PSMD13;PSMA7;PLAA;FBXW7;ITCH;CUL4B;PSME4;PSMD12;PSMD14;PSMB6;PSMC4;UBE2W;KBTBD7;SEL1L;DDIT3;GID4;PRKN;PPP2R5C;FBXW11;ZNRF1;PSMB3;DERL1;GID8;SIRT2
prerank,negative regulation of protein dephosphorylation (GO:0035308),0.30255423348196625,0.7394167041564284,0.8102643856920684,0.9910829039817258,1.0,7/21,16.59%,FKBP1B;BOD1L1;GSK3B;MASTL;ENSA;PTPA;YWHAE
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",0.32628060113370216,0.739189838098899,0.7853658536585366,0.9909390023699719,1.0,7/15,28.98%,CNTNAP4;ZDHHC3;ZDHHC12;NLGN2;USP46;ADRA1A;STXBP1
prerank,histone mRNA metabolic process (GO:0008334),-0.23487013799401316,-0.7390789873623821,0.8780487804878049,0.9631892525984098,1.0,7/27,17.41%,SSB;TENT2;SNRPE;TUT7;MTPAP;NCBP1;LSM11
prerank,selective autophagy (GO:0061912),0.25372767815099195,0.738620450437013,0.8344459279038718,0.9913028570621539,1.0,16/56,23.16%,DYNLL1;WDR81;ATG5;DDRGK1;DYNLL2;HDAC6;UBQLN1;LGALS8;ATG2B;MAP1LC3B;DYNC1LI2;RB1CC1;PRKN;ATG14;DYNC1I1;TEX264
prerank,telomere maintenance via telomere trimming (GO:0090737),-0.30406345636838955,-0.7385142019461554,0.8018223234624146,0.961460525559407,1.0,2/10,5.83%,WRN;BLM
prerank,t-circle formation (GO:0090656),-0.30406345636838955,-0.7385142019461554,0.8018223234624146,0.961460525559407,1.0,2/10,5.83%,WRN;BLM
prerank,formation of extrachromosomal circular DNA (GO:0001325),-0.30406345636838955,-0.7385142019461554,0.8018223234624146,0.961460525559407,1.0,2/10,5.83%,WRN;BLM
prerank,transcription by RNA polymerase I (GO:0006360),-0.22019378652948712,-0.7384674379386865,0.8600682593856656,0.960724759098847,1.0,12/34,23.88%,MNAT1;TAF1D;ERCC2;TCOF1;POLR2F;CCNH;TAF1C;GTF2H4;POLR2K;POLR1C;POLR1F;RRN3
prerank,synaptic vesicle exocytosis (GO:0016079),0.26891072006306294,0.7374318769855341,0.821236559139785,0.9925976046461896,1.0,13/40,22.27%,STX1A;RIMS2;RAB3A;CPLX1;STX2;STX19;OTOF;UNC13B;STX4;SNAP23;SNAP29;VAMP2;SNPH
prerank,positive regulation of macrophage chemotaxis (GO:0010759),-0.2805090396668176,-0.7373333767719398,0.8307692307692308,0.9614111827520792,1.0,6/14,18.85%,CMKLR1;IL34;THBS1;PTK2;CSF1;RARRES2
prerank,cellular lipid catabolic process (GO:0044242),0.291767974965619,0.7367395475579874,0.7935779816513762,0.993140460207341,1.0,4/27,10.43%,CEL;MGST2;ABHD12;ACOT8
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.27261386300204604,0.7366245949619565,0.804005722460658,0.9928022687314205,1.0,7/34,16.91%,DOCK5;DOCK1;RREB1;FERMT2;P4HB;MDK;ARHGEF7
prerank,V(D)J recombination (GO:0033151),-0.30334950354840307,-0.7351849470486445,0.8126410835214447,0.9633351569913624,1.0,4/11,24.64%,DCAF1;LIG3;XRCC4;LIG4
prerank,positive regulation of interleukin-10 production (GO:0032733),-0.22262686982357677,-0.7344784554571194,0.8978328173374613,0.9634120291716002,1.0,8/30,27.91%,CD34;PLCG2;PRKCZ;LGALS9;ISG15;NOD2;PYCARD;STAT3
prerank,IRE1-mediated unfolded protein response (GO:0036498),-0.20087300869095348,-0.7344376468776617,0.9308943089430894,0.9626649715305534,1.0,14/52,21.54%,DNAJC3;PREB;GOSR2;SSR1;WIPI1;TPP1;SYVN1;LMNA;GSK3A;TLN1;DNAJB11;TATDN2;SEC31A;XBP1
prerank,mitotic sister chromatid cohesion (GO:0007064),0.3187496582272301,0.7340869350373926,0.7915309446254072,0.9960224373886606,1.0,3/16,17.56%,PDS5B;REC8;DSCC1
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.32328501002219423,0.7338431582122277,0.7840136054421769,0.9958702442951287,1.0,3/14,11.14%,TSEN54;RTRAF;TSEN34
prerank,leukocyte tethering or rolling (GO:0050901),0.31551314625741167,0.7337057097741937,0.7777777777777778,0.9955727960918517,1.0,6/17,24.51%,ITGB7;PODXL2;ITGB1;GOLPH3;CX3CR1;ROCK1
prerank,regulation of neurogenesis (GO:0050767),0.25171771504677964,0.7331243027362468,0.8307291666666666,0.995924880235643,1.0,13/55,21.50%,RGS14;HEYL;BHLHE40;DOCK7;MME;HOOK3;PCM1;YAP1;GPER1;NAP1L1;IL6;CX3CL1;CX3CR1
prerank,myelination in peripheral nervous system (GO:0022011),0.331773449568985,0.7328772447830215,0.7785467128027682,0.9957806135204771,1.0,8/13,24.39%,NF1;CNTNAP1;NCMAP;DICER1;ARHGEF10;PRX;SIRT2;SKI
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.23627416310948726,0.732197699336433,0.8877805486284289,0.9962764687648537,1.0,13/86,15.23%,PRKCE;CDC42EP4;TRPV4;FER;NCK2;ARF6;OCLN;PLEK;EFEMP2;CTTN;CFL2;CDC42EP3;SLAIN2
prerank,protein localization to mitochondrion (GO:0070585),0.3356538434807953,0.7319927327415573,0.7777777777777778,0.9960653408440077,1.0,1/11,1.76%,HK2
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.3138348227053912,0.7318158468186395,0.7868852459016393,0.995816257909146,1.0,2/16,9.80%,CRTAM;LAMP1
prerank,response to UV-B (GO:0010224),0.3277161758749315,0.7316302325098162,0.7923875432525952,0.9955698114261582,1.0,2/12,11.01%,MSH2;MME
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.23723111009950726,0.7314150495141418,0.8699878493317132,0.9953893888544838,1.0,16/88,16.29%,FXR2;GIGYF2;EIF2AK3;CNOT10;SAMD4B;CLN8;PUS7;IGF2BP2;CNOT7;ILF3;RIC1;HDAC6;DDX6;FXR1;SYNCRIP;CPEB3
prerank,positive regulation of hormone secretion (GO:0046887),0.3104282414758586,0.731142980687385,0.7962085308056872,0.9952772719895215,1.0,3/17,11.50%,TFR2;RASL10B;VAMP8
prerank,positive regulation of mRNA metabolic process (GO:1903313),-0.28229883496952024,-0.7309353444910612,0.8452655889145496,0.9662219032147377,1.0,4/13,17.11%,ZC3HAV1;ZC3H12A;MOV10;RC3H1
prerank,protein targeting (GO:0006605),-0.1724438729131257,-0.7306727789085183,0.9712230215827338,0.9657454189279896,1.0,27/118,20.66%,PARD3;KIF13B;ZFAND6;AKAP6;RASSF9;AQP11;RABGEF1;TIMM44;GABARAP;AP4E1;TIMM17B;ZFAND2A;TAOK2;SPCS1;MICALL1;ZDHHC2;HACL1;PEX6;AIP;VPS37C;PEX1;ZDHHC14;TIMM8B;TIMM10B;KATNB1;ZDHHC24;CDC37
prerank,regulation of stem cell population maintenance (GO:2000036),0.3107061073801461,0.7304330850580096,0.7818791946308725,0.9958166359327757,1.0,8/18,27.68%,NCOA3;CNOT1;ZC3H13;LOXL2;ELAVL1;CNOT2;REST;TAF6L
prerank,mitochondrial fission (GO:0000266),0.31708355978009983,0.730404377811055,0.7660626029654036,0.9953570056253319,1.0,3/16,8.56%,DNM1;FIS1;MIEF1
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.27779278775900024,0.7303672296112095,0.8096676737160121,0.9949087796543671,1.0,6/30,16.09%,TNIP3;TICAM1;UBE2D1;UBE2D3;TICAM2;TBK1
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.29001471457899736,0.7303377492232335,0.7932618683001531,0.9944514974774545,1.0,10/25,22.08%,CUL3;LONP1;ZYG11B;HDAC6;FBXL17;RNF185;KLHL15;UBE2W;YME1L1;DERL1
prerank,mitochondrial translation (GO:0032543),0.23011945169870365,0.7300424453281851,0.8804878048780488,0.9943743496207484,1.0,28/104,21.71%,MRPL37;MRPL43;MRPL33;FASTKD2;MRPS28;MRPS35;RARS2;PTCD3;MRPL41;MRPS33;MRPS22;MRPS15;MRPL3;CHCHD1;MRPL16;NDUFA7;MTRF1L;MRPL40;MRPL22;MRRF;GADD45GIP1;MRPL4;MRPL2;MRPL34;GFM1;GATB;TSFM;MRPS7
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.2919658063021099,0.7295828303203221,0.8077519379844961,0.9945518505205002,1.0,5/23,19.41%,ALOXE3;LTA4H;ELOVL6;HPGD;FADS1
prerank,dendritic spine morphogenesis (GO:0060997),-0.27772819830582024,-0.7286393090877673,0.8403990024937655,0.967395688758818,1.0,2/15,2.61%,SHANK3;CDC42
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.34284537684156724,0.728357374770558,0.7775947281713345,0.9958086553927682,1.0,3/12,7.71%,GLI2;EPHB2;PAFAH1B1
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.2479368169841581,0.7282464683274412,0.8421052631578947,0.9954619175953541,1.0,12/57,16.16%,BRCC3;BRSK1;NBN;RINT1;FBXO31;UIMC1;MDC1;DONSON;RFWD3;EME2;FZR1;NEK11
prerank,hematopoietic stem cell proliferation (GO:0071425),0.342477423827781,0.7278131527494,0.769100169779287,0.9955584584945134,1.0,2/11,4.77%,WNT2B;WNT5A
prerank,mitochondrial translational termination (GO:0070126),0.23393985085622523,0.727649698398989,0.8773234200743495,0.9952818719474275,1.0,20/88,18.47%,MRPL37;MRPL43;MRPL33;MRPS28;MRPS35;PTCD3;MRPL41;MRPS33;MRPS22;MRPS15;MRPL3;CHCHD1;MRPL16;MTRF1L;MRPL40;MRPL22;MRRF;GADD45GIP1;MRPL4;MRPL2
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.3052010423968399,0.7272718887298271,0.8016129032258065,0.995325346075304,1.0,9/18,28.84%,NAIF1;BAD;BNIP3;MUL1;SLC25A5;BCL2L1;SPG7;BCL2;PPIF
prerank,regulation of autophagosome assembly (GO:2000785),0.27604023162554764,0.7272312351707612,0.8179148311306902,0.9948763220830575,1.0,6/33,10.17%,PIP4K2B;LRSAM1;RAB3GAP2;MTMR3;CHMP4B;CHMP4A
prerank,regulation of mRNA stability (GO:0043488),0.22033151099383746,0.7271506726379925,0.911036036036036,0.9945091526243659,1.0,29/145,18.81%,FXR2;DND1;GIGYF2;CELF1;PRKCA;PSME3;SAMD4B;EXOSC5;IGF2BP2;PSMB5;TENT5C;AXIN2;TENT5D;TAF15;ZFP36L2;PSMA6;FXR1;PUM2;FASTKD1;PSMB2;PSMA2;PSMD13;PSMA7;E2F1;PSME4;PSMD12;PSMD14;PSMB6;PSMC4
prerank,cellular response to fatty acid (GO:0071398),-0.2857595141460992,-0.7270369599862644,0.8626506024096385,0.9686020382384412,1.0,2/12,10.10%,PID1;ZC3H12A
prerank,lysosome localization (GO:0032418),0.2650373989494444,0.7270353193381914,0.8268398268398268,0.9941787757709052,1.0,8/37,13.62%,RAB3A;BORCS6;TFEB;SPAG9;HDAC6;ARL8B;KIF5B;RAB34
prerank,inflammatory response (GO:0006954),0.21797781032706454,0.7268834032424715,0.9227421109902068,0.993878989725535,1.0,8/195,4.57%,HRH1;F11R;PTGFR;FOLR2;IL1A;REL;HNRNPA0;HDAC4
prerank,mesenchymal cell development (GO:0014031),0.3041061262514559,0.726789162010999,0.7920792079207921,0.9935053118210204,1.0,2/18,7.94%,HEYL;CDH2
prerank,chromatin assembly or disassembly (GO:0006333),0.3381655345707028,0.7264467320393618,0.7810858143607706,0.9935079809193152,1.0,3/11,20.12%,CDAN1;SUV39H2;RBBP4
prerank,glutathione metabolic process (GO:0006749),-0.20992995485871402,-0.7254710558653662,0.9046052631578947,0.9697664860028178,1.0,12/38,25.49%,GCLM;CTNS;ETHE1;GLRX2;GGCT;CNDP2;GSTT2;HPGDS;GCLC;GSTT1;GSR;GGT5
prerank,positive regulation of translation (GO:0045727),0.23188437563461067,0.725346594178565,0.8863080684596577,0.9945520789513798,1.0,25/94,22.69%,BCL3;FXR2;PIWIL2;RMND1;FASTKD2;METTL5;PLD1;UPF3B;NSUN5;SOX4;MPV17L2;FXR1;PYM1;ERBB2;CPEB3;RPUSD4;YBX3;HNRNPD;DHX9;LARP4;IL6;HABP4;ELAVL1;PKM;NIBAN1
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),0.303089451122455,0.7252687519928723,0.7990353697749196,0.9941630541707872,1.0,5/20,24.27%,ANO6;GPER1;RGCC;IL6;PDCD4
prerank,positive regulation of locomotion (GO:0040017),0.2855914638011389,0.7249411927264007,0.8110119047619048,0.9941314335707264,1.0,2/27,5.06%,NTN1;CAVIN1
prerank,positive regulation of insulin secretion (GO:0032024),0.2630288152909876,0.7247874638468789,0.8181818181818182,0.9938584970260222,1.0,13/36,22.17%,GPLD1;ISL1;GCK;SOX4;GPER1;BAD;ADCY8;STX4;IRS2;TRPM4;GLUD1;TCF7L2;NLGN2
prerank,piRNA metabolic process (GO:0034587),0.2994140643353618,0.7246628254067589,0.8231611893583725,0.9935406033727495,1.0,2/19,12.50%,PIWIL2;TEX15
prerank,vacuolar acidification (GO:0007035),0.2982386391050101,0.7243660131497105,0.8074534161490683,0.993492859370075,1.0,4/21,11.74%,ATP6V0D2;DMXL1;ATP6V0A1;DMXL2
prerank,regulation of mitochondrial membrane potential (GO:0051881),-0.20828614708933538,-0.7242139395555792,0.8922558922558923,0.97044125880585,1.0,7/40,14.26%,PID1;ARL6IP5;AKT1;VCP;SLC25A33;LRRK2;MAPT
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),-0.30708045535389783,-0.7240054757351935,0.8349514563106796,0.9698984015157618,1.0,6/11,36.21%,AKAP6;LRRC38;ALG10B;LRRC55;TREM2;RNF207
prerank,response to UV (GO:0009411),0.2317454291045167,0.7239257841867398,0.8807785888077859,0.9936404934491759,1.0,14/95,13.15%,EGFR;BCL3;SCARA3;MSH6;BRSK1;N4BP1;MSH2;USP47;ERCC6;NEDD4;INO80;MEN1;CREBBP;AQP1
prerank,DNA strand elongation (GO:0022616),0.30311962993538644,0.7237341845181253,0.7776,0.9933998665854193,1.0,3/18,8.33%,RFC3;NBN;GINS4
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.32032124163139397,0.7235529426908998,0.7986688851913477,0.9931608904859078,1.0,2/13,7.51%,BMS1;NOP14
prerank,positive regulation of T-helper cell differentiation (GO:0045624),0.31600744887165244,0.7231246346216009,0.7781569965870307,0.9932595922136709,1.0,2/14,7.54%,SOCS5;RARA
prerank,regulation of macrophage chemotaxis (GO:0010758),-0.24643952049706508,-0.7231073564108766,0.8649425287356322,0.9701775817736685,1.0,8/21,23.80%,CMKLR1;IL34;THBS1;PTK2;CSF1;RARRES2;MIF;MTUS1
prerank,cellular response to interferon-beta (GO:0035458),0.3169027154288129,0.7227526971228836,0.7687188019966722,0.993279749440564,1.0,3/14,14.10%,ACOD1;IRGM;HTRA2
prerank,tRNA processing (GO:0008033),0.24268105804106554,0.7222242886715882,0.8460543337645536,0.993517266489265,1.0,19/61,24.09%,TSEN54;PUS3;WDR4;CDKAL1;KARS1;RTRAF;POP7;TSEN34;FTSJ1;ADAT1;ANKRD16;URM1;PTCD1;TYW5;RPP21;TRMT1;THG1L;RPP30;TSEN2
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),-0.29295755105147164,-0.7220769890276866,0.8215102974828375,0.9705867250953021,1.0,6/11,42.62%,KDM1A;MIF;TAF9;TRIAP1;MUC1;CD74
prerank,regulation of transport (GO:0051049),0.26791983342549763,0.7219498058256165,0.8382147838214784,0.9934044721243368,1.0,10/36,21.67%,CLDN19;LEPR;CLDN10;WWC1;MBTPS1;PINK1;ICA1L;MUL1;PRKN;VAMP2
prerank,response to interleukin-1 (GO:0070555),0.24324410233260024,0.7219120495854048,0.8634146341463415,0.9929620579915346,1.0,6/73,4.67%,ADAMTS12;PRKCA;SOX9;SRC;HDAC4;IRAK3
prerank,hematopoietic stem cell differentiation (GO:0060218),-0.30561980783715725,-0.7211535771442973,0.8004750593824228,0.9708482423525188,1.0,2/10,4.83%,HOXB4;ACE
prerank,peptidyl-serine dephosphorylation (GO:0070262),-0.27044290829084083,-0.7197761629584116,0.821917808219178,0.971672643313973,1.0,1/14,1.34%,PPP2R2B
prerank,RNA interference (GO:0016246),0.3075181105683179,0.7196404437923524,0.807936507936508,0.9956690290658532,1.0,6/17,19.61%,CELF1;AGO1;DICER1;TSNAX;PRKRA;DHX9
prerank,dendritic cell migration (GO:0036336),-0.2621331610474731,-0.7196212168947643,0.8315217391304348,0.9710498073481547,1.0,1/16,0.56%,EPS8
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.3035424771139238,0.7193410767144517,0.800978792822186,0.9955834471210692,1.0,2/17,9.80%,CRTAM;LAMP1
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.2531250857668493,0.7192484615912633,0.855755894590846,0.9952099234321874,1.0,14/45,23.57%,FOXO3;GCNT2;EIF4E;ATXN2;EIF2B4;PUM2;SPOUT1;LARP4;NUDT21;PUM1;ATG14;DDX25;YTHDC1;ZC3H7B
prerank,cellular response to oxygen levels (GO:0071453),-0.30324398383075496,-0.7191561326616023,0.8313253012048193,0.9707792572316776,1.0,3/10,22.81%,CPEB4;PICK1;CCDC115
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.2770734622173129,0.7182916920816516,0.8211624441132638,0.9960477549447287,1.0,5/29,18.29%,TEX11;SIRT7;MEI4;REC8;SYCP2
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),-0.25501720802445504,-0.7176812618768968,0.8515625,0.9716136597742261,1.0,4/17,22.52%,WASF3;FCHSD2;PICK1;CORO1B
prerank,positive regulation of double-strand break repair (GO:2000781),-0.20474503266006225,-0.7175215347924345,0.9137931034482759,0.970966632817663,1.0,10/39,21.01%,SHLD2;SLF2;SLF1;ARID2;ACTR2;MMS19;PARP1;TIMELESS;MAD2L2;KDM4D
prerank,protein import into peroxisome matrix (GO:0016558),-0.2844285051588933,-0.7173864508998057,0.836405529953917,0.970310550068034,1.0,4/12,19.50%,PEX26;PEX6;PEX1;PEX10
prerank,regulation of protein binding (GO:0043393),0.2252443199853436,0.7172312209995685,0.8971098265895954,0.9970171620007768,1.0,29/114,22.08%,CAV1;EFHB;ADD1;HDAC4;DACT1;STYX;TRIM21;AMFR;GSK3B;STK3;MEN1;PKD1;CTNNBIP1;CAPRIN2;RAN;BAG2;PPP1CA;GNL3L;SYMPK;BAX;PPP2CA;PIN1;DDX11;PRKN;MAPK8;TCF7L2;NMD3;AKTIP;DERL1
prerank,cell proliferation in forebrain (GO:0021846),-0.30351390382221377,-0.7167613294971575,0.8214285714285714,0.9702252773192852,1.0,1/10,0.77%,NUMB
prerank,tRNA modification (GO:0006400),0.24095273020444408,0.715940570790052,0.8691709844559585,0.9983466241824464,1.0,19/62,22.32%,TARBP1;PUS7;PUS3;WDR4;CDKAL1;THADA;FTSJ1;TRMT5;ALKBH1;ANKRD16;URM1;THUMPD3;TYW5;METTL2B;METTL2A;OSGEP;TRMO;TRMT1;THG1L
prerank,pentose-phosphate shunt (GO:0006098),-0.2932143903874348,-0.7155776815424971,0.8429951690821256,0.9707103314135107,1.0,4/11,18.57%,RPIA;PGLS;PGD;RBKS
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.296897355257825,0.7153928267519023,0.8048,0.9986025356876587,1.0,4/20,8.17%,ACACA;SCD5;GCDH;HSD17B4
prerank,phagosome acidification (GO:0090383),-0.22876832782420742,-0.7152006472370623,0.8952095808383234,0.9703303777325547,1.0,8/26,24.04%,ATP6V0A4;ATP6V0C;ATP6V1C1;ATP6V1D;ATP6V1F;ATP6V1E1;RAB7A;RAB38
prerank,positive regulation of lymphocyte activation (GO:0051251),-0.22477481377480052,-0.7151756554513968,0.887459807073955,0.9695623743995327,1.0,11/28,34.48%,SIRPA;SH3KBP1;CYRIB;NCKAP1L;NOD2;PYCARD;TNIP2;CCR2;HSPD1;CCL2;PRKCQ
prerank,positive regulation of transporter activity (GO:0032411),0.322502348697673,0.715053837189309,0.7929824561403509,0.9985624714650858,1.0,2/13,11.99%,KMT2A;SGK1
prerank,cellular response to UV-A (GO:0071492),-0.28488476095463744,-0.7149485357748436,0.8544152744630071,0.968988885626813,1.0,2/11,11.31%,MMP2;MMP1
prerank,autophagy of peroxisome (GO:0030242),-0.2835281577620634,-0.7148468900326034,0.8402777777777778,0.9683156625661714,1.0,4/12,15.65%,SQSTM1;NBR1;ACBD5;USP30
prerank,protein localization to condensed chromosome (GO:1903083),0.33259414863499703,0.7145872372872561,0.8031088082901554,0.9986942822710794,1.0,4/12,22.38%,BUB3;ZWILCH;ZW10;MIS12
prerank,regulation of postsynaptic membrane potential (GO:0060078),-0.21437169020246732,-0.7145290176728165,0.9295774647887324,0.9678776320668024,1.0,8/34,19.13%,GRIN2B;GABRA2;AKT1;GRIN1;GSK3A;LRRK2;GABRE;GABRA5
prerank,positive regulation of T cell mediated immunity (GO:0002711),-0.24367454367403074,-0.7144565675285924,0.8885714285714286,0.9671707764891186,1.0,4/22,14.57%,B2M;TRAF6;CYRIB;ZBTB1
prerank,regulation of cell growth (GO:0001558),0.21001645270046015,0.7142803380599558,0.9418729817007535,0.9985986735025358,1.0,47/204,21.91%,PTCH2;VGLL4;PLCE1;CEACAM1;CAMK2D;EGFR;DCBLD2;ADAM10;NDUFS3;LTBP4;PTPRJ;EBAG9;RPS6KA3;USP47;S100A9;INO80;SGK1;KIF26A;CRLF3;KLHL22;FHL1;NAIF1;RTN4;CAPRIN2;SIPA1;MMP14;NDRG3;EI24;ERBB2;RAB33B;ARHGEF11;ITCH;MINAR1;SOCS2;PPP2CA;RPTOR;EIF4G2;FRZB;SERTAD2;ENO1;MUL1;CCAR2;CISH;TAF9B;CEP43;OSGIN1;RBBP7
prerank,positive regulation of T cell migration (GO:2000406),0.2960487147216483,0.7139245337675058,0.8297546012269938,0.9985908579159545,1.0,5/20,18.55%,WNT5A;ADAM10;TNFRSF14;RHOA;DOCK8
prerank,sulfur amino acid metabolic process (GO:0000096),-0.2329428577362934,-0.7138858067648821,0.8662420382165605,0.9670192296284364,1.0,11/24,31.51%,NOX4;MTHFR;MTR;MTRR;CBS;GCLC;ADI1;CTH;MSRA;MPST;CDO1
prerank,regulation of intracellular transport (GO:0032386),0.2589179591951288,0.713362059280473,0.8716502115655853,0.998876321735944,1.0,8/38,16.04%,RINT1;ATP9A;INPP5F;LAMP1;WWC1;TTC21B;ATPSCKMT;LCP1
prerank,serine family amino acid metabolic process (GO:0009069),-0.2636046385214472,-0.713336621164094,0.8383084577114428,0.9668049871026122,1.0,9/16,33.84%,PSPH;CBS;GCLC;SEPHS2;CTH;THNSL2;SHMT2;CDO1;SHMT1
prerank,positive regulation of macrophage migration (GO:1905523),-0.25454935067704887,-0.7130859358732202,0.8690476190476191,0.9662729920436075,1.0,7/19,18.85%,CMKLR1;IL34;THBS1;PTK2;CSF1;P2RX4;RARRES2
prerank,cGMP biosynthetic process (GO:0006182),-0.30111399971007596,-0.7123338691715039,0.8428571428571429,0.9662974017940842,1.0,1/10,4.35%,NPR1
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.30625116561612814,0.7120815720320134,0.8143322475570033,1.0,1.0,1/15,1.77%,KCNA5
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.3084798840989017,0.7116218761709702,0.8075601374570447,1.0,1.0,1/15,1.43%,AK5
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.29466958218782074,0.7112607202025077,0.8248772504091653,1.0,1.0,8/19,24.40%,HDAC6;HTT;HTRA2;FBXW7;CSNK2A2;PINK1;PRKN;DNM1L
prerank,peptidyl-arginine modification (GO:0018195),-0.2658687376756588,-0.7106082447206967,0.8571428571428571,0.9673691642525732,1.0,11/15,50.51%,ART3;PRMT7;KRTCAP2;PRMT1;PADI2;PARK7;ART1;PADI1;PADI4;ART4;ART5
prerank,negative regulation of cellular catabolic process (GO:0031330),0.23824197956772025,0.7102422040110798,0.8854961832061069,1.0,1.0,9/63,11.19%,LEPR;GPLD1;FOXK1;PTPN22;MCL1;FOXK2;EIF4E;RIC1;TAB2
prerank,positive regulation of interferon-alpha production (GO:0032727),0.2937279520189563,0.7101413445348889,0.823240589198036,1.0,1.0,6/19,24.75%,TLR7;TBK1;SETD2;DHX9;IFIH1;RIPK2
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.24184711198791092,0.7100436879536342,0.8616600790513834,1.0,1.0,21/59,25.90%,CAMK2D;PRKCA;HIPK1;DYRK1A;CAD;GSK3B;CIT;TBK1;CSNK2A2;LMTK2;DYRK2;PDPK1;ACVR1;CDC42BPG;MAPK8;MAPK1;PRKCD;ROCK1;HIPK2;TAF1;TNKS
prerank,TOR signaling (GO:0031929),0.2787553515931877,0.7097674090371486,0.8305343511450382,1.0,1.0,3/26,9.81%,PRR5;SYAP1;MAPKAP1
prerank,DNA replication initiation (GO:0006270),-0.2067863885490327,-0.7097533610764105,0.9201388888888888,0.9674644766615174,1.0,8/37,14.23%,PRIM2;POLE4;MCM6;ORC2;POLA1;LRWD1;CDC7;TOPBP1
prerank,pinocytosis (GO:0006907),0.3381743596058928,0.709738187123064,0.7898423817863398,0.9997952117299247,1.0,3/10,14.84%,DOCK2;RAB34;SNX5
prerank,regulation of megakaryocyte differentiation (GO:0045652),-0.19822372011696693,-0.709731485217457,0.9294605809128631,0.9667074514336104,1.0,17/49,28.38%,EP300;SETD1A;HDAC1;MYL9;AGO3;THBS1;AGO4;MOV10;TNRC6C;KAT2B;RAB7B;NR4A3;CIB1;KMT2B;L3MBTL1;WDR5;KMT2E
prerank,retrograde axonal transport (GO:0008090),0.30466315385147136,0.7092363356709576,0.7869415807560137,0.9999632349650769,1.0,4/16,13.22%,ACTR10;PAFAH1B1;KIF5A;KIF5B
prerank,I-kappaB phosphorylation (GO:0007252),0.33527486998265343,0.7092102113614974,0.8037383177570093,0.9995042895355866,1.0,1/10,5.56%,TLR7
prerank,neuron remodeling (GO:0016322),-0.3011444918939933,-0.7091621225270732,0.837708830548926,0.966492685615931,1.0,5/10,30.98%,EPHA8;C1QA;SCARF1;C3;RND1
prerank,cellular response to tumor necrosis factor (GO:0071356),0.21457150840738295,0.7090344566783509,0.9212253829321663,0.9992623561819365,1.0,35/175,22.16%,EDA;TNFSF8;ADAMTS12;FOXO3;PSME3;TRADD;PSMB5;ACOD1;NFE2L2;CDIP1;TNFRSF11B;ZFP36L2;TXNDC17;PSMA6;PSMB2;PSMA2;TNFRSF14;GPER1;PSMD13;PSMA7;PSME4;PSMD12;PSMD14;PSMB6;ASAH1;PSMC4;YBX3;CCL14;DHX9;ST18;TRAF5;CX3CL1;TRAF3;PSMB3;LTBR
prerank,histone exchange (GO:0043486),-0.20689239787609548,-0.7088125203137887,0.9407407407407408,0.9660950445365724,1.0,16/37,31.71%,NPM1;RUVBL1;SMARCA5;ANP32E;CENPT;RNF8;CENPP;CENPC;MIS18BP1;CENPO;CENPQ;CENPX;CENPI;MIS18A;CENPN;CENPA
prerank,telomere capping (GO:0016233),0.29902346538247565,0.7086922998302176,0.8184873949579832,0.9991981807894311,1.0,4/16,19.33%,STN1;NBN;TERF2;MRE11
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.2722958043015757,0.7085306091299538,0.8352272727272727,0.9989283763081779,1.0,6/31,13.87%,WEE1;DACT1;KANK2;APC;PTEN;FHL1
prerank,positive regulation of type I interferon production (GO:0032481),-0.18296166260864882,-0.7077707960524363,0.9642857142857143,0.9663968103998335,1.0,17/73,20.79%,EP300;POLR3E;POLR3B;IRF1;GAPDH;POLR3A;DHX33;POLR3H;ISG15;POLR2F;DHX36;FLOT1;CGAS;POLR2K;TLR3;POLR1C;RIOK3
prerank,cellular response to glucose stimulus (GO:0071333),0.2642968687325622,0.7076947554579388,0.826151560178306,0.999532136183128,1.0,8/30,15.74%,ZBTB20;RAB11FIP5;SOX4;ERN1;UNC13B;TRA2B;GPER1;ADCY8
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.2622307326194806,0.7075231782061396,0.8632986627043091,0.9992554904761728,1.0,10/31,22.76%,DCP1B;EXOSC5;DIS3L2;CNOT7;DDX6;CNOT8;LSM3;EXOSC7;DCPS;LSM2
prerank,positive regulation of histone modification (GO:0031058),0.26363320035419086,0.7072148518033526,0.841726618705036,0.9991502741044309,1.0,3/33,9.28%,PPARGC1A;PAF1;TET1
prerank,regulation of telomere maintenance (GO:0032204),0.27634583297939247,0.7071748785285402,0.8262910798122066,0.9987150349219344,1.0,12/26,27.93%,NBN;ERCC1;TERF2;MRE11;HNRNPD;SMG6;ATRX;YLPM1;PML;RAD50;SMG5;TERF2IP
prerank,chromatin-mediated maintenance of transcription (GO:0048096),-0.289501878066449,-0.7066085317842169,0.8551068883610451,0.9668058529234514,1.0,4/11,25.27%,SMARCD1;SERTAD1;ZMIZ2;CDCA4
prerank,regulation of ceramide biosynthetic process (GO:2000303),-0.26299285457003596,-0.7064177316736112,0.8618925831202046,0.9662125693924629,1.0,6/15,22.63%,SPHK1;ORMDL1;ORMDL2;SMPD3;RACK1;ORMDL3
prerank,axon extension (GO:0048675),0.2827449594759519,0.7062609748642952,0.8146964856230032,0.9993902701480918,1.0,7/23,21.68%,NRP2;SEMA3A;SLC9A6;AUTS2;USP9X;SPG11;NLGN3
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),-0.23913059939273723,-0.7060499240439219,0.9161849710982659,0.9658010656965367,1.0,6/22,18.81%,PHF8;DHX33;NCL;HEATR1;PWP1;ATF4
prerank,recombinational repair (GO:0000725),0.23292936734528338,0.7057370305141784,0.9121287128712872,0.9995936970756653,1.0,18/77,19.33%,SMC5;NBN;PALB2;SWI5;ZSWIM7;ZFYVE26;INO80;GEN1;NUCKS1;RFWD3;SFPQ;RAD51AP2;REV3L;RECQL5;RHNO1;SFR1;PSMD14;MRE11
prerank,neurotransmitter biosynthetic process (GO:0042136),0.3083347019698701,0.7056944849621289,0.8101694915254237,0.999160265424965,1.0,1/14,1.73%,ALDH9A1
prerank,histone modification (GO:0016570),0.2217511721514417,0.7053038570900153,0.9295261239368166,0.9991900983911349,1.0,19/109,16.16%,EYA1;KAT6B;HDAC4;TAF10;RCOR3;SIN3B;MSL3;SIRT7;HDAC2;TRRAP;HDAC6;PHF20L1;CREBBP;BAZ2A;KAT8;BRD8;PRMT6;MORF4L2;NEK11
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.2374930424387379,0.7050970667007095,0.8738621586475943,0.9989694543375902,1.0,17/65,18.81%,PSME3;CHFR;PSMB5;USP47;CHMP4C;FHL1;PSMA6;PSMB2;PSMA2;PSMD13;PSMA7;INTS3;PSME4;PSMD12;PSMD14;PSMB6;PSMC4
prerank,neutrophil activation involved in immune response (GO:0002283),0.20212676823527315,0.7049644477884961,0.9786368260427264,0.9986609743741923,1.0,78/428,19.47%,DYNLL1;NAPRT;CEACAM1;ARG1;RAP1A;ARHGAP9;ANO6;CD55;ITGAX;PTPRC;NIT2;CD53;DOCK2;CDK13;NCSTN;ADAM10;PPIE;NRAS;NEU1;ACTR10;RAB3A;DSN1;PGM1;ILF2;YPEL5;PTPRJ;FRMPD3;ATP6V0A1;HMGB1;LAMP1;IST1;CANT1;PLD1;S100A9;MME;MANBA;PAFAH1B2;VAMP8;LAIR1;TSPAN14;CEP290;CCT2;MVP;PGRMC1;LTA4H;ATG7;DERA;GSDMD;MLEC;TMEM30A;PTPN6;TMEM63A;HEXB;PSMA2;PSMD13;TICAM2;AP2A2;ATP8B4;HGSNAT;SYK;CTSB;ATP6AP2;GLIPR1;CRACR2A;CYBB;CREG1;RHOA;PSMD12;ERP44;PSMD14;SNAP23;ASAH1;LAMP2;RNASE3;SNAP29;PRDX6;XRCC6;PTGES2
prerank,positive regulation of JNK cascade (GO:0046330),0.2324601363513005,0.7047918828837052,0.8950777202072538,0.9983896584051459,1.0,10/70,12.10%,AXIN1;SH3RF2;MINK1;WNT16;SEMA3A;MAP3K5;RASSF2;HMGB1;MAPK8IP1;MTURN
prerank,regulation of intracellular pH (GO:0051453),-0.21173868663903916,-0.7046394736693442,0.9166666666666666,0.9665447577478816,1.0,9/34,17.36%,SLC4A10;NOX1;SLC9A1;LRRK2;SLC9A9;SLC9A5;CA2;SLC9B1;SLC9A2
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.3285269938745786,0.7041392218111403,0.8053097345132744,0.998777659812385,1.0,2/10,11.39%,RACGAP1;APC
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),-0.2885432000614565,-0.7039552336235562,0.8450363196125908,0.9665226969946871,1.0,2/11,12.33%,SLC30A10;ABCD2
prerank,JNK cascade (GO:0007254),0.25136865948775655,0.7038561424450047,0.8577348066298343,0.9986667462730269,1.0,6/40,12.15%,MINK1;MAPK10;PTGER4;MAP3K5;TAB2;ARHGEF6
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),0.31111314321914957,0.7038357931380694,0.8243021346469622,0.9982062621507183,1.0,3/15,9.68%,TMEM129;SELENOS;NPLOC4
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),0.23206984258211968,0.7037621820890104,0.8857509627727856,0.9978101507177958,1.0,15/72,16.93%,IRAK3;PTPRC;TNFAIP3;HIPK1;TRADD;AXL;TAX1BP1;SHARPIN;IL7;CBFB;PTPN6;RUNX1;SOCS1;JAK1;SYK
prerank,regulation of trophoblast cell migration (GO:1901163),-0.26218649709747005,-0.7037417319567009,0.8378378378378378,0.9659676262705337,1.0,7/14,32.46%,GJA1;SMURF2;C1QBP;YTHDF3;ACVR1B;TIMP1;CALR
prerank,positive regulation of protein localization to Cajal body (GO:1904871),-0.28806877987914875,-0.7036233709527189,0.8276699029126213,0.964536881660538,1.0,2/11,11.97%,CCT7;CCT8
prerank,regulation of protein localization to Cajal body (GO:1904869),-0.28806877987914875,-0.7036233709527189,0.8276699029126213,0.964536881660538,1.0,2/11,11.97%,CCT7;CCT8
prerank,regulation of mast cell activation (GO:0033003),-0.29819982617769547,-0.703272440580328,0.8288288288288288,0.9641179044902031,1.0,7/10,41.85%,LYN;CRLF2;CD300LF;MILR1;CD84;TSLP;CD226
prerank,urogenital system development (GO:0001655),0.3348246827520037,0.7032140417556842,0.8129496402877698,0.99803679851029,1.0,2/11,6.25%,SOX9;EPHB2
prerank,negative regulation of binding (GO:0051100),0.23033539315296755,0.7019198322798716,0.9072681704260651,0.9992183819602131,1.0,19/81,21.42%,CAV1;EFHB;DACT1;STYX;GSK3B;SMO;CTNNBIP1;E2F1;BAG2;PPP1CA;GNL3L;SYMPK;BAX;PIN1;SUMO1;DDX11;RSF1;HABP4;MAPK8
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),-0.2175189959151147,-0.7019129313510403,0.9149659863945578,0.9647415945884183,1.0,5/32,12.60%,RPS19;RPL30;PGLYRP1;GAPDH;CCL13
prerank,negative regulation by host of viral transcription (GO:0043922),-0.2753828689844274,-0.7015024087725344,0.849624060150376,0.9644021772363724,1.0,7/12,43.94%,HDAC1;POU2F3;TFAP4;HMGA2;CCL5;CCL4;TARDBP
prerank,cellular biogenic amine catabolic process (GO:0042402),-0.28965714212663096,-0.7013838557589525,0.8353808353808354,0.9637545255135374,1.0,6/10,33.62%,COMT;SARDH;CHDH;SLC44A1;HNMT;DMGDH
prerank,mitochondrial translational elongation (GO:0070125),0.22536041037877239,0.7012757529476756,0.9122373300370828,0.9995400968228523,1.0,34/88,27.94%,MRPL37;MRPL43;MRPL33;MRPS28;MRPS35;PTCD3;MRPL41;MRPS33;MRPS22;MRPS15;MRPL3;CHCHD1;MRPL16;MRPL40;MRPL22;GADD45GIP1;MRPL4;MRPL2;MRPL34;GFM1;TSFM;MRPS7;MRPL11;MRPL19;MRPS18A;MRPL1;MRPL39;MRPL57;MRPL13;MRPL47;DAP3;MRPL21;MRPL46;GFM2
prerank,ncRNA export from nucleus (GO:0097064),0.2612776665940301,0.7011336702579809,0.86,0.9992285603780743,1.0,10/36,15.65%,NUP62;NUP160;NUP37;TPR;NUP50;RANBP2;NUP153;NUP210;RAN;NUP93
prerank,regulation of sensory perception of pain (GO:0051930),-0.2826447403128839,-0.7002982691439548,0.8486997635933806,0.9640882114178272,1.0,4/11,31.02%,CCN3;ACP3;SPX;F2R
prerank,cytoplasmic sequestering of protein (GO:0051220),-0.27091250130432526,-0.7001549558416961,0.8691358024691358,0.9634669379525155,1.0,5/13,22.17%,FLNA;SUFU;DBN1;GOPC;GET4
prerank,neutrophil degranulation (GO:0043312),0.2006758220073991,0.7000753908932116,0.9786585365853658,1.0,1.0,77/425,19.47%,DYNLL1;NAPRT;CEACAM1;ARG1;RAP1A;ARHGAP9;ANO6;CD55;ITGAX;PTPRC;NIT2;CD53;DOCK2;CDK13;NCSTN;ADAM10;PPIE;NRAS;NEU1;ACTR10;RAB3A;DSN1;PGM1;ILF2;YPEL5;PTPRJ;FRMPD3;ATP6V0A1;HMGB1;LAMP1;IST1;CANT1;PLD1;S100A9;MME;MANBA;PAFAH1B2;VAMP8;LAIR1;TSPAN14;CEP290;CCT2;MVP;PGRMC1;LTA4H;ATG7;DERA;GSDMD;MLEC;TMEM30A;PTPN6;TMEM63A;HEXB;PSMA2;PSMD13;TICAM2;AP2A2;ATP8B4;HGSNAT;CTSB;ATP6AP2;GLIPR1;CRACR2A;CYBB;CREG1;RHOA;PSMD12;ERP44;PSMD14;SNAP23;ASAH1;LAMP2;RNASE3;SNAP29;PRDX6;XRCC6;PTGES2
prerank,regulation of RIG-I signaling pathway (GO:0039535),0.2918555320881723,0.7000114542904462,0.8145800316957211,0.9997362311387145,1.0,6/18,23.00%,SEC14L1;NPLOC4;USP15;PUM2;PUM1;DHX58
prerank,cardiac muscle cell action potential (GO:0086001),0.267351758048319,0.6998322577128886,0.8424153166421208,0.9994704269133259,1.0,3/30,5.41%,SCN10A;SLC4A3;ATP1A2
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.2268736809663001,0.6996595215206084,0.8992628992628993,0.9992140429410153,1.0,5/77,7.18%,ITGA6;SRC;PSME3;NDUFS3;MCL1
prerank,protein targeting to lysosome (GO:0006622),0.2881496102918831,0.6994541609170292,0.8255451713395638,0.9989876695553758,1.0,7/20,18.93%,ZFYVE16;M6PR;GCC2;NEDD4;SCARB2;AP3M1;LAMP2
prerank,necroptotic process (GO:0070266),-0.24924852600132158,-0.6991890602816588,0.8586118251928021,0.9636051105357837,1.0,6/16,27.53%,PGAM5;IPMK;TRPM7;TLR3;RIPK1;LY96
prerank,cardiac muscle cell contraction (GO:0086003),0.2875282048416289,0.6991213780235347,0.8475409836065574,0.9989258108819822,1.0,1/19,1.41%,CAMK2D
prerank,regulation of early endosome to late endosome transport (GO:2000641),0.2926578523484721,0.6990688598616039,0.8151658767772512,0.9985072218611398,1.0,7/18,19.00%,SRC;RDX;RAB21;EZR;VPS11;SNX12;DENND10
prerank,nuclear export (GO:0051168),0.22944246858389644,0.6987558692984809,0.9024390243902439,0.9984255394567195,1.0,25/80,25.05%,RBM8A;SRSF4;NUP62;EIF4E;TPR;UPF3B;CSE1L;NUP153;PKD1;THOC3;LSG1;RAN;THOC5;CHP1;XPO5;SLU7;SRSF3;DHX38;SRSF11;STRADB;XPO4;XPO7;SARNP;NUP188;NXF1
prerank,regulation of transcription by RNA polymerase I (GO:0006356),0.2932710624780378,0.6984832309473976,0.8389694041867954,0.9982941254667985,1.0,3/18,9.47%,EIF2AK3;UTP15;SIRT7
prerank,osteoclast differentiation (GO:0030316),0.28781783401769523,0.6978938561463296,0.8252279635258358,0.9985844268931668,1.0,4/22,11.84%,SRC;SNX10;GAB2;GPR183
prerank,sodium ion import across plasma membrane (GO:0098719),0.2956559127182876,0.6977787354446161,0.821256038647343,0.998247165022916,1.0,3/17,11.27%,SLC12A2;SLC9A7;SLC9A6
prerank,inositol phosphate catabolic process (GO:0071545),-0.2750510336020936,-0.6971759473816135,0.8697674418604651,0.9648104943048937,1.0,6/12,29.06%,NUDT3;IMPA1;INPP5A;INPP5B;SYNJ1;INPP5J
prerank,microtubule-based transport (GO:0099111),0.320299235544177,0.6970065882272533,0.8175787728026535,0.9987060449587305,1.0,5/12,25.19%,SPAG17;HTT;CCDC40;DYNC1I1;DYNC1I2
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.21782624110834845,0.6966231416606397,0.9153936545240893,0.9982220263267949,1.0,23/104,18.96%,SRC;PSME3;NRAS;KRAS;PSMB5;TAB2;CREBBP;PRKACB;PSMA6;PSMB2;PSMA2;RELB;PSMD13;PSMA7;PAK3;SYK;PSME4;PSMD12;PDPK1;PSMD14;PSMB6;PSMC4;RAF1
prerank,cellular response to lectin (GO:1990858),0.21782624110834845,0.6966231416606397,0.9153936545240893,0.9982220263267949,1.0,23/104,18.96%,SRC;PSME3;NRAS;KRAS;PSMB5;TAB2;CREBBP;PRKACB;PSMA6;PSMB2;PSMA2;RELB;PSMD13;PSMA7;PAK3;SYK;PSME4;PSMD12;PDPK1;PSMD14;PSMB6;PSMC4;RAF1
prerank,neurogenesis (GO:0022008),0.25017074996707145,0.6957110490525064,0.8594436310395315,0.9988994223373815,1.0,8/43,18.15%,LPAR1;NTN5;BTBD2;ERCC6;WDR62;CIT;BTBD6;NDUFS2
prerank,negative regulation of cell cycle process (GO:0010948),0.23275233907713297,0.6955256609718395,0.8978007761966365,0.998628861164015,1.0,18/61,25.15%,FBXO43;TOM1L1;FBXO5;CCP110;TOM1L2;CHMP4C;GPER1;E2F1;TERF2;FOXO4;RBBP4;TFDP1;CHMP2A;RBBP7;NME6;BMP7;APAF1;CBX3
prerank,porphyrin-containing compound catabolic process (GO:0006787),-0.26460785523502683,-0.6953962054646512,0.8598382749326146,0.9650143609607436,1.0,1/14,2.48%,ABCG2
prerank,heme catabolic process (GO:0042167),-0.26460785523502683,-0.6953962054646512,0.8598382749326146,0.9650143609607436,1.0,1/14,2.48%,ABCG2
prerank,"transcription, DNA-templated (GO:0006351)",0.2053779912285343,0.6953190169743054,0.9585547290116897,0.9983881503006826,1.0,36/207,17.12%,BCL3;DTX1;MLLT3;FOXO3;TAF10;LEO1;GTF3C6;TAF4B;CDK7;PAF1;SMN1;RREB1;POLR3G;ELL;NELFB;SUPT4H1;TFB2M;ERCC6;GTF2F2;NAT14;NFKBIB;TAF15;GTF2H1;TRIP11;MBD1;CBFB;BRF2;BAZ2A;GTF3C5;TEFM;TAF5;E2F1;CRCP;ELOA;TCEA1;RTF1
prerank,positive regulation of extracellular matrix organization (GO:1903055),-0.2430787812681365,-0.6952106031976172,0.8617886178861789,0.9644153519916392,1.0,1/18,0.70%,SMAD3
prerank,regulation of immunoglobulin production (GO:0002637),0.2787214284877075,0.6951701341167176,0.8062015503875969,0.9981017175003476,1.0,2/23,6.25%,PTPRC;EPHB2
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),-0.2579977842617759,-0.6951531795681878,0.8743718592964824,0.9637298890765057,1.0,6/15,21.80%,ATF2;TIPIN;MUS81;RAD17;RAD9B;FANCD2
prerank,centromere complex assembly (GO:0034508),-0.21000156487209218,-0.6950195550148454,0.9219858156028369,0.9630856187131489,1.0,16/36,31.71%,NPM1;RUVBL1;SMARCA5;CENPT;CENPP;CENPC;MIS18BP1;CENPE;CENPO;CENPQ;CENPX;CENPI;MIS18A;CENPF;CENPN;CENPA
prerank,vitamin D metabolic process (GO:0042359),0.31374010147562664,0.6948845055572096,0.8125,0.9980029282422377,1.0,2/13,10.19%,CUBN;GC
prerank,translational termination (GO:0006415),0.22064208255763776,0.6947209976561627,0.9236453201970444,0.9977196849466293,1.0,21/95,18.47%,MRPL37;MRPL43;MRPL33;MRPS28;MRPS35;PTCD3;MRPL41;MRPS33;MRPS22;MRPS15;MRPL3;ETF1;CHCHD1;MRPL16;MTRF1L;MRPL40;MRPL22;MRRF;GADD45GIP1;MRPL4;MRPL2
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.21672835956615044,0.6946987182246639,0.9223529411764706,0.9972699735217999,1.0,23/105,18.96%,SRC;PSME3;NRAS;KRAS;PSMB5;TAB2;CREBBP;PRKACB;PSMA6;PSMB2;PSMA2;RELB;PSMD13;PSMA7;PAK3;SYK;PSME4;PSMD12;PDPK1;PSMD14;PSMB6;PSMC4;RAF1
prerank,fluid transport (GO:0042044),0.3169211067423352,0.6937756922336834,0.8252595155709342,0.9979301031864148,1.0,2/12,13.15%,SLC4A11;AQP1
prerank,regulation of secretion (GO:0051046),-0.2711895777282821,-0.6937311762278249,0.8727735368956743,0.9636382922935435,1.0,2/13,2.67%,ACSL3;MYO6
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.21918368688478873,0.6936458320123529,0.9221698113207547,0.9976223398819354,1.0,10/104,8.76%,TRIB2;CCND3;SRC;SLC27A1;TSG101;CDK7;CCNG1;SYAP1;CCNJ;IRGM
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),-0.25002622666449414,-0.693308440356763,0.8473282442748091,0.963266498936603,1.0,7/16,28.23%,SLC39A14;GSK3A;MRAP2;PDE6H;C3;ACP3;GRP
prerank,mitochondrial transport (GO:0006839),0.2373740644170061,0.6895037398121077,0.9062918340026773,1.0,1.0,9/53,17.46%,TOMM34;MFN2;FIS1;SLC25A13;STARD3;TOMM40;BCS1L;BAD;BNIP3
prerank,regulation of cytoplasmic transport (GO:1903649),0.319549758476526,0.6893812113099924,0.8169257340241797,1.0,1.0,2/11,9.28%,SRC;ATP9A
prerank,neural crest cell migration (GO:0001755),0.2558836813151449,0.6892921830261504,0.874826147426982,1.0,1.0,8/36,16.97%,FOLR1;SEMA4B;FN1;SEMA3A;SEMA4D;SEMA6C;ERBB4;SEMA4C
prerank,phosphate ion transmembrane transport (GO:0035435),-0.2741034747338773,-0.6887537433145325,0.8481308411214953,0.9668650089757799,1.0,5/12,28.84%,SLC25A30;SLC25A11;SLC37A1;SLC37A2;SLC37A3
prerank,entry into host (GO:0044409),0.3081028270856699,0.6887313370468663,0.8317152103559871,1.0,1.0,3/13,15.86%,SRC;CCR5;CDH1
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),0.3326538798700891,0.6882921144257697,0.8487972508591065,1.0,1.0,2/10,8.22%,PIEZO1;DPP4
prerank,negative regulation of mRNA processing (GO:0050686),0.29948793303753585,0.6877114924249167,0.8461538461538461,1.0,1.0,6/15,23.81%,SRSF4;SFSWAP;SAP18;SRSF12;SRSF10;RBMX
prerank,negative regulation of lipid catabolic process (GO:0050995),0.2900219236978161,0.6875635254765539,0.8416149068322981,1.0,1.0,2/17,10.61%,GPLD1;ADRA2A
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),0.30951366952715553,0.6875622590205065,0.8295652173913044,1.0,1.0,1/12,2.27%,JAG1
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),-0.26739177652023927,-0.6874475657086149,0.8801955990220048,0.9673378659690722,1.0,1/13,1.53%,GLI3
prerank,natural killer cell mediated immunity (GO:0002228),-0.2547309591671832,-0.6866546294492838,0.8865435356200527,0.9673261962760763,1.0,4/15,21.67%,CEBPG;TUBB4B;PLEKHM2;RAET1E
prerank,positive regulation of chemokine production (GO:0032722),0.2416733718295308,0.6860370603353589,0.8761904761904762,1.0,1.0,8/44,16.93%,WNT5A;IL17RA;TLR7;HMGB1;EGR1;IL7;LPL;SYK
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.22909932727379562,-0.6857599824716395,0.9109195402298851,0.966595673009547,1.0,7/21,20.58%,RBX1;ERCC2;XPA;GTF2H4;PARP1;ERCC4;ERCC5
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.22909932727379562,-0.6857599824716395,0.9109195402298851,0.966595673009547,1.0,7/21,20.58%,RBX1;ERCC2;XPA;GTF2H4;PARP1;ERCC4;ERCC5
prerank,protein oxidation (GO:0018158),-0.27769090822432574,-0.6856690209306692,0.871331828442438,0.9659239851360185,1.0,2/11,12.74%,LOXL1;LOXL3
prerank,purine ribonucleotide catabolic process (GO:0009154),0.2792900357687571,0.6851317724304993,0.8557993730407524,1.0,1.0,5/21,12.66%,PDE4D;ACAT1;NT5E;NT5C2;NUDT18
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.3053951551614548,0.6845343209988958,0.814262023217247,1.0,1.0,6/13,25.27%,DYRK1A;YJU2;TWIST1;MDM2;PTTG1IP;SNAI1
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.3016668278402441,0.6844969527665926,0.830155979202773,1.0,1.0,2/14,6.41%,CREB3L1;SELENOS
prerank,chromatin remodeling at centromere (GO:0031055),-0.2119383534075147,-0.6842735092978828,0.9366666666666666,0.9664435024882231,1.0,14/31,31.71%,NPM1;RUVBL1;SMARCA5;CENPT;CENPP;CENPC;MIS18BP1;CENPO;CENPQ;CENPX;CENPI;MIS18A;CENPN;CENPA
prerank,interleukin-27-mediated signaling pathway (GO:0070106),0.30950471939648866,0.6841026093873589,0.8330494037478705,1.0,1.0,4/13,18.29%,TYK2;IL6ST;JAK1;OAS2
prerank,macrophage activation (GO:0042116),0.2499734060912561,0.6828508046093937,0.8690140845070422,1.0,1.0,1/34,0.69%,LBP
prerank,negative regulation of myotube differentiation (GO:0010832),-0.2730417317018792,-0.6828143379923214,0.85,0.9670152512255898,1.0,5/12,24.87%,CCN3;HDAC1;BDNF;XBP1;NOTCH1
prerank,oligodendrocyte differentiation (GO:0048709),0.2842679783652324,0.6822295830904741,0.8634294385432474,1.0,1.0,4/19,13.39%,EIF2B3;SOX9;EIF2B4;NSUN5
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.23867498685803584,0.6821270208721164,0.8853754940711462,1.0,1.0,17/53,24.43%,PSME3;BCKDK;PSMB5;PSMA6;PSMB2;PSMA2;PSMD13;PSMA7;PSME4;PSMD12;PSMD14;PSMB6;PSMC4;PSMB3;OAZ2;AZIN1;PSMD2
prerank,positive regulation of viral life cycle (GO:1903902),0.27724469080124103,0.6821235119756281,0.8433179723502304,1.0,1.0,4/22,14.18%,TSG101;KPNA2;AXL;P4HB
prerank,positive regulation of RNA splicing (GO:0033120),0.26576075761955487,0.6821213185612357,0.8556547619047619,1.0,1.0,7/29,14.81%,SLC38A2;RBM22;DYRK1A;CELF4;RBMXL1;ERN1;TRA2B
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.23252408440911643,0.6819837799029518,0.9130434782608695,1.0,1.0,17/60,21.57%,RUNX2;SOX9;MED7;AGO1;MED13;MECP2;MED23;PTEN;CBFB;MED12;MED8;MED31;BAX;MED15;IL6;TCF7L2;MED16
prerank,positive regulation of heart contraction (GO:0045823),0.28682220849798234,0.6819718577947397,0.8426966292134831,1.0,1.0,2/19,5.41%,APLN;ATP1A2
prerank,innate immune response in mucosa (GO:0002227),0.32676537010550855,0.6818787485478801,0.8345195729537367,1.0,1.0,2/10,18.97%,DEFA6;RNASE3
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),-0.2237032828606572,-0.6803351148813467,0.9147058823529411,0.9684722232518543,1.0,10/24,27.07%,RBPJ;HIF1A;KLF2;HSF1;CEBPB;ATF4;ATF6;NOTCH1;ATF3;ATF6B
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",0.2954090980481879,0.6801228775792217,0.8371335504885994,1.0,1.0,6/17,22.08%,TMEM129;SELENOS;NPLOC4;HM13;SEL1L;DERL1
prerank,DNA replication-independent nucleosome assembly (GO:0006336),-0.1980762389040997,-0.6796473063881734,0.9430604982206405,0.96828493526177,1.0,17/38,31.71%,NPM1;HIRA;RUVBL1;SMARCA5;CENPT;CENPP;UBN1;CENPC;MIS18BP1;CENPO;CENPQ;IPO4;CENPX;CENPI;MIS18A;CENPN;CENPA
prerank,neutrophil mediated immunity (GO:0002446),0.19458835961443732,0.6794553523988998,0.9888097660223805,1.0,1.0,84/432,20.87%,DYNLL1;NAPRT;CEACAM1;ARG1;RAP1A;ARHGAP9;ANO6;CD55;ITGAX;PTPRC;NIT2;CD53;DOCK2;CDK13;NCSTN;ADAM10;PPIE;NRAS;NEU1;ACTR10;RAB3A;DSN1;PGM1;ILF2;YPEL5;PTPRJ;FRMPD3;ATP6V0A1;HMGB1;LAMP1;IST1;CANT1;PLD1;S100A9;MME;MANBA;PAFAH1B2;VAMP8;LAIR1;TSPAN14;CEP290;CCT2;MVP;PGRMC1;LTA4H;ATG7;DERA;GSDMD;MLEC;TMEM30A;PTPN6;TMEM63A;HEXB;PSMA2;PSMD13;TICAM2;AP2A2;ATP8B4;HGSNAT;CTSB;ATP6AP2;GLIPR1;CRACR2A;CYBB;CREG1;RHOA;PSMD12;ERP44;PSMD14;SNAP23;ASAH1;LAMP2;RNASE3;SNAP29;PRDX6;XRCC6;PTGES2;AP1M1;CAPN1;ALDH3B1;RAB37;ACTR1B;CD63;IL6
prerank,lipid biosynthetic process (GO:0008610),0.22345316603809853,0.6790408700223858,0.9338327091136079,1.0,1.0,15/77,20.76%,HSD17B3;AGPAT4;CLN8;ACACA;SCD5;AGPAT5;PRLR;LSS;LPL;SCD;STAR;FADS1;AGPS;GGPS1;DOLPP1
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.2737281812956425,0.6786578084121276,0.8479880774962743,1.0,1.0,5/23,14.97%,DFFB;HMGB1;EXOG;DICER1;REXO4
prerank,organelle fission (GO:0048285),0.26869101643840854,0.6784628931177348,0.8521870286576169,1.0,1.0,4/24,10.43%,DNM1;FIS1;MIEF1;ACOT8
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),-0.28029254743700377,-0.6784241897671349,0.8534883720930233,0.9686642397751942,1.0,2/10,17.11%,ZC3H12A;RC3H1
prerank,amino sugar biosynthetic process (GO:0046349),0.3121273425005858,0.6776623444467439,0.8501742160278746,1.0,1.0,8/12,31.18%,NAGK;GNPDA2;GFPT2;GFPT1;AMDHD2;RENBP;GNPNAT1;GNPDA1
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.1948980805892578,0.6768810402362263,0.9784172661870504,1.0,1.0,79/314,22.52%,NEDD4L;FBXL15;RNF122;PCBP2;SPSB4;PSME3;TMEM129;SELENOS;FBXO5;FBXO31;SIAH1;CUL3;PSMB5;AMFR;CDC20;ANAPC5;ANAPC7;SIAH3;NPLOC4;UBE3D;ANAPC11;SHARPIN;FBXL19;NEDD4;SPOPL;FBXL5;FBXL17;BUB3;FAF1;NFE2L2;FBXO38;ANAPC2;KLHL22;RNF185;UBE2J2;UBE2D1;UBE2D3;PSMA6;KLHL15;PSMB2;FEM1C;PSMA2;ANAPC4;WWP2;PSMD13;FZR1;FBXL12;PSMA7;UBQLN1;PLAA;LTN1;FBXW7;DMAC2;ITCH;FBXL3;CUL4B;PSME4;ANAPC16;CDC23;PSMD12;WFS1;PSMD14;PSMB6;PSMC4;UBE2W;KBTBD7;SEL1L;DDIT3;GID4;PRKN;PPP2R5C;FBXW11;ZNRF1;CUL5;PSMB3;DERL1;GID8;SIRT2;RHBDD2
prerank,polarized epithelial cell differentiation (GO:0030859),0.30562254287996576,0.6768642571822587,0.8391959798994975,1.0,1.0,5/13,18.19%,OPHN1;ZDHHC7;EZR;SCRIB;RHOA
prerank,translational elongation (GO:0006414),0.21457343612605345,0.676670376458927,0.9443099273607748,1.0,1.0,39/101,27.94%,MRPL37;MRPL43;MRPL33;MRPS28;MRPS35;EEFSEC;PTCD3;MRPL41;MRPS33;MRPS22;MRPS15;MRPL3;CHCHD1;MRPL16;LTN1;MRPL40;MRPL22;GADD45GIP1;MRPL4;GTPBP1;MRPL2;MRPL34;EEF1G;GFM1;TSFM;MRPS7;MRPL11;GTPBP2;MRPL19;MRPS18A;MRPL1;MRPL39;MRPL57;MRPL13;MRPL47;DAP3;MRPL21;MRPL46;GFM2
prerank,N-terminal protein amino acid modification (GO:0031365),0.2972575268486719,0.6760632976687173,0.8377049180327869,1.0,1.0,5/14,24.68%,NAA35;NAA10;NAA40;NAA60;METAP1D
prerank,regulation of synapse maturation (GO:0090128),0.3160537429999801,0.6755269449693567,0.8309608540925267,1.0,1.0,3/10,13.52%,CDC20;RELN;ANAPC2
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.21988684597655425,0.6754091396731592,0.9238329238329238,1.0,1.0,22/88,18.81%,FBXL15;PSME3;FBXO31;PSMB5;FBXL5;FBXL17;FBXO38;PSMA6;PSMB2;PSMA2;PSMD13;FBXL12;PSMA7;FBXW7;DMAC2;FBXL3;CUL4B;PSME4;PSMD12;PSMD14;PSMB6;PSMC4
prerank,DNA-dependent DNA replication (GO:0006261),0.2075718066002345,0.6748546412974636,0.9588100686498856,1.0,1.0,32/128,18.81%,PSME3;RFC3;ORC5;GINS4;PSMB5;SIRT7;ORC3;SRPK2;CDK2AP1;CDC6;TEFM;PSMA6;POLG2;POLB;PSMB2;PSMA2;REV3L;RECQL5;PSMD13;POLE;PSMA7;GMNN;RFC1;PSME4;ORC6;GINS3;NOC3L;PSMD12;ORC1;PSMD14;PSMB6;PSMC4
prerank,microtubule bundle formation (GO:0001578),0.24350663750790097,0.6746167086197609,0.893646408839779,1.0,1.0,5/42,9.63%,NCKAP5L;SPEF1;CAPN6;SPAST;FOXJ1
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.27711113353411065,0.6741037913662669,0.8715596330275229,1.0,1.0,2/21,7.57%,KCNA5;NOS1AP
prerank,negative regulation of translation (GO:0017148),0.21952149595834494,0.6737034464685432,0.9341317365269461,1.0,1.0,11/87,10.70%,FXR2;GIGYF2;EIF2AK3;CELF1;CNOT10;SAMD4B;PUS7;IGF2BP2;CNOT7;ILF3;TPR
prerank,defense response to Gram-positive bacterium (GO:0050830),0.24352053176575614,0.6728201521735895,0.8907103825136612,1.0,1.0,1/40,0.69%,LBP
prerank,coenzyme A metabolic process (GO:0015936),-0.2624412435370229,-0.6725212510760246,0.8927613941018767,0.9730259553541228,1.0,4/14,13.19%,ACOT7;PANK1;ACLY;PPCDC
prerank,cellular response to misfolded protein (GO:0071218),0.2746234322134707,0.6723703251088645,0.8580542264752791,1.0,1.0,10/20,30.52%,CUL3;RNF185;KLHL15;UBE2W;DERL1;STUB1;UGGT1;UGGT2;DNAJB12;DNAJC18
prerank,protein catabolic process (GO:0030163),0.22667318733388714,0.6722973978353827,0.920881971465629,1.0,1.0,5/59,7.50%,CEACAM1;LRSAM1;CLN8;SOCS6;SIAH1
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.2500668640958168,0.6715458836106332,0.8835904628330996,1.0,1.0,6/34,9.74%,IRAK3;TNFAIP3;ACOD1;NLRP2B;SARM1;TICAM1
prerank,positive regulation of bone resorption (GO:0045780),0.30918444465601236,0.671006580522813,0.8313856427378965,1.0,1.0,1/11,4.02%,PRKCA
prerank,regulation of microtubule nucleation (GO:0010968),0.3166689103171414,0.6708817659992542,0.8405797101449275,1.0,1.0,3/10,16.91%,CKAP5;MECP2;ARHGEF7
prerank,purine-containing compound biosynthetic process (GO:0072522),0.26918101036113595,0.6707884358021609,0.8526785714285714,1.0,1.0,8/25,20.39%,MTHFD1;PPAT;PRPSAP2;PRPS1;PRPS1L1;DCK;GART;ADSL
prerank,anterograde axonal transport (GO:0008089),0.25011487201334187,0.6707814303963548,0.8977591036414566,1.0,1.0,11/37,22.59%,SPAST;KIF5A;KIF5B;AP3B1;RAB21;AP3M1;RAB27B;AP3S2;BLOC1S2;DLG2;MAPK8IP3
prerank,cellular response to virus (GO:0098586),-0.20667195606966715,-0.6707430846315325,0.9433333333333334,0.9737118299369684,1.0,10/30,31.93%,GSDME;HIF1A;ZC3H12A;LGALS9;RIOK3;CCL19;DDX3X;VWCE;EIF5A;CXCL10
prerank,positive regulation of protein transport (GO:0051222),0.2269470125405558,0.6707136920451353,0.9107373868046572,1.0,1.0,14/67,17.28%,RAB29;KIF20B;IL1A;FRMD4A;CEP131;ARHGEF5;RIPOR1;ARF6;TPR;CEP290;PCM1;UNC13B;EZR;CHP1
prerank,tRNA 5'-leader removal (GO:0001682),0.30197863109355116,0.670399401840923,0.8330578512396695,1.0,1.0,6/13,24.83%,POP4;POP7;RPP14;RPP21;RPP30;PRORP
prerank,heterochromatin assembly (GO:0031507),0.2752720680264749,0.669867983682924,0.8717948717948718,1.0,1.0,8/20,26.91%,BEND3;SUV39H1;BAZ2A;ZNFX1;SIRT2;EZH1;CENPV;RRP8
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),0.2900871819333282,0.6692704069916136,0.8541666666666666,1.0,1.0,8/15,29.48%,RAB3GAP2;SEC61G;RAB3GAP1;SRPRA;SEC61A1;ZFAND2B;SRPRB;SPCS3
prerank,negative regulation of calcium ion transport (GO:0051926),0.2927736703089862,0.6691974680440819,0.8512,1.0,1.0,4/15,19.36%,ATP1A2;ADRA2A;PACSIN3;CBARP
prerank,NIK/NF-kappaB signaling (GO:0038061),0.22527316310059417,0.6690681357999205,0.9330759330759331,1.0,1.0,16/72,18.81%,REL;PSME3;CARD10;PSMB5;DICER1;PSMA6;PSMB2;PSMA2;RELB;PSMD13;PSMA7;PSME4;PSMD12;PSMD14;PSMB6;PSMC4
prerank,sensory perception of pain (GO:0019233),-0.22559996439764096,-0.6688725956375823,0.915068493150685,0.974515429807189,1.0,12/21,35.86%,P2RX7;P2RX4;OPRM1;OPRK1;KCNA2;TRPA1;CHRNA4;SCN9A;CCR2;CCL2;OPRL1;CHRNB2
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.24155206011079816,0.6686736149772118,0.8904694167852063,1.0,1.0,2/40,2.22%,GLMN;AXIN1
prerank,negative regulation of leukocyte migration (GO:0002686),0.3166380476411256,0.6685741611793419,0.8535714285714285,1.0,1.0,2/10,9.00%,BMP5;CD200R1
prerank,protein localization to vacuole (GO:0072665),-0.2557282079020841,-0.6684100614899764,0.8883495145631068,0.9741526724443389,1.0,3/13,13.59%,SH3GLB1;GLMP;LMBRD1
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.26181416222322734,0.6679719916990742,0.8652694610778443,1.0,1.0,8/25,21.46%,B3GALT1;B4GAT1;NDST1;EXT1;EXT2;B3GNT8;NDST4;HS2ST1
prerank,cellular biogenic amine metabolic process (GO:0006576),0.302023668666736,0.6673304311464808,0.8370497427101201,1.0,1.0,2/12,4.98%,SLC29A4;SLC22A3
prerank,positive regulation of chromosome organization (GO:2001252),0.29256431880132805,0.6669095741276813,0.8583617747440273,1.0,1.0,7/15,26.87%,NBN;SHCBP1L;MRE11;DDX11;ATRX;PML;RAD50
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.21080167606681388,-0.6668426708125113,0.944954128440367,0.9746489051378929,1.0,2/28,3.02%,ITPR1;TMEM117
prerank,global genome nucleotide-excision repair (GO:0070911),0.26212220255087265,0.6666409064176263,0.8870967741935484,1.0,1.0,8/26,18.12%,ERCC1;CETN2;GTF2H1;DDB2;CHD1L;USP45;CUL4B;GTF2H3
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.28382526308862915,0.6663497723005393,0.8536977491961415,1.0,1.0,2/16,8.64%,KMT5C;WRAP53
prerank,integrated stress response signaling (GO:0140467),0.2937180941931992,0.6662188370237772,0.8409090909090909,1.0,1.0,6/14,24.09%,EIF2AK3;NFE2L2;QRICH1;DDIT3;IMPACT;HSPA5
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.3193145594602391,0.6658809030067622,0.8321554770318021,1.0,1.0,2/10,9.68%,SEC14L1;NPLOC4
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.2281713998777944,0.6644065129723861,0.9184491978609626,1.0,1.0,16/52,23.73%,DCP1B;CNOT10;SAMD4B;EXOSC5;CNOT7;PAN2;DDX6;TNKS1BP1;CNOT8;PNLDC1;CNOT1;LSM3;EXOSC7;DCPS;LSM2;CNOT2
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.2941034937918611,0.6643822954241082,0.8607142857142858,1.0,1.0,2/14,12.82%,RAB29;CD81
prerank,protein localization to chromosome (GO:0034502),-0.20118117065012725,-0.6635821867007068,0.9413680781758957,0.9764718109370687,1.0,13/34,31.71%,SLF2;TPP1;SLF1;ESR1;PINX1;XRCC4;ACD;TNKS2;CHMP7;TINF2;MCM9;PARP3;CENPA
prerank,cellular response to steroid hormone stimulus (GO:0071383),0.2802348519696918,0.6628274587399292,0.854632587859425,1.0,1.0,3/17,8.70%,SRC;ATP1A2;ACOD1
prerank,nucleosome assembly (GO:0006334),0.25132915555466073,0.6622409644968141,0.8741058655221745,1.0,1.0,3/31,4.41%,SOX9;HAT1;KAT6B
prerank,glycerophospholipid metabolic process (GO:0006650),0.22008125982336524,0.6614142015643751,0.917910447761194,1.0,1.0,8/75,9.38%,PLCB3;GPLD1;ACP6;PAFAH1B1;ABHD12;PIGB;PLEK;PIGA
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),0.30837935590248017,0.6610529256627166,0.8434925864909391,1.0,1.0,2/11,9.91%,SELENOS;AXL
prerank,magnesium ion transport (GO:0015693),0.3062985699919307,0.6605789902122735,0.849912739965096,1.0,1.0,3/12,12.68%,NIPA2;MRS2;TUSC3
prerank,carbohydrate transport (GO:0008643),0.30540545662226914,0.6604855583597352,0.8547008547008547,1.0,1.0,2/11,13.15%,SLC2A2;AQP1
prerank,ruffle organization (GO:0031529),-0.24173314402793816,-0.6599525631809172,0.8900255754475703,0.9785796063452608,1.0,5/16,22.52%,TPM1;AIF1L;PIP5K1A;CARMIL1;CORO1B
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),-0.22512044337247522,-0.658838596025441,0.919889502762431,0.9786828964425212,1.0,7/22,21.45%,RNF115;VPS4A;MVB12A;VPS37C;UBAP1;VPS28;RNF126
prerank,regulation of microtubule depolymerization (GO:0031114),0.2497209901521641,0.6584009662828199,0.8867313915857605,1.0,1.0,2/25,3.41%,SPEF1;TRPV4
prerank,tRNA methylation (GO:0030488),0.2405504083157768,0.6574611568557748,0.9048295454545454,1.0,1.0,13/34,25.40%,TARBP1;THADA;FTSJ1;TRMT5;THUMPD3;METTL2B;METTL2A;TRMT1L;TRMO;TRMT1;THUMPD2;PRORP;MTO1
prerank,lipoxygenase pathway (GO:0019372),0.292768740415125,0.6574204189965618,0.8426395939086294,1.0,1.0,3/14,21.04%,ALOXE3;HPGD;PON3
prerank,positive regulation of lipid storage (GO:0010884),-0.22037892688702726,-0.6569018574987331,0.9345238095238095,0.9794333056492976,1.0,6/21,25.77%,OSBPL11;ZC3H12A;PLIN3;FITM2;SCARB1;C3
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.22509647235588034,0.6568143027087717,0.9222520107238605,1.0,1.0,6/55,8.70%,COQ7;MPV17;RAC2;DHRS4;AATF;ACOD1
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.2265515861393837,0.6565402043721204,0.914249684741488,1.0,1.0,13/56,18.19%,RACGAP1;SON;USP8;SPAST;PDCD6IP;IST1;CHMP4B;APC;CIT;RTKN;STAMBP;SPTBN1;RHOA
prerank,heart looping (GO:0001947),0.2383373451506494,0.6559414702636808,0.913769123783032,1.0,1.0,4/39,7.53%,FOLR1;STIL;TBX2;CCDC39
prerank,regulation of myelination (GO:0031641),0.25450018441005695,0.6556196757003174,0.8935185185185185,1.0,1.0,5/25,14.26%,ITGAX;EIF2AK3;NCMAP;NSUN5;DICER1
prerank,lipid homeostasis (GO:0055088),0.2264320913685699,0.6552723589575998,0.9255989911727617,1.0,1.0,11/57,17.61%,ZBTB20;CLN8;USF2;ABCA1;TLCD3A;THADA;ABCD1;PNPLA8;PPARG;FBXW7;IRS2
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),0.30673546041626465,0.6547492044070903,0.8469387755102041,1.0,1.0,1/11,4.77%,WNT5A
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.21057371595715427,0.6544503747490471,0.9543817527010804,1.0,1.0,22/86,20.19%,PSME3;EGLN3;ANKRD2;BAG3;MAPK7;PSMB5;INO80;NFE2L2;CREBBP;PSMA6;PSMB2;PSMA2;PSMD13;PSMA7;BACH1;PSME4;PSMD12;PSMD14;PSMB6;PSMC4;GCN1;DDIT3
prerank,mitotic metaphase plate congression (GO:0007080),0.22899781232600463,0.6542302396532546,0.9224598930481284,1.0,1.0,15/51,22.38%,NUP62;CUL3;CHMP5;PDCD6IP;CHMP4B;CHMP4A;CHMP4C;ZW10;PIBF1;MAD1L1;CDC23;DCTN2;RRS1;CHMP2A;MIS12
prerank,axonemal dynein complex assembly (GO:0070286),0.25336183876012563,0.6535132448433055,0.8797653958944281,1.0,1.0,7/27,22.75%,CFAP73;CCDC39;DNAH5;CCDC40;ODAD1;DNAI4;CFAP100
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.22629514207195406,0.6532033606380353,0.9250985545335085,1.0,1.0,13/56,18.36%,NDUFA6;NDUFB10;NDUFS3;NDUFS6;NDUFA3;NDUFV2;NDUFV1;NDUFA7;BCS1L;NDUFAF5;DMAC2;NDUFS2;NDUFAF6
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.22629514207195406,0.6532033606380353,0.9250985545335085,1.0,1.0,13/56,18.36%,NDUFA6;NDUFB10;NDUFS3;NDUFS6;NDUFA3;NDUFV2;NDUFV1;NDUFA7;BCS1L;NDUFAF5;DMAC2;NDUFS2;NDUFAF6
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),0.28399336310608414,0.6531070621419082,0.853448275862069,1.0,1.0,4/13,18.01%,GCC2;CD81;TMEM30A;TM9SF4
prerank,positive regulation of interleukin-8 production (GO:0032757),0.22513768501364162,0.6525097105801843,0.9181208053691275,1.0,1.0,3/49,9.55%,LBP;TLR7;HMGB1
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.23694296222814068,0.6525066296284369,0.9165507649513213,1.0,1.0,14/40,25.37%,BOD1L1;DONSON;GEN1;NUCKS1;RFWD3;ETAA1;EME2;FAM111A;POLE;ATR;DDX11;PRIMPOL;FBH1;ATRX
prerank,intracellular pH reduction (GO:0051452),-0.20031947119871202,-0.6523571745135855,0.9531772575250836,0.9821018657102473,1.0,11/33,25.01%,ATP6V0A4;ATP6V0C;ATP6V1C1;TMEM9;ATP6V1D;ATP6V1F;ATP6V1E1;RAB7A;RAB38;GPR89A;GPR89B
prerank,positive regulation of defense response to virus by host (GO:0002230),0.2623994567905114,0.6516049717111613,0.8798798798798799,1.0,1.0,2/24,6.13%,PTPN22;ZDHHC1
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.22226250967653077,0.6508544393521588,0.927694406548431,1.0,1.0,6/56,11.19%,LBP;TLR7;RPS6KA3;HMGB1;S100A9;TAB2
prerank,regulation of activin receptor signaling pathway (GO:0032925),-0.24339208914903812,-0.6507471965521308,0.9185185185185185,0.9825484794572962,1.0,5/15,26.88%,FKBP1A;LEMD3;CSNK2B;FSTL3;ACVR1B
prerank,positive regulation of telomere capping (GO:1904355),0.27457783751832027,0.6506587793165783,0.8710743801652893,1.0,1.0,4/17,25.90%,NEK7;HNRNPD;MAPK1;TNKS
prerank,protein localization to cell junction (GO:1902414),0.26176437889408594,0.6506163979606473,0.8783570300157978,1.0,1.0,6/22,22.17%,TJP2;CGNL1;FERMT2;JAK1;ARHGEF18;NLGN2
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.23648757874962764,0.6504787597129871,0.930298719772404,1.0,1.0,9/37,18.12%,NTHL1;RFC3;ERCC1;GTF2H1;DDB2;CHD1L;CUL4B;RFC1;GTF2H3
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.21425341064052478,-0.6496381157640683,0.9375,0.9826064124178889,1.0,7/22,20.83%,WDR12;NOP9;RPS21;EXOSC3;NOL9;KRI1;ERI3
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.31273796117055536,0.6491112757530524,0.864406779661017,1.0,1.0,3/10,23.20%,CRTAM;SCRIB;PRNP
prerank,establishment of mitotic spindle localization (GO:0040001),0.2526457064204148,0.6468703707651638,0.913235294117647,1.0,1.0,8/28,21.76%,SAPCD2;PAFAH1B1;NDE1;HTT;ZW10;ITGB1;GPSM2;FBXW11
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.2763040669735452,0.6462370053463699,0.8911222780569514,1.0,1.0,2/17,7.48%,EMC9;EMC7
prerank,mitochondrial membrane organization (GO:0007006),0.24086944875794425,0.6452798751407732,0.8947368421052632,1.0,1.0,15/32,29.86%,MFN2;MICOS10;MTX1;CHCHD6;BAD;BNIP3;CHCHD3;HSPA9;APOOL;SLC25A5;BCL2L1;SPG7;BCL2;PPIF;APOO
prerank,cell cycle G1/S phase transition (GO:0044843),0.21895820043735323,0.6450501951912235,0.9276315789473685,1.0,1.0,9/61,17.22%,PLK2;CDK7;CUL3;EIF4E;CRLF3;POLE;E2F1;USP37;CUL4B
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.28034784558695897,0.6449299151805978,0.8569023569023569,1.0,1.0,5/14,23.04%,USP15;PUM2;PUM1;DHX58;ZDHHC5
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.25969813870590863,0.6444447794761345,0.8877245508982036,1.0,1.0,4/23,13.22%,HOOK2;HOOK3;KIF5A;KIF5B
prerank,peptidyl-methionine modification (GO:0018206),-0.2574151786358437,-0.644292860211176,0.9093198992443325,0.9856827705175354,1.0,1/12,5.98%,NAA15
prerank,regulation of cell cycle (GO:0051726),0.1866114062714863,0.644157721558726,0.9958592132505176,1.0,1.0,49/271,17.91%,FAP;MYBBP1A;PPP1R13B;KIF20B;SOX9;MFN2;PTPRC;SON;RPRD1B;NEK7;NBN;TRIM21;ADAM10;CDK7;LIN54;FBXO5;RARA;BRINP1;E4F1;PES1;NLRP2B;MASTL;POU4F1;TRNP1;SRPK2;APC;ZBTB49;FBXL17;NF2;MEN1;DHCR24;PKD1;CRLF3;ERN1;HTRA2;TTC28;FZD9;SIPA1;GPER1;FBXL12;CDC14A;HPGD;RGCC;CSNK2A2;FBXL3;GMNN;GADD45GIP1;LIN37;FGF10
prerank,snRNA metabolic process (GO:0016073),0.2705471257264422,0.642647599311587,0.8707482993197279,1.0,1.0,2/17,6.05%,INTS10;TUT1
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.2628249296879118,0.6424237445284495,0.9096573208722741,1.0,1.0,9/20,25.81%,AGO1;DICER1;PUM2;SPOUT1;TSNAX;PRKRA;PUM1;ZC3H7B;AGO2
prerank,regulation of neuroblast proliferation (GO:1902692),0.27757914447796656,0.6423899566438322,0.8713550600343053,1.0,1.0,4/15,21.50%,NF1;FZD3;CX3CL1;CX3CR1
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),-0.19849740017572265,-0.6423322091700253,0.9469026548672567,0.9862258932254673,1.0,15/29,35.88%,IKBKB;CASP8;CD40;TLR3;IKBKG;RIPK1;UBB;BIRC3;LY96;TANK;CD300LF;IKBKE;TLR6;UBC;RPS27A
prerank,positive regulation of response to external stimulus (GO:0032103),0.1994031750417754,0.6422835491003502,0.9706214689265537,1.0,1.0,22/128,16.28%,PRKCA;WNT5A;MGST2;LRSAM1;ABCC1;IL17RA;TLR7;TRADD;PTGER4;POLR3G;TNIP1;ACOD1;PLSCR1;S100A9;POLR3D;USP15;PUM2;PLG;NFKBIZ;LPL;MDK;IL15
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",-0.2451412571712568,-0.6418449217929929,0.9046454767726161,0.9858100599273768,1.0,5/14,29.85%,TPP1;PINX1;ACD;TNKS2;TINF2
prerank,nuclear migration (GO:0007097),0.2922172013544424,0.6416043766877638,0.8642611683848798,1.0,1.0,5/13,14.20%,PAFAH1B1;DOCK7;HOOK3;PCM1;CLMN
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),0.2975059692343352,0.641365356804989,0.868421052631579,1.0,1.0,6/11,24.38%,FXR1;PUM2;XPO5;DHX9;PUM1;FMR1
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.2907344187997954,0.6411211057722473,0.8735440931780366,1.0,1.0,1/12,4.14%,SOX9
prerank,ESCRT III complex disassembly (GO:1904903),0.30507609695489946,0.6404904748155997,0.886986301369863,1.0,1.0,2/10,9.90%,CHMP5;IST1
prerank,ESCRT complex disassembly (GO:1904896),0.30507609695489946,0.6404904748155997,0.886986301369863,1.0,1.0,2/10,9.90%,CHMP5;IST1
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.24261236478747097,0.6403238765271051,0.9232914923291492,1.0,1.0,6/33,13.87%,WEE1;DACT1;KANK2;APC;PTEN;FHL1
prerank,phosphate ion transport (GO:0006817),-0.23507350807882463,-0.6403025041842875,0.922879177377892,0.9860900313478534,1.0,5/16,28.84%,SLC25A30;SLC25A11;SLC37A1;SLC37A2;SLC37A3
prerank,pancreas development (GO:0031016),0.28662846459611957,0.6391469065339723,0.8916518650088809,1.0,1.0,4/12,15.37%,CCDC39;ISL1;FOXF1;CCDC40
prerank,mRNA destabilization (GO:0061157),0.2309586906345847,0.6383562484596261,0.9435364041604755,1.0,1.0,4/38,7.79%,DND1;GIGYF2;CELF1;DIS3L2
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.26737719086692063,0.6377457686224929,0.8811074918566775,1.0,1.0,5/18,21.16%,MAPK7;NFE2L2;HTRA2;PINK1;PRKN
prerank,cytosolic transport (GO:0016482),0.20485244052254767,0.6376378037487451,0.96875,1.0,1.0,31/108,22.93%,HOOK2;RAB29;WDR81;PHETA2;KIF16B;GOSR1;LAMP1;GCC2;RIC1;DENND2A;SPAG9;HOOK3;SNX2;EVI5;PIK3C3;SNX5;SNX1;WDR91;VPS13A;STX5;LMTK2;ANKFY1;TBC1D5;RAB5A;VPS53;TBC1D10A;VPS50;AKTIP;ERC1;RAB9A;VPS29
prerank,regulation of interleukin-1 beta production (GO:0032651),0.21308697155748677,0.6374034700884245,0.9528535980148883,1.0,1.0,8/66,13.67%,USP50;WNT5A;TNFAIP3;NLRC4;ISL1;NLRP2B;EGR1;GSDMD
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.24496632131735593,0.637302056749472,0.9001490312965723,1.0,1.0,4/28,11.08%,KMT5C;WRAP53;SIRT7;ERCC6
prerank,protein-DNA complex assembly (GO:0065004),0.20076558802326253,0.6368535026489032,0.9778296382730455,1.0,1.0,34/116,22.01%,SOX9;KAT6B;PSME3;ORC5;CDK7;PSMB5;ORC3;CETN2;CDC6;GTF2H1;PSMA6;PSMB2;PSMA2;PSMD13;PSMA7;DDB2;CHD1L;CUL4B;GMNN;PSME4;ORC6;NAP1L1;GTF2H3;PSMD12;ORC1;PSMD14;PSMB6;SPTY2D1;PSMC4;NAA60;RSF1;DAXX;RPA3;PSMB3
prerank,glycosphingolipid metabolic process (GO:0006687),0.23299099308283278,0.6366894830524596,0.9232839838492598,1.0,1.0,7/42,11.17%,A4GALT;SUMF1;CERK;NEU1;HEXA;ST8SIA5;ST8SIA3
prerank,DNA geometric change (GO:0032392),-0.20727354592743719,-0.6365766691957742,0.9375,0.9878092939393063,1.0,6/24,19.13%,WRN;BLM;ANXA1;ZRANB3;DHX36;DDX1
prerank,negative regulation of interferon-gamma production (GO:0032689),0.25944370884886203,0.6363880678478373,0.8955223880597015,1.0,1.0,3/23,9.91%,RARA;HMGB1;AXL
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.28920812743333885,0.6363077794164305,0.8921739130434783,1.0,1.0,4/12,20.54%,WRAP53;CCT2;GNL3L;CCT3
prerank,cardiac left ventricle morphogenesis (GO:0003214),-0.24633156253330335,-0.6361885417136066,0.9293193717277487,0.9873123110848933,1.0,3/13,17.21%,RBPJ;GSK3A;SMAD4
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.2544783542278846,0.6361000957991942,0.8960244648318043,1.0,1.0,7/25,21.64%,ZNF326;ELL;SUPT4H1;ERCC6;THOC5;CCAR2;TSFM
prerank,B cell proliferation (GO:0042100),-0.2299548496738763,-0.635748078248993,0.9496402877697842,0.9868526004453847,1.0,1/17,1.74%,CTPS1
prerank,exit from mitosis (GO:0010458),0.28710328793209683,0.6347312339137785,0.8873483535528596,1.0,1.0,3/12,10.16%,SPAST;SIRT7;CHMP4B
prerank,sphingosine biosynthetic process (GO:0046512),0.29616335052206433,0.6341931032242908,0.8740875912408759,1.0,1.0,1/11,2.62%,ACER3
prerank,sphingoid biosynthetic process (GO:0046520),0.29616335052206433,0.6341931032242908,0.8740875912408759,1.0,1.0,1/11,2.62%,ACER3
prerank,mitochondrial protein processing (GO:0034982),-0.26220263132448707,-0.6340194068531732,0.9229024943310657,0.9871699774933043,1.0,1/11,1.47%,OMA1
prerank,very-low-density lipoprotein particle assembly (GO:0034379),-0.247558357140816,-0.633447093106256,0.9130434782608695,0.9867761698568617,1.0,2/12,12.92%,ACSL3;MFSD2A
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.23146719731185209,0.633216083910113,0.9337175792507204,1.0,1.0,6/36,15.78%,TXK;WNT5A;IRGM;AXL;IL7;TICAM2
prerank,regulation of cellular amine metabolic process (GO:0033238),0.2233610443637714,0.6324857471621355,0.9350132625994695,1.0,1.0,16/50,24.43%,PSME3;PSMB5;PSMA6;PSMB2;PSMA2;PSMD13;PSMA7;PSME4;PSMD12;PSMD14;PSMB6;PSMC4;PSMB3;OAZ2;AZIN1;PSMD2
prerank,regulation of microglial cell activation (GO:1903978),-0.24111278101327188,-0.6315670718345007,0.9324324324324325,0.9871962988293574,1.0,3/15,13.27%,LDLR;TTBK1;SPHK1
prerank,positive regulation of TORC1 signaling (GO:1904263),0.26823214426146824,0.6315503781650524,0.8963815789473685,1.0,1.0,7/16,24.72%,SIK3;KLHL22;RRAGB;GPR137C;LAMTOR5;RRAGA;CLEC16A
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.22635870409199962,0.6308478859758386,0.9425770308123249,1.0,1.0,9/39,18.12%,NTHL1;RFC3;ERCC1;GTF2H1;DDB2;CHD1L;CUL4B;RFC1;GTF2H3
prerank,regulation of protein modification process (GO:0031399),0.21917908623864016,0.6285290001602374,0.9325236167341431,1.0,1.0,14/50,21.22%,CDH5;SPRED1;FN1;FER;STAT2;SPRED2;ATG7;SOCS1;WARS1;RABL3;PPP2CA;PIN1;CCAR2;ATG14
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.27408985331004176,0.6283864679215738,0.8851674641148325,1.0,1.0,5/15,24.83%,AP3B1;AP3M1;AP3S2;BLOC1S2;BLOC1S4
prerank,anterograde synaptic vesicle transport (GO:0048490),0.27408985331004176,0.6283864679215738,0.8851674641148325,1.0,1.0,5/15,24.83%,AP3B1;AP3M1;AP3S2;BLOC1S2;BLOC1S4
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-0.2265017721372272,-0.6272858883884869,0.9318181818181818,0.9890886892012215,1.0,4/16,16.38%,TRA2A;SNW1;NCL;NCBP1
prerank,outer dynein arm assembly (GO:0036158),-0.22875481498555145,-0.627261840102092,0.9445910290237467,0.98834368421871,1.0,8/14,41.80%,LRRC49;DNAL1;ODAD2;ODAD3;ODAD4;DNAH17;CCDC63;DNAAF4
prerank,rRNA catabolic process (GO:0016075),0.2720003920911739,0.6257058853888562,0.9038785834738617,1.0,1.0,2/16,9.67%,EXOSC5;EXOSC10
prerank,aromatic amino acid family metabolic process (GO:0009072),0.30161702386447004,0.6255430779756118,0.8837606837606837,1.0,1.0,1/10,3.11%,IL4I1
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.295675471276133,0.6254237725444998,0.8533568904593639,1.0,1.0,4/11,24.35%,ATL2;RTN4;VCPIP1;VAPB
prerank,positive regulation of protein sumoylation (GO:0033235),-0.26154330543151283,-0.625024025733049,0.9135514018691588,0.9889372444480251,1.0,4/10,19.82%,UBA2;PIAS3;RWDD3;GNL3
prerank,endoderm formation (GO:0001706),0.232892357166531,0.6250154119977289,0.926657263751763,1.0,1.0,3/35,5.38%,MMP15;ITGA7;FN1
prerank,negative regulation of dephosphorylation (GO:0035305),0.2581143541309322,0.6248497255904238,0.9161392405063291,1.0,1.0,4/18,17.28%,SH3RF2;ENSA;PTPA;CHP1
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.2434249532545098,0.6241898329387812,0.9139941690962099,1.0,1.0,7/28,21.16%,AXIN1;DDRGK1;PTEN;FBXW7;BAG2;TMTC3;PRKN
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.29584302344328295,0.6238552386916425,0.8843416370106761,1.0,1.0,3/10,21.16%,HDAC6;ETFBKMT;PRKN
prerank,negative regulation of cation channel activity (GO:2001258),0.2455753012929595,0.6235005330863015,0.8956780923994039,1.0,1.0,7/26,20.81%,FKBP1B;EPHB2;CASQ2;KCNAB1;UBQLN1;CBARP;CALM2
prerank,regulation of cAMP-mediated signaling (GO:0043949),-0.20416954480982047,-0.6232356141892331,0.9538461538461539,0.9891875816474527,1.0,3/24,12.01%,RAPGEF2;PDE2A;PRKAR2B
prerank,regulation of chromatin binding (GO:0035561),-0.261354435051777,-0.6223967514379094,0.910913140311804,0.9889469235075197,1.0,3/10,25.38%,MED25;KDM4D;BTAF1
prerank,central nervous system myelination (GO:0022010),0.29769939569464926,0.6204622666555171,0.8672413793103448,1.0,1.0,2/11,12.65%,CNTNAP1;PTEN
prerank,B cell mediated immunity (GO:0019724),0.28874071086429176,0.6203546070436088,0.9016100178890877,1.0,1.0,1/10,7.73%,MSH2
prerank,telomere organization (GO:0032200),-0.17462320745071766,-0.6203167160314857,0.9790940766550522,0.9894040086272872,1.0,13/43,30.89%,SP100;WRN;BLM;DCLRE1B;PARP1;ERCC4;POLD2;ACD;PTGES3;CTC1;ATM;TINF2;PARP3
prerank,renal absorption (GO:0070293),0.29041944623022864,0.620254762696861,0.8939670932358318,1.0,1.0,2/10,11.99%,MAGED2;SGK1
prerank,male meiosis I (GO:0007141),-0.22822680303066362,-0.6197983203257973,0.9282051282051282,0.9889617473402729,1.0,2/16,8.65%,FOXJ3;MYBL1
prerank,striated muscle contraction (GO:0006941),-0.17268731611233099,-0.6197175939824462,1.0,0.988246987606636,1.0,18/53,32.96%,DMD;TPM1;SLC8A1;ATP1B1;SCN4B;NOS1;TNNT3;STAC3;SCN1B;MYL4;KCNH2;STAC2;TTN;SCN5A;KCNQ1;RYR2;KLHL41;PIK3CA
prerank,synaptic vesicle localization (GO:0097479),0.2778928179456912,0.6194576441219832,0.8879598662207357,1.0,1.0,4/13,19.75%,KIF5A;KIF5B;TMEM230;SPG11
prerank,histone ubiquitination (GO:0016574),0.2517089512107773,0.6186481967803236,0.9089506172839507,1.0,1.0,2/21,6.89%,LEO1;PAF1
prerank,regulation of T cell mediated immunity (GO:0002709),-0.2615573180423028,-0.6186347745652603,0.9126436781609195,0.9881093997118818,1.0,4/10,29.47%,TNFRSF1B;ZBTB1;AGER;CCR2
prerank,regulation of cellular pH (GO:0030641),0.23522518799918468,0.6185691338076246,0.9280359820089955,1.0,1.0,4/29,11.27%,SLC4A3;SLC4A4;SLC9A7;SLC9A6
prerank,microtubule anchoring at centrosome (GO:0034454),0.29369673844401667,0.6184753415989915,0.8596774193548387,1.0,1.0,4/10,21.59%,HOOK3;PCM1;CCDC120;CEP19
prerank,autophagy of nucleus (GO:0044804),-0.22629155518029423,-0.6183895634941238,0.9385026737967914,0.9874884567332369,1.0,7/16,24.97%,ULK2;WIPI1;ATG13;WIPI2;ATG12;WDR45B;WDR45
prerank,regulation of viral genome replication (GO:0045069),0.21221639242722884,0.6180709346180191,0.9595687331536388,1.0,1.0,8/56,10.97%,PPIE;N4BP1;SRPK1;TNIP1;PLSCR1;CNOT7;ILF3;SRPK2
prerank,regulation of interferon-beta production (GO:0032648),0.21876352306310948,0.6180294826214773,0.9513888888888888,1.0,1.0,14/46,24.75%,REL;TLR7;POLR3G;POLR3D;RELB;TBK1;OAS2;DHX9;TRAF3;DHX58;IFIH1;POLR3C;YY1;RIPK2
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),0.21564848874163556,0.6160878470666407,0.9630118890356671,1.0,1.0,3/55,7.50%,CAV1;FIS1;SIAH1
prerank,regulation of mRNA catabolic process (GO:0061013),0.19168549988293676,0.6159967963916373,0.9836829836829837,1.0,1.0,29/121,22.01%,FXR2;PRKCA;PSME3;SAMD4B;EXOSC5;IGF2BP2;PSMB5;CNOT7;ZFP36L2;PSMA6;FXR1;PUM2;PSMB2;PSMA2;PSMD13;PSMA7;PSME4;PSMD12;CNOT8;GTPBP1;PSMD14;PSMB6;PSMC4;CNOT1;HNRNPD;PUM1;EXOSC7;ELAVL1;PSMB3
prerank,protein acetylation (GO:0006473),0.23144976407409087,0.6153991688303302,0.9108187134502924,1.0,1.0,8/30,19.70%,HAT1;NAA35;CREBBP;NAT9;NAA10;DSCC1;NAA40;NAA60
prerank,DNA methylation (GO:0006306),0.2489253051737591,0.6149230208453873,0.9263803680981595,1.0,1.0,4/23,14.21%,BEND3;TEX15;BAZ2A;ZFP57
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),0.27553128210529365,0.6144860130414737,0.9176672384219554,1.0,1.0,8/13,31.18%,NAGK;GNPDA2;GFPT2;GFPT1;AMDHD2;RENBP;GNPNAT1;GNPDA1
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),-0.2291029167229839,-0.6141494158313398,0.9195121951219513,0.9891357014953862,1.0,5/15,29.83%,ARMC10;KDM1A;MIF;TAF9;TRIAP1
prerank,B cell activation (GO:0042113),0.20612752055193043,0.6137508338375266,0.9681274900398407,1.0,1.0,7/68,8.07%,TPD52;HDAC4;PTPRC;BANK1;EPHB2;MSH2;PTPRJ
prerank,programmed necrotic cell death (GO:0097300),-0.2119150448573613,-0.6134601910317028,0.936986301369863,0.9887520407767406,1.0,6/18,27.53%,PGAM5;IPMK;TRPM7;TLR3;RIPK1;LY96
prerank,cellular response to nutrient levels (GO:0031669),0.2096661683585721,0.6133751536979517,0.9491525423728814,1.0,1.0,13/62,19.76%,INHBB;KLF10;PDK4;RIPOR1;STK24;TFEB;ATG7;RRAGB;LPL;LAMP2;MAP1LC3B;FADS1;RPTOR
prerank,AMP metabolic process (GO:0046033),-0.23899467735547897,-0.6130302320509882,0.9491094147582697,0.988217877669554,1.0,3/13,18.99%,XDH;NUDT2;NT5C1A
prerank,regulation of response to cytokine stimulus (GO:0060759),0.25176681990310823,0.6126551048349991,0.9131147540983606,1.0,1.0,5/19,19.61%,WNT5A;MAPK7;CBFB;RUNX1;DHX9
prerank,regulation of oxidoreductase activity (GO:0051341),0.274414730653592,0.6126505327559094,0.9074380165289256,1.0,1.0,2/13,11.44%,ABL2;HDAC6
prerank,N-acetylneuraminate metabolic process (GO:0006054),0.28690107750565635,0.6123933164474042,0.8921232876712328,1.0,1.0,3/10,14.38%,ST6GAL1;NAGK;GNPDA2
prerank,regulation of multicellular organismal development (GO:2000026),0.24304725038220537,0.6120917725359776,0.9262048192771084,1.0,1.0,2/25,3.82%,TDG;RACGAP1
prerank,ATP transport (GO:0015867),-0.2582120704695699,-0.6120446738859293,0.9280575539568345,0.9880285117747194,1.0,3/10,26.38%,ABCC6;SLC25A24;SLC25A42
prerank,protein export from nucleus (GO:0006611),0.2420600820051218,0.6117555159483998,0.9063893016344725,1.0,1.0,10/27,23.48%,STYX;TPR;CSE1L;PKD1;RAN;CHP1;XPO5;STRADB;XPO4;XPO7
prerank,telomere maintenance (GO:0000723),-0.1667561912829565,-0.6108835184804471,0.9881889763779528,0.9878617211425754,1.0,18/50,30.89%,SP100;WRN;BLM;DCLRE1B;SMC6;TPRKB;PARP1;ERCC4;POLD2;ACD;RAD51;PTGES3;CTC1;ATM;TINF2;TEN1;XRCC3;PARP3
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.24484843002725248,0.6107361370695477,0.9239940387481371,1.0,1.0,7/24,19.05%,SEMA4B;DSCAM;SEMA3A;SEMA4D;SEMA6C;SEMA4C;SEMA4A
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.2819439480269754,0.610423837957112,0.8919354838709678,1.0,1.0,3/11,14.90%,COASY;ACAT1;PANK2
prerank,coenzyme A biosynthetic process (GO:0015937),0.2819439480269754,0.610423837957112,0.8919354838709678,1.0,1.0,3/11,14.90%,COASY;ACAT1;PANK2
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.2819439480269754,0.610423837957112,0.8919354838709678,1.0,1.0,3/11,14.90%,COASY;ACAT1;PANK2
prerank,ribonucleoprotein complex assembly (GO:0022618),0.1876373887433369,0.6096250966804599,0.978675645342312,1.0,1.0,13/132,11.37%,RPSA;SF3B1;CELF1;ZRSR2;SNRPF;SMN1;SRPK1;RBM5;NAF1;CELF2;CELF4;SRPK2;LUC7L2
prerank,DNA methylation or demethylation (GO:0044728),0.25619915228394047,0.6094466636188255,0.9077901430842608,1.0,1.0,3/19,13.73%,BEND3;TEX15;BAZ2A
prerank,DNA alkylation (GO:0006305),0.25619915228394047,0.6094466636188255,0.9077901430842608,1.0,1.0,3/19,13.73%,BEND3;TEX15;BAZ2A
prerank,sensory perception (GO:0007600),0.22009141339127253,0.608815790690529,0.9587912087912088,1.0,1.0,7/45,14.13%,SCN10A;ALOXE3;GNAL;MME;TMEM150C;TRPV2;KCNK4
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.25004853117162856,0.6076587349252094,0.9170812603648425,1.0,1.0,1/18,2.87%,GPLD1
prerank,gene silencing by miRNA (GO:0035195),0.22842539617542856,0.6074970768022249,0.9421128798842258,1.0,1.0,11/32,21.09%,AGO1;CNOT7;DICER1;PUM2;RAN;SPOUT1;PRKRA;XPO5;CNOT8;CNOT1;PUM1
prerank,stress granule assembly (GO:0034063),0.24834733217992694,0.6073196962495417,0.9227129337539433,1.0,1.0,4/20,13.47%,ATXN2;UBAP2L;CSDE1;DDX6
prerank,negative regulation of ion transport (GO:0043271),-0.20018875062081048,-0.6069705020085387,0.9734513274336283,0.9891392390576174,1.0,14/24,43.34%,ACTN2;PXK;NOS1;PLN;WNK1;GPM6B;WNK2;STC1;LILRB1;SNCA;HTR1B;CD33;HRH3;VIP
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),-0.23123814984725208,-0.6065228449952962,0.9543010752688172,0.9886320857028226,1.0,3/15,11.97%,CCT7;RUVBL1;CCT8
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.2708993222343062,0.6063955013180509,0.9200680272108843,1.0,1.0,4/13,22.05%,SPI1;ARID1B;SERTAD2;ARID1A
prerank,hyaluronan metabolic process (GO:0030212),0.24214936040708585,0.6063672270739754,0.923896499238965,1.0,1.0,5/23,17.28%,HEXA;CEMIP2;HEXB;CEMIP;CHP1
prerank,intracellular sterol transport (GO:0032366),0.27418901925186945,0.6054826205163872,0.9194630872483222,1.0,1.0,7/13,25.83%,ABCA1;OSBPL2;STAR;NPC1;RELCH;NPC2;STARD4
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.199344083920811,0.6054145823861841,0.9829476248477467,1.0,1.0,18/84,19.86%,FXR2;GIGYF2;EIF2AK3;CNOT10;SAMD4B;PUS7;IGF2BP2;CNOT7;ILF3;DDX6;FXR1;RTN4;SYNCRIP;CPEB3;CNOT8;CHRNA7;CNOT1;PIN1
prerank,protein methylation (GO:0006479),0.2197968295653526,0.6051664978258633,0.9526542324246772,1.0,1.0,12/40,25.75%,ETF1;ATPSCKMT;LCMT1;METTL22;PRMT6;CAMKMT;ICMT;ETFBKMT;VCPKMT;EEF2KMT;PRMT8;PRMT3
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.2056179185703545,-0.6050227973614724,0.9666666666666667,0.9885857983898743,1.0,10/23,35.88%,RBX1;XPA;COPS6;GPS1;PARP1;UBB;DDB1;COPS8;UBC;RPS27A
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.2807725820689618,0.6049922454563039,0.9132743362831859,1.0,1.0,1/11,4.28%,HAT1
prerank,negative regulation of translational initiation (GO:0045947),-0.2354990907372182,-0.6045426775449144,0.9312039312039312,0.9880815481344396,1.0,2/13,10.11%,PAIP2;EIF2AK4
prerank,phosphatidylglycerol metabolic process (GO:0046471),0.23917561274185212,0.6045273295163052,0.9262048192771084,1.0,1.0,3/24,13.04%,SLC27A1;CDS2;PNPLA8
prerank,nucleoside salvage (GO:0043174),0.2876639240146583,0.604383462992853,0.8929765886287625,1.0,1.0,1/10,4.03%,UPP2
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),-0.1977925756932783,-0.6043726614792357,0.9791044776119403,0.9874337580270561,1.0,11/25,32.44%,HSPA8;DNAJB5;SDF2;BAG1;HSPA1A;HSPA14;PTGES3;HSPA1B;DNAJB1;HSPA2;SDF2L1
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.26639577461703245,0.6041917716002166,0.9071661237785016,1.0,1.0,2/15,10.61%,GPLD1;ADRA2A
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.18580369664059732,0.6036936403990568,0.9895833333333334,1.0,1.0,37/148,21.91%,PRR5;PPP1R13B;CHD3;PRKAG1;PIP4K2B;TAF10;HIPK1;TAF4B;RFC3;NBN;CCNG1;MAPKAP1;POU4F1;HDAC2;HEXIM1;SGK1;TAF15;TAF5;BRIP1;CSNK2A2;RHNO1;DYRK2;TTC5;PDPK1;MRE11;ATR;PIN1;KMT5A;RBBP4;TAF2;RRS1;RAD9A;TAF9B;PPP2R5C;DAXX;RPA3;RBBP7
prerank,phagosome maturation (GO:0090382),-0.17872307332014556,-0.6031687856347666,0.9756944444444444,0.9872596482976711,1.0,9/35,24.04%,ATP6V0A4;ATP6V0C;ATP6V1C1;ATP6V1D;RAB32;ATP6V1F;ATP6V1E1;RAB7A;RAB38
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),-0.212572088022864,-0.6028158728940087,0.9505208333333334,0.9867029893752292,1.0,3/18,9.31%,NPHP3;RFX3;SPEF2
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.20847628545323127,0.6027905353594493,0.9498018494055482,1.0,1.0,14/55,18.81%,PSME3;PSMB5;USP47;FHL1;PSMA6;PSMB2;PSMA2;PSMD13;PSMA7;PSME4;PSMD12;PSMD14;PSMB6;PSMC4
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.19007512315250727,-0.6023564936481665,0.9832775919732442,0.9861778458023163,1.0,8/29,20.58%,RBX1;MNAT1;ERCC2;XPA;CCNH;GTF2H4;PARP1;ERCC5
prerank,rRNA 3'-end processing (GO:0031125),-0.2513296624241762,-0.6019630731728854,0.9377880184331797,0.9856364731446695,1.0,3/10,20.83%,RPS21;EXOSC3;ERI3
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.2589160409552275,0.6015175458981339,0.9219512195121952,1.0,1.0,2/16,9.38%,PIGB;PIGA
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.22914076706825903,0.6011138938551005,0.9480916030534351,1.0,1.0,9/29,22.76%,DCP1B;EXOSC5;CNOT7;DDX6;CNOT8;LSM3;EXOSC7;DCPS;LSM2
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),-0.2447364824565078,-0.6010724562066646,0.9456264775413712,0.9853315521956976,1.0,4/10,28.77%,SSBP1;CDC7;WIZ;E2F7
prerank,regulation of response to stress (GO:0080134),0.2838054925973388,0.6005974197556431,0.9143897996357013,1.0,1.0,1/10,3.26%,SLC38A2
prerank,positive regulation of osteoclast differentiation (GO:0045672),-0.22873097757926314,-0.6002738952943506,0.9489247311827957,0.9849726927128301,1.0,2/14,15.93%,TRAF6;CSF1
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),0.2838671706611324,0.5989372140851297,0.9159369527145359,1.0,1.0,3/10,20.54%,WRAP53;CCT2;CCT3
prerank,positive regulation of chromatin organization (GO:1905269),-0.23480962109337755,-0.5987986421000033,0.9260969976905312,0.9849277921952821,1.0,4/12,29.85%,UBE2N;TAL1;ACD;TINF2
prerank,negative regulation of transforming growth factor beta production (GO:0071635),0.2859918173649866,0.5981017566462437,0.9056603773584906,1.0,1.0,3/10,18.59%,FN1;LAPTM4B;CDH3
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.19937673067512257,0.5977043601908532,0.9713930348258707,1.0,1.0,17/70,18.81%,PSME3;TAPBP;PSMB5;LNPEP;VAMP8;PSMA6;PSMB2;PSMA2;PSMD13;PSMA7;PSME4;CYBB;PSMD12;PSMD14;PSMB6;SNAP23;PSMC4
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.2755039113473131,0.5972265703426212,0.9087779690189329,1.0,1.0,3/12,19.04%,CACNA1H;STARD3;STAR
prerank,establishment of vesicle localization (GO:0051650),0.25270340888031556,0.5971954148051518,0.9031746031746032,1.0,1.0,5/18,19.75%,LIMK2;KIF5A;KIF5B;TMEM230;SPG11
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),0.28209550149553386,0.5969959680354529,0.9083191850594228,1.0,1.0,5/10,26.62%,AP2A2;AP2S1;MYLIP;CLTA;VLDLR
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),0.28209550149553386,0.5969959680354529,0.9083191850594228,1.0,1.0,5/10,26.62%,AP2A2;AP2S1;MYLIP;CLTA;VLDLR
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.2722259244794081,0.5968566672146663,0.9003436426116839,1.0,1.0,4/11,24.09%,CREB3L1;DDIT3;MBTPS2;HSPA5
prerank,positive regulation of neuroblast proliferation (GO:0002052),0.2799646964333589,0.5954423959065211,0.895870736086176,1.0,1.0,4/10,27.00%,FZD3;CX3CL1;CX3CR1;SMARCD3
prerank,COPII-coated vesicle cargo loading (GO:0090110),-0.22677368736033637,-0.5953952803667754,0.941747572815534,0.9858666288924433,1.0,4/14,26.53%,SCAP;SEC23A;SEC31A;SEC31B
prerank,regulation of response to oxidative stress (GO:1902882),0.2759279859111916,0.5953910631193867,0.8973913043478261,1.0,1.0,4/11,21.16%,ABCD1;AIFM2;PINK1;PRKN
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.2245697433807888,-0.5952411953105916,0.9493087557603687,0.9851926926101852,1.0,3/13,12.16%,SEC16A;SEC16B;SAR1B
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.25283693312800787,0.5952300095315147,0.9286926994906621,1.0,1.0,3/16,16.29%,DND1;ZFP36L2;CPEB3
prerank,homologous chromosome segregation (GO:0045143),-0.20236708427495737,-0.5952227030443874,0.9786666666666667,0.9844629958542117,1.0,15/20,50.43%,TERB1;PTTG1;CENPC;FANCD2;ZCWPW1;SGO1;MAJIN;MEIOB;IHO1;PRDM9;FMN2;RNF212B;MEIKIN;ANKRD31;TERB2
prerank,regulation of lipid catabolic process (GO:0050994),0.2470896287344895,0.5949761322569375,0.9146537842190016,1.0,1.0,4/19,21.65%,ADRA2A;ABCD1;TYSND1;ALK
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.2758911290785543,0.593574068673245,0.921875,1.0,1.0,3/11,20.54%,WRAP53;CCT2;CCT3
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.2434844903599174,0.5931532184440029,0.9202453987730062,1.0,1.0,5/20,19.19%,CELF1;AGO1;CNOT7;CNOT8;CNOT1
prerank,histone lysine methylation (GO:0034968),0.21918299468591904,0.5931408724303947,0.9559659090909091,1.0,1.0,8/33,21.06%,KMT2A;SUV39H1;MEN1;KMT2D;DYDC2;SUV39H2;ASH2L;SETDB1
prerank,water transport (GO:0006833),-0.23998333896377014,-0.5929714820664336,0.9527363184079602,0.9847573358766104,1.0,3/12,32.14%,AQP11;AQP4;PDPN
prerank,termination of RNA polymerase I transcription (GO:0006363),0.2201805926100902,0.592451931263306,0.9399141630901288,1.0,1.0,3/30,6.57%,CAVIN1;POLR1E;CDK7
prerank,peptidyl-lysine methylation (GO:0018022),0.22868236705197326,0.5892221859034406,0.9469578783151326,1.0,1.0,8/26,22.59%,SUV39H1;ATPSCKMT;SETD2;SUV39H2;KMT5A;ETFBKMT;VCPKMT;EEF2KMT
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),0.25972603357680596,0.5885230979358002,0.9282051282051282,1.0,1.0,4/14,23.25%,TUT1;ERN1;NUDT21;CPSF2
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.2774468216837463,0.5885111656751085,0.8900900900900901,1.0,1.0,2/10,18.81%,HMGB1;PSMC4
prerank,fatty acid metabolic process (GO:0006631),0.18423648858898933,0.5864479663870877,0.9939613526570048,1.0,1.0,16/115,16.79%,PPARGC1A;CEL;ALOXE3;PEX2;ACACA;SLC27A4;ACSF2;ACOT8;ACOT2;MSMO1;PNPLA8;AASDH;GGT1;LPL;PPARG;HPGD
prerank,nucleotide-excision repair (GO:0006289),0.18351765753288343,0.5858770503031693,0.986904761904762,1.0,1.0,20/101,18.12%,SLC30A9;FANCC;RFC3;PPIE;CDK7;ERCC6;ERCC1;CETN2;GTF2H1;POLB;COPS5;POLE;DDB2;BRIP1;TCEA1;CHD1L;USP45;CUL4B;RFC1;GTF2H3
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.22080875686929832,0.5856244289280425,0.9468085106382979,1.0,1.0,1/27,1.43%,AK5
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.25729675583709016,0.5832747545641993,0.9282371294851794,1.0,1.0,2/15,9.74%,IL17RA;TICAM1
prerank,modulation by symbiont of host process (GO:0044003),-0.24188787041678886,-0.5830999723627905,0.9174528301886793,0.9883089563128643,1.0,1/10,4.57%,B2M
prerank,positive regulation of interferon-beta production (GO:0032728),0.21691720986354887,0.5827720657522042,0.9598811292719168,1.0,1.0,10/33,24.75%,TLR7;POLR3G;POLR3D;TBK1;OAS2;DHX9;DHX58;IFIH1;POLR3C;RIPK2
prerank,cranial nerve development (GO:0021545),-0.23864532434627272,-0.5823543716932704,0.9591836734693877,0.9878922504558129,1.0,4/11,23.37%,CHD7;TMEM126A;SALL1;ERBB3
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.256269919847543,0.5818415804909586,0.9275123558484349,1.0,1.0,3/13,13.38%,TPR;GEN1;LCMT1
prerank,regulation of protein sumoylation (GO:0033233),0.243195420346937,0.5811216285900553,0.9389067524115756,1.0,1.0,6/17,24.81%,HDAC4;EGR1;GNL3L;MUL1;SAE1;PIAS1
prerank,double-strand break repair via homologous recombination (GO:0000724),0.18775900647731497,0.5808268073396715,0.9916167664670659,1.0,1.0,19/95,19.33%,SMC5;NBN;PALB2;SWI5;GINS4;ZSWIM7;ZFYVE26;INO80;GEN1;NUCKS1;RFWD3;SFPQ;RAD51AP2;REV3L;RECQL5;REC8;SFR1;PSMD14;MRE11
prerank,cellular response to topologically incorrect protein (GO:0035967),0.2192495625771999,0.5803718637819971,0.9476047904191617,1.0,1.0,10/31,25.59%,BAG3;HDAC6;ERN1;BAX;UBE2W;PRKN;DAXX;HSPA9;HSPA5;STUB1
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.26294718437352604,0.580237701509118,0.9226713532513181,1.0,1.0,1/12,4.02%,PRKCA
prerank,response to growth factor (GO:0070848),0.2082566594799057,0.5798400458698209,0.9571823204419889,1.0,1.0,8/41,16.01%,BMPR1B;IBSP;ACVR1C;MAPK7;HDAC6;EMD;HTRA2;ERBB2
prerank,cellular response to corticosteroid stimulus (GO:0071384),-0.21165784811381985,-0.5784116587534245,0.9559585492227979,0.9887046390759398,1.0,2/15,7.85%,BCL2L11;ANXA1
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.23835912578655202,0.5775902945388732,0.9561688311688312,1.0,1.0,4/18,18.08%,RFC3;GINS4;POLE;GINS3
prerank,P-body assembly (GO:0033962),-0.22845576521276603,-0.5761941220387834,0.9418604651162791,0.9888361821991162,1.0,7/12,36.48%,EDC3;RC3H1;LIMD1;LSM4;DYNC1H1;EIF4ENIF1;PATL2
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.22742705318915743,0.5750809577469204,0.9503012048192772,1.0,1.0,7/27,21.09%,EGFR;DDX6;FXR1;PUM2;DHX9;IL6;PUM1
prerank,positive regulation of type 2 immune response (GO:0002830),-0.21541938696485494,-0.5748013002052246,0.9733656174334141,0.9886233316447912,1.0,4/14,23.14%,IL18;PRKCZ;RSAD2;NOD2
prerank,tRNA 5'-end processing (GO:0099116),0.25139021173139503,0.5730921854570189,0.9320388349514563,1.0,1.0,6/15,24.83%,POP4;POP7;RPP14;RPP21;RPP30;PRORP
prerank,cellular response to unfolded protein (GO:0034620),-0.189415833179986,-0.5729770628643168,0.9859943977591037,0.9885692818243985,1.0,12/26,36.07%,HSPA8;HSF1;ABCB10;TMBIM6;OPTN;HSPA1A;HSPA14;HSPA1B;HSPD1;HSPA2;PACRG;DAB2IP
prerank,insulin secretion (GO:0030073),0.23707315458317657,0.5702389143068182,0.9367909238249594,1.0,1.0,4/19,18.98%,RIMS2;RAB11FIP5;CAMK2G;RAB11FIP2
prerank,regulation of mitotic sister chromatid separation (GO:0010965),-0.21186609637026416,-0.5693772937748652,0.9554317548746518,0.9891369679259909,1.0,5/15,24.95%,HECW2;ANAPC1;PTTG1;CENPE;TACC3
prerank,replication fork processing (GO:0031297),0.20749646231766652,0.5691056801419236,0.9615384615384616,1.0,1.0,16/38,28.78%,BOD1L1;GEN1;NUCKS1;RFWD3;ETAA1;EME2;FAM111A;MRE11;ATR;DDX11;PRIMPOL;FBH1;ATRX;FANCM;BRCA2;DNA2
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),0.2715596470500453,0.5677032354328108,0.924956369982548,1.0,1.0,1/10,4.37%,DIP2A
prerank,regulation of interferon-alpha production (GO:0032647),0.22646104993308014,0.567589491110202,0.953416149068323,1.0,1.0,6/23,24.75%,TLR7;TBK1;SETD2;DHX9;IFIH1;RIPK2
prerank,lipid droplet formation (GO:0140042),-0.2366423414399588,-0.5675528416519717,0.9552572706935123,0.9890969230951412,1.0,5/10,35.91%,FITM2;AUP1;BSCL2;SQLE;CDS1
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.21448444060534927,0.5665542314052211,0.9727793696275072,1.0,1.0,7/31,19.86%,AXIN1;CDC20;PTEN;FZR1;FBXW7;PINK1;PIN1
prerank,histone monoubiquitination (GO:0010390),0.22291216609783132,0.5651070997153042,0.9523809523809523,1.0,1.0,8/24,23.27%,LEO1;PAF1;DDB2;CUL4B;CDC73;PCGF1;DTX3L;RNF20
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.2405442694353645,0.5643349394584602,0.9419568822553898,1.0,1.0,7/16,26.13%,NAA35;CREBBP;NAA10;NAA40;NAA60;NAA30;NAA20
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.1883687673974546,0.5633005238280655,0.9874843554443054,1.0,1.0,16/67,18.81%,PSME3;TAPBP;PSMB5;VAMP8;PSMA6;PSMB2;PSMA2;PSMD13;PSMA7;PSME4;CYBB;PSMD12;PSMD14;PSMB6;SNAP23;PSMC4
prerank,organelle transport along microtubule (GO:0072384),0.20776397422422965,0.5620645346986948,0.9697406340057637,1.0,1.0,8/31,22.73%,PAFAH1B1;NDE1;COPG1;KIF5B;HTT;FBXW11;DYNC1I1;RHOT2
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.23484508228430803,0.56197117906083,0.9573820395738204,1.0,1.0,5/18,20.54%,NAF1;EXOSC10;CCT2;RUVBL2;CCT3
prerank,DNA replication (GO:0006260),0.17634873888307584,0.5612280334696381,0.992831541218638,1.0,1.0,29/105,23.06%,RFC3;ORC5;NBN;PTMS;ORC3;TOP1;CDK2AP1;CDC6;DONSON;POLG2;POLB;REV3L;RECQL5;FAM111A;POLE;BRIP1;RHNO1;RFC1;ORC6;NAP1L1;ORC1;MRE11;ATR;RPAIN;RAD9A;RPA3;HELB;POLE2;MCM4
prerank,DNA biosynthetic process (GO:0071897),-0.20115750645616692,-0.5603296089279399,0.9533678756476683,0.9908913506560685,1.0,6/16,35.29%,WRN;POLA1;POLD2;CDKN2D;POLL;TYMS
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.2066455150893925,0.5594716762652664,0.9631205673758865,1.0,1.0,3/32,6.57%,CAVIN1;POLR1E;CDK7
prerank,regulation of RNA export from nucleus (GO:0046831),0.25996381034158356,0.5584819368137002,0.9180327868852459,1.0,1.0,5/11,23.83%,TPR;NUP153;SETD2;DHX9;IWS1
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.25506079784272423,0.5580694098516906,0.9028662420382165,1.0,1.0,4/12,21.59%,HOOK3;PCM1;CCDC120;CEP19
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.24342258211295,0.5571882912568631,0.9384615384615385,1.0,1.0,2/14,8.82%,PES1;RPL35
prerank,protein deneddylation (GO:0000338),-0.2338823905552035,-0.5567244752324679,0.9651416122004357,0.9913400385173394,1.0,4/10,31.55%,COPS6;GPS1;COPS8;TOR1A
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.20568877531186336,0.5562588027908142,0.9839883551673945,1.0,1.0,12/33,27.96%,STN1;WRAP53;TNKS1BP1;PPP6R3;TERF2;RFC1;MRE11;PPP6C;RAD50;RPA1;TERF2IP;SHQ1
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.21103373492529487,0.5558446970623031,0.9733333333333334,1.0,1.0,2/29,7.40%,AXIN1;FBXO5
prerank,positive regulation of TOR signaling (GO:0032008),0.20207833561322175,0.5556752749946677,0.9788434414668548,1.0,1.0,14/40,24.72%,WDR24;MIOS;SIK3;KLHL22;RRAGB;GPR137C;HDAC3;LAMTOR5;RPTOR;WDR59;GOLPH3;SEC13;RRAGA;CLEC16A
prerank,positive regulation of cardiocyte differentiation (GO:1905209),-0.2281797623443121,-0.5545729812387882,0.9722863741339491,0.9912656812862596,1.0,4/11,24.50%,TGFB2;MYOCD;DHX36;GREM1
prerank,regulation of leukocyte migration (GO:0002685),0.2316510568274777,0.5543130743029617,0.9503205128205128,1.0,1.0,2/16,12.82%,RAC2;CD81
prerank,resolution of meiotic recombination intermediates (GO:0000712),-0.19891842517775404,-0.5528787309564002,0.9761273209549072,0.9910504496045679,1.0,11/16,45.67%,MUS81;ERCC4;TOP2A;TOP2B;CENPX;RMI1;MEIOB;MSH4;EME1;SHOC1;CENPS
prerank,regulation of nervous system development (GO:0051960),0.20390031133197906,0.5521969630653752,0.9760900140646976,1.0,1.0,9/37,22.39%,HEYL;BHLHE40;DOCK7;NSUN5;YAP1;GBX1;CX3CL1;CX3CR1;SIRT2
prerank,protein targeting to mitochondrion (GO:0006626),0.1904912568523172,0.5509585687673173,0.9817415730337079,1.0,1.0,9/52,20.04%,TOMM34;MFN2;FIS1;IMMP2L;TOMM40;MIPEP;HSPA4;DNAJC19;GRPEL2
prerank,protein localization to kinetochore (GO:0034501),0.2430797438541517,0.5505488700610557,0.9423728813559322,1.0,1.0,3/14,14.80%,BUB3;ZWILCH;ZW10
prerank,positive regulation of lipid catabolic process (GO:0050996),0.22872261634911484,0.5499409827832884,0.9534510433386838,1.0,1.0,6/19,24.91%,ABCD1;IRS2;AKT2;TWIST1;PRKCD;DAGLB
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.20873838872646147,0.5496382870695832,0.9575113808801214,1.0,1.0,11/29,27.96%,WRAP53;TNKS1BP1;PPP6R3;TERF2;RFC1;MRE11;PPP6C;RAD50;RPA1;TERF2IP;SHQ1
prerank,telomere maintenance via telomerase (GO:0007004),0.20907459210415263,0.5485716342106972,0.9651515151515152,1.0,1.0,11/28,27.96%,WRAP53;TNKS1BP1;PPP6R3;TERF2;RFC1;MRE11;PPP6C;RAD50;RPA1;TERF2IP;SHQ1
prerank,central nervous system neuron axonogenesis (GO:0021955),0.25384960146199065,0.5483802613658925,0.9419152276295133,1.0,1.0,2/12,12.65%,EPHB2;PTEN
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),-0.2097875192720017,-0.5481109063640045,0.9788235294117648,0.991810800362591,1.0,4/13,22.67%,NCBP1;CPSF1;CPSF7;CPSF6
prerank,production of siRNA involved in RNA interference (GO:0030422),0.2574466969821666,0.5478294114279003,0.9369676320272572,1.0,1.0,3/10,16.96%,DICER1;TSNAX;PRKRA
prerank,protein localization to chromatin (GO:0071168),0.23129201604563293,0.5468264407258522,0.9385826771653544,1.0,1.0,4/18,18.66%,MSH2;PPHLN1;LEMD2;RUVBL2
prerank,regulation of protein targeting to membrane (GO:0090313),0.2084452862488378,0.5456785342851218,0.9753265602322206,1.0,1.0,6/28,17.28%,FIS1;GDI1;MIEF1;ERBB2;CEMIP;CHP1
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.23618232468126127,0.545468614905769,0.9502487562189055,1.0,1.0,5/14,21.47%,ABCD1;TYSND1;IRS2;AKT2;TWIST1
prerank,cytoplasmic translational initiation (GO:0002183),0.23073997952344844,0.5443213277373822,0.9530516431924883,1.0,1.0,1/17,3.53%,EIF2B3
prerank,peptidyl-lysine monomethylation (GO:0018026),-0.23171387534574917,-0.5435918252215378,0.975,0.992345445623548,1.0,5/10,37.02%,SMYD2;SETD6;METTL18;SETD7;EHMT1
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.2466883787995164,0.5432876167795591,0.9446366782006921,1.0,1.0,4/13,25.19%,ALG9;DPAGT1;ALG12;ALG14
prerank,protein auto-ADP-ribosylation (GO:0070213),0.24591695515923045,0.5419554469188063,0.9393939393939394,1.0,1.0,3/12,12.98%,PARP11;PARP6;PARP8
prerank,'de novo' posttranslational protein folding (GO:0051084),-0.16812103290275862,-0.5414908102041952,0.9907120743034056,0.9922420911136738,1.0,12/30,32.44%,HSPA8;ENTPD5;DNAJB5;SDF2;BAG1;HSPA1A;HSPA14;PTGES3;HSPA1B;DNAJB1;HSPA2;SDF2L1
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.25088652643934695,0.5402821366262195,0.9554794520547946,1.0,1.0,4/13,24.09%,DDRGK1;WFS1;NCK1;HSPA5
prerank,RNA biosynthetic process (GO:0032774),0.2028568939681397,0.5392104759259176,0.9641319942611191,1.0,1.0,5/31,15.56%,TAF10;SMN1;NAT14;BRF2;TAF5
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.2076447577058501,-0.53642571627612,0.9666666666666667,0.9928467366410241,1.0,3/13,17.05%,PABPC1;TNRC6C;ZFP36
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",-0.1761875796197267,-0.5361842081489016,0.9889196675900277,0.9921763045842305,1.0,7/24,21.49%,JARID2;BMI1;SUZ12;DNMT3B;EED;TASOR;DNMT3A
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",-0.19749850041039424,-0.5356190471750294,0.9794871794871794,0.9915845679041678,1.0,9/16,34.23%,CACTIN;SRSF1;WBP4;WBP11;DDX23;SNRPC;SART1;CWC15;NCBP2
prerank,cell differentiation in hindbrain (GO:0021533),0.24700632579848522,0.535386573800183,0.9496753246753247,1.0,1.0,1/11,3.53%,OPHN1
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.2454962023727324,0.5343866797815512,0.9407665505226481,1.0,1.0,11/11,75.47%,RTP3;RTP2;TAS1R3;PIGR;GNAT2;GNAT3;TAS1R2;LPO;RTP4;PKD1L3;PKD2L1
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.21541748369653796,0.5342446020979126,0.9515625,1.0,1.0,6/22,24.77%,PPM1A;DUSP8;PPP1CA;PPP2CA;PPM1E;DUSP6
prerank,transcription by RNA polymerase III (GO:0006383),0.2087848670467694,0.5340872949496891,0.9715994020926756,1.0,1.0,8/27,23.60%,GTF3C6;POLR3G;ELL;GTF3C5;CRCP;ICE2;SNAPC3;POLR3K
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),0.22834950233386436,0.5340244157919852,0.9612277867528272,1.0,1.0,6/18,24.51%,ITGB7;PODXL2;ITGB1;GOLPH3;CX3CR1;ROCK1
prerank,"synaptic transmission, GABAergic (GO:0051932)",0.25176126475833277,0.5334558551315502,0.944954128440367,1.0,1.0,2/10,11.42%,GABRG2;GABRG1
prerank,positive regulation of viral genome replication (GO:0045070),0.20222883014419363,0.5329074085891629,0.9732540861812778,1.0,1.0,4/29,10.97%,PPIE;SRPK1;CNOT7;SRPK2
prerank,positive regulation of T cell differentiation (GO:0045582),0.19907003846776317,0.5307143906221508,0.9854439592430859,1.0,1.0,6/36,16.32%,GLI2;IL4I1;IL7;SOX4;MDK;SOCS1
prerank,phospholipid homeostasis (GO:0055091),0.24156813844990027,0.529424543765416,0.9442567567567568,1.0,1.0,1/11,8.05%,ABCA1
prerank,sulfur amino acid catabolic process (GO:0000098),0.25063261562508365,0.5292644932880535,0.9476439790575916,1.0,1.0,2/10,15.61%,BLMH;TXN2
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.21428189249759824,0.5290560788217831,0.9818731117824774,1.0,1.0,6/22,18.12%,CETN2;GTF2H1;DDB2;CHD1L;CUL4B;GTF2H3
prerank,acylglycerol catabolic process (GO:0046464),0.20508813204081322,0.5285889899369338,0.9794721407624634,1.0,1.0,5/30,19.93%,ABHD12;LIPE;LPL;LYPLA2;FAAH
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),0.25006380401980033,0.5282179130952792,0.9498269896193772,1.0,1.0,1/10,6.30%,SIRT3
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),0.25006380401980033,0.5282179130952792,0.9498269896193772,1.0,1.0,1/10,6.30%,SIRT3
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.24274323460263542,0.5275984035739519,0.9585406301824212,1.0,1.0,3/12,15.86%,CDC20;PTEN;FZR1
prerank,skeletal muscle contraction (GO:0003009),0.22139949722745278,0.5267564115614175,0.9592169657422512,1.0,1.0,3/19,17.26%,TNNI1;TNNI3;RCSD1
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.22615391227405718,0.5260099171301972,0.9648829431438127,1.0,1.0,8/15,31.23%,CNOT7;CPEB3;CNOT1;TENT4B;AGO2;TENT4A;POLR2G;TOB1
prerank,inorganic ion transmembrane transport (GO:0098660),0.2373041759907122,0.5244042883118955,0.9597902097902098,1.0,1.0,1/12,4.85%,CACNA1H
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.24129351068915894,0.5242081295010841,0.9473684210526315,1.0,1.0,4/11,24.20%,OCRL;PTEN;INPP1;SYNJ2
prerank,inositol phosphate dephosphorylation (GO:0046855),0.24129351068915894,0.5242081295010841,0.9473684210526315,1.0,1.0,4/11,24.20%,OCRL;PTEN;INPP1;SYNJ2
prerank,regulation of double-strand break repair (GO:2000779),0.1858697900576429,0.5240243288563844,0.9914285714285714,1.0,1.0,10/39,22.92%,UBR5;OTUB2;WRAP53;SIRT7;MGMT;PPP4C;SETD2;DDX11;TWIST1;SPIDR
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),-0.2037481174189005,-0.5215390558009256,0.9622166246851386,0.9942846102404534,1.0,2/13,15.47%,LRRK2;OPA1
prerank,response to peptide (GO:1901652),0.1967458353406385,0.5213440911038325,0.9885714285714285,1.0,1.0,4/33,12.27%,EIF2B3;MMP12;EIF2B4;STAT2
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.1964762818409459,0.5198314564602242,0.9884559884559885,1.0,1.0,6/32,22.82%,NEK7;NAF1;CCT2;ATR;CCT3;MAPK1
prerank,phagosome-lysosome fusion (GO:0090385),0.24700986239221506,0.5194936673696412,0.9552772808586762,1.0,1.0,3/10,19.16%,ARL8B;RAB34;RAB39A
prerank,pyroptosis (GO:0070269),0.2240844814346591,0.5189457146810539,0.9728434504792333,1.0,1.0,3/15,19.61%,NLRC4;GSDMD;DHX9
prerank,steroid catabolic process (GO:0006706),0.2469244288224957,0.5185979253068045,0.9404761904761905,1.0,1.0,10/10,75.32%,HSD11B1;HSD17B11;SPP1;HSD17B6;CYP19A1;CYP27B1;FGF23;CYP24A1;HSD17B14;YWHAH
prerank,histone methylation (GO:0016571),0.20221846997631926,0.5184492758107929,0.9843014128728415,1.0,1.0,5/26,17.85%,SUV39H1;SIRT7;CREBBP;PRMT6;SUV39H2
prerank,regulation of macrophage migration (GO:1905521),0.2463752199531226,0.5183966237070117,0.9398625429553265,0.9999325052256438,1.0,2/10,12.82%,CD200R1;CD81
prerank,negative regulation of interleukin-12 production (GO:0032695),0.22931670893386194,0.5170071320967705,0.9636963696369637,0.9999596341931923,1.0,1/14,4.67%,IRAK3
prerank,T cell differentiation in thymus (GO:0033077),0.2294570217365016,0.5168669096145335,0.9699499165275459,0.9995781601476708,1.0,3/14,18.43%,PTPRC;ZFP36L2;RABL3
prerank,antibacterial humoral response (GO:0019731),0.22146176064297365,0.516671636890215,0.9719934102141681,0.9992145927275851,1.0,16/16,77.88%,DEFA6;RNASE3;ANG;WFDC2;DMBT1;PLA2G1B;RNASE7;LTF;DEFB1;WFDC3;RNASE6;CAMP;JCHAIN;SLPI;PLA2G6;RPL39
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),-0.1890682007064435,-0.5138859181650796,0.9876847290640394,0.9952271304255254,1.0,7/16,29.85%,PINX1;DHX36;PARP1;ERCC4;TNKS2;ATM;TINF2
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.21514318266073518,0.513354435588889,0.9806138933764136,0.9997992183936082,1.0,7/17,25.27%,DYRK1A;YJU2;PRKN;TWIST1;MDM2;PTTG1IP;SNAI1
prerank,negative regulation of interferon-beta production (GO:0032688),0.24910183928540447,0.513135592720746,0.9535283993115319,0.9994386603484547,1.0,1/10,4.24%,REL
prerank,detection of calcium ion (GO:0005513),-0.19951158523383303,-0.5130086573313147,0.9812646370023419,0.994658620123171,1.0,8/13,48.11%,CALM1;CALM3;SYT1;RYR2;KCNMB2;KCNMB1;CASR;KCNIP2
prerank,regulation of tau-protein kinase activity (GO:1902947),0.24522959202417602,0.5123834144879197,0.9582577132486388,0.9992308667640314,1.0,1/10,11.47%,EGR1
prerank,error-free translesion synthesis (GO:0070987),0.20453978181770432,0.5116647539139092,0.9764150943396226,0.9990092862811917,1.0,3/22,10.98%,RFC3;NPLOC4;RCHY1
prerank,cholesterol efflux (GO:0033344),0.20814813912696878,0.5110401951536367,0.978328173374613,0.9987643659325798,1.0,2/20,8.05%,SOAT1;ABCA1
prerank,immunoglobulin mediated immune response (GO:0016064),0.2381370826010543,0.5109621295147736,0.9713774597495528,0.9983641984283637,1.0,10/10,76.20%,CD81;ZP3;GAPT;CD19;CARD9;CD74;TLR8;FCER1G;FCGR2B;CD27
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.21861499287753822,0.5091940750741905,0.9716666666666667,0.9979938085350014,1.0,4/15,19.19%,CNOT7;ZFP36L2;CPEB3;CNOT1
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.21861499287753822,0.5091940750741905,0.9716666666666667,0.9979938085350014,1.0,4/15,19.19%,CNOT7;ZFP36L2;CPEB3;CNOT1
prerank,negative regulation of cellular metabolic process (GO:0031324),0.1896002704170229,0.5088844228536881,0.9970887918486172,0.9976637424137367,1.0,8/37,22.39%,NCOR1;AATF;ATXN2;ANKRD13B;PINK1;PRKN;PAX2;SIRT2
prerank,cellular response to radiation (GO:0071478),0.1794775722301029,0.5063283071866473,0.9958041958041958,0.9979614869228507,1.0,9/40,22.92%,OPN1MW;OPN1MW3;SWI5;INO80;TNKS1BP1;RHNO1;GPR52;RAD9A;SPIDR
prerank,regulation of response to interferon-gamma (GO:0060330),0.21409252315438715,0.5052703670003885,0.9589490968801314,0.9978158758166459,1.0,5/14,26.31%,SOCS1;JAK1;SUMO1;PIAS1;PTPN2
prerank,nuclear membrane disassembly (GO:0051081),0.2186691903117044,0.5043531350363468,0.9595959595959596,0.9976421585699976,1.0,1/14,4.02%,PRKCA
prerank,regulation of mast cell degranulation (GO:0043304),0.21610922106263952,0.5038059482130979,0.9790996784565916,0.9973581039508815,1.0,2/14,9.16%,FER;GAB2
prerank,positive regulation of T cell activation (GO:0050870),0.16985866675390357,0.5035446132679644,0.9960988296488946,0.9970003991144063,1.0,13/62,21.75%,FLOT2;PTPRC;NCK2;CD276;IL6ST;IL7;CD81;MDK;IL15;DOCK8;IL6;NCK1;CCDC88B
prerank,endoplasmic reticulum mannose trimming (GO:1904380),0.21364750747968753,0.503205396144144,0.9752321981424149,0.9966656298397703,1.0,8/18,27.66%,AMFR;RNF185;EDEM2;SEL1L;RNF103;MAN1B1;UGGT1;UGGT2
prerank,peptide hormone secretion (GO:0030072),0.1978174030041586,0.5024046302692888,0.9822222222222222,0.9964760190908009,1.0,2/26,7.33%,RIMS2;LTBP4
prerank,positive regulation of immune response (GO:0050778),0.1659635005287247,0.4946284017270831,0.9974093264248705,0.9979592861736709,1.0,9/64,17.29%,PTPRC;POLR3G;PLSCR1;KARS1;IL6ST;POLR3D;CD81;IL15;STX4
prerank,serine family amino acid catabolic process (GO:0009071),-0.19758401900675987,-0.49199507148132465,0.9905437352245863,0.9975736029047627,1.0,5/10,33.84%,CBS;GCSH;THNSL2;SHMT2;SHMT1
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.21107789113469289,0.48860864393171094,0.9800664451827242,0.9989594505414329,1.0,4/15,23.41%,POP7;DICER1;RPP30;RNASEH1
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.19246493519374006,0.4856548509003947,0.9878971255673222,0.9991702920976177,1.0,6/25,18.91%,CIDEB;GPER1;BAD;BNIP3;PINK1;BAX
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.21210475101784654,0.48534217707031135,0.9748743718592965,0.9988230303429932,1.0,1/14,5.41%,CARD10
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.21415139740339792,0.4788241799467733,0.976068376068376,0.9997047245316052,1.0,4/14,24.09%,DDRGK1;COPS5;BAX;HSPA5
prerank,spermatid development (GO:0007286),0.17910781805268033,0.4754088915675719,0.9912663755458515,0.9999434935117439,1.0,6/32,23.05%,TDRD5;IQCG;CEP57;CDYL;DDX25;SYCP3
prerank,lipid droplet organization (GO:0034389),0.19089195979899504,0.4753282098950957,0.9785276073619632,0.9995322322533786,1.0,22/22,80.94%,HILPDA;CDS2;RAB18;RAB3GAP1;PLA2G4C;FAF2;ZFYVE1;PPIA;FITM1;CIDEC;TSPO2;HSD17B13;SMIM22;CIDEA;PLIN5;CDS1;PPID;SQLE;BSCL2;AUP1;FITM2;PNPLA3
prerank,protein homotrimerization (GO:0070207),-0.18020138182941237,-0.46963505205783684,0.9952830188679245,0.9990472811780258,1.0,1/14,3.22%,SCARA5
prerank,protein trimerization (GO:0070206),-0.18020138182941237,-0.46963505205783684,0.9952830188679245,0.9990472811780258,1.0,1/14,3.22%,SCARA5
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.18451094387044367,0.46734771217507315,0.9921507064364207,1.0,1.0,5/24,21.89%,RFC3;POLB;POLE;RFC1;RPA3
prerank,secretory granule organization (GO:0033363),0.2167534169676571,0.4667831647621403,0.9788359788359788,1.0,1.0,1/10,8.05%,ABCA1
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.21520996239132623,0.46667445883746395,0.977112676056338,0.9998107954517065,1.0,1/12,7.99%,GCNT2
prerank,regulation of MHC class II biosynthetic process (GO:0045346),-0.19296412342484642,-0.4648280986025143,0.9910714285714286,0.998842486977572,1.0,3/11,27.79%,JAK2;XBP1;CIITA
prerank,glycine metabolic process (GO:0006544),0.20891399874450717,0.45917383674300977,0.9836867862969005,1.0,1.0,12/12,79.12%,GLDC;DLD;SDSL;SDS;AMT;BAAT;GLYAT;SHMT1;GCAT;SHMT2;GCSH;RIDA
prerank,spliceosomal snRNP assembly (GO:0000387),0.16608409149565684,0.45887040102775356,0.9929278642149929,1.0,1.0,3/38,7.06%,SNRPF;PRPF3;SMN1
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.18935764307997002,0.4564940209728828,0.9937007874015747,1.0,1.0,7/19,25.84%,NAGK;GNPDA2;PMM1;GFPT2;GFPT1;PMM2;AMDHD2
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.190483058476442,0.455946718767535,0.9905956112852664,0.9998497961252171,1.0,3/18,13.69%,ISL1;AQP1;ZFP36L2
prerank,neural crest cell differentiation (GO:0014033),0.1930044713163297,0.45498617023335003,0.9833333333333333,0.9995744518054367,1.0,2/18,11.87%,CDH2;FBXL17
prerank,protein ADP-ribosylation (GO:0006471),0.17850691003659075,0.45443244022925144,0.9954476479514416,0.9992429580487966,1.0,4/28,12.98%,SIRT3;PARP11;PARP6;PARP8
prerank,negative regulation of interleukin-17 production (GO:0032700),0.21817725332663818,0.4543129674773521,0.9854014598540146,0.9988427741128891,1.0,10/10,78.20%,DDIT3;PRNP;VSIR;IFNG;TNFSF4;IL12B;FOXP3;IL12A;TLR4;NCKAP1L
prerank,T cell activation involved in immune response (GO:0002286),-0.1798303594641896,-0.45314840176337495,0.9851116625310173,0.9992151963019671,1.0,10/12,52.45%,EIF2AK4;ICAM1;SLC11A1;LILRB1;FCER1G;CD74;ITGAL;F2RL1;IFNK;TNFSF18
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.18120554760913296,0.4527935424490004,0.9940564635958395,0.9986387104919131,1.0,2/23,9.80%,CRTAM;LAMP1
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",0.18272237561914345,0.4518096728750412,0.9881481481481481,0.998349369241027,1.0,9/22,27.66%,AMFR;RNF185;EDEM2;SEL1L;RNF103;MAN1B1;MAN1C1;UGGT1;UGGT2
prerank,negative regulation of receptor internalization (GO:0002091),0.20914570700218663,0.45002302563789837,0.9858156028368794,0.998170085767803,1.0,2/12,14.90%,ATXN2;ANKRD13B
prerank,ER-associated misfolded protein catabolic process (GO:0071712),-0.18201192353504736,-0.44690191226192605,0.9976190476190476,0.9990404568875801,1.0,5/11,37.34%,VCP;AUP1;TOR1A;POMT2;UFD1
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),-0.19040133947117271,-0.4457064894547576,0.9976580796252927,0.9983883125353277,1.0,6/10,41.83%,AKT1;MYD88;TREM2;TLR6;CD36;TLR4
prerank,positive regulation of superoxide anion generation (GO:0032930),-0.16937660870111118,-0.44043744300101695,0.995085995085995,0.9980603104244288,1.0,13/13,83.08%,MAPT;ITGB2;ITGAM;TGFB1;CRP;GSTP1;F2RL1;CD177;FPR2;TYROBP;SOD1;PRKCD;SYK
prerank,phagolysosome assembly (GO:0001845),0.20063603914634726,0.4387558658226312,0.9965337954939342,0.9991177687213189,1.0,3/12,19.16%,ARL8B;RAB34;RAB39A
prerank,regulation of AMPA receptor activity (GO:2000311),0.17465842200867104,0.4375109174763316,0.9969135802469136,0.9988340956933104,1.0,1/25,2.65%,MINK1
prerank,cell-cell junction maintenance (GO:0045217),-0.17294760204370124,-0.4368156165925434,0.9953271028037384,0.9975622136491195,1.0,5/11,37.54%,MYADM;TJP1;F2R;PRTN3;PARD6A
prerank,positive regulation of lymphocyte migration (GO:2000403),0.20260452341648422,0.43664462952655714,0.9869281045751634,0.9985089893443858,1.0,3/12,18.55%,TNFRSF14;RHOA;DOCK8
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.1885495748053766,0.43297128693399173,0.9966887417218543,0.9984757225812583,1.0,2/14,19.70%,NLRP2B;CCDC3
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.1592718651997614,0.4288063937682176,1.0,0.9984852971802142,1.0,6/35,22.82%,NEK7;NAF1;CCT2;ATR;CCT3;MAPK1
prerank,regulation of lipid storage (GO:0010883),0.17486430858000573,0.42757306379251303,0.9938080495356038,0.9981901891908934,1.0,4/22,20.87%,HILPDA;LPL;FBXW7;IL6
prerank,regulation of superoxide anion generation (GO:0032928),0.18439888114820696,0.4232491510864039,0.9949238578680203,0.9981735800245659,1.0,2/14,16.93%,AATF;SYK
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.19061531090450035,0.41920979335682723,0.9931506849315068,0.9980965712566264,1.0,2/13,21.70%,NEDD4;EPN2
prerank,regulation of chromosome organization (GO:0033044),0.16816226628440284,0.4171439678596696,0.995260663507109,0.9978576761678543,1.0,8/22,27.93%,SHCBP1L;TERF2;HNRNPD;SMG6;CENPV;YLPM1;SMG5;TERF2IP
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.19632226332348496,0.4167610880874989,0.9891500904159132,0.9974790470231951,1.0,4/11,27.66%,SIRT7;DDX11;MTOR;NOL11
prerank,sensory perception of smell (GO:0007608),0.1949680437590856,0.41199752897189124,0.9933884297520661,0.9974470889481657,1.0,10/11,50.45%,ADCY3;UBR3;SLC24A4;OBP2B;GFY;DRD2;OMP;SYT10;BEST2;BBS4
prerank,interleukin-35-mediated signaling pathway (GO:0070757),0.18120326465784395,0.3913650136853303,0.9948364888123924,0.9982614975559531,1.0,2/11,16.55%,IL6ST;JAK1
